Citrus Sinensis ID: 003280
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 834 | 2.2.26 [Sep-21-2011] | |||||||
| O81905 | 850 | Receptor-like serine/thre | yes | no | 0.918 | 0.901 | 0.442 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.944 | 0.930 | 0.439 | 0.0 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.942 | 0.943 | 0.427 | 0.0 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.946 | 0.933 | 0.427 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.944 | 0.934 | 0.435 | 0.0 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.972 | 0.955 | 0.420 | 1e-178 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.906 | 0.965 | 0.420 | 1e-175 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.953 | 0.932 | 0.423 | 1e-171 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.941 | 0.915 | 0.419 | 1e-170 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.972 | 0.963 | 0.405 | 1e-170 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 644 bits (1661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/804 (44%), Positives = 500/804 (62%), Gaps = 38/804 (4%)
Query: 22 SLAADTVTPAS--FIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPD-TVVWVAN 78
S++A+T++ + I +VS FELGFF PG YLGIW++ + T VWVAN
Sbjct: 26 SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85
Query: 79 RDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFS-EVKNP-VAQLRDDGNLVIRDNS 136
RD P+S L IS+ NLV+L+Q++ +WSTN+ +V++P VA+L D+GN V+RD S
Sbjct: 86 RDTPLSSSIGTLKISD-SNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-S 143
Query: 137 SGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKV 196
+ + LWQSFD+PTDTLL MK+GWD K R++ SW+S DDPS G F+ +LE +
Sbjct: 144 KNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEG 203
Query: 197 IPKMCIFNGSVKFACSGQWNGAAFVSAISYTNFLYEQY-LVENQDEISYWYEPFNRPSIM 255
P++ ++N + SG WNG F F Y + +++E++Y +
Sbjct: 204 FPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYS 263
Query: 256 TLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFK 315
L ++ SGLL R W +W+ + P + C +Y CG C + P+C C++GFK
Sbjct: 264 RLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFK 323
Query: 316 LKSKFN---QTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECL 372
++ + G C R C GG F++L ++ PD +++ + +++C +CL
Sbjct: 324 PRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCL 383
Query: 373 KNCTCRAYANSNVT-EGSGCLMWFGDLLDANRPTRNFT--GQSVYIRVPASETGKRKLLW 429
++C C A+AN+++ GSGC+ W G+L D RN+ GQ +Y+R+ A++ ++
Sbjct: 384 RDCNCTAFANTDIRGSGSGCVTWTGELFD----IRNYAKGGQDLYVRLAATDLEDKRNRS 439
Query: 430 ILVI---LVLPLVLLPSFYIFCRRRRNCKEKETENMET---DQDLLAFDINMG---ITTR 480
+I + + ++LL SF IF +R K+K + +ET D L + D+ M I++R
Sbjct: 440 AKIIGSSIGVSVLLLLSFIIFFLWKR--KQKRSILIETPIVDHQLRSRDLLMNEVVISSR 497
Query: 481 TNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEV 540
+ E N D D LPL VA AT NFS KLG+GGFG VYKG+LL+GQE+
Sbjct: 498 RHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEM 551
Query: 541 AVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL 600
AVKRLS S QG +EFKNE+ LIA+LQH NLV+LL CCV+ GEK+LI EY+ N SLD L
Sbjct: 552 AVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHL 611
Query: 601 FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660
FD ++ L WQ R II GIA+GLLYLHQ SRFRIIHRDLKASN+LLD M PKISDFG
Sbjct: 612 FDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFG 671
Query: 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY 720
+AR+FG DE + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +S K+N G Y
Sbjct: 672 MARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFY 731
Query: 721 NAD-SFNLLGYAWDLWKDDKFHELIDPVITQDEISL--PVLVRYINVALLCVQDNAADRP 777
N+D NLLG W WK+ K E+IDP+IT + ++R I + LLCVQ+ A DRP
Sbjct: 732 NSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRP 791
Query: 778 TMSDVVSIINSERLELPSPKEPAF 801
TMS V+ ++ SE +P PK P +
Sbjct: 792 TMSLVILMLGSESTTIPQPKAPGY 815
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 644 bits (1661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/837 (43%), Positives = 509/837 (60%), Gaps = 49/837 (5%)
Query: 27 TVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVP-DTVVWVANRDRPISD 85
+ T + I + ++S SQ FELGFF+P S YLGIW++ +P T VWVANRD P+S
Sbjct: 31 SATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSS 90
Query: 86 HNAVLTISNKGNLVLLNQTNGTIWSTNVFS-EVKNPVA-QLRDDGNLVIRDNSSGNTTES 143
N L IS+ NLV+ +Q++ +WSTN+ +V++PVA +L D GN V+RD S N
Sbjct: 91 SNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD-SKNNKPSG 148
Query: 144 YLWQSFDYPTDTLLQGMKMGWDLKNR-LERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCI 202
+LWQSFD+PTDTLL MKMGWD K+ R L SW++ DDPS G F+++L P+ I
Sbjct: 149 FLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYI 208
Query: 203 FNGSVKFACSGQWNGAAFVSAISYTNFLY-EQYLVENQDEISYWYEPFNRPSIMT-LKLN 260
+N SG W G F S Y + EN ++ Y Y N+ +I + L L+
Sbjct: 209 YNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYR-VNKTNIYSILSLS 267
Query: 261 PSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKF 320
+GLL R W W ++ P + C Y CG C + PIC C++GF+
Sbjct: 268 STGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFE---PM 324
Query: 321 NQTGPIK-----CERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNC 375
N+ ++ C R C G F++L +R PD E ++K + L++C CLK C
Sbjct: 325 NEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGC 384
Query: 376 TCRAYANSNVTEG-SGCLMWFGDLLDANRPTRNFT--GQSVYIRVPASETGKRKLLWILV 432
C A+AN+++ G SGC++W G L D RN+ GQ +Y+RV A + +++ +
Sbjct: 385 NCTAFANTDIRNGGSGCVIWSGGLFD----IRNYAKGGQDLYVRVAAGDLEDKRIKSKKI 440
Query: 433 I---LVLPLVLLPSFYIFCRRRRNCKEKETENMET-------DQDLLAFDINMGITTRTN 482
I + + ++LL SF IF +R K+K + ++T QD L ++ + T+
Sbjct: 441 IGSSIGVSILLLLSFIIFHFWKR--KQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTS 498
Query: 483 EFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAV 542
+ ++K LPL ++A AT NFS KLG+GGFG VYKG LL+G+E+AV
Sbjct: 499 K--------ENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAV 550
Query: 543 KRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD 602
KRLS S QG +EF NE+ LIAKLQH NLV+LLGCCV++GEK+LI EY+ N SLD LFD
Sbjct: 551 KRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFD 610
Query: 603 PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662
T+ L WQ R II GIA+GLLYLHQ SR RIIHRDLKASNVLLD +M PKISDFG+A
Sbjct: 611 QTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMA 670
Query: 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA 722
R+FG +E + NT+R+VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +SGK+N G YN+
Sbjct: 671 RIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNS 730
Query: 723 D-SFNLLGYAWDLWKDDKFHELIDPV---ITQDEISLPVLVRYINVALLCVQDNAADRPT 778
+ NLLG+ W WK+ K E++DP+ E ++R I + LLCVQ+ A DRP
Sbjct: 731 NRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPV 790
Query: 779 MSDVVSIINSERLELPSPKEPAFIKG-INVKNSSHSNDGMSNLCSVNDVTVSLVYPR 834
MS V+ ++ SE +P PK P F G +++ S S+ + C+VN VT+S++ R
Sbjct: 791 MSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 644 bits (1661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/843 (42%), Positives = 508/843 (60%), Gaps = 57/843 (6%)
Query: 23 LAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPD-TVVWVANRDR 81
++ DT+ +RDGE ++S +RF GFFS G S+ RY+GIW+ Q+ T+VWVANRD
Sbjct: 17 ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 82 PISDHNAVLTISNKGNLVLLNQTNGT--IWSTNVFSEVKNP--VAQLRDDGNLVIRDNSS 137
PI+D + ++ SN+GNL + N T IWSTNV + P VA L D GNLV+ D +
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVT 136
Query: 138 GNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVI 197
G + W+SFD+PTDT L M++G+ K+ L+R L+SW+S DP G R+E +
Sbjct: 137 GRS----FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGF 192
Query: 198 PKMCIFNGSVKFACSGQWNGAAFVSAISY-TNFLYEQYLVENQDEISYWYEPFNRPSIMT 256
P++ ++ G + G W G + +++ V N+DE+S+ Y + I
Sbjct: 193 PQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITR 252
Query: 257 LKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTIC-SPDQKPI-CECLEGF 314
+N +G + R W W+ +S P E C Y +CG N C SP K C CL GF
Sbjct: 253 TMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGF 312
Query: 315 KLK---SKFNQTGPIKC-ERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAE 370
+ K F + C ++ +S C F+KL ++ PD + ++ ++ L++C
Sbjct: 313 EPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQR 372
Query: 371 CLKNCTCRAYANS--NVTEGS-GCLMWFGDLLDANRPTRNFTGQSVYIRVPASE------ 421
CLKNC+C AYA++ G+ GCL W G +LDA T +GQ YIRV E
Sbjct: 373 CLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDAR--TYLNSGQDFYIRVDKEELARWNR 430
Query: 422 ---TGKRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGIT 478
+GKR++L IL+ L+ ++LL + +FC R K + + + FD
Sbjct: 431 NGLSGKRRVLLILISLIAAVMLL-TVILFCVVRERRKSNRHRSSSANFAPVPFD------ 483
Query: 479 TRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQ 538
F E +DK ++ LPLF L ++ AAT NFS Q KLG GGFGPVYKG L N
Sbjct: 484 -----FDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRM 538
Query: 539 EVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDV 598
E+AVKRLS SGQG+EEFKNE+ LI+KLQHRNLV++LGCCVE EK+L+ EY+PNKSLD
Sbjct: 539 EIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDY 598
Query: 599 FLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISD 658
F+F ++ L W R+ I+ GIA+G+LYLHQ SR RIIHRDLKASN+LLD +M PKISD
Sbjct: 599 FIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISD 658
Query: 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTG 718
FG+AR+FGG++++G T R+VGT+GYM+PEYA++G FSIKSDV+SFG+LMLE ++GKKN+
Sbjct: 659 FGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSA 718
Query: 719 VYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPT 778
++ +S NL+G+ WDLW++ + E+ID ++ Q+ +++ I + LLCVQ+NA+DR
Sbjct: 719 -FHEESSNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVD 777
Query: 779 MSDVVSIINSERLELPSPKEPAFIKGINVKNSSHSNDGMSNLC-------SVNDVTVSLV 831
MS VV ++ LP+PK PAF S+ G + C SVNDVT S +
Sbjct: 778 MSSVVIMLGHNATNLPNPKHPAF-------TSARRRGGENGACLKGQTGISVNDVTFSDI 830
Query: 832 YPR 834
R
Sbjct: 831 QGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 636 bits (1640), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/843 (42%), Positives = 523/843 (62%), Gaps = 54/843 (6%)
Query: 26 DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPD-TVVWVANRDRPIS 84
+T+ + ++DG+ + S +RF GFFS G SK RY+GIW+ QV + T+VWVANRD PI+
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 85 DHNAVLTISNKGNLVLLNQTNGT--IWSTNVFSEVKNP--VAQLRDDGNLVIRDNSSGNT 140
D + ++ S +GNL + NGT IWST+V ++ P VA+L D GNLV+ D +G +
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTGKS 142
Query: 141 TESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKM 200
W+SF++PT+TLL MK G+ ++ ++R ++SW+S DP G T R+E + P+M
Sbjct: 143 ----FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQM 198
Query: 201 CIFNGSVKFACSGQWNGAAFVSAISYTN-FLYEQYLVENQDEISYWYEPFNRPSIMTLKL 259
++ G + +G W G + TN F++ V N DE+S Y + + L
Sbjct: 199 MMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVL 258
Query: 260 NPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTIC--SPDQKPICECLEGFKLK 317
N +G L R WN W +S P++ C Y +CG N C + +K C CL G++ K
Sbjct: 259 NETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPK 318
Query: 318 SK---FNQTGPIKCERSHS-SECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLK 373
+ F + C R + S C G F KL ++ P+ V ++ ++ L++C CLK
Sbjct: 319 TPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLK 378
Query: 374 NCTCRAYANS---NVTEGSGCLMWFGDLLDANRPTRNF--TGQSVYIRVPASE------- 421
NC+C AYA++ + GCL W G++LD TR + +GQ Y+RV SE
Sbjct: 379 NCSCVAYASAYHESQDGAKGCLTWHGNMLD----TRTYLSSGQDFYLRVDKSELARWNGN 434
Query: 422 --TGKRKLLWILVILV-LPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLA---FDINM 475
+GK++L+ IL+ L+ + ++LL SF+ + R+RR + ++ + A FD+
Sbjct: 435 GASGKKRLVLILISLIAVVMLLLISFHCYLRKRR--QRTQSNRLRKAPSSFAPSSFDLED 492
Query: 476 GITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLL 535
E DK + LPLF L+++A AT NF+ Q KLG GGFGPVYKG L
Sbjct: 493 SFILEELE---------DKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQ 543
Query: 536 NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKS 595
NG E+AVKRLS SGQG+EEFKNE+ LI+KLQHRNLV++LGCCVE EK+L+ EY+PNKS
Sbjct: 544 NGMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKS 603
Query: 596 LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPK 655
LD F+F ++ L W R+ II GI +G+LYLHQ SR RIIHRDLKASNVLLD +M PK
Sbjct: 604 LDYFIFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPK 663
Query: 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
I+DFGLAR+FGG++++G+T R+VGTYGYMSPEYA+DG FSIKSDV+SFG+L+LE ++GK+
Sbjct: 664 IADFGLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKR 723
Query: 716 NTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAAD 775
N+ Y +S NL+ + WD W++ + E+ID ++ ++ +++ +++ LLCVQ+N++D
Sbjct: 724 NSAFYE-ESLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSD 782
Query: 776 RPTMSDVVSIINSERLELPSPKEPAFIKG--INVKNSSHSNDGMSNLCS--VNDVTVSLV 831
RP MS VV ++ ++LPSPK PAF G N K S++ S S +NDVT++ V
Sbjct: 783 RPDMSSVVFMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSSTINDVTLTDV 842
Query: 832 YPR 834
R
Sbjct: 843 QGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 634 bits (1636), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/833 (43%), Positives = 515/833 (61%), Gaps = 45/833 (5%)
Query: 27 TVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVP-DTVVWVANRDRPISD 85
+ T + I + ++S SQ FELGFF+P S YLGIW++ +P T VWVANRD P+S
Sbjct: 31 SATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSS 90
Query: 86 HNAVLTISNKGNLVLLNQTNGTIWSTNVFS-EVKNPVA-QLRDDGNLVIRDNSSGNTTES 143
N L IS NLV+ +Q++ +WSTN+ +V++PVA +L D+GN ++RD+++
Sbjct: 91 SNGTLKISG-NNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSNN-----R 144
Query: 144 YLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIF 203
LWQSFD+PTDTLL MK+GWD K R L SW++ DDPS G+F+++LE P+ I
Sbjct: 145 LLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYIC 204
Query: 204 NGSVKFACSGQWNGAAFVSAISYTNFLYEQY-LVENQDEISYWYEPFNRPSIMT-LKLNP 261
+ SG WNG F S Y Y +++E++Y Y N+ ++ + L LN
Sbjct: 205 SKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYR-INKTNLYSRLYLNS 263
Query: 262 SGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKFN 321
+GLL R W W ++ P + C Y CG C + P C C++GFK ++
Sbjct: 264 AGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNEQA 323
Query: 322 ---QTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCR 378
+ G C R C G F +L ++ PD +++ + L+ C CL++C C
Sbjct: 324 WDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCT 383
Query: 379 AYANSNVTEG-SGCLMWFGDLLDANRPTRNFT--GQSVYIRVPASETGKRKLLWILVI-- 433
A+AN+++ G SGC++W ++LD RN+ GQ +Y+R+ A+E +++ +I
Sbjct: 384 AFANADIRNGGSGCVIWTREILDM----RNYAKGGQDLYVRLAAAELEDKRIKNEKIIGS 439
Query: 434 -LVLPLVLLPSFYIFC---RRRRNCKEKETENMET--DQDLLAFDINMGITTRTNEFGEV 487
+ + ++LL SF IF R+++ +T N++ QD L D+ + T++
Sbjct: 440 SIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSK---- 495
Query: 488 NGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSS 547
+ K + LPL L ++A AT NFS KLG+GGFG VYKGRLL+G+E+AVKRLS
Sbjct: 496 ----EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSK 551
Query: 548 QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKR 607
S QG +EF NE+ LIAKLQH NLV+LLGCCV++GEK+LI EY+ N SLD LFD T+
Sbjct: 552 MSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSS 611
Query: 608 LLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667
L WQ R II GIA+GLLYLHQ SR RIIHRDLKASNVLLD +M PKISDFG+AR+FG
Sbjct: 612 NLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGR 671
Query: 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD-SFN 726
+E + NT+R+VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +SGK+N G YN++ N
Sbjct: 672 EETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLN 731
Query: 727 LLGYAWDLWKDDKFHELIDPVITQDEIS--LPV--LVRYINVALLCVQDNAADRPTMSDV 782
LLG+ W WK+ E++DP I D +S P ++R I + LLCVQ+ A DRP MS V
Sbjct: 732 LLGFVWRHWKEGNELEIVDP-INIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSV 790
Query: 783 VSIINSERLELPSPKEPAFIKGIN-VKNSSHSNDGMSNLCSVNDVTVSLVYPR 834
+ ++ SE +P PK P F G + ++ S S+ + C+VN +T+S++ R
Sbjct: 791 MVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 626 bits (1614), Expect = e-178, Method: Compositional matrix adjust.
Identities = 361/858 (42%), Positives = 530/858 (61%), Gaps = 47/858 (5%)
Query: 8 SIFCSLILSLSV-KVSLAADTVTPASFIRDG---EKLVSFSQRFELGFFSPGKSKSRYLG 63
S++ SL L + + S+AA+T+ +RDG + LVS + FELGFFSPG S R+LG
Sbjct: 8 SLYLSLFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLG 67
Query: 64 IWFRQVPD-TVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEV---KN 119
IW+ + D VVWVANR PISD + VL ISN GNLVLL+ N T+WS+N+ S N
Sbjct: 68 IWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNN 127
Query: 120 PVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQS 179
V + D GN V+ S T+ +W+SF++PTDT L M++ + + SW+S
Sbjct: 128 RVVSIHDTGNFVL----SETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRS 183
Query: 180 DDDPSPGKFTSRLEIKVIPKMCIFNGS-VKFACSGQWNGAAFVSAISY---TNFLYEQYL 235
+ DPSPG ++ ++ P++ ++ G+ + SGQWN A F + TN+LY L
Sbjct: 184 ETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKL 243
Query: 236 VENQDE---ISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYG 292
DE + + Y P + ++ K+ +G WN W S PD C +Y
Sbjct: 244 SSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYN 303
Query: 293 YCGANTICS-PDQKPICECLEGFKLKSKFN------QTGPIKCERSHSSECIGGHQFIKL 345
CG IC IC C+ G++ S N + P+KCER+ S +G +F+ L
Sbjct: 304 RCGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNIS---VGEDEFLTL 360
Query: 346 DNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPT 405
+++ PDF E+ + ++ + C CL+NC+C AY+ + G GC++W DL+D +
Sbjct: 361 KSVKLPDF-EIPEHNLVDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVDLQQFE 416
Query: 406 RNFTGQSVYIRVPASETG--KRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETE--N 461
G S++IR+ SE G ++ + ++V +++ ++L+ F + R + K+
Sbjct: 417 AG--GSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCG 474
Query: 462 METDQDLLAFDINMGITTRTNEFGEVNGDGKDKGKD-SWLPLFSLASVAAATENFSMQCK 520
TD ++ D+ T + G V+ + K + S LP+FSL ++A AT +F + +
Sbjct: 475 KNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENE 534
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580
LG GGFGPVYKG L +G+E+AVKRLS +SGQG++EFKNE++LIAKLQHRNLV+LLGCC E
Sbjct: 535 LGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFE 594
Query: 581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRD 640
EK+L+ EYMPNKSLD FLFD TK+ L+ W+ R +IIEGIA+GLLYLH+ SR RIIHRD
Sbjct: 595 GEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRD 654
Query: 641 LKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDV 700
LK SNVLLD +MNPKISDFG+AR+FGG++ + NT R+VGTYGYMSPEYA++GLFS+KSDV
Sbjct: 655 LKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDV 714
Query: 701 FSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVR 760
+SFG+L+LE +SGK+NT + +++ +L+GYAW L+ + EL+DP I + S +R
Sbjct: 715 YSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKI-RVTCSKREALR 773
Query: 761 YINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAFIKGINVKNSSHSNDGMSN- 819
I+VA+LCVQD+AA+RP M+ V+ ++ S+ L +P++P F +NS N + +
Sbjct: 774 CIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTS--TRRNSIDVNFALDSS 831
Query: 820 ---LCSVNDVTVSLVYPR 834
+ S N++T ++V R
Sbjct: 832 QQYIVSSNEITSTVVLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 617 bits (1591), Expect = e-175, Method: Compositional matrix adjust.
Identities = 353/840 (42%), Positives = 503/840 (59%), Gaps = 84/840 (10%)
Query: 13 LILSL--SVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVP 70
LI+SL ++ ++ A D + ++DG+ +VS FE+GFFSPG S++RYLGIW++++
Sbjct: 10 LIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKIS 69
Query: 71 -DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVF-----SEVKNPVAQL 124
TVVWVANRD P+ D + L +S G+L L N N IWS++ + ++NP+ Q+
Sbjct: 70 LQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQI 129
Query: 125 RDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPS 184
D GNLV+R+ SG+ + Y+WQS DYP D L GMK G + L R+L+SW++ DDPS
Sbjct: 130 LDTGNLVVRN--SGDD-QDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPS 186
Query: 185 PGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYT-NFLYEQYLVENQDEIS 243
G +T++++ +P+ + SV +G WNG F + N +Y V ++E+
Sbjct: 187 TGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVY 246
Query: 244 YWYEPFNRPSIMT-LKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSP 302
Y Y+ N PS++T ++LNP+G L R W +N W+ S + C +Y CG+ C+
Sbjct: 247 YTYKLEN-PSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNI 305
Query: 303 DQKPICECLEGFKLKSKFNQTG---PIKCERSHSSECIGGHQ-FIKLDNIRAPDFIEVFL 358
++ P C CL+GF K+ C R +C G F+K+ ++ PD +
Sbjct: 306 NESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWY 365
Query: 359 NKSMNLQQCAAECLKNCTCRAYANSNVTE-GSGCLMWFGDLLDANRPTRNFTGQSVYIRV 417
+K+M+L +C CL+NCTC AY+ ++ + G GC++WFGDL+D N GQ +Y+R+
Sbjct: 366 DKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNEN--GQDLYVRL 423
Query: 418 PAS--ETGKRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINM 475
+S ET +R+ R + +++E E++E
Sbjct: 424 ASSEIETLQRE----------------------SSRVSSRKQEEEDLE------------ 449
Query: 476 GITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLL 535
LP L +V+ AT FS KLG+GGFGPVYKG L
Sbjct: 450 ------------------------LPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLA 485
Query: 536 NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKS 595
GQEVAVKRLS S QG+EEFKNE+ LIAKLQHRNLVK+LG CV++ E++LI EY PNKS
Sbjct: 486 CGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKS 545
Query: 596 LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPK 655
LD F+FD ++R L W RV II+GIA+G+LYLH+ SR RIIHRDLKASNVLLD DMN K
Sbjct: 546 LDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAK 605
Query: 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
ISDFGLAR GGDE + NT R+VGTYGYMSPEY +DG FS+KSDVFSFG+L+LE +SG++
Sbjct: 606 ISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRR 665
Query: 716 NTGVYNAD-SFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAA 774
N G N + NLLG+AW + +DK +E+ID + + + ++R I++ LLCVQ +
Sbjct: 666 NRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPK 725
Query: 775 DRPTMSDVVSIINSERLELPSPKEPAFIKGINVKNSSHSNDGMSNLCSVNDVTVSLVYPR 834
DRP MS VV ++ S + L P++P F N+ S + + + S N T+S++ PR
Sbjct: 726 DRPNMS-VVVLMLSSEMLLLDPRQPGFFNERNLLFSDTVSINLE-IPSNNFQTMSVIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 602 bits (1551), Expect = e-171, Method: Compositional matrix adjust.
Identities = 360/851 (42%), Positives = 511/851 (60%), Gaps = 56/851 (6%)
Query: 15 LSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPD-TV 73
LS+SV A +++T I + +VS FELGFF S YLGIW++++ T
Sbjct: 28 LSISVNTLSATESLT----ISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTY 82
Query: 74 VWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPV-AQLRDDGNLVI 132
VWVANRD P+S+ +L ISN NLV+L+ ++ +WSTN+ V++ V A+L D+GN V+
Sbjct: 83 VWVANRDTPLSNPIGILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVL 141
Query: 133 RDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRL 192
R S N ++ +LWQSFD+PTDTLL MK+G D K L R+++SW+S DPS G F +L
Sbjct: 142 R-GSKINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKL 200
Query: 193 EIKVIPKMCIFNGSVKFACSGQWNGAAFVSAIS---YTNFLYEQYLVENQDEISYWYEPF 249
E +P+ F ++ SG W+G F + + + +Y EN++E++Y +
Sbjct: 201 ETLGLPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYN--FTENREEVAYTFRVT 258
Query: 250 NRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICE 309
+ S L +N G L +W +W++ + P + C YG CG C P C
Sbjct: 259 DHNSYSRLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCN 318
Query: 310 CLEGFK-LKSKFNQTGPI--KCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQ 366
C++GF+ L + +G + +C R C G +F +L N++ P ++K + L++
Sbjct: 319 CIKGFQPLSPQDWASGDVTGRCRRKTQLTC-GEDRFFRLMNMKIPATTAAIVDKRIGLKE 377
Query: 367 CAAECLKNCTCRAYANSNVTEG-SGCLMWFGDLLDANRPTRNFT--GQSVYIRVPASETG 423
C +C +C C AYANS++ G SGC++W G+ R RN+ GQ +++R+ A+E G
Sbjct: 378 CEEKCKTHCNCTAYANSDIRNGGSGCIIWIGEF----RDIRNYAADGQDLFVRLAAAEFG 433
Query: 424 KRKLLWILVILVL---PLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGITTR 480
+R+ + +I ++ L+L+ SF I+C ++ K A +G R
Sbjct: 434 ERRTIRGKIIGLIIGISLMLVLSFIIYCFWKKKQKRAR-----------ATAAPIGYRDR 482
Query: 481 TNEFGEVNGDGKDKGK-------DSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGR 533
E NG G+ D LPL +V ATENFS LG GGFG VYKGR
Sbjct: 483 IQELIITNGVVMSSGRRLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGR 542
Query: 534 LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN 593
LL+GQE+AVKRLS S QG EFKNE+ LIA+LQH NLV+LL CC+ EKILI EY+ N
Sbjct: 543 LLDGQEIAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLEN 602
Query: 594 KSLDVFLFDPTKK-RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM 652
SLD LF+ T+ L WQ R +II GIA+GLLYLHQ SRF+IIHRDLKASNVLLD +M
Sbjct: 603 GSLDSHLFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNM 662
Query: 653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
PKISDFG+AR+F DE + NT+++VGTYGYMSPEYA++G+FS+KSDVFSFG+L+LE +S
Sbjct: 663 TPKISDFGMARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVS 722
Query: 713 GKKNTGVYNA-DSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPV-----LVRYINVAL 766
GK+N G +N+ NLLGY W+ WK+ K E++D +I S+ + ++R I + L
Sbjct: 723 GKRNRGFHNSGQDNNLLGYTWENWKEGKGLEIVDSIIVDSSSSMSLFQPHEVLRCIQIGL 782
Query: 767 LCVQDNAADRPTMSDVVSIINSERLELPSPKEPAFIKG---INVKNSSHSNDGMSNLCSV 823
LCVQ+ A DRP MS VV ++ SE+ E+P PK P + G ++ +SS S S +V
Sbjct: 783 LCVQERAEDRPKMSSVVLMLGSEKGEIPQPKRPGYCVGRSSLDTADSSSSTKRDSESLTV 842
Query: 824 NDVTVSLVYPR 834
N +TVS++ R
Sbjct: 843 NQITVSVINAR 853
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 600 bits (1547), Expect = e-170, Method: Compositional matrix adjust.
Identities = 346/825 (41%), Positives = 495/825 (60%), Gaps = 40/825 (4%)
Query: 1 MAILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSR 60
M+ L F + + +LS+ ++ + T + I + LVS FE+GFF ++ SR
Sbjct: 13 MSFLLVFVVMILIHPALSIYINTLSSTESLT--ISSNKTLVSPGSIFEVGFF---RTNSR 67
Query: 61 -YLGIWFRQVPD-TVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVF--SE 116
YLG+W+++V D T VWVANRD P+S+ L IS NLVLL+ +N +W TN+ +E
Sbjct: 68 WYLGMWYKKVSDRTYVWVANRDNPLSNAIGTLKISG-NNLVLLDHSNKPVWWTNLTRGNE 126
Query: 117 VKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSS 176
VA+L +GN V+RD+S+ + +E YLWQSFDYPTDTLL MK+G++LK L R+L+S
Sbjct: 127 RSPVVAELLANGNFVMRDSSNNDASE-YLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTS 185
Query: 177 WQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYTNFLYEQY-L 235
W+S DDPS G F+ +LE + +P+ + + SG WNG F Y Y
Sbjct: 186 WRSSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNF 245
Query: 236 VENQDEISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFP-DEYCGKYGYC 294
+EN +E++Y + N L L G R W + W+ +S P D C Y C
Sbjct: 246 IENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMC 305
Query: 295 GANTICSPDQKPICECLEGFKLKS--KFNQ-TGPIKCERSHSSECIGGHQFIKLDNIRAP 351
G C + P+C C++GF ++ +++Q C R C G F ++ ++ P
Sbjct: 306 GPYAYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSC-SGDGFTRMKKMKLP 364
Query: 352 DFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEG-SGCLMWFGDLLDA-NRPTRNFT 409
+ +++S+ +++C C+ +C C A+AN+++ G SGC++W L D N T
Sbjct: 365 ETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAID 424
Query: 410 GQSVYIRVPASETGKRK----LLWILVILVLPLVLLPSFYIFCRRRRNCKEKETE--NME 463
GQ +Y+R+ A++ K++ + L + V L+LL F ++ R+++ K N +
Sbjct: 425 GQDLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIANTQ 484
Query: 464 TDQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGE 523
+Q+L +N + + EF G+ K ++ LPL + +V ATENFS KLG+
Sbjct: 485 RNQNL---PMNEMVLSSKREFS-----GEYKFEELELPLIEMETVVKATENFSSCNKLGQ 536
Query: 524 GGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE 583
GGFG VYKGRLL+G+E+AVKRLS S QG +EF NE+ LIA+LQH NLV++LGCC+E E
Sbjct: 537 GGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDE 596
Query: 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKA 643
K+LI EY+ N SLD +LF T++ L W R I G+A+GLLYLHQ SRFRIIHRDLK
Sbjct: 597 KMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKV 656
Query: 644 SNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSF 703
SN+LLD +M PKISDFG+AR+F DE + NT ++VGTYGYMSPEYA+ G+FS KSDVFSF
Sbjct: 657 SNILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSF 716
Query: 704 GILMLETLSGKKNTGVYNADSFN-LLGYAWDLWKDDKFHELIDPVITQDEISLPVL---- 758
G+++LE +SGKKN G YN D N LL Y W WK+ + E++DPVI S P +
Sbjct: 717 GVIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQ 776
Query: 759 --VRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAF 801
++ I + LLCVQ+ A RP MS VV + SE E+P PK P +
Sbjct: 777 EVLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKPPGY 821
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 599 bits (1545), Expect = e-170, Method: Compositional matrix adjust.
Identities = 348/858 (40%), Positives = 504/858 (58%), Gaps = 47/858 (5%)
Query: 1 MAILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSR 60
+ ++ IF L ++S S ++ T IR+G+ L+S + FELGFF+P S R
Sbjct: 8 LTLVTTLLIFHQLCSNVSCSTS---NSFTRNHTIREGDSLISEDESFELGFFTPKNSTLR 64
Query: 61 YLGIWFRQV-PDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKN 119
Y+GIW++ + P TVVWVANR++P+ DH L I++ GNLV++N N TIWSTNV E N
Sbjct: 65 YVGIWYKNIEPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNN 124
Query: 120 PVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQS 179
VA L G+LV+ S + + W+SF+ PTDT L GM++ + R W+S
Sbjct: 125 TVAVLFKTGDLVL---CSDSDRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKS 181
Query: 180 DDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVS---AISYTNFLYEQYLV 236
+ DPSPGK++ ++ ++ I+ G + SG WN A F + +TN++Y L
Sbjct: 182 ESDPSPGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLS 241
Query: 237 ENQDE---ISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGY 293
D + + Y + + + P G+ + WN + +W+L+ P C KY
Sbjct: 242 SPPDRDGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNR 301
Query: 294 CGANTICSPDQKPI----CECLEGFKLKSK---FNQTGPIKCERSHSSEC----IGGHQ- 341
CG ++C D K C C++GF+ + N+ C+R C + G +
Sbjct: 302 CGNYSVCD-DSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQED 360
Query: 342 -FIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLD 400
F L I+ PDF V L+ N + C C ++C+C+AYA + G GC++W DL+D
Sbjct: 361 GFTVLKGIKVPDFGSVVLHN--NSETCKDVCARDCSCKAYA---LVVGIGCMIWTRDLID 415
Query: 401 ANRPTRNFTGQSVYIRVPASETGKRK---LLWILVILVLPLVLLP-SFYIFCRRRRNCKE 456
R G S+ IR+ S+ G K LWI+V V+ LL +I + +++ K
Sbjct: 416 MEHFERG--GNSINIRLAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKA 473
Query: 457 KETENMETDQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFS 516
+ +D+ DI ++ + GD D LP+FS SVA+AT +F+
Sbjct: 474 F----LWKKKDITVSDIIENRDYSSSPIKVLVGDQVDTPD---LPIFSFDSVASATGDFA 526
Query: 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
+ KLG+GGFG VYKG G+E+AVKRLS +S QGLEEFKNE++LIAKLQHRNLV+LLG
Sbjct: 527 EENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLG 586
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
CC+E EK+L+ EYMPNKSLD FLFD +K+ L W+ R +I GIA+GLLYLH+ SR +I
Sbjct: 587 CCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKI 646
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
IHRDLKASN+LLD +MNPKISDFG+AR+F + NT R+VGTYGYM+PEYA++G+FS
Sbjct: 647 IHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSE 706
Query: 697 KSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLP 756
KSDV+SFG+L+LE +SG+KN D +L+GYAW LW K E+IDP++ +D +
Sbjct: 707 KSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIV-KDTRDVT 765
Query: 757 VLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAFIKGINVKNSSHSNDG 816
+R I+V +LC QD+ RP M V+ ++ S+ +LP P++P F +N + + DG
Sbjct: 766 EAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDG 825
Query: 817 MSNLCSVNDVTVSLVYPR 834
++ SVNDVT + + R
Sbjct: 826 -HDVASVNDVTFTTIVGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 834 | ||||||
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.944 | 0.982 | 0.477 | 0.0 | |
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.940 | 0.956 | 0.473 | 0.0 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.959 | 0.956 | 0.480 | 0.0 | |
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.920 | 0.710 | 0.479 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.955 | 0.959 | 0.469 | 0.0 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.941 | 0.966 | 0.460 | 0.0 | |
| 255555127 | 834 | S-locus-specific glycoprotein S6 precurs | 0.974 | 0.974 | 0.452 | 0.0 | |
| 224113149 | 820 | predicted protein [Populus trichocarpa] | 0.950 | 0.967 | 0.466 | 0.0 | |
| 255587572 | 822 | S-locus-specific glycoprotein S6 precurs | 0.966 | 0.980 | 0.468 | 0.0 | |
| 356545297 | 824 | PREDICTED: G-type lectin S-receptor-like | 0.961 | 0.973 | 0.473 | 0.0 |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/848 (47%), Positives = 529/848 (62%), Gaps = 60/848 (7%)
Query: 1 MAILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSR 60
M LP F F +L + +S +AD +TP ++DG+ L+S SQ FELGFFSPG SK R
Sbjct: 1 MESLPFFIFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKYR 60
Query: 61 YLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNP 120
Y+GIW+++ P+TVVWVANR+ P++DH VLTI N+GNLVLL+Q IWS+N S + P
Sbjct: 61 YVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAGP 120
Query: 121 VAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSD 180
VAQL D GNLV+RDN S TESY WQSFD P+DTLL GMK+GW+LK ERYL +W+S
Sbjct: 121 VAQLLDSGNLVVRDNGSSRNTESYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRSI 180
Query: 181 DDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYTNFLYEQYLVENQD 240
DPSPG FT RL+I +P++ I GSVK SG WNG F N ++E LV N+D
Sbjct: 181 SDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNED 240
Query: 241 EISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTIC 300
EI Y Y N L LN SG + R + + W ++S P + C YG CGAN IC
Sbjct: 241 EIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGIC 300
Query: 301 SPDQKPICECLEGFKLKSK-----FNQTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIE 355
PICECL+GFK + N G KCE + +C G F+KL ++ PD +E
Sbjct: 301 RTRTSPICECLKGFKSIPEEELDIQNFYGSRKCETRLTLDCQSGEGFLKLPGVKLPDLLE 360
Query: 356 VFLNKSMNLQQCAAECLKNCTCRAYANSNVT---EGSGCLMWFGDLLDANRPTRNFTGQS 412
LN+SMNL++C AEC KNC+C A+A +N++ +GSGCLMWFG+L+D + + GQ
Sbjct: 361 FRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIGQD 420
Query: 413 VYIRVPASE-----TGKRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQD 467
++IRVPASE + KRK + ++ LL F RR+ E ME
Sbjct: 421 IHIRVPASELEMARSSKRKKMLKTALVASMSALLGIFVSGMDRRK-------EGMEA--- 470
Query: 468 LLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFG 527
PLF L ++A AT NF+ +G GGFG
Sbjct: 471 ---------------------------------PLFDLDTIATATNNFAPDSIIGAGGFG 497
Query: 528 PVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587
VYKG+LL GQE+AVK+LS SGQG+EEF+NE++LIAKLQHRNLV LLG C+ + E++LI
Sbjct: 498 SVYKGKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGSCIHREERMLI 557
Query: 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVL 647
EYMPNKSLD F+FD + LLGW+ R II GIA+GLLYLHQ S+ +I+HRDLK SNVL
Sbjct: 558 YEYMPNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLHQDSKLQIVHRDLKPSNVL 617
Query: 648 LDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
LD ++ PKISDFGLAR+ G D + T+R++GTYGYM+PEYA+DG FS+KSDVFS G+L+
Sbjct: 618 LDSNLIPKISDFGLARISGDDGKETKTRRVIGTYGYMAPEYAIDGKFSVKSDVFSLGVLL 677
Query: 708 LETLSGKKNTGVYNAD-SFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVAL 766
LE +SGKKN G + D +LLG+AW +W + + ELID + +D L+R I V L
Sbjct: 678 LEIISGKKNRGFVHPDHHHHLLGHAWLMWNEGRASELIDTGL-EDTSGKSQLLRCIQVGL 736
Query: 767 LCVQDNAADRPTMSDVVSIINSERLELPSPKEPAFIKGINVKNSSHSNDGMSNLCSVNDV 826
LCVQ DRP MS VV ++ +E LP PK+P F I + S + + S N+
Sbjct: 737 LCVQKLPEDRPVMSTVVFMLANEGAVLPQPKQPGFF--IERGSVSEATSRNEDSYSTNEA 794
Query: 827 TVSLVYPR 834
++++ R
Sbjct: 795 NITILEAR 802
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1875), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/847 (47%), Positives = 531/847 (62%), Gaps = 63/847 (7%)
Query: 7 FSIFCSLILSLSVKVSLAADTVTPASFIRDG--EKLVSFSQRFELGFFSPGKSKSRYLGI 64
FS FC+ A+T+T + IRDG LVS FELGFFSPG S++RY+GI
Sbjct: 18 FSRFCN-----------TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGI 66
Query: 65 WFRQVP-DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTI-WSTNVFSEVKNPVA 122
W++ +P TVVWVANR+ PI+D + L + N GN VL++ N T+ WS+N ++ +
Sbjct: 67 WYKNIPVRTVVWVANRNNPINDSSGFLMLDNTGNFVLVSNNNSTVVWSSNSKKAAQSAMG 126
Query: 123 QLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDD 182
+L+D GNLV+RD N+ YLWQSFDYP+DTLL GMK+GWDL+ L+R LS+W+S DD
Sbjct: 127 ELQDSGNLVLRDEKDDNSG-IYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDD 185
Query: 183 PSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISY-TNFLYEQYLVENQDE 241
PS G FT +++ P++ ++ GS K+ SG WNG F ++ N ++ V++ +E
Sbjct: 186 PSSGDFTWGTQLQSNPELVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDFVDDGEE 245
Query: 242 ISYWYEPFNRPSIMTLKLNPSGLL-TRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTIC 300
+ Y Y N+ I + +N + R WN W L + P +YC Y CGA C
Sbjct: 246 VYYTYNLKNKSLITRIVMNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNC 305
Query: 301 SPDQKPICECLEGFKLKS--KFNQTGPIK-CERSHSSECIGGHQFIKLDNIRAPDFIEVF 357
Q P+C+CLE F +S +N K C R+ +C G F+K ++ PD +
Sbjct: 306 IMSQSPVCQCLEKFTPRSPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSW 365
Query: 358 LNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFT--GQSVYI 415
+NK+MNL++C ++CL+NC+C AY +N+ E SGC +WFGDL+D R F+ GQ +YI
Sbjct: 366 VNKTMNLKECRSKCLQNCSCMAYTATNIKERSGCAVWFGDLID----IRQFSAAGQEIYI 421
Query: 416 RVPASETGKRKLLWI-------LVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDL 468
R+ ASE+ + I L I V +LL ++YIF R+ ++ EN + D
Sbjct: 422 RLNASESRAKAASKIKMTVGSALSIFVACGILLVAYYIFKRKAKHIGGNREENDQIDSG- 480
Query: 469 LAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGP 528
+D LPLF ++A AT FS KLGEGGFGP
Sbjct: 481 -------------------------PKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGP 515
Query: 529 VYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588
VYKG L +GQE+A K LS SGQGL EFKNE++LI KLQHRNLVKLLGCC++ EKIL+
Sbjct: 516 VYKGTLEDGQEIAAKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVY 575
Query: 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648
EYMPNKSLD F+FD T+ +LL W R +II GIA+GLLYLHQ SR RI+HRDLKASNVLL
Sbjct: 576 EYMPNKSLDSFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLL 635
Query: 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
D DMNPKISDFGLARMFGGD+ +GNT R+VGTYGYM+PEYA DGLFS+KSDVFSFGILML
Sbjct: 636 DKDMNPKISDFGLARMFGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILML 695
Query: 709 ETLSGKKNTGVYNAD-SFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALL 767
E +SGKK+ G + D S +L+G+AW LWKD K LI+ + V++R IN++LL
Sbjct: 696 EIISGKKSRGFCHPDHSLSLIGHAWRLWKDGKPLGLIEAFPGESCNLSEVIMRCINISLL 755
Query: 768 CVQDNAADRPTMSDVVSIINSERLELPSPKEPAFIKGINVKNSSHSNDGMSNLCSVNDVT 827
CVQ + DRP+M+ VV ++ E LP PKEP F KG S S+ + L S N++T
Sbjct: 756 CVQQHPDDRPSMATVVWMLGGEN-TLPQPKEPGFFKGSGPFRPSSSSKN-TELFSNNEIT 813
Query: 828 VSLVYPR 834
SL+YPR
Sbjct: 814 SSLLYPR 820
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 725 bits (1872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/853 (48%), Positives = 540/853 (63%), Gaps = 53/853 (6%)
Query: 7 FSIFCSLILSLSVKVSLAADTVTPASFIRDG--EKLVSFSQRFELGFFSPGKSKSRYLGI 64
FS FC+ A+T+T + IRDG LVS FELGFFSPG S++RY+GI
Sbjct: 12 FSRFCN-----------TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGI 60
Query: 65 WFRQVP-DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTI-WSTNVFSEVKNPVA 122
W++ +P TVVWVANR+ PI+D + L + N GNLVL++ N T+ WS+N ++ +
Sbjct: 61 WYKNIPVRTVVWVANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMG 120
Query: 123 QLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDD 182
+L D GNLV+RD N+ SYLWQSFDYP+DT+L GMK+GWDL+ L+R LS+W+S DD
Sbjct: 121 ELLDSGNLVLRDEKDVNSG-SYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDD 179
Query: 183 PSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVS-AISYTNFLYEQYLVENQDE 241
PS G FT +++ P++ I+ GS K+ SG WNG F A N ++ V+N +E
Sbjct: 180 PSSGDFTWGTQLQSNPELVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFVDNGEE 239
Query: 242 ISYWYEPFNRPSIMTLKLNPSGLLTRQ--IWNNNGNDWDLVFSFPDEYCGKYGYCGANTI 299
+ Y Y N+ I L +N + RQ WN W+L P +YC Y CGA
Sbjct: 240 VYYTYNLKNKSLITRLVMNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGN 299
Query: 300 CSPDQKPICECLEGFKLKS--KFNQTGPIK-CERSHSSECIGGHQFIKLDNIRAPDFIEV 356
C Q P+CECLE F KS +N + C R+ +C G F+K ++ PD
Sbjct: 300 CIISQSPVCECLEKFTPKSPESWNSMNWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNS 359
Query: 357 FLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFT--GQSVY 414
++NK+MNL++C ++CL+NC+C AY +++ E SGC +WFGDL+D R F GQ +Y
Sbjct: 360 WVNKTMNLKECRSKCLQNCSCMAYTATDIKERSGCAIWFGDLID----IRQFPDGGQEIY 415
Query: 415 IRVPASETG------KRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDL 468
IR+ ASE+ K ++ L I V +LL ++YIF K TE ++
Sbjct: 416 IRMNASESSECLSLIKMEMGIALSIFVACGMLLVAYYIF---------KRTEKLKAHYSF 466
Query: 469 LAF----DINMGITTRTNEFGEVNGDGKDKG--KDSWLPLFSLASVAAATENFSMQCKLG 522
L D + ++ +T E N D D G +D LPLF ++A AT FS+ K+G
Sbjct: 467 LLVYHVCDSHSLLSEKTGGNREEN-DQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIG 525
Query: 523 EGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG 582
EGGFGPVYKG L +GQE+AVK LS SGQGL EFKNE++LI KLQHRNLVKLLGCC++
Sbjct: 526 EGGFGPVYKGTLEDGQEIAVKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGE 585
Query: 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLK 642
EKIL+ EYMPN+SLD F+FD T+ +LL W R +II GIA+GLLYLHQ SR RI+HRDLK
Sbjct: 586 EKILVYEYMPNRSLDSFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLK 645
Query: 643 ASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFS 702
ASNVLLD DMNPKISDFGLARM GGD+ +GNT R++GTYGYM+PEYA DGLFS+KSDVFS
Sbjct: 646 ASNVLLDKDMNPKISDFGLARMVGGDQTEGNTTRVIGTYGYMAPEYATDGLFSVKSDVFS 705
Query: 703 FGILMLETLSGKKNTGVYNAD-SFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRY 761
FGILMLE +SGKK+ G Y+ D S +L +AW LWKD K +LI+ + V++R
Sbjct: 706 FGILMLEIISGKKSRGFYHPDRSLSLTAHAWRLWKDGKPLDLIEAFPGESRNLSEVIMRC 765
Query: 762 INVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAFIKGINVKNSSHSNDGMSNLC 821
IN++LLCVQ + DRP+M+ VV ++ E LP P EP F KG S S+ + L
Sbjct: 766 INISLLCVQHHPDDRPSMATVVWMLGGEN-TLPQPNEPGFFKGSGPFGPSSSSSNIE-LY 823
Query: 822 SVNDVTVSLVYPR 834
S N+ T SL+YPR
Sbjct: 824 SNNEFTASLLYPR 836
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1869), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/828 (47%), Positives = 511/828 (61%), Gaps = 60/828 (7%)
Query: 25 ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPIS 84
AD++ I D E LVS Q FELGFFSPG SK+RYLGIW++ P T VWVANR+ PI+
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 85 DHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESY 144
D VLTI N G LVLLNQ+ IWS N+ +NPVAQL + GNLV+RD S+ T++SY
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRDGSN-ETSKSY 414
Query: 145 LWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFN 204
+WQSFD P+DT+L GMK+GW+LK L+R L+SW+S DDPS G F+ +I V+P + +
Sbjct: 415 IWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLGV 474
Query: 205 GSVKFACSGQWNGAAFVSAISYTNFLYEQYLVENQDEISYWYEPFNRPSIMTLKLNPSGL 264
GS K SG WNG F N +Y+ V N DE+ YE N I L LN SG
Sbjct: 475 GSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSGF 534
Query: 265 LTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSK----- 319
L R + + WD ++S P E C YG+CGAN IC + ICECL GF KS+
Sbjct: 535 LQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQEEWDM 594
Query: 320 FNQTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRA 379
FN + C R +C F+K+ ++ PD I+ + ++L++C CL NC+C A
Sbjct: 595 FNTSS--GCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCTA 652
Query: 380 YANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETG------KRKLLWILVI 433
YA +N GCLMW GDL+D T + +YIR+ SE G K+KL+ ILVI
Sbjct: 653 YAYTNPNGSGGCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIILVI 712
Query: 434 LVLPLVL---LPSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGITTRTNEFGEVNGD 490
+L L ++ F ++R M TDQ+
Sbjct: 713 STFSGILTLGLSFWFRFWKKR---------TMGTDQE----------------------- 740
Query: 491 GKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG 550
K ++ LPLF L ++A AT NFS K+G GGFG VYKG L G VAVKRLS S
Sbjct: 741 --SKKENLELPLFDLPTIATATNNFSNTNKIGAGGFGSVYKGNLPEGVAVAVKRLSKNSA 798
Query: 551 QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLG 610
QG++EFKNE +LIAKLQH+NLV+LLGCC++ E+IL+ EYMPNKSLD F+FD ++ LL
Sbjct: 799 QGVQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFIFDQNRRALLA 858
Query: 611 WQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670
W R I+ GIA+GLLYLHQ SRF+IIHRDLK SN+LLD ++NPKISDFGLAR+FG +E+
Sbjct: 859 WDKRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLARIFGENEM 918
Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD-SFNLLG 729
+ TKRIVGTYGYMSPEY +DG FSIK DVFSFG+L+LE +SG+KN G + D NLLG
Sbjct: 919 ETRTKRIVGTYGYMSPEYVIDGHFSIKLDVFSFGVLLLEIVSGEKNRGFSHPDHHHNLLG 978
Query: 730 YAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789
+AW LW+ ++ EL+D + ++ VL R I V LLCVQ+ ADRP MS V+ ++ +E
Sbjct: 979 HAWLLWEQNRALELMDACLEDSCVASQVL-RCIQVGLLCVQNLPADRPAMSSVIFMLGNE 1037
Query: 790 RLELPSPKEPAFIKGINVKNSSHSNDGMS---NLCSVNDVTVSLVYPR 834
LP PK P F + SS D MS L S N VT+S++ R
Sbjct: 1038 GATLPQPKHPGFF----TERSSVDTDTMSGKIELHSENAVTISMLKGR 1081
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 716 bits (1849), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/840 (46%), Positives = 533/840 (63%), Gaps = 43/840 (5%)
Query: 12 SLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPD 71
S++ LS+ S A +++ + DG+ LVS FELGFFSPG S++RY+GIW++++
Sbjct: 18 SIVFFLSIP-STAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYKKISS 76
Query: 72 -TVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNL 130
TVVWVANR+ P++D + +L + GNL +N TNGTIWS+N+ NPVAQL D GNL
Sbjct: 77 FTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLDTGNL 136
Query: 131 VIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTS 190
V+R + N E++LWQSFDYP D+ L GMK G L RYL+SW+S DPS GK+T+
Sbjct: 137 VVRAEND-NDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGKYTN 195
Query: 191 RLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYT-NFLYEQYLVENQDEISYWYEPF 249
+L+ +P+ + GSV SG WNG F I+ N +Y V NQ+EI Y Y+
Sbjct: 196 KLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVFNQEEIYYKYQIA 255
Query: 250 NRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICE 309
N + + L+P G+L R W + DW L + + C ++ CGA+ +C+ + P C+
Sbjct: 256 NSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNINNSPACD 315
Query: 310 CLEGFKLKSKFNQTGP---IKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQ 366
CL+ F+ KS T C R +C G FIK I+ PD + + NK++NL++
Sbjct: 316 CLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNKTINLEE 375
Query: 367 CAAECLKNCTCRAYANSNVTEG-SGCLMWFGDLLDANRPTRNFTGQSVYIRVPAS----- 420
C CLKNC+C AYAN +V +G SGC++WFGDL+D + N GQ +YIR+ AS
Sbjct: 376 CEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQYNEN--GQDIYIRIAASVIDKP 433
Query: 421 --ETGKRKLLWILV---ILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINM 475
GK+++ I++ ++ L+ L F F R+ + + N+ T+ +
Sbjct: 434 VKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREGNVVTNPE-------- 485
Query: 476 GITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLL 535
RT E + +D LPLF LA++ AT FS+ KLG+GGFGPVYKG L
Sbjct: 486 --QDRTKE---------SRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGILQ 534
Query: 536 NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKS 595
+GQE+AVKRLS +S QG+ EF+NE++ IAKLQHRNLVKLLGCC+E E++LI EYMPNKS
Sbjct: 535 DGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNKS 594
Query: 596 LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPK 655
LD F+FD + LL W R II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +MNPK
Sbjct: 595 LDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNPK 654
Query: 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
ISDFG+AR FGGDE NT RIVGTYGYMSPEYA+DGLFS+KSDVFSFG+L+LE +SG+K
Sbjct: 655 ISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGRK 714
Query: 716 NTGVYNAD-SFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAA 774
N G +A+ NLLG+AW L K+ + +LID I D + ++R I VALLCVQ +
Sbjct: 715 NRGFRHAEHKLNLLGHAWMLHKEGRPLDLIDESIV-DTCIISEVLRSIEVALLCVQKSPE 773
Query: 775 DRPTMSDVVSIINSERLELPSPKEPAFIKGINVKNSSHSNDGMSNLCSVNDVTVSLVYPR 834
DRP MS VV +++S+ + LP PKEP F ++ N S S + SVN++T +L+ R
Sbjct: 774 DRPKMSIVVLMLSSD-IVLPQPKEPGFFTERDLSNDSSSTI-KHEISSVNELTSTLLEAR 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1821), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/854 (46%), Positives = 528/854 (61%), Gaps = 69/854 (8%)
Query: 3 ILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYL 62
++ +S+F S++ K+S A D + +RDGE LVS FELGFF+P S SRYL
Sbjct: 6 VIFVYSLFFSIL-----KISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYL 60
Query: 63 GIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVA 122
G+W+++ P TVVWVANR PIS+ L ++++G LVLLN TN +WS+N + V+NPVA
Sbjct: 61 GLWYKKSPQTVVWVANRGIPISNKFGTLNVTSQGILVLLNGTNNIVWSSNTSTTVQNPVA 120
Query: 123 QLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDD 182
QL D GNLV+RD + N +++LWQSFDYP DTLL GMK+G +L L +LSSW+ ++
Sbjct: 121 QLLDSGNLVVRDGND-NKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKEN 179
Query: 183 PSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYT-NFLYEQYLVENQDE 241
P+PG+FT ++++ P++ + + G WNG F + +Y V N++E
Sbjct: 180 PAPGQFTLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFEFVFNRNE 239
Query: 242 ISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICS 301
+ + +E N L + PSGL+ W++ NDW + + + C Y CGAN C
Sbjct: 240 VYFKFELQNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFATAVVDRCENYALCGANARCD 299
Query: 302 PDQKPICECLEGFKLKSKF-----NQTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEV 356
+ P+C+CL+GF KS N TG C R +C F ++ PD
Sbjct: 300 SNSSPVCDCLDGFIHKSPTEWNSQNWTG--GCIRRTPLDCTDKDGFQSYTGVKLPDTSSS 357
Query: 357 FLNKSMNLQQCAAECLKNCTCRAYANSNVT-EGSGCLMWFGDLLDANRPTRNFTGQSVYI 415
+ + S +L +C C++NC+C AYAN + GSGCL WFGDL+D R GQ +YI
Sbjct: 358 WYDDSFSLVECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEG--GQDIYI 415
Query: 416 RVPASETG-----KRK------LLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMET 464
R+ AS++G KRK ++ VIL +++L +FC RRR ++
Sbjct: 416 RLAASQSGVTGEKKRKKKTHAGVIGGAVILGSSILILG--IVFCIRRRKHRK-------- 465
Query: 465 DQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSW-LPLFSLASVAAATENFSMQCKLGE 523
NG+ +D+ ++ LP+ L ++ AT+NFS KLGE
Sbjct: 466 -----------------------NGNFEDRKEEEMELPMLDLTTIEHATDNFSSSKKLGE 502
Query: 524 GGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE 583
GGFG VYKG L+ GQE+AVKRLS SGQGL EFKNE++LIAKLQHRNLVKLLGCC+ + E
Sbjct: 503 GGFGAVYKGELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDE 562
Query: 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKA 643
K+LI EYMPN+SLD F+FDPT+++ L W R II+GIA+GLLYLHQ SR RIIHRD+KA
Sbjct: 563 KMLIYEYMPNRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKA 622
Query: 644 SNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSF 703
SN+LLD ++NPKISDFGLARMFGGD+ + NTKR+VGTYGYMSPEYALDG FS+KSDVFSF
Sbjct: 623 SNILLDNELNPKISDFGLARMFGGDQTEANTKRVVGTYGYMSPEYALDGHFSVKSDVFSF 682
Query: 704 GILMLETLSGKKNTGVYNAD--SFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRY 761
G+L+LE +SGKKN G + D NLLG+AW LW + ELID D + +R
Sbjct: 683 GVLVLEIVSGKKNRGFCHPDYNQKNLLGHAWMLWFNGIPLELIDECFA-DSCTPSEALRC 741
Query: 762 INVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAFIKGIN-VKNSSHSNDGMSNL 820
I+VALLCVQ DRP MS VV ++ SE LP PK+P F G N + + SN S+
Sbjct: 742 IHVALLCVQQRPEDRPNMSSVVLMLGSEN-PLPQPKQPGFFMGSNPPEKDTSSNKHQSH- 799
Query: 821 CSVNDVTVSLVYPR 834
S N+VTV+L+ R
Sbjct: 800 -SANEVTVTLLQAR 812
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555127|ref|XP_002518601.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223542446|gb|EEF43988.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1821), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/840 (45%), Positives = 539/840 (64%), Gaps = 27/840 (3%)
Query: 5 PCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGI 64
P F +F + + + + S ++DT+T + +G+ L+S Q+FELGFF+PG SK+ Y+GI
Sbjct: 12 PIF-LFFTFLSFYAPRFSFSSDTLTSTQSLINGQTLLSTRQKFELGFFTPGNSKNWYVGI 70
Query: 65 WFRQVPD-TVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQ 123
W++ + D T VWVANRD P+++ + + I N+ ++VL +Q N IWS+N + NPV Q
Sbjct: 71 WYKNISDRTYVWVANRDNPLTNSSGIFKIFNQ-SIVLFDQGNNLIWSSNQI-KATNPVMQ 128
Query: 124 LRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDP 183
L D G+LV+R+ N YLWQSFDYPTDTLL MK+GWDL L RYLSSW+S DDP
Sbjct: 129 LLDTGDLVLRE---ANVNNQYLWQSFDYPTDTLLPDMKLGWDLNKSLHRYLSSWKSKDDP 185
Query: 184 SPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYTNFLYEQY-LVENQDEI 242
G ++ +L+ P++ ++N K SG WNG F Y + V NQ E+
Sbjct: 186 GAGDYSFKLDYHGFPEIFLWNDGRKIYRSGPWNGLRFSGVPEMKPLDYISFDFVTNQSEV 245
Query: 243 SYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSP 302
Y + + + L + SG L R W DW+ + P + C Y CG IC
Sbjct: 246 FYSFHISSNSTYSRLTVTSSGELQRYTWIPERQDWNSFWYAPKDQCDDYKECGPYGICDS 305
Query: 303 DQKPICECLEGFKLKS--KFN-QTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLN 359
+ P+C+C+ GF+ K+ +N + G C R +C+ +F+ L NI+ P+ F++
Sbjct: 306 NASPVCKCMRGFEPKNLQAWNLRDGSGGCVRKTDLQCMN-DKFLHLKNIKLPESSTSFVD 364
Query: 360 KSMNLQQCAAECLKNCTCRAYANSNVTEG-SGCLMWFGDLLDANRPTRNFTGQSVYIRVP 418
+ ++L+ C CL+NC+C AYANS+++ G +GC++WFG+LLD + T GQ +Y+R+
Sbjct: 365 RIISLKICEELCLRNCSCTAYANSDISNGGTGCVLWFGELLDMRQYTEG-GGQDLYVRLA 423
Query: 419 ASETGKRKLLWILVILV---LPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINM 475
AS+ G K + L+I + + +LL F +RR+ ++++ E Q+LL ++
Sbjct: 424 ASDIGDGKNVAALIIGISVGIGTLLLGLAACFIWKRRSVRKEQKGVQERSQNLLLNEVV- 482
Query: 476 GITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLL 535
I+++ + GE + D + LPLF ++A AT+NFS + KLG+GGFG VYKGRL+
Sbjct: 483 -ISSKRDYSGEKDKDELE------LPLFDFGTIATATDNFSDENKLGQGGFGCVYKGRLV 535
Query: 536 NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKS 595
GQ VAVKRLS S QG+EEFKNE+ LIA+LQHRNLV+LLGCC+E EK+LI EYM ++S
Sbjct: 536 EGQVVAVKRLSKTSVQGIEEFKNEVNLIARLQHRNLVRLLGCCIETNEKVLIYEYMEHRS 595
Query: 596 LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPK 655
LD +F+ K+ LL WQ R I+ GIA+GLLY+HQ SRFRIIHRDLKASN+LLD + NPK
Sbjct: 596 LDSVIFNNAKRSLLNWQRRFNIVCGIARGLLYMHQDSRFRIIHRDLKASNILLDGEWNPK 655
Query: 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
ISDFG+AR+FGGD+ + +TKR+VGTYGYMSPEYA+DG FS+KSDVFSFG+L+LE +SG K
Sbjct: 656 ISDFGMARIFGGDQTEASTKRVVGTYGYMSPEYAMDGHFSVKSDVFSFGVLVLEIVSGNK 715
Query: 716 NTGVYNADS-FNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAA 774
N G Y+++S NLLG+AW LWK++K E++D + VL R I V LLCVQ+ A
Sbjct: 716 NRGFYHSNSELNLLGHAWRLWKEEKGLEILDSSVGSSFSPSEVL-RCIQVGLLCVQERAE 774
Query: 775 DRPTMSDVVSIINSERLELPSPKEPAFIKGINVKNSSHSNDGMSNLCSVNDVTVSLVYPR 834
DRPTMS VV +++SE +P PK P F G N + S+ +VN VTV+++ R
Sbjct: 775 DRPTMSSVVLMLSSENATMPHPKTPGFCLGRNPFETDSSSGKQDESYTVNQVTVTMLDAR 834
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/844 (46%), Positives = 525/844 (62%), Gaps = 51/844 (6%)
Query: 7 FSIFCSLILSLSVKVSLAADTVTPASFIRDG--EKLVSFSQRFELGFFSPGKSKSRYLGI 64
FS FC+ A+T+T + + DG LVS FELGFFSPG S++RY+GI
Sbjct: 12 FSRFCN-----------TANTLTLSQSVCDGGTRTLVSKDGSFELGFFSPGSSRNRYVGI 60
Query: 65 WFRQVP-DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTI-WSTNVFSEVKNPVA 122
W++ +P TVVWVANR+ PI+D + L + N GNLVL++ N T+ WS+N ++ +
Sbjct: 61 WYKNIPVRTVVWVANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMG 120
Query: 123 QLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDD 182
+L D GNLV+RD N+ YLWQSFDYP+DTLL GMK+GWDL+ L+R LS+W+S DD
Sbjct: 121 ELLDSGNLVLRDEKDANSG-IYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDD 179
Query: 183 PSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISY-TNFLYEQYLVENQDE 241
PS G FT +++ P++ ++ GS ++ SG WNG F N ++ V++ +E
Sbjct: 180 PSSGDFTWGTQLQSNPELVMWKGSKEYYRSGPWNGIGFSGGPELRINPVFYFDFVDDGEE 239
Query: 242 ISYWYEPFNRPSIMTLKLNPSGLL-TRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTIC 300
+ Y Y N+ I + +N S R WN W L + P +YC Y CGA C
Sbjct: 240 VYYTYNLKNKSLITRIVMNQSTYFRQRYTWNEINQTWVLYANVPRDYCDTYSLCGAYGNC 299
Query: 301 SPDQKPICECLEGFKLKSKFNQTG---PIKCERSHSSECIGGHQFIKLDNIRAPDFIEVF 357
Q P+CECLE F KS + C R+ +C G F+K ++ PD +
Sbjct: 300 IISQSPVCECLEKFTPKSPESWNSMDWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSW 359
Query: 358 LNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRV 417
+NK+MNL++C + CL+NC+C AY +N+ E SGC +WFGDL+D + GQ +YIR+
Sbjct: 360 VNKTMNLKECRSICLENCSCMAYTATNIKERSGCAIWFGDLIDITQLPA--AGQEIYIRM 417
Query: 418 PASETGKRKLLWILV------ILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAF 471
ASE+ + L ++ I V +LL ++YIF R+ + L
Sbjct: 418 NASESSECLSLVLMAVGIALSIFVACGILLVAYYIFKRKAK----------------LIG 461
Query: 472 DINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYK 531
+ + + E +++ K+ D LPLF ++A AT FS KLGEGGFGPVYK
Sbjct: 462 KVTLTAFSNREENDQIDSGPKE---DLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYK 518
Query: 532 GRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591
G L +GQE+A K S SGQG+ EFKNE++LI KLQHRNLVKLLGCC++ EKIL+ EYM
Sbjct: 519 GTLEDGQEIAAKTHSRSSGQGINEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYM 578
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
PNKSLD F+FD T+ LL W R +II GIA+GLLYLHQ SR RI+HRDLKASNVLLD D
Sbjct: 579 PNKSLDSFIFDQTRGELLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKD 638
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
MNPKISDFGLARMFGGD+ +GNT R+VGTYGYM+PEYA DGLFS+KSDVFSFGILMLE +
Sbjct: 639 MNPKISDFGLARMFGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEII 698
Query: 712 SGKKNTGVYNAD-SFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQ 770
SGKK+ G Y+ D S +L+G+AW LWKD K +LI+ + V++R IN++LLCVQ
Sbjct: 699 SGKKSRGFYHPDHSLSLIGHAWRLWKDGKPLDLIEAFPGESRNLSEVIMRCINISLLCVQ 758
Query: 771 DNAADRPTMSDVVSIINSERLELPSPKEPAFIKGINVKNSSHSNDGMSNLCSVNDVTVSL 830
+ DRP+M+ VV ++ E LP P EP F KG S S+ + S N++T SL
Sbjct: 759 QHPDDRPSMATVVWMLGCEN-TLPQPNEPGFFKGSGPFGPSSSSSNIELS-SNNEITTSL 816
Query: 831 VYPR 834
YPR
Sbjct: 817 FYPR 820
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1809), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/831 (46%), Positives = 520/831 (62%), Gaps = 25/831 (3%)
Query: 19 VKVSLAA-DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVP-DTVVWV 76
++VS A +T+ P ++DGE L+S FELGFFS G S+SRYLGIW++++P TVVWV
Sbjct: 2 LRVSAAQLETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVWV 61
Query: 77 ANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNS 136
NR+ P D+ VL ++ +G ++L N T G IWS+N KNPV QL D GNL+++D +
Sbjct: 62 GNREVPSFDNLGVLQVNEQGVIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKDGN 121
Query: 137 SGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKV 196
GN ++ +WQSFD+P +TLL MK+GW+L L RYL+SW+S DDP+ G F+ ++++
Sbjct: 122 -GNNPDNIVWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRG 180
Query: 197 IPKMCIFNGSVKFACSGQWNGAAFVSAISYT-NFLYEQYLVENQDEISYWYEPFNRPSIM 255
P++ + G SG WNG F + N ++ V N+ EI Y YE N +
Sbjct: 181 FPQLFMKKGDAVQVRSGPWNGLQFTGSPQLNPNPVFNFSFVSNKHEIYYSYELKNTSVVS 240
Query: 256 TLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFK 315
L ++ G L R W + W L FS P + C Y CGA C+ + P+C CLEGF
Sbjct: 241 RLIVSEKGALERHNWIDRTQSWTLFFSVPTDQCDTYLLCGAYASCNINSYPVCSCLEGFV 300
Query: 316 LKSKFNQTGPI---KCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECL 372
KS + + C R C G F KL ++ PD +++ SM+L++C CL
Sbjct: 301 PKSPTDWSASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMCL 360
Query: 373 KNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGKRK------ 426
+NC+C AYANS++ GSGCL+WF L+D + T GQ +YIR+ ASE K K
Sbjct: 361 RNCSCLAYANSDI-RGSGCLLWFDHLIDMRKFTEG--GQDLYIRIAASELAKGKSHGKRV 417
Query: 427 -LLWILVILVLPLVLLPSFYIFCRRRRNCKEKETE-NMETDQDLLAFDINMGITTRTNEF 484
++ +I+ + + L S +R+RN + + + F I G+ T +
Sbjct: 418 AIIVSCLIIGMGMTALGSLLYTRKRKRNILGQAVPLVLLVSSFAIHFYIISGLAKET--Y 475
Query: 485 GEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR 544
E GD K +D+ L F L ++ AT NFS KLGEGGFGPVYKG LL+GQE+AVKR
Sbjct: 476 IENYGDNGAK-EDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIAVKR 534
Query: 545 LSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT 604
LS SGQG +EFKNE++LIA+LQHRNLVKLLGCC+ EK+LI EYMPNKSLD F+FD
Sbjct: 535 LSETSGQGGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIFDKK 594
Query: 605 KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
+ LL W II GIA+GLLYLHQ SR RIIHRDLKASN+LLD DMNPKISDFGLAR
Sbjct: 595 RSMLLDWHMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGLART 654
Query: 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD- 723
FG D+ NTKR+VGTYGYMSPEYA+DGLFS+KSDVFSFG+L+LE +SGK+N G + D
Sbjct: 655 FGKDQNAANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGFSHLDH 714
Query: 724 SFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVV 783
S NLLG+AW LW +++ EL D +QDE S+ ++R I V LLCVQ DRP MS VV
Sbjct: 715 SLNLLGHAWRLWMEERALELFDK-FSQDEYSVSQVLRCIQVGLLCVQRLPHDRPDMSAVV 773
Query: 784 SIINSERLELPSPKEPAFIKGINVKNSSHSNDGMSNLCSVNDVTVSLVYPR 834
++ SE LP PK+P F + + S+ + S N+++ +L+ PR
Sbjct: 774 VMLGSES-SLPQPKQPGFYTERD-PFEADSSTSKERVWSRNEISSTLIEPR 822
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545297|ref|XP_003541080.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/856 (47%), Positives = 532/856 (62%), Gaps = 54/856 (6%)
Query: 1 MAILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGK-SKS 59
MA+L F + LI S K + A DT+ + D LVS FELGFF PG S +
Sbjct: 1 MAMLTIFLLVSKLIFFFS-KFAAATDTINQFESLEDNTTLVSNDGTFELGFFIPGSTSPN 59
Query: 60 RYLGIWFRQVP-DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVK 118
RYLGIW++ +P TVVWVANR+ PI D+++ L I+ +G+LVLLNQ IWS N ++
Sbjct: 60 RYLGIWYKNIPIRTVVWVANRETPIKDNSSKLNITPEGSLVLLNQNKTVIWSANPTTKGV 119
Query: 119 NPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQ 178
VAQL D GNLV+RD N E+YLWQSFD PTDT L GMK+GWDLK L L++W+
Sbjct: 120 VVVAQLLDSGNLVLRDEKDTNP-ENYLWQSFDNPTDTFLPGMKLGWDLKKGLNTVLTAWK 178
Query: 179 SDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISY-TNFLYEQYLVE 237
+ DDPSPG FT P+ ++ G+ K+ SG W+G F S +N + +V
Sbjct: 179 NWDDPSPGDFTDITLRTNYPEEVMWKGTTKYWRSGPWDGTKFSGNPSVPSNAIVNYTIVS 238
Query: 238 NQDEISYWYEPFNRPSIMTLKLNPSGLLTRQ--IWNNNGNDWDLVFSFPDEYCGKYGYCG 295
N+DE Y ++ I + +N S L RQ WN + W + P + C Y CG
Sbjct: 239 NKDEFYATYSMTDKSIISRIVMNQS-LYVRQRLTWNTDSQTWRVSSELPGDLCDHYNTCG 297
Query: 296 ANTICSPDQKPICECLEGFKLKS--KFNQTGPIK-CERSHSSECIGGHQ--FIKLDNIRA 350
A IC Q P+C+CL+GFK KS +NQ + C + + C ++ F K N++A
Sbjct: 298 AFGICVAGQAPVCKCLDGFKPKSPRNWNQMNWNQGCVHNQTWSCREKNKDGFTKFSNVKA 357
Query: 351 PDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVT-EGSGCLMWFGDLLDANRPTRNFT 409
PD ++N SM L +C +C +NC+C AYANSN+ EGSGC +W GDLLD R N
Sbjct: 358 PDTERSWVNASMTLGECRVKCWENCSCMAYANSNIRGEGSGCAIWIGDLLDI-RLMPN-A 415
Query: 410 GQSVYIRVPASETGKR---------KLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETE 460
GQ +YIR+ SET ++ K + ++ + ++ + +IF K KE
Sbjct: 416 GQDLYIRLAVSETAQQSHDQKDNSNKKVVVIASTISSVIAMILIFIFIYWSYRNKNKE-- 473
Query: 461 NMETDQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCK 520
I GI ++NE + +D LPLF L +A AT++FS K
Sbjct: 474 ------------IITGIEGKSNE---------SQQEDFELPLFDLVLIAQATDHFSDHKK 512
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580
LGEGGFGPVYKG L +GQEVAVKRLS S QGL+EFKNE+ML A+LQHRNLVK+LGCC +
Sbjct: 513 LGEGGFGPVYKGTLPDGQEVAVKRLSQTSRQGLKEFKNEVMLCAELQHRNLVKVLGCCFQ 572
Query: 581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRD 640
EK+LI EYM NKSLDVFLFD ++ +LL W R II GIA+GLLYLHQ SR RIIHRD
Sbjct: 573 DDEKLLIYEYMSNKSLDVFLFDSSRSKLLDWPKRFCIINGIARGLLYLHQDSRLRIIHRD 632
Query: 641 LKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDV 700
LKASNVLLD +MNPKISDFGLARM GGD+++G T RIVGTYGYM+PEYA DGLFSIKSDV
Sbjct: 633 LKASNVLLDNEMNPKISDFGLARMCGGDQIEGETSRIVGTYGYMAPEYAFDGLFSIKSDV 692
Query: 701 FSFGILMLETLSGKKNTGV-YNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLV 759
FSFG+L+LE +SGKKN+ + Y D NL+G+AW LWK+ + ID + +D L +
Sbjct: 693 FSFGVLLLEIVSGKKNSRLFYPNDYNNLIGHAWRLWKEGNPMQFIDSSL-EDSCILYEAL 751
Query: 760 RYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAFI-KGINVKNSSHSNDGMS 818
R I++ LLCVQ + DRP M+ VV ++++E LP PK+P+++ K I+ + S S + S
Sbjct: 752 RCIHIGLLCVQHHPNDRPNMASVVVLLSNEN-ALPLPKDPSYLSKDISTERESSSENFTS 810
Query: 819 NLCSVNDVTVSLVYPR 834
S+NDVT+S++ R
Sbjct: 811 --VSINDVTISMLSDR 824
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 834 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.443 | 0.472 | 0.544 | 8.4e-175 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.953 | 0.938 | 0.440 | 1.8e-174 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.946 | 0.928 | 0.434 | 3.3e-173 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.947 | 0.937 | 0.435 | 3e-172 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.408 | 0.418 | 0.548 | 2.1e-167 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.953 | 0.936 | 0.424 | 7.1e-164 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.941 | 0.932 | 0.408 | 8.9e-157 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.393 | 0.407 | 0.532 | 1.1e-150 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.944 | 0.929 | 0.409 | 1e-148 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.941 | 0.945 | 0.397 | 1e-148 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 966 (345.1 bits), Expect = 8.4e-175, Sum P(2) = 8.4e-175
Identities = 206/378 (54%), Positives = 260/378 (68%)
Query: 460 ENMETDQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQC 519
E E QDL + I T E V+ K + +D LP L +V+ AT FS
Sbjct: 411 EYNENGQDLYVRLASSEIETLQRESSRVSSR-KQEEEDLELPFLDLDTVSEATSGFSAGN 469
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
KLG+GGFGPVYKG L GQEVAVKRLS S QG+EEFKNE+ LIAKLQHRNLVK+LG CV
Sbjct: 470 KLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCV 529
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
++ E++LI EY PNKSLD F+FD ++R L W RV II+GIA+G+LYLH+ SR RIIHR
Sbjct: 530 DEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHR 589
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSD 699
DLKASNVLLD DMN KISDFGLAR GGDE + NT R+VGTYGYMSPEY +DG FS+KSD
Sbjct: 590 DLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSD 649
Query: 700 VFSFGILMLETLSGKKNTGVYNAD-SFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVL 758
VFSFG+L+LE +SG++N G N + NLLG+AW + +DK +E+ID + + + +
Sbjct: 650 VFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEV 709
Query: 759 VRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAFIKGINVKNSSHSNDGMS 818
+R I++ LLCVQ + DRP MS VV +++SE L L P++P F N +N S+
Sbjct: 710 LRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLL-DPRQPGFF---NERNLLFSDTVSI 765
Query: 819 NL--CSVNDVTVSLVYPR 834
NL S N T+S++ PR
Sbjct: 766 NLEIPSNNFQTMSVIDPR 783
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1695 (601.7 bits), Expect = 1.8e-174, P = 1.8e-174
Identities = 366/830 (44%), Positives = 502/830 (60%)
Query: 27 TVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVP-DTVVWVANRDRPISD 85
+ T + I + ++S SQ FELGFF+P S YLGIW++ +P T VWVANRD P+S
Sbjct: 31 SATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSS 90
Query: 86 HNAVLTISNKGNLVLLNQTNGTIWSTNVFS-EVKNPVA-QLRDDGNLVIRDNSSGNTTES 143
N L IS+ NLV+ +Q++ +WSTN+ +V++PVA +L D GN V+RD S N
Sbjct: 91 SNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD-SKNNKPSG 148
Query: 144 YLWQSFDYPTDTLLQGMKMGWDLKNR-LERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCI 202
+LWQSFD+PTDTLL MKMGWD K+ R L SW++ DDPS G F+++L P+ I
Sbjct: 149 FLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYI 208
Query: 203 FNG-SVKFACSGQWNGAAFVSAISYTNFLY-EQYLVENQDEISYWYEPFNRPSIMT-LKL 259
+N S+ + SG W G F S Y + EN ++ Y Y N+ +I + L L
Sbjct: 209 YNKESITYR-SGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYR-VNKTNIYSILSL 266
Query: 260 NPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSK 319
+ +GLL R W W ++ P + C Y CG C + PIC C++GF+ ++
Sbjct: 267 SSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMNE 326
Query: 320 FN--QTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTC 377
+ + C R C G F++L +R PD E ++K + L++C CLK C C
Sbjct: 327 QAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNC 386
Query: 378 RAYANSNVTEG-SGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGKRKXXXXXXXXXX 436
A+AN+++ G SGC++W G L D + GQ +Y+RV A + ++
Sbjct: 387 TAFANTDIRNGGSGCVIWSGGLFDIRNYAKG--GQDLYVRVAAGDLEDKRIKSKKIIGSS 444
Query: 437 XXXXXX---SFYIFCRRRRNCKEKETENMETDQDLLAFDINMGITTRTNEFGEVNGDGKD 493
SF IF +R K+K + ++T D+ + NE + +
Sbjct: 445 IGVSILLLLSFIIFHFWKR--KQKRSITIQTP----IVDLVRSQDSLMNELVKASRSYTS 498
Query: 494 K-GKDSWL--PLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG 550
K K +L PL ++A AT NFS KLG+GGFG VYKG LL+G+E+AVKRLS S
Sbjct: 499 KENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSS 558
Query: 551 QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLG 610
QG +EF NE+ LIAKLQH NLV+LLGCCV++GEK+LI EY+ N SLD LFD T+ L
Sbjct: 559 QGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLN 618
Query: 611 WQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670
WQ R II GIA+GLLYLHQ SR RIIHRDLKASNVLLD +M PKISDFG+AR+FG +E
Sbjct: 619 WQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREET 678
Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD-SFNLLG 729
+ NT+R+VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +SGK+N G YN++ NLLG
Sbjct: 679 EANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLG 738
Query: 730 YAWDLWKDDKFHELIDPVITQDEIS--LPV--LVRYINVALLCVQDNAADRPTMSDVVSI 785
+ W WK+ K E++DP I D +S P ++R I + LLCVQ+ A DRP MS V+ +
Sbjct: 739 FVWRHWKEGKELEIVDP-INIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVM 797
Query: 786 INSERLELPSPKEPAFIKG-INVKNSSHSNDGMSNLCSVNDVTVSLVYPR 834
+ SE +P PK P F G +++ S S+ + C+VN VT+S++ R
Sbjct: 798 LGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1683 (597.5 bits), Expect = 3.3e-173, P = 3.3e-173
Identities = 358/823 (43%), Positives = 496/823 (60%)
Query: 34 IRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPD-TVVWVANRDRPISDHNAVLTI 92
I +VS FELGFF PG YLGIW++ + T VWVANRD P+S L I
Sbjct: 40 ISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRDTPLSSSIGTLKI 99
Query: 93 SNKGNLVLLNQTNGTIWSTNVFS-EVKNP-VAQLRDDGNLVIRDNSSGNTTESYLWQSFD 150
S+ NLV+L+Q++ +WSTN+ +V++P VA+L D+GN V+RD S + + LWQSFD
Sbjct: 100 SDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-SKNSAPDGVLWQSFD 157
Query: 151 YPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFA 210
+PTDTLL MK+GWD K R++ SW+S DDPS G F+ +LE + P++ ++N +
Sbjct: 158 FPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRMY 217
Query: 211 CSGQWNGAAFVSAISYTNFLYEQY-LVENQDEISYWYEPFNRPSIMTLKLNPSGLLTRQI 269
SG WNG F F Y + +++E++Y + L ++ SGLL R
Sbjct: 218 RSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQRFT 277
Query: 270 WNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKFN---QTGPI 326
W +W+ + P + C +Y CG C + P+C C++GFK ++ + G
Sbjct: 278 WIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRNPQVWGLRDGSD 337
Query: 327 KCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVT 386
C R C GG F++L ++ PD +++ + +++C +CL++C C A+AN+++
Sbjct: 338 GCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIR 397
Query: 387 -EGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETG---KRKXXXXXXXXXXXXXXXX 442
GSGC+ W G+L D + GQ +Y+R+ A++ R
Sbjct: 398 GSGSGCVTWTGELFDIRNYAKG--GQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLL 455
Query: 443 SFYIFCRRRRNCKEKETENMET---DQDLLAFDINMG---ITTRTNEFGEVNGDGKDKGK 496
SF IF +R K+K + +ET D L + D+ M I++R + E N D
Sbjct: 456 SFIIFFLWKR--KQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTD------ 507
Query: 497 DSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEF 556
D LPL VA AT NFS KLG+GGFG VYKG+LL+GQE+AVKRLS S QG +EF
Sbjct: 508 DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEF 567
Query: 557 KNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT 616
KNE+ LIA+LQH NLV+LL CCV+ GEK+LI EY+ N SLD LFD ++ L WQ R
Sbjct: 568 KNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFD 627
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
II GIA+GLLYLHQ SRFRIIHRDLKASN+LLD M PKISDFG+AR+FG DE + NT++
Sbjct: 628 IINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRK 687
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD-SFNLLGYAWDLW 735
+VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +S K+N G YN+D NLLG W W
Sbjct: 688 VVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNW 747
Query: 736 KDDKFHELIDPVITQDEISLPV--LVRYINVALLCVQDNAADRPTMSDVVSIINSERLEL 793
K+ K E+IDP+IT + ++R I + LLCVQ+ A DRPTMS V+ ++ SE +
Sbjct: 748 KEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTI 807
Query: 794 PSPKEPAFI--KGINVKNSSHSNDGMSNLCSVNDVTVSLVYPR 834
P PK P + + + +SS S +VN +TVS++ R
Sbjct: 808 PQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1674 (594.3 bits), Expect = 3.0e-172, P = 3.0e-172
Identities = 362/831 (43%), Positives = 505/831 (60%)
Query: 27 TVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVP-DTVVWVANRDRPISD 85
+ T + I + ++S SQ FELGFF+P S YLGIW++ +P T VWVANRD P+S
Sbjct: 31 SATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSS 90
Query: 86 HNAVLTISNKGNLVLLNQTNGTIWSTNVFS-EVKNPVA-QLRDDGNLVIRDNSSGNTTES 143
N L IS NLV+ +Q++ +WSTN+ +V++PVA +L D+GN ++RD+++
Sbjct: 91 SNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSNN-----R 144
Query: 144 YLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIF 203
LWQSFD+PTDTLL MK+GWD K R L SW++ DDPS G+F+++LE P+ I
Sbjct: 145 LLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYIC 204
Query: 204 NGSVKFACSGQWNGAAFVSAISYTNFLYEQY-LVENQDEISYWYEPFNRPSIMT-LKLNP 261
+ SG WNG F S Y Y +++E++Y Y N+ ++ + L LN
Sbjct: 205 SKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYR-INKTNLYSRLYLNS 263
Query: 262 SGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKFN 321
+GLL R W W ++ P + C Y CG C + P C C++GFK ++
Sbjct: 264 AGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNEQA 323
Query: 322 ---QTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCR 378
+ G C R C G F +L ++ PD +++ + L+ C CL++C C
Sbjct: 324 WDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCT 383
Query: 379 AYANSNVTEG-SGCLMWFGDLLDANRPTRNFTGQSVYIRVPASET-GKR--KXXXXXXXX 434
A+AN+++ G SGC++W ++LD + GQ +Y+R+ A+E KR
Sbjct: 384 AFANADIRNGGSGCVIWTREILDMRNYAKG--GQDLYVRLAAAELEDKRIKNEKIIGSSI 441
Query: 435 XXXXXXXXSFYIFCRRRRNCKEK---ETENMET--DQDLLAFDINMGITTRTNEFGEVNG 489
SF IF +R K +T N++ QD L D+ + +R G +
Sbjct: 442 GVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDV---VVSRR---GYTSK 495
Query: 490 DGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS 549
+ K + + LPL L ++A AT NFS KLG+GGFG VYKGRLL+G+E+AVKRLS S
Sbjct: 496 EKKSEYLE--LPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMS 553
Query: 550 GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLL 609
QG +EF NE+ LIAKLQH NLV+LLGCCV++GEK+LI EY+ N SLD LFD T+ L
Sbjct: 554 SQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNL 613
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
WQ R II GIA+GLLYLHQ SR RIIHRDLKASNVLLD +M PKISDFG+AR+FG +E
Sbjct: 614 NWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREE 673
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD-SFNLL 728
+ NT+R+VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +SGK+N G YN++ NLL
Sbjct: 674 TEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLL 733
Query: 729 GYAWDLWKDDKFHELIDPVITQDEIS--LPV--LVRYINVALLCVQDNAADRPTMSDVVS 784
G+ W WK+ E++DP I D +S P ++R I + LLCVQ+ A DRP MS V+
Sbjct: 734 GFVWRHWKEGNELEIVDP-INIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMV 792
Query: 785 IINSERLELPSPKEPAFIKGIN-VKNSSHSNDGMSNLCSVNDVTVSLVYPR 834
++ SE +P PK P F G + ++ S S+ + C+VN +T+S++ R
Sbjct: 793 MLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 961 (343.3 bits), Expect = 2.1e-167, Sum P(2) = 2.1e-167
Identities = 192/350 (54%), Positives = 253/350 (72%)
Query: 489 GDGKDKG---KDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRL 545
G+ KG +D LP+F +++ AT++FS LG GGFGPVYKG+L +GQE+AVKRL
Sbjct: 471 GENFRKGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRL 530
Query: 546 SSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK 605
S+ SGQG+EEFKNE+ LIAKLQHRNLV+LLGCC++ E +LI EYMPNKSLD F+FD +
Sbjct: 531 SANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERR 590
Query: 606 KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665
L W+ R+ II G+A+G+LYLHQ SR RIIHRDLKA NVLLD DMNPKISDFGLA+ F
Sbjct: 591 STELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSF 650
Query: 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD-S 724
GGD+ + +T R+VGTYGYM PEYA+DG FS+KSDVFSFG+L+LE ++GK N G +AD
Sbjct: 651 GGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHD 710
Query: 725 FNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784
NLLG+ W +W +D+ E+ + ++ +P ++R I+VALLCVQ DRPTM+ VV
Sbjct: 711 LNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVL 770
Query: 785 IINSERLELPSPKEPAFIKGINVKNSSHSNDGMSNLCSVNDVTVSLVYPR 834
+ S+ LP P +P F NV + S S +L S N+V+++++ R
Sbjct: 771 MFGSDS-SLPHPTQPGFFTNRNVPDISSS----LSLRSQNEVSITMLQGR 815
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1595 (566.5 bits), Expect = 7.1e-164, P = 7.1e-164
Identities = 357/841 (42%), Positives = 513/841 (60%)
Query: 24 AADTVTPASFIRDG---EKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPD-TVVWVANR 79
AA+T+ +RDG + LVS + FELGFFSPG S R+LGIW+ + D VVWVANR
Sbjct: 25 AANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKAVVWVANR 84
Query: 80 DRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEV---KNPVAQLRDDGNLVIRDNS 136
PISD + VL ISN GNLVLL+ N T+WS+N+ S N V + D GN V+ +
Sbjct: 85 ATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSETD 144
Query: 137 SGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKV 196
T+ +W+SF++PTDT L M++ + + SW+S+ DPSPG ++ ++
Sbjct: 145 ----TDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSG 200
Query: 197 IPKMCIFNGS-VKFACSGQWNGAAF--VSAISY-TNFLYEQYLVENQDE---ISYWYEPF 249
P++ ++ G+ + SGQWN A F + +S TN+LY L DE + + Y P
Sbjct: 201 APEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPS 260
Query: 250 NRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICS-PDQKPIC 308
+ ++ K+ +G WN W S PD C +Y CG IC IC
Sbjct: 261 DPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSNGIC 320
Query: 309 ECLEGFKLKSKFNQT-G-----PIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSM 362
C+ G++ S N + G P+KCER+ S +G +F+ L +++ PDF E+ + +
Sbjct: 321 SCIHGYEQVSVGNWSRGCRRRTPLKCERNIS---VGEDEFLTLKSVKLPDF-EIPEHNLV 376
Query: 363 NLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASET 422
+ + C CL+NC+C AY+ + G GC++W DL+D + G S++IR+ SE
Sbjct: 377 DPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVDLQQFEAG--GSSLHIRLADSEV 431
Query: 423 GK-RKXXXXXXXXXXXXXXXXS-FYIFCRRRRNCKEKETE--NMETDQDLLAFDINMGIT 478
G+ RK F + R + K+ TD ++ D+
Sbjct: 432 GENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKE 491
Query: 479 TRTNEFGEVNGDGKDKGKD-SWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNG 537
T + G V+ + K + S LP+FSL ++A AT +F + +LG GGFGPVYKG L +G
Sbjct: 492 TTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDG 551
Query: 538 QEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLD 597
+E+AVKRLS +SGQG++EFKNE++LIAKLQHRNLV+LLGCC E EK+L+ EYMPNKSLD
Sbjct: 552 REIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLD 611
Query: 598 VFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS 657
FLFD TK+ L+ W+ R +IIEGIA+GLLYLH+ SR RIIHRDLK SNVLLD +MNPKIS
Sbjct: 612 FFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKIS 671
Query: 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNT 717
DFG+AR+FGG++ + NT R+VGTYGYMSPEYA++GLFS+KSDV+SFG+L+LE +SGK+NT
Sbjct: 672 DFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNT 731
Query: 718 GVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRP 777
+ +++ +L+GYAW L+ + EL+DP I + S +R I+VA+LCVQD+AA+RP
Sbjct: 732 SLRSSEHGSLIGYAWYLYTHGRSEELVDPKI-RVTCSKREALRCIHVAMLCVQDSAAERP 790
Query: 778 TMSDVVSIINSERLELPSPKEPAFIKGINVKNSSHSNDGMSN----LCSVNDVTVSLVYP 833
M+ V+ ++ S+ L +P++P F +NS N + + + S N++T ++V
Sbjct: 791 NMASVLLMLESDTATLAAPRQPTFTS--TRRNSIDVNFALDSSQQYIVSSNEITSTVVLG 848
Query: 834 R 834
R
Sbjct: 849 R 849
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1528 (542.9 bits), Expect = 8.9e-157, P = 8.9e-157
Identities = 335/821 (40%), Positives = 480/821 (58%)
Query: 34 IRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQV-PDTVVWVANRDRPISDHNAVLTI 92
IR+G+ L+S + FELGFF+P S RY+GIW++ + P TVVWVANR++P+ DH L I
Sbjct: 38 IREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKPLLDHKGALKI 97
Query: 93 SNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYP 152
++ GNLV++N N TIWSTNV E N VA L G+LV+ +S + W+SF+ P
Sbjct: 98 ADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVLCSDSD---RRKWYWESFNNP 154
Query: 153 TDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACS 212
TDT L GM++ + R W+S+ DPSPGK++ ++ ++ I+ G + S
Sbjct: 155 TDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIVIWEGEKRKWRS 214
Query: 213 GQWNGAAFVSA---ISYTNFLYEQYLVENQDE---ISYWYEPFNRPSIMTLKLNPSGLLT 266
G WN A F + +TN++Y L D + + Y + + + P G+
Sbjct: 215 GPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSDFLRFWIRPDGVEE 274
Query: 267 RQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPI----CECLEGFKL--KSKF 320
+ WN + +W+L+ P C KY CG ++C D K C C++GF+ + ++
Sbjct: 275 QFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCD-DSKEFDSGKCSCIDGFEPVHQDQW 333
Query: 321 NQTG-PIKCERSHSSEC----IGGHQ--FIKLDNIRAPDFIEVFLNKSMNLQQCAAECLK 373
N C+R C + G + F L I+ PDF V L+ N + C C +
Sbjct: 334 NNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGSVVLHN--NSETCKDVCAR 391
Query: 374 NCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGKRKXXXXXXX 433
+C+C+AYA + G GC++W DL+D R G S+ IR+ S+ G K
Sbjct: 392 DCSCKAYA---LVVGIGCMIWTRDLIDMEHFERG--GNSINIRLAGSKLGGGKENSTLWI 446
Query: 434 XXXXXXXXXSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGITTRTNEFGEVNGDGKD 493
+ K+ + +D+ DI ++ + GD D
Sbjct: 447 IVFSVIGAFLLGLCIWILWKFKKSLKAFLWKKKDITVSDIIENRDYSSSPIKVLVGDQVD 506
Query: 494 KGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGL 553
D LP+FS SVA+AT +F+ + KLG+GGFG VYKG G+E+AVKRLS +S QGL
Sbjct: 507 T-PD--LPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGL 563
Query: 554 EEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQA 613
EEFKNE++LIAKLQHRNLV+LLGCC+E EK+L+ EYMPNKSLD FLFD +K+ L W+
Sbjct: 564 EEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRK 623
Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673
R +I GIA+GLLYLH+ SR +IIHRDLKASN+LLD +MNPKISDFG+AR+F + N
Sbjct: 624 RWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHAN 683
Query: 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWD 733
T R+VGTYGYM+PEYA++G+FS KSDV+SFG+L+LE +SG+KN D +L+GYAW
Sbjct: 684 TIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWH 743
Query: 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLEL 793
LW K E+IDP++ +D + +R I+V +LC QD+ RP M V+ ++ S+ +L
Sbjct: 744 LWSQGKTKEMIDPIV-KDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQL 802
Query: 794 PSPKEPAFIKGINVKNSSHSNDGMSNLCSVNDVTVSLVYPR 834
P P++P F +N + + DG ++ SVNDVT + + R
Sbjct: 803 PPPRQPTFHSFLNSGDIELNFDG-HDVASVNDVTFTTIVGR 842
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 881 (315.2 bits), Expect = 1.1e-150, Sum P(2) = 1.1e-150
Identities = 179/336 (53%), Positives = 236/336 (70%)
Query: 500 LPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNE 559
L F + ++ AT NFS+ KLG+GGFG VYKG+L +G+E+AVKRLSS SGQG EEF NE
Sbjct: 476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535
Query: 560 MMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE 619
++LI+KLQHRNLV++LGCC+E+ EK+LI E+M NKSLD FLFD K+ + W R II+
Sbjct: 536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
GIA+GLLYLH SR R+IHRDLK SN+LLD MNPKISDFGLARM+ G E Q NT+R+VG
Sbjct: 596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGV-YNADSFNLLGYAWDLWKDD 738
T GYMSPEYA G+FS KSD++SFG+LMLE +SG+K + Y + L+ YAW+ W +
Sbjct: 656 TLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWESWSEY 715
Query: 739 KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKE 798
+ +L+D + L V R I + LLCVQ ADRP ++++++ + +LPSPK+
Sbjct: 716 RGIDLLDQDLADSCHPLEV-GRCIQIGLLCVQHQPADRPNTLELLAMLTTTS-DLPSPKQ 773
Query: 799 PAFIKGINVKNSSHSNDGMSNLCSVNDVTVSLVYPR 834
P F + S SND L +VN +T S++ R
Sbjct: 774 PTFAFHTR-DDESLSND----LITVNGMTQSVILGR 804
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 1452 (516.2 bits), Expect = 1.0e-148, P = 1.0e-148
Identities = 346/844 (40%), Positives = 487/844 (57%)
Query: 26 DTVTPASFIRDGEKLVSFSQR-FELGFFSPG-KSKSR-YLGIWFRQV-PDTVVWVANRDR 81
DT+ + LVS + FE GFF+P K SR YLGIW+ + P TVVWVANR
Sbjct: 26 DTLRQGESLSGAATLVSSPEGVFEAGFFAPDPKQPSRQYLGIWYHSISPRTVVWVANRVA 85
Query: 82 PISDHNAVLTISNKGNLVLLNQT--NGT-----IWSTNVFSEVKNP----VAQLRDDGNL 130
P + + LT++ G+L +L+ T NGT +WS+N S P A L+D G+L
Sbjct: 86 PATSASPSLTLTVTGDLRVLDGTAANGTADAPLLWSSNTTSRA-GPRGGYSAVLQDTGSL 144
Query: 131 VIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNR--LERYL-SSWQSDDDPSPGK 187
+R + LW SF +PTDT+L GM++ R ER L +SW S+ DPSPG+
Sbjct: 145 EVRSE------DGVLWDSFWHPTDTILSGMRITLQAPGRGPKERMLFTSWASETDPSPGR 198
Query: 188 FTSRLEIKVIPKMCIF-NGSVKFACSGQWNGAAFVSAISYTNFLYEQYLVENQDEI--SY 244
+ L+ + I+ +G+V + SGQWNG F+ I + LY D + +Y
Sbjct: 199 YALGLDPGNSGQAYIWKDGNVTYWRSGQWNGVNFIG-IPWRP-LYRSGFTPAIDPVLGNY 256
Query: 245 WYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTIC--SP 302
+ S+ + P+G + + DW+LV+ P C Y CG N C S
Sbjct: 257 YTYTATNTSLQRFVVLPNGTDICYMVRKSSQDWELVWYQPSNECEYYATCGPNAKCTASQ 316
Query: 303 DQKPICECLEGF--KLKSKFNQTGPIK-CERSHSSECI---GGHQFIKLDNIRAPDFIEV 356
D K C CL+GF KL+ ++N + C RS C G F+ + NI+ PDF
Sbjct: 317 DGKAKCTCLKGFHPKLQEQWNAGNWSQGCIRSPPLGCETNQSGDGFLPMGNIKWPDF-SY 375
Query: 357 FLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANR-PTRNFTGQSVYI 415
+++ + C CL NC+C AY + T GCL W +L+D + T +T + +
Sbjct: 376 WVSTVGDEPGCRTVCLNNCSCGAYVYTATT---GCLAWGNELIDMHELQTGAYT---LNL 429
Query: 416 RVPASET-GKRKX--XXXXXXXXXXXXXXXSFYIFCRRRRNCKEKETENMETDQDLLAFD 472
++PASE G ++ + RN K+ + +
Sbjct: 430 KLPASELRGHHPIWKIATIISAIVLFVLAACLLLWWKHGRNIKDAVHGSWRSRHSSTQSQ 489
Query: 473 INMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKG 532
N + + + D +D GK L ++SL + AT NFS KLGEGGFGPVY G
Sbjct: 490 QNSAMLDISQSI-RFDDDVED-GKSHELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMG 547
Query: 533 RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592
L G+EVAVKRL SGQGLEEFKNE++LIAKLQHRNLV+LLGCC+ + EKIL+ EYMP
Sbjct: 548 TLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMP 607
Query: 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM 652
NKSLD FLF+P K+RLL W+ R IIEGIA+GLLYLH+ SR R++HRDLKASN+LLD DM
Sbjct: 608 NKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADM 667
Query: 653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
PKISDFG+ARMFGGD+ Q NT R+VGT+GYMSPEYA++G+FS+KSDV+ FG+L+LE ++
Sbjct: 668 KPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIIT 727
Query: 713 GKKNTGVY-NADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQD 771
GK+ + + DS N+ GYAW W +D ELIDPVI + S+ ++R I++ALLCVQD
Sbjct: 728 GKRAVSFHCHEDSLNIAGYAWRQWNEDNAAELIDPVI-RASCSVRQVLRCIHIALLCVQD 786
Query: 772 NAADRPTMSDVVSIINSERLELPSPKEPAF-IKGINVKNSSHSNDGMSNLCSVNDVTVSL 830
+A +RP + V+ +++++ LP+P+ P ++G +++S S S+ S+ VT++
Sbjct: 787 HADERPDIPTVILMLSNDSSSLPNPRPPTLMLRGREIESSKSSEKDRSH--SIGTVTMTQ 844
Query: 831 VYPR 834
++ R
Sbjct: 845 LHGR 848
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1452 (516.2 bits), Expect = 1.0e-148, P = 1.0e-148
Identities = 332/836 (39%), Positives = 485/836 (58%)
Query: 24 AADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVP-DTVVWVANRDRP 82
A D +T +S RD E +VS F GFFSP S RY GIWF +P TVVWVAN + P
Sbjct: 21 ATDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTVVWVANSNSP 80
Query: 83 ISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVK-NPV-AQLRDDGNLVIRDNSSGNT 140
I+D + +++IS +GNLV+++ WSTNV V N A+L + GNLV+ + NT
Sbjct: 81 INDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLVLLGTT--NT 138
Query: 141 TESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKM 200
+ LW+SF++P + L M + D K L SW+S DPSPG++++ L P++
Sbjct: 139 GDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLPFPEL 198
Query: 201 CIFNGSVKFACSGQWNGAAFVSA--ISYTNFLYEQYLV-ENQDEISYWYEPFNRPSIMTL 257
++ + SG WNG F+ + Y L+E L +N+ +S Y +
Sbjct: 199 VVWKDDLLMWRSGPWNGQYFIGLPNMDYRINLFELTLSSDNRGSVSMSYA--GNTLLYHF 256
Query: 258 KLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTIC--SPDQKPICECLEGFK 315
L+ G + ++ WN +W P C Y CG C +P P C C+ GFK
Sbjct: 257 LLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMCIRGFK 316
Query: 316 LKS--KFN---------QTGPIKCE-RSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMN 363
+S ++N + P++CE R ++ F+++ ++ P + N
Sbjct: 317 PQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNPQ---RSGAN 373
Query: 364 LQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSV--YIRVPASE 421
Q C CLKNC+C AY+ G GCL+W G+L+D + F+G V YIR+ SE
Sbjct: 374 EQDCPESCLKNCSCTAYS---FDRGIGCLLWSGNLMDM----QEFSGTGVVFYIRLADSE 426
Query: 422 TGKRKXXXXXXXXXXXXXXXXSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGITTRT 481
KR ++F K ++ E +++ + M + +
Sbjct: 427 FKKRTNRSIVITVTLLVGA----FLFAGTVVLALWKIAKHREKNRNTRLLNERMEALS-S 481
Query: 482 NEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVA 541
N+ G + + + K K+ LPLF +A AT NFS+ KLG+GGFG VYKGRL G ++A
Sbjct: 482 NDVGAILVN-QYKLKE--LPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIA 538
Query: 542 VKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLF 601
VKRLS SGQG+EEF NE+++I+KLQHRNLV+LLG C+E E++L+ E+MP LD +LF
Sbjct: 539 VKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLF 598
Query: 602 DPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661
DP K+RLL W+ R II+GI +GL+YLH+ SR +IIHRDLKASN+LLD ++NPKISDFGL
Sbjct: 599 DPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGL 658
Query: 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN 721
AR+F G+E + +T R+VGTYGYM+PEYA+ GLFS KSDVFS G+++LE +SG++N+ YN
Sbjct: 659 ARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYN 718
Query: 722 -ADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMS 780
+ NL YAW LW + L+DPVI ++ + R ++V LLCVQD+A DRP+++
Sbjct: 719 DGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIR-RCVHVGLLCVQDHANDRPSVA 777
Query: 781 DVVSIINSERLELPSPKEPAFI--KGINVKNSSHSNDGMSNLCSVNDVTVSLVYPR 834
V+ +++SE LP PK+PAFI +G + SS +D + S+N+V+++ + R
Sbjct: 778 TVIWMLSSENSNLPEPKQPAFIPRRGTSEVESSGQSDPRA---SINNVSLTKITGR 830
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81905 | SD18_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4427 | 0.9184 | 0.9011 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_XI001046 | hypothetical protein (802 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 834 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-55 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-54 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-41 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 4e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-38 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 2e-37 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-36 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-35 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-31 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-27 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-27 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-26 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-25 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-25 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-24 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-23 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-23 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 2e-23 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-21 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 6e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-21 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-20 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-17 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 3e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-09 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 1e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.003 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.003 | |
| PTZ00163 | 230 | PTZ00163, PTZ00163, hypothetical protein; Provisio | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 7e-55
Identities = 100/282 (35%), Positives = 145/282 (51%), Gaps = 36/282 (12%)
Query: 516 SMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHR 569
++ KLGEG FG VYKG L EVAVK L S Q +EEF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
N+VKLLG C E+ ++++EYMP L +L + + L ++ IA+G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVGTYGYMSPEY 688
S+ IHRDL A N L+ ++ KISDFGL+R ++ D + ++ +M+PE
Sbjct: 121 --SK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPES 175
Query: 689 ALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL--GYAWDLWKDDKFHELI 744
+G F+ KSDV+SFG+L+ E TL + G+ NA+ L GY L K
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR--LPK-------- 225
Query: 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
P E+ + L C ++ DRPT S++V I+
Sbjct: 226 -PPNCPPEL--------YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 188 bits (481), Expect = 1e-54
Identities = 98/283 (34%), Positives = 140/283 (49%), Gaps = 39/283 (13%)
Query: 516 SMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHR 569
++ KLGEG FG VYKG+L EVAVK L S Q +EEF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
N+VKLLG C E+ +++EYM L +L K L ++ IA+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE 119
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL--QGNTKRIVGTYGYMSPE 687
IHRDL A N L+ ++ KISDFGL+R D+ + K + +M+PE
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPE 173
Query: 688 YALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL--GYAWDLWKDDKFHEL 743
+G F+ KSDV+SFG+L+ E TL + G+ N + L GY L +
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR--LPQ------- 224
Query: 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
P E+ ++ L C ++ DRPT S++V I+
Sbjct: 225 --PPNCPPEL--------YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (481), Expect = 2e-54
Identities = 98/281 (34%), Positives = 141/281 (50%), Gaps = 35/281 (12%)
Query: 520 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKL 574
KLGEG FG VYKG+L EVAVK L S + ++F E ++ KL H N+V+L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLYL 628
LG C E+ L+LEYM L +L F +K L + ++ IA+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVGTYGYMSPE 687
S+ + +HRDL A N L+ D+ KISDFGL+R ++ D + T + +M+PE
Sbjct: 122 A--SK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPE 177
Query: 688 YALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745
DG+F+ KSDV+SFG+L+ E TL G+ N + L +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-------RKGYRLP--K 228
Query: 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
P DE+ Y + L C Q + DRPT S++V +
Sbjct: 229 PEYCPDEL-------Y-ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 93/289 (32%), Positives = 137/289 (47%), Gaps = 48/289 (16%)
Query: 515 FSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQH 568
+ KLGEG FG VYKG L +VAVK L + + EEF E ++ KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
N+V+LLG C + ++ EYMP L FL L + + + IA+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNTKRIVGTYGYMS 685
S+ +HRDL A N L+ ++ KISDFGL+R D+ +G K + +M+
Sbjct: 119 E--SK-NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI---KWMA 172
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYA-WDLWKDDKFHELI 744
PE DG F+ KSDV+SFG+L+ E + LG + +++ EL+
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFT---------------LGEQPYPGMSNEEVLELL 217
Query: 745 D-------PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
+ P DE+ Y + L C + DRPT S++V +
Sbjct: 218 EDGYRLPRPENCPDEL-------Y-ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 77/193 (39%), Positives = 108/193 (55%), Gaps = 11/193 (5%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
LGEGGFG VY R G++VA+K + S LEE E+ ++ KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
++ L++EY SL L + K L + I+ I +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 639 RDLKASNVLLD-MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSI 696
RDLK N+LLD + K++DFGL+++ D+ T IVGT YM+PE L G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 697 KSDVFSFGILMLE 709
KSD++S G+++ E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 1e-47
Identities = 71/199 (35%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
KLG G FG VYK + G+ VAVK L S+ + + + E+ ++ +L H N+V+L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
++ L++EY L +L ++ L I I +GL YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL-FS 695
IHRDLK N+LLD + KI+DFGLA+ + VGT YM+PE L G +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 696 IKSDVFSFGILMLETLSGK 714
K DV+S G+++ E L+GK
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 68/207 (32%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLV 572
+ + KLGEG FG VY R G+ VA+K + + + E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGLLY 627
+L ++ + L++EY L L + R Q I L Y
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ--------ILSALEY 112
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
LH I+HRDLK N+LLD D + K++DFGLAR E VGT YM+PE
Sbjct: 113 LHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPE 166
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
L + D++S G+++ E L+GK
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 9e-41
Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 519 CKLGEGGFGPVYKGRLL-NGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
LG G FG VY G+ +AVK LS S + LE + E+ +++ LQH N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 576 GCCVEQGEKIL--ILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGLLYL 628
G ++ + L LEY+ SL L R Q I +GL YL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ--------ILEGLAYL 117
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H I+HRD+K +N+L+D D K++DFG A+ G E T + GT +M+PE
Sbjct: 118 H---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
+ +D++S G ++E +GK
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-40
Identities = 54/115 (46%), Positives = 71/115 (61%), Gaps = 6/115 (5%)
Query: 70 PDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGN 129
TVVWVANR P++D + L + + GNLVL + +WS+N + VA L+DDGN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 130 LVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPS 184
LV+ DNS LWQSFD+PTDTLL G K G ++ R L+SW+S+ DPS
Sbjct: 61 LVLYDNSG-----KVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 68/197 (34%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
K+G+GGFG VYK R G+EVA+K + +S + E+ NE+ ++ K +H N+VK G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRL-LGWQARVTIIEGIAQGLLYLHQYSRFRII 637
+++ E +++E+ SL L T + L A + + + +GL YLH II
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIA--YVCKELLKGLEYLHSN---GII 120
Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
HRD+KA+N+LL D K+ DFGL+ +VGT +M+PE + K
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 698 SDVFSFGILMLETLSGK 714
+D++S GI +E GK
Sbjct: 178 ADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 50/119 (42%), Positives = 66/119 (55%), Gaps = 6/119 (5%)
Query: 34 IRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTIS 93
+ G+ LVS FELGFF Y I ++ TVVWVANRD P S + LT+
Sbjct: 4 LSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQ 62
Query: 94 NKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYP 152
+ GNLV+ + + +WS+N N V L DDGNLV+ D+ ++LWQSFDYP
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 79/201 (39%), Positives = 106/201 (52%), Gaps = 14/201 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG G FG V+ G +VAVK L + E F E ++ KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLV 64
Query: 573 KLLGCCVEQGEKILIL-EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
+L C + E I I+ EYM SL FL K+L V + IA+G+ YL
Sbjct: 65 QLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE-- 120
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEY 688
IHRDL A N+L+ ++ KI+DFGLAR+ DE +G I T +PE
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEA 175
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
A G F+IKSDV+SFGIL+ E
Sbjct: 176 ANYGRFTIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 15/206 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRN 570
N+ + +G G FG VYKG L G VA+K++S + + L+ E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYL 628
+VK +G +ILEY N SL + F P + L+ + + QGL YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA-----VYVYQVLQGLAYL 115
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H+ +IHRD+KA+N+L D K++DFG+A + +VGT +M+PE
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEV 170
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
S SD++S G ++E L+G
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 85/283 (30%), Positives = 133/283 (46%), Gaps = 21/283 (7%)
Query: 520 KLGEGGFGPVYKGRLLN-----GQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLVK 573
+LGEG FG V R G++VAVK L+ S Q +F+ E+ ++ L H N+VK
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 574 LLGCCVEQGEKI--LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
G C + G + LI+EY+P+ SL +L + L + I +G+ YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICKGMDYLGSQ 128
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYA 689
R IHRDL A N+L++ + KISDFGLA++ D + Y +PE
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 690 LDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID--PV 747
FS SDV+SFG+ + E + + A+ ++G A + EL+
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER 244
Query: 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790
+ + S P V + LC + DRP+ +D++ I++ R
Sbjct: 245 LPRPP-SCPDEVYDLMK--LCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 73/207 (35%), Positives = 109/207 (52%), Gaps = 20/207 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
E F+++ KLG G FG V++G N VA+K L S ++F+ E+ + +L+H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARVTIIEGIAQGL 625
L C +I E M SL FL P + L + Q +A+G+
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
YL + IHRDL A N+L+ D+ K++DFGLAR+ D + K+I Y + +
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTA 172
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
PE A G FS KSDV+SFGIL+ E +
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 52/120 (43%), Positives = 69/120 (57%), Gaps = 7/120 (5%)
Query: 32 SFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLT 91
+ + G+ LVS + FELGFF+ Y I ++ TVVWVANRD P+SD + LT
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSSSRTVVWVANRDNPVSD-SCTLT 59
Query: 92 ISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDY 151
+ + GNLVL + +WS+N N V L DDGNLVI D+ ++LWQSFDY
Sbjct: 60 LQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDG-----NFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 75/213 (35%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 521 LGEGGFGPVYKGRL--LNGQE----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVK 573
LGEG FG VYKG L N + VA+K L + + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLF-------------DPTKKRLLGWQARVTIIEG 620
LLG C ++ ++ EY+ + L FL D T K L + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVG 679
IA G+ YL S +HRDL A N L+ + KISDFGL+R ++ D + +K ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M PE L G F+ +SD++SFG+++ E S
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 520 KLGEGGFGPVYKG-RLLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
K+GEG G VYK G+EVA+K RL Q+ + + NE++++ +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYYD 82
Query: 577 CCVEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
+ E +++EYM SL D+ R+ Q + + QGL YLH
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDII--TQNFVRMNEPQI-AYVCREVLQGLEYLHS---QN 136
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
+IHRD+K+ N+LL D + K++DFG A + + +VGT +M+PE +
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGTPYWMAPEVIKRKDYG 194
Query: 696 IKSDVFSFGILMLETLSG 713
K D++S GI+ +E G
Sbjct: 195 PKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (316), Expect = 3e-31
Identities = 83/313 (26%), Positives = 134/313 (42%), Gaps = 21/313 (6%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH-R 569
++ + KLGEG FG VY R + + VA+K L+ + + +E F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
N+VKL ++G L++EY+ SL+ L +K L + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 630 QYSRFRIIHRDLKASNVLLDMDMN-PKISDFGLARMFGGD----ELQGNTKRIVGTYGYM 684
IIHRD+K N+LLD D K+ DFGLA++ + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 685 SPEYALDGLF---SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH 741
+PE L S SD++S GI + E L+G + + + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPTP 233
Query: 742 ELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAF 801
L P+ + + ++ + + +R + S +S L+L
Sbjct: 234 SLASPLSPSNPELISKAAS--DLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDL 291
Query: 802 IKGINVKNSSHSN 814
+K + S
Sbjct: 292 LKPDDSAPLRLSL 304
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRN 570
+ LG+G G VYK R G+ A+K++ + ++ E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARV--TIIEGIAQGLLYL 628
+VK G ++GE ++LEYM SL L K++ V I I +GL YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYL 115
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H IIHRD+K SN+L++ KI+DFG++++ + VGT YMSPE
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPER 171
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
+S +D++S G+ +LE GK
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 77/210 (36%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 521 LGEGGFGPVYKGRLLN-------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLV 572
LG G FG VY+G + VAVK L + Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKR----LLGWQARVTIIEGIAQGLLYL 628
KLLG C+ + +I+E M L +L D +R LL + + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 629 HQYSRFRIIHRDLKASNVLL-----DMDMNPKISDFGLAR-MFGGDELQGNTKRIVGTYG 682
Q IHRDL A N L+ D D KI DFGLAR ++ D + + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE LDG F+ +SDV+SFG+LM E L+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 64/203 (31%), Positives = 110/203 (54%), Gaps = 15/203 (7%)
Query: 521 LGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKL 574
LG G FG VYKG + VA+K L ++ + +E +E ++A + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
LG C+ ++ LI + MP L ++ + +G Q + IA+G+ YL +
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEK-- 128
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
R++HRDL A NVL+ + KI+DFGLA++ DE + + + +M+ E L +
Sbjct: 129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187
Query: 694 FSIKSDVFSFGILMLETLS-GKK 715
++ KSDV+S+G+ + E ++ G K
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 69/218 (31%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 521 LGEGGFGPVYKGRLLNGQE------VAVKRLSSQSGQGLEE-FKNEMMLIAKLQHRNLVK 573
LGEG FG V+ G + + VAVK L + + F+ E L+ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRL---------LGWQARVTIIEGIA 622
G C E I++ EYM + L+ FL P L L + I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-- 680
G++YL + +HRDL N L+ D+ KI DFG++R D + R+ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 681 --YGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKK 715
+M PE + F+ +SDV+SFG+++ E + GK+
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 88/275 (32%), Positives = 136/275 (49%), Gaps = 33/275 (12%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLL 575
+G G FG V +GRL L G++ VA+K L + S + +F E ++ + H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 576 GCCVEQGEKILIL-EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
G V + ++I+ EYM N SLD FL + K V ++ GIA G+ YL S
Sbjct: 72 GV-VTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL---SEM 125
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK--RIVGTYGYMSPEYALDG 692
+HRDL A N+L++ ++ K+SDFGL+R E TK +I + +PE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYR 183
Query: 693 LFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751
F+ SDV+SFGI+M E +S G++ Y WD+ D + D
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERP---Y-----------WDMSNQDVIKAVEDGYRLPP 229
Query: 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
+ P + + L C Q + +RPT S +VS +
Sbjct: 230 PMDCPSALYQL--MLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 71/197 (36%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
+ KLG G FG V++G N VAVK L + ++F E ++ KL+H L++L
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 577 CCVEQGEKILIL-EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
C E I I+ E M SL +L R L + + +A G+ YL +
Sbjct: 69 VCT-LEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQN--- 123
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDG 692
IHRDL A NVL+ + K++DFGLAR+ D + G + +PE AL
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYN 179
Query: 693 LFSIKSDVFSFGILMLE 709
FSIKSDV+SFGIL+ E
Sbjct: 180 RFSIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 68/280 (24%), Positives = 127/280 (45%), Gaps = 43/280 (15%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
++G+G FG VY R +G+ +K LS+ S + E+ NE+ ++ KL H N++K
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARV-----TIIEGIAQ---GLLYL 628
E+G+ +++EY L + KK+ + I++ Q L YL
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKI----KKQK---KEGKPFPEEQILDWFVQLCLALKYL 119
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H SR +I+HRD+K N+ L + K+ DFG++++ T +VGT Y+SPE
Sbjct: 120 H--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPEL 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748
+ ++ KSD++S G ++ E + K + ++ EL ++
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKH---PFEGENLL---------------ELALKIL 216
Query: 749 TQDEISLPVLV--RYINVALLCVQDNAADRPTMSDVVSII 786
+P N+ +Q + +RP+++ ++
Sbjct: 217 KGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 68/195 (34%), Positives = 102/195 (52%), Gaps = 17/195 (8%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580
+G+G FG V G GQ+VAVK L S + F E ++ L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 581 QGEKILILEYMPNKSLDVFLFDPTKKR-LLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
++ EYM SL +L ++ R ++ ++ + +G+ YL + +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYALDGLFSIK 697
DL A NVL+ D+ K+SDFGLA+ + QG G + +PE + FS K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQD---SGKLPVKWTAPEALREKKFSTK 179
Query: 698 SDVFSFGILMLETLS 712
SDV+SFGIL+ E S
Sbjct: 180 SDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 72/201 (35%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKLLGCC 578
K+G+G FG VYKG L EVAVK S L +F E ++ + H N+VKL+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 579 VEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
V++ +++E +P SL FL T K+LL A G+ YL +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDA------AAGMEYLESKN-- 113
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD--ELQGNTKRIVGTYGYMSPEYALDG 692
IHRDL A N L+ + KISDFG++R G + K+I + +PE G
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYG 170
Query: 693 LFSIKSDVFSFGILMLETLSG 713
++ +SDV+S+GIL+ ET S
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 65/207 (31%), Positives = 113/207 (54%), Gaps = 15/207 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKLQHRN 570
+F + K+G+G FG V+K R + + A+K+ LS + + EE +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL---LGWQARVTIIEGIAQGLLY 627
+++ +++G+ +++EY N L L + L W+ + I+ G+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
LH +I+HRD+K+ N+ LD N KI D G+A++ + NT IVGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
D ++ KSDV++ G+++ E +GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 29/214 (13%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEF----KNEMMLIAKLQHR 569
+ ++GEG +G VYK R G+ VA+K++ ++ + E F E+ L+ KL+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHP 58
Query: 570 NLVKLLGCCVE--QGEKILILEYMPN------KSLDVFLFDPTKKRLLGWQARVTIIEGI 621
N+V+L +G ++ EYM + S +V + K + + +
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM---------KQL 109
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
+GL YLH I+HRD+K SN+L++ D K++DFGLAR + T R++ T
Sbjct: 110 LEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TL 165
Query: 682 GYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
Y PE L + + D++S G ++ E GK
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
++G G FG V+ G L ++VA+K + + E+F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
E+ L+ E+M + L +L ++ + + + + +G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLFSI 696
DL A N L+ + K+SDFG+ R D+ +T GT + SPE +S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 697 KSDVFSFGILMLETLSGKK 715
KSDV+SFG+LM E S K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 78/205 (38%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 517 MQCKLGEGGFGPV--YKGRLLN---GQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHRN 570
LGEG FG V Y N G+ VAVK L + GQ +K E+ ++ L H N
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 571 LVKLLGCCVEQGEKI--LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
+VK GCC EQG K LI+EY+P SL +L K L + + I +G+ YL
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF-GGDELQGNTKRIVGTYGYMSPE 687
H IHRDL A NVLLD D KI DFGLA+ G E + + + E
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
+ FS SDV+SFG+ + E L+
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 70/197 (35%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580
LG G FG V+ G+ +VA+K + + ++F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRD 640
Q ++ EYM N L +L +K LG + + + + + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 641 LKASNVLLDMDMNPKISDFGLARMFGGDEL--QGNTKRIVGTYGYMSPEYALDGLFSIKS 698
L A N L+ D K+SDFGLAR D+ TK V + PE FS KS
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV---KWAPPEVFDYSRFSSKS 182
Query: 699 DVFSFGILMLETLSGKK 715
DV+SFG+LM E S K
Sbjct: 183 DVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 70/269 (26%), Positives = 119/269 (44%), Gaps = 36/269 (13%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMM---LIAKLQHRNLVKLL 575
+LG G G V K G+ +AVK + + K + ++ K +V
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 576 GCCVEQGEKILILEYMPNKSLDVFL---FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
G G+ + +EYM SLD L +R+LG I + +GL YLH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH--E 118
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
+ +IIHRD+K SN+L++ K+ DFG++ G + K VGT YM+PE
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQGN 174
Query: 693 LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID---PVIT 749
+S+KSD++S G+ ++E +G+ N + + +++ P +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF---------ELLQYIVNEPPPRLP 225
Query: 750 QDEISLPVLVRYINVALLCVQDNAADRPT 778
+ S P ++N LC+ + +RP+
Sbjct: 226 SGKFS-PDFQDFVN---LCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 73/231 (31%), Positives = 117/231 (50%), Gaps = 26/231 (11%)
Query: 511 ATENFSMQCKLGEGGFGPVYKG--RLLNG----QEVAVKRL-SSQSGQGLEEFKNEMMLI 563
++ ++ LG G FG VY+G R +G +VAVK L S S Q +F E +++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIE 619
+K H+N+V+L+G E+ + ++LE M L FL + P + L + +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLAR-MFGGDELQGNTK 675
+A+G YL + IHRD+ A N LL KI+DFG+AR ++ + +
Sbjct: 124 DVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-------GKKNTGV 719
++ +M PE LDG+F+ K+DV+SFG+L+ E S G+ N V
Sbjct: 181 AML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 77/204 (37%), Positives = 107/204 (52%), Gaps = 15/204 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
E + KLG G FG V+ G +VA+K L S E F E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64
Query: 573 KLLGCCVEQGEKILIL-EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
+L V E I I+ EYM N SL FL P +L + + IA+G+ ++
Sbjct: 65 RLYA--VVTQEPIYIITEYMENGSLVDFLKTPEGIKL-TINKLIDMAAQIAEGMAFIE-- 119
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEY 688
R IHRDL+A+N+L+ + KI+DFGLAR+ +E +G I T +PE
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEA 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
G F+IKSDV+SFGIL+ E ++
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
E F + KLGEG +G VYK GQ VA+K + + L+E E+ ++ + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60
Query: 572 VKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
VK G + + +++EY S D + T K L + I+ +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNKTLTEEEI-AAILYQTLKGLEYLHS 117
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+ IHRD+KA N+LL+ + K++DFG++ + NT ++GT +M+PE
Sbjct: 118 N---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQ 172
Query: 691 DGLFSIKSDVFSFGILMLETLSGK 714
+ ++ K+D++S GI +E GK
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 87/280 (31%), Positives = 124/280 (44%), Gaps = 44/280 (15%)
Query: 521 LGEGGFGPVYKG--RLLNGQE--VAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
LG G FG V KG + +G+E VAVK L G +EF E ++A+L H +V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDP---TKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
G C + +L++E P L +L L +V A G+ YL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES-K 114
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARM--FGGDELQGNT--KRIVGTYGYMSPEY 688
F +HRDL A NVLL KISDFG++R G D + T + + Y +PE
Sbjct: 115 HF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APEC 169
Query: 689 ALDGLFSIKSDVFSFGILMLETLS--GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746
G FS KSDV+S+G+ + E S K + A+ +L + L P
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML---------ESGERLPRP 220
Query: 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
EI Y ++ L C + DRPT S++ S
Sbjct: 221 EECPQEI-------Y-SIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 68/199 (34%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
LG+G FG V R + G+ A+K L + + +E E +++++ H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 577 CCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
+ EK+ L+LEY P L L + R +AR E I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAE-IVLALEYLHSL---G 113
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
II+RDLK N+LLD D + K++DFGLA+ + + NT GT Y++PE L +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYG 171
Query: 696 IKSDVFSFGILMLETLSGK 714
D +S G+L+ E L+GK
Sbjct: 172 KAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 71/227 (31%), Positives = 113/227 (49%), Gaps = 24/227 (10%)
Query: 521 LGEGGFGPVYKGRL----LNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
LGEG FG V +G+L + +VAVK +L + +EEF +E + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 575 LGCCVEQGEK------ILILEYMPNKSLDVFLFDP---TKKRLLGWQARVTIIEGIAQGL 625
+G C E ++IL +M + L FL L Q + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDEL-QGNTKRIVGTYGY 683
YL S IHRDL A N +L DM ++DFGL++ ++ GD QG ++ +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGKKN--TGVYNADSFNLL 728
++ E D +++ KSDV++FG+ M E + + GV N + ++ L
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 78/216 (36%), Positives = 112/216 (51%), Gaps = 29/216 (13%)
Query: 520 KLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLV 572
+LGE FG VYKG L Q VA+K L ++ L EEFK+E M+ ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLF-------------DPTKKRLLGWQARVTIIE 619
LLG ++ +I Y + L FL D T K L V I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--ELQGNTKR 676
IA G+ +L S ++H+DL NVL+ +N KISD GL R ++ D +L GN+
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +MSPE + G FSI SD++S+G+++ E S
Sbjct: 189 PI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 521 LGEGGFGPVYKGRLLNGQE------VAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRNLVK 573
LG G FG V+ + +E V VK L + L+ EF+ E+ + KL H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLY 627
LLG C E +ILEY L FL + K L + +V + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
L S R +HRDL A N L+ K+S L++ E ++ +++PE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
+ FS KSDV+SFG+LM E +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 29/279 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
E+ + KLG G FG V+ G N +VAVK L + ++ F E L+ LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+L ++ +I EYM SL FL ++L + IA+G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE--- 120
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
R IHRDL+A+NVL+ + KI+DFGLAR+ +E T R + + +PE
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAIN 177
Query: 691 DGLFSIKSDVFSFGILMLETLSGKK--NTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748
G F+IKSDV+SFGIL+ E ++ K G+ N+D + L + + + + + + ++
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM 237
Query: 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787
C ++ A +RPT + S+++
Sbjct: 238 KT-----------------CWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 77/298 (25%), Positives = 135/298 (45%), Gaps = 52/298 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLS--SQSGQGLEEFKNEMMLIA 564
E ++ +LG+G FG VY+G VA+K ++ + + +E F NE ++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMK 64
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYM-------------PNKSLDVFLFDPTKKRLLGW 611
+ ++V+LLG ++++E M P + L PT ++ +
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 612 QARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDEL 670
A IA G+ YL + +HRDL A N ++ D+ KI DFG+ R ++ D
Sbjct: 125 AAE------IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175
Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
+ K ++ +M+PE DG+F+ KSDV+SFG+++ E TL+ + G+ N + +
Sbjct: 176 RKGGKGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234
Query: 729 GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
D H + E + P + + +C Q N RPT ++VS +
Sbjct: 235 I--------DGGH------LDLPE-NCPDKLLEL--MRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 31/219 (14%)
Query: 521 LGEGGFGPVYKGR---LLNGQE---VAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVK 573
+G+G FG V++ R LL + VAVK L + S +F+ E L+A+ H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-------------------LGWQAR 614
LLG C L+ EYM L+ FL + + L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGN 673
+ I + +A G+ YL S + +HRDL N L+ +M KI+DFGL+R ++ D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +M PE ++ +SDV+++G+++ E S
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 70/208 (33%), Positives = 106/208 (50%), Gaps = 30/208 (14%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFK----NEMMLIAKLQHRNLVKL 574
KLGEG +G VYK R G+ VA+K++ + E E+ L+ +L+H N+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLY 627
L K+ L+ EY + L +L P + + +Q + +GL Y
Sbjct: 64 LDVIH-TERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQ--------LLRGLAY 113
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
H + RI+HRDLK N+L++ D K++DFGLAR F G L+ T +V T Y +PE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPE 168
Query: 688 YAL-DGLFSIKSDVFSFGILMLETLSGK 714
L +S D++S G + E ++GK
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 91/307 (29%), Positives = 151/307 (49%), Gaps = 45/307 (14%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKL 574
LG G FG VYKG + E VA+K L+ +G + EF +E +++A + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
LG C+ + L+ + MP+ L ++ + K +G Q + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
R++HRDL A NVL+ + KI+DFGLAR+ GDE + N +M+ E F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752
+ +SDV+S+G+ + E T GK G+ + +LL +K L P I +
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL---------EKGERLPQPPICTID 239
Query: 753 ISLPVLVRYINVALLCVQDNAADRPTMSDVVS--------------IINSERLELPSPKE 798
+ + V+V+ C +A RP ++ + I +R++LPSP +
Sbjct: 240 VYM-VMVK-------CWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPND 291
Query: 799 PAFIKGI 805
F + +
Sbjct: 292 SKFFQNL 298
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 77/205 (37%), Positives = 108/205 (52%), Gaps = 13/205 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
E+ + KLG G FG V+ G +VAVK L + E F E ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
LV+L E+ I + EYM SL FL D + R L V + +A G+ Y+
Sbjct: 63 LVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE- 119
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPE 687
R IHRDL+++N+L+ + KI+DFGLAR+ +E QG I T +PE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APE 173
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
AL G F+IKSDV+SFGIL+ E ++
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 5e-25
Identities = 78/201 (38%), Positives = 108/201 (53%), Gaps = 15/201 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + E F E ++ KL+H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64
Query: 573 KLLGCCVEQGEKILIL-EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
+L E E I I+ EYM SL FL K L Q V + IA G+ Y+
Sbjct: 65 QLYAVVSE--EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE-- 119
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEY 688
R +HRDL+A+N+L+ ++ K++DFGLAR+ +E QG I T +PE
Sbjct: 120 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEA 174
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
AL G F+IKSDV+SFGIL+ E
Sbjct: 175 ALYGRFTIKSDVWSFGILLTE 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 8/207 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
+++ + +G G VY L N ++VA+KR+ + ++E + E+ +++ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+VK V E L++ Y+ SL + + L T+++ + +GL YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEY 688
+ IHRD+KA N+LL D + KI+DFG++ GGD + K VGT +M+PE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 689 ALDGL-FSIKSDVFSFGILMLETLSGK 714
+ K+D++SFGI +E +G
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 516 SMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
+M+ KLG G +G VY+G VAVK L + +EEF E ++ +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
LG C + +I E+M +L +L + ++ + + + I+ + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL--QGNTKRIVGTYGYMSPEYALDG 692
IHRDL A N L+ + K++DFGL+R+ GD K + + +PE
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYN 180
Query: 693 LFSIKSDVFSFGILMLE 709
FSIKSDV++FG+L+ E
Sbjct: 181 KFSIKSDVWAFGVLLWE 197
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN--EMMLIAKLQHRNLVKLLG 576
K+GEG +G VYK R L G+ VA+K++ + E+ L+ +L H N++KLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 577 CCVEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+G+ L+ E+M + L + + + +Q + QGL + H
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQ--------LLQGLAFCHS 116
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+ I+HRDLK N+L++ + K++DFGLAR FG V T Y +PE L
Sbjct: 117 H---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLL 171
Query: 691 -DGLFSIKSDVFSFGILMLETLSGK 714
D +S D++S G + E LS +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 60/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
+ + + +LG+G FG VYK + G A K + +S + LE+F E+ ++++ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+V L + + +++E+ +LD + ++ L Q R + + + L +LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH- 120
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR--IVGTYGYMSPEY 688
++IHRDLKA N+LL +D + K++DFG++ LQ KR +GT +M+PE
Sbjct: 121 --SHKVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQ---KRDTFIGTPYWMAPEV 174
Query: 689 AL-----DGLFSIKSDVFSFGILMLE 709
D + K+D++S GI ++E
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 26/209 (12%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS------SQSGQGLEEFKNEMMLIAKLQHRNLVK 573
LG G F Y+ R + G +AVK+++ S+ + +E + E+ L+A+L H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
+LG E L +E+M S+ L + K+ ++ + E + +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122
Query: 632 SRFRIIHRDLKASNVLLD-MDMNPKISDFGLA-----RMFGGDELQGNTKRIVGTYGYMS 685
+IIHRD+K +N+L+D +I+DFG A + G E QG +++GT +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
PE + DV+S G +++E + K
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 81/298 (27%), Positives = 132/298 (44%), Gaps = 51/298 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRL-SSQSGQGLEEFKNEMMLIAK 565
+ ++ LGEG FG V K + VAVK L + + L + +EM ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 566 L-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD---------------PTKKRLL 609
+ +H+N++ LLG C ++G +++EY + +L FL P + L
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET--L 129
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
+ V+ +A+G+ +L + IHRDL A NVL+ D KI+DFGLAR +
Sbjct: 130 TQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
T +M+PE D +++ +SDV+SFG+L+ E TL G G+ + F L
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246
Query: 728 L--GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVV 783
L GY + P E+ ++ C + + RPT +V
Sbjct: 247 LKEGYRME-----------KPQNCTQEL--------YHLMRDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 71/213 (33%), Positives = 111/213 (52%), Gaps = 30/213 (14%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKR--LSSQSGQG-------LEEFKNEMMLIAKLQHRN 570
+G G FG VY G +G+ +AVK+ L S S L+ E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGL 625
+V+ LG ++ + LEY+P S+ L F+ T R + I +GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKGL 119
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG--NTKR--IVGTY 681
YLH +R IIHRD+K +N+L+D KISDFG+++ + L N R + G+
Sbjct: 120 NYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
+M+PE ++ K+D++S G L++E L+GK
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLNGQ-EVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
LG+G +G VY R L+ Q +A+K + + + ++ E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 580 EQGEKILILEYMPNKSLDVFL---FDPTKKRLLGWQARVTII---EGIAQGLLYLHQYSR 633
E G + +E +P SL L + P K TII + I +GL YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDN------EQTIIFYTKQILEGLKYLHDN-- 127
Query: 634 FRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
+I+HRD+K NVL++ KISDFG ++ G + T+ GT YM+PE G
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKG 184
Query: 693 L--FSIKSDVFSFGILMLETLSGK 714
+ +D++S G ++E +GK
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 82/275 (29%), Positives = 113/275 (41%), Gaps = 35/275 (12%)
Query: 520 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKL 574
KLG+G FG V +G VAVK L S +++F E ++ L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII----EGIAQGLLYLHQ 630
G V +++ E P SL L L ++ + IA G+ YL
Sbjct: 62 YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFL-----ISTLCDYAVQIANGMRYLES 115
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEY 688
R IHRDL A N+LL D KI DFGL R D V + + +PE
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPES 171
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748
FS SDV+ FG+ + E + Y + + L + L K DK E +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT-------YGEEPWAGLSGSQILKKIDKEGER----L 220
Query: 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVV 783
+ E NV L C N ADRPT + +
Sbjct: 221 ERPEACPQ---DIYNVMLQCWAHNPADRPTFAALR 252
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 73/199 (36%), Positives = 107/199 (53%), Gaps = 25/199 (12%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
+GEG FG V +G GQ+VAVK + + F E ++ KL H+NLV+LLG +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE------GIAQGLLYLHQYSR 633
G I ++E M +L FL T+ R L V++I+ +A+G+ YL
Sbjct: 70 HNGLYI-VMELMSKGNLVNFL--RTRGRAL-----VSVIQLLQFSLDVAEGMEYLESK-- 119
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
+++HRDL A N+L+ D K+SDFGLAR+ G N+K V + +PE
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPV---KWTAPEALKHKK 173
Query: 694 FSIKSDVFSFGILMLETLS 712
FS KSDV+S+G+L+ E S
Sbjct: 174 FSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 79/289 (27%), Positives = 131/289 (45%), Gaps = 40/289 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSSQSGQ-GLEEFKNEMMLIAKL 566
+ ++ L EG FG ++ G L++ +EV VK + + + + E L+ L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDP-----TKKRLLGWQARVTIIEG 620
H+N++ +L C+E GE +L N L +FL + L Q V +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDE--LQGNTKRI 677
IA G+ YLH+ +IH+D+ A N ++D ++ KI+D L+R +F D L N R
Sbjct: 126 IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLLGYAWDLW 735
V +M+ E ++ +S SDV+SFG+L+ E TL + D F + Y D +
Sbjct: 183 V---KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI---DPFEMAAYLKDGY 236
Query: 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784
+ L P+ DE+ V C + +RP+ S +V
Sbjct: 237 R------LAQPINCPDEL--------FAVMACCWALDPEERPSFSQLVQ 271
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-23
Identities = 28/65 (43%), Positives = 45/65 (69%)
Query: 336 CIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWF 395
C GG F++L N++ PD +++S+ L++C CL NC+C AYA +++ GSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWT 60
Query: 396 GDLLD 400
G+L+D
Sbjct: 61 GELVD 65
|
Length = 66 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 84/241 (34%), Positives = 120/241 (49%), Gaps = 28/241 (11%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLSSQ-SGQGLEEFKNEMMLI 563
+ + LGEG FG V K R VAVK L + + L + +EM L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLL 609
+ +H+N++ LLG C ++G +I+EY +L FL FD TK + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
++ V+ +A+G+ YL SR R IHRDL A NVL+ D KI+DFGLAR +
Sbjct: 132 SFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
T +M+PE D +++ +SDV+SFGILM E TL G G+ + F L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
Query: 728 L 728
L
Sbjct: 249 L 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 76/203 (37%), Positives = 109/203 (53%), Gaps = 13/203 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
E+ + KLG+G FG V+ G +VA+K L + E F E ++ KL+H LV
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLV 64
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
L E+ I + E+M SL FL + K L Q V + IA G+ Y+
Sbjct: 65 PLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE--- 119
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEYA 689
R IHRDL+A+N+L+ ++ KI+DFGLAR+ +E QG I + +PE A
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI----KWTAPEAA 175
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
L G F+IKSDV+SFGIL+ E ++
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 85/275 (30%), Positives = 125/275 (45%), Gaps = 38/275 (13%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
+LG G FG V G+ +VA+K + S +EF E ++ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL--HQYSRFRII 637
+Q ++ EYM N L +L + KR Q + + + + +G+ YL Q+ I
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLRE-HGKRFQPSQL-LEMCKDVCEGMAYLESKQF-----I 122
Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLF 694
HRDL A N L+D K+SDFGL+R DE + VG+ + PE L F
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKF 178
Query: 695 SIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753
S KSDV++FG+LM E S GK +N E ++ V +
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNS------------------ETVEKVSQGLRL 220
Query: 754 SLPVLV--RYINVALLCVQDNAADRPTMSDVVSII 786
P L + + C + A +RPT ++S I
Sbjct: 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 85/303 (28%), Positives = 136/303 (44%), Gaps = 54/303 (17%)
Query: 514 NFSMQCKLGEGGFGPVYKGRL--LNGQ----EVAVKRLSSQSGQG-LEEFKNEMMLIAKL 566
N + LGEG FG V K L G+ VAVK L + L + +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--------------------- 605
H +++KL G C + G +LI+EY SL FL + K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 606 KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665
+R L ++ I++G+ YL + +++HRDL A NVL+ KISDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 666 GGDE--LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
++ ++ + RI +M+ E D +++ +SDV+SFG+L+ E TL G G+
Sbjct: 178 YEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 722 ADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSD 781
FNLL + + + + E + N+ L C + RPT +D
Sbjct: 236 ERLFNLLKTGYRMERPENCSEEM-----------------YNLMLTCWKQEPDKRPTFAD 278
Query: 782 VVS 784
+
Sbjct: 279 ISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 68/208 (32%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 521 LGEGGFGPVYKGRL-----LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
LG+G FG V R G+ VAVK+L + + L +F+ E+ ++ LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 576 GCCVEQGEK--ILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLY 627
G C G + L++EY+P SL +L D K L Q I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG---TYGYM 684
L R +HRDL N+L++ + KI DFGL ++ D+ + R G + Y
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY- 178
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLS 712
+PE + FS+ SDV+SFG+++ E +
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 10/203 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQ 567
NF ++ K+G+G F VYK LL+G+ VA+K++ + ++ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK-KRLLGWQARVTIIEGIAQGLL 626
H N++K L +E E ++LE L + K KRL+ + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
++H RI+HRD+K +NV + K+ D GL R F ++ VGT YMSP
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSP 175
Query: 687 EYALDGLFSIKSDVFSFGILMLE 709
E + ++ KSD++S G L+ E
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 5e-23
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLE-EFKNEMMLIAKLQHRN 570
E +LGEG G V K RL N + A+K +++ L+ + E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 571 LVKLLGCCVE--QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT------IIEGIA 622
+VK G ++ + +EY SLD K++ R+ I E +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY-----KKVKKRGGRIGEKVLGKIAESVL 115
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
+GL YLH +IIHRD+K SN+LL K+ DFG++ G+ + GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSF 168
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
YM+PE +SI SDV+S G+ +LE +
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKR-----LSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
LG+G FG VY ++ G+E+AVK+ S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
GC + + +EYMP S+ L + + + R I +G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILEGVEYLH--- 121
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV-GTYGYMSPEYALD 691
I+HRD+K +N+L D N K+ DFG ++ G + V GT +MSPE
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 692 GLFSIKSDVFSFGILMLETLSGK 714
+ K+DV+S G ++E L+ K
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 81/282 (28%), Positives = 139/282 (49%), Gaps = 44/282 (15%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
+G G FG V++G L + G++ VA+K L + + ++F +E ++ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGIAQGLLYLHQY 631
G + ++I EYM N +LD +L D + +L+G ++ GIA G+ YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG------MLRGIAAGMKYL--- 123
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------YMS 685
S +HRDL A N+L++ ++ K+SDFGL+R+ L+ + + T G + +
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTA 178
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745
PE F+ SDV+SFGI+M E +S F Y WD+ + + D
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMS------------FGERPY-WDMSNHEVMKAIND 225
Query: 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787
+ P V + L C Q + A RP D+V++++
Sbjct: 226 GFRLPAPMDCPSAVY--QLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLV 572
F++ +G+G FG VYK Q VA+K + ++ +E+ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
K G ++ + +I+EY S D K L I+ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR---IVGTYGYMSPEYA 689
IHRD+KA+N+LL + + K++DFG++ +L + VGT +M+PE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
+ K+D++S GI +E G+
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 517 MQCKLGEGGFGPVYKGR---LLNGQE---VAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
++ +LGEG FG V+ LL Q+ VAVK L S ++F+ E L+ LQH++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRL----------LGWQARVTII 618
+V+ G C E +++ EYM + L+ FL P K L L + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
IA G++YL + +HRDL N L+ + KI DFG++R + R +
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKK 715
+M PE L F+ +SD++SFG+++ E + GK+
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 51/226 (22%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN-----------EMM 561
+ KLGEG + VYK R G+ VA+K++ L E K E+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIK 54
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMP--------NKSLDVFLFDPTKKRLLGWQA 613
L+ +L+H N++ LL + L+ E+M +KS+ L K +
Sbjct: 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI--VLTPADIKSYM-LM- 110
Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673
+GL YLH I+HRDLK +N+L+ D K++DFGLAR FG +
Sbjct: 111 -------TLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT 160
Query: 674 TKRIVGTYGYMSPEYALDGLFSIKS-----DVFSFGILMLETLSGK 714
+ V T Y +PE LF + D++S G + E L
Sbjct: 161 HQ--VVTRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 78/293 (26%), Positives = 126/293 (43%), Gaps = 44/293 (15%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SSQSGQGLEEFKNEMM 561
KLGEG FG V+ Q+ VAVK L S E+F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--------FDPTKKRLLGWQA 613
++++L N+ +LLG C +I+EYM N L+ FL + L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--EL 670
+ + IA G+ YL +HRDL N L+ + KI+DFG++R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGY 730
QG R +M+ E L G F+ KSDV++FG+ + E L+ + + ++
Sbjct: 189 QG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIEN 245
Query: 731 AWDLWKDDKFHELID-PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDV 782
A ++DD + P +I + L C + + DRPT ++
Sbjct: 246 AGHFFRDDGRQIYLPRPPNCPKDI--------YELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 83/267 (31%), Positives = 131/267 (49%), Gaps = 35/267 (13%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLS----SQSGQG-LEEFKNEMMLIAKLQHRNLVKL 574
LG G FG VY+G L +G AVK +S Q+GQ +++ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
LG E+ + LE +P SL L + + ++ R I GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH--D 120
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD- 691
R +HRD+K +N+L+D + K++DFG+A+ K G+ +M+PE
Sbjct: 121 R-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 692 GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751
G + + +D++S G +LE +GK G A ++K + EL P I D
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLE-------GVAA-VFKIGRSKEL--PPIP-D 225
Query: 752 EISLPVLVRYINVALLCVQDNAADRPT 778
+S +I L C+Q + + RPT
Sbjct: 226 HLS-DEAKDFI---LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 7e-22
Identities = 85/280 (30%), Positives = 134/280 (47%), Gaps = 36/280 (12%)
Query: 521 LGEGGFGPVYKGRLL--NGQEV--AVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLL 575
+G+G FG VY G L+ +GQ++ AVK L+ + + +E+F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 576 GCCV-EQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
G C+ +G +++L YM + L F+ PT K L+G+ +V A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG--NTKRIVGTYGYMSPEY 688
+ +HRDL A N +LD K++DFGLAR E N +M+ E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748
F+ KSDV+SFG+L+ E ++ + + DSF++ Y L+ P
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITVYLLQ------GRRLLQPEY 226
Query: 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
D + V L C RPT S++VS I
Sbjct: 227 CPDPL--------YEVMLSCWHPKPEMRPTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 37/217 (17%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVK----------RLSSQSGQGLEEFKNEMMLIAKLQHR 569
+G+G +G VY + G+ +AVK R S+ ++ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 570 NLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIA 622
N+V+ LG E E+ L LEY+P S+ L F+ R Q +
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VL 118
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN--TKRIVGT 680
+GL YLH I+HRDLKA N+L+D D KISDFG+++ D++ N + G+
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGS 173
Query: 681 YGYMSPEY-ALDGL-FSIKSDVFSFGILMLETLSGKK 715
+M+PE +S K D++S G ++LE +G++
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-21
Identities = 64/198 (32%), Positives = 110/198 (55%), Gaps = 17/198 (8%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
+LG+G FG VYK + G A K + ++S + LE++ E+ ++A H +VKLLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
G+ +++E+ P ++D + + + L Q +V I + + L YLH +IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR--IVGTYGYMSPEYAL-----D 691
RDLKA NVLL +D + K++DFG++ ++ +R +GT +M+PE + D
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 692 GLFSIKSDVFSFGILMLE 709
+ K+D++S GI ++E
Sbjct: 190 TPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK-----NEMMLIAKL-QHRNLVK 573
+GEG F V + +E A+K L + Q ++E K E ++ +L H ++K
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
L ++ +LEY PN L ++ K L + I L YLH
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLHSK-- 121
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL------------------QGNTK 675
IIHRDLK N+LLD DM+ KI+DFG A++ + +
Sbjct: 122 -GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
VGT Y+SPE + SD+++ G ++ + L+GK
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 71/203 (34%), Positives = 106/203 (52%), Gaps = 18/203 (8%)
Query: 521 LGEGGFGPV----YKGRLLN-GQEVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKL 574
LGEG FG V Y N G++VAVK L +SG + + K E+ ++ L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL--HQ 630
G C E G LI+E++P+ SL +L P K + + ++ I +G+ YL Q
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-YGYMSPEYA 689
Y +HRDL A NVL++ + KI DFGL + D+ K + + + +PE
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
+ F I SDV+SFG+ + E L+
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-21
Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 13/205 (6%)
Query: 509 AAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH 568
A + + +G+G FG V G G +VAVK + + + + F E ++ +L+H
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 58
Query: 569 RNLVKLLGCCVEQ-GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
NLV+LLG VE+ G ++ EYM SL +L + +LG + + + + Y
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
L + +HRDL A NVL+ D K+SDFGL + Q K V + +PE
Sbjct: 118 LEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPE 169
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
+ FS KSDV+SFGIL+ E S
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
+LG G FG V+ G+ +VA+K ++ + E+F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
+Q ++ E+M N L +L ++ L +++ + + +G+ YL + S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------YMSPEYALDGL 693
DL A N L+ K+SDFG+ R DE + G + PE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-------TSSSGAKFPVKWSPPEVFNFSK 177
Query: 694 FSIKSDVFSFGILMLETLSGKK 715
+S KSDV+SFG+LM E + K
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 81/284 (28%), Positives = 132/284 (46%), Gaps = 48/284 (16%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
+G G FG V GRL L G+ VA+K L + + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE------GIAQGLLYLH 629
G + +++ EYM N SLD FL +K + T+I+ GIA G+ YL
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL----RKH----DGQFTVIQLVGMLRGIASGMKYL- 122
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------Y 683
S +HRDL A N+L++ ++ K+SDFGL+R+ D T R G +
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRW 175
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743
+PE F+ SDV+S+GI+M E +S Y + W++ D +
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMS-------YGERPY------WEMSNQDVIKAI 222
Query: 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787
+ + P + + L C Q + +RP +VSI++
Sbjct: 223 EEGYRLPAPMDCPAALH--QLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 81/284 (28%), Positives = 135/284 (47%), Gaps = 42/284 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG G FG V+ +VAVK + S +E F E ++ LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKR-----LLGWQARVTIIEGIAQGLLY 627
KL V + +I E+M SL FL + L+ + A+ IA+G+ +
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAF 117
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMS 685
+ Q + IHRDL+A+N+L+ + KI+DFGLAR+ +E T R + + +
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTA 171
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGKKN--TGVYNADSFNLLGYAWDLWKDDKF-HE 742
PE G F+IKSDV+SFGIL++E ++ + G+ N + L + + + + E
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE 231
Query: 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
L + + + C ++ +RPT + S++
Sbjct: 232 LYN------------------IMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 72/214 (33%), Positives = 107/214 (50%), Gaps = 25/214 (11%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVK 573
+LGE FG +YKG L + Q VA+K L + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLF--------------DPTKKRLLGWQARVTIIE 619
LLG ++ ++ EY+ L FL D T K L + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIV 678
IA G+ YL S F +H+DL A N+L+ ++ KISD GL+R ++ D + K ++
Sbjct: 132 QIAAGMEYLS--SHF-FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M PE + G FS SD++SFG+++ E S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-21
Identities = 78/266 (29%), Positives = 134/266 (50%), Gaps = 34/266 (12%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLL 575
++G G FG VY R + + VA+K++S Q E++++ E+ + +L+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
GC + + L++EY + D+ + KK L + I G QGL YLH + R
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDIL--EVHKKPLQEVEI-AAICHGALQGLAYLHSHER-- 136
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DG 692
IHRD+KA N+LL K++DFG A + N+ VGT +M+PE L +G
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVILAMDEG 189
Query: 693 LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752
+ K DV+S GI +E L+ +K ++N ++ + L + + ++D P ++ ++
Sbjct: 190 QYDGKVDVWSLGITCIE-LAERKPP-LFNMNAMSAL---YHIAQNDS------PTLSSND 238
Query: 753 ISLPVLVRYINVALLCVQDNAADRPT 778
S + N C+Q DRP+
Sbjct: 239 WSD----YFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 68/194 (35%), Positives = 100/194 (51%), Gaps = 9/194 (4%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRNLVKLLGCCV 579
LG+G FG V+KG L + VAVK Q L+ +F +E ++ + H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
++ +++E +P D F KK L + V A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 640 DLKASNVLLDMDMNPKISDFGLARMF-GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
DL A N L+ + KISDFG++R G K+I + +PE G +S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 699 DVFSFGILMLETLS 712
DV+S+GIL+ ET S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 6e-21
Identities = 39/113 (34%), Positives = 54/113 (47%), Gaps = 11/113 (9%)
Query: 212 SGQWNGAAF-----VSAISYTNFLYEQYLVENQDEISYWYEPFNRPSIMT-LKLNPSGLL 265
SG WNG F + +SY + + EN +E+ Y Y SI + L L+ G L
Sbjct: 3 SGPWNGIRFSGIPEMQKLSYYVYNF----TENNEEVYYTYR-MTNNSIYSRLTLSSEGSL 57
Query: 266 TRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKS 318
R W N DW+L +S P + C YG CG C + P C C++GF K+
Sbjct: 58 ERFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 73/229 (31%), Positives = 121/229 (52%), Gaps = 29/229 (12%)
Query: 521 LGEGGFGPVYKGRLLNGQ---EVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
LGEG FG V +G+L +VAVK +++ + +E+F +E + + + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 576 GCCVEQGEK------ILILEYMPNKSLDVFLFDPTKKRL------LGWQARVTIIEGIAQ 623
G C++ E ++IL +M + L FL RL L Q V + IA
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL---YSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDEL-QGNTKRIVGTY 681
G+ YL S IHRDL A N +L+ +MN ++DFGL+ +++ GD QG ++
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PV 178
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
+++ E D +++ KSDV+SFG+ M E T GV N++ ++ L
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 7e-21
Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 514 NFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKLQHRN 570
+F + KLG+G +G VYK RL + Q A+K L S S + E+ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 571 LVK-----LLGCCVEQGEKILILEYMPNKSLDVFLFDPTK-KRLLGWQARVTIIEGIAQG 624
++ L G + +++EY P L + K ++L+ Q I + +G
Sbjct: 61 IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
L LH+ +I+HRDLK++N+LL + KI D G++++ + K +GT YM
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYM 168
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744
+PE +S KSD++S G L+ E + + A S L Y K I
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPP---FEARSMQDLRYKVQRGKYPP----I 221
Query: 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDV 782
P+ +QD N +Q RP +
Sbjct: 222 PPIYSQD---------LQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 8e-21
Identities = 75/233 (32%), Positives = 118/233 (50%), Gaps = 28/233 (12%)
Query: 521 LGEGGFGPVYKGRLLNGQE--------VAVKRLSSQSGQ-GLEEFKNEMMLIAKL-QHRN 570
LGEG FG V + + VAVK L S + + L + +EM ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTI 617
++ LLG C + G +I+EY +L +L ++PT+ + L ++ V+
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
+A+G+ YL + + IHRDL A NVL+ D KI+DFGLAR + T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
+M+PE D +++ +SDV+SFG+L+ E TL G GV + F LL
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 69/207 (33%), Positives = 112/207 (54%), Gaps = 27/207 (13%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFK-NEMMLIAKLQHRNLVKLL 575
K+GEG +G VYK R L G+ VA+K RL ++ +G+ E+ L+ +L H N+V+LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLL 64
Query: 576 GCCVEQGEKI-LILEYMP---NKSLD---VFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
V K+ L+ E++ K +D + DP + +Q +++GIA Y
Sbjct: 65 DV-VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ----LLQGIA----YC 115
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H + R++HRDLK N+L+D + K++DFGLAR F G ++ T +V T Y +PE
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEI 170
Query: 689 ALDG-LFSIKSDVFSFGILMLETLSGK 714
L +S D++S G + E ++ +
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 25/216 (11%)
Query: 521 LGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
LG+G FG VY GR L ++V S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 575 LGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARVTII-----EGIAQGLLY 627
GC ++ EK L +EYMP S+ K +L + A + I +G+ Y
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSV--------KDQLKAYGALTESVTRKYTRQILEGMSY 121
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYMSP 686
LH I+HRD+K +N+L D N K+ DFG ++ + G R + GT +MSP
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA 722
E + K+DV+S G ++E L+ K Y A
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 30/236 (12%)
Query: 515 FSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQH 568
F++ LG+G FG V + +L + Q+VAVK L + S +EEF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 569 RNLVKLLGCCVEQGEK------ILILEYMPNKSLDVFLFDPTKKRL------LGWQARVT 616
N++KL+G + K ++IL +M + L FL R+ L Q V
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL---MSRIGEEPFTLPLQTLVR 117
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDEL-QGNT 674
+ IA G+ YL S IHRDL A N +L+ +M ++DFGL++ ++ GD QG
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
++ +++ E D +++ SDV++FG+ M E T GV N++ +N L
Sbjct: 175 SKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 76/271 (28%), Positives = 129/271 (47%), Gaps = 35/271 (12%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
GC + + L++EY + D+ K+ L + G QGL YLH ++
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DG 692
+IHRD+KA N+LL K+ DFG A + VGT +M+PE L +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVILAMDEG 189
Query: 693 LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752
+ K DV+S GI +E ++ ++N ++ + L + + +++ P +
Sbjct: 190 QYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSAL---YHIAQNES------PALQSGH 238
Query: 753 ISLPVLVRYINVALLCVQDNAADRPTMSDVV 783
S + N C+Q DRPT S+V+
Sbjct: 239 WS----EYFRNFVDSCLQKIPQDRPT-SEVL 264
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 520 KLGEGGFGPVYK-GRLLNGQEVAVKRLS--SQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
+G+G FG V K R +G+ + K + + + + ++ +E+ ++ +L+H N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 577 CCV-EQGEKI-LILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYLH--- 629
+ + + +++EY L + +K + I + Q LL L+
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI----EEEFIWRILTQLLLALYECH 122
Query: 630 --QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
++HRDLK +N+ LD + N K+ DFGLA++ G D K VGT YMSPE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYYMSPE 180
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
+ KSD++S G L+ E +
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 25/206 (12%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
+G G FG V +GRL L G+ VA+K L S + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 576 GCCVEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
G + ++I E+M N +LD FL F + L+G ++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ--LVG------MLRGIAAGMKYL- 122
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG---TYGYMSP 686
S +HRDL A N+L++ ++ K+SDFGL+R D +G + +P
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 687 EYALDGLFSIKSDVFSFGILMLETLS 712
E F+ SDV+S+GI+M E +S
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 3e-20
Identities = 91/381 (23%), Positives = 153/381 (40%), Gaps = 58/381 (15%)
Query: 418 PASETGKRKLLWILV---ILVLPLVLLPSF-YIFCRRRRNCKEKETENMETDQDLLAFDI 473
P K W + + ++ L +F ++F R R N + K EN + +L FD
Sbjct: 618 PCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD- 676
Query: 474 NMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCK----LGEGGFGPV 529
S S + + K + G G
Sbjct: 677 ------------------------------SKVSKSITINDILSSLKEENVISRGKKGAS 706
Query: 530 YKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588
YKG+ + NG + VK ++ + E + + KLQH N+VKL+G C + LI
Sbjct: 707 YKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIH 762
Query: 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648
EY+ K+L L R L W+ R I GIA+ L +LH ++ +L +++
Sbjct: 763 EYIEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816
Query: 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
D P + L + D I + Y++PE + KSD++ FG++++
Sbjct: 817 DGKDEPHLR-LSLPGLLCTD----TKCFI--SSAYVAPETRETKDITEKSDIYGFGLILI 869
Query: 709 ETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD-EISLPVLVRYINVALL 767
E L+GK +++ +A + D IDP I D ++ +V +N+AL
Sbjct: 870 ELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALH 929
Query: 768 CVQDNAADRPTMSDVVSIINS 788
C + RP +DV+ + S
Sbjct: 930 CTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 3e-20
Identities = 70/226 (30%), Positives = 108/226 (47%), Gaps = 34/226 (15%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN---GQE---VAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
N ++ +LGEG FG V+ N Q+ VAVK L S ++F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLF-------------DPTKKRLLGWQAR 614
H ++VK G CVE I++ EYM + L+ FL P + L
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE---LTQSQM 122
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT 674
+ I + IA G++YL + +HRDL N L+ ++ KI DFG++R D +
Sbjct: 123 LHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDY 175
Query: 675 KRIVG----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKK 715
R+ G +M PE + F+ +SDV+S G+++ E + GK+
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 4e-20
Identities = 77/257 (29%), Positives = 127/257 (49%), Gaps = 34/257 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNG---QEVAVKRLSSQSGQG-LEEFKNEMMLIAKL-QH 568
+ Q +GEG FG V K R+ + A+KR+ + + +F E+ ++ KL H
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------FDP------TKKRLLGWQARV 615
N++ LLG C +G L +EY P+ +L FL DP + L Q +
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
+A+G+ YL Q + IHRDL A N+L+ + KI+DFGL+R G E+ K
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VK 179
Query: 676 RIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLLGYA 731
+ +G +M+ E +++ SDV+S+G+L+ E +L G G+ A+ + L
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239
Query: 732 WDLWK----DDKFHELI 744
+ L K DD+ ++L+
Sbjct: 240 YRLEKPLNCDDEVYDLM 256
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 71/219 (32%), Positives = 104/219 (47%), Gaps = 34/219 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR---LLNGQ---EVAVKRLSSQSGQGLEE-FKNEMMLIAK 565
N S LG G FG V + L +VAVK L + E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 566 L-QHRNLVKLLGCCVEQGEKILILEY--------MPNKSLDVFLFDPTKKRLLGWQARVT 616
L H N+V LLG C G ++I EY + + FL T + LL + +V
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFL---TLEDLLSFSYQV- 150
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGN 673
A+G+ +L + IHRDL A NVLL KI DFGLAR D ++GN
Sbjct: 151 -----AKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN 202
Query: 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ V +M+PE + +++ +SDV+S+GIL+ E S
Sbjct: 203 ARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYL 628
+V G + + + +E+M SLD P +LG I + +GL YL
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL 119
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
Y+ RI+HRD+K SN+L++ K+ DFG++ G+ + VGT YMSPE
Sbjct: 120 --YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPER 173
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID--- 745
G +++KSDV+S GI ++E GK N D L D +++
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL---DLLQQIVQEPP 230
Query: 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVV 783
P + + L +++ C+ + +RPT +
Sbjct: 231 PRLPSSDFP-EDLRDFVD---ACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 6e-20
Identities = 59/196 (30%), Positives = 104/196 (53%), Gaps = 10/196 (5%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
K+GEG G V R +G++VAVK + + Q E NE++++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
+ E +++E++ +L D + L + T+ E + Q L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
RD+K+ ++LL +D K+SDFG D + K +VGT +M+PE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 699 DVFSFGILMLETLSGK 714
D++S GI+++E + G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 6e-20
Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 35/222 (15%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRLSSQSGQGLE-EFKNEMM 561
KLGEG FG V+ ++ VAVK L + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--------FDPTKKRLLGWQA 613
++++L+ N+++LL C+ +I EYM N L+ FL + + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--EL 670
+ + IA G+ YL S +HRDL N L+ + KI+DFG++R ++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
QG R V +MS E L G F+ SDV++FG+ + E L+
Sbjct: 189 QG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQHR 569
NF ++ K+G G F VY+ LL+ + VA+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLD-VFLFDPTKKRLLG----WQARVTIIEGIAQG 624
N++K L +E E ++LE L + + +KRL+ W+ V + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
H +SR R++HRD+K +NV + K+ D GL R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
SPE + ++ KSD++S G L+ E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 8e-20
Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 31/220 (14%)
Query: 520 KLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVK 573
+LGEG FG V+ N VAVK L + ++F+ E L+ LQH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRL-----------LGWQARVTIIEG 620
G C + I++ EYM + L+ FL P L LG + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG- 679
IA G++YL + +HRDL N L+ ++ KI DFG++R D + R+ G
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 184
Query: 680 ---TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKK 715
+M PE + F+ +SDV+SFG+++ E + GK+
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 33/209 (15%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQG------LEEFKNEMMLIAKLQHRNLV 572
++GEG G V+K + G+ VA+K+++ + +G L E K + QH +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62
Query: 573 KLLGCCVEQGEKILILEYMPN------KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
KLL +L++EYMP+ + + L + K + +++G+A
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYM-----RMLLKGVA---- 113
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
Y+H I+HRDLK +N+L+ D KI+DFGLAR+F +E + + + V T Y +P
Sbjct: 114 YMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAP 169
Query: 687 EYALDGL--FSIKSDVFSFGILMLETLSG 713
E L G + D+++ G + E L+G
Sbjct: 170 EL-LYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 9e-20
Identities = 70/230 (30%), Positives = 112/230 (48%), Gaps = 43/230 (18%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRLSSQSGQGLE-EFKNEMM 561
KLGEG FG V+ ++N Q+ VAVK L + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--------------FDPTKKR 607
++++L+ N+++LLG CV++ +I EYM N L+ FL P
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 608 LL--GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-M 664
L + + + + IA G+ YL S +HRDL N L+ ++ KI+DFG++R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 665 FGGD--ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ GD +QG R V +M+ E L G F+ SDV++FG+ + E L
Sbjct: 189 YAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
K+GEG +G VYKGR GQ VA+K RL S+ E+ L+ +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 577 CCVEQGEKILILEYMP---NKSLDVF----LFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
+++ LI E++ K LD D + +Q I QG+L+ H
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ--------ILQGILFCH 118
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
R++HRDLK N+L+D K++DFGLAR F G ++ T +V T Y +PE
Sbjct: 119 SR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVL 173
Query: 690 LDG-LFSIKSDVFSFGILMLETLSGK 714
L +S D++S G + E + K
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-19
Identities = 72/233 (30%), Positives = 114/233 (48%), Gaps = 28/233 (12%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKL-QHRN 570
LGEG FG V K + VAVK L + + L + +EM ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTI 617
++ LLG C + G +I+EY +L +L +D + + ++ V+
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
+A+G+ YL + + IHRDL A NVL+ + KI+DFGLAR + T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
+M+PE D +++ +SDV+SFG+LM E TL G G+ + F LL
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 63/205 (30%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRN 570
E F+ ++G+G FG VYKG +EV A+K + + + +E+ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 571 LVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
+ + G ++ + +I+EY+ S LD+ P ++ + TI+ I +GL YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLH 118
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
R IHRD+KA+NVLL + K++DFG+A +++ NT VGT +M+PE
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 173
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
+ K+D++S GI +E G+
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRN 570
NF K+GEG +G VYK R L G+ VA+K RL +++ E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+VKLL + + L+ E++ ++ L F+ D + + + + + QGL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+ R++HRDLK N+L++ + K++DFGLAR F G ++ T +V T Y +PE L
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILL 173
Query: 691 DG-LFSIKSDVFSFGILMLETLSGK 714
+S D++S G + E ++ +
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 25/208 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
E++ + ++G G +G VYK R + G+ VA+K + + G E + E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 572 VKLLGCCVEQGEKILILEYMPNKSL-DVF--LFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
V G + + + +++EY SL D++ P + + + R T+ +GL YL
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYL 117
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT--KR--IVGTYGYM 684
H+ IHRD+K +N+LL D + K++DFG++ T KR +GT +M
Sbjct: 118 HE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGTPYWM 168
Query: 685 SPEYA---LDGLFSIKSDVFSFGILMLE 709
+PE A G + K D+++ GI +E
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 72/233 (30%), Positives = 115/233 (49%), Gaps = 32/233 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRN 570
NF KLGEG + VYKGR G+ VA+K L ++ G + E+ L+ +L+H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59
Query: 571 LVKLLGCCVEQGEKILILEYMPN---KSLDVF----LFDPTKKRLLGWQARVTIIEGIAQ 623
+V+L + + +L+ EYM K +D DP + +Q + +
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQ--------LLK 111
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYG 682
G+ + H+ R++HRDLK N+L++ K++DFGLAR FG + NT V T
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLW 165
Query: 683 YMSPEYALDG-LFSIKSDVFSFGILMLETLSGKK-NTGVYNADS----FNLLG 729
Y +P+ L +S D++S G +M E ++G+ G N D F ++G
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG 218
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 77/276 (27%), Positives = 135/276 (48%), Gaps = 34/276 (12%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKN---EMMLIAKLQHRN 570
F+ ++G G FG VY R + EV A+K++S Q E++++ E+ + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
++ GC + + L++EY + D L + KK L + I G QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAITHGALQGLAYLHS 143
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
++ +IHRD+KA N+LL K++DFG A + VGT +M+PE L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194
Query: 691 ---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747
+G + K DV+S GI +E ++ ++N ++ + L + + +++ P
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSAL---YHIAQNES------PT 243
Query: 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVV 783
+ +E S + N C+Q DRPT +++
Sbjct: 244 LQSNEWS----DYFRNFVDSCLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 57/202 (28%), Positives = 107/202 (52%), Gaps = 21/202 (10%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG-LEEFKNEMMLIAKLQH---RNLVKLL 575
+G G +G VY+G+ + G+ VA+K ++ + + + + E+ L+++L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 576 GCCVEQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
G ++ +I+EY S+ + P ++ + II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYIS-----VIIREVLVALKYIHKVG-- 121
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI--VGTYGYMSPEYALDG 692
+IHRD+KA+N+L+ N K+ DFG+A + Q ++KR VGT +M+PE +G
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKRSTFVGTPYWMAPEVITEG 176
Query: 693 -LFSIKSDVFSFGILMLETLSG 713
+ K+D++S GI + E +G
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 10/214 (4%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKNEM 560
L ++ SV + ++ K+G+G G VY + GQEVA+K+++ Q E NE+
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
+++ + +H N+V L + E +++EY+ SL D + + +
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
Q L +LH ++IHRD+K+ N+LL MD + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
+M+PE + K D++S GI+ +E + G+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 67/269 (24%), Positives = 127/269 (47%), Gaps = 31/269 (11%)
Query: 521 LGEGGFGP--VYK----GRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
LG+G FG +Y+ L+ +EV + RLS + + NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
++ ++ +EY +L + K +L + + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
I+HRD+K N+ L K+ DFG++++ G + T +VGT YMSPE +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 695 SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEIS 754
+ KSD+++ G ++ E L+ K+ ++A N L + + + + V + + IS
Sbjct: 179 NFKSDIWALGCVLYELLTLKR---TFDAT--NPLNLVVKIVQ--GNYTPVVSVYSSELIS 231
Query: 755 LPVLVRYINVALLCVQDNAADRPTMSDVV 783
LV +Q + RPT +V+
Sbjct: 232 ---LVHS------LLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 2e-19
Identities = 60/214 (28%), Positives = 112/214 (52%), Gaps = 10/214 (4%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEM 560
L ++ S+ + ++ K+G+G G V+ + GQEVA+K+++ Q E NE+
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
+++ +L++ N+V L + E +++EY+ SL D + + +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
Q L +LH ++IHRD+K+ NVLL MD + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
+M+PE + K D++S GI+ +E + G+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 32/214 (14%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGC- 577
+GEG +G VYK R GQ VA+K + EE K E ++ K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 578 -----CVEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARVT------IIEGIAQGL 625
+ L++E S+ D+ K L R+ I+ +GL
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
YLH+ ++IHRD+K N+LL + K+ DFG++ + NT +GT +M+
Sbjct: 127 AYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FIGTPYWMA 181
Query: 686 PE-----YALDGLFSIKSDVFSFGILMLETLSGK 714
PE D + +SDV+S GI +E GK
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 20/206 (9%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGL------EEFKNEMMLIAKLQHRNLVKL 574
LG+G +G VY G GQ +AVK++ + L E+ + E+ L+ L+H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
LG C++ + +E++P S+ L F P + + + I++G+A YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHNNC 122
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV----GTYGYMSPEY 688
++HRD+K +NV+L + K+ DFG AR L G ++ GT +M+PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
+ + KSD++S G + E +GK
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKL 574
LG G FG V+KG + + VA+K + +SG Q +E + M+ + L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLY 627
LG C G + L+ + P SL + DP +RLL W + IA+G+ Y
Sbjct: 75 LGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQ------IAKGMYY 124
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
L ++ R++HR+L A N+LL D +I+DFG+A + D+ + +M+ E
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
L G ++ +SDV+S+G+ + E +S
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 3e-19
Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 10/214 (4%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKNEM 560
L S+ SV + ++ K+G+G G VY + GQEVA+K+++ Q E NE+
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
+++ + ++ N+V L + E +++EY+ SL D + + +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
Q L +LH ++IHRD+K+ N+LL MD + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
+M+PE + K D++S GI+ +E + G+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 58/187 (31%), Positives = 97/187 (51%), Gaps = 19/187 (10%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SSQSGQGLEEFKNEMMLIAKL 566
++ + KLGEG FG VYK R + G+ VA+K++ + + G + + E+ ++ KL
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64
Query: 567 QHRNLVKLLGCCVEQGEKI--------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTII 618
+H N+V L+ VE+ +K ++ YM + L L +P +L Q + +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENP-SVKLTESQIK-CYM 121
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ +G+ YLH+ I+HRD+KA+N+L+D KI+DFGLAR + G
Sbjct: 122 LQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 679 GTYGYMS 685
GT Y +
Sbjct: 179 GTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 68/206 (33%), Positives = 108/206 (52%), Gaps = 20/206 (9%)
Query: 520 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSSQSGQGLEEFKNEMMLIAKLQHR----NLV 572
+LG G FG V KG ++ Q +VA+K L +++ + + + EMM A++ H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD---EMMREAEIMHQLDNPYIV 58
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+++G C E +L++E L+ FL KK + V ++ ++ G+ YL +
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
+HRDL A NVLL KISDFGL++ G D+ R G + + +PE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECIN 171
Query: 691 DGLFSIKSDVFSFGILMLETLS-GKK 715
FS +SDV+S+GI M E S G+K
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 74/233 (31%), Positives = 115/233 (49%), Gaps = 28/233 (12%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRN 570
LGEG FG V K + VAVK L + + L + +EM ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTI 617
++ LLG C + G +++EY +L +L FD K + L ++ V+
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
+A+G+ YL + + IHRDL A NVL+ D KI+DFGLAR + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
+M+PE D +++ +SDV+SFG+L+ E TL G G+ + F LL
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 10/214 (4%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEM 560
L S+ SV + ++ K+G+G G VY + GQEVA+++++ Q E NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
+++ + ++ N+V L + E +++EY+ SL D + + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
Q L +LH ++IHRD+K+ N+LL MD + K++DFG + Q +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
+M+PE + K D++S GI+ +E + G+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
LG+GGFG V ++ G+ A K+L + +G + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
+ + L++ M L +++ + +A + I GL +LHQ RI
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQR---RI 116
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
++RDLK NVLLD N +ISD GLA G K GT GYM+PE ++
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 697 KSDVFSFGILMLETLSGK 714
D F+ G + E ++G+
Sbjct: 174 SVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 34/214 (15%)
Query: 520 KLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQG--LEEFKNEMMLIAKLQHRNLVKLLG 576
K+G G FG VY L+ E+ AVK + Q ++E +EM ++ L+H NLVK G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT------IIEGIAQGLLYLHQ 630
V + + + +EY +L+ L R+L V ++EG+A YLH
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELL---EHGRIL--DEHVIRVYTLQLLEGLA----YLHS 117
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG------GDELQGNTKRIVGTYGYM 684
+ I+HRD+K +N+ LD + K+ DFG A G+E+Q + GT YM
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPAYM 170
Query: 685 SPEYALDGLFSIK---SDVFSFGILMLETLSGKK 715
+PE G +D++S G ++LE +GK+
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-19
Identities = 77/258 (29%), Positives = 127/258 (49%), Gaps = 34/258 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQG-LEEFKNEMMLIAKL-Q 567
E+ + +GEG FG V + + A+K L + + +F E+ ++ KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------FDPTKKRLLGWQARVT---- 616
H N++ LLG C +G + +EY P +L FL DP + G + +T
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 617 --IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT 674
+A G+ YL S + IHRDL A NVL+ ++ KI+DFGL+R G+E+
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY--V 173
Query: 675 KRIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLLGY 730
K+ +G +M+ E +++ KSDV+SFG+L+ E +L G G+ A+ + L
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233
Query: 731 AWDLWK----DDKFHELI 744
+ + K DD+ +EL+
Sbjct: 234 GYRMEKPRNCDDEVYELM 251
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 83/304 (27%), Positives = 144/304 (47%), Gaps = 45/304 (14%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
LG G FG VYKG + E VA+K L + S + +E +E ++A + + ++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
LG C+ + LI + MP L ++ + K +G Q + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEER--- 128
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
R++HRDL A NVL+ + KI+DFGLA++ G DE + + + +M+ E L ++
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752
+ +SDV+S+G+ + E T K G+ ++ ++L +K L P I +
Sbjct: 189 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---------EKGERLPQPPICTID 239
Query: 753 ISLPVLVRYINVALLCVQDNAADRPTMSDVVS--------------IINSERLELPSPKE 798
+ + + + C +A RP +++ I ER+ LPSP +
Sbjct: 240 VYM--------IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTD 291
Query: 799 PAFI 802
F
Sbjct: 292 SNFY 295
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 63/202 (31%), Positives = 109/202 (53%), Gaps = 25/202 (12%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
+LG+G FG VYK + G A K + ++S + LE++ E+ ++A H N+VKLL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
+ +++E+ ++D + + ++ L Q RV + + + L YLH+ +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI------VGTYGYMSPEYAL-- 690
RDLKA N+L +D + K++DFG++ NT+ I +GT +M+PE +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 691 ---DGLFSIKSDVFSFGILMLE 709
D + K+DV+S GI ++E
Sbjct: 179 TSKDRPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCV 579
+G G +G VYKGR + ++A ++ +G EE K E+ ++ K HRN+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 580 EQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
++ + L++E+ S+ L TK L + I I +GL +LHQ+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL--- 690
++IHRD+K NVLL + K+ DFG++ D G +GT +M+PE
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 691 --DGLFSIKSDVFSFGILMLETLSG 713
D + KSD++S GI +E G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 65/221 (29%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 520 KLGEGGFGPVYKGRLLNGQE---------------VAVKRLSSQ-SGQGLEEFKNEMMLI 563
KLGEG FG V+ E VAVK L + + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLL---------GWQAR 614
++L++ N+++LLG CV +I EYM N L+ FL +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--ELQ 671
+ + IA G+ YL + +HRDL N L+ KI+DFG++R ++ GD +Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
G R V +M+ E L G F+ SDV++FG+ + E +
Sbjct: 189 G---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 521 LGEGGFGPVYKGRLLNGQ-EVAVKRLSSQSGQGLEEF--KNEMMLIAKLQHRNLVKLLGC 577
+G G FG V+ R Q V +K++ + E +NE ++ L H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
+E ++++EY P +L ++ +KR TI+ Q LL LH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYI----QKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 638 HRDLKASNVLLDM-DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
HRDLK N+LLD M KI DFG++++ + +VGT Y+SPE ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 697 KSDVFSFGILMLETLSGKK 715
KSD+++ G ++ E S K+
Sbjct: 181 KSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 32/214 (14%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN--EMMLIAKLQ-HRN 570
+ + +LG+G FG VY R G+ VA+K++ + EE N E+ + KL H N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 571 LVKLLGCCVEQGEKILILEYMPN------KSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
+VKL E E + EYM K F + R + +Q I QG
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQ--------ILQG 111
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN---TKRIVGTY 681
L ++H++ F HRDLK N+L+ KI+DFGLAR E++ T V T
Sbjct: 112 LAHIHKHGFF---HRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVSTR 162
Query: 682 GYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
Y +PE L +S D+++ G +M E + +
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 75/281 (26%), Positives = 129/281 (45%), Gaps = 31/281 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSS---QSGQGLEEFKNEMMLIAKLQHR 569
NF ++ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLL-----GWQARVTIIEGIAQG 624
N++K +E E ++LE L + K++ L W+ V + +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
H +SR R++HRD+K +NV + K+ D GL R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744
SPE + ++ KSD++S G L+ E + + + D NL + L K K +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL----YSLCK--KIEQCD 224
Query: 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785
P + D S L + +N +C+ + RP ++ V +
Sbjct: 225 YPPLPSDHYSEE-LRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 33/216 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN----EMMLIAKLQ 567
+ + +GEG +G V K R G+ VA+K+ E+ K E+ ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLR 58
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIA 622
H N+V L +G L+ EY+ L++ P R WQ +
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LL 110
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR----IV 678
Q + Y H IIHRD+K N+L+ K+ DFG AR L+ V
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYV 162
Query: 679 GTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSG 713
T Y +PE + D + DV++ G +M E L G
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKN---EMMLIAKLQHR 569
+F + +G+G FG V + + +++ A+K ++ Q +N E ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 570 NLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
LV L + E + L+++ + L L K + Q + I E I L YL
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYL 116
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H IIHRD+K N+LLD + I+DF +A D T GT GYM+PE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEV 170
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKK 715
+S+ D +S G+ E L GK+
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 7e-18
Identities = 73/252 (28%), Positives = 123/252 (48%), Gaps = 38/252 (15%)
Query: 521 LGEGGFGPVYK------GRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVK 573
+GEG FG V K G ++ +K +S+ +F E+ ++ KL H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIIN 60
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFL-------FDPTKKRLLGWQARVT------IIEG 620
LLG C +G L +EY P+ +L FL DP + ++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+A+G+ YL S+ + IHRDL A N+L+ + KI+DFGL+R G E+ K+ +G
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGR 172
Query: 681 YG--YMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLLGYAWDLWK 736
+M+ E +++ SDV+S+G+L+ E +L G G+ A+ + L + L K
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232
Query: 737 ----DDKFHELI 744
DD+ ++L+
Sbjct: 233 PLNCDDEVYDLM 244
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 84/300 (28%), Positives = 139/300 (46%), Gaps = 52/300 (17%)
Query: 511 ATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLS-SQSGQGLEEFKNEMMLI 563
A E +M +LG+G FG VY KG + + E VA+K ++ + S + EF NE ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 564 AKLQHRNLVKLLGCCVEQGEKIL-ILEYMPNKSLDVFLFD-------------PTKKRLL 609
+ ++V+LLG V QG+ L I+E M L +L P+ K+++
Sbjct: 64 KEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD 668
IA G+ YL+ + +HRDL A N ++ D KI DFG+ R ++ D
Sbjct: 123 QMAGE------IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
Query: 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFN 726
+ K ++ +MSPE DG+F+ SDV+SFG+++ E TL+ + G+ N
Sbjct: 174 YYRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232
Query: 727 LLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
+ L K D +++ + +C Q N RP+ +++S I
Sbjct: 233 FVMEGGLLDKPDNCPDML-----------------FELMRMCWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 61/205 (29%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRN 570
E F+ ++G+G FG V+KG Q+V A+K + + + +E+ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 571 LVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
+ K G ++ + +I+EY+ S LD+ P + + T+++ I +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLH 118
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+ IHRD+KA+NVLL + K++DFG+A +++ NT VGT +M+PE
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 173
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
+ K+D++S GI +E G+
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 513 ENFSMQCKLGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL 566
N+ + LG G FG VY GR L ++V S ++ + + + E+ L+ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 567 QHRNLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQA---RVT--IIE 619
+H +V+ GC + EK L +EYMP S+ K +L + A VT
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI--------KDQLKAYGALTENVTRRYTR 113
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN-TKRIV 678
I QG+ YLH I+HRD+K +N+L D N K+ DFG ++ + G K +
Sbjct: 114 QILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA 722
GT +MSPE + K+DV+S ++E L+ K Y A
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 8e-18
Identities = 75/273 (27%), Positives = 130/273 (47%), Gaps = 38/273 (13%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLL 575
++G G FG VY + E VAVK++S Q E++++ E+ + +L+H N ++
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
GC +++ L++EY + D+ K+ L I G QGL YLH ++
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DG 692
+IHRD+KA N+LL K++DFG A VGT +M+PE L +G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 693 LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752
+ K DV+S GI +E ++ ++N ++ + L + + ++D P + +E
Sbjct: 196 QYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSAL---YHIAQNDS------PTLQSNE 244
Query: 753 I--SLPVLVRYINVALLCVQDNAADRPTMSDVV 783
S V Y C+Q +RP ++++
Sbjct: 245 WTDSFRGFVDY------CLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 520 KLGEGGFGPVYKG--RLLNGQE-VAVKRLSSQSGQGLEEFKNEMMLIAK----LQHRNLV 572
+LG G FG V KG ++ ++ VAVK L + + K+E++ A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+++G C E +L++E L+ FL K + + + ++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEY 688
+HRDL A NVLL KISDFGL++ G DE + + K V Y +PE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APEC 169
Query: 689 ALDGLFSIKSDVFSFGILMLETLS-GKK 715
FS KSDV+SFG+LM E S G+K
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRL-----SSQSGQGLEEFKNEMMLIAKLQ 567
N+ + LG+G FG VY + G+E+AVK++ S ++ + + + E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 568 HRNLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQA---RVT--IIEG 620
H +V+ GC + E+ L +E+MP S+ K +L + A VT
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSI--------KDQLKSYGALTENVTRKYTRQ 114
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN-TKRIVG 679
I +G+ YLH I+HRD+K +N+L D N K+ DFG ++ L G K + G
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
T +MSPE + K+D++S G ++E L+ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 56/204 (27%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
K+GEG G V + G++VAVK++ + Q E NE++++ QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 572 VKLLGCCVEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
V++ + E +++E++ +L D+ T R+ Q T+ + + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQI-ATVCLAVLKALSFLHA 133
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+IHRD+K+ ++LL D K+SDFG + + K +VGT +M+PE
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVIS 188
Query: 691 DGLFSIKSDVFSFGILMLETLSGK 714
+ + D++S GI+++E + G+
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 62/205 (30%), Positives = 108/205 (52%), Gaps = 13/205 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRN 570
E F+ K+G+G FG V+KG Q+V A+K + + + +E+ + E+ ++++
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 571 LVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
+ K G ++ + +I+EY+ S LD+ P + + TI+ I +GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLH 118
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+ IHRD+KA+NVLL K++DFG+A +++ N VGT +M+PE
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVI 173
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
+ K+D++S GI +E G+
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 19/200 (9%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFK-NEMMLIAKLQ---HRNLVKL 574
+GEG +G VYK R L G+ VA+K++ S +G+ E+ L+ +L+ H N+V+L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 575 LGCC-VEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
L C + ++ L+ E++ ++ L +L K L + ++ + +G+ +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFLH 124
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+ RI+HRDLK N+L+ D KI+DFGLAR++ + +V T Y +PE
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAPEVL 178
Query: 690 LDGLFSIKSDVFSFGILMLE 709
L ++ D++S G + E
Sbjct: 179 LQSSYATPVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 521 LGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
LG+GGFG V G+L +++ KRL + +G E E ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-------RLLGWQARVTIIEGIAQGLLY 627
+ + L++ M L +++ ++ R + A+ I GL +
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ------IISGLEH 112
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
LHQ RII+RDLK NVLLD D N +ISD GLA + Q TK GT G+M+PE
Sbjct: 113 LHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPE 167
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
+ D F+ G+ + E ++ +
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 24/206 (11%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFK-NEMMLIAKLQHRNLVKLLG 576
K+GEG +G VYK R + + +A+K++ Q +G+ E+ L+ ++QH N+V+L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 577 CCVEQGEKILILEYMP---NKSLDV---FLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+ L+ EY+ K +D F +P + +Q I+ GIA Y H
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ----ILRGIA----YCHS 120
Query: 631 YSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+ R++HRDLK N+L+D N K++DFGLAR F G ++ T +V T Y +PE
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEIL 175
Query: 690 LDGL-FSIKSDVFSFGILMLETLSGK 714
L +S D++S G + E ++ K
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-17
Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 325 PIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSN 384
P+ C S+ F+KL +++ PD +++L++C CL NC+C AYA +N
Sbjct: 2 PLNCGGDGST-----DGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN 54
Query: 385 VTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVP 418
GCL+W G L + + G ++Y+R+
Sbjct: 55 G--SGGCLLWNGLLNNLRSL--SSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRNLVKLLGC 577
++G G FG V+ GRL + VAVK L+ +F E ++ + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
C ++ +++E + FL T+ L + + ++E A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
HRDL A N L+ KISDFG++R G G K+I + +PE G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 696 IKSDVFSFGILMLETLS 712
+SDV+SFGIL+ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQS--GQGLEE-FKNEMMLIAKLQHRNLVKLLG 576
LG GGFG V ++ + A+K + + G +E +E ++ + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
++ +++EY L L D + + AR I + YLH I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLHNRG---I 114
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
I+RDLK N+LLD + K+ DFG A+ + T GT Y++PE L+ +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDF 171
Query: 697 KSDVFSFGILMLETLSGK 714
D +S GIL+ E L+G+
Sbjct: 172 SVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 49/203 (24%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRL--SSQSGQGLEEFK-NEMMLIAKLQH 568
+ ++ +G G +G VYK + N G+E A+K+ + G+ + E+ L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 569 RNLVKLLGCCVEQGEKI--LILEYMPNKSLDVFLF----------DPTKKRLLGWQARVT 616
N+V L+ +E +K L+ +Y + + F K LL WQ
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL-WQ---- 116
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP----KISDFGLARMF------- 665
I G+ YLH S + ++HRDLK +N+L+ + KI D GLAR+F
Sbjct: 117 ----ILNGVHYLH--SNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 666 -GGDELQGNTKRIVGTYGYMSPE 687
D +V T Y +PE
Sbjct: 170 ADLD-------PVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 9e-17
Identities = 55/203 (27%), Positives = 107/203 (52%), Gaps = 16/203 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
E+F + ++G G +G VYK R +N G+ A+K + + G+ + E++++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 572 VKLLGCCVEQGEKILILEYMPNKSL-DVF-LFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
V G + + + + +E+ SL D++ + P + + + +R T+ QGL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+ +HRD+K +N+LL + + K++DFG++ K +GT +M+PE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVA 178
Query: 690 L---DGLFSIKSDVFSFGILMLE 709
G ++ D+++ GI +E
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 80/308 (25%), Positives = 144/308 (46%), Gaps = 40/308 (12%)
Query: 511 ATENFSMQCKLGEGGFGPVYKG---RLLNGQ---EVAVKRLS-SQSGQGLEEFKNEMMLI 563
+ E ++ +LG+G FG VY+G ++ G+ VAVK ++ S S + EF NE ++
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLF-------DPTKKRLLGWQARVT 616
++V+LLG + ++++E M + L +L + + Q +
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTK 675
+ IA G+ YL+ + +HRDL A N ++ D KI DFG+ R ++ D + K
Sbjct: 124 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLLGYAWD 733
++ M+PE DG+F+ SD++SFG+++ E +L+ + G+ N +
Sbjct: 181 GLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239
Query: 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLEL 793
L + D E R ++ +C Q N RPT ++V+++ + L
Sbjct: 240 LDQPDNCPE-----------------RVTDLMRMCWQFNPKMRPTFLEIVNLLK-DDLH- 280
Query: 794 PSPKEPAF 801
PS E +F
Sbjct: 281 PSFPEVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 520 KLGEGGFGPVYKG--RLLNGQE--VAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL 574
+GEG FG VY+G ++ VAVK + + + E+F E ++ + H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
+G E I ++E P L +L K L + + ++ L YL S+
Sbjct: 73 IGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLE--SK- 126
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
R +HRD+ A NVL+ K+ DFGL+R + +K + +M+PE F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESINFRRF 185
Query: 695 SIKSDVFSFGILMLETLS-GKKN-TGVYNAD 723
+ SDV+ FG+ M E L G K GV N D
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 524 GGFGPVYKGR-LLNGQEVAVKRLSSQSGQG---LEEFKNEMMLIAKLQHRNLVKLLGCCV 579
G +G V+ + G A+K + +++ E ++++ Q +VKL
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF- 62
Query: 580 EQGEKILIL--EYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
QG+K L L EY+P L L D AR+ I E I L YLH
Sbjct: 63 -QGKKNLYLVMEYLPGGDLASLLENVGSLDED-------VARIYIAE-IVLALEYLHSNG 113
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLA------RMFGGDELQGNTKRIVGTYGYMSP 686
IIHRDLK N+L+D + + K++DFGL+ R ++ + KRIVGT Y++P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
E L S D +S G ++ E L G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 45/227 (19%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKR--LSSQSGQGLEEFKN------------EMMLIAK 565
LGEG +G V K L G+ VA+K+ + S ++ + E+ ++ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPN---KSLD--VFLFDPTKKRLLGWQARVTIIEG 620
++H N++ L+ VE L+++ M + K +D + L + K +L Q
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL-LQ-------- 127
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI--- 677
I GL LH++ +HRDL +N+ ++ KI+DFGLAR +G +
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 678 ---------VGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGK 714
V T Y +PE + + D++S G + E L+GK
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 514 NFSMQCKLGEGGFGPVY--KGRLLNGQEVAVK-RLSSQSGQGLEEFKNEMMLIAKLQHRN 570
+ + K+GEG FG +Y K + + V + L+ + E K E++L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSL-------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
+V E G +++EY L LF ++ ++L W + I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWFVQ------ISL 112
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
GL ++H +I+HRD+K+ N+ L + M K+ DFG+AR T VGT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPY 167
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLE 709
Y+SPE + ++ K+D++S G ++ E
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYE 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 515 FSMQCKLGEGGFGPVY---------KGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAK 565
+ +Q +LG+G FG VY + RL +E+ V L+ + E L++K
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSK 58
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQ 623
L H +VK +E+ +I EY + LD L T K L + + E Q
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL----SENQVCEWFIQ 114
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
LL +H + RI+HRDLKA N+ L ++ KI DFG++R+ G T GT Y
Sbjct: 115 LLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYY 171
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLE 709
MSPE + KSD++S G ++ E
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 77/272 (28%), Positives = 130/272 (47%), Gaps = 31/272 (11%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
LG G FG VYKG + E VA+K L + S + +E +E ++A + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
LG C+ + L+ + MP L ++ + K +G Q + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEE---V 128
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
R++HRDL A NVL+ + KI+DFGLAR+ DE + + +M+ E L F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752
+ +SDV+S+G+ + E T K G+ + +LL +K L P I +
Sbjct: 189 THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL---------EKGERLPQPPICTID 239
Query: 753 ISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784
+ + ++V+ C ++ RP ++V
Sbjct: 240 VYM-IMVK-------CWMIDSECRPRFRELVD 263
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 82/311 (26%), Positives = 138/311 (44%), Gaps = 58/311 (18%)
Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMM-LIAKLQHR---NLVK 573
+LG G +G V K R + G +AVKR+ + +E K +M L ++ V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVT 64
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVF---LFDP---TKKRLLGWQARVTIIEGIAQGLLY 627
G +G+ + +E M + SLD F ++D + +LG I I + L Y
Sbjct: 65 FYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEY 118
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSP 686
LH S+ +IHRD+K SNVL++ + K+ DFG++ G + K I G YM+P
Sbjct: 119 LH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKPYMAP 172
Query: 687 EYALDGL-----FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH 741
E ++ + +KSDV+S GI M+E +G+ + +D WK F
Sbjct: 173 E-RINPELNQKGYDVKSDVWSLGITMIELATGR---------------FPYDSWK-TPFQ 215
Query: 742 ELID------PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPS 795
+L P + ++ S P ++N C++ N +RP +++ E +
Sbjct: 216 QLKQVVEEPSPQLPAEKFS-PEFQDFVNK---CLKKNYKERPNYPELLQHPFFELHLSKN 271
Query: 796 PKEPAFIKGIN 806
+F+ I
Sbjct: 272 TDVASFVSLIL 282
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-16
Identities = 56/203 (27%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
++ + ++G G +G VYK R L G+ AVK + + G + E+ ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 572 VKLLGCCVEQGEKILILEYMPNKSL-DVF-LFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
V G + + + + +EY SL D++ + P + + + R T+ QGL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+ +HRD+K +N+LL + + K++DFG+A K +GT +M+PE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVA 178
Query: 690 L---DGLFSIKSDVFSFGILMLE 709
+G ++ D+++ GI +E
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 8e-16
Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGLEEFK---NEMMLIAKLQHRN 570
F + ++G+GG+G V+ + + E VA+KR+ L E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
LVKLL + L +EY+P L L AR + E + LH+
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALHE 119
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
IHRDLK N L+D + K++DFGL++ G +VG+ YM+PE
Sbjct: 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTY---ANSVVGSPDYMAPEVLR 171
Query: 691 DGLFSIKSDVFSFGILMLETLSG 713
+ D +S G ++ E L G
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 68/212 (32%), Positives = 112/212 (52%), Gaps = 22/212 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SSQSGQGLEEFKNEMMLIAKLQH 568
+ + ++ EG +G VY+ R G+ VA+K+L + G + + E+ ++ KLQH
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 569 RNLVKLLGCCVEQG-EKI-LILEYMPN--KSLDVFLFDPTKKRLLGWQARV-TIIEGIAQ 623
N+V + V +KI +++EY+ + KSL + K+ L Q+ V ++ +
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSL----METMKQPFL--QSEVKCLMLQLLS 117
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
G+ +LH I+HRDLK SN+LL+ KI DFGLAR + G L+ T+ +V T Y
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV-TLWY 172
Query: 684 MSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
+PE L +S D++S G + E L+ K
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 20/202 (9%)
Query: 520 KLGEGGFGPVYKGRLLN--GQEVAVKRL---SSQSGQGLEEFKNEMML--IAKLQHRNLV 572
++GEG +G V+K R L G+ VA+KR+ + + G L + +L + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 573 KLLGCCV-----EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
+L C + + L+ E++ ++ L +L D + + + ++ + +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
LH + R++HRDLK N+L+ K++DFGLAR++ Q +V T Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179
Query: 688 YALDGLFSIKSDVFSFGILMLE 709
L ++ D++S G + E
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 65/200 (32%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQ----SGQGLEEFKNEMMLIAKLQHRNLVKLL 575
LG G FG V R + A+K LS Q +E NE ++ ++H LV L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKK--RLLGWQARVTIIEGIAQGLLYLHQYSR 633
G + L++EY+P L F +K R AR + + L YLH
Sbjct: 68 GSFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPEPVARFYAAQ-VVLALEYLHSLD- 121
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
I++RDLK N+LLD D KI+DFG A+ ++G T + GT Y++PE L
Sbjct: 122 --IVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKG 174
Query: 694 FSIKSDVFSFGILMLETLSG 713
+ D ++ GIL+ E L+G
Sbjct: 175 YGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 38/213 (17%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRL---SSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
++GEG +G VY+ R +G+ VA+K++ + + G + + E+ L+ L+H N+V+L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72
Query: 576 GCCV-EQGEKI-LILEY-----------MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA 622
V + + I L++EY MP F ++ + L Q +
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP------FSESQVKCLMLQ--------LL 118
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
+GL YLH F IIHRDLK SN+LL KI+DFGLAR + G + T ++V T
Sbjct: 119 RGLQYLH--ENF-IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLW 173
Query: 683 YMSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
Y +PE L + D+++ G ++ E L+ K
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCV 579
+G G +G VYKGR + ++A ++ + EE K E+ ++ K HRN+ G +
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 580 EQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
++ + L++E+ S+ L TK L I I +GL +LH +
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAYICREILRGLAHLHAH-- 140
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL--- 690
++IHRD+K NVLL + K+ DFG++ D G +GT +M+PE
Sbjct: 141 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 197
Query: 691 --DGLFSIKSDVFSFGILMLETLSG 713
D + +SD++S GI +E G
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 39/212 (18%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
++G G G VYK G+ A+K + + + E+ ++ + H N+VK
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 578 CVEQGEKILILEYMPNKSLD-------VFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
GE ++LE+M SL+ FL D ++ I+ GIA YLH
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----------ILSGIA----YLH- 185
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY-- 688
R I+HRD+K SN+L++ N KI+DFG++R+ N+ VGT YMSPE
Sbjct: 186 --RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERIN 241
Query: 689 ------ALDGLFSIKSDVFSFGILMLETLSGK 714
A DG D++S G+ +LE G+
Sbjct: 242 TDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 80/285 (28%), Positives = 124/285 (43%), Gaps = 52/285 (18%)
Query: 521 LGEGGFGPVYKG--RLLNGQE--VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
LG G FG + +G +L + +E VA+ L + S + F E + + + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
G +++ EYM N +LD FL + +L+ Q + ++ G+A G+ YL S
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQL-MGMLPGLASGMKYL---SEMG 127
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS---------P 686
+H+ L A VL++ D+ KIS F + + Y MS P
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR----------RLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746
E FS SDV+SFGI+M E +S Y + WD+ D +I
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMS-------YGERPY------WDMSGQD----VIKA 220
Query: 747 VITQDEISLPVLVRYIN----VALLCVQDNAADRPTMSDVVSIIN 787
V +D LP N + L C Q +RP S + SI++
Sbjct: 221 V--EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 39/212 (18%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLLG 576
+G G +G V G++VA+K+LS + Q K E+ L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 577 CCVEQGEKILILEYMPNKSL----DVFLFDP---------TKKRLLGWQARVTIIEGIAQ 623
+ P SL DV+L K + L ++ I +
Sbjct: 82 V------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
GL Y+H IIHRDLK SN+ ++ D KI DFGLAR DE+ G V T Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----YVATRWY 181
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
+PE L+ + ++ D++S G +M E L+GK
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKR-LSSQSGQG-----LEEFKNEMMLIAKLQHRNLV 572
K+G+G FG V+K R Q VA+K+ L +G L E K ++ L+H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 74
Query: 573 KLLGCCVEQGEK--------ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
L+ C + L+ E+ + L L + K L +++ + G
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS--EIKKVMKMLLNG 131
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG---GDELQGNTKRIVGTY 681
L Y+H R +I+HRD+KA+N+L+ D K++DFGLAR F + T R+V T
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TL 187
Query: 682 GYMSPEYAL-DGLFSIKSDVFSFGILMLE 709
Y PE L + + D++ G +M E
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 5e-15
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 16/196 (8%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRNLVKLLGCC 578
LG G G VYK LL + +AVK + L+ + +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
+ + E+M SLDV+ P + +LG R+ + + +GL YL +I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIP--EHVLG---RIAV--AVVKGLTYLWS---LKILH 118
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
RD+K SN+L++ K+ DFG++ + K VGT YM+PE + I S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 699 DVFSFGILMLETLSGK 714
DV+S GI +E G+
Sbjct: 175 DVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 32/211 (15%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN---LVKLLG 576
+G G FG V K G +AVKR+ S E+ + M L ++ + +VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 577 CCVEQGEKILILEYMPNKSLDVF---LFDPTKKRL----LGWQARVTIIEGIAQGLLYLH 629
+G+ + +E M + SLD F +++ K + LG A T+ + L YL
Sbjct: 71 ALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATV-----KALNYLK 124
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI--VGTYGYMSPE 687
+ +IIHRD+K SN+LLD + N K+ DFG++ +L + + G YM+PE
Sbjct: 125 E--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPE 177
Query: 688 ----YALDGLFSIKSDVFSFGILMLETLSGK 714
A DG + ++SDV+S GI + E +GK
Sbjct: 178 RIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 1e-14
Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 44/225 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMML 562
+ + KLG+G +G V+K + VA+K++ + F+N E+M
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMF 59
Query: 563 IAKL-QHRNLVKLLGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE 619
+ +L H N+VKLL + +K L+ EYM + L + +L + I+
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMY 114
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-- 677
+ + L Y+H S +IHRDLK SN+LL+ D K++DFGLAR EL+ N +
Sbjct: 115 QLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVL 169
Query: 678 ---VGTYGYMSPEYALDGLFSIKS-----DVFSFGILMLETLSGK 714
V T Y +PE L D++S G ++ E L GK
Sbjct: 170 TDYVATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 53/196 (27%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 520 KLGEGGFGPV-YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
K+GEG G V G++VAVK++ + Q E NE++++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
+ E +++E++ +L D + + T+ + + L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
RD+K+ ++LL D K+SDFG + + K +VGT +M+PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 699 DVFSFGILMLETLSGK 714
D++S GI+++E + G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
K+GEG G V + +G+ VAVK++ + Q E NE++++ QH N+V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
+ E +++E++ +L D + + + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
RD+K+ ++LL D K+SDFG E+ K +VGT +M+PE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVP-RRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 699 DVFSFGILMLETLSGK 714
D++S GI+++E + G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 59/238 (24%), Positives = 98/238 (41%), Gaps = 31/238 (13%)
Query: 486 EVNGDGKDKGKD-----SWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEV 540
E + D D +P A A+ +++ L G G V+ GQ
Sbjct: 34 EYSDDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPD 92
Query: 541 AVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL 600
V Q G L E ML+ + H +++++ V ++L P+ S D++
Sbjct: 93 PVVLKIGQKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYT 145
Query: 601 FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660
+ + R L + I + I +GL YLH RIIHRD+K N+ ++ I D G
Sbjct: 146 YLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG 202
Query: 661 LAR------MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
A+ F G + GT +PE ++ K+D++S GI++ E L+
Sbjct: 203 AAQFPVVAPAFLG---------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN--EMMLIAKLQ-HRNLVKL 574
K+GEG F V K + G+ A+K + + + LE+ N E+ + +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 575 LGCCVEQ--GEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARV-TIIEGIAQGLLYLH 629
+ ++ G L+ E M D+ L++ K KR L + RV + + + + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMH 117
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
R I HRD+K N+L+ D K++DFG R G T+ I T Y +PE
Sbjct: 118 ---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECL 170
Query: 690 L-DGLFSIKSDVFSFGILMLETLS 712
L DG + K D+++ G + E LS
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDP-----TKKRLLGWQARVTIIEGIAQGLLYLH 629
+ L+L M L +++ ++R + + A +T GL LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC------GLEDLH 119
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEY 688
R RI++RDLK N+LLD + +ISD GLA + G+ ++G VGT GYM+PE
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPEV 172
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
+ ++ D + G L+ E + GK
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
LG+GGFG V G++ + + KR+ + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDP-----TKKRLLGWQARVTIIEGIAQGLLYLH 629
+ L+L M L +++ ++R L + A I GL LH
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE------ILCGLEDLH 119
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEY 688
+ + ++RDLK N+LLD + +ISD GLA ++ G+ ++G VGT GYM+PE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEV 172
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
+ +++ D + G L+ E + G+
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGL--EEFKNEMMLIAKLQHRN 570
++F +LG G G V K + + ++L + + E+ ++ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYL 628
+V G GE + +E+M SLD L + + + +LG +V+I + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVSI--AVLRGLAYL 119
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
+ + +I+HRD+K SN+L++ K+ DFG++ G + VGT YMSPE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
+S++SD++S G+ ++E G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
+ L+L M L ++ + +A E I GL LHQ
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLHQE--- 121
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
RI++RDLK N+LLD + +ISD GLA + G ++G VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER 177
Query: 694 FSIKSDVFSFGILMLETLSGK 714
++ D ++ G L+ E ++G+
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQ-GLE-EFKNEMMLIAKLQ---HRNLVK 573
++G G +G VYK R +G VA+K + Q+ + GL E+ L+ +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 574 LLGCC----VEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
L+ C ++ K+ L+ E++ ++ L +L D L + ++ +GL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H I+HRDLK N+L+ K++DFGLAR++ Q +V T Y +PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
L ++ D++S G + E K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 25/216 (11%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFK----NEMMLIAKLQHR 569
F + ++GEG +G VYK R G+ VA+K++ + + E F E+ ++ +L HR
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHR 66
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW----------QARVTIIE 619
N+V L + K L++ +K +F+ L+G + ++
Sbjct: 67 NIVNLKEIVTD---KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
+ +GL Y H+ + +HRD+K SN+LL+ K++DFGLAR++ +E + T +++
Sbjct: 124 QLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179
Query: 680 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
T Y PE L + + DV+S G ++ E + K
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
++ +G G FG V+ R ++ A+K ++ + + NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
+++L +Q +++EY+P L F + R E I L YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCALEYL 117
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H I++RDLK N+LLD + + K++DFG A+ +L+ T + GT Y++PE
Sbjct: 118 HSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPE- 168
Query: 689 ALDGLFSIKS-------DVFSFGILMLETLSGK 714
I+S D ++ GIL+ E L G
Sbjct: 169 ------VIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 21/156 (13%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-VAVKRLSSQS-GQGLEEFK-NEMMLIAKLQHRNLVKLLG 576
K+GEG +G V+K + E VA+KR+ +G+ E+ L+ +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 577 CCVEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+ L+ EY ++ L + DP + +Q + +GL + H
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQ--------LLKGLAFCHS 117
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666
+ ++HRDLK N+L++ + K++DFGLAR FG
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 40/226 (17%)
Query: 505 LASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN----- 558
+V T + +G G FG V R L GQ VA+K++ ++ F
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54
Query: 559 ----EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614
E+ L+ L+H N++ L + E I + + L L R L Q
Sbjct: 55 RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFI 110
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-----MFGGDE 669
+ I +GL Y+H ++HRDLK SN+L++ + + KI DFGLAR M G
Sbjct: 111 QYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG--- 164
Query: 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
V T Y +PE L + ++ D++S G + E L GK
Sbjct: 165 -------YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 69/287 (24%), Positives = 122/287 (42%), Gaps = 48/287 (16%)
Query: 521 LGEGGFGPVYK-------GRLLNGQEVAVKRLS-----SQSGQGLEEFKNEMMLIAK-LQ 567
LG G FG VYK LL +E+ V + + + + + +E+ +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
H N+V+ +E ++++ + L + F KK+ + I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
YLH+ R I+HRDL +N++L D I+DFGLA+ + +VGT Y P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCP 182
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYA-------WDLWKDDK 739
E + + K+DV++FG ++ + + Y S N+L A ++ +
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCT--LQPPFY---STNMLSLATKIVEAVYEPLPEGM 237
Query: 740 FHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
+ E + VIT C+ +A RP + V ++I
Sbjct: 238 YSEDVTDVITS-----------------CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
I GL +LH+ II+RDLK NVLLD + + KI+DFG+ + + GG T
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
GT Y++PE + D ++ G+L+ E L+G+
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 521 LGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGLEEF--KNEMMLIAKLQHRNLVKL 574
LG+G FG V+ R + GQ A+K L + + + K E ++A++ H +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI-IEGIAQGLLYLHQYSR 633
+G+ LIL+++ L F K ++ + V + +A L +LH
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH---S 116
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
II+RDLK N+LLD + + K++DFGL++ E + GT YM+PE
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRG 174
Query: 694 FSIKSDVFSFGILMLETLSG 713
+ +D +SFG+LM E L+G
Sbjct: 175 HTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 21/150 (14%)
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK------RLLGWQARVTIIEGIAQG 624
+V G GE + +E+M SLD L KK +LG +++I + +G
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPENILG---KISI--AVLRG 111
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
L YL + + +I+HRD+K SN+L++ K+ DFG++ G + VGT YM
Sbjct: 112 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYM 165
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
SPE ++++SD++S G+ ++E G+
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
+G G +G V Y RL Q+VAVK+LS QS E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 576 -----GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+E ++ Y+ + L + K + L + +I + +GL Y+H
Sbjct: 81 DVFTPATSIENFNEV----YLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
IIHRDLK SNV ++ D +I DFGLAR DE+ G V T Y +PE L
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWYRAPEIML 188
Query: 691 DGL-FSIKSDVFSFGILMLETLSGK 714
+ + ++ D++S G +M E L GK
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 9/96 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
IA GL +LH II+RDLK NV+LD + + KI+DFG+ + +FGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
GT Y++PE + D ++FG+L+ E L+G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
LG+GGFG V G++ +++ KRL +SG+ + + E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-----RLLGWQARVTIIEGIAQGLLYLH 629
+ L++ M L +++ ++ R++ + A+ I G+L+LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLH 112
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEY 688
I++RD+K NVLLD N ++SD GLA + G + T+R GT GYM+PE
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQR-AGTNGYMAPEI 165
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
+ +S D F+ G + E ++G+
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSS----QSGQGLEEFKNEMMLIAK 565
NF + LG G +G V+ R ++G + A+K L Q + E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 566 LQHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG-IAQ 623
++ + L + K+ LIL+Y+ L F +R + V I G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSGEIVL 116
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
L +LH + II+RD+K N+LLD + + ++DFGL++ F DE++ GT Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEY 172
Query: 684 MSPEYAL--DGLFSIKSDVFSFGILMLETLSG 713
M+P+ DG D +S G+LM E L+G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-13
Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 26/194 (13%)
Query: 537 GQEVAVKRLSSQSGQGLEE---FKNEMMLIAKLQHRNLVKLL--GCCVEQGEKILILEYM 591
G EVA+K L + + + + F+ E L A+L H N+V LL G G + EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEG---IAQGLLYLHQYSRFRIIHRDLKASNVLL 648
P ++L + +L + E + Q L L I+HRDLK N+++
Sbjct: 62 PGRTL---------REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMV 112
Query: 649 ---DMDMNPKISDFGLARMFGG----DELQGN-TKRIVGTYGYMSPEYALDGLFSIKSDV 700
+ + K+ DFG+ + G D T ++GT Y +PE + SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 701 FSFGILMLETLSGK 714
+++G++ LE L+G+
Sbjct: 173 YAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 28/216 (12%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFK--NEMMLIAKL 566
AAT +++ KLGEG + VYKG +NGQ VA+K +S ++ +G+ F E L+ L
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60
Query: 567 QHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIE 619
+H N+V LL + E + + EYM + L ++ P RL +Q
Sbjct: 61 KHANIV-LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ------- 111
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
+ +GL Y+H I+HRDLK N+L+ K++DFGLAR Q + +V
Sbjct: 112 -LLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV- 165
Query: 680 TYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
T Y P+ L +S D++ G + +E L G+
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 53/154 (34%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
KLGEG + VYKGR L GQ VA+K RL + G + E L+ L+H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69
Query: 576 GCCVEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
+ L+ EY+ + L ++ RL +Q + +GL Y H
Sbjct: 70 DIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ--------LLRGLAYCH 120
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
Q R++HRDLK N+L+ K++DFGLAR
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 65/251 (25%), Positives = 115/251 (45%), Gaps = 34/251 (13%)
Query: 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFK-NEMMLIAKLQHRNLVKLLGC 577
CK+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 578 CVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY-----LHQ 630
+ ++ L+ +Y + + F K + V + G+ + LLY +H
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 631 YSRFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFGGD-ELQGNTKRIVGTYGYM 684
++HRDLK +N+L+ M P KI+D G AR+F + + +V T+ Y
Sbjct: 124 LHANWVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 685 SPEYALDGLFSIKS-DVFSFGILMLETLSGK----------KNTGVYNADS----FNLLG 729
+PE L K+ D+++ G + E L+ + K + Y+ D FN++G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242
Query: 730 YAWDL-WKDDK 739
+ D W+D K
Sbjct: 243 FPADKDWEDIK 253
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 520 KLGEGGFGPVYKGRLL----NGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRNLVK 573
K+GEG FG K L+ +G++ +K + S S + EE + E+ +++ ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
E G ++++Y L + +R + + I++ Q L L
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKI---NAQRGVLFPED-QILDWFVQICLALKHVHD 119
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDG 692
+I+HRD+K+ N+ L D K+ DFG+AR+ EL + +GT Y+SPE +
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---ARTCIGTPYYLSPEICENR 176
Query: 693 LFSIKSDVFSFGILMLETLSGK 714
++ KSD+++ G ++ E + K
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 9e-13
Identities = 91/339 (26%), Positives = 138/339 (40%), Gaps = 96/339 (28%)
Query: 521 LGEGGFGPVYK------GRLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
LG G FG V + + + + VAVK L + G E+K M +LI H N
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKML--KEGATASEYKALMTELKILIHIGHHLN 72
Query: 571 LVKLLGCCVEQGEKIL-ILEYMPNKSLDVFL------FDPT----------------KKR 607
+V LLG C + G ++ I+EY +L +L F P K+R
Sbjct: 73 VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132
Query: 608 LL-----------GWQA--RVTIIEGIAQG-------------LLYLHQYSR---F---- 634
L G+ ++ +E +G + Y Q +R F
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR 192
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYALDG 692
+ IHRDL A N+LL + KI DFGLAR D ++ R+ +M+PE D
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDK 250
Query: 693 LFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE---LIDPV 747
+++ +SDV+SFG+L+ E +L GV + F + E + P
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC-----------RRLKEGTRMRAPE 299
Query: 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
EI ++ L C +N DRPT S++V I+
Sbjct: 300 YATPEI--------YSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 520 KLGEGGFGPVYKG---RLLNGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
++G G FG V G R ++ V VK L +S + F E+ +L H N+++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT--IIEGIAQGLLYLHQYSR 633
G C+E +L+LE+ P L +L Q V + +A GLL+LHQ
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD- 120
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYA--- 689
IH DL N L D++ KI D+GLA + D V +++PE
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEIR 177
Query: 690 ----LDGLFSIKSDVFSFGILMLE 709
L + KS+++S G+ M E
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVKR-LSSQSGQGLEEFK-NEMMLIAKLQHRNLVKLL 575
K+GEG +G V+K R GQ VA+K+ + S+ +++ E+ ++ +L+H NLV L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
+ + L+ EY + L+ +P R + II Q + + H+++
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN--- 120
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL-DGLF 694
IHRD+K N+L+ K+ DFG AR+ G + V T Y +PE + D +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPELLVGDTQY 178
Query: 695 SIKSDVFSFGILMLETLSG 713
DV++ G + E L+G
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRLSS----QSGQGLEEFKNEMMLIAK 565
NF + LG G +G V+ R + G + A+K L Q + E + E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 566 LQHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
++ + L + K+ LIL+Y+ L L+ ++ + RV I E I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY--QREHFTESEVRVYIAE-IVLA 117
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
L +LHQ II+RD+K N+LLD + + ++DFGL++ F +E + GT YM
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 685 SPEYAL--DGLFSIKSDVFSFGILMLETLSG 713
+PE G D +S G+L E L+G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 67/211 (31%), Positives = 99/211 (46%), Gaps = 37/211 (17%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
+G G +G V G VAVK+LS QS + E+ L+ ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 578 CVEQGEKILILEYMPNKSL----DVFLF---------DPTKKRLLGWQARVTIIEGIAQG 624
+ P +SL DV+L + K + L +I I +G
Sbjct: 85 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
L Y+H IIHRDLK SN+ ++ D KI DFGLAR DE+ G V T Y
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 184
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
+PE L+ + ++ D++S G +M E L+G+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 38/211 (18%)
Query: 521 LGEGGFGPV----YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEM------MLIAKLQHRN 570
LG G FG V YK G+ A+K L +E ++ M +H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQG 624
LV L C + ++EY L DVF ++ R + + A V + G
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF----SEPRAVFYAACVVL------G 113
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYG 682
L YLH+ +I++RDLK N+LLD + KI+DFGL + M GD T GT
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TSTFCGTPE 166
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
+++PE + ++ D + G+L+ E L G
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 47/158 (29%), Positives = 84/158 (53%), Gaps = 13/158 (8%)
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARVT 616
E+ ++ + +V G GE + +E+M SLD L + +++LG +V+
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVS 109
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
I + +GL YL + + +I+HRD+K SN+L++ K+ DFG++ G +
Sbjct: 110 I--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANS 161
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
VGT YMSPE +S++SD++S G+ ++E G+
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 51/149 (34%), Positives = 71/149 (47%), Gaps = 9/149 (6%)
Query: 520 KLGEGGFGPVYKGRL---LNGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
++G G FG V G + +V VK L S S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARV--TIIEGIAQGLLYLHQYSR 633
G C E +L++E+ P L +L K L+ + IA GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLA 662
IH DL N LL D+ KI D+GL+
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQ-----GLEEFKNEMMLIAKL 566
+ +GEG +G V G +VA+K++S Q L E K ++ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 567 QHRNLVKLLGC----CVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
+H N++ +L E + ++ E M L+ K + L + I
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQI 115
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI---V 678
+GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR+ D +T + V
Sbjct: 116 LRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYV 170
Query: 679 GTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
T Y +PE L+ K+ D++S G ++ E LS +
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 29/230 (12%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLEEFKNEM 560
+ L S+ T+ + + +G+G +G VYK +G AVK L S EE + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 561 MLIAKL-QHRNLVKLLGCCVEQ-----GEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614
++ L H N+VK G + G+ L+LE S+ + K LL R
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124
Query: 615 VT------IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668
+ I+ G GL +LH RIIHRD+K +N+LL + K+ DFG++
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181
Query: 669 ELQGNTKRIVGTYGYMSPEY-----ALDGLFSIKSDVFSFGILMLETLSG 713
L+ NT VGT +M+PE D + + DV+S GI +E G
Sbjct: 182 RLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
E ++ ++G G +G V G++VA+K+LS QS + E+ L+ +QH
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 570 NLVKLLGCCVEQG------EKILILEYMPNKSLDV--FLFDPTKKRLLGWQARVTIIEGI 621
N++ LL + L++ YM + K + L +Q +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ--------M 126
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
GL Y+H IIHRDLK N+ ++ D KI DFGLAR E+ G V T
Sbjct: 127 LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTR 178
Query: 682 GYMSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
Y +PE L+ + ++ D++S G +M E L+GK
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKR-LSSQSGQGLEEFK-NEMMLIAKLQHR 569
E + +GEG +G V K + GQ VA+K+ L S+ + +++ E+ ++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP------TKKRLLGWQARVTIIEGIAQ 623
NLV L+ + L+ E++ + LD P ++ L +Q I+ GI
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL-FQ----ILRGIE- 114
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF-GGDELQGNTKRIVGTYG 682
+ H ++ IIHRD+K N+L+ K+ DFG AR E+ + V T
Sbjct: 115 ---FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRW 165
Query: 683 YMSPEYAL-DGLFSIKSDVFSFGILMLETLSG 713
Y +PE + D + D+++ G L+ E L+G
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 52/191 (27%), Positives = 93/191 (48%), Gaps = 8/191 (4%)
Query: 521 LGEGGFG-PVYKGRLLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
+GEG FG + + + Q+ A+K + +S +E+ + E +L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
G +++EY L + + +L TI++ Q L + R++H
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPED---TILQWFVQMCLGVQHIHEKRVLH 123
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
RD+K+ N+ L + K+ DFG AR+ T VGT Y+ PE + ++ KS
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKS 181
Query: 699 DVFSFGILMLE 709
D++S G ++ E
Sbjct: 182 DIWSLGCILYE 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 27/207 (13%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMM--LIAKLQHR--NLVKLL 575
+G G G VYK R G +AVK++ + EE K +M + H +VK
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 576 GCCVEQGEKILILEYMPN--KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
G + + + +E M L + P + +LG ++T+ I + L YL + +
Sbjct: 81 GYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG---KMTV--AIVKALHYLKE--K 133
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYALD- 691
+IHRD+K SN+LLD N K+ DFG++ R+ + + T R G YM+PE +D
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPE-RIDP 188
Query: 692 ----GLFSIKSDVFSFGILMLETLSGK 714
+ I++DV+S GI ++E +G+
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
+ L+L M L +++ +A E + GL L R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-LCCGLEDLQ---RE 121
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
RI++RDLK N+LLD + +ISD GLA ++ G+ ++G VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEK 177
Query: 694 FSIKSDVFSFGILMLETLSGK 714
++ D + G L+ E + G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 7e-12
Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 49/220 (22%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMMLIAKLQHRN 570
+G G +G V G++VA+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 571 LVKLL-----GCCVEQGEKILILEYMPN------KSLDVFLFDPTKKRLLGWQARVTIIE 619
++ LL + + ++ E M KS + L +
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS----------PQPLTDDHIQYFLY 110
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN--TKRI 677
I +GL YLH +IHRDLK SN+L++ + + KI DFGLAR DE + T+ +
Sbjct: 111 QILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 678 VGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSGK 714
V T Y +PE L +I D++S G + E L+ K
Sbjct: 168 V-TRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 521 LGEGGFGPVYKGRLLNGQE----VAVKRLSS----QSGQGLEEFKNEMMLIAKLQHRNLV 572
LG+GG+G V++ R + G + A+K L ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 573 KLLGCCVEQGEKILILEYMPNKSL-------DVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
L+ G+ LILEY+ L +F+ D L I+ L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL----------SEISLAL 113
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN--TKRIVGTYGY 683
+LHQ II+RDLK N+LLD + K++DFGL + + + T GT Y
Sbjct: 114 EHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEY 166
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
M+PE + D +S G LM + L+G
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 39/99 (39%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNTKRI 677
+AQG+ +L + IHRD+ A NVLL KI DFGLAR D ++GN +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716
V +M+PE D +++++SDV+S+GIL+ E S K+
Sbjct: 278 V---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
KLGEG + VYKGR L VA+K RL + G + E+ L+ L+H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
+ L+ EY+ +K L +L D + + + +GL Y H R ++
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCH---RRKV 125
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYALDGL-F 694
+HRDLK N+L++ K++DFGLAR + T V T Y P+ L +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182
Query: 695 SIKSDVFSFGILMLETLSGK 714
S + D++ G + E +G+
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKR-LSSQSGQGLEEFK-NEMMLIAKLQHRN-LVKLL 575
K+GEG +G VYK R G+ VA+K+ +G+ E+ L+ L +V+LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 576 GCCVEQGEK-------ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG----IAQG 624
VE E+ L+ EY+ D+ F + R G I+ + +G
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL---DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGY 683
+ + H++ ++HRDLK N+L+D KI+D GL R F ++ T IV T Y
Sbjct: 123 VAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWY 177
Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLETLSG 713
+PE L +S D++S G + E
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 38/195 (19%)
Query: 537 GQEVAVKRLSSQSGQGLEEFKN---------EMMLIAKLQHRNLVKLLGCCVEQ------ 581
GQ VA+K+LS F+N E++L+ + H+N++ LL Q
Sbjct: 41 GQNVAIKKLS-------RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93
Query: 582 GEKILILEYMPNKSLDVFLFDPTKKRL--LGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
+ L++E M V D +R+ L +Q + G+ +LH IIHR
Sbjct: 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQ--------MLCGIKHLHSAG---IIHR 142
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSD 699
DLK SN+++ D KI DFGLAR G + T +V Y Y +PE L + D
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVD 199
Query: 700 VFSFGILMLETLSGK 714
++S G +M E + G
Sbjct: 200 IWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
KLGEG + V+KGR L VA+K RL + G + E+ L+ L+H N+V L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
L+ EY+ +K L ++ D ++ + I +GL Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCH---RRKV 125
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYAL-DGLF 694
+HRDLK N+L++ K++DFGLAR + T V T Y P+ L +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 695 SIKSDVFSFGILMLETLSGK 714
S + D++ G + E SG+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEE--FKNEMMLIAKLQHRNLVKLLGC 577
+G+G +G V R +G++ +K+L+ ++ E + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 578 CV-EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
E G +++ + L L + K L Q ++ IA L YLH+ I
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ-IAMALQYLHEK---HI 123
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
+HRDLK NV L K+ D G+AR+ +T ++GT YMSPE + ++
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNY 181
Query: 697 KSDVFSFGILMLETLSGKKNTGVYNADSFNLLGY 730
KSDV++ G + E + K +NA N L Y
Sbjct: 182 KSDVWALGCCVYEMATLKH---AFNAKDMNSLVY 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 35/210 (16%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEMMLIAK------LQHRNLVK 573
LG+G FG V L E A+K L LE+ E ++ + +H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 574 LLGCCVEQGEKIL--ILEYMPNKSL-----DVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
L C Q ++ L ++EY+ L FD + R + I GL
Sbjct: 61 LF--CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE--------IICGLQ 110
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
+LH+ II+RDLK NVLLD D + KI+DFG+ + M G +G GT Y+
Sbjct: 111 FLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFCGTPDYI 163
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
+PE ++ D +SFG+L+ E L G+
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 63/249 (25%), Positives = 117/249 (46%), Gaps = 34/249 (13%)
Query: 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFK-NEMMLIAKLQHRNLVKLLGC 577
CK+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 578 CVEQGEK--ILILEYMPNKSLDVFLF----DPTKKRLLGWQARV-TIIEGIAQGLLYLHQ 630
+ ++ L+ +Y + + F KK + ++ V +++ I G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 631 YSRFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFGGD-ELQGNTKRIVGTYGYM 684
++HRDLK +N+L+ M P KI+D G AR+F + + +V T+ Y
Sbjct: 127 N---WVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 685 SPEYALDGLFSIKS-DVFSFGILMLETLSGK----------KNTGVYNADS----FNLLG 729
+PE L K+ D+++ G + E L+ + K + ++ D F+++G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242
Query: 730 YAWDL-WKD 737
+ D W+D
Sbjct: 243 FPADKDWED 251
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAV-----KRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
+G GGFG VY R + G+ A+ KR+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGLLYL 628
+ +K+ IL+ M L L F + R + II G+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAE----IILGLE------ 111
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H ++RF +++RDLK +N+LLD + +ISD GLA F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 689 ALDGL-FSIKSDVFSFGILMLETLSG 713
G+ + +D FS G ++ + L G
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 521 LGEGGFGPV-YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
+G G +G V G +VA+K+L QS + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 578 CVEQGEKILILEYMPNKSLDVF----LFDP---------TKKRLLGWQARVTIIEGIAQG 624
+ P+ SLD F L P K L ++ + +G
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
L Y+H IIHRDLK N+ ++ D KI DFGLAR E+ G V T Y
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSEMTG----YVVTRWYR 182
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
+PE L+ + ++ D++S G +M E L+GK
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 29/201 (14%)
Query: 524 GGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN----EMMLIAKLQHRNLVKLLGCC 578
G FG VY + G A+K L + N +++ + + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLG-----WQARVTIIEGIAQGLLYLHQYSR 633
+ L++EY+ + + LG W A+ I E + G+ LHQ
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDW-AKQYIAE-VVLGVEDLHQRG- 117
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
IIHRD+K N+L+D + K++DFGL+R G E K+ VGT Y++PE + G+
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDYLAPE-TILGV 168
Query: 694 FSIK-SDVFSFGILMLETLSG 713
K SD +S G ++ E L G
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
KLGEG + VYKG+ +NG+ VA+K RL + G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 577 CCVEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+ L+ EY+ + L ++ P +L +Q + +GL Y+HQ
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQ--------LLRGLSYIHQ 121
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYA 689
R+ I+HRDLK N+L+ K++DFGLAR + +T V T Y P+
Sbjct: 122 --RY-ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 690 LDGL-FSIKSDVFSFGILMLETLSG 713
L +S D++ G + +E + G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGLEEFKN----EMMLIAKLQHRNLVKLL 575
+GEG +G V K R +E VA+K+ EE K E+ ++ L+ N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELK 66
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
+G+ L+ EY+ L++ P + + R I + I +H +
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKA----IHWCHKND 120
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
I+HRD+K N+L+ + K+ DFG AR + N V T Y SPE L +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 696 IKSDVFSFGILMLETLSGK 714
D++S G ++ E G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 36/96 (37%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I +GL YLH I+HRD+K N+L++ + KI DFGLAR+ DE + T+ +V
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 681 YGYMSPEYALDGL--FSIKSDVFSFGILMLETLSGK 714
Y Y +PE L G ++ D++S G + E L +
Sbjct: 169 Y-YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 521 LGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
+G GGFG VY G++ + + KR+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGLLYL 628
+ +K+ IL+ M L L F + R + II G+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATE----IILGLE------ 111
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H ++RF +++RDLK +N+LLD + +ISD GLA F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 689 ALDGL-FSIKSDVFSFGILMLETLSG 713
G + +D FS G ++ + L G
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 85/337 (25%), Positives = 129/337 (38%), Gaps = 91/337 (27%)
Query: 521 LGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
LG G FG V + + VAVK L + G E K M +LI H N
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKML--KEGATASEHKALMSELKILIHIGNHLN 72
Query: 571 LVKLLGCCVE-QGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQ 623
+V LLG C + G ++I+E+ +L FL F P +++ + R + ++
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 624 G-------------------------------------------LLYLHQYSR------- 633
+ Y Q +R
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYALD 691
+ IHRDL A N+LL + KI DFGLAR D ++ + R+ +M+PE D
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL--PLKWMAPESIFD 250
Query: 692 GLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749
+++ +SDV+SFG+L+ E +L GV + F KD + P
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF------CQRLKDGT--RMRAPENA 302
Query: 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
EI + L C Q + +RPT S +V I+
Sbjct: 303 TPEIY--------RIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSS----QSGQGLEEFKNEMMLIAK 565
NF + LG G +G V+ R + G + A+K L Q + +E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 566 LQHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG-IAQ 623
++ + L + K+ LIL+Y+ + L+ +R + V G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIIL 116
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
L +LH + I++RD+K N+LLD + + ++DFGL++ F +E + T GT Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLE--------TLSGKKNT 717
M+PE K+ D +S GIL+ E TL G++NT
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRNLVKLL 575
LG+G FG V RL +G+ AVK L ++ + M +L H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 576 GCCVEQGEKIL-ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG-IAQGLLYLHQYSR 633
CC + +++ ++E++ L +F K R +AR I L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSALMFLHDKG- 116
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPEYALD 691
II+RDLK NVLLD + + K++DFG+ + +F G T GT Y++PE +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK----TTSTFCGTPDYIAPEILQE 170
Query: 692 GLFSIKSDVFSFGILMLETLSG 713
L+ D ++ G+L+ E L G
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMM----LIAKLQHRNLVKLL 575
LG+G FG V+ L Q A+K L ++ + M+ L +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 576 GCCVEQGEKIL-ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG-IAQGLLYLHQYSR 633
C + E + ++EY+ L +F K L R T I GL +LH
Sbjct: 63 -CTFQTKENLFFVMEYLNGGDL-MFHIQSCHKFDL---PRATFYAAEIICGLQFLHSKG- 116
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPEYALD 691
I++RDLK N+LLD D + KI+DFG+ + M G T GT Y++PE L
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLG 170
Query: 692 GLFSIKSDVFSFGILMLETLSGK 714
++ D +SFG+L+ E L G+
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 521 LGEGGFGPVYKGRLLN---------GQEVAVKR-LSSQSGQGLEEFKNEMMLIAKLQHRN 570
LG+G F +YKG L GQEV+V + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
LVKL G CV E I++ EY+ LDVFL L W+ V + +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119
Query: 631 YSRFRIIHRDLKASNVLL---DMDMNP----KISDFGLARMFGG-DELQGNTKRIVGTYG 682
+++H ++ N+L+ ++ K+SD G+ +E +RI
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV---ERI----P 169
Query: 683 YMSPEYALDGLFSIKS--DVFSFGILMLETLSGKK 715
+++PE +G S+ D +SFG +LE S +
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 20/185 (10%)
Query: 537 GQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILIL 588
G VAVK+LS Q+ + E++L+ + H+N++ LL Q + L++
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648
E M V + +R+ ++ + G+ +LH IIHRDLK SN+++
Sbjct: 106 ELMDANLCQVIHMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156
Query: 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
D KI DFGLAR + + T +V Y Y +PE L + D++S G +M
Sbjct: 157 KSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMG 213
Query: 709 ETLSG 713
E + G
Sbjct: 214 ELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFK-NEMMLIAKLQHR----NL 571
+LG+G +G VYK G +A+K RL L+E K N++++ + H+ +
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSPYI 61
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
V G +G + +EYM SLD + I + +GL +L +
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE- 120
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY--- 688
IIHRD+K +NVL++ + K+ DFG++ G+ + K +G YM+PE
Sbjct: 121 -EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 689 ---ALDGLFSIKSDVFSFGILMLETLSGK 714
+ ++++SDV+S G+ +LE G+
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 31/198 (15%)
Query: 537 GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL--------------LGCCVEQG 582
+ VAVK++ Q ++ E+ +I +L H N+VK+ +G E
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 583 EKILILEYMPNKSLDVFLFDPTKK---RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
++ EYM +V P + RL +Q + +GL Y+H + ++HR
Sbjct: 90 SVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ--------LLRGLKYIHSAN---VLHR 138
Query: 640 DLKASNVLLDM-DMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
DLK +NV ++ D+ KI DFGLAR+ +G + T Y SP L K
Sbjct: 139 DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTK 198
Query: 698 S-DVFSFGILMLETLSGK 714
+ D+++ G + E L+GK
Sbjct: 199 AIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
LG+G FG V L EV A+K L ++ E ++A + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 577 CCVEQGEKIL-ILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
CC + +++ ++EY+ L + FD + R + A VT+ L++LH+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF--YAAEVTL------ALMFLHR 114
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPEY 688
+ +I+RDLK N+LLD + + K++DFG+ + + G T GT Y++PE
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPDYIAPEI 167
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
+ + D ++ G+LM E ++G+
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 521 LGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCC 578
+G+G +G V+K NG + AVK L EE + E ++ L H N+VK G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 579 ----VEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ----GLLYLH 629
V+ G+++ L+LE S+ + K+ G + II I GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR---GERMEEPIIAYILHEALMGLQHLH 141
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY- 688
+ IHRD+K +N+LL + K+ DFG++ L+ NT VGT +M+PE
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVI 196
Query: 689 ----ALDGLFSIKSDVFSFGILMLETLSG 713
LD + + DV+S GI +E G
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
KLGEG + V+KGR L VA+K RL + G + E+ L+ L+H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
+ L+ EY+ + D+ + L+ + + +GL Y H + +I
Sbjct: 71 IIHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKI 124
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYALDGL-F 694
+HRDLK N+L++ K++DFGLAR + T V T Y P+ L +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 695 SIKSDVFSFGILMLETLSGK 714
S D++ G ++ E +G+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 38/94 (40%), Positives = 57/94 (60%), Gaps = 7/94 (7%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIV 678
+A+G+ +L SR + IHRDL A N+LL + KI DFGLAR D ++ R+
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-10
Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNTKRI 677
+A+G+ +L + IHRDL A N+LL KI DFGLAR D ++GN +
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
V +M+PE + +++ +SDV+S+GIL+ E S
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRNLVKLL 575
+G+G FG V + +G+ AVK L ++ +E K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 576 GCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
+ +K+ +L+Y+ L F ++ +AR E IA L YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---L 115
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
II+RDLK N+LLD + ++DFGL + G E T GT Y++PE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 695 SIKSDVFSFGILMLETLSG 713
D + G ++ E L G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 32/93 (34%), Positives = 53/93 (56%)
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
Q LL +H +IHRD+K++N+LL + K+ DFG ++M+ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
Y++PE +S K+D+FS G+L+ E L+ K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQ--EVAVKRLSSQS---GQGLEEFKNEMMLIAKLQ 567
E+F+ LG G FG V N VA+KR + ++ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
H V L G ++ L+LE++ FL +R + V AQ +L
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-----RRNKRFPNDVGCFYA-AQIVLI 143
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
I++RDLK N+LLD D K++DFG A++ + T + GT Y++PE
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPE 198
Query: 688 YALDGLFSIKSDVFSFGILMLETLSG 713
L+ +D ++ GI + E L G
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 521 LGEGGFGPVY-KGRLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRNLVKLL 575
+G+G FG V R +G AVK L ++ +E + M +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 576 GCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
+ EK+ +L+Y+ L F ++ L +AR E +A + YLH +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHSLN-- 116
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
II+RDLK N+LLD + ++DFGL + G E + T GT Y++PE +
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 695 SIKSDVFSFGILMLETLSG 713
D + G ++ E L G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 20/185 (10%)
Query: 538 QEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILE 589
+ VA+K+LS Q+ + E++L+ + H+N++ LL Q + L++E
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649
M V + +R+ ++ + G+ +LH IIHRDLK SN+++
Sbjct: 103 LMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153
Query: 650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
D KI DFGLAR G + T +V Y Y +PE L + D++S G +M E
Sbjct: 154 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 710 TLSGK 714
+ K
Sbjct: 211 MVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 24/192 (12%)
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQ-ARVTIIEGIAQGLL 626
H LV L C + ++EY+ L +F ++R L + AR E I+ L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 110
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
YLH+ II+RDLK NVLLD + + K++D+G+ + + GD T GT Y+
Sbjct: 111 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYI 163
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744
+PE + D ++ G+LM E ++G+ F+++G + + D + +
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRS--------PFDIVGSSDN--PDQNTEDYL 213
Query: 745 DPVITQDEISLP 756
VI + +I +P
Sbjct: 214 FQVILEKQIRIP 225
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
IA GL +LH II+RDLK NV+LD + + KI+DFG+ + D + TK GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
Y++PE + D ++FG+L+ E L+G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
LG+G FG V L G+ AVK L +E E ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 577 CCVEQGEKIL-ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
C + E + ++E++ L + D K R ++A E I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAE-IVCGLQFLHSKG--- 116
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
II+RDLK NV+LD D + KI+DFG+ + +FG GT Y++PE
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIAPEILQGLK 172
Query: 694 FSIKSDVFSFGILMLETLSGK 714
++ D +SFG+L+ E L G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-09
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 49/230 (21%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ-SGQGL--EEFKNEMMLIAKLQHRNLVKLL 575
+G+GG G VY + + VA+K++ S L + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLG--WQ---------------ARVTII 618
C G+ + MP ++ T K LL WQ A ++I
Sbjct: 69 SIC-SDGD--PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE-----LQGN 673
I + Y+H S+ ++HRDLK N+LL + I D+G A +E + +
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 674 TK-----------RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +IVGT YM+PE L S +D+++ G+++ + L+
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 20/185 (10%)
Query: 538 QEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILE 589
+ VA+K+LS Q+ + E++L+ + H+N++ LL Q + +++E
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649
M V + +R+ ++ + G+ +LH IIHRDLK SN+++
Sbjct: 110 LMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
D KI DFGLAR G + T +V Y Y +PE L + D++S G +M E
Sbjct: 161 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 710 TLSGK 714
+ G
Sbjct: 218 MIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 47/147 (31%), Positives = 73/147 (49%), Gaps = 14/147 (9%)
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQ-ARVTIIEGIAQGLLYLH 629
LV L C L++EY+ L +F ++R L + AR E I L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLH 113
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPE 687
+ II+RDLK NVLLD D + K++D+G+ + + GD T GT Y++PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPE 166
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
+ D ++ G+LM E ++G+
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 61/236 (25%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------SQSGQGLEEFKNEMMLIAKLQHRNLV 572
+G G FG V+ R + +V A+K L +Q E +++ A +V
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAE--RDILADAD--SPWIV 64
Query: 573 KLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG------IAQG 624
KL Q E+ L ++EYMP L + R + IA+
Sbjct: 65 KLY--YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAEL 110
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA--------RMFGGDELQGNTKR 676
+L L + IHRD+K N+L+D D + K++DFGL R + ++ R
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 677 -------------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
VGT Y++PE + ++ D +S G+++ E L G
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 38/97 (39%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIV 678
I GL Y+H + ++HRDLK N+L++ D KI DFGLAR F E G V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 679 GTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
T Y +PE L K+ DV+S G ++ E L K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-09
Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 46/224 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEMM---------- 561
E+F + +G G FG V R + ++V A+K LS K EM+
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS----------KFEMIKRSDSAFFWE 92
Query: 562 ---LIAKLQHRNLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFL--FDPTKKRLLGWQAR 614
++A +V+L Q +K L ++EYMP L + +D +K W AR
Sbjct: 93 ERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----W-AR 145
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGN 673
E + L +H IHRD+K N+LLD + K++DFG +M ++ +
Sbjct: 146 FYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201
Query: 674 TKRIVGTYGYMSPEYAL----DGLFSIKSDVFSFGILMLETLSG 713
T VGT Y+SPE DG + + D +S G+ + E L G
Sbjct: 202 TA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 6e-09
Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 16/224 (7%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLLG 576
LG+G FG V R +G+ A+K L + +E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
+ ++EY+ L F +++R+ I L YLH +I
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
++RDLK N++LD D + KI+DFGL + G K GT Y++PE D +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 697 KSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKF 740
D + G++M E + G+ YN D L + L +D KF
Sbjct: 175 AVDWWGLGVVMYEMMCGR--LPFYNQDHEKL--FELILMEDIKF 214
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
I+ GL +LH+ II+RDLK NV+LD + + KI+DFG+ + M G T+
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFC 162
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
GT Y++PE + D +++G+L+ E L+G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 521 LGEGGFGPVYKG--------RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
LG+G F ++KG L+ EV +K L E F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
G CV E I++ EY+ SLD +L + W+ V + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVA--KQLAWALHFLEDKG 120
Query: 633 RFRIIHRDLKASNVLL-----DMDMNP---KISDFGLARMFGGDELQGNTKRIVGTYGYM 684
+ H ++ A NVLL NP K+SD G++ E+ +RI ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWV 171
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSG 713
PE + S+ +D +SFG + E SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 9e-09
Identities = 58/191 (30%), Positives = 92/191 (48%), Gaps = 32/191 (16%)
Query: 533 RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE--- 589
RL+ + A R + Q +NE++ + +L H N++K+ E+IL E
Sbjct: 194 RLIAKRVKAGSRAAIQ-------LENEILALGRLNHENILKI--------EEILRSEANT 238
Query: 590 YMPNKSLDV----FLFDPT---KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLK 642
YM + D F++D K R L Q R I++ + + Y+H ++IHRD+K
Sbjct: 239 YMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIK 294
Query: 643 ASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE-YALDGLFSIKSDVF 701
N+ L+ D + DFG A F E + VGT SPE A DG I +D++
Sbjct: 295 LENIFLNCDGKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIW 352
Query: 702 SFGILMLETLS 712
S G+++L+ LS
Sbjct: 353 SCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-08
Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 7/82 (8%)
Query: 338 GGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLK-NCTCRAYANSNVTEGSGCLMW-F 395
F++L N + P F + ++ +L++CA++CL NC+CR++ +N T GCL+W
Sbjct: 2 SDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNNGT--KGCLLWSE 58
Query: 396 GDLLDANRPTRNFTGQSVYIRV 417
L DA G +Y ++
Sbjct: 59 SSLGDA--RLFPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 35/92 (38%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+A+G+ +L + +HRDL A NVLL KI DFGLAR D +
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D L++ SDV+S+GIL+ E S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 40/126 (31%), Positives = 62/126 (49%), Gaps = 8/126 (6%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I L YLH S +++RDLK N++LD D + KI+DFGL + G + K GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGT 159
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKF 740
Y++PE D + D + G++M E + G+ YN D L + L ++ +F
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKL--FELILMEEIRF 215
Query: 741 HELIDP 746
+ P
Sbjct: 216 PRTLSP 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 14/150 (9%)
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQ-ARVTIIEGIAQGLL 626
H LV L C + ++E++ L +F ++R L + AR E I+ L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 110
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
+LH+ II+RDLK NVLLD + + K++D+G+ + + GD T GT Y+
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYI 163
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
+PE + D ++ G+LM E ++G+
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 40/136 (29%), Positives = 60/136 (44%), Gaps = 24/136 (17%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I L YLH +++RD+K N++LD D + KI+DFGL + D K GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKF 740
Y++PE D + D + G++M E + G+ YN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD----------------- 199
Query: 741 HELIDPVITQDEISLP 756
HE + +I +EI P
Sbjct: 200 HERLFELILMEEIRFP 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 18/211 (8%)
Query: 516 SMQCKLGE----GGFGPVYKGRLLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKLQHR 569
+ +G+ + K + VAVK+ L S S + L+ + E++ +LQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
N++ + + E ++ M S + L L A I++ + L Y+H
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIH 118
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQ----GNTKRIVGTYGYM 684
IHR +KAS++LL D +S + M + Q K V ++
Sbjct: 119 SKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175
Query: 685 SPEYALDGL--FSIKSDVFSFGILMLETLSG 713
SPE L ++ KSD++S GI E +G
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 2/93 (2%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
A+ L L +F +I+RDLK N+LLD + + DFGL ++ D+ + NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
Y++PE L ++ D ++ G+L+ E L+G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 51/222 (22%)
Query: 514 NFSMQCKLGEGGFGPV----YKGRLLNGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL 566
+F M LG G FG V +KG G+ A+K L + + ++ E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 567 QHRNLVKLLGCCVEQGEKILILEYM---------------PNKSLDVFLFDPTKKRLLGW 611
H +V ++ ++ +LE++ PN DV F +
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN---DVAKF---------Y 123
Query: 612 QARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671
A + + YLH II+RDLK N+LLD + K++DFG A+ ++
Sbjct: 124 HAELVL------AFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVP 169
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
T + GT Y++PE D ++ G+L+ E ++G
Sbjct: 170 DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I L YLH +++RDLK N++LD D + KI+DFGL + G K GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 158
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD 723
Y++PE D + D + G++M E + G+ YN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 51/219 (23%)
Query: 521 LGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGC- 577
+G G FG VY+ ++ E VA+K++ ++KN E++++ L H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYY 128
Query: 578 ---CVEQGEKIL----ILEYMP-------------NKSLDVFLFDPTKKRLLGWQARVTI 617
C ++ EK + ++E++P N +L +FL +L +Q
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV-----KLYSYQ----- 178
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLAR-MFGGDELQGNTK 675
+ + L Y+H S+F I HRDLK N+L+D + + K+ DFG A+ + G Q +
Sbjct: 179 ---LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVS 229
Query: 676 RIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSG 713
I + Y +PE L ++ D++S G ++ E + G
Sbjct: 230 YICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ +GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR E V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171
Query: 681 YGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGK 714
Y +PE L + +I DV+S G + E L K
Sbjct: 172 RWYRAPELLLNCSEYTTAI--DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 67/226 (29%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ----SGQGLEEFKNEMMLIAKLQH 568
E++ + +G G FG V R + Q+V +L S+ F E ++A
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 569 RNLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQG 624
+V+L C Q +K L ++EYMP L + +D +K W T A+
Sbjct: 103 PWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYT-----AEV 151
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGY 683
+L L +IHRD+K N+LLD + K++DFG +M ++ +T VGT Y
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDY 209
Query: 684 MSPEY----ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF 725
+SPE DG + + D +S G+ + E L G +T Y ADS
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY-ADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 8/100 (8%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG-LARMFGGDELQGNTKRIVG 679
IA+ +L +H + +HRD+K NVLLDM+ + +++DFG +M +Q + VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG 165
Query: 680 TYGYMSPEY--ALD---GLFSIKSDVFSFGILMLETLSGK 714
T Y+SPE A++ G + + D +S G+ M E L G+
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEM----MLIAKLQHRNLVKLL 575
+G+G FG V R ++ AVK L ++ +E K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
+ +L+Y+ L F ++ L +AR E IA L YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS---LN 116
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
I++RDLK N+LLD + ++DFGL + E G T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 696 IKSDVFSFGILMLETLSG 713
D + G ++ E L G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 15/167 (8%)
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII 618
E+ ++ + HR ++ L+ K + MP D+F + + L + +TI
Sbjct: 136 EIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTY-VDRSGPLPLEQAITIQ 191
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ + L YLH IIHRD+K N+ LD N + DFG A
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 679 GTYGYMSPEY-ALDGLFSIKSDVFSFGILMLE------TLSGKKNTG 718
GT SPE ALD + K+D++S G+++ E TL GK+
Sbjct: 249 GTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
|
Length = 392 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
IA+ +L L ++ I++RDLK N+LLD + + DFGL++ D NT GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGT 159
Query: 681 YGYMSPEYALDGL-FSIKSDVFSFGILMLETLSG 713
Y++PE LD ++ D +S G+L+ E G
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVA---VKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
++G G FG V + VA VK L ++ S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKR----LLGWQARVTIIEGIAQGLLYLHQY 631
G CVE +L+ EY L +L R LL Q IA G+ ++H++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC---EIAAGVTHMHKH 118
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+ +H DL N L D+ K+ D+G+ + D ++ + V +++PE
Sbjct: 119 N---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVG 174
Query: 691 ---DGLFSIK----SDVFSFGILMLE 709
GL + + S+V++ G+ + E
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWE 200
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG-LARMFGGDELQGNTKRIVG 679
+A+ +L + + +HRD+K NVLLD + + +++DFG R+ +Q N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 680 TYGYMSPEY--ALD---GLFSIKSDVFSFGILMLETLSGK 714
T Y+SPE A++ G + + D +S G+ M E L G+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 15/199 (7%)
Query: 521 LGEGGFGPVY-KGRLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRNLVKLL 575
+G+G FG V R L+G+ AVK L + +E K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW-QARVTIIEGIAQGLLYLHQYSRF 634
+ +L+++ L F ++R +AR E IA L YLH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAE-IASALGYLHS---I 115
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
I++RDLK N+LLD + ++DFGL + G T GT Y++PE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 695 SIKSDVFSFGILMLETLSG 713
D + G ++ E L G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 54/271 (19%), Positives = 116/271 (42%), Gaps = 49/271 (18%)
Query: 529 VYKGRLLNGQEVAVKRL---SSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK- 584
+YKG N +EV ++ ++ +NE+ + ++ N++K+ G ++ +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 585 ---ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDL 641
LILEY L L K++ L ++ ++ + +GL L++Y+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNL 149
Query: 642 KASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS---IKS 698
+ + L+ + KI GL ++ L + V Y S + D +FS IK
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKMLND-IFSEYTIKD 203
Query: 699 DVFSFGILMLETLSGK---KN---TGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752
D++S G+++ E +GK +N +Y+ + + +L
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDL-----------IINKNNSLKL--------P 244
Query: 753 ISLPVLVRYINVALLCVQDNAADRPTMSDVV 783
+ P+ ++ I A C ++ RP + +++
Sbjct: 245 LDCPLEIKCIVEA--CTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 36/95 (37%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+A G+ +L + +HRDL A NVL+ KI DFGLAR D +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSG 713
+M+PE + L++ SDV+SFGIL+ E TL G
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG 339
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 6e-07
Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 42/242 (17%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIA-----KLQHRNLVKL 574
K+G G FG V+ + QE + + S +GL+E + ++I +L+H+N+V+
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 575 LGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLG---WQARVTIIEGIAQGLLYLH 629
+ + + + L ++E+ L + K + G A V I + L Y H
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCH 135
Query: 630 QY----SRFRIIHRDLKASNVLL---------------DMDMNP--KISDFGLARMFGGD 668
+ R++HRDLK N+ L +++ P KI DFGL++ G
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG-- 193
Query: 669 ELQGNTKRIVGTYGYMSPEYALDGLFSI--KSDVFSFGILMLETLSGKKNTGVYNADSFN 726
++ VGT Y SPE L S KSD+++ G ++ E SGK T + A++F+
Sbjct: 194 -IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFHKANNFS 250
Query: 727 LL 728
L
Sbjct: 251 QL 252
|
Length = 1021 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 8/95 (8%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
+ +GL Y+H + +IHRDLK SN+L++ D +I DFG+AR E + V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 679 GTYGYMSPE--YALDGLFSIKSDVFSFGILMLETL 711
T Y +PE +L ++ D++S G + E L
Sbjct: 173 ATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEE---FKNEMMLIAKLQH 568
E+F + +G G FG V +L N +V A+K L+ E F+ E ++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
+ + L ++ L+++Y L + L + RL AR + A+ ++ +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYL----AEMVIAI 115
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFG-LARMFGGDELQGNTKRIVGTYGYMSPE 687
+ +HRD+K N+L+DM+ + +++DFG ++ +Q + VGT Y+SPE
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPE 173
Query: 688 Y--ALD---GLFSIKSDVFSFGILMLETLSGK 714
A++ G + + D +S G+ M E L G+
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 31/146 (21%), Positives = 55/146 (37%), Gaps = 13/146 (8%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV-KLLGCC 578
L G VY ++ +K S+ E + ++ + + V K+L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
G L++E++ ++LD + + I E +A+ L LHQ + H
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSE----------EEKEDIAEQLAELLAKLHQLPLLVLCH 112
Query: 639 RDLKASNVLLDMDMNPKISDFGLARM 664
DL N+L+D I D+ A
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 37/97 (38%), Positives = 47/97 (48%), Gaps = 10/97 (10%)
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVGTY 681
+ L Y+H + F HRDLK N+L + D KI DFGLAR F V T
Sbjct: 114 RALKYIHTANVF---HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 682 GYMSPEYALDGLFSIKS----DVFSFGILMLETLSGK 714
Y +PE L G F K D++S G + E L+GK
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 2/156 (1%)
Query: 557 KNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT 616
++E+ +A H +VK + +LI+EY L+ + K+ L + V
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
++ Q +L L + +++HRDLK++N+ L K+ DFG ++ +
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
GT Y++PE +S K+D++S G+++ E L+
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 16/102 (15%)
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM---------FGG----DELQ 671
L YLH Y I+HRDLK N+L+ + K++DFGL+++ + G D +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
K++ GT Y++PE L + D ++ GI++ E L G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 24/141 (17%)
Query: 586 LILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
L++EY P L L FD + +A+ +L +H + +HR
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----------LAELVLAIHSVHQMGYVHR 126
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY--ALDG----L 693
D+K NVL+D + K++DFG A +++ N+K VGT Y++PE ++G
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 694 FSIKSDVFSFGILMLETLSGK 714
+ ++ D +S G++ E + G+
Sbjct: 186 YGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 37/230 (16%)
Query: 513 ENFSMQCKLGEGGFG-----------PVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMM 561
E++ + +G G FG VY +LL+ E+ +KR S F E
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAF------FWEERD 95
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIE 619
++A +V+L + +++EYMP L + +D +K W T
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYT--- 148
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
A+ +L L IHRD+K N+LLD + K++DFG + + VG
Sbjct: 149 --AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVG 205
Query: 680 TYGYMSPEY----ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF 725
T Y+SPE DG + + D +S G+ + E L G +T Y ADS
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 64/240 (26%), Positives = 94/240 (39%), Gaps = 60/240 (25%)
Query: 521 LGEGGFGPVYKGRL----LNGQEVAVKRLSS----QSGQGLEEFKNEMMLIAKLQHRNLV 572
+G G FG V RL G A+K+L + Q + + E ++A+ + +V
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVV 64
Query: 573 KLLGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGW-QARVTIIEGIAQGLLYLH 629
KL Q E LI+EY+P + L KK + R I E I L +
Sbjct: 65 KLY--YSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETI----LAID 115
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGL------------ARMFGGD--------- 668
+ IHRD+K N+LLD + K+SDFGL R+
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 669 -------ELQGNTKR--------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
KR VGT Y++PE L ++ + D +S G++M E L G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 42/156 (26%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
L++++ H +L + G CV E I++ E++ + LDV L + + W ++T+ + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVL-----LDMDMNP--KISDFGLARMFGGDELQGNT 674
A L YL + ++H ++ A N+L L +P K+SD G++ F +
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181
Query: 675 KRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 709
+RI +++PE G S +D +SFG +LE
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 38/156 (24%), Positives = 68/156 (43%), Gaps = 8/156 (5%)
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII 618
E ++ + H ++++L G LIL P D++ + K+ + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDI-LAIE 188
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ + + YLH+ RIIHRD+KA N+ ++ + + DFG A F D
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
GT +PE + D++S GI++ E +
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 44/149 (29%), Positives = 66/149 (44%), Gaps = 15/149 (10%)
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-RLLGWQARVTIIEGIAQGLL 626
+ N +KL +LI++Y+ D LFD KK L II + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
LH++ IIH D+K NVL D + + D+GL ++ G GT Y S
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFS 174
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
PE + + D ++ G+L E L+GK
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 62/270 (22%), Positives = 97/270 (35%), Gaps = 95/270 (35%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH 568
E+F +G+G FG V RL+ G+ A+K L K+EM +L H
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTL----------LKSEMFKKDQLAH 47
Query: 569 ----RNL---------VKLLGCCVEQGEKILILEYMPNKSL-------DVFLFDPTKKRL 608
R++ V L + LI+E++P L D F D T+
Sbjct: 48 VKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY- 106
Query: 609 LGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA------ 662
+A+ +L + + IHRD+K N+L+D + K+SDFGL+
Sbjct: 107 ------------MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154
Query: 663 -------RMFGGDELQ-GNTKR-------------------------------IVGTYGY 683
++ G + R VGT Y
Sbjct: 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDY 214
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
++PE L + + D +S G +M E L G
Sbjct: 215 IAPEIFLQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 40/222 (18%)
Query: 517 MQCKLGEG--GFGPVYKGRLL-NGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
+Q ++G G VY R G V V+ L + + + L+ +NE++L +H N+
Sbjct: 2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI 61
Query: 572 VKLLGCCVEQGEKILILEYMP----NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
+ +I +M N L + + + L+G I+ G +GL Y
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-----NILFGALRGLNY 116
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL-----QGNTKRIVGTYG 682
LHQ IHR++KAS++L IS GL + G L G ++V +
Sbjct: 117 LHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFP 165
Query: 683 --------YMSPEYALDGL--FSIKSDVFSFGILMLETLSGK 714
++SPE L +++KSD++S GI E +G+
Sbjct: 166 QFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 21/173 (12%)
Query: 558 NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI 617
+E L+ +L H ++ LL V G L+L P D++ + + R LG A+VT
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVL---PKYRSDLYTYLGARLRPLG-LAQVT- 263
Query: 618 IEGIAQGLL----YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673
+A+ LL Y+H IIHRD+K NVL++ + + DFG A G
Sbjct: 264 --AVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFN 726
I GT +PE ++ D++S G+++ E V+ A F+
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE-------AAVHTASLFS 364
|
Length = 461 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 54/243 (22%), Positives = 98/243 (40%), Gaps = 55/243 (22%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
LG G FG V ++ + A+K L + + + K E ++A+ + +VKL
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
++ +++Y+P + L R+ + + IA+ L + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI-----RMEVFPEVLARFY-IAELTLAIESVHKMGF 122
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFG------------------------------ 666
IHRD+K N+L+D+D + K++DFGL F
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 667 ---GDELQGNTKR------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
GD L+ +R +VGT Y++PE L ++ D +S G+++ E L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 712 SGK 714
G+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 1e-04
Identities = 18/48 (37%), Positives = 25/48 (52%), Gaps = 1/48 (2%)
Query: 788 SERLELPSPKEPAFIKG-INVKNSSHSNDGMSNLCSVNDVTVSLVYPR 834
SE E+P PK+P F G + S S+ +VN VTVS++ R
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-04
Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 32/167 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
E F + + G FG VY GR N + AVK + + N+ M+ R+
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA------DMINKNMVHQVQAERDA 57
Query: 572 VKL--------LGCCVEQGEKI-LILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTI 617
+ L L ++ + L++EY+ + L FD + V
Sbjct: 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE--------EMAVKY 109
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
I +A L YLH++ IIHRDLK N+L+ + + K++DFGL+++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 49/241 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGLEE---FKNEMMLIAK 565
E+F +G G FG V RL+ G A+K L E+ + E ++ +
Sbjct: 1 EDFESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE 57
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
+VK+ ++ LI+E++P + L KK L + I A+ +
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYI---AETV 111
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---------------- 669
L + + IHRD+K N+LLD + K+SDFGL
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 670 -LQG-NTKR---------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
Q N+KR VGT Y++PE + ++ D +S G++M E L
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 713 G 713
G
Sbjct: 232 G 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 44/161 (27%), Positives = 64/161 (39%), Gaps = 39/161 (24%)
Query: 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645
LI+E++P + L KK L +A I + +HQ IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDN 131
Query: 646 VLLDMDMNPKISDFGLARMFGGDE-----------------LQG-NTKR----------- 676
+LLD + K+SDFGL Q N+KR
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 677 ----IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
VGT Y++PE + ++ D +S G++M E L G
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 29/161 (18%)
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
++ ++ H+++V L G CV E I++ E++ LD+F+ + W+ +V + +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVA--KQL 114
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLL-----DMDMNP--KISDFG-----LARMFGGDE 669
A L YL ++H ++ N+LL D + P K+SD G L+R
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------ 165
Query: 670 LQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLE 709
Q +RI +++PE D SI +D +SFG + E
Sbjct: 166 -QECVERI----PWIAPECVEDSKNLSIAADKWSFGTTLWE 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 0.001
Identities = 60/227 (26%), Positives = 90/227 (39%), Gaps = 39/227 (17%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLL 575
LG+G G V+ RL G+ A+K L + + K E ++A L H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
+ L+++Y P L L K L AR E + L YLH
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLLG--- 123
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLA-----------RMFGGDELQGNTKRI------- 677
I++RDLK N+LL + +SDF L+ + + + I
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 678 ---------VGTYGYMSPEY-ALDG-LFSIKSDVFSFGILMLETLSG 713
VGT Y++PE + DG ++ D ++ GIL+ E L G
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 29/78 (37%), Positives = 41/78 (52%), Gaps = 8/78 (10%)
Query: 521 LGEGGFGPVYK------GRLLNGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKL-QHRNLV 572
LG G FG V + G+ N VAVK L +S E +E+ +++ L QH+N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 573 KLLGCCVEQGEKILILEY 590
LLG C G ++I EY
Sbjct: 106 NLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 53/243 (21%), Positives = 97/243 (39%), Gaps = 55/243 (22%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
LG G FG V R ++ + + A+K L + + K E ++A+ + +V+L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
++ +++Y+P + L R+ + + IA+ + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI-----RMGIFPEDLARFY-IAELTCAVESVHKMGF 122
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFG------------------------------ 666
IHRD+K N+L+D D + K++DFGL F
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 667 ---GDELQGNTKR------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
GD L+ +R +VGT Y++PE L ++ D +S G+++ E L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 712 SGK 714
G+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 54/241 (22%), Positives = 95/241 (39%), Gaps = 55/241 (22%)
Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
+G G FG V R ++ + A+K L K E ++A+ + +VKL
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 577 CCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
++ +++Y+P + L ++ L AR I E + + +H +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL----ARFYIAE-LTCAIESVH---KM 120
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMF-----------GG----------DELQGN 673
IHRD+K N+L+D D + K++DFGL F G +E
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180
Query: 674 TKR--------------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
+ +VGT Y++PE L ++ D +S G+++ E L G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 714 K 714
+
Sbjct: 241 Q 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|185490 PTZ00163, PTZ00163, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 27/84 (32%), Positives = 39/84 (46%), Gaps = 10/84 (11%)
Query: 111 TNVFSEVKNPVAQLRD-------DGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMG 163
T++FS KNP + R D V DN+ N E+++ S D P D L M
Sbjct: 62 TSIFSGNKNPQKRERKNEEENQKDNTKVDNDNNMENEMENHIDDSIDDPMDDL---MNDK 118
Query: 164 WDLKNRLERYLSSWQSDDDPSPGK 187
W+ N LE + + + DPS G+
Sbjct: 119 WEHHNSLEDRIKEYYTLTDPSDGE 142
|
Length = 230 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 834 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.4 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.94 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.93 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.7 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.7 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.39 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.36 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.35 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.25 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.22 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.18 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.18 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.16 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.05 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.0 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.94 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.93 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.88 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.73 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.72 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.66 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.63 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.56 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.56 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.56 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.45 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.29 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.29 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.04 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.02 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 96.89 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.82 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.79 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.74 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.73 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.7 | |
| PLN02236 | 344 | choline kinase | 96.68 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.64 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.58 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.31 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.91 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.87 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.68 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.5 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-51 Score=447.41 Aligned_cols=288 Identities=44% Similarity=0.731 Sum_probs=256.0
Q ss_pred CcCcccHHHHHHHhcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEE
Q 003280 499 WLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578 (834)
Q Consensus 499 ~~~~~~~~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 578 (834)
....|++.++..||++|...+.||+|+||.||+|.+.+|+.||||++.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46679999999999999999999999999999999999999999998766543146699999999999999999999999
Q ss_pred EecC-eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceee
Q 003280 579 VEQG-EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS 657 (834)
Q Consensus 579 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 657 (834)
.+.+ +++||||||++|+|+++|+..... .++|..|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875544 88999999999999999999999998899999999999999999999999
Q ss_pred eecceeecCCCcccccccee-cccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCC-CCcccHhHHHHhHh
Q 003280 658 DFGLARMFGGDELQGNTKRI-VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN-ADSFNLLGYAWDLW 735 (834)
Q Consensus 658 Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~-~~~~~l~~~~~~~~ 735 (834)
|||+|+...... ...... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+... .....+..|++..+
T Consensus 220 DFGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999997654311 111112 89999999999999999999999999999999999998877544 34456899999999
Q ss_pred cCCccccccccccccCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 736 KDDKFHELIDPVITQDEISL-PVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..+++.+++|+.+....... .+..++..++..|++.+|++||+|.||+++|+.+
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 99999999999986455554 6888899999999999999999999999999765
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=368.97 Aligned_cols=251 Identities=26% Similarity=0.395 Sum_probs=208.8
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC-eEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-EKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E 589 (834)
.+++.++.||+|..|+|||++++. ++.+|+|++... .+...+++.+|+++++..+||+||.++|+|.... .+.++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 355667899999999999999875 788999999554 4455688999999999999999999999999999 5999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||.+|+|+.++. ..+.+++...-+++.+|++||.|||+ ++ ||||||||+|||++..|++||+|||.++.+.+.
T Consensus 159 YMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999983 33668999999999999999999996 55 999999999999999999999999999987554
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....+..............+.
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p---------- 298 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP---------- 298 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC----------
Confidence 345689999999999999999999999999999999999999998765322222221111111111
Q ss_pred ccCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 749 TQDEISL-PVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
....+. ....++..++..||+.||.+||+++|+++
T Consensus 299 -pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 299 -PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111122 35568899999999999999999999987
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=384.11 Aligned_cols=261 Identities=33% Similarity=0.525 Sum_probs=212.2
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccc--cHHHHHHHHHHHHhhcCCCcceEEeEEEecC-eEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ--GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-EKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E 589 (834)
.++.+.+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ...+|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 344556679999999999999955445999999765322 2569999999999999999999999999988 7999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC-CceeeeecceeecCCC
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMFGGD 668 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~ 668 (834)
||++|+|..+++.. ....+++..+++++.|||+||.|||+++. ||||||||+|||++.++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999999765 56789999999999999999999999874 99999999999999997 9999999999876543
Q ss_pred ccccccceeccccccccccccc--CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYAL--DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~--~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
. .......||+.|||||++. ...|+.|+|||||||+||||+||+.||..... .+. +....... ..+
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~---~~~v~~~~-----~Rp 265 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQV---ASAVVVGG-----LRP 265 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHH---HHHHHhcC-----CCC
Confidence 2 1222368999999999999 56999999999999999999999999976543 111 11111111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccC
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLEL 793 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 793 (834)
.+ +......+..++.+||+.||++||++.|++..|+.+....
T Consensus 266 ~~-----p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 266 PI-----PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CC-----CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 11 1123456788999999999999999999999998774433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=382.16 Aligned_cols=246 Identities=28% Similarity=0.427 Sum_probs=212.2
Q ss_pred cCccccceeeeecceeEEEEEE-CCCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.+|+..+.||+|+|+.||.++. ..|+.||+|++.+. .....+.+.+||++.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5789999999999999999998 67999999999763 4455678999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
|+|++++|.+++ ++.+.+.+.+++.+++||+.||.|||+++ |+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999988 46778999999999999999999999998 999999999999999999999999999998654
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.. ...+.+|||.|+|||++....++..+||||+|||||-|+.|++||+...-. +..+...
T Consensus 172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk------------------ety~~Ik 231 (592)
T KOG0575|consen 172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK------------------ETYNKIK 231 (592)
T ss_pred cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH------------------HHHHHHH
Confidence 32 345689999999999999999999999999999999999999999753211 1111100
Q ss_pred -ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 749 -TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 749 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.....+.....+..+||.++|+.+|.+|||+++|+.
T Consensus 232 ~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 232 LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011222234556789999999999999999999987
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=361.23 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=202.5
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccc-------cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ-------GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 584 (834)
+.|.+.+.||+|+||.|-+|..+ .|+.||||+++++.-. ....+.+|+++|++|+|||||++.++|......
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 67888999999999999999764 5999999999765211 223467999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC---CCceeeeecc
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGL 661 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgl 661 (834)
||||||+++|.|.+.+. ..+.+.+..-..+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+
T Consensus 252 YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred EEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999884 4456777888899999999999999999 9999999999999655 7799999999
Q ss_pred eeecCCCccccccceecccccccccccccCCcc---CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF---SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD 738 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 738 (834)
|+..+... ...+.+||+.|.|||++.++.+ ..++|+||+||+||-+++|.+||.....+.- ..+....+
T Consensus 326 AK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-----l~eQI~~G 397 (475)
T KOG0615|consen 326 AKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-----LKEQILKG 397 (475)
T ss_pred hhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----HHHHHhcC
Confidence 99876432 3566899999999999986643 3478999999999999999999975432220 11111111
Q ss_pred ccccccccccccC-CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 739 KFHELIDPVITQD-EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 739 ~~~~lid~~l~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+ ...+ ..-.+..++..++|.+||..||++|||+.|+++
T Consensus 398 ~--------y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 398 R--------YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred c--------ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1 1111 112334568899999999999999999999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=360.95 Aligned_cols=200 Identities=30% Similarity=0.545 Sum_probs=181.3
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.+|.+.+.||+|+|++||+|+++. +..||||.+.+. .....+.+..|+++|+.++|||||++++++..++.++||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 678899999999999999999864 889999998765 56667788999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC------CCceeeeeccee
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD------MNPKISDFGLAR 663 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~Dfgla~ 663 (834)
||.+|+|..|++ +.+.+++.....++.|||.||++||+++ ||||||||+||||... -.+||+|||+|+
T Consensus 90 yC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999994 4457899999999999999999999998 9999999999999764 458999999999
Q ss_pred ecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCC
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN 721 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~ 721 (834)
.+.... ...+.+|++-|||||++....|+.|+|+||+|+||||+++|+.||....
T Consensus 164 ~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 987543 3445799999999999999999999999999999999999999997544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=376.82 Aligned_cols=255 Identities=33% Similarity=0.508 Sum_probs=211.8
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
+.+.+.+.||+|.||.||.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..++.++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 445667899999999999999977779999999765 3445789999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
.|+|.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+|+....+++..
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999999965 35667889999999999999999999998 9999999999999999999999999999666555443
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
... ..-+..|.|||.+..+.++.|+|||||||+||||+| |+.|++..... +++ ..+..+ ..+-.
T Consensus 361 ~~~-~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--ev~----~~le~G--yRlp~------ 425 (468)
T KOG0197|consen 361 SEG-GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--EVL----ELLERG--YRLPR------ 425 (468)
T ss_pred cCC-CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH--HHH----HHHhcc--CcCCC------
Confidence 322 345678999999999999999999999999999999 88886643321 111 111111 11111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
+...+..+++|+..||..+|++|||++.+...|+..
T Consensus 426 --P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 426 --PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred --CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 122445788999999999999999999999999876
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=353.73 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=205.7
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
.++|+++++||+|+||+||.++..+ ++.+|+|++++.. ....+..++|..+|.+++||.||+++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 3789999999999999999998765 8899999998752 33467789999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
+||+.||.|..+| ++.+.+++..+..++..|+.||.|||+++ ||||||||+|||||++|+++|+|||+++..-.
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999998 55677999999999999999999999999 99999999999999999999999999996433
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. ..+.+.+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+.. .+........ .
T Consensus 178 ~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-----~~~~~I~~~k--------~ 242 (357)
T KOG0598|consen 178 DG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-----KMYDKILKGK--------L 242 (357)
T ss_pred CC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-----HHHHHHhcCc--------C
Confidence 22 3455589999999999999999999999999999999999999998754321 1111111111 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC----CHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRP----TMSDVV 783 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl 783 (834)
. ..+.-...+..+++...|+.||++|. .+.++-
T Consensus 243 ~---~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 243 P---LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred C---CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 0 01111234677899999999999995 455543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=386.11 Aligned_cols=258 Identities=29% Similarity=0.458 Sum_probs=214.4
Q ss_pred cCccccceeeeecceeEEEEEECC------CcEEEEEEccCcccc-cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
.+.+..+.||+|+||+||+|+... .+.||||.++..+.. ..++|++|+++++.++|||||+|+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 456677899999999999998532 457999999987665 6789999999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCC-------C----CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCc
Q 003280 586 LILEYMPNKSLDVFLFDPT-------K----KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP 654 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 654 (834)
||+|||..|+|.+||.... . ...++..+.+.|+.|||.||.||-++. +|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 9999999999999995311 1 234888999999999999999999998 9999999999999999999
Q ss_pred eeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHh
Q 003280 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWD 733 (834)
Q Consensus 655 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~ 733 (834)
||+|||+++.....++........-.++|||||.+..++||+++|||||||+|||+++ |+.|+.....++ +..
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------VIe 716 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------VIE 716 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH------HHH
Confidence 9999999998866555443333455789999999999999999999999999999999 888865433221 111
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
....+++ -..+...+.+++.|+..||+.+|++||+++||-..|+..
T Consensus 717 ~i~~g~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 717 CIRAGQL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred HHHcCCc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 2222222 112233456889999999999999999999999999876
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=339.47 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=208.0
Q ss_pred cCccccceeeeecceeEEEEEE-CCCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEe-EEEecCe-EEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLG-CCVEQGE-KILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~-~~~~~~~-~~lV 587 (834)
.+|+++++||+|.||+|||+.. .+|..||.|.++-. +.+..+.+..|+.+|++|+|||||++++ -+.+..+ +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 5788999999999999999974 57999999998743 3445678899999999999999999998 4555555 8999
Q ss_pred EeecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCC-CceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 588 LEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSR-FRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
|||+..|+|...+... +..+.+++..+++++.|++.||.++|.+-+ ..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999998543 456679999999999999999999998431 24999999999999999999999999999998
Q ss_pred CCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
..... .....+|||.||+||.+.+..|+.|+||||+||++|||..-++||... ++..... ....++.
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~-KI~qgd~----- 245 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCK-KIEQGDY----- 245 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHH-HHHcCCC-----
Confidence 76543 234579999999999999999999999999999999999999998653 2221111 1111111
Q ss_pred cccccCCCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 746 PVITQDEIS-LPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 746 ~~l~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
...+ ...+.++..||..|+..||+.||+...++..+.
T Consensus 246 -----~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 246 -----PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -----CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1122 345678889999999999999998655555443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=330.51 Aligned_cols=263 Identities=22% Similarity=0.337 Sum_probs=207.8
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCccc--ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
+.|+.+.++|+|+||+|||++.++ |+.||||++....+ ...+-.++|+++|++++|||+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468888899999999999999875 99999999976533 334567899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|++..-|+++- .....++.+.+.+++.|+++|+.|+|+++ +|||||||+||||..++.+||+|||+|+.+...
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 99998887765 23445788999999999999999999998 999999999999999999999999999998631
Q ss_pred cccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCc-cc--------HhHHHHhHhcCCc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADS-FN--------LLGYAWDLWKDDK 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~-~~--------l~~~~~~~~~~~~ 739 (834)
....+.++.|..|.|||.+.+ .+|+..+||||+||++.||++|.+-|+...+-. .. +.......+....
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 122344688999999999987 689999999999999999999999887665422 11 1112223332222
Q ss_pred -cccccccccccCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 740 -FHELIDPVITQDEISL-----PVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 740 -~~~lid~~l~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+..+.-|.. ....+. ....-+++++..||+.||.+|++-+|++.
T Consensus 234 ~F~Gv~lP~~-~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEP-EHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCC-CCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 222221211 111111 12336789999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=348.65 Aligned_cols=250 Identities=27% Similarity=0.360 Sum_probs=208.7
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 586 (834)
..+|...+.||+|+|++|++|+.. .++.+|||++.+. .+...+.+..|-.+|.+| .||.|++|+..|++...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 478999999999999999999865 4899999999764 234456678899999999 89999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
|+||+++|+|.++|. +.+.+++...+.++.+|+.||+|||+.| ||||||||+|||||+++++||+|||.|+.+.
T Consensus 152 vLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999994 4577999999999999999999999999 9999999999999999999999999999986
Q ss_pred CCccc---------ccc--ceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh
Q 003280 667 GDELQ---------GNT--KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 667 ~~~~~---------~~~--~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
..... ... ..++||..|.+||++..+..+..+|+|+||||||+|+.|++||...++-. .
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl----i------ 295 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL----I------ 295 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH----H------
Confidence 43222 111 45899999999999999999999999999999999999999997544311 0
Q ss_pred cCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+.++++- ....+......+.+|+.+.|..||.+|+|.+||-+
T Consensus 296 ----FqkI~~l---~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 296 ----FQKIQAL---DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ----HHHHHHh---cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1111111 11112222356778999999999999999999977
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=338.42 Aligned_cols=255 Identities=27% Similarity=0.419 Sum_probs=203.4
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC--eEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG--EKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~E 589 (834)
.++...+.||+|+||.||++...+ |+..|||.+........+.+.+|+.+|.+++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456778899999999999998765 8999999987654333678999999999999999999999855555 6899999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-CCCceeeeecceeecCC-
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGG- 667 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~- 667 (834)
|+++|+|.+++..... .+++..+..+..||++||+|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999954322 6999999999999999999999998 999999999999999 79999999999998764
Q ss_pred CccccccceecccccccccccccCCc-cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
...........||+.|||||++..+. ...++|||||||++.||+||++||... .....+..........
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~~~------ 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGREDSL------ 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccCCC------
Confidence 12222344578999999999999643 346999999999999999999998643 1111111111111101
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 786 (834)
..++...+.+..+++..|++.+|++|||++|+++-.
T Consensus 242 ----P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 242 ----PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ----CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 122333455788999999999999999999999843
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=360.40 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=211.1
Q ss_pred cCccccceeeeecceeEEEEEECC----CcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
....|.++||.|.||.|++|+++. ...||||.|+.. .+....+|..|..+|.+++||||++|.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 456788999999999999999853 347999999876 455577899999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
.|||+||+|+.||..+ .+.+.+.+..-++++||.|+.||.+.+ +|||||..+|||++.+..+|++|||+++.+..
T Consensus 709 TEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999653 456899999999999999999999998 99999999999999999999999999998865
Q ss_pred Ccccc-ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 668 DELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 668 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
+.... .+..-.-..+|.|||.+...++|.++|||||||+|||.++ |.+|+-.+ ..++.+ +.++
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm--SNQdVI-------------kaIe 848 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--SNQDVI-------------KAIE 848 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc--chHHHH-------------HHHH
Confidence 54111 1111233579999999999999999999999999999888 99885321 111111 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
... +-..+.+.+..|.+|++.|||.|-.+||.+.||+..|++.+
T Consensus 849 ~gy-RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 849 QGY-RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred hcc-CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 111 11223345567899999999999999999999999999874
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.08 Aligned_cols=266 Identities=27% Similarity=0.444 Sum_probs=216.2
Q ss_pred HHhcCccccceeeeecceeEEEEEECCCcEEEEEEccCccccc-HHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.......+.++||+|-||.|.+.....+..||||+++..+... ..+|..|+++|.+++||||++++|+|..++.+++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 3446678889999999999999999888999999999875544 489999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
|||++|+|.+|+...+... +......+|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||+++-+...
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999996543222 455667789999999999999987 999999999999999999999999999987666
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhc--CCCCCCCCCCCcccHhHHHHhHhcCCcccc-ccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--GKKNTGVYNADSFNLLGYAWDLWKDDKFHE-LID 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~-lid 745 (834)
++.....+.+-+++|||||.+..++++.++|||+||+.+||+++ ...|+....++ +....+...+..+.... +..
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhcCCCCcceeccC
Confidence 65554445667889999999999999999999999999999876 55676543222 22322333333322211 112
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
|. -.+..++++++.||..+.++||+++++...|.+.
T Consensus 769 P~--------~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 769 PP--------ACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CC--------cCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 22 2234678999999999999999999999998764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=313.65 Aligned_cols=266 Identities=26% Similarity=0.344 Sum_probs=206.9
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc--ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|...++||+|.||.||+|++. .|+.||||+++.... .......+|++.|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888899999999999999864 599999999876422 224567899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
||+. +|+..+.+ +...+....+..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9975 67777743 4557888999999999999999999998 9999999999999999999999999999987654
Q ss_pred cccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC---c---ccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD---K---FHE 742 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---~---~~~ 742 (834)
... ...+-|..|.|||.+.+. .|+..+|+||.|||+.||+-|.+-|....+-+ .+......+-.. . ...
T Consensus 156 ~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 156 RIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred ccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HHHHHHHHcCCCCcccCccccc
Confidence 322 223678899999999875 59999999999999999999988776544321 111111111111 1 111
Q ss_pred cccccc-------ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 743 LIDPVI-------TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 743 lid~~l-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
+.|... .....-.....+..+++..++..||.+|+++.|++++=.-
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf 284 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYF 284 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhh
Confidence 111110 1111222334567899999999999999999999987544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.33 Aligned_cols=285 Identities=26% Similarity=0.355 Sum_probs=221.2
Q ss_pred CCCCCCCCCCcCcccHHHHHHHhcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHH--Hhhc
Q 003280 490 DGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLI--AKLQ 567 (834)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l--~~l~ 567 (834)
+...++..+.+|.+-..++. ++..+.+.||+|.||+||+|++ .|+.||||+|...++.+ +.+|.++. ..|+
T Consensus 191 ~~~tSGSGSGlplLVQRTia---rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~S---WfrEtEIYqTvmLR 263 (513)
T KOG2052|consen 191 DLETSGSGSGLPLLVQRTIA---RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERS---WFRETEIYQTVMLR 263 (513)
T ss_pred hhccCCCCCCchhHhHHhhh---heeEEEEEecCccccceeeccc-cCCceEEEEecccchhh---hhhHHHHHHHHHhc
Confidence 34456667788887666665 6789999999999999999998 78999999998765544 44455544 4679
Q ss_pred CCCcceEEeEEEecC----eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhh-----cCCCceEe
Q 003280 568 HRNLVKLLGCCVEQG----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-----YSRFRIIH 638 (834)
Q Consensus 568 HpnIv~l~~~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~ivH 638 (834)
|+||+.+++.-..+. +++||.+|.++|+|.+|| ....++....++++..+|.||++||. ++.+.|.|
T Consensus 264 HENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAH 339 (513)
T KOG2052|consen 264 HENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAH 339 (513)
T ss_pred cchhhhhhhccccCCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhc
Confidence 999999999876554 789999999999999999 44678899999999999999999994 57788999
Q ss_pred ccCCCCcEEEcCCCCceeeeecceeecCCC--ccccccceecccccccccccccCCc----c--CccCceeehhhhHHHh
Q 003280 639 RDLKASNVLLDMDMNPKISDFGLARMFGGD--ELQGNTKRIVGTYGYMSPEYALDGL----F--SIKSDVFSFGILMLET 710 (834)
Q Consensus 639 ~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~--~~~~~~~~~~gt~~y~aPE~l~~~~----~--t~~~DVwSlGvvl~el 710 (834)
||||++|||+..++.+.|+|+|+|...... .........+||.+|||||++.+.- + -..+||||||+|+||+
T Consensus 340 RDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEi 419 (513)
T KOG2052|consen 340 RDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEI 419 (513)
T ss_pred cccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHH
Confidence 999999999999999999999999988654 3334455679999999999997643 2 1459999999999998
Q ss_pred hcCC----------CCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 003280 711 LSGK----------KNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMS 780 (834)
Q Consensus 711 ltG~----------~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 780 (834)
.-.. .||-..-+....... .+.--..+-++|.+.....+.+.+..+.+++..||..+|.-|-|+-
T Consensus 420 arRc~~ggi~eey~~Pyyd~Vp~DPs~ee-----MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltAL 494 (513)
T KOG2052|consen 420 ARRCESGGIVEEYQLPYYDVVPSDPSFEE-----MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTAL 494 (513)
T ss_pred HHHhhcCCEehhhcCCcccCCCCCCCHHH-----HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHH
Confidence 6533 233221111111111 1111122334555555566778899999999999999999999999
Q ss_pred HHHHHHhccc
Q 003280 781 DVVSIINSER 790 (834)
Q Consensus 781 evl~~L~~~~ 790 (834)
.+-+.|.++.
T Consensus 495 riKKtl~~l~ 504 (513)
T KOG2052|consen 495 RIKKTLAKLS 504 (513)
T ss_pred HHHHHHHHHh
Confidence 9999888763
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=351.80 Aligned_cols=262 Identities=27% Similarity=0.396 Sum_probs=204.3
Q ss_pred HhcCccccceeeeecceeEEEEEE------CCCcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecC
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG 582 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 582 (834)
..++|++.++||+|+||.||+|.+ ..++.||||+++... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 347899999999999999999974 125689999997543 23356789999999999 8999999999887654
Q ss_pred -eEEEEEeecCCCCccccccCCCC--------------------------------------------------------
Q 003280 583 -EKILILEYMPNKSLDVFLFDPTK-------------------------------------------------------- 605 (834)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 605 (834)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 58899999999999988853211
Q ss_pred ---CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccceeccccc
Q 003280 606 ---KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682 (834)
Q Consensus 606 ---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 682 (834)
...+.+..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134778888999999999999999998 99999999999999999999999999987643322222223456778
Q ss_pred ccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHH
Q 003280 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRY 761 (834)
Q Consensus 683 y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l 761 (834)
|+|||++.+..++.++|||||||++|||++ |..||........ + . .....+.. .. .+......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~---~-~~~~~~~~-----~~-----~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-F---C-QRLKDGTR-----MR-----APENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-H---H-HHHhcCCC-----CC-----CCCCCCHHH
Confidence 999999999999999999999999999997 9999865432211 1 1 11111110 00 011223467
Q ss_pred HHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 762 INVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 762 ~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.+++.+||+.||++|||+.|+++.|+...
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 89999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=348.25 Aligned_cols=266 Identities=29% Similarity=0.431 Sum_probs=211.4
Q ss_pred HHHHHHhcCccccceeeeecceeEEEEEECCCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe
Q 003280 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 506 ~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 583 (834)
.+.....+.+.+.+.||+|+||+||+|++. ..||||++.-. .++..+.|++|+..+++-+|.||+-+.|+|.++..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 344444567788899999999999999984 36999998654 44567899999999999999999999999999887
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.+|+.+|++.+|+.++|..+ ..++....+.|+.||++|+.|||.++ |||||||..||+|.+++.|||+|||++.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999997543 56888999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceecccccccccccccCC---ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcc
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKF 740 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 740 (834)
....-.-........|...|||||+++.. +|++.+||||||+|+|||++|..|+...+.+..- +..++-
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi--------fmVGrG 608 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII--------FMVGRG 608 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE--------EEeccc
Confidence 65432222223335678899999999753 6899999999999999999999998743332211 111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 003280 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERL 791 (834)
Q Consensus 741 ~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 791 (834)
.-..|.. ........++.+|+..||..++++||.+.+|+..|+.+..
T Consensus 609 ~l~pd~s----~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 YLMPDLS----KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccCccch----hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1111111 1122234467889999999999999999999998887743
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.66 Aligned_cols=262 Identities=25% Similarity=0.374 Sum_probs=208.9
Q ss_pred hcCccccceeeeecceeEEEEEE-CCCcEEEEEEccCccc-ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.+.||.|..++||+|+. +.++.||||++.-... ...+.+.+|+..|..++||||++++..|..+..+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 47899999999999999999986 4579999999975533 336899999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
||.+|++.+++...... .+++..+..|++++++||.|||++| .||||||+.||||+++|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999998654443 3889999999999999999999999 9999999999999999999999999877653322
Q ss_pred cc--cccceecccccccccccccCC--ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 670 LQ--GNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 670 ~~--~~~~~~~gt~~y~aPE~l~~~--~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
.+ ....+..||+.|||||+++.. .|+.|+||||||+...||.+|..||..+.+-..-++. +.. ....+.-
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-----Lqn-~pp~~~t 254 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-----LQN-DPPTLLT 254 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-----hcC-CCCCccc
Confidence 11 112567999999999996543 5999999999999999999999999876543322211 111 1111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+ ...........+.+++..||+.||++|||++++++
T Consensus 255 ~~~-~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGL-DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccC-ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000 11111222336788999999999999999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=334.08 Aligned_cols=264 Identities=26% Similarity=0.357 Sum_probs=203.5
Q ss_pred hcCccccceeeeecceeEEEEEE-CCCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 586 (834)
.+.|+.+++||+|.||.||||+. ..|+.||+|+++... +....-..+||.+|++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 46788899999999999999986 458999999987653 44556678899999999999999999999887 68999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
|+|||++ +|.-++. ...-.+++.++..++.||+.||.|+|..+ |+|||||..|||||.+|.+||+|||||+.+.
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999987 4555552 23446889999999999999999999999 9999999999999999999999999999887
Q ss_pred CCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhH--------hcC
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDL--------WKD 737 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~--------~~~ 737 (834)
.......+ ..+-|..|.|||++.+. .|+.++|+||.||||.||+.|++.+....+-++ +....++ |..
T Consensus 270 ~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ--l~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 270 PSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ--LHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred CCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH--HHHHHHHhCCCChhcccc
Confidence 66544333 35679999999999875 699999999999999999999998876554221 1111111 110
Q ss_pred Ccc--ccccccccccCCCCH----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 DKF--HELIDPVITQDEISL----PVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~--~~lid~~l~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.++ ...+.+.......-. ......++|+..+|..||.+|.|+.++++
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 001 011111110000000 11235678999999999999999999987
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=373.46 Aligned_cols=259 Identities=32% Similarity=0.506 Sum_probs=212.4
Q ss_pred cCccccceeeeecceeEEEEEECC--Cc----EEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN--GQ----EVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~--g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
+..+..+.||+|+||.||.|...+ |. .||||.+++. +.+...+|.+|..+|+.++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 456677899999999999998653 43 4999999875 5566789999999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCC----CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecc
Q 003280 586 LILEYMPNKSLDVFLFDPT----KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 661 (834)
+++|||++|+|..||.+.+ ....+...+.+.++.|||+|+.||++++ +|||||..+|+||++...+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999996542 2456889999999999999999999998 99999999999999999999999999
Q ss_pred eeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcc
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKF 740 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 740 (834)
|+.+...++........-...|||||.+..+.|+.|+|||||||+|||++| |..|++..... +++.. ....+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--~v~~~---~~~gg-- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--EVLLD---VLEGG-- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--HHHHH---HHhCC--
Confidence 997655554444433344568999999999999999999999999999999 88887654322 22211 11222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 741 ~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.+-. +...+..+++|+.+||+.+|++||++..+++.+..+.
T Consensus 922 -RL~~--------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 922 -RLDP--------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred -ccCC--------CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 1111 1223446789999999999999999999999887763
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.76 Aligned_cols=249 Identities=27% Similarity=0.419 Sum_probs=208.2
Q ss_pred cCccccceeeeecceeEEEEEE-CCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
..|...++||+|+-|.||.|+. ..++.||||++........+-+.+|+.+|+..+|+|||.++..|...++++.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4566678999999999999975 458899999997766666678999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++|+|.+.+ ....+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 999999887 4445899999999999999999999999 99999999999999999999999999998866554
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
...+.+||+.|||||+.....|++|.||||||++++||+-|++||-..+ .... .+-....+. + .-
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~--PlrA---lyLIa~ng~------P---~l 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN--PLRA---LYLIATNGT------P---KL 489 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC--hHHH---HHHHhhcCC------C---Cc
Confidence 3445799999999999999999999999999999999999999974321 1110 011111110 1 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.........+.+++.+||+.|+++||+++|+|+
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 122234457889999999999999999999997
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=314.73 Aligned_cols=236 Identities=28% Similarity=0.370 Sum_probs=201.2
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++++.||.|+||.|.+++.+. |..+|+|++.+.. -...+...+|..+|+.+.||.++++.+.+.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 688999999999999999999864 7889999998753 234566788999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|.|..++ ++.+.+++..++.++.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+.+..
T Consensus 124 eyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 999999999999 45567999999999999999999999998 99999999999999999999999999998754
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.+-+.+|||.|+|||++....|..++|.|||||++|||+.|.+||...++. .. ++ +++...+
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----~i--Y~--------KI~~~~v 258 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----QI--YE--------KILEGKV 258 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----HH--HH--------HHHhCcc
Confidence 355689999999999999999999999999999999999999998754431 11 11 1111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCC
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADR 776 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~R 776 (834)
..+.-...++.+|+...|+.|-.+|
T Consensus 259 ---~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 ---KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2233334567889999999999988
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=344.45 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=209.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.-|++.+.||+|+-|.|-.|++. .|+.+|||++.+. .......+.+|+.+|+.+.|||++++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45788899999999999999874 5999999999765 2333567899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|-|.+++ ...+.+++.+..+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-..+
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999998 46677899999999999999999999998 999999999999999999999999999875443
Q ss_pred ccccccceecccccccccccccCCcc-CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~-t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
. ...+.+|.+.|.|||++.+.+| +.++||||.|||||.|++|+.||+..+. ..++ .....+.
T Consensus 166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--r~LL----lKV~~G~-------- 228 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI--RVLL----LKVQRGV-------- 228 (786)
T ss_pred c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH--HHHH----HHHHcCc--------
Confidence 3 3345799999999999999998 5889999999999999999999973221 1111 1111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
.+++.....++.+|+.+|+..||++|.|++||++ .|.+
T Consensus 229 ---f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 229 ---FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred ---ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 1223334567889999999999999999999998 4444
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=338.89 Aligned_cols=264 Identities=27% Similarity=0.451 Sum_probs=203.1
Q ss_pred cCccccceeeeecceeEEEEEECC-----------------CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKL 574 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l 574 (834)
++|++.++||+|+||.||++.+.+ +..||+|.++... .....+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 678899999999999999997532 3369999987643 3345679999999999999999999
Q ss_pred EeEEEecCeEEEEEeecCCCCccccccCCC----------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEe
Q 003280 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPT----------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638 (834)
Q Consensus 575 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 638 (834)
++++.+.+..++||||+++++|.+++.... ....+++..+.+++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999998874321 1134678889999999999999999998 999
Q ss_pred ccCCCCcEEEcCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcC--CCC
Q 003280 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG--KKN 716 (834)
Q Consensus 639 ~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG--~~p 716 (834)
|||||+|||++.++.+||+|||+++.+.............++..|+|||++.++.++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999876443322222334557889999999999999999999999999999975 445
Q ss_pred CCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 717 TGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 717 ~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
+.... ...........+......... ..+...+..+.+++.+||+.+|++|||+.||++.|++
T Consensus 242 ~~~~~--~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELT--DEQVIENAGEFFRDQGRQVYL-------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCC--HHHHHHHHHHHhhhccccccc-------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 54322 222222222211111100000 0011223467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=337.07 Aligned_cols=262 Identities=25% Similarity=0.332 Sum_probs=206.1
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHH--HHHHHHHHHhhc-CCCcceEEeEEEecC-eEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEE--FKNEMMLIAKLQ-HRNLVKLLGCCVEQG-EKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~--~~~E~~~l~~l~-HpnIv~l~~~~~~~~-~~~l 586 (834)
.++|.++++||.|.||.||+|+.. .++.||||++++.-.. +++ -.+|++.|.+|. |||||++.+++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 478999999999999999999854 5899999999765333 333 357999999998 999999999999888 9999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
|||||+. +|.+++.+ +++.+++..+..|+.||++||+|+|++| +.|||+||+|||+.....+||+|||+|+.+.
T Consensus 88 VfE~Md~-NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 9999965 67777754 4788999999999999999999999999 9999999999999999999999999999875
Q ss_pred CCccccccceeccccccccccccc-CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc------
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK------ 739 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~-~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~------ 739 (834)
... ..+.++.|..|.|||++. .+.|+.+.|+|++|||++|+.+-++-|++.++-.+ + --..+.+-...
T Consensus 162 Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i-~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 162 SKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-I-YKICEVLGTPDKDSWPE 236 (538)
T ss_pred cCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-H-HHHHHHhCCCccccchh
Confidence 543 334578899999999885 56799999999999999999999998876554221 1 00111111100
Q ss_pred ---ccccccccccc------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 740 ---FHELIDPVITQ------DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 740 ---~~~lid~~l~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
+...+.-.+.. ...-.....++.+++.+|++.||.+|||++|+++.
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00111111100 11122256688999999999999999999999984
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.55 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=204.2
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc----cc-ccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ----SG-QGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 584 (834)
..+|.+.+.||+|+||.|+.|.+. .++.||||++.+. .. ...+.+.+|+.++++++ ||||++++.++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 478999999999999999999764 5899999977553 12 33556778999999999 99999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC-CCceeeeeccee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLAR 663 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~ 663 (834)
++||||+.+|+|.+++.. .+.+.+....+++.|++.|++|||+++ |+||||||+|||++.+ +++||+|||++.
T Consensus 96 ~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 999999999999999943 566888999999999999999999998 9999999999999999 999999999999
Q ss_pred ecCCCccccccceecccccccccccccCCc-cC-ccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccc
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGL-FS-IKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH 741 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~t-~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (834)
.... ......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+. ...... ...+.
T Consensus 170 ~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----~~l~~k-i~~~~-- 239 (370)
T KOG0583|consen 170 ISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----PNLYRK-IRKGE-- 239 (370)
T ss_pred ccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----HHHHHH-HhcCC--
Confidence 8741 122345579999999999999977 85 789999999999999999999975221 111111 11110
Q ss_pred cccccccccCCCCHHH-HHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 742 ELIDPVITQDEISLPV-LVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 742 ~lid~~l~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. .++.-. ..++..++.+|++.+|.+|+++.|+++
T Consensus 240 ------~---~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 ------F---KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ------c---cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 0 011111 557889999999999999999999984
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=328.78 Aligned_cols=267 Identities=28% Similarity=0.404 Sum_probs=206.6
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHH--hhcCCCcceEEeEEEecC----eEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIA--KLQHRNLVKLLGCCVEQG----EKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~--~l~HpnIv~l~~~~~~~~----~~~l 586 (834)
...++.++||+|+||.||||++ +++.||||++... ..+.|.+|-.+.. .++|+||++++++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3455678999999999999999 4599999999654 4466777777766 458999999999987766 8999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc------CCCceEeccCCCCcEEEcCCCCceeeeec
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY------SRFRIIHRDLKASNVLLDMDMNPKISDFG 660 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 660 (834)
|+||.+.|+|.+|| +...++|....+|+..+++||+|||+. ..++|+|||||.+||||.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 556799999999999999999999964 34689999999999999999999999999
Q ss_pred ceeecCCCccccccceecccccccccccccCCc-cC-----ccCceeehhhhHHHhhcCCCCCCCCCCCccc--H-----
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGL-FS-----IKSDVFSFGILMLETLSGKKNTGVYNADSFN--L----- 727 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~t-----~~~DVwSlGvvl~elltG~~p~~~~~~~~~~--l----- 727 (834)
+|..+............+||.+|||||++.+.. +. .+.||||+|.|||||++...-.......+.+ +
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999998776666666689999999999997653 22 4689999999999999977543211111111 0
Q ss_pred ----hHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 003280 728 ----LGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERL 791 (834)
Q Consensus 728 ----~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 791 (834)
..-.+..... +..+|.+.........+..+.+.+..||..||+.|.|+.=|.+++.+...
T Consensus 442 ~hPt~e~mq~~VV~----kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 442 NHPTLEEMQELVVR----KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCCCHHHHHHHHHh----hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 0111111111 11222222222222445678899999999999999999999998887643
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=328.86 Aligned_cols=247 Identities=21% Similarity=0.372 Sum_probs=210.1
Q ss_pred cCccccceeeeecceeEEEEEE-CCCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.+|++.+.||+|.||.|-+|.. ..|+.||||.+++. ++++.-.+.+|+++|..|+||||+.++.+|+..+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 5789999999999999999975 56999999999765 4556677899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||..+|.|++|+ ...+.+++.+...+++||+.|+.|+|+++ ++|||||.+|||||.++++||+|||++..+...
T Consensus 133 EYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999 56677999999999999999999999998 999999999999999999999999999887654
Q ss_pred ccccccceecccccccccccccCCcc-CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~-t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. ..+++|++.|.+||++.+.+| .+.+|-|||||+||.|+.|..||+..+. ...+.+..+
T Consensus 207 kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lvrQIs~----------- 267 (668)
T KOG0611|consen 207 KF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLVRQISR----------- 267 (668)
T ss_pred cH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHHHHhhc-----------
Confidence 42 345799999999999999998 5899999999999999999999975432 111222111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 786 (834)
.....++.+....-||.|||..+|++|.|+.+|..-.
T Consensus 268 --GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 268 --GAYREPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --ccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1111122234566799999999999999999998843
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=337.85 Aligned_cols=245 Identities=27% Similarity=0.427 Sum_probs=207.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+. .+...+.+.+|+++++.++|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999865 4789999998765 34456789999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+.+ +|..++ ...+.++++.+..++.+++.||.|||+.+ |+|||+||+|||++.++.+|++|||+|+....+.
T Consensus 82 ~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9988 999988 45567999999999999999999999998 9999999999999999999999999999875533
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
.....+.|||.|||||+..+++|+..+|+||+|||+||+++|++||-.. .+.+++...+.
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------------------si~~Lv~~I~~ 214 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------------------SITQLVKSILK 214 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------------------HHHHHHHHHhc
Confidence 2334579999999999999999999999999999999999999997421 11112222221
Q ss_pred cC-CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 750 QD-EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. ..+......+.+++...|+.||.+|.+-.+++.
T Consensus 215 d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 215 DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 11 122245567889999999999999999999976
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=341.83 Aligned_cols=243 Identities=23% Similarity=0.375 Sum_probs=206.3
Q ss_pred HHhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeE
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 584 (834)
...++|.++++||+|+||+|+++.++. ++.+|||.+++. .....+..+.|.+++... +||.++.++.+|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345899999999999999999999864 789999999886 355678888999998888 599999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+.||++..+. ..+.+++..+..++..|+.||.|||+++ ||+||||.+|||||.+|.+||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999955544 4467899999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
.-.. ...+.+++||+.|||||++.+..|+.++|.|||||+||||+.|..||...++++ +.
T Consensus 518 ~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------------------~F 577 (694)
T KOG0694|consen 518 GMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------------------VF 577 (694)
T ss_pred cCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------------------HH
Confidence 5322 235677999999999999999999999999999999999999999998655443 22
Q ss_pred ccccccC-CCCHHHHHHHHHHHHhccccCCCCCCCH
Q 003280 745 DPVITQD-EISLPVLVRYINVALLCVQDNAADRPTM 779 (834)
Q Consensus 745 d~~l~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~ 779 (834)
|..+..+ .++.-...+.+.|+.++|..+|++|.-+
T Consensus 578 dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2222111 2233345678899999999999999865
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=335.50 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=204.4
Q ss_pred HhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
..++|+++++||+|+||.||+++-++ |..+|+|++++.. ....+.++.|-.+|....+|.||+++..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45899999999999999999998654 8999999998864 3345678889999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+|||++..+| .+.+.|++..+..++.+++-|+.-+|+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999998 46678999999999999999999999999 9999999999999999999999999986442
Q ss_pred CC----------------------cccc-----cc------------------ceecccccccccccccCCccCccCcee
Q 003280 667 GD----------------------ELQG-----NT------------------KRIVGTYGYMSPEYALDGLFSIKSDVF 701 (834)
Q Consensus 667 ~~----------------------~~~~-----~~------------------~~~~gt~~y~aPE~l~~~~~t~~~DVw 701 (834)
.. +... .. ...+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 0000 00 024799999999999999999999999
Q ss_pred ehhhhHHHhhcCCCCCCCCCCCcc--cHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-
Q 003280 702 SFGILMLETLSGKKNTGVYNADSF--NLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPT- 778 (834)
Q Consensus 702 SlGvvl~elltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs- 778 (834)
|||||+||||.|.+||....+... .+..|...+. . ....+...+..+||.+|+. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---------f------P~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK---------F------PEEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---------C------CCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 999999999999999976554332 2222211110 0 0011112567899999999 9999974
Q ss_pred --HHHHHH
Q 003280 779 --MSDVVS 784 (834)
Q Consensus 779 --~~evl~ 784 (834)
++||-+
T Consensus 437 ~G~~EIK~ 444 (550)
T KOG0605|consen 437 KGAEEIKK 444 (550)
T ss_pred ccHHHHhc
Confidence 666655
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=342.79 Aligned_cols=265 Identities=29% Similarity=0.403 Sum_probs=210.3
Q ss_pred HHHhcCccccceeeeecceeEEEEEECC--C--cE-EEEEEccC---cccccHHHHHHHHHHHHhhcCCCcceEEeEEEe
Q 003280 509 AAATENFSMQCKLGEGGFGPVYKGRLLN--G--QE-VAVKRLSS---QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580 (834)
Q Consensus 509 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~~--g--~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 580 (834)
+...++..+.++||+|+||.||+|++.. + .. ||||..+. .......+|++|.++|++++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3345667777999999999999998753 2 23 89999875 346667899999999999999999999999999
Q ss_pred cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeec
Q 003280 581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 660 (834)
...+++|||+|.||+|+++|.... ..++..+++.++.++|.||+|||+++ +|||||..+|+|++.++.+||+|||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence 999999999999999999995432 26899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCc
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDK 739 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 739 (834)
+++.... +........-+..|+|||.+..+.|+.++|||||||++||+++ |..|+...... ++. ......+.
T Consensus 308 Ls~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~---~kI~~~~~ 380 (474)
T KOG0194|consen 308 LSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVK---AKIVKNGY 380 (474)
T ss_pred cccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHH---HHHHhcCc
Confidence 9876431 1111112245679999999999999999999999999999999 78887643321 111 11111111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCCC
Q 003280 740 FHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPS 795 (834)
Q Consensus 740 ~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 795 (834)
. -..+...+.++..++.+|++.+|++||+|.++.+.|+.+......
T Consensus 381 r----------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 381 R----------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred c----------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1 111112344567788899999999999999999999988655544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=329.57 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=208.6
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
..|+..+.||+|.||.||+|.... ++.||+|++.-. .....+.+..|+.++.+++|+||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 456777899999999999998754 889999999754 344567889999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+.+|++.+.+ +.+..+++..+..+++++..||.|||.++ .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999988 34555688888899999999999999998 99999999999999999999999999998876554
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
.. .+++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+. +..-++-+.- .
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---------------rvlflIpk~~-P 228 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM---------------RVLFLIPKSA-P 228 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc---------------eEEEeccCCC-C
Confidence 43 5689999999999999889999999999999999999999997644331 1111111111 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+.......+.+++..||+.+|+.||++.++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2222244556889999999999999999999987
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=344.54 Aligned_cols=260 Identities=28% Similarity=0.402 Sum_probs=203.7
Q ss_pred hcCccccceeeeecceeEEEEEE------CCCcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 583 (834)
.++|++.++||+|+||.||+|+. ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++.....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35789999999999999999963 235689999997543 33456788999999999 89999999999999999
Q ss_pred EEEEEeecCCCCccccccCCC-----------------------------------------------------------
Q 003280 584 KILILEYMPNKSLDVFLFDPT----------------------------------------------------------- 604 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 604 (834)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999988875321
Q ss_pred -------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 605 -------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 605 -------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1124788899999999999999999998 999999999999999999999999999876443221
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
.......++..|+|||++.+..++.++|||||||++|||++ |..||....... .+. .....+... . .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~----~~~~~~~~~--~---~-- 338 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFY----KMIKEGYRM--L---S-- 338 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHH----HHHHhCccC--C---C--
Confidence 11222345678999999999999999999999999999998 888875432211 111 111111100 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
+.....++.+++.+|++.||++||++.|+++.|++.
T Consensus 339 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 ---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 011134678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=330.04 Aligned_cols=244 Identities=19% Similarity=0.336 Sum_probs=198.0
Q ss_pred ceeeeecceeEEEEEECCCcEEEEEEccCccccc---HHHHHHHHHHHHhhcCCCcceEEeEEEe----cCeEEEEEeec
Q 003280 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG---LEEFKNEMMLIAKLQHRNLVKLLGCCVE----QGEKILILEYM 591 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~Ey~ 591 (834)
..||+|++|.||+|+. +|+.||||+++...... .+.|.+|+.+|.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5899999999999998 78999999997653332 5778899999999999999999999877 34789999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
++|+|.+++.. ...+++.....++.+++.||+|||+. + ++||||||+||++++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999843 34688999999999999999999985 5 7899999999999999999999999998654321
Q ss_pred ccccceecccccccccccccC--CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~--~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ++.. ...... . ..
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~---~i~~~~-~----~~-- 241 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYD---LIINKN-N----SL-- 241 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHH---HHHhcC-C----CC--
Confidence 12467889999999976 68999999999999999999999998744321 1111 111110 0 00
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..+......+.+++.+||+.||++|||++|+++.|+..
T Consensus 242 ---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 242 ---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred ---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11112345688999999999999999999999999875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=344.73 Aligned_cols=260 Identities=30% Similarity=0.426 Sum_probs=203.7
Q ss_pred hcCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 583 (834)
.++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.+++.+ +|+||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 367999999999999999998742 24579999997543 33356788999999999 89999999999999999
Q ss_pred EEEEEeecCCCCccccccCCC-----------------------------------------------------------
Q 003280 584 KILILEYMPNKSLDVFLFDPT----------------------------------------------------------- 604 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 604 (834)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999998874321
Q ss_pred --------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccce
Q 003280 605 --------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676 (834)
Q Consensus 605 --------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (834)
....+++..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1124778889999999999999999998 99999999999999999999999999987643322111222
Q ss_pred ecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCH
Q 003280 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISL 755 (834)
Q Consensus 677 ~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~ 755 (834)
..++..|+|||++.+..++.++|||||||++|||++ |+.||....... ... ...... ..... +.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~----~~~~~~-----~~~~~-----~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFY----KMVKRG-----YQMSR-----PD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHH----HHHHcc-----cCccC-----CC
Confidence 345678999999999999999999999999999997 999986533221 111 111110 00000 01
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 756 PVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 756 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..+.++.+++.+||+.+|++||++.+|+++|+++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1134678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=376.70 Aligned_cols=262 Identities=27% Similarity=0.457 Sum_probs=214.4
Q ss_pred hcCccccceeeeecceeEEEEEE-CCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
...|...+.||+|+||.||+|+. .+++.||||+++..... ...|++.+++++|||||++++++.+....++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 35677788999999999999987 46899999998654322 23468899999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++|+|.+++. .++|..+.+++.||++||+|||....++|+||||||+||+++.++..++. |+.+......
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 99999999984 27899999999999999999997655669999999999999999888875 6655433211
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
....+|+.|+|||++.+..++.++|||||||++|||++|+.|+.........+..|+............+|+.+..
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1236789999999999999999999999999999999999998654444455666666555555555566666532
Q ss_pred C-CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 751 D-EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 751 ~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
. ....++..++.+++.+|++.+|++||+|+|+++.|+...
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 2 334566778899999999999999999999999999873
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=333.94 Aligned_cols=247 Identities=28% Similarity=0.445 Sum_probs=202.3
Q ss_pred ccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCc
Q 003280 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 517 ~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
.++-||+|+.|.||+|++ .++.||||+++... ..+|+-|++|+||||+.+.|+|.....+++|||||..|.|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 356899999999999999 67899999986432 3578889999999999999999999999999999999999
Q ss_pred cccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccce
Q 003280 597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (834)
...| +.+..+.......|..+||.|+.|||.+. |||||||.-||||.-+..+||+|||-++..... .....
T Consensus 200 ~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS 270 (904)
T KOG4721|consen 200 YEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS 270 (904)
T ss_pred HHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence 9999 45667888889999999999999999998 999999999999999999999999999876443 23345
Q ss_pred ecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHH
Q 003280 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~ 756 (834)
+.||..|||||++.+.+.++|+||||||||||||+||..|+...+.. ...|..- .+...+ ..+..
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----AIIwGVG--sNsL~L--------pvPst 335 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----AIIWGVG--SNSLHL--------PVPST 335 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----eeEEecc--CCcccc--------cCccc
Confidence 79999999999999999999999999999999999999997532211 1111110 011111 12222
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCCC
Q 003280 757 VLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPS 795 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 795 (834)
.+.-+.-|+.+||+..|+.||++++++.-|+-...++-.
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~ 374 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLS 374 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhc
Confidence 334566788999999999999999999998766555433
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.78 Aligned_cols=253 Identities=22% Similarity=0.332 Sum_probs=203.6
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|+... ++.||||+++... ......+.+|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468999999999999999998764 8899999997542 233567889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999984 3446889999999999999999999998 99999999999999999999999999986543
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ..... ...+....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~---~i~~~---~~~~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--TWE---NLKYW---KETLQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--HHH---HHHhc---cccccCCC
Confidence 2234578999999999999999999999999999999999999986543211 100 00000 00011000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
..........++.+++.+||+.+|++||+++|+++.
T Consensus 222 -~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 -YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000011234567889999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=320.82 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=201.5
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--------------cccHHHHHHHHHHHHhhcCCCcceEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--------------GQGLEEFKNEMMLIAKLQHRNLVKLL 575 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--------------~~~~~~~~~E~~~l~~l~HpnIv~l~ 575 (834)
..++|++++.||+|.||.|-+|+.. +++.||||++.+.. ....+.+.+|+.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3478999999999999999999865 58999999986531 11246789999999999999999999
Q ss_pred eEEEec--CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC
Q 003280 576 GCCVEQ--GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN 653 (834)
Q Consensus 576 ~~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 653 (834)
.+..+. +.+|||+|||..|.+...- .....+...++++++++++.||.|||.++ ||||||||.|+||+++|.
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 998765 4799999999999875442 22333899999999999999999999999 999999999999999999
Q ss_pred ceeeeecceeecCCCc---cccccceecccccccccccccCCc----cCccCceeehhhhHHHhhcCCCCCCCCCCCccc
Q 003280 654 PKISDFGLARMFGGDE---LQGNTKRIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSGKKNTGVYNADSFN 726 (834)
Q Consensus 654 ~kl~Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~----~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~ 726 (834)
+||+|||.+..+.... .........|||.|+|||...++. .+.+.||||+||.||.|+.|+.||-.... ..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--~~ 326 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--LE 326 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--HH
Confidence 9999999998773321 112223468999999999998743 36789999999999999999999853211 00
Q ss_pred HhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 727 LLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 727 l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
+ ..+++...+ .-....+..+++.+||.++|+.||++|.+..+|....-
T Consensus 327 l------------~~KIvn~pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 327 L------------FDKIVNDPL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred H------------HHHHhcCcc-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 0 112222222 11222345667889999999999999999999977543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=331.59 Aligned_cols=263 Identities=23% Similarity=0.323 Sum_probs=204.3
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.+.||+|+||.||+++.. .+..+|+|.++.. .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 378999999999999999999876 4788999998754 23345679999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ .|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999998843 345889999999999999999999853 3999999999999999999999999999765332
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh-cC--Cc-------
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW-KD--DK------- 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~-~~--~~------- 739 (834)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... +........ .. +.
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCcc
Confidence 1233578999999999999999999999999999999999999986433211 110000000 00 00
Q ss_pred --------------------cccccccccc---cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 740 --------------------FHELIDPVIT---QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 740 --------------------~~~lid~~l~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
..++.+.... ..........++.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 000011234578899999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=323.87 Aligned_cols=250 Identities=25% Similarity=0.312 Sum_probs=199.9
Q ss_pred ccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
|+..+.||+|+||.||++... +++.||||++.... ......+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677899999999999999864 58999999986532 22335678999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++|+|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999998877532 2345889999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
.....||..|+|||++.+..++.++|||||||++|||++|+.||........ .......... . .
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~--------~---~ 221 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVKE--------D---Q 221 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhhc--------c---c
Confidence 2234789999999999999999999999999999999999999875433211 0000010000 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPT-----MSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 784 (834)
..........+.+|+.+||+.||++||+ ++|+++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1111223446789999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.76 Aligned_cols=257 Identities=30% Similarity=0.498 Sum_probs=206.4
Q ss_pred cCccccceeeeecceeEEEEEECC------CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
++|++.+.||+|+||.||+|.... .+.||+|.++... ....++|.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 578899999999999999998643 2579999987543 334567999999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCC-------------CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC
Q 003280 586 LILEYMPNKSLDVFLFDPTK-------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM 652 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 652 (834)
++|||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998854211 145788899999999999999999998 99999999999999999
Q ss_pred CceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHH
Q 003280 653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYA 731 (834)
Q Consensus 653 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~ 731 (834)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ++.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~--- 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVI--- 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH---
Confidence 999999999987644332222333456789999999999999999999999999999998 99887543221 111
Q ss_pred HhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 732 WDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 732 ~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
.....+.. ...+...+.++.+|+.+||+.+|++||+++||++.|+.
T Consensus 237 -~~i~~~~~----------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 -EMIRSRQL----------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHcCCc----------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111 11122334578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.20 Aligned_cols=244 Identities=22% Similarity=0.293 Sum_probs=200.2
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 67999999999999999999876 48899999986542 234567899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999998884 3346788899999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ......+..
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~----~~~i~~~~~-------- 232 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RI----YEKILAGRL-------- 232 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HH----HHHHhcCCc--------
Confidence 2 2357899999999999999999999999999999999999998543211 11 111111110
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPT-----MSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 784 (834)
..+.....++.+++.+||+.||++||+ ++++++
T Consensus 233 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 ---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 001112245779999999999999996 677764
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=325.16 Aligned_cols=264 Identities=22% Similarity=0.312 Sum_probs=202.0
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999986 47889999987542 3345678899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|++++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999988765542 2346889999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHH----------HhH-hcCC
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYA----------WDL-WKDD 738 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~----------~~~-~~~~ 738 (834)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||........ +.... ... ....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccc
Confidence 1 122235789999999999998999999999999999999999999875432111 10000 000 0000
Q ss_pred ccccccccccccC-----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 739 KFHELIDPVITQD-----EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 739 ~~~~lid~~l~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.......+..... .........+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111110100000 000112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.67 Aligned_cols=256 Identities=26% Similarity=0.380 Sum_probs=203.2
Q ss_pred hcCccccceeeeecceeEEEEEEC----CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+|.+. .+..||+|+++... ....+.|.+|+.++.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 367899999999999999999763 35689999997653 3334678999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999988532 346889999999999999999999998 9999999999999999999999999876543
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
..... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .+.. . ..... .
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~---~-~~~~~-----~ 226 (266)
T cd05064 159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIK---A-VEDGF-----R 226 (266)
T ss_pred ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHH---H-HHCCC-----C
Confidence 22111 1112345678999999999999999999999999999775 99998643221 1111 1 11110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
. ..+...+..+.+++.+||+.+|++||+++|+++.|+..
T Consensus 227 ~-----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 L-----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred C-----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 11112334678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.37 Aligned_cols=241 Identities=23% Similarity=0.290 Sum_probs=195.5
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCC
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+.||+|+||.||+++.. +|+.||||+++... ......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999875 58899999987542 233456788999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccccc
Q 003280 595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT 674 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (834)
+|..++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 9988884 3456889999999999999999999998 9999999999999999999999999987542211 123
Q ss_pred ceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCC
Q 003280 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEIS 754 (834)
Q Consensus 675 ~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~ 754 (834)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +.. ....+. . ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~----~~~~~~------~-----~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFE----LILMEE------I-----RFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHH----HHHcCC------C-----CCC
Confidence 34679999999999999999999999999999999999999985432111 110 010000 0 111
Q ss_pred HHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 755 LPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 755 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
.....++.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 12234678999999999999999 7999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=338.75 Aligned_cols=261 Identities=28% Similarity=0.390 Sum_probs=205.6
Q ss_pred HhcCccccceeeeecceeEEEEEECC------CcEEEEEEccCcc-cccHHHHHHHHHHHHhhc-CCCcceEEeEEEecC
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQG 582 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~ 582 (834)
..++|.+.++||+|+||.||+|.... +..||||+++... ....+.+.+|+++++++. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35789999999999999999997532 3479999997543 333567999999999996 999999999999999
Q ss_pred eEEEEEeecCCCCccccccCCC----------------------------------------------------------
Q 003280 583 EKILILEYMPNKSLDVFLFDPT---------------------------------------------------------- 604 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 604 (834)
..++||||+++|+|.++++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999988875321
Q ss_pred -----------------------------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc
Q 003280 605 -----------------------------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649 (834)
Q Consensus 605 -----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 649 (834)
....+++..+..++.||++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0124778888999999999999999988 99999999999999
Q ss_pred CCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHh
Q 003280 650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLL 728 (834)
Q Consensus 650 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~ 728 (834)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.....+.. +
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~- 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-F- 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-H-
Confidence 999999999999987644322222223456788999999999999999999999999999997 8888764322111 0
Q ss_pred HHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 729 GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 729 ~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
......+. .. .........+.+++.+||+.+|++||++.+|+++|+..
T Consensus 350 ---~~~~~~~~-----~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 350 ---YNKIKSGY-----RM-----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ---HHHHhcCC-----CC-----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 11111110 00 01112345678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=329.47 Aligned_cols=244 Identities=23% Similarity=0.279 Sum_probs=199.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999875 58899999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999884 3346889999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... +. .... ... .
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~---~~i~-~~~--------~ 215 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--IY---EKIL-AGK--------L 215 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH---HHHH-hCC--------c
Confidence 223578999999999999999999999999999999999999986432211 11 1111 110 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPT-----MSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 784 (834)
..+......+.+++.+||+.||.+||+ ++|+++
T Consensus 216 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 ---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 011112346789999999999999995 888776
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=324.10 Aligned_cols=257 Identities=26% Similarity=0.454 Sum_probs=206.2
Q ss_pred cCccccceeeeecceeEEEEEECC------CcEEEEEEccCcccc-cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
++|.+.+.||+|+||.||+|...+ ++.||||+++..... ..+.+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 568889999999999999998643 478999999765444 4578999999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCC-----------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCc
Q 003280 586 LILEYMPNKSLDVFLFDPT-----------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP 654 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 654 (834)
+||||+++++|.+++.... ....+++..+..++.||+.|++|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999985421 2345788899999999999999999998 9999999999999999999
Q ss_pred eeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHh
Q 003280 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWD 733 (834)
Q Consensus 655 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~ 733 (834)
||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~---- 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIE---- 235 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH----
Confidence 9999999986543322222223345788999999999999999999999999999998 999875433211 111
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
....+... .........+.+++.+||+.+|++||++.|+++.|++
T Consensus 236 ~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 CITQGRLL----------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111110 0111223467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=318.40 Aligned_cols=255 Identities=29% Similarity=0.420 Sum_probs=206.0
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46789999999999999999998778899999987543 34577899999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985432 346889999999999999999999998 999999999999999999999999999887532211
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
.......+..|+|||++.+..++.++||||||+++|||++ |+.|+...... .+. ........
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~----~~~~~~~~---------- 222 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVL----QQVDQGYR---------- 222 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHH----HHHHcCCC----------
Confidence 1111223458999999999999999999999999999999 88887543211 111 11111000
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
..........+.+++.+|++.+|++||++.++++.|++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00111223567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=325.56 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=210.0
Q ss_pred cCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
.+|.+.+.||+|+||.||+|+.. ++..+++|.++.......+.+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 56888899999999999999742 345699999877666666789999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCC-------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC
Q 003280 587 ILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN 653 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 653 (834)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985421 2235789999999999999999999998 999999999999999999
Q ss_pred ceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHH
Q 003280 654 PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAW 732 (834)
Q Consensus 654 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~ 732 (834)
++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... . .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~----~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--V----I 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H----H
Confidence 99999999986644332222233456788999999999999999999999999999998 999875433211 1 1
Q ss_pred hHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 003280 733 DLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLE 792 (834)
Q Consensus 733 ~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 792 (834)
.....+..... ....+..+.+++.+|++.+|++||++++|+++|+.+...
T Consensus 236 ~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 ECITQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHhCCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11111111110 111234678999999999999999999999999998553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.92 Aligned_cols=255 Identities=30% Similarity=0.442 Sum_probs=206.4
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+......+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 36799999999999999999998888899999986533 34578999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999988543 2345788899999999999999999988 999999999999999999999999999876543221
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
. .....++..|+|||++....++.++|||||||++|||++ |+.||...... ...... .... ..
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~----~~~~-----~~---- 223 (261)
T cd05072 160 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSAL----QRGY-----RM---- 223 (261)
T ss_pred c-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHH----HcCC-----CC----
Confidence 1 122345678999999998899999999999999999998 89888643211 111111 1110 00
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
.........+.+++.+|++.+|++||++++++++|+.
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 -PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0001123467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=297.58 Aligned_cols=265 Identities=22% Similarity=0.253 Sum_probs=213.0
Q ss_pred HHhcCccccceeeeecceeEEEEE-ECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC-----e
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-----E 583 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~ 583 (834)
.+.++|++.++||+|||.-||.++ ..+++.+|+|++.....+..+..++|++..++++|||+++++++...+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 455899999999999999999998 4568899999998887788899999999999999999999998875443 5
Q ss_pred EEEEEeecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 584 KILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
.|++++|...|+|.+.+... .++..+++.++++|+.+|++||++||+.. ++++||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999888653 34457999999999999999999999986 48999999999999999999999999998
Q ss_pred eecCCCccc-------cccceeccccccccccccc---CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHH
Q 003280 663 RMFGGDELQ-------GNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAW 732 (834)
Q Consensus 663 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~l~---~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~ 732 (834)
....-.-.. ........|.-|.|||.+. +...++++|||||||+||+|+.|..||+..-.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------- 246 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------- 246 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------
Confidence 764211000 0011235688999999885 55689999999999999999999999864221
Q ss_pred hHhcCCccc-cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 733 DLWKDDKFH-ELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 733 ~~~~~~~~~-~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..+.+. .+....+.... ..+.++.+.+++.+|++.||.+||++.|++..++.+
T Consensus 247 ---~GgSlaLAv~n~q~s~P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 ---QGGSLALAVQNAQISIPN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ---cCCeEEEeeeccccccCC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 112221 12222332211 222667889999999999999999999999998865
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=324.02 Aligned_cols=251 Identities=35% Similarity=0.542 Sum_probs=194.0
Q ss_pred cccceeeeecceeEEEEEEC-----CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 516 SMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 516 ~~~~~LG~G~~G~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++.+.||.|.||.||+|.+. .+..|+||+++... ....+.|.+|++.+.+++||||++++|++...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35679999999999999886 25689999996543 3347899999999999999999999999998888999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++|+|.+++... ....+++..+..++.||++||+|||+.+ ++|+||+++||++++++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999654 2456899999999999999999999988 9999999999999999999999999998873332
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.............|+|||.+....++.++||||||+++|||++ |+.|+..... .++ .... .......
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~---~~~~-~~~~~~~------ 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEI---IEKL-KQGQRLP------ 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHH---HHHH-HTTEETT------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccc---cccc-cccccce------
Confidence 2222233456789999999999999999999999999999999 6777643321 111 1111 1111110
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 786 (834)
.+......+.+++.+||+.+|++||+++++++.|
T Consensus 226 ----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111234678999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=325.51 Aligned_cols=264 Identities=25% Similarity=0.289 Sum_probs=197.3
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc-ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 378999999999999999999876 588999999875432 233567889999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 566665532 2345788899999999999999999998 9999999999999999999999999997653221
Q ss_pred cccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC---ccc---c
Q 003280 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD---KFH---E 742 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---~~~---~ 742 (834)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....+....+.. ........ ... .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLER-IFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH-HHHHhCCCChhhccchhh
Confidence 11223467899999999875 45889999999999999999999999754321111111 10000000 000 0
Q ss_pred --cccc-ccc-cCCCCH-------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 743 --LIDP-VIT-QDEISL-------PVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 743 --lid~-~l~-~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..++ ... ...... .....+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 000 000000 01235778999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=341.16 Aligned_cols=268 Identities=25% Similarity=0.295 Sum_probs=215.1
Q ss_pred HhcCccccceeeeecceeEEEEEECCC-cEEEEEEccCcccccHHHHHHHHHHHHhhc-CCCcceEEeE-EEec------
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGC-CVEQ------ 581 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~-~~~~------ 581 (834)
...++++.+.|.+|||+.||.|....+ ..+|+|++-..++...+.+++|+.+|++|+ |+|||.+++. ....
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 446788899999999999999998775 999999988888888999999999999997 9999999993 3221
Q ss_pred CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecc
Q 003280 582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 661 (834)
-+.+|.||||.+|.|-+++......+ |.+.++++|+.++++|+++||... ++|||||||-+||||..+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 26789999999999999985444444 999999999999999999999975 7899999999999999999999999999
Q ss_pred eeecCCCccccc-------cceecccccccccccc---cCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHH
Q 003280 662 ARMFGGDELQGN-------TKRIVGTYGYMSPEYA---LDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYA 731 (834)
Q Consensus 662 a~~~~~~~~~~~-------~~~~~gt~~y~aPE~l---~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~ 731 (834)
|........... .-...-|+.|.|||++ .+..+++|+|||+|||+||-|+....||+...
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------- 262 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------- 262 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----------
Confidence 875422211000 0012468999999987 57789999999999999999999999997432
Q ss_pred HhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc-cccCCCCCCC
Q 003280 732 WDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE-RLELPSPKEP 799 (834)
Q Consensus 732 ~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~-~~~~~~p~~p 799 (834)
...+++... .-....+....+.+||..||+.||++||++.||++.+-++ .++.+.++.+
T Consensus 263 --------~laIlng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 263 --------KLAILNGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred --------ceeEEeccc-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 122333333 1222356778899999999999999999999999987665 2334444444
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=314.43 Aligned_cols=266 Identities=24% Similarity=0.333 Sum_probs=204.7
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccC--cccccHHHHHHHHHHHHhhcCCCcceEEeEEEe-----cCe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE-----QGE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----~~~ 583 (834)
...|..++.||+|+||.|+++... +|+.||||++.. ......++-.+|+++|++++|+||+.+++.+.- -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 456666789999999999999875 589999999973 345567888999999999999999999998865 347
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.|+|+|+| ..+|...+ +.+..+.......++.||++||.|+|+.+ |+||||||.|+|++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 66788887 34455889999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCC-cccHhHHH--------Hh
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNAD-SFNLLGYA--------WD 733 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~-~~~l~~~~--------~~ 733 (834)
...........+..+.|..|.|||++.. ..|+.+.||||.||||.||++|++-|.+.+.- +..+.... ..
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 9865422333456788999999998864 57999999999999999999999988765531 11111111 01
Q ss_pred HhcCCccccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 734 LWKDDKFHELIDPVITQDEIS-----LPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
....+.....+.........+ .......++|+.+||..||.+|+|++|.++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111111111111111111111 112346789999999999999999999987
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.42 Aligned_cols=255 Identities=30% Similarity=0.472 Sum_probs=210.1
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
..+|++.++||+|+||.||+|...+++.+|+|.++.........+.+|+.+++.++||||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 46789999999999999999998889999999998776656778999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999998653 2346789999999999999999999998 999999999999999999999999999876433221
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+...... ....... .. ..
T Consensus 161 ~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~----~~-----~~----- 222 (261)
T cd05148 161 S--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQIT----AG-----YR----- 222 (261)
T ss_pred c--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHH----hC-----Cc-----
Confidence 1 12345678999999998899999999999999999998 88888543311 1111110 00 00
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
...+......+.+++.+|++.+|++|||++++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01112223467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=317.15 Aligned_cols=252 Identities=28% Similarity=0.440 Sum_probs=202.5
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|++.+.||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 568889999999999999999888889999998643 3335678999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999988532 235889999999999999999999998 9999999999999999999999999998654332211
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ..... ....... ...+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~---~i~~~~~---~~~~----- 223 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVE---MISRGFR---LYRP----- 223 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHH---HHHCCCC---CCCC-----
Confidence 112245668999999998899999999999999999999 8888754321 11111 1111110 0011
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
......+.+++.+|++.+|++||+++|+++.|.
T Consensus 224 ---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 ---KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112246789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=325.35 Aligned_cols=240 Identities=21% Similarity=0.276 Sum_probs=192.0
Q ss_pred eeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCc
Q 003280 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
||+|+||.||+|+.. +++.||+|+++.. .......+.+|+.++.+++||||+++++++.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 4789999998653 233456788999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccce
Q 003280 597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (834)
.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 988843 346889999999999999999999998 9999999999999999999999999998643222 12234
Q ss_pred ecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHH
Q 003280 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~ 756 (834)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... .. ..+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~~~~~---------~~---~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRKILQE---------PL---RFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcC---------CC---CCCCc
Confidence 57899999999999999999999999999999999999998643211 111111111 00 11112
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 757 VLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
....+.+++.+||+.||++||++..+.++
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 23467899999999999999864433333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=322.30 Aligned_cols=262 Identities=23% Similarity=0.316 Sum_probs=198.2
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.++||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999875 58899999986543 23345778999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++ +|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 78777632 2345788899999999999999999998 99999999999999999999999999986543221
Q ss_pred ccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh--------c----C
Q 003280 671 QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW--------K----D 737 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~--------~----~ 737 (834)
......+++.|+|||++.+ ..++.++|||||||++|||++|+.||........ ........ . .
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE--LHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhccccc
Confidence 1223467899999999875 5689999999999999999999999865432111 11000000 0 0
Q ss_pred CccccccccccccCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 DKFHELIDPVITQDE---ISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~lid~~l~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
........+...... .......++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 001111111100000 00012346789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.36 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=203.2
Q ss_pred HhcCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 583 (834)
++++|++.+.||+|+||.||+|... .+..||||++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 24679999986532 2345678999999999999999999999999999
Q ss_pred EEEEEeecCCCCccccccCCCC-------CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCcee
Q 003280 584 KILILEYMPNKSLDVFLFDPTK-------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 656 (834)
.++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999998854221 234578889999999999999999987 999999999999999999999
Q ss_pred eeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHh
Q 003280 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..|+...... .... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~----~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLR----FV 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH----HH
Confidence 99999986644332222222345778999999999999999999999999999999 67787543221 1111 11
Q ss_pred cCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
....... .+......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 235 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111110 011123467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=329.41 Aligned_cols=262 Identities=23% Similarity=0.296 Sum_probs=208.0
Q ss_pred cCccccceeeeecceeEEEEEECC--CcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~--g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++..++||||+++++++.+....++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 679999999999999999998643 368999998643 233456788999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999884 3346889999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .........
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~----~~~~i~~~~-------- 244 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--L----IYQKILEGI-------- 244 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--H----HHHHHhcCC--------
Confidence 2 23457899999999999989999999999999999999999998643221 0 011111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH--Hhc------ccccCCCCCCCccc
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVSI--INS------ERLELPSPKEPAFI 802 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~--L~~------~~~~~~~p~~p~~~ 802 (834)
. ..+......+.+++.+|++.+|++|+ +++|+++. +.+ ....++.|..|.+.
T Consensus 245 ~---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~ 309 (340)
T PTZ00426 245 I---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYK 309 (340)
T ss_pred C---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence 0 01111223567899999999999995 89998773 221 12345566666653
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=323.58 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=207.8
Q ss_pred cCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 67889999999999999999752 245689999987666667789999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCC----------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCcee
Q 003280 587 ILEYMPNKSLDVFLFDPT----------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 656 (834)
||||+++++|.+++.... ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999998885321 2235899999999999999999999998 999999999999999999999
Q ss_pred eeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHh
Q 003280 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||....... .. ...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~----~~i 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VI----ECI 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HHH
Confidence 99999986643322222223345778999999999999999999999999999998 888875432211 11 111
Q ss_pred cCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
..+.... . .. .....+.+++.+|++.+|.+|||++|+++.|+.+.
T Consensus 236 ~~~~~~~-----~-~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 236 TQGRVLQ-----R-PR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HcCCcCC-----C-CC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111110 0 11 12245789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=317.54 Aligned_cols=256 Identities=30% Similarity=0.460 Sum_probs=205.0
Q ss_pred cCccccceeeeecceeEEEEEECC----CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
++|++.+.||+|+||.||+|.+.. ...||||+++... .....+|.+|+.++.+++||||+++++.+......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 678999999999999999998743 3579999987543 33456789999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998542 236889999999999999999999988 99999999999999999999999999998753
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
...........++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .+. .........
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~----~~~~~~~~~----- 227 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVI----KAVEDGYRL----- 227 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHH----HHHHcCCCC-----
Confidence 222212222345678999999999999999999999999999998 98887533211 111 111111000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.........+.+++.+|++.+|++||+++|+++.|++.
T Consensus 228 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00112234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=320.40 Aligned_cols=267 Identities=30% Similarity=0.368 Sum_probs=202.3
Q ss_pred ccccceeeeecceeEEEEEE-----CCCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeEEE
Q 003280 515 FSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKIL 586 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 586 (834)
|++.+.||+|+||+||++.. .+++.||+|.++... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988653 347789999987643 23457789999999999999999999988764 35889
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999998843 34899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccc-ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........................+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 432111 1112245667999999998899999999999999999999999875433221111111110011111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
... ....+...+..+.+++.+|++.+|++|||+++++++|+.+
T Consensus 239 ~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111 1111222345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=321.31 Aligned_cols=257 Identities=29% Similarity=0.447 Sum_probs=203.4
Q ss_pred cCccccceeeeecceeEEEEEE-----CCCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~-----~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
++|++.+.||+|+||.||+|.. ..++.|++|.++.. .......+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5688889999999999999974 24678999999753 33345688999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCC--------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC
Q 003280 587 ILEYMPNKSLDVFLFDPT--------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM 652 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 652 (834)
||||+++++|.+++.... ....+++..+..++.|++.||+|||+++ ++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999884221 1234788889999999999999999998 99999999999999999
Q ss_pred CceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHH
Q 003280 653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYA 731 (834)
Q Consensus 653 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~ 731 (834)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... ..+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~-- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIE-- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHH--
Confidence 999999999987644332222333455778999999998899999999999999999998 8888754321 11111
Q ss_pred HhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 732 WDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 732 ~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
......... .......++.+++.+|++.+|++||++.++++.|..
T Consensus 238 --~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 --MVRKRQLLP----------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111100 011123467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=327.24 Aligned_cols=241 Identities=23% Similarity=0.289 Sum_probs=195.1
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCC
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+.||+|+||.||+++.. +++.||||++.+. .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999875 5889999999754 2334567889999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccccc
Q 003280 595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT 674 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (834)
+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 9988874 3346889999999999999999999998 9999999999999999999999999987543221 122
Q ss_pred ceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCC
Q 003280 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEIS 754 (834)
Q Consensus 675 ~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~ 754 (834)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..... . +. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--~~---~~~~~-~------~~-----~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LF---ELILM-E------DI-----KFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--HH---HHhcc-C------Cc-----cCC
Confidence 34578999999999999999999999999999999999999986432111 10 00000 0 00 111
Q ss_pred HHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 755 LPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 755 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
.....++.+++.+||+.||++|| ++.|+++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 12234678999999999999997 8999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=341.19 Aligned_cols=252 Identities=19% Similarity=0.233 Sum_probs=203.7
Q ss_pred CccccceeeeecceeEEEEEECC--CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.|.+.+.||+|++|.||+|.... ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 48899999999999999997543 5788999876555555567889999999999999999999999999999999999
Q ss_pred CCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 592 PNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 592 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
++|+|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887542 23446888999999999999999999998 99999999999999999999999999997754332
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ...... +...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--~~---~~~~~~-~~~~--------- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--EI---MQQVLY-GKYD--------- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HH---HHHHHh-CCCC---------
Confidence 22234467999999999999999999999999999999999999998543211 11 111111 1000
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+......+.+++..||+.+|++||++++++.
T Consensus 290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011122346789999999999999999999864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.75 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=212.1
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe-EEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE-KILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-~~lV~ 588 (834)
++|..++++|+|+||.++..+++ +++.+|+|++.-. .....+....|+.++++++|||||.+.+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999875 4778999987543 33444577899999999999999999999999998 99999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
+|++||+|.+.+... ++..++++.+..++.||+.|+.|||+.. |+|||||+.||++..+..|||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999998553 3577899999999999999999999876 999999999999999999999999999998766
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
. .......||+.||.||++.+.+|..|+|||||||++|||++-+++|...+.... +.+... ..
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-----i~ki~~---------~~- 222 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-----ILKINR---------GL- 222 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-----HHHHhh---------cc-
Confidence 4 234457999999999999999999999999999999999999999875443221 111111 11
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
....+.....++..++..|++.+|+.||++.+++..
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 233455566788899999999999999999999874
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.52 Aligned_cols=247 Identities=26% Similarity=0.362 Sum_probs=194.0
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 56777889999999999999875 58999999986543 33456789999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|.... ...+..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986543 3456778899999999999999998 99999999999999999999999999987643221
Q ss_pred ccccceecccccccccccccC-----CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~-----~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
......||..|+|||++.. ...+.++|||||||++|||++|+.||....... ............
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~------- 292 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICMSQ------- 292 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhccC-------
Confidence 1223578999999998753 234578999999999999999999987332211 111111000000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..........++.+++.+||+.||++||++.|+++
T Consensus 293 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 ----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred ----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111123346889999999999999999999987
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=329.78 Aligned_cols=260 Identities=28% Similarity=0.428 Sum_probs=203.1
Q ss_pred hcCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEec-C
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ-G 582 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~ 582 (834)
.++|++.+.||+|+||.||+|... .++.||+|+++... ....+.+..|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 367999999999999999999642 24789999987543 22345678899999999 899999999988654 5
Q ss_pred eEEEEEeecCCCCccccccCCCC---------------------------------------------------------
Q 003280 583 EKILILEYMPNKSLDVFLFDPTK--------------------------------------------------------- 605 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 605 (834)
..+++|||+++++|..++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 68899999999999988743211
Q ss_pred -CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccceeccccccc
Q 003280 606 -KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684 (834)
Q Consensus 606 -~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~ 684 (834)
...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125789999999999999999999998 9999999999999999999999999998764433222223345677899
Q ss_pred ccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHH
Q 003280 685 SPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYIN 763 (834)
Q Consensus 685 aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~ 763 (834)
|||++.+..++.++|||||||++|||++ |+.||......+. +. ........ . ..+.....++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~----~~~~~~~~-----~-----~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FC----RRLKEGTR-----M-----RAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HH----HHHhccCC-----C-----CCCccCCHHHHH
Confidence 9999999999999999999999999998 9988864322111 11 11111100 0 001122346789
Q ss_pred HHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 764 VALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 764 li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
++.+|++.+|++||++.|+++.|+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=329.96 Aligned_cols=252 Identities=21% Similarity=0.324 Sum_probs=195.4
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.|++++.||+|+||+||+|+.. .++.||||+++... ....+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999875 47899999996542 3345678999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999998843 345888899999999999999999998 9999999999999999999999999976431100
Q ss_pred c---------------------------------------------ccccceecccccccccccccCCccCccCceeehh
Q 003280 670 L---------------------------------------------QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFG 704 (834)
Q Consensus 670 ~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlG 704 (834)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001234799999999999999999999999999
Q ss_pred hhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHh--ccccCCCCCCCHHHH
Q 003280 705 ILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALL--CVQDNAADRPTMSDV 782 (834)
Q Consensus 705 vvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~ev 782 (834)
|++|||++|+.||.......... ......... .+.. ......++.+++.+ |+..+|..||++.|+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~-----~i~~~~~~~-----~~~~---~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQL-----KVINWENTL-----HIPP---QVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHH-----HHHcccccc-----CCCC---CCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999986543221111 111000000 0000 00122356677766 556667779999999
Q ss_pred HH
Q 003280 783 VS 784 (834)
Q Consensus 783 l~ 784 (834)
++
T Consensus 303 l~ 304 (381)
T cd05626 303 KA 304 (381)
T ss_pred hc
Confidence 87
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=326.90 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=201.4
Q ss_pred cCccccceeeeecceeEEEEEEC-CCc----EEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
.+|++.+.||+|+||.||+|++. +++ .||||+++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 57999999999999999999864 333 48999987543 34467899999999999999999999998764 5789
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
|+||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999988542 345788899999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
............++..|+|||++.+..++.++|||||||++|||++ |+.|+....... +. ........ .
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~----~~~~~~~~--~-- 230 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS----SILEKGER--L-- 230 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HH----HHHhCCCC--C--
Confidence 4332222222334678999999999999999999999999999998 999876432111 11 11111100 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
........++.+++.+|++.+|++||++.+++..|...
T Consensus 231 ------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 231 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00111224578899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=323.83 Aligned_cols=200 Identities=27% Similarity=0.383 Sum_probs=174.3
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.++||+|+||.||++... .++.+|+|+++.. .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 378999999999999999999876 4788999988654 23345678999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++++|.+++. ..+.+++..+..++.+++.||.|||+.+ .|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999884 3345788999999999999999999753 39999999999999999999999999987653221
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCC
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY 720 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~ 720 (834)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 22346899999999999989999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=326.86 Aligned_cols=241 Identities=22% Similarity=0.291 Sum_probs=194.4
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCC
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+.||+|+||.||+++.. +|+.||+|+++.. .......+.+|+++++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999875 5899999998754 2234456788999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccccc
Q 003280 595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT 674 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (834)
+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 9988773 3346889999999999999999999998 9999999999999999999999999987542221 112
Q ss_pred ceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCC
Q 003280 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEIS 754 (834)
Q Consensus 675 ~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~ 754 (834)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ...... .. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~---~~~~~~-~~-----------~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LF---ELILME-EI-----------RFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--HH---HHHhcC-CC-----------CCC
Confidence 23578999999999999999999999999999999999999986433211 10 011100 00 011
Q ss_pred HHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 755 LPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 755 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 11234677899999999999998 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=294.17 Aligned_cols=248 Identities=27% Similarity=0.371 Sum_probs=206.8
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
.++|++.+.||+|.||.||.|+.+. +-.||+|++.+. ..+...++.+|+++...|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3789999999999999999998754 678999998654 233457899999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
+||.+.|.|...|... ....+++.....++.|+|.||.|+|..+ ||||||||+|+|++..+.+||+|||-+..-+
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999988532 4456788889999999999999999988 9999999999999999999999999987654
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||+....++. ++.... .++
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et------YkrI~k---~~~---- 239 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET------YKRIRK---VDL---- 239 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH------HHHHHH---ccc----
Confidence 2334568999999999999999999999999999999999999999975442211 000000 011
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.++......+.++|..|+..+|.+|.+..|++.
T Consensus 240 ----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 240 ----KFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ----cCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 111223346789999999999999999999876
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=321.44 Aligned_cols=260 Identities=28% Similarity=0.452 Sum_probs=206.5
Q ss_pred HhcCccccceeeeecceeEEEEEECC------CcEEEEEEccCc-ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecC
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG 582 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 582 (834)
..++|++.+.||+|+||.||++.... ...+|+|+++.. ......++.+|+.++.++ +|+||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 44678999999999999999998642 367999998754 233456788999999999 8999999999999999
Q ss_pred eEEEEEeecCCCCccccccCC-------------CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc
Q 003280 583 EKILILEYMPNKSLDVFLFDP-------------TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 649 (834)
..+++|||+++++|..++... .....+++..++.++.||+.||+|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999988532 23456889999999999999999999988 99999999999999
Q ss_pred CCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHh
Q 003280 650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLL 728 (834)
Q Consensus 650 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~ 728 (834)
+++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+....... +
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~- 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--L- 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--H-
Confidence 999999999999987654332222222345678999999999999999999999999999998 888875432211 1
Q ss_pred HHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 729 GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 729 ~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.......... ..+......+.+++.+|++.+|++|||+.|+++.|+.+
T Consensus 244 ---~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 ---FKLLKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111111100 01112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=324.12 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=197.5
Q ss_pred CccccceeeeecceeEEEEEEC----CCcEEEEEEccCcc----cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 584 (834)
+|++.+.||+|+||.||+++.. .++.||+|++.+.. ....+.+..|+.++.++ +||||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788999999999999999753 47899999986532 23345688899999999 599999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999998884 3346889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ..........
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~------- 225 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK------- 225 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc-------
Confidence 5432221 22245799999999999875 478999999999999999999999864332211 1111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
.++.+ +......+.+++.+||+.||++|| +++++++
T Consensus 226 ~~~~~-----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 CDPPF-----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCC-----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 01111 111234577899999999999999 6778875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=329.98 Aligned_cols=263 Identities=18% Similarity=0.200 Sum_probs=196.7
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
..+|++.++||+|+||.||++... .++.||+|+... +.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999875 488999997532 4567899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+. ++|..++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 86 67777663 2345789999999999999999999998 9999999999999999999999999997543211
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCC------cccHhHHHHhHhc------CC
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD------SFNLLGYAWDLWK------DD 738 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~------~~~l~~~~~~~~~------~~ 738 (834)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+-..... ...+......... ..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 11223357999999999999999999999999999999999999875432210 0011100000000 00
Q ss_pred ---cccccc----cccc--ccCCC----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 739 ---KFHELI----DPVI--TQDEI----SLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 739 ---~~~~li----d~~l--~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
...... .... ..... ......++.+++.+||+.||++|||++|+++ .+..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 000000 0000 00000 0123457889999999999999999999986 4544
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=318.24 Aligned_cols=265 Identities=27% Similarity=0.422 Sum_probs=206.4
Q ss_pred hcCccccceeeeecceeEEEEEECC-----------------CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcce
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVK 573 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~ 573 (834)
.++|++.++||+|+||.||+|.... +..||+|++.... ....+++.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4689999999999999999997643 2458999987653 344678999999999999999999
Q ss_pred EEeEEEecCeEEEEEeecCCCCccccccCCC--------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCc
Q 003280 574 LLGCCVEQGEKILILEYMPNKSLDVFLFDPT--------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645 (834)
Q Consensus 574 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 645 (834)
+++++......++||||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999885432 1236889999999999999999999988 9999999999
Q ss_pred EEEcCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc--CCCCCCCCCCC
Q 003280 646 VLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--GKKNTGVYNAD 723 (834)
Q Consensus 646 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt--G~~p~~~~~~~ 723 (834)
|+++.++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ +..|+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999987644332222333456788999999998899999999999999999998 556654322
Q ss_pred cccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 724 SFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 724 ~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
...........+.......... .....+.++.+++.+|++.+|++|||+.||++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLP-------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHHhccccccccccCC-------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1122222222211111111110 111123578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=312.97 Aligned_cols=260 Identities=24% Similarity=0.381 Sum_probs=208.1
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.++||+|+||.||+|+.. +++.||||.++.. .......+.+|+++++.++||||+++++++......++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999865 5899999987643 2333467899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCC-CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 589 EYMPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
||+++++|..++.... ....++...+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988874322 3345788999999999999999999998 99999999999999999999999999987644
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.|+.........+ ... ..... .+
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~---~~~-~~~~~-----~~- 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL---CQK-IEQCD-----YP- 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHH---HHH-HhcCC-----CC-
Confidence 321 1223467889999999998889999999999999999999999975432221111 111 11100 01
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
..........+.+++.+||+.+|++||+++|+++.|+..+
T Consensus 227 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 ---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1111223456889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=331.82 Aligned_cols=252 Identities=24% Similarity=0.322 Sum_probs=198.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|+.. .++.||||++.... ......+.+|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999875 48899999997532 234466889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999998843 346899999999999999999999998 999999999999999999999999998765322
Q ss_pred cccc------------------------------------ccceecccccccccccccCCccCccCceeehhhhHHHhhc
Q 003280 669 ELQG------------------------------------NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712 (834)
Q Consensus 669 ~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt 712 (834)
.... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 003280 713 GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPT---MSDVVS 784 (834)
Q Consensus 713 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 784 (834)
|+.||....... . ......... .+ .. .. .......+.+++.+|+. +|.+|++ ++|+++
T Consensus 235 G~~Pf~~~~~~~--~---~~~i~~~~~--~~---~~-~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQE--T---YRKIINWKE--TL---QF-PD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHH--H---HHHHHcCCC--cc---CC-CC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999986433211 1 111111000 00 00 00 01123456788888886 8999998 888877
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=330.05 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=203.1
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999876 58999999987542 234567899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998532 56889999999999999999999988 999999999999999999999999999876433
Q ss_pred c---------------------------cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCC
Q 003280 669 E---------------------------LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN 721 (834)
Q Consensus 669 ~---------------------------~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~ 721 (834)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012233578999999999999999999999999999999999999986543
Q ss_pred CCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 003280 722 ADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPT-MSDVVSI 785 (834)
Q Consensus 722 ~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 785 (834)
... ......... .....+ . ......++.+++..|++ +|++||+ ++|+++.
T Consensus 235 ~~~-----~~~~i~~~~--~~~~~p---~---~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQE-----TYNKIINWK--ESLRFP---P---DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH-----HHHHHhccC--CcccCC---C---CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 211 011111100 000000 0 00124567789999997 9999999 9999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=322.01 Aligned_cols=241 Identities=27% Similarity=0.358 Sum_probs=193.5
Q ss_pred ceeeeecceeEEEEEEC----CCcEEEEEEccCcc----cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 519 CKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+.||+|+||.||+++.. .++.||||+++... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999753 47899999987532 22345678899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|..++. ..+.+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999988883 3456788888999999999999999998 9999999999999999999999999987543222
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ .. .
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~-~~--------~-- 217 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILK-GK--------L-- 217 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHc-CC--------C--
Confidence 1123357899999999999989999999999999999999999998643321 11111111 10 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
..+......+.+++.+||+.+|++|| +++++++
T Consensus 218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 01111234678999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=322.37 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=193.6
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+|+.. +++.||+|++++. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 4789999998754 233445678898888776 899999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 99988773 3356889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCC---cccHhHHHHhHhcCCcccccccccccc
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD---SFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 23457899999999999999999999999999999999999998532211 11111122221111110
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPT------MSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 784 (834)
..+......+.+++.+||+.||++||+ +.++++
T Consensus 223 -~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 223 -RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 111222346779999999999999998 456654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=309.32 Aligned_cols=263 Identities=24% Similarity=0.332 Sum_probs=197.4
Q ss_pred CccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC-----eEEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-----EKILI 587 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV 587 (834)
.|+..+++|.|+||.||+|.+.. ++.||||+.-...+ .-.+|+++|++++|||||+++.+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46677899999999999998754 78999998854432 2246899999999999999999987643 34589
Q ss_pred EeecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC-CCceeeeecceeec
Q 003280 588 LEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMF 665 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~ 665 (834)
|||||. +|.+.+... ..+..++...+.-+..||.+||+|||+.+ |+||||||+|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 566666432 23456777888899999999999999988 9999999999999987 99999999999998
Q ss_pred CCCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC---Ccc-
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD---DKF- 740 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~---~~~- 740 (834)
..++.. .....|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+..... ++.. ..+.+-. +++
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d-QL~e-Iik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD-QLVE-IIKVLGTPTREDIK 251 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH-HHHH-HHHHhCCCCHHHHh
Confidence 665432 335678899999999875 69999999999999999999999887643321 1211 1111111 111
Q ss_pred ------ccccccccccCC----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 741 ------HELIDPVITQDE----ISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 741 ------~~lid~~l~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
.+.-.+.+.... .......+..+++.++++.+|.+|.++.|++. .++++
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 011112221111 22234557889999999999999999999986 45544
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.99 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=195.2
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC-----eEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-----EKI 585 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 585 (834)
+|++.++||+|+||.||+|+.. +++.||||+++.. ......++.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999875 5899999998643 2233457889999999999999999999886432 579
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+||||++ ++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 57877773 3345889999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcc-ccccceecccccccccccccC--CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhH--------
Q 003280 666 GGDEL-QGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDL-------- 734 (834)
Q Consensus 666 ~~~~~-~~~~~~~~gt~~y~aPE~l~~--~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~-------- 734 (834)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ........
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH--QLDLITDLLGTPSPET 231 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCCHHH
Confidence 33211 111233578999999999876 678999999999999999999999986543211 00000000
Q ss_pred ---hcCCccccccccccccCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 735 ---WKDDKFHELIDPVITQDEISL-----PVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 735 ---~~~~~~~~lid~~l~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.......+.+........... .....+.+++.+||+.+|++|||++|+++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000000000000000 11245779999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.64 Aligned_cols=255 Identities=28% Similarity=0.438 Sum_probs=204.5
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.+|++.++||+|+||.||+|... .++.||+|+++.. ....+++.+|++++.+++||||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 46888899999999999999875 4889999998654 334578899999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999988432 2345789999999999999999999988 999999999999999999999999999876543221
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
. .....++..|+|||.+.+..++.++|||||||++|||++ |..|+....... . ....... ....
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~----~~~~~~~-----~~~~--- 225 (263)
T cd05052 161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V----YELLEKG-----YRME--- 225 (263)
T ss_pred c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H----HHHHHCC-----CCCC---
Confidence 1 111234568999999999999999999999999999998 888875432111 1 1111111 0000
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.+...+..+.+++.+|++.+|++||++.|++++|+.+
T Consensus 226 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 --RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=343.54 Aligned_cols=256 Identities=20% Similarity=0.304 Sum_probs=204.4
Q ss_pred HHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC----
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG---- 582 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 582 (834)
...++|++.+.||+|+||+||+|+.. +++.||||++... .......+.+|+..+..++|+|++++...+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34579999999999999999999864 5899999998654 3344567889999999999999999988775432
Q ss_pred ----eEEEEEeecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceee
Q 003280 583 ----EKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS 657 (834)
Q Consensus 583 ----~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 657 (834)
..++||||+++|+|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999988543 23456889999999999999999999998 9999999999999999999999
Q ss_pred eecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC
Q 003280 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD 737 (834)
Q Consensus 658 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 737 (834)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-----~~~~~~~~- 259 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-----EVMHKTLA- 259 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHhc-
Confidence 999998765433223334467999999999999999999999999999999999999998643211 11111111
Q ss_pred CccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 DKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
... + ..+.....++.+++.+||+.+|++||++.++++
T Consensus 260 ~~~----~------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 260 GRY----D------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCC----C------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 110 0 111122346789999999999999999999976
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=318.57 Aligned_cols=264 Identities=25% Similarity=0.407 Sum_probs=201.0
Q ss_pred cCccccceeeeecceeEEEEEECC---------------CcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN---------------GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLG 576 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~---------------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 576 (834)
++|++.++||+|+||.||++.... ...||+|+++.. .....+.|.+|++++.+++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 679999999999999999987532 235899998764 2334567999999999999999999999
Q ss_pred EEEecCeEEEEEeecCCCCccccccCCC---------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEE
Q 003280 577 CCVEQGEKILILEYMPNKSLDVFLFDPT---------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVL 647 (834)
Q Consensus 577 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 647 (834)
++......++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999884321 1124678899999999999999999998 999999999999
Q ss_pred EcCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc--CCCCCCCCCCCcc
Q 003280 648 LDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--GKKNTGVYNADSF 725 (834)
Q Consensus 648 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt--G~~p~~~~~~~~~ 725 (834)
+++++.+||+|||++................++..|+|||++.++.++.++|||||||+++||++ +..||..... .
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--E 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--H
Confidence 99999999999999986543322222222345678999999999999999999999999999998 4455543221 1
Q ss_pred cHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 726 NLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 726 ~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
.........+......... ..+...+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111110000000 0011123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.98 Aligned_cols=252 Identities=30% Similarity=0.442 Sum_probs=202.4
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|++.+.||+|+||.||+|+..++..+|||.++... ...+++.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 5688899999999999999988777789999987543 345779999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+++|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999988532 236889999999999999999999998 9999999999999999999999999998764332211
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... . .......... ..
T Consensus 158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~---~~~~~~~~~~------~~--- 222 (256)
T cd05113 158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--T---VEKVSQGLRL------YR--- 222 (256)
T ss_pred -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--H---HHHHhcCCCC------CC---
Confidence 111235678999999998889999999999999999998 888876433211 1 1111111000 00
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
.......+.+++.+||+.+|++||++.++++.|+
T Consensus 223 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 --PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0112356789999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=320.13 Aligned_cols=257 Identities=31% Similarity=0.461 Sum_probs=202.6
Q ss_pred cCccccceeeeecceeEEEEEECC------CcEEEEEEccCcccc-cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
.+|++.++||+|+||.||+|.... ++.||||+++..... ..+.+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 457788999999999999998632 578999999755332 3467899999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCC-------------CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC
Q 003280 586 LILEYMPNKSLDVFLFDP-------------TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM 652 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 652 (834)
+++||+++++|..++... .....+++..+..++.|++.||+|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999887421 11235788889999999999999999998 99999999999999999
Q ss_pred CceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHH
Q 003280 653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYA 731 (834)
Q Consensus 653 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~ 731 (834)
.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..|+...... ...
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~--- 236 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVI--- 236 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH---
Confidence 999999999887643332222233456789999999998899999999999999999998 77776543211 111
Q ss_pred HhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 732 WDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 732 ~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
......... .........+.+++.+|++.+|++||+++|+++.|+.
T Consensus 237 -~~i~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 -EMIRNRQVL----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHcCCcC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111110 1111233467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.28 Aligned_cols=248 Identities=26% Similarity=0.374 Sum_probs=196.0
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCc
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999875 58899999886543 34456799999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccce
Q 003280 597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (834)
.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 998843 2345789999999999999999999998 99999999999999999999999999876543221111111
Q ss_pred ecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCH
Q 003280 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISL 755 (834)
Q Consensus 677 ~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~ 755 (834)
...+..|+|||.+.++.++.++||||||+++|||++ |..|+...... ... ...... .. .....
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~----~~~~~~-----~~-----~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTR----EAIEQG-----VR-----LPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHH----HHHHcC-----CC-----CCCcc
Confidence 223457999999999999999999999999999998 88777532211 111 111000 00 01111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 756 PVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 756 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
..+..+.+++.+|++.+|++||++.|++++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=317.62 Aligned_cols=241 Identities=26% Similarity=0.335 Sum_probs=190.0
Q ss_pred ceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+|+... ++.||||+++... ....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999998754 7889999987532 23345556677777654 899999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 99988874 3346889999999999999999999998 9999999999999999999999999998653322 22
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... + ...... . .+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--~---~~~i~~-~------~~-----~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--L---FDSILN-D------RP-----HF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--H---HHHHHc-C------CC-----CC
Confidence 334578999999999999999999999999999999999999986543211 1 111111 0 00 01
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 003280 754 SLPVLVRYINVALLCVQDNAADRPTMS-DVVS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 784 (834)
+.....++.+++.+||+.+|++||++. ++++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 111234567899999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=313.84 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=201.4
Q ss_pred ccccceeeeecceeEEEEEECC----CcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe-----
Q 003280 515 FSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE----- 583 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 583 (834)
|++.+.||+|+||.||+|.+.. +..||||+++... ....+.+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998643 3679999987542 3345689999999999999999999998876554
Q ss_pred -EEEEEeecCCCCccccccCCC---CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeee
Q 003280 584 -KILILEYMPNKSLDVFLFDPT---KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDF 659 (834)
Q Consensus 584 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 659 (834)
.++||||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999998885432 2346889999999999999999999988 999999999999999999999999
Q ss_pred cceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCC
Q 003280 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDD 738 (834)
Q Consensus 660 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 738 (834)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... .+.... ..+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~----~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYL----RHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH----HcC
Confidence 99987654332222222345678999999998899999999999999999999 88887543211 111111 111
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 739 KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 739 ~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
... ..+.....++.+++.+|++.||++||++.|+++.|+++
T Consensus 232 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 100 01112344688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.43 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=204.6
Q ss_pred cCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
++|...++||+|+||.||++... .+..+|+|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 57888899999999999999642 356799999887766667889999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCC------------CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCc
Q 003280 587 ILEYMPNKSLDVFLFDPTK------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP 654 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 654 (834)
+|||+++++|.+++..... ...+++..+..++.||+.|++|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999998854221 135789999999999999999999998 9999999999999999999
Q ss_pred eeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHh
Q 003280 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWD 733 (834)
Q Consensus 655 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~ 733 (834)
||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... . ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~---~~~ 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--A---IEC 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--H---HHH
Confidence 9999999986643322222222345678999999999999999999999999999998 888875322111 1 111
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
. ...... ..+...+..+.+++.+||+.+|++||+++||++.|+.
T Consensus 237 ~-~~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 I-TQGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred H-HcCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1 110000 0011123457799999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.44 Aligned_cols=249 Identities=28% Similarity=0.490 Sum_probs=208.9
Q ss_pred eeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCccc
Q 003280 520 KLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDV 598 (834)
Q Consensus 520 ~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 598 (834)
+||+|.||+||.|++.+ ...+|||.+.....+..+-+.+|+.+-++++|.|||+++|.+.+++..-+.||.+|||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999765 45799999988877777889999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCcC--CHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-CCCceeeeecceeecCCCccccccc
Q 003280 599 FLFDPTKKRLL--GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGGDELQGNTK 675 (834)
Q Consensus 599 ~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~ 675 (834)
++... -+++ ++..+-.+.+||++||.|||++. |||||||-+||||+- .|.+||+|||-++.+.+ ....+.
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 99543 3445 77888899999999999999998 999999999999965 58999999999998754 335667
Q ss_pred eecccccccccccccCCc--cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 676 RIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 676 ~~~gt~~y~aPE~l~~~~--~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
++.||..|||||++..++ |+.++|||||||.+.||.||++||-....... ..++.+-.. ....+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-------AMFkVGmyK-------vHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-------AMFKVGMYK-------VHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-------hhhhhccee-------cCCCC
Confidence 789999999999998764 89999999999999999999999865443221 111111110 12345
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 754 SLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
+.+...+...+|++|+..+|.+||+++++++ +|+..
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 6667788999999999999999999999987 55544
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.01 Aligned_cols=262 Identities=24% Similarity=0.371 Sum_probs=193.8
Q ss_pred cCccccceeeeecceeEEEEEEC--CCcEEEEEEccCcc--cccHHHHHHHHHHHHhh---cCCCcceEEeEEEe-----
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKL---QHRNLVKLLGCCVE----- 580 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~----- 580 (834)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 36789999886532 22334566787777766 69999999999853
Q ss_pred cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeec
Q 003280 581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 660 (834)
....++||||++ ++|..++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999997 5787777432 2345789999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhc---C
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWK---D 737 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~ 737 (834)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||....... .......... .
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGE 230 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCCh
Confidence 99876433 12234578999999999999999999999999999999999999987543211 1111100000 0
Q ss_pred Ccccc---ccccccc-cCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 DKFHE---LIDPVIT-QDE-----ISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~---lid~~l~-~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..... +...... ... ........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 0000000 000 00112345679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=329.76 Aligned_cols=251 Identities=21% Similarity=0.295 Sum_probs=193.6
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
+|+++++||+|+||.||+|+.. .++.||||++.+.. ....+.+.+|++++++++||||+++++.+.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999875 47899999987542 2345678899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++|+|..++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998843 346788889999999999999999998 9999999999999999999999999975431100
Q ss_pred ---------------------------------------------cccccceecccccccccccccCCccCccCceeehh
Q 003280 670 ---------------------------------------------LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFG 704 (834)
Q Consensus 670 ---------------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlG 704 (834)
.........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00001224689999999999999999999999999
Q ss_pred hhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC---HHH
Q 003280 705 ILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPT---MSD 781 (834)
Q Consensus 705 vvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~e 781 (834)
|++|||++|+.||........ .......... . .. ........++.+++.+++ .+|++|++ +.|
T Consensus 236 vil~elltG~~Pf~~~~~~~~-----~~~i~~~~~~--~---~~---p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLET-----QMKVINWQTS--L---HI---PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHH-----HHHHHccCCC--c---CC---CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 999999999999865432111 0111110000 0 00 000112234566777765 49999997 777
Q ss_pred HHH
Q 003280 782 VVS 784 (834)
Q Consensus 782 vl~ 784 (834)
+++
T Consensus 302 i~~ 304 (382)
T cd05625 302 IKA 304 (382)
T ss_pred Hhc
Confidence 765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=330.47 Aligned_cols=253 Identities=24% Similarity=0.294 Sum_probs=196.2
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.++||+|+||.||++... +++.||||++.+.. ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999865 58899999986532 334567889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999884 3356888899999999999999999998 999999999999999999999999999643210
Q ss_pred cc-------------c--------------------------------cccceecccccccccccccCCccCccCceeeh
Q 003280 669 EL-------------Q--------------------------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSF 703 (834)
Q Consensus 669 ~~-------------~--------------------------------~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSl 703 (834)
.. . .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 00012468999999999999999999999999
Q ss_pred hhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCC---CCHH
Q 003280 704 GILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADR---PTMS 780 (834)
Q Consensus 704 Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ 780 (834)
||++|||++|+.||....... .. ........... + .. ......++.+++.+|++ +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~--~~---~~i~~~~~~~~-----~-p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE--TY---RKIINWRETLY-----F-PD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH--HH---HHHHccCCccC-----C-CC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999986433211 10 11111000000 0 00 00123457789999997 66665 5999
Q ss_pred HHHHH
Q 003280 781 DVVSI 785 (834)
Q Consensus 781 evl~~ 785 (834)
|+++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.73 Aligned_cols=262 Identities=24% Similarity=0.299 Sum_probs=197.7
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccc--cHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQ--GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 587 (834)
+.|+.++.|++|.||.||+|+++. ++.||+|+++-..+. .--.-.+||.+|.+.+|||||.+..+..-. +.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 678999999999999999999764 788999999754322 122357899999999999999999887643 479999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
||||++ +|..++.. ....+...++..+..|+++|++|||.+. |+|||||++|+|+...|.+||+|||+|+.++.
T Consensus 156 Me~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999987 56776643 2356888899999999999999999998 99999999999999999999999999999875
Q ss_pred CccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC--------C
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD--------D 738 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~--------~ 738 (834)
.. ......+-|..|.|||.+.+. .|+++.|+||+|||+.||+++++.|....+-. .+......+-. -
T Consensus 230 p~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 230 PL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred Cc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHHHhCCCccccCCCc
Confidence 42 123346779999999999875 59999999999999999999999887654321 11111111100 0
Q ss_pred ccccccc-cccccC-------CCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 739 KFHELID-PVITQD-------EISLP-VLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 739 ~~~~lid-~~l~~~-------~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.....+. -..... .+... ....-.+|+..+|..||++|.|++|.++
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0000000 000000 00000 2245678899999999999999999987
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.61 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=195.5
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.+|++++.||+|+||.||+++.. .++.||||++.+.. ....+.+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999875 48899999986532 233567889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|.+++. +.+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999984 3446788889999999999999999998 999999999999999999999999997533100
Q ss_pred c-----------------------------------------cccccceecccccccccccccCCccCccCceeehhhhH
Q 003280 669 E-----------------------------------------LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707 (834)
Q Consensus 669 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl 707 (834)
. .........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 00001134799999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCC---CHHHHHH
Q 003280 708 LETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRP---TMSDVVS 784 (834)
Q Consensus 708 ~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~ 784 (834)
|||++|+.||.......... ....... ....+. ... ....+.+++.+|+ .+|++|+ ++.|+++
T Consensus 235 yell~G~~Pf~~~~~~~~~~-----~i~~~~~--~~~~~~--~~~----~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQL-----KVINWET--TLHIPS--QAK----LSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHHH-----HHhccCc--cccCCC--CCC----CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999986543221100 0100000 000000 011 2234566777765 4999999 8899886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.28 Aligned_cols=257 Identities=29% Similarity=0.455 Sum_probs=202.7
Q ss_pred CccccceeeeecceeEEEEEECC------CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
+|++.+.||+|+||.||+|.... ...+++|.+.... ....+++.+|+.+++.++||||+++++.+......++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999997532 3578999887543 2345678999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCC---------------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCc
Q 003280 587 ILEYMPNKSLDVFLFDPT---------------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 645 (834)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999998874321 1235788999999999999999999988 9999999999
Q ss_pred EEEcCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCc
Q 003280 646 VLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADS 724 (834)
Q Consensus 646 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~ 724 (834)
|++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.|+......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543322112222345678999999998899999999999999999998 98887543221
Q ss_pred ccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 725 FNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.+. ....... ... .......++.+++.+|++.+|++||++.|+++.|++.
T Consensus 237 -~~~----~~~~~~~-----~~~-----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 237 -RLF----NLLKTGY-----RME-----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred -HHH----HHHhCCC-----CCC-----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 111 1111110 000 0111234678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.29 Aligned_cols=241 Identities=22% Similarity=0.277 Sum_probs=193.7
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCC
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+.||+|+||.||+++.. .++.||+|+++... ......+.+|++++..++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 58899999987542 234467788999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
+|..++. ....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 9988873 34468899999999999999999997 56 9999999999999999999999999987543221 12
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ...... .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~----~i~~~~------~~-----~ 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFE----LILMEE------IR-----F 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHH----HHhcCC------CC-----C
Confidence 233579999999999999999999999999999999999999986433211 110 000000 00 1
Q ss_pred CHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 754 SLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
+.....++.+++.+||+.||++|+ ++.++++
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 111234677899999999999996 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=328.26 Aligned_cols=202 Identities=26% Similarity=0.354 Sum_probs=174.9
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||+||+++.. .++.||||++++.. ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999875 48899999997542 233467888999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|.+++. +.+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999884 3456889999999999999999999998 999999999999999999999999998765321
Q ss_pred ccc---------------------------------cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCC
Q 003280 669 ELQ---------------------------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715 (834)
Q Consensus 669 ~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~ 715 (834)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCCC
Q 003280 716 NTGVY 720 (834)
Q Consensus 716 p~~~~ 720 (834)
||...
T Consensus 235 Pf~~~ 239 (363)
T cd05628 235 PFCSE 239 (363)
T ss_pred CCCCC
Confidence 98643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=321.13 Aligned_cols=247 Identities=22% Similarity=0.344 Sum_probs=195.0
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+++.. +++.||||++++. .....+.+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999875 4889999999754 233456688899999988 799999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
|+|..++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 99988773 3356899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCc---ccHhHHHHhHhcCCcccccccccccc
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS---FNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------
Confidence 234578999999999999999999999999999999999999986432211 1111112221111110
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPT------MSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 784 (834)
..+......+.+++.+||+.||++||+ ++++++
T Consensus 223 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 -RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 111122346788999999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.33 Aligned_cols=252 Identities=20% Similarity=0.312 Sum_probs=200.3
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999875 58899999997542 234567889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999988432 246889999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccceeccccccccccccc------CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYAL------DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~------~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .............
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~i~~~~~~~~ 229 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-----TYNNIMNFQRFLK 229 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-----HHHHHHcCCCccC
Confidence 221 222347899999999986 4567899999999999999999999986432211 1111111111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. .........+.+++..|++ +|++||+++++++
T Consensus 230 ~--------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 F--------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C--------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 0011123457788999998 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.71 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=200.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCc----EEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
++|++.+.||+|+||.||+|... +++ .+++|++.... .....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 57888999999999999999864 344 47888876443 233467888999999999999999999875 456789
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
++||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999853 2346889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
............++..|+|||++.++.++.++||||||+++|||++ |+.|+...... .+. +....+... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~----~~~~~~~~~--~~ 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVP----DLLEKGERL--AQ 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHHCCCcC--CC
Confidence 4332222333567789999999999999999999999999999998 99887543211 111 111111100 01
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
+.. ....+.+++.+|++.+|++|||+.|+++.|...
T Consensus 233 ~~~--------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 233 PQI--------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred CCC--------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 100 123567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.12 Aligned_cols=251 Identities=29% Similarity=0.439 Sum_probs=201.1
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
.+|++.+.||+|+||.||+|....+..+|+|++.... ...+.+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4688889999999999999998777789999986432 234678899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+++|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999988532 236889999999999999999999998 9999999999999999999999999998764322111
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ... ... ....
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~---~~~-~~~-----~~~~---- 221 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVV---ESV-SAG-----YRLY---- 221 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHH---HHH-HcC-----CcCC----
Confidence 111233457999999999999999999999999999999 78887643221 111 111 110 0000
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 786 (834)
.+...+..+.+++.+|++.+|++|||+.|+++.|
T Consensus 222 -~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 -RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1111344688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.61 Aligned_cols=271 Identities=25% Similarity=0.403 Sum_probs=201.9
Q ss_pred cCccccceeeeecceeEEEEEEC-----CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 585 (834)
++|++.+.||+|+||.||++... .++.||+|+++.......+.+.+|++++.+++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57889999999999999999742 4789999999877666678899999999999999999999987543 4688
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998432 345889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccc-cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHh-HhcCCccccc
Q 003280 666 GGDELQGN-TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWD-LWKDDKFHEL 743 (834)
Q Consensus 666 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~-~~~~~~~~~l 743 (834)
........ .....++..|+|||++.+..++.++|||||||+++||++|..++................ ........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 43321111 111223456999999999899999999999999999999877643221110000000000 0000000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
+.... ..........++.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNG-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000 0001111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.77 Aligned_cols=261 Identities=25% Similarity=0.399 Sum_probs=207.3
Q ss_pred HhcCccccceeeeecceeEEEEEECC-----CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEe-cCe
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE-QGE 583 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~-----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 583 (834)
..++|++.+.||+|+||.||+|...+ ++.|++|+++... ....+.+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35789999999999999999998765 6889999987543 3345678899999999999999999998776 467
Q ss_pred EEEEEeecCCCCccccccCCCCC-----CcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKK-----RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISD 658 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 658 (834)
.++++||+++++|..++...... ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999988543222 56889999999999999999999988 99999999999999999999999
Q ss_pred ecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcC
Q 003280 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKD 737 (834)
Q Consensus 659 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 737 (834)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..+..+ ...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~----~~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAY----LKD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHH----HHc
Confidence 999987644332222222345678999999998899999999999999999999 9998754321 111111 111
Q ss_pred CccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 738 DKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 738 ~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
+.. + ......+..+.+++.+|++.+|++|||+.|+++.|+.+.
T Consensus 235 ~~~-------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 GYR-------L---AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CCC-------C---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 100 0 001112346789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=315.87 Aligned_cols=258 Identities=28% Similarity=0.450 Sum_probs=202.3
Q ss_pred HhcCccccceeeeecceeEEEEEECC------CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 583 (834)
..++|.+.+.||+|++|.||+|.+.. +..||+|.+.... ......|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34779999999999999999998753 5679999886543 3344678999999999999999999999999999
Q ss_pred EEEEEeecCCCCccccccCCCC----CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC---Ccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTK----KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM---NPKI 656 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 656 (834)
.++||||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999998854321 235889999999999999999999998 99999999999998765 5999
Q ss_pred eeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHh
Q 003280 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||...... .+... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~---~~ 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEF---VT 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH---HH
Confidence 99999987643322221222233568999999999999999999999999999997 88887643221 11111 11
Q ss_pred cCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
.... ...+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 236 ~~~~-----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGR-----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCc-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1100 0011112346789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=328.88 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=199.8
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
..++|++.+.||+|+||.||+++.. .++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3478999999999999999999875 4889999998643 22334567889999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++|+|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998842 34788888999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccceecccccccccccccCC----ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~----~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .............
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----~~~~i~~~~~~~~ 267 (370)
T cd05596 194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-----TYSKIMDHKNSLT 267 (370)
T ss_pred CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-----HHHHHHcCCCcCC
Confidence 33211 12335799999999998653 47899999999999999999999986433211 0111111100000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHH
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAAD--RPTMSDVVS 784 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 784 (834)
. .........+.+++.+||+.+|++ ||++.|+++
T Consensus 268 -----~---~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 268 -----F---PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred -----C---CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 0 001112356788999999999987 999999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=310.72 Aligned_cols=255 Identities=29% Similarity=0.448 Sum_probs=203.3
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|++.++||+|+||.||+|+..++..||+|+++... ...+++.+|+.++.+++||||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 36799999999999999999988777789999997532 34567899999999999999999999875 45689999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++.+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998542 2345789999999999999999999988 999999999999999999999999999876443221
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
......++..|+|||++.+..++.++||||||+++|||++ |+.||....... .. ....... .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~----~~~~~~~----------~ 221 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VL----DQVERGY----------R 221 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HH----HHHhcCC----------C
Confidence 1122345678999999999999999999999999999999 777775432111 11 1111000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.....+.+..+.+++.+|++.+|++||++++++++|++.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011223345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=322.39 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=193.0
Q ss_pred ccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHH---HhhcCCCcceEEeEEEecCeEEEE
Q 003280 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLI---AKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
|++.+.||+|+||.||+|... +++.||||++++.. ....+.+..|++++ ..++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999875 48899999997542 23345667776655 456799999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988773 346899999999999999999999998 99999999999999999999999999875422
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||....... . ....... . .
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--~---~~~i~~~-~------~- 218 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--V---FDSIVND-E------V- 218 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--H---HHHHHhC-C------C-
Confidence 21 12234678999999999999999999999999999999999999986433211 1 1111110 0 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
..+......+.+++.+||+.||++|| ++.++++
T Consensus 219 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 01111234577899999999999999 5666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=310.24 Aligned_cols=253 Identities=31% Similarity=0.478 Sum_probs=202.5
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|++.++||+|+||.||+|....+..+|+|.++.... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 67899999999999999999988888999999976433 3467999999999999999999999875 456899999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+++|.+++... ....+++..+..++.+++.||+|||+.+ ++||||||+||++++++.++|+|||++..+......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 99999988542 2345789999999999999999999998 999999999999999999999999999876443211
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
......++..|+|||.+.+..++.++|+||||+++|||++ |+.||...... .... ...... . .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~---~~~~~~------~-----~ 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLE---QVERGY------R-----M 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHH---HHHcCC------C-----C
Confidence 1112245668999999998899999999999999999999 88887543211 1111 111100 0 0
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
..+......+.+++.+|++.+|++|||+.++++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.00 Aligned_cols=264 Identities=26% Similarity=0.434 Sum_probs=201.9
Q ss_pred cCccccceeeeecceeEEEEEEC-----------------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-----------------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKL 574 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-----------------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l 574 (834)
++|++.++||+|+||.||++... +...+|+|+++... ....+.+.+|+.++..++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998532 23468999997643 3345789999999999999999999
Q ss_pred EeEEEecCeEEEEEeecCCCCccccccCCC--------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcE
Q 003280 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPT--------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNV 646 (834)
Q Consensus 575 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 646 (834)
++++......++||||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999999885422 1234778889999999999999999998 99999999999
Q ss_pred EEcCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc--CCCCCCCCCCCc
Q 003280 647 LLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--GKKNTGVYNADS 724 (834)
Q Consensus 647 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt--G~~p~~~~~~~~ 724 (834)
++++++.++|+|||+++.+.............++..|+|||....+.++.++|||||||++|||++ |..|+......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 999999999999999986643322222222344678999999988899999999999999999998 56666433221
Q ss_pred ccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 725 FNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
.........+......... + .+......+.+++.+||+.||++||++.||++.|++
T Consensus 241 -~~~~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 -QVIENTGEFFRDQGRQVYL-P------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -HHHHHHHHHHhhccccccC-C------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111111000000 0 011123567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=310.46 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=201.4
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++.+++||||+++++.+......++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 57999999999999999999874 58899999997655555667889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 9999998884 2346789999999999999999999988 99999999999999999999999999987643221
Q ss_pred cccceeccccccccccccc---CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~---~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
......++..|+|||.+. ...++.++|||||||++|||++|+.|+.......... ...... ...+..
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~~~~~---~~~~~~ 231 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMSKSN---FQPPKL 231 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------eeecCC---CCCCCC
Confidence 122346888999999884 4457889999999999999999999874322111000 000000 000000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 786 (834)
.........+.+++.+||+.+|++||+++++++.|
T Consensus 232 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 ---KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ---ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 01112345778999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=311.80 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=205.5
Q ss_pred hcCccccceeeeecceeEEEEEECC------CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3688999999999999999998643 3689999986543 23356788999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCC-------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceee
Q 003280 585 ILILEYMPNKSLDVFLFDPT-------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS 657 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 657 (834)
++||||+++++|..++.... ....+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999885422 1234788899999999999999999988 9999999999999999999999
Q ss_pred eecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhc
Q 003280 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWK 736 (834)
Q Consensus 658 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 736 (834)
|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.|+...... .... ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~----~~~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLK----FVI 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHH----HHh
Confidence 9999987654332222233456789999999998899999999999999999998 88887543221 1111 111
Q ss_pred CCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 737 DDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 737 ~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
...... .+......+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 236 ~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGHLD----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111100 111124578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.84 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=208.8
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999886 6899999988642 2333578999999999999999999999999999999999
Q ss_pred eecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 589 EYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
||+++++|..++... .....+++..+..++.++++||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999888542 23456889999999999999999999998 99999999999999999999999999887643
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
... ......++..|+|||.+.+..++.++|||||||++|||++|+.|+...... ...... ........
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~-~~~~~~~~------ 226 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCK-KIEKCDYP------ 226 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHHh-hhhcCCCC------
Confidence 321 122346788999999999989999999999999999999999997533211 111111 11111000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..........+.+++.+|++.+|++||++.+|+++|++.
T Consensus 227 ---~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 227 ---PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 001112344678999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.55 Aligned_cols=238 Identities=28% Similarity=0.320 Sum_probs=191.4
Q ss_pred ceeeeecceeEEEEEE----CCCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 519 CKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~----~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
+.||+|+||.||+++. ..|+.||+|+++... ......+..|++++.+++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6899999999999875 247899999997542 2234567889999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+++|.+++. +...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 999988884 3446899999999999999999999998 9999999999999999999999999998654321 1
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~ 752 (834)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ...... . . .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~---~~i~~~-~--------~---~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETM---TMILKA-K--------L---G 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHH---HHHHcC-C--------C---C
Confidence 223457899999999999989999999999999999999999998643211 111 111110 0 0 0
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 003280 753 ISLPVLVRYINVALLCVQDNAADRPTMSD 781 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e 781 (834)
.+......+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11112346778999999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=318.54 Aligned_cols=259 Identities=28% Similarity=0.432 Sum_probs=205.3
Q ss_pred hcCccccceeeeecceeEEEEEEC--------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ 581 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 581 (834)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+++.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 477889999999999999999741 24579999987542 34457889999999999 899999999999999
Q ss_pred CeEEEEEeecCCCCccccccCCC-------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE
Q 003280 582 GEKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 648 (834)
...++||||+++++|.+++.... ....+++..+..++.||++||+|||+++ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 99999999999999999985432 1235788889999999999999999998 9999999999999
Q ss_pred cCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccH
Q 003280 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l 727 (834)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+......
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---- 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 246 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----
Confidence 9999999999999987754332222223345678999999999899999999999999999998 77776433211
Q ss_pred hHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 728 LGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
... ......... .........+.+++.+||+.+|++||++.|+++.|+++
T Consensus 247 -~~~-~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 247 -ELF-KLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred -HHH-HHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 111 111111100 00112235678899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=319.47 Aligned_cols=241 Identities=23% Similarity=0.338 Sum_probs=193.4
Q ss_pred ceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+|+... ++.||||+++... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 479999999999998754 7899999987542 33445677888888876 799999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 99988874 3346889999999999999999999998 9999999999999999999999999987643222 12
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ....... .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~---~~i~~~~----~~--------~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--LF---ESILHDD----VL--------Y 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--HH---HHHHcCC----CC--------C
Confidence 233578999999999999999999999999999999999999986543211 11 1111110 00 0
Q ss_pred CHHHHHHHHHHHHhccccCCCCCC-------CHHHHHH
Q 003280 754 SLPVLVRYINVALLCVQDNAADRP-------TMSDVVS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~ 784 (834)
+.....++.+++..||+.+|++|| +++++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 111234678899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=312.39 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=198.2
Q ss_pred ccccceeeeecceeEEEEEECCC-c--EEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEec------Ce
Q 003280 515 FSMQCKLGEGGFGPVYKGRLLNG-Q--EVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------GE 583 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~~g-~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~ 583 (834)
|.+.++||+|+||.||+|..... + .+|+|.++.. .....+.+..|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999987543 2 6899988654 344467889999999999999999999987532 24
Q ss_pred EEEEEeecCCCCccccccCC---CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeec
Q 003280 584 KILILEYMPNKSLDVFLFDP---TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 660 (834)
.+++|||+++|+|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999998887422 12345889999999999999999999987 9999999999999999999999999
Q ss_pred ceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCc
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDK 739 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 739 (834)
+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+. .....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~----~~~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIY----DYLRQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH----HHHHcCC
Confidence 9987644322111222345678999999999999999999999999999999 7888754221 1111 1111111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 740 FHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 740 ~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
... ........+.+++.+||+.+|++|||+.|+++.|+..
T Consensus 232 ~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 0111234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=320.53 Aligned_cols=241 Identities=24% Similarity=0.328 Sum_probs=192.6
Q ss_pred CccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCC-CcceEEeEEEecCeEEEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHR-NLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~ 588 (834)
+|++.+.||+|+||.||+|+... ++.||||++++. .....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 57889999999999999998764 778999998753 233456788899999999765 5888999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999988884 3345788999999999999999999998 999999999999999999999999998753221
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ... ... .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~---~i~-~~~------~-- 218 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQ---SIM-EHN------V-- 218 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHH---HHH-cCC------C--
Confidence 1 1223457899999999999999999999999999999999999998643321 1111 111 100 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTM 779 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 779 (834)
..+.....++.+++.+||+.+|++||+.
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 ---SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0111123467789999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=312.00 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=195.5
Q ss_pred eeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCc
Q 003280 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
||+|+||+||++... +++.||+|++.... ....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 58899999986532 22345678899999999999999999999999999999999999999
Q ss_pred cccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccc
Q 003280 597 DVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675 (834)
Q Consensus 597 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 675 (834)
..++... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 8877532 23456899999999999999999999998 99999999999999999999999999987644322 123
Q ss_pred eecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCH
Q 003280 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISL 755 (834)
Q Consensus 676 ~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~ 755 (834)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....... ...... ....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~---------~~~~~~---~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQR---------ILNDSV---TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHh---------hcccCC---CCcc
Confidence 35789999999999999999999999999999999999999865332111 0000000 001100 1112
Q ss_pred HHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 756 PVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 756 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
.....+.+++.+||+.||++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2345678999999999999999 6777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=325.57 Aligned_cols=255 Identities=21% Similarity=0.257 Sum_probs=198.3
Q ss_pred HHhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
...++|++.+.||+|+||.||+++... ++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 345789999999999999999998764 789999998643 2223456889999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++..+
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999998832 34788899999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccceecccccccccccccCC----ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccc
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH 741 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (834)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .............
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-----~~~~~i~~~~~~~ 266 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-----GTYSKIMDHKNSL 266 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCccc
Confidence 43221 122345799999999999754 3789999999999999999999998643221 1111111110000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003280 742 ELIDPVITQDEISLPVLVRYINVALLCVQDNAAD--RPTMSDVVSI 785 (834)
Q Consensus 742 ~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 785 (834)
. + .........+.+++..|++.++.+ ||++.|+++.
T Consensus 267 ~-----~---p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 N-----F---PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred C-----C---CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 0 001112345678888899855543 8899999884
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.19 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=201.7
Q ss_pred cCccccceeeeecceeEEEEEECC-Cc--EEEEEEccCc-ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 587 (834)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998754 33 4789988753 334456789999999999 799999999999999999999
Q ss_pred EeecCCCCccccccCCC-------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCc
Q 003280 588 LEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP 654 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 654 (834)
|||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999885421 1235888999999999999999999988 9999999999999999999
Q ss_pred eeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHh
Q 003280 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWD 733 (834)
Q Consensus 655 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~ 733 (834)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||....... +. .
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~~----~ 229 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LY----E 229 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HH----H
Confidence 999999986432111 1111223557999999999899999999999999999997 999885432211 11 1
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccC
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLEL 793 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 793 (834)
....+ ... ..+......+.+++.+|++.+|.+||+++++++.|+......
T Consensus 230 ~~~~~-----~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 KLPQG-----YRM-----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHhcC-----CCC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111 000 011112346789999999999999999999999988774333
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=319.43 Aligned_cols=236 Identities=26% Similarity=0.355 Sum_probs=189.8
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 4789999998753 233456677888888876 699999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 99988874 3346889999999999999999999998 9999999999999999999999999987643221 12
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. .... .... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~---~~i~-~~~~-----------~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--LF---EAIL-NDEV-----------VY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HH---HHHh-cCCC-----------CC
Confidence 234578999999999999999999999999999999999999986433211 11 1111 1100 01
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCH
Q 003280 754 SLPVLVRYINVALLCVQDNAADRPTM 779 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPs~ 779 (834)
+.....++.+++.+||+.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 11123467899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=316.61 Aligned_cols=260 Identities=26% Similarity=0.429 Sum_probs=203.2
Q ss_pred HhcCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 583 (834)
..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 24579999986543 2234568899999999999999999999999999
Q ss_pred EEEEEeecCCCCccccccCCC-------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCcee
Q 003280 584 KILILEYMPNKSLDVFLFDPT-------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 656 (834)
.++||||+++|+|.+++.... ....+.+..+..++.|++.||+|||+++ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999985421 1234567788999999999999999998 999999999999999999999
Q ss_pred eeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHh
Q 003280 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... .... ...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~---~~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLK---FVM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH---HHH
Confidence 99999986543322222222345678999999999999999999999999999998 67777532211 1111 111
Q ss_pred cCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
...... .+......+.+++.+|++.+|++|||+.++++.|++.
T Consensus 236 -~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 236 -DGGYLD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -cCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111100 0111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.92 Aligned_cols=259 Identities=29% Similarity=0.439 Sum_probs=203.8
Q ss_pred cCccccceeeeecceeEEEEEEC--------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG 582 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 582 (834)
++|.+.+.||+|+||.||+++.. ....+|+|.++... .....++.+|+.++.++ +||||+++++++....
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 67999999999999999999752 23579999997542 33456788999999999 7999999999999999
Q ss_pred eEEEEEeecCCCCccccccCCC-------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc
Q 003280 583 EKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 649 (834)
..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 9999999999999999985432 1235888999999999999999999988 99999999999999
Q ss_pred CCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHh
Q 003280 650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLL 728 (834)
Q Consensus 650 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~ 728 (834)
.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.|+...... .+.
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--~~~ 252 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--ELF 252 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHH
Confidence 999999999999986643222111222234568999999999999999999999999999998 88887533211 111
Q ss_pred HHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 729 GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 729 ~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
......... ..+.....++.+++.+|++.+|++||++.|+++.|+.+.
T Consensus 253 ----~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 253 ----KLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred ----HHHHcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 111111100 111122346788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=328.20 Aligned_cols=260 Identities=27% Similarity=0.393 Sum_probs=203.4
Q ss_pred hcCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 583 (834)
.++|.+.++||+|+||.||+|++. .++.||||+++... ....+.+.+|++++.++. ||||+++++++.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 356888899999999999999863 24689999997643 233457899999999997 9999999999999999
Q ss_pred EEEEEeecCCCCccccccCCC-----------------------------------------------------------
Q 003280 584 KILILEYMPNKSLDVFLFDPT----------------------------------------------------------- 604 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 604 (834)
.++||||+++|+|.++++...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999885421
Q ss_pred ------------------------------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE
Q 003280 605 ------------------------------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648 (834)
Q Consensus 605 ------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 648 (834)
....+++..+..++.||+.||+|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 1124667788899999999999999987 9999999999999
Q ss_pred cCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccH
Q 003280 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l 727 (834)
++++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.|+........ +
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-F 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-H
Confidence 9999999999999987543221111222356788999999999899999999999999999998 8888754332111 1
Q ss_pred hHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 728 LGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
......+. .. ..+.....++.+++.+|++.+|++||+++||++.|+..
T Consensus 352 ----~~~~~~~~-----~~-----~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 352 ----YNAIKRGY-----RM-----AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ----HHHHHcCC-----CC-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111110 00 01111235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=308.56 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=207.3
Q ss_pred cCccccceeeeecceeEEEEEE-CCCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|++|.||++.. .+++.+|||.+... .....+++.+|+.+++.++||||+++++++.+....+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999986 46899999988653 2233467899999999999999999999999999999999
Q ss_pred eecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 589 EYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
||+++++|.+++... .....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999887532 23456889999999999999999999998 99999999999999999999999999887643
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
... ......++..|+|||++.+..++.++|+||||+++|||++|..|+.....+...... . +.....+.
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~------~~~~~~~~ 227 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---K------IEQCDYPP 227 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh---h------hhcCCCCC
Confidence 321 122346888999999999989999999999999999999999997543222111110 0 01111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
. ........+.+++.+|++.+|++||||.+|++++++.
T Consensus 228 ~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 L----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 1112345688999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=316.43 Aligned_cols=259 Identities=29% Similarity=0.430 Sum_probs=204.6
Q ss_pred hcCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 583 (834)
.++|++.+.||+|+||.||++... .+..||||+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 367999999999999999999742 24579999987653 33356789999999999 79999999999999999
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.++||||+++++|.+++.... ...+++..+..++.||+.||+|||+++ |+|+||||+||+++.++.++|+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999885422 234899999999999999999999988 9999999999999999999999999998
Q ss_pred ecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.|+........ + ......+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~----~~~~~~~~--- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-F----YKLIKEGY--- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-H----HHHHHcCC---
Confidence 6643321111222345778999999999999999999999999999998 8888754332110 1 01111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.. ........++.+++.+|++.+|++||++.|+++.|+..
T Consensus 262 --~~-----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 --RM-----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --cC-----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 00111234688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=314.17 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=201.9
Q ss_pred cCccccceeeeecceeEEEEEE-----CCCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEK 584 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 584 (834)
+.|++.+.||+|+||.||+++. ..++.||+|.++... ....+.+.+|+.++++++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578889999999999999974 247789999987553 34456899999999999999999999998875 568
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+++++|..++... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999988432 235789999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCC----------cccHhHHHHh
Q 003280 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD----------SFNLLGYAWD 733 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~----------~~~l~~~~~~ 733 (834)
+...... .......++..|+|||++.+..++.++||||||+++|||++++.|....... ..... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 237 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT-RLVR 237 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH-HHHH
Confidence 6443211 1122345677899999999889999999999999999999987654221100 00000 0001
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
....... ..........+.+++.+|++.+|++||+++++++.|+.+
T Consensus 238 ~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKR----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCcc----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111100 001111345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=303.78 Aligned_cols=273 Identities=22% Similarity=0.284 Sum_probs=217.3
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++++.||.|.-|+||++++.. +..+|+|++.+.. .....+...|-+||+.++||.++.|++.++.+...+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 578888999999999999999875 5889999997753 444567788999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC-
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG- 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~- 667 (834)
|||+||+|..+++. +..+.++++.+..++..++-||+|||-.| ||.|||||+||||.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999987754 46678999999999999999999999999 99999999999999999999999998764311
Q ss_pred --------------------------------Ccc---------------------ccccceecccccccccccccCCcc
Q 003280 668 --------------------------------DEL---------------------QGNTKRIVGTYGYMSPEYALDGLF 694 (834)
Q Consensus 668 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~l~~~~~ 694 (834)
... ......++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 011223579999999999999999
Q ss_pred CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCC
Q 003280 695 SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAA 774 (834)
Q Consensus 695 t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~ 774 (834)
+.++|.|+|||+||||+.|+.||...+.++ .+..++-..+.-.. ....+..+.+||...|..||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~--------------Tl~NIv~~~l~Fp~-~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--------------TLRNIVGQPLKFPE-EPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh--------------hHHHHhcCCCcCCC-CCcchhHHHHHHHHHhccChh
Confidence 999999999999999999999997655432 11222222221111 114456788999999999999
Q ss_pred CCCC----HHHHHH--HHhccc----ccCCCCCCCccccc
Q 003280 775 DRPT----MSDVVS--IINSER----LELPSPKEPAFIKG 804 (834)
Q Consensus 775 ~RPs----~~evl~--~L~~~~----~~~~~p~~p~~~~~ 804 (834)
+|.. +.||-+ ++++.. .-..+|..|...+.
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG 417 (459)
T ss_pred hhhccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence 9998 888865 444432 22455555766655
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=308.30 Aligned_cols=254 Identities=31% Similarity=0.451 Sum_probs=203.8
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 46789999999999999999998889999999987543 34568899999999999999999999864 45789999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999987543 2346889999999999999999999988 999999999999999999999999999876532221
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
. .....++..|+|||++....++.++||||||+++|||++ |+.||...... .... . ...... .
T Consensus 159 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~---~-~~~~~~-----~---- 222 (260)
T cd05067 159 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQ---N-LERGYR-----M---- 222 (260)
T ss_pred c-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHH---H-HHcCCC-----C----
Confidence 1 112345678999999999999999999999999999999 99998643211 1111 1 111100 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
........++.+++.+|++.+|++||++++++++|+.
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 -PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0111123468899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.80 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=198.3
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.++||+|+||.||+|... +++.||+|++... ......++.+|+.++++++||||+++++++......++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46788899999999999999864 5889999998654 233456789999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999986543 3678888999999999999999998 9999999999999999999999999998654321
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhH-HHHhHhcCCccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG-YAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~-~~~~~~~~~~~~~lid~~l~ 749 (834)
.....++..|+|||++.+..++.++||||||+++|||++|+.||............ .......... .+.+.
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 221 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLP 221 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCC
Confidence 22357899999999999999999999999999999999999998643322111100 0000100000 01110
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
. .....++.+++.+|++.+|++||+++|+++.
T Consensus 222 ~----~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 V----GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred C----CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1 1123467899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=300.68 Aligned_cols=265 Identities=25% Similarity=0.320 Sum_probs=200.0
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccc--cHHHHHHHHHHHHhhcCCC-cceEEeEEEecC------
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ--GLEEFKNEMMLIAKLQHRN-LVKLLGCCVEQG------ 582 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~------ 582 (834)
..|...++||+|+||+||+|+.. .|+.||+|+++...++ .-....+|+.++++++|+| |+.+.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45667789999999999999865 5889999999765432 3345688999999999999 999999999877
Q ss_pred eEEEEEeecCCCCccccccCCCCC-CcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecc
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKK-RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 661 (834)
..++|+||+.. +|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 78999999954 677777443221 35667889999999999999999998 99999999999999999999999999
Q ss_pred eeecCCCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC--
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD-- 738 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-- 738 (834)
|+.+.-.. ......++|..|.|||++.+. .|+...||||+|||++||++++.-|....+. +........+...
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHHHHHHHHcCCCCc
Confidence 99764222 113345789999999999887 6999999999999999999999888765542 2222222221111
Q ss_pred -cc---cccccccc--ccC----CCCHHH---HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 739 -KF---HELIDPVI--TQD----EISLPV---LVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 739 -~~---~~lid~~l--~~~----~~~~~~---~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
.. ..+.+... ... ...... ..+..+++.+||+.+|.+|.|++.+++.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00 11111110 000 001111 1367899999999999999999999986
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=314.86 Aligned_cols=258 Identities=27% Similarity=0.451 Sum_probs=203.7
Q ss_pred hcCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+|... .+..||+|+++... .....++.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999863 36789999987643 33456799999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCC-------------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCc
Q 003280 585 ILILEYMPNKSLDVFLFDPT-------------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 645 (834)
++||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 1234788889999999999999999998 9999999999
Q ss_pred EEEcCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCc
Q 003280 646 VLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADS 724 (834)
Q Consensus 646 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~ 724 (834)
|++++++.++|+|||++..+..............+..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999986543322222222344678999999999999999999999999999997 77776432211
Q ss_pred ccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 725 FNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
.. .. ......... .+.....++.+++.+|++.+|++|||+.|+++.|+.
T Consensus 240 -~~---~~-~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -EV---IY-YVRDGNVLS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -HH---HH-HHhcCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 11 111111100 011123568899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=318.99 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=195.1
Q ss_pred CccccceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
+|++.+.||+|+||.||+|+... ++.||||++++.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 57888999999999999998764 7799999987542 22345567788888777 5899999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999988874 3345889999999999999999999998 999999999999999999999999999764322
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ... ... .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~---~i~-~~~--------~ 218 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQ---SIM-EHN--------V 218 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHH---HHH-hCC--------C
Confidence 1 1223457899999999999999999999999999999999999998653321 1111 111 110 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTM-----SDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 784 (834)
..+.....++.+++.+|++.+|++|++. .++.+
T Consensus 219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 0111223467889999999999999984 56543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.36 Aligned_cols=251 Identities=26% Similarity=0.317 Sum_probs=200.1
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.|++.++||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999875 58899999986532 2223567889999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999998887542 2345889999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ............
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~~~~~~~~~----------- 220 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREEVERRVKED----------- 220 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHHHHHHhhhc-----------
Confidence 1 123468999999999999999999999999999999999999987533211 000000000000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
...........+.+++..|++.||++|| +++++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0111222345678999999999999999 7888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=312.09 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=201.2
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCc----EEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
.++|++.++||+|+||+||+|+.. +++ .||+|+++... ....+++.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 367899999999999999999853 344 48999987543 3345678999999999999999999999875 4578
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+++||+++|+|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999988532 346889999999999999999999998 999999999999999999999999999877
Q ss_pred CCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
.............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... .+.. ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~----~~~~~~~~--- 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPD----LLEKGERL--- 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH----HHHCCCcC---
Confidence 54322111222244678999999999999999999999999999998 88887533211 1111 11111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
........++.+++.+||+.||++||++.|+++.|+..
T Consensus 231 -------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 231 -------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred -------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 00111234678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.57 Aligned_cols=240 Identities=25% Similarity=0.328 Sum_probs=190.4
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+|+.. .++.||+|+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999876 48899999987542 23345667788888765 899999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999888743 345788999999999999999999998 9999999999999999999999999987532111 12
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.. ..... .+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~----~~~~~------~~~~----- 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFE----SIRVD------TPHY----- 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHH----HHHhC------CCCC-----
Confidence 23467899999999999999999999999999999999999998643321 1111 11100 0111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 003280 754 SLPVLVRYINVALLCVQDNAADRPTMS-DVV 783 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 783 (834)
+.....++.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111234677899999999999999985 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=302.82 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=203.3
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|++|.||+|... +++.|++|.+... .....+++.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999875 5889999998643 334567889999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999988643 2356889999999999999999999988 99999999999999999999999999987654322
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
. .....+++.|+|||++.+..++.++|+||||++++||++|+.||...... .. ..... .+..
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~---~~~~~-~~~~---------- 218 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--AL---ILKII-RGVF---------- 218 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HH---HHHHH-cCCC----------
Confidence 1 22346788999999999999999999999999999999999998644311 11 11111 1111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..........+.+++.+|++.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 0111123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=308.24 Aligned_cols=246 Identities=28% Similarity=0.412 Sum_probs=194.6
Q ss_pred eeeeecceeEEEEEEC---CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCC
Q 003280 520 KLGEGGFGPVYKGRLL---NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 520 ~LG~G~~G~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+||+|+||.||+|.+. +++.+|+|+++... ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999653 47889999986543 234578999999999999999999999875 45678999999999
Q ss_pred CccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc-c
Q 003280 595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG-N 673 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~ 673 (834)
+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||.||+++.++.+||+|||+++......... .
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999884 3346889999999999999999999998 9999999999999999999999999998764432211 1
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~ 752 (834)
.....++..|+|||.+....++.++|+|||||++|||++ |+.||...... .+.. ....+... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~----~i~~~~~~----------~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQ----MIESGERM----------E 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHCCCCC----------C
Confidence 112234578999999988889999999999999999998 99998643221 1111 11111100 0
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 753 ISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
.+.....++.+++.+|++.+|++||++.+|.+.|++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111223567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=312.40 Aligned_cols=271 Identities=28% Similarity=0.404 Sum_probs=204.7
Q ss_pred cCccccceeeeecceeEEEEEEC-----CCcEEEEEEccCcccc-cHHHHHHHHHHHHhhcCCCcceEEeEEEe--cCeE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVE--QGEK 584 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 584 (834)
++|++.+.||+|+||.||+|.+. .++.||||+++..... ..+.|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 56788899999999999999864 3678999999765443 56789999999999999999999999887 5578
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998532 235889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
....... .......++..|+|||.+.+..++.++||||||++++||++|+.|+........................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 7532211 111122445679999999988999999999999999999999988654322211100000000000000001
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
+.... ..........++.+++.+|++.+|++||++.||+++|+.+
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGE-RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCC-cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11000 0001112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.27 Aligned_cols=242 Identities=24% Similarity=0.358 Sum_probs=191.6
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+++.. +++.||+|++++.. ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 47899999997642 23456688899999888 699999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
++|..++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 99988773 3346899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCc-ccHhHHHHhHhcCCccccccccccccCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS-FNLLGYAWDLWKDDKFHELIDPVITQDE 752 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~lid~~l~~~~ 752 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ................ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------~ 221 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-----------R 221 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-----------C
Confidence 234578999999999999999999999999999999999999996433221 1111122222111100 1
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCH
Q 003280 753 ISLPVLVRYINVALLCVQDNAADRPTM 779 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPs~ 779 (834)
.+......+.+++.+||+.||++||++
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 111123456789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=309.40 Aligned_cols=256 Identities=28% Similarity=0.461 Sum_probs=201.8
Q ss_pred cCccccceeeeecceeEEEEEECC-C---cEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
.+|++.+.||+|+||.||+|.+.. + ..||||.++.. .....++|..|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457888999999999999998753 3 36999998764 344467899999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|..++... .+.+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988532 346889999999999999999999998 99999999999999999999999999886643
Q ss_pred Cccccccce-ec--ccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 668 DELQGNTKR-IV--GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 668 ~~~~~~~~~-~~--gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
......... .. .+..|+|||.+.+..++.++|||||||++|||++ |..||...... ...... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i----~~~----- 227 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAI----EQD----- 227 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHH----HcC-----
Confidence 322111111 11 2457999999999999999999999999999886 99887543211 111111 100
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.. + ......+..+.+++.+|++.+|++||+++++++.|+..
T Consensus 228 ~~--~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YR--L---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred Cc--C---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0 01112234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=308.91 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=213.5
Q ss_pred cCccccceeeeecceeEEEEEE-CCCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.-|.+.+.||+|.|.+|-+|++ ..|+.||||++.+.. ......+..|++.|+.++|||||+++.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4477778999999999999976 469999999997753 3344578889999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-CCCceeeeecceeecCCC
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~ 668 (834)
.-.+|+|.+||.+... .+.+....+++.||+.|+.|+|+.. +|||||||+||.+-+ -|-+||.|||++..+...
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999965443 4889999999999999999999998 999999999998854 588999999999877654
Q ss_pred ccccccceecccccccccccccCCccC-ccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t-~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
+ ...+.+|...|.|||++.+..|+ +++||||||||||-|++|+.||...++.+ .+..++|-
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--------------TLTmImDC- 234 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--------------TLTMIMDC- 234 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh--------------hhhhhhcc-
Confidence 3 34457999999999999999986 67899999999999999999997655432 23334443
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
....+.....++.+||..||+.||++|.+.+|++. .|+..
T Consensus 235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 44566677889999999999999999999999986 45543
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=316.77 Aligned_cols=260 Identities=29% Similarity=0.449 Sum_probs=204.2
Q ss_pred cCccccceeeeecceeEEEEEEC--------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG 582 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 582 (834)
++|.+.++||+|+||.||+++.. ....+|+|+++... ....+++.+|+.++.++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 67889999999999999999742 24579999987542 34456789999999999 6999999999999999
Q ss_pred eEEEEEeecCCCCccccccCCC-------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc
Q 003280 583 EKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 649 (834)
..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ ++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999985422 2245889999999999999999999988 99999999999999
Q ss_pred CCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHh
Q 003280 650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLL 728 (834)
Q Consensus 650 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~ 728 (834)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~ 246 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--ELF 246 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 999999999999987643222111222234567999999999999999999999999999999 88887543211 111
Q ss_pred HHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 003280 729 GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERL 791 (834)
Q Consensus 729 ~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 791 (834)
......... ........++.+++.+|++.+|++||++.|+++.|+....
T Consensus 247 ----~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 247 ----KLLREGHRM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred ----HHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111111100 0111123467789999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.74 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=192.4
Q ss_pred ceeeeecceeEEEEEECC---CcEEEEEEccCccc-ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCC
Q 003280 519 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~---g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+.||+|+||.||+|...+ +..+|+|+++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998643 45799999876532 33457889999999999999999999999999999999999999
Q ss_pred CccccccCCC--CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 595 SLDVFLFDPT--KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 595 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+|.+++.... .....++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999985432 2234567788899999999999999998 9999999999999999999999999997654332222
Q ss_pred ccceecccccccccccccCC-------ccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 673 NTKRIVGTYGYMSPEYALDG-------LFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~-------~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
......++..|+|||++.+. .++.++|+||||+++|||++ |+.||....... ..... .. +......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~---~~-~~~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYT---VR-EQQLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHH---hh-cccCCCC
Confidence 22234567889999998642 35789999999999999996 999986433221 11111 00 1111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
++.+ .......+.+++..|+ .+|++|||++||+..|+
T Consensus 232 ~~~~-----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRL-----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCcc-----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111 1112335677888898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=316.68 Aligned_cols=241 Identities=24% Similarity=0.338 Sum_probs=191.2
Q ss_pred ceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+|+... ++.||||+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999998764 7899999987542 23345567788888764 899999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 99998884 3346788999999999999999999998 9999999999999999999999999987542211 12
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ..... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~----~i~~~------~~~~----- 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQ----SIRMD------NPCY----- 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHH----HHHhC------CCCC-----
Confidence 23457899999999999999999999999999999999999998643321 1111 11100 0111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 003280 754 SLPVLVRYINVALLCVQDNAADRPTMS-DVVS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 784 (834)
+.....++.+++.+||+.+|++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 111234577899999999999999997 6643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=318.42 Aligned_cols=237 Identities=23% Similarity=0.281 Sum_probs=187.0
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHH-HHHhhcCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMM-LIAKLQHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||+||+|+.. +++.||||++.... .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999875 58899999986532 222344555544 56788999999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 99988874 3456889999999999999999999998 9999999999999999999999999987542211 12
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ......... . . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~-~--------~---~~ 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMYDNILNK-P--------L---RL 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcC-C--------C---CC
Confidence 23457899999999999999999999999999999999999998643211 111111110 0 0 01
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHH
Q 003280 754 SLPVLVRYINVALLCVQDNAADRPTMS 780 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPs~~ 780 (834)
.......+.+++.+||+.||++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111234678999999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=324.15 Aligned_cols=261 Identities=20% Similarity=0.262 Sum_probs=199.0
Q ss_pred hcCccccceeeeecceeEEEEEEC---CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
..+|++.+.||+|+||.||++... .++.||+|.+... ..+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 367999999999999999999753 3578999988643 23568999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
|++. ++|..++ .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 5677766 23456899999999999999999999998 999999999999999999999999999876544
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCc-ccHhHHHHhHhcCCccc------
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS-FNLLGYAWDLWKDDKFH------ 741 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~------ 741 (834)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .................
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 33333334679999999999999999999999999999999999999986543221 11111011100000000
Q ss_pred -cc------cccccccCCCCH-------HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 742 -EL------IDPVITQDEISL-------PVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 742 -~l------id~~l~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
.+ ..... ...... ....++.+++.+||+.||++|||+.|++..
T Consensus 319 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVL-RPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccc-cCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00000 000000 112467789999999999999999999874
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.96 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=203.0
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.+|++.+.||+|++|.||+|... +++.|++|.+........+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 68899999999999999999864 58899999997765556678999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 9999999883 235788999999999999999999998 99999999999999999999999999876543221
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||........ +. ...... . +.+
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~----~~~~~~-~-----~~~--- 236 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LY----LIATNG-T-----PEL--- 236 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HH----HHhcCC-C-----CCC---
Confidence 11234688899999999988899999999999999999999999864332110 00 000000 0 000
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.........+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 011123346788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.74 Aligned_cols=253 Identities=30% Similarity=0.465 Sum_probs=201.7
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|++.+.||+|++|.||+|....+..+|+|++.... ...+.+.+|+.++++++|||++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688999999999999999998777789999986543 34567899999999999999999998875 456889999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999988543 2345789999999999999999999988 9999999999999999999999999998764332211
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .... ..... . ..
T Consensus 160 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~----~~~~~-~----~~----- 222 (260)
T cd05069 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLE----QVERG-Y----RM----- 222 (260)
T ss_pred -cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcC-C----CC-----
Confidence 112345678999999998999999999999999999999 88887543211 1111 11110 0 00
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
......+..+.+++.+|++.+|++||++++++++|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.60 Aligned_cols=256 Identities=29% Similarity=0.469 Sum_probs=202.9
Q ss_pred cCccccceeeeecceeEEEEEECC-C---cEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
++|+..+.||+|+||.||+|+... + ..+|+|+++.. .....+.+.+|++++.+++|||++++++++......++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 578888999999999999998753 3 37999998754 233456799999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|..++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999998843 2346889999999999999999999998 99999999999999999999999999987643
Q ss_pred Cccccc-cceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 668 DELQGN-TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 668 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
...... ......+..|+|||++....++.++|||||||++|||++ |+.|+...... .+. .. .....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~---~~-i~~~~------ 227 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVM---KA-INDGF------ 227 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHH---HH-HhcCC------
Confidence 221111 111223457999999998899999999999999999997 99997543221 111 11 11100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
...........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0001112234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.74 Aligned_cols=238 Identities=22% Similarity=0.280 Sum_probs=187.7
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHH-HHHhhcCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMM-LIAKLQHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+|+.. +|+.||||++.+.. .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999875 58899999986542 223345555654 46778999999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 99988773 3456889999999999999999999998 9999999999999999999999999987542211 12
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... + ....... .. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~---~~~~~~~-~~------~~----- 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--M---YDNILHK-PL------VL----- 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--H---HHHHHcC-Cc------cC-----
Confidence 234578999999999999999999999999999999999999986432111 1 1111111 00 00
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHH
Q 003280 754 SLPVLVRYINVALLCVQDNAADRPTMSD 781 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPs~~e 781 (834)
.......+.+++.+|++.+|++||++++
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 1112345778999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=301.79 Aligned_cols=250 Identities=35% Similarity=0.505 Sum_probs=203.3
Q ss_pred ceeeeecceeEEEEEECC----CcEEEEEEccCcccc-cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+|.... +..|++|.++..... ..+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 788999999765433 367899999999999999999999999999999999999999
Q ss_pred CCccccccCCCC------CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 594 KSLDVFLFDPTK------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 594 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
++|.+++..... ...+++..+..++.|+++||+|||+++ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865321 367899999999999999999999988 99999999999999999999999999988765
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
...........++..|+|||.+....++.++||||||+++|||++ |..|+...... .+. . .......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~---~-~~~~~~~------ 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVL---E-YLRKGYR------ 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHH---H-HHHcCCC------
Confidence 432222334567889999999998899999999999999999999 58887654211 111 1 1111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
...+.....++.+++.+|++.+|++||++.|+++.|+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111122457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.84 Aligned_cols=252 Identities=27% Similarity=0.395 Sum_probs=200.8
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-----cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-----GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
++|++.+.||+|++|.||++... .++.||+|.++... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 58899999886432 1224578899999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
|+||+++++|.+++. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999998874 3345788999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccc-cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQGN-TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.||...... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~------ 224 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AAIFKIATQPT------ 224 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HHHHHHhccCC------
Confidence 3221111 12346788999999999999999999999999999999999997532211 00111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
....+......+.+++.+||+.+|++|||++|+++.
T Consensus 225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 ----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011112233467889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=316.75 Aligned_cols=259 Identities=28% Similarity=0.429 Sum_probs=203.8
Q ss_pred cCccccceeeeecceeEEEEEECC--------CcEEEEEEccCc-ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG 582 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~--------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 582 (834)
.+|++.+.||+|+||.||++.... +..||+|.++.. .....+++.+|+.++.++ +||||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 568999999999999999997421 236899988754 234467899999999999 7999999999999999
Q ss_pred eEEEEEeecCCCCccccccCCC-------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc
Q 003280 583 EKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 649 (834)
..+++|||+++|+|.+++.... ....+++..+..++.||+.||+|||+.+ ++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999885421 2335788899999999999999999998 99999999999999
Q ss_pred CCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHh
Q 003280 650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLL 728 (834)
Q Consensus 650 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~ 728 (834)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+....... +
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~- 245 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--L- 245 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--H-
Confidence 999999999999987644322222222344568999999999999999999999999999998 788875432111 1
Q ss_pred HHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 729 GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 729 ~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.. ........ ........++.+++.+|++.+|++||++.|+++.|+.+.
T Consensus 246 --~~-~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 246 --FK-LLKEGHRM----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred --HH-HHHcCCCC----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 11 11111100 011122346789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.11 Aligned_cols=250 Identities=29% Similarity=0.419 Sum_probs=204.0
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|++.+.||+|+||.||+|.. .++.||+|.++.... ..+++.+|+.++..++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 36788999999999999999987 488999999976544 5678999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999885322 236899999999999999999999998 99999999999999999999999999987632211
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
....+..|+|||.+....++.++||||||++++||++ |+.|+...... .+.. ........
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~----~~~~~~~~--------- 218 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVP----HVEKGYRM--------- 218 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHH----HHhcCCCC---------
Confidence 2234568999999998899999999999999999997 88887543211 1111 11111000
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
..+...+..+.+++.+|++.+|++||+++|++++|+.
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 -EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0111223567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=319.33 Aligned_cols=257 Identities=21% Similarity=0.242 Sum_probs=199.0
Q ss_pred HHHHhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe
Q 003280 508 VAAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 508 ~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 583 (834)
+....++|++.+.||+|+||.||+++... ++.+|+|++.+. .....+.+.+|+.+++.++||||+++++.+.+...
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34455899999999999999999998764 789999998643 22334567889999999999999999999999999
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.++||||+++|+|..++.. ..++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999998832 34788888999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceecccccccccccccCC----ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK 739 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 739 (834)
.+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.. ...........
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~~~i~~~~~ 264 (371)
T cd05622 191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYSKIMNHKN 264 (371)
T ss_pred EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-----HHHHHHHcCCC
Confidence 7643321 122345799999999998754 3789999999999999999999998643221 11111111111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003280 740 FHELIDPVITQDEISLPVLVRYINVALLCVQDNAAD--RPTMSDVVSI 785 (834)
Q Consensus 740 ~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 785 (834)
..... ........+.+++..|++.++.+ ||+++|+++.
T Consensus 265 ~~~~~--------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 265 SLTFP--------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cccCC--------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00000 01122346778999999844433 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.83 Aligned_cols=241 Identities=25% Similarity=0.313 Sum_probs=193.6
Q ss_pred ceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+|+... ++.||||++++.. ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999998764 7899999997542 33456678898998888 799999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 99988874 3346899999999999999999999998 9999999999999999999999999987532221 12
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... +. .. ...... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--~~---~~-i~~~~~-----------~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--LF---QS-ILEDEV-----------RY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--HH---HH-HHcCCC-----------CC
Confidence 233578999999999999999999999999999999999999986433211 11 11 111100 01
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003280 754 SLPVLVRYINVALLCVQDNAADRPTM-----SDVVS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 784 (834)
+......+.+++.+||+.||++||++ .++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11123467899999999999999999 88875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.55 Aligned_cols=247 Identities=28% Similarity=0.367 Sum_probs=197.6
Q ss_pred ceeeeecceeEEEEEECCCcEEEEEEccCccc-ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCcc
Q 003280 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLD 597 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (834)
++||+|+||.||+|...+++.+|+|+++.... .....+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999988889999999876533 33457899999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccccccee
Q 003280 598 VFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677 (834)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 677 (834)
+++... ...+++..+..++.+++.+|.|||+.+ ++||||||+||++++++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 987432 345789999999999999999999998 999999999999999999999999999765432211 11122
Q ss_pred cccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHH
Q 003280 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLP 756 (834)
Q Consensus 678 ~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~ 756 (834)
.++..|+|||++.+..++.++||||||+++|||++ |..||...... ... ....... .. .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~----~~~~~~~-----~~-----~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAR----EQVEKGY-----RM-----SCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHH----HHHHcCC-----CC-----CCCCC
Confidence 34568999999998999999999999999999998 88887543211 111 1111110 00 11112
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 757 VLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
....+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.20 Aligned_cols=249 Identities=30% Similarity=0.420 Sum_probs=199.0
Q ss_pred ceeeeecceeEEEEEECC--C--cEEEEEEccCccc-ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLLN--G--QEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|++|.||+|.+.. + ..||||.++.... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998743 3 3699999987655 567789999999999999999999999988 889999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc-c
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ-G 672 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 672 (834)
++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999855332 56899999999999999999999998 999999999999999999999999999877542211 1
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
......++..|+|||.+.+..++.++|||||||++|||++ |+.|+...... +... ...... ...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~---~~~~~~-------~~~--- 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILK---KIDKEG-------ERL--- 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHH---HHHhcC-------CcC---
Confidence 1123456789999999999999999999999999999998 99997533211 1111 111000 000
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
..+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011122356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.00 Aligned_cols=255 Identities=32% Similarity=0.479 Sum_probs=205.7
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|++.++||+|+||.||+|...+++.||||.++... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 47899999999999999999998888899999987543 34578999999999999999999999999989999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.+++.|++|||+.+ ++|+||||+||++++++.+||+|||++..+......
T Consensus 84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 999999998543 2345889999999999999999999998 999999999999999999999999999876532211
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
.......+..|+|||.+.+..++.++||||||++++||++ |+.||...... .... ..... ...
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~---~~~~~------~~~---- 223 (261)
T cd05034 160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLE---QVERG------YRM---- 223 (261)
T ss_pred -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH---HHHcC------CCC----
Confidence 1112234568999999999899999999999999999998 89887543211 1111 11110 000
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
..+...+.++.+++.+|++.+|++||+++|+++.|+.
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011113467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=322.89 Aligned_cols=261 Identities=22% Similarity=0.299 Sum_probs=196.5
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC-----eEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-----EKI 585 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 585 (834)
+|++.++||+|+||.||++... +++.||||++... .....+++.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999874 5899999998653 2234567889999999999999999999998776 789
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+||||+.+ +|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~~-~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQS-DLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeecccc-CHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99999974 6666653 3456889999999999999999999998 999999999999999999999999999875
Q ss_pred CCCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc--
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE-- 742 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~-- 742 (834)
...... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||...+... ...............+
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCCCCHHHHH
Confidence 433221 12224678899999999874 47999999999999999999999986543211 1111111000000000
Q ss_pred ---------cccccccc------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 743 ---------LIDPVITQ------DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 743 ---------lid~~l~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+....... .........++.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000000 0011112446789999999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.18 Aligned_cols=255 Identities=28% Similarity=0.442 Sum_probs=199.9
Q ss_pred cCccccceeeeecceeEEEEEECC-Cc--EEEEEEccCc-ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 587 (834)
++|++.+.||+|+||.||+|.+.. +. .+++|.++.. .....+++.+|++++.++ +||||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578899999999999999998743 44 4688877653 334456889999999999 899999999999999999999
Q ss_pred EeecCCCCccccccCCC-------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCc
Q 003280 588 LEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP 654 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 654 (834)
|||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999885432 1235789999999999999999999998 9999999999999999999
Q ss_pred eeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHh
Q 003280 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWD 733 (834)
Q Consensus 655 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~ 733 (834)
||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~---- 234 (303)
T cd05088 164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYE---- 234 (303)
T ss_pred EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHH----
Confidence 999999986432111 1111234668999999988889999999999999999998 99887543221 1110
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..... .. . .........+.+++.+|++.+|++||++.++++.|+..
T Consensus 235 ~~~~~-----~~--~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 235 KLPQG-----YR--L---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHhcC-----Cc--C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01100 00 0 00111234678999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=323.54 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=195.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||++... .++.||||+++... ....+.+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999875 48899999986532 334567888999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|.+++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999884 3456889999999999999999999998 999999999999999999999999998754321
Q ss_pred cc---------------------------------ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCC
Q 003280 669 EL---------------------------------QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715 (834)
Q Consensus 669 ~~---------------------------------~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~ 715 (834)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 000113479999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 003280 716 NTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPT---MSDVVS 784 (834)
Q Consensus 716 p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 784 (834)
||....... . ........ ..+ .+... .+...++.+++.+++. +|++|++ +.|+++
T Consensus 235 Pf~~~~~~~--~---~~~i~~~~--~~~---~~p~~---~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 235 PFCSETPQE--T---YRKVMNWK--ETL---VFPPE---VPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCHHH--H---HHHHHcCC--Cce---ecCCC---CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 986433211 1 01111100 000 00000 1123456778887764 9999985 566655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=329.93 Aligned_cols=265 Identities=18% Similarity=0.306 Sum_probs=193.2
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEec--------C
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--------G 582 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------~ 582 (834)
.++|++.+.||+|+||.||+|... .++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 468999999999999999999875 58899999885432 2345799999999999999999887532 2
Q ss_pred eEEEEEeecCCCCccccccC-CCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC-Cceeeeec
Q 003280 583 EKILILEYMPNKSLDVFLFD-PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFG 660 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg 660 (834)
.+++||||+++ +|..++.. ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999986 55554432 234456889999999999999999999998 99999999999998665 69999999
Q ss_pred ceeecCCCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC-
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD- 738 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~- 738 (834)
+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|++||....... .+.. ........
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~-i~~~~~~p~ 291 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVR-IIQVLGTPT 291 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHH-HHHHhCCCC
Confidence 998764332 12235789999999998764 68999999999999999999999986543211 1111 11111000
Q ss_pred ---------cccccccccccc----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 739 ---------KFHELIDPVITQ----DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 739 ---------~~~~lid~~l~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
...++.-+.+.. ...+.....++.+|+.+||+.||.+|||+.|+++ .++.+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 000000000000 0011112357889999999999999999999985 44443
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.18 Aligned_cols=260 Identities=28% Similarity=0.416 Sum_probs=200.3
Q ss_pred hcCccccceeeeecceeEEEEEE------CCCcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEec-C
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ-G 582 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~ 582 (834)
.++|++.+.||+|+||.||+|.. ..++.||||+++... ....+.+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 36899999999999999999973 246789999997543 23356788999999999 689999999988654 4
Q ss_pred eEEEEEeecCCCCccccccCCCC---------------------------------------------------------
Q 003280 583 EKILILEYMPNKSLDVFLFDPTK--------------------------------------------------------- 605 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 605 (834)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999988753210
Q ss_pred -------CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccceec
Q 003280 606 -------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678 (834)
Q Consensus 606 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 678 (834)
...+++..+..++.||+.||+|||+++ |+||||||+||++++++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124678888999999999999999998 9999999999999999999999999998754332211222234
Q ss_pred ccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHH
Q 003280 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPV 757 (834)
Q Consensus 679 gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~ 757 (834)
++..|+|||.+.+..++.++||||||+++|||++ |..|+....... .+. .....+... .. .. ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~----~~~~~~~~~-----~~-~~----~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFC----RRLKEGTRM-----RA-PD----YT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHH----HHHhccCCC-----CC-CC----CC
Confidence 5678999999999999999999999999999997 888875432211 111 111111000 00 01 11
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 758 LVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 758 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..++.+++..|++.+|++||++.|+++.|+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 23578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=303.14 Aligned_cols=248 Identities=29% Similarity=0.409 Sum_probs=198.4
Q ss_pred ceeeeecceeEEEEEECCCcEEEEEEccCcccc-cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCcc
Q 003280 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLD 597 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (834)
++||+|+||.||++...+++.||+|+++..... ..+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 5578999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccccccee
Q 003280 598 VFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677 (834)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 677 (834)
+++... ...+++..+..++.+++.+|+|||+++ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 988432 235788899999999999999999998 999999999999999999999999999866432222121222
Q ss_pred cccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHH
Q 003280 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLP 756 (834)
Q Consensus 678 ~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~ 756 (834)
..+..|+|||.+.++.++.++|+||||+++|||++ |..|+....... .. ....... ....+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~----~~~~~~~----------~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TR----ERIESGY----------RMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HH----HHHhcCC----------CCCCCcc
Confidence 34567999999998899999999999999999999 777775432211 11 0111000 0011112
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 757 VLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
.+..+.+++.+|++.+|++||++.|+++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.01 Aligned_cols=240 Identities=22% Similarity=0.340 Sum_probs=189.2
Q ss_pred ceeeeecceeEEEEEECC-------------CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 519 CKLGEGGFGPVYKGRLLN-------------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
+.||+|+||.||+|+... ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 478999999999997532 2258999987665555678899999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC-------ceeee
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN-------PKISD 658 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~D 658 (834)
+||||+++++|+.++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999888743 2345889999999999999999999998 999999999999987664 89999
Q ss_pred ecceeecCCCccccccceeccccccccccccc-CCccCccCceeehhhhHHHhh-cCCCCCCCCCCCcccHhHHHHhHhc
Q 003280 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETL-SGKKNTGVYNADSFNLLGYAWDLWK 736 (834)
Q Consensus 659 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~t~~~DVwSlGvvl~ell-tG~~p~~~~~~~~~~l~~~~~~~~~ 736 (834)
||++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|+.|+....... .. . ..
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~----~-~~ 222 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KE----R-FY 222 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HH----H-HH
Confidence 9998765322 1245778899999987 466899999999999999998 4777764322111 00 0 00
Q ss_pred CCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 737 DDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 737 ~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
.... ....+...++.+++.+||+.||++||+++++++.|+
T Consensus 223 ~~~~-----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQC-----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCc-----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0000 011112346789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.68 Aligned_cols=264 Identities=23% Similarity=0.333 Sum_probs=197.0
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.++||+|+||.||+|+.. .++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67899999999999999999875 47889999987543 23345678899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 986 67666633 2345788899999999999999999998 99999999999999999999999999976533221
Q ss_pred ccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcc-cHhHH--------HHhHhcCC-c
Q 003280 671 QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF-NLLGY--------AWDLWKDD-K 739 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~-~l~~~--------~~~~~~~~-~ 739 (834)
......+++.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..... .|...... .
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223467899999999865 4689999999999999999999999865432211 00000 00000000 0
Q ss_pred cccccccccccC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 740 FHELIDPVITQD---EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 740 ~~~lid~~l~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
....-.+..... ........++.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000 000112346779999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=306.55 Aligned_cols=245 Identities=24% Similarity=0.322 Sum_probs=191.8
Q ss_pred eeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCc
Q 003280 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
||+|+||.||+++.. .|+.+|+|++.... ......+..|++++.+++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 48999999986432 12234556799999999999999999999999999999999999999
Q ss_pred cccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccce
Q 003280 597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (834)
..++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 8887532 2334788999999999999999999998 9999999999999999999999999998764322 1123
Q ss_pred ecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHH
Q 003280 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~ 756 (834)
..|+..|+|||++.+..++.++|||||||++|||++|+.||........ .......... .. +.. .. ..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~-~~----~~~--~~----~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLE-DE----VKF--EH----QN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhc-cc----ccc--cc----cc
Confidence 4688999999999998999999999999999999999999864332111 1111111110 00 000 00 11
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 757 VLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...++.+++..||+.||++||+++|+++
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 2346789999999999999999987664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=339.37 Aligned_cols=260 Identities=21% Similarity=0.299 Sum_probs=202.1
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.++||+|+||.||+|... .++.||||+++... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999875 48899999987532 233567999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCC--------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeec
Q 003280 589 EYMPNKSLDVFLFDPT--------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 660 (834)
||+++++|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999998875321 1233566778899999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCccc----------------cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCc
Q 003280 661 LARMFGGDELQ----------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS 724 (834)
Q Consensus 661 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~ 724 (834)
+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99876221100 01112469999999999999999999999999999999999999986432211
Q ss_pred ccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcc
Q 003280 725 FNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRP-TMSDVVSIINSE 789 (834)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~ 789 (834)
... . ..+.++.- . ......+..+.+++.+|++.||++|| +++++++.|+..
T Consensus 239 i~~-----~-------~~i~~P~~-~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ISY-----R-------DVILSPIE-V-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhh-----h-------hhccChhh-c-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 100 0 00000000 0 00112234577899999999999996 677777777654
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=310.52 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=200.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.+.||+|+||.||++... .++.+|+|.++.. .....+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999875 4788999988654 233456788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
+++++|.+++.. .+.+++..+..++.||++||+|||+. + ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999843 35688999999999999999999974 5 9999999999999999999999999987653221
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhH---hcCCc-------
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDL---WKDDK------- 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~---~~~~~------- 739 (834)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ........ .....
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCccccccccCCcccccC
Confidence 223568899999999988889999999999999999999999975432211 10000000 00000
Q ss_pred ----------cccccccccccC--CC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003280 740 ----------FHELIDPVITQD--EI-SLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786 (834)
Q Consensus 740 ----------~~~lid~~l~~~--~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 786 (834)
..+..+...... .. ......++.+++.+||+.+|++||+++|+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000000 00 001234688999999999999999999998853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=324.33 Aligned_cols=262 Identities=21% Similarity=0.258 Sum_probs=195.3
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
..+|.+.+.||+|+||.||++.+.. ++.||||... ...+.+|++++++++|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999998865 7889999642 23467899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+. ++|..++.. ....+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 677777632 2346899999999999999999999998 99999999999999999999999999987644322
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCC-CCc-----ccHhHHHHhH-hcCCccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN-ADS-----FNLLGYAWDL-WKDDKFHEL 743 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~-~~~-----~~l~~~~~~~-~~~~~~~~l 743 (834)
........||..|+|||++.+..++.++|||||||+||||++|..++-... ... ..+....... .....+...
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 222234579999999999999999999999999999999999886542211 110 1111111100 000000000
Q ss_pred cc-------------ccccc-CCCCH----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 744 ID-------------PVITQ-DEISL----PVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 744 id-------------~~l~~-~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
.. ..... ..... .....+.+|+.+||+.||++|||+.|+++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 00000 00000 112357789999999999999999999873
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.39 Aligned_cols=256 Identities=28% Similarity=0.447 Sum_probs=202.7
Q ss_pred cCccccceeeeecceeEEEEEECC----CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
.+|++.+.||+|+||.||+|.... +..+|+|.++... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 578899999999999999998642 3379999987543 33456889999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998532 345789999999999999999999998 99999999999999999999999999987644
Q ss_pred Ccccc-ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 668 DELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 668 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
..... ......++..|+|||.+.+..++.++|+||||+++||+++ |+.||....... .... ..... .
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~----~~~~~-----~ 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKA----IEEGY-----R 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHH----HhCCC-----c
Confidence 32111 1111233568999999999899999999999999999886 999975433211 1111 11110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
. ......+..+.+++.+|++.+|++||++.++++.|++.
T Consensus 228 ~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 L-----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C-----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 00111234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=305.73 Aligned_cols=252 Identities=23% Similarity=0.418 Sum_probs=200.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|++.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 57888999999999999999875 58899999987665555667889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++. ..+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 9999999874 3346889999999999999999999998 9999999999999999999999999988664322
Q ss_pred cccceeccccccccccccc---CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~---~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.......|+..|+|||++. ...++.++|||||||++|||++|+.|+........ +. .. ...... .+..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~----~~-~~~~~~---~~~~ 231 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LF----LM-TKSNFQ---PPKL 231 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HH----hh-hccCCC---CCcc
Confidence 1223357899999999984 45688999999999999999999998753322110 00 00 000000 0000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. .......+.+++.+|++.+|++||+++++++
T Consensus 232 -~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 -KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 0112345789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=308.57 Aligned_cols=251 Identities=27% Similarity=0.450 Sum_probs=201.4
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.|++.++||+|+||.||+|+... ++.+++|.+........+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 678899999999999999998764 8899999998776666788999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|..++.. ....+++..+..++.|++++|+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 99999887643 2345889999999999999999999988 9999999999999999999999999987643221
Q ss_pred cccceeccccccccccccc-----CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~-----~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
.......++..|+|||++. ...++.++|||||||++|||++|+.|+....... ......... .+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~------~~ 233 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSE------PP 233 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-----HHHHHhcCC------Cc
Confidence 1123456788999999985 3457889999999999999999999975432111 011111100 00
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. ..+.....++.+++.+||+.+|++||+++|+++
T Consensus 234 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TL---SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 111123346788999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=311.30 Aligned_cols=237 Identities=23% Similarity=0.276 Sum_probs=185.9
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHH-HHHhhcCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMM-LIAKLQHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||.||+|+.. +++.||+|++.+.. ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 48899999986532 122344555554 57888999999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 99987773 3445788889999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ........ . .+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~-~--------~~---~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-----QMYDNILH-K--------PL---QL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-----HHHHHHhc-C--------CC---CC
Confidence 33457899999999999999999999999999999999999998643211 11111111 0 00 11
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHH
Q 003280 754 SLPVLVRYINVALLCVQDNAADRPTMS 780 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPs~~ 780 (834)
+......+.+++.+||+.+|++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 112234678999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.14 Aligned_cols=240 Identities=23% Similarity=0.279 Sum_probs=187.0
Q ss_pred ceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHH-HHHHhhcCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEM-MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+|+... ++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999998764 7789999986532 12223444444 456788999999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
++|..++.. ...+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999988843 345778888899999999999999998 9999999999999999999999999997543221 12
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...... . .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~---~~~i~~-~--------~~---~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--M---YDNILN-K--------PL---QL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--H---HHHHHh-C--------Cc---CC
Confidence 334579999999999999999999999999999999999999986432211 1 111111 0 00 01
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003280 754 SLPVLVRYINVALLCVQDNAADRPTMSDVV 783 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl 783 (834)
.......+.+++.+|++.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 111234577899999999999999887543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.70 Aligned_cols=252 Identities=30% Similarity=0.464 Sum_probs=199.4
Q ss_pred ccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHH--HHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLE--EFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
|++.+.||+|+||+||+++... ++.+|+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6778999999999999999865 668999999876443322 3456999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++. ....+++..+..++.||++||++||+.+ |+|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999885 4566899999999999999999999998 99999999999999999999999999986411 12
Q ss_pred cccceeccccccccccccc-CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~-~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
.......++..|+|||++. +..++.++||||||+++++|++|+.|+...... +........... . ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~~~----~-~~~~--- 222 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEKILKR----P-LPSS--- 222 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHHHHHT----H-HHHH---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhhcccc----c-cccc---
Confidence 2333457899999999998 888999999999999999999999998654111 110000000000 0 0000
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.....+....+.+++.+||+.||++||++.++++
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000011257889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=299.19 Aligned_cols=250 Identities=21% Similarity=0.334 Sum_probs=201.8
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999875 5889999998643 3344577889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++... ....++...+..++.||+.||.|||+++ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998877432 3445788999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.. ....... .+...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~-~~~~~---------- 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLILKVC-QGSYK---------- 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHHHHh-cCCCC----------
Confidence 122356888999999999989999999999999999999999998643211 1111111 11111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
..+......+.+++.+||+.+|++||++.|++..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0111223457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=311.13 Aligned_cols=255 Identities=21% Similarity=0.256 Sum_probs=194.9
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+++.. +++.||||++.+. .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999875 4889999998653 2233466889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999998843 2345888999999999999999999998 999999999999999999999999999776433
Q ss_pred ccccccceecccccccccccccC-----CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ..............+
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~~~~ 229 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHKEHFQF 229 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-----HHHHHHHcCCCcccC
Confidence 211 1223468999999999863 45788999999999999999999998643211 111111111110000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhcccc--CCCCCCCHHHHHHH
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQD--NAADRPTMSDVVSI 785 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~ 785 (834)
. .........+.+++.+|+.. ++..||+++++++-
T Consensus 230 -~------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 -P------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -C------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 00011234566777777654 33447899999874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=302.95 Aligned_cols=255 Identities=28% Similarity=0.432 Sum_probs=199.2
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
+++.+.....||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 4555666679999999999999865 477899999877666667789999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-CCCceeeeecceeecCCC
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~ 668 (834)
|+++++|..++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 9999999999854322212277888899999999999999988 999999999999976 679999999999866432
Q ss_pred ccccccceecccccccccccccCCc--cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~--~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
.. ......+++.|+|||++.+.. ++.++||||||+++|||++|+.|+.......... +...... .
T Consensus 163 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--~~~~~~~-------~-- 229 (268)
T cd06624 163 NP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--FKVGMFK-------I-- 229 (268)
T ss_pred CC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--hhhhhhc-------c--
Confidence 21 122245789999999987644 7899999999999999999999975432211100 0000000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
....+.....++.+++.+||+.+|++|||+.|+++
T Consensus 230 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 ---HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 01112223356788999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.08 Aligned_cols=248 Identities=29% Similarity=0.415 Sum_probs=198.6
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEE-ecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV-EQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~Ey~ 591 (834)
++|++.+.||+|+||.||++.. .+..||+|.++... ..+.+.+|+.++++++|+|++++++++. ..+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 5788999999999999999976 47889999986432 3467899999999999999999999764 456789999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999988542 2335789999999999999999999998 9999999999999999999999999988653322
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
....++..|+|||++.+..++.++|||||||++|||++ |+.|+...... .+ ... ...+.. +
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~--~~---~~~-~~~~~~-----~---- 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DV---VPR-VEKGYK-----M---- 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HH---HHH-HhcCCC-----C----
Confidence 12344568999999999899999999999999999997 88887533211 11 111 111100 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
......+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1111223467899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.60 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=189.4
Q ss_pred ceeeeecceeEEEEEECC---CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCC
Q 003280 519 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
++||+|+||.||+|.... ...+|+|.+.... ......+.+|+..++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 4578899876543 333467889999999999999999999999999999999999999
Q ss_pred CccccccCCCC--CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 595 SLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 595 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999855322 233567788899999999999999998 9999999999999999999999999987643322211
Q ss_pred ccceecccccccccccccC-------CccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 673 NTKRIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~-------~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
......++..|+|||++.. ..++.++|||||||++|||++ |..|+...... ... ....... ...+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~---~~~~~~~-~~~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVL---KQVVREQ-DIKLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHH---HHHhhcc-CccCC
Confidence 1222345678999998743 356889999999999999999 77776533211 111 1111111 11111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
++.+ .......+.+++..|+ .||++|||++||+++|.
T Consensus 232 ~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2211 1222345567778888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=306.58 Aligned_cols=251 Identities=26% Similarity=0.404 Sum_probs=199.9
Q ss_pred CccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
.|++.+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++||||+++++++......++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 36778899999999999998764 77889999877666667789999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+++|..++.. ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 9999887743 2346899999999999999999999998 9999999999999999999999999987653321 1
Q ss_pred ccceeccccccccccccc-----CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 673 NTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~-----~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
......++..|+|||++. +..++.++|||||||++|||++|+.||....... . ........ .....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~---~~~~~~~~-~~~~~--- 229 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--V---LLKIAKSE-PPTLA--- 229 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--H---HHHHhhcC-CCCCC---
Confidence 223356889999999984 4457889999999999999999999975432111 0 01111100 00000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
.+.....++.+++.+||+.+|++||++.++++.
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 -----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011123467899999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=313.25 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=209.2
Q ss_pred HhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccc---cHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQ---GLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~ 585 (834)
..+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34679999999999999999999876 999999999775433 4568999999999998 999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC----CCceeeeecc
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD----MNPKISDFGL 661 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgl 661 (834)
+|||++.+|.|.+.+... .+++..+..++.||+.+++|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999988654 2899999999999999999999998 9999999999999543 4799999999
Q ss_pred eeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccc
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH 741 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (834)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... .....+.
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF- 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC-
Confidence 998865 234566899999999999999999999999999999999999999987654332211 1111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 742 ELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 742 ~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. ....-......+.+++..++..||.+|+|+.++++
T Consensus 256 -----~f-~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 -----DF-TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -----CC-CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 11 01111123456789999999999999999999998
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=301.82 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=203.4
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|++.+.||+|+||.||+|.... ++.+++|.++.... .+++.+|++++++++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678999999999999999999865 78999999875533 678999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999998843 3456899999999999999999999998 99999999999999999999999999987644321
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
......++..|+|||++.+..++.++||||||+++|||++|+.|+.......... . ... .... ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-----~-~~~-----~~~~---~~ 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-----M-IPN-----KPPP---TL 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----h-hcc-----CCCC---CC
Confidence 2223457889999999999999999999999999999999999986432211100 0 000 0000 00
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+......+.+++.+|++.+|++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111223346789999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.39 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=194.1
Q ss_pred eeeeecceeEEEEEEC---CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCC
Q 003280 520 KLGEGGFGPVYKGRLL---NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 520 ~LG~G~~G~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 595 (834)
.||+|+||.||+|.+. .+..||+|++.... ....+++.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 35579999987653 333567999999999999999999999875 457899999999999
Q ss_pred ccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc-c
Q 003280 596 LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN-T 674 (834)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~ 674 (834)
|.+++.. ....+++..+.+++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++..+........ .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9998843 2346889999999999999999999998 99999999999999999999999999986543322111 1
Q ss_pred ceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 675 ~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
....++..|+|||.+....++.++||||||+++|||++ |+.||....... .. ........ ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~----~~~~~~~~----------~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VM----SFIEQGKR----------LDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HH----HHHHCCCC----------CCC
Confidence 11233578999999998889999999999999999996 999976432211 11 11111100 011
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 754 SLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
+.....++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 112245678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=308.55 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=203.2
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 68999999999999999999864 68999999997665555678899999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 9999999883 235788899999999999999999998 999999999999999999999999999875433211
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+....... ....+ .+. .
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~------~~~---~ 235 (297)
T cd06656 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNG------TPE---L 235 (297)
T ss_pred --cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCC------CCC---C
Confidence 2234678899999999999999999999999999999999999854332111000 00000 000 0
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+......+.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011122345778999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=302.64 Aligned_cols=248 Identities=31% Similarity=0.452 Sum_probs=195.9
Q ss_pred ceeeeecceeEEEEEECC----CcEEEEEEccCccc-ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||.||+|+... +..+|+|.++.... ...+++.+|+.+++++.||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999976543 34567999999999999999999999875 5578999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc-
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG- 672 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 672 (834)
++|.+++.. ...+++..+..++.|++.||+|||..+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999853 236889999999999999999999998 9999999999999999999999999998764332211
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.... ......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~----~~~~~~---------- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAML----ESGERL---------- 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH----HcCCcC----------
Confidence 1111233567999999999999999999999999999998 9998864322 1121111 111100
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..+......+.+++.+|++.+|++||++.+++++|++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 01111234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=302.23 Aligned_cols=254 Identities=29% Similarity=0.431 Sum_probs=203.6
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|++.++||+|+||.||+|....+..+|+|.++... ...+.+.+|+.++++++|+||+++.+.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 47899999999999999999998778889999887542 345678999999999999999999999887 7789999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999998543 2345788899999999999999999987 999999999999999999999999999876433211
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
......++..|+|||++....++.++|+|||||++||+++ |+.||...... .+.. ........
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~----~~~~~~~~--------- 222 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIR----ALERGYRM--------- 222 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHH----HHhCCCCC---------
Confidence 1112345678999999998899999999999999999999 88887643211 1111 11111000
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
.........+.+++.+|++.+|++||++.+++++|+.
T Consensus 223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111223467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=316.82 Aligned_cols=198 Identities=26% Similarity=0.358 Sum_probs=171.3
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhc-C-----CCcceEEeEEEecCeEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-H-----RNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~l~~~~~~~~~~~l 586 (834)
+|++.+.||+|.||.|.++... .++.||||+++... .-..+-..|+.+|.+|+ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8999999999999999999765 48999999997653 34566688999999997 4 379999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC--CCceeeeecceee
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD--MNPKISDFGLARM 664 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~~ 664 (834)
|+|.+ ..+|.+++.... ...++...++.++.||+.||..||+.+ |||+||||+||||.+. ..+||+|||.+..
T Consensus 266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99988 458899886543 345899999999999999999999998 9999999999999654 4699999999987
Q ss_pred cCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCC
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA 722 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~ 722 (834)
...... ....+..|.|||++.+.+|+.+.||||||||++||++|.+-|...++
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 654322 46778899999999999999999999999999999999887776554
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=314.16 Aligned_cols=241 Identities=23% Similarity=0.345 Sum_probs=191.7
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 588 (834)
+|+..+.||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999875 5889999998753 2233456788888888885 577888999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999988873 3346889999999999999999999998 999999999999999999999999998764322
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..... .. .
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~---~~i~~-~~--------~ 218 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELF---QSIME-HN--------V 218 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHH---HHHHh-CC--------C
Confidence 11 123356899999999999999999999999999999999999998653321 111 11111 00 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTM 779 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 779 (834)
..+.....++.+++.+||+.+|.+|++.
T Consensus 219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111123467789999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=302.30 Aligned_cols=252 Identities=27% Similarity=0.459 Sum_probs=202.0
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
.+|++.+.||+|+||.||+|...+++.+|+|+++... ...++|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4688889999999999999988778899999986542 234678999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+++|.+++... ...+++..+..++.+++.+++|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999888432 345789999999999999999999998 9999999999999999999999999998764332211
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
.....++..|+|||.+.++.++.++||||||+++|||++ |+.|+...... .+ .... ... .....+..
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~---~~~~-~~~--~~~~~~~~--- 225 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EV---VETI-NAG--FRLYKPRL--- 225 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HH---HHHH-hCC--CCCCCCCC---
Confidence 112234678999999998899999999999999999998 88887543211 11 1111 110 01111111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
....+.+++.+||+.+|++||++.|+++.|.
T Consensus 226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=317.05 Aligned_cols=261 Identities=24% Similarity=0.273 Sum_probs=194.8
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC------
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------ 582 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 582 (834)
.++|++.+.||+|+||.||++... .++.||||++... ......++.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999875 4889999998653 2334567889999999999999999999986543
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
..++||||++++ |...+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 579999999765 444442 23678889999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcc-------------cHhH
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF-------------NLLG 729 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~-------------~l~~ 729 (834)
+...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ....
T Consensus 171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 171 RTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 7643321 12235789999999999999999999999999999999999999875432110 0000
Q ss_pred ----HHHhHhcCC------cccccccccccc--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 730 ----YAWDLWKDD------KFHELIDPVITQ--DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 730 ----~~~~~~~~~------~~~~lid~~l~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
......... ...+........ ..........+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 000000000000 0001112346789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=309.39 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=204.7
Q ss_pred cCccccceeeeecceeEEEEEE-CCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.+|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4699999999999999999986 458999999997665556678899999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|..++. ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 9999999873 235889999999999999999999998 999999999999999999999999998865443221
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||........ .. ..... .... +
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~----~~~~~-~~~~-----~--- 235 (296)
T cd06655 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY----LIATN-GTPE-----L--- 235 (296)
T ss_pred --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH----HHHhc-CCcc-----c---
Confidence 2234678899999999998999999999999999999999999865332111 00 00000 0000 0
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
.........+.+++.+||+.+|++||++.++++ .++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 011112345778999999999999999999987 4444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=300.19 Aligned_cols=253 Identities=24% Similarity=0.397 Sum_probs=204.4
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|++.+.||+|+||.||+|... .++.+++|.+........+.+.+|+.++++++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 67899999999999999999875 47889999998766666788999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 99999998743 2246889999999999999999999988 99999999999999999999999999886543211
Q ss_pred cccceecccccccccccccCC---ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~---~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
......++..|+|||.+... .++.++||||||+++|||++|+.|+........ .. .. .... .....+
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~----~~-~~~~---~~~~~~ 226 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LF----LI-SKSN---FPPPKL 226 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HH----HH-Hhcc---CCCccc
Confidence 12234678899999999877 889999999999999999999999864332111 00 00 0000 000000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
........++.+++.+|++.+|.+|||+++++.
T Consensus 227 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 ---KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ---cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112234567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=303.33 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=199.5
Q ss_pred CccccceeeeecceeEEEEEECCCcEEEEEEccCcc------cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS------GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
+|++.+.||+|+||.||+|...+++.+|||.++... ....+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999988789999999886432 12245688999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999843 345788999999999999999999988 99999999999999999999999999886532
Q ss_pred Cc----cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 668 DE----LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 668 ~~----~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
.. .........++..|+|||++.+..++.++||||||+++|||++|+.||........ .. ..... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~----~~~~~---~~- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MF----YIGAH---RG- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HH----Hhhhc---cC-
Confidence 11 11112234688999999999998999999999999999999999999864321110 00 00000 00
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+.+ .......+.+++.+||+.+|++||++.|+++
T Consensus 226 ~~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMPRL-----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCC-----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00111 1123446789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=305.81 Aligned_cols=263 Identities=26% Similarity=0.342 Sum_probs=197.3
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|++|.||+|+.. +++.||||+++... ....+.+.+|+.++.+++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999875 58899999986532 23356788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
++ ++|..++........+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 578777754444467899999999999999999999998 99999999999999999999999999986543211
Q ss_pred ccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHh-------HhcC----C
Q 003280 671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWD-------LWKD----D 738 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~-------~~~~----~ 738 (834)
......+++.|+|||++.+. .++.++||||||++++||++|+.||........ +...... .+.. .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhhH
Confidence 11223568899999988754 578999999999999999999999864322110 0000000 0000 0
Q ss_pred ccccccccccccCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 739 KFHELIDPVITQDE---ISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 739 ~~~~lid~~l~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.....+.... ... .......++.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWK-KGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccC-cchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 000 00112346779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=303.97 Aligned_cols=249 Identities=29% Similarity=0.423 Sum_probs=194.3
Q ss_pred ceeeeecceeEEEEEECC-Cc--EEEEEEccCc-ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+|.+.+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998754 33 5788988753 334456889999999999 899999999999999999999999999
Q ss_pred CCccccccCCC-------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeec
Q 003280 594 KSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660 (834)
Q Consensus 594 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 660 (834)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999885422 1235789999999999999999999987 9999999999999999999999999
Q ss_pred ceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCc
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDK 739 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 739 (834)
++...... ........+..|+|||++....++.++||||||+++|||++ |..||...... .. ... .....
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~---~~~-~~~~~ 228 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--EL---YEK-LPQGY 228 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HH---HHH-HhCCC
Confidence 98632211 11111233567999999998899999999999999999997 99987543211 11 111 11110
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 740 FHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 740 ~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.. ........++.+++.+|++.+|.+|||+.|+++.|+.+
T Consensus 229 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 229 RL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 01111234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=305.08 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=197.7
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEec------C
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ------G 582 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~------~ 582 (834)
+++.|++.+.||+|+||.||+|... .++.||+|++.... .....+..|+.++.++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4577899999999999999999875 47889999986543 3456788999999998 799999999998763 4
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
..++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 688999999999999988542 2346889999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceeccccccccccccc-----CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD 737 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 737 (834)
....... .......|+..|+|||++. +..++.++|||||||++|||++|+.|+........ ......
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~~~~~~- 230 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIPR- 230 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----HHHHhc-
Confidence 8754322 1223457899999999986 34588899999999999999999999853321110 000011
Q ss_pred CccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 DKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
....... .. .....+.+++.+||+.+|.+|||+.|+++
T Consensus 231 ~~~~~~~-----~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPAPRLK-----SK----KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCCC-----CC----CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1011111 11 12346789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=305.79 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=200.6
Q ss_pred HHHHHHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEE----
Q 003280 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCV---- 579 (834)
Q Consensus 506 ~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~---- 579 (834)
..+..+.++|++.+.||+|+||.||++... .++.+|+|+++... ...+++.+|+.++.++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 444556789999999999999999999875 47899999886532 2346788899999999 6999999999884
Q ss_pred -ecCeEEEEEeecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceee
Q 003280 580 -EQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS 657 (834)
Q Consensus 580 -~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 657 (834)
.+...++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 345689999999999999887532 23456788999999999999999999988 9999999999999999999999
Q ss_pred eecceeecCCCccccccceecccccccccccccC-----CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHH
Q 003280 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAW 732 (834)
Q Consensus 658 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~ 732 (834)
|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+....... .+.
T Consensus 167 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~~---- 239 (286)
T cd06638 167 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALF---- 239 (286)
T ss_pred cCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HHh----
Confidence 9999987643321 1223468999999999853 457899999999999999999999975432211 000
Q ss_pred hHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 733 DLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 733 ~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
. ..........++ ......+.+++.+|++.+|++|||+.|+++.
T Consensus 240 ~-~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 K-IPRNPPPTLHQP--------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred h-ccccCCCcccCC--------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 000000001111 1122457899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.57 Aligned_cols=255 Identities=29% Similarity=0.459 Sum_probs=199.5
Q ss_pred cCccccceeeeecceeEEEEEEC-CCc----EEEEEEccCccc-ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
++|+..+.||+|+||.||+|... +++ .||+|.+..... ....++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 67888899999999999999864 343 579998875432 3345789999999999999999999998754 5679
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
++||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999998843 2335788999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..... ....+... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~----~~~~~~~~--~- 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPD----LLEKGERL--P- 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH----HHHCCCCC--C-
Confidence 4332222223345678999999999999999999999999999997 8888754321 11111 11111000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
........+.+++..|+..+|++||+++++++.|+.+
T Consensus 232 -------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 232 -------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011234678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=301.27 Aligned_cols=249 Identities=28% Similarity=0.453 Sum_probs=199.1
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccc---------cHHHHHHHHHHHHhhcCCCcceEEeEEEecCe
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ---------GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 583 (834)
+|.+.+.||+|++|.||+|... .++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999864 4789999988654221 23568899999999999999999999999999
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.++||||+++++|..++. ....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999883 3356788899999999999999999988 9999999999999999999999999998
Q ss_pred ecCCCcccc----ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc
Q 003280 664 MFGGDELQG----NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK 739 (834)
Q Consensus 664 ~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 739 (834)
......... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~--- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-----AIFKIGE--- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-----HHHHHhc---
Confidence 775322111 1123457889999999999899999999999999999999999986432110 0001000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 740 FHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 740 ~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...+ ..+......+.+++.+||+.+|++||++.|+++
T Consensus 227 ---~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ---NASP-----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---cCCC-----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111 111223456789999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=288.64 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=198.9
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccC--cccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++.|++-+.||+|.|+.|++.... .|+.+|+|++.. -...+.+++.+|+.+.+.|+||||+++...+.+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 467888899999999999998654 588899987643 23446788999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC---CCceeeeecceeec
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMF 665 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~ 665 (834)
|+|.+++|..-+ ..+-..++..+-..++||+.+|.|+|..+ |||||+||+|++|... --+||+|||+|..+
T Consensus 90 e~m~G~dl~~eI---V~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDI---VAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999985544 23345677788899999999999999998 9999999999999543 45899999999998
Q ss_pred CCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
+.... .....|||+|||||++...+|+..+|||+.|||||-|+.|.+||-..+.. .+- +....+. .|
T Consensus 164 ~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--rly----e~I~~g~----yd 230 (355)
T KOG0033|consen 164 NDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLY----EQIKAGA----YD 230 (355)
T ss_pred CCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--HHH----HHHhccc----cC
Confidence 74432 23468999999999999999999999999999999999999998542211 111 1111110 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+ ....-....++..+|+.+||..||.+|.|+.|.++
T Consensus 231 --~-~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 --Y-PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --C-CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 0 00001112346779999999999999999999876
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=304.50 Aligned_cols=256 Identities=29% Similarity=0.425 Sum_probs=202.8
Q ss_pred cCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcccc-cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
++|++.+.||+|+||.||+|+.. ..+.|++|.+...... ..+++.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 67889999999999999999864 2467999988765443 4678999999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCC------CcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeee
Q 003280 586 LILEYMPNKSLDVFLFDPTKK------RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDF 659 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 659 (834)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998543322 25899999999999999999999998 999999999999999999999999
Q ss_pred cceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCC
Q 003280 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDD 738 (834)
Q Consensus 660 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 738 (834)
|++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ... .. ....
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~---~~-~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVL---NR-LQAG 234 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHH---HH-HHcC
Confidence 998754332211 1222356778999999998889999999999999999999 77777432211 111 11 1111
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 739 KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 739 ~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
.... ......+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 235 ~~~~---------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLEL---------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1110 001122346789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=305.12 Aligned_cols=255 Identities=29% Similarity=0.421 Sum_probs=202.0
Q ss_pred cCccccceeeeecceeEEEEEECC-Cc----EEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
.+|++.+.||+|+||.||+|.... ++ .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 578889999999999999998643 33 58999887654 3345788999999999999999999999987 78999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999988542 335889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
............++..|+|||.+....++.++|+||||+++|||++ |+.|+....... +. .. ...... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~---~~-~~~~~~--~-- 230 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IP---DL-LEKGER--L-- 230 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HH---HH-HhCCCC--C--
Confidence 3322111111233568999999988899999999999999999998 999986432211 11 11 111100 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..+.....++.+++.+|+..+|++||++.++++.|+..
T Consensus 231 ------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 ------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00111223577899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.70 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=200.5
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.+.||+|+||.||++... .++.||+|.++.. .....+.+.+|+.++++++||||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999876 5899999988654 333457889999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
+++++|..++........+++..+..++.+|++||.|||+. + |+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999998885543345789999999999999999999974 5 9999999999999999999999999987653321
Q ss_pred cccccceecccccccccccccCC------ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~------~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
.....++..|+|||.+.+. .++.++|+|||||++|||++|+.||....... ....... .
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~---------~ 222 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLSA---------I 222 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHHH---------H
Confidence 2234578899999998554 35889999999999999999999985432111 1110000 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.+.. ..........++.+++.+|++.+|++||++++++.
T Consensus 223 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 223 VDGD--PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hhcC--CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0000 01122224456789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.35 Aligned_cols=250 Identities=26% Similarity=0.317 Sum_probs=198.0
Q ss_pred ccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
|++.+.||+|+||.||++... .++.||||.+.... ....+.+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677789999999999999875 48899999986542 22235678899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999887432 2235889999999999999999999988 99999999999999999999999999976543221
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||........ .......... .. .
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~~~~~~~--~~----~---- 222 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKE--VQ----E---- 222 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHHHhhhhh--hh----h----
Confidence 1224689999999999999999999999999999999999999865332110 0000000000 00 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPT-----MSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 784 (834)
.........+.+++.+||+.||++||| ++|+++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 -EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011112345789999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=303.38 Aligned_cols=248 Identities=24% Similarity=0.398 Sum_probs=202.3
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.+.||.|++|.||+|+.. +++.||+|++.... ......+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999875 48899999986543 34456789999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999998843 26889999999999999999999998 9999999999999999999999999998875432
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
.......++..|+|||++.+..++.++||||||+++|||++|+.|+....... . ... .... ..+.+..
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~---~~~-~~~~-----~~~~~~~ 220 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--V---LFL-IPKN-----NPPSLEG 220 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--H---HHH-hhhc-----CCCCCcc
Confidence 12233567889999999999889999999999999999999999986433111 0 000 0001 1111101
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. .....+.+++.+||..+|++||+++++++
T Consensus 221 ~----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 N----KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred c----ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1 03346788999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=286.60 Aligned_cols=250 Identities=25% Similarity=0.361 Sum_probs=198.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-----c---ccHHHHHHHHHHHHhh-cCCCcceEEeEEEecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-----G---QGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG 582 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-----~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 582 (834)
+.|...+.||.|..++|-+..++ .|+.+|+|++.... + ...+.-..|+.+|+++ -||+|+.+.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 56778889999999999988765 48899999875321 1 1234456789999998 6999999999999999
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
..++|+|.|+.|.|.++| ...-.++++...+|++|+..|+.|||..+ ||||||||+|||+|++.++||+|||++
T Consensus 97 F~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 999999999999999999 45567899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceecccccccccccccC------CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhc
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWK 736 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~ 736 (834)
+.+.... .....+|||+|+|||.+.- ..|+...|+|++|||||.|+.|.+||=... +++ ......
T Consensus 171 ~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk----Qml--MLR~Im 241 (411)
T KOG0599|consen 171 CQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK----QML--MLRMIM 241 (411)
T ss_pred eccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH----HHH--HHHHHH
Confidence 9987654 3345799999999999853 358899999999999999999999973210 010 001111
Q ss_pred CCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 737 DDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 737 ~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+++.. . ..+.=.+......+||.+||+.||.+|.|++|++.
T Consensus 242 eGkyq------F-~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 242 EGKYQ------F-RSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred hcccc------c-CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11110 0 00001123446789999999999999999999987
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=304.93 Aligned_cols=261 Identities=24% Similarity=0.345 Sum_probs=192.0
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhh---cCCCcceEEeEEEec-----C
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKL---QHRNLVKLLGCCVEQ-----G 582 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~-----~ 582 (834)
+|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788999999999999999876 48899999987542 22234566777777665 699999999988652 3
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
..++||||+++ +|..++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57999999985 777776432 2345889999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC---Cc
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD---DK 739 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~---~~ 739 (834)
+...... ......+|..|+|||++.+..++.++|||||||++|||++|++||....... .+.. ....... ..
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~-~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGK-IFDLIGLPPEDD 230 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHH-HHHHhCCCChhh
Confidence 8764322 1223467899999999999999999999999999999999999986433211 1100 0000000 00
Q ss_pred ccc---cccccccc------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 740 FHE---LIDPVITQ------DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 740 ~~~---lid~~l~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
... ........ ..........+.+++.+||+.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00000000 0011122346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=312.58 Aligned_cols=193 Identities=24% Similarity=0.318 Sum_probs=164.4
Q ss_pred HHhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
....+|++.+.||+|+||.||+|+... ++.||+|+.... ....|+.++++++||||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 445689999999999999999998754 678999975432 2356899999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+. ++|..++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 577776643 3456899999999999999999999998 999999999999999999999999999753222
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCC
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNT 717 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~ 717 (834)
. ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 P---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 222356899999999999999999999999999999999866553
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=310.88 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=203.2
Q ss_pred HHhcCccccceeeeecceeEEEEEECCCcEEEEEEccC--cccccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEE
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 586 (834)
.....|+++++||+||.+.||++...+.+.+|+|++.. .+.+..+-|.+|+..|.+|+ |.+||++++|-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34567999999999999999999987888899997653 46677889999999999995 9999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||- ..+|..+|... ...++.-.+..+..|+++|+.++|+++ |||.||||.|+|+- .|.+||+|||+|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~--~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKK--KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 99975 55788888432 222332377889999999999999998 99999999999994 6899999999999998
Q ss_pred CCccccccceecccccccccccccCC-----------ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDG-----------LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
.+.........+||+.|||||.+... ..+.++||||||||||+|+.|+.||+.... .+
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~----- 579 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QI----- 579 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HH-----
Confidence 87766666678999999999998543 256889999999999999999999864211 01
Q ss_pred cCCcccccccccc--ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 736 KDDKFHELIDPVI--TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 736 ~~~~~~~lid~~l--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.++..+.++.. .....+. .-++++++..||+.||++||+..|+|+
T Consensus 580 --aKl~aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 --AKLHAITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHHhhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 12334444422 1111111 123889999999999999999999987
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=306.50 Aligned_cols=252 Identities=25% Similarity=0.427 Sum_probs=202.4
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|++.+.||+|+||.||+|... +++.+|+|.++.......+.+.+|++++++++||||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 367999999999999999999875 5889999999776666677899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|..++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999998843 2346899999999999999999999998 99999999999999999999999999876533221
Q ss_pred ccccceeccccccccccccc-----CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~-----~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
......+++.|+|||++. ...++.++||||||+++|||++|+.|+....... . ........ .
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~---~~~~~~~~-~----- 225 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--V---LLKILKSE-P----- 225 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--H---HHHHhcCC-C-----
Confidence 123356889999999985 3457889999999999999999999986432211 0 11111100 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+.+ ..+......+.+++..||+.+|++||+++++++
T Consensus 226 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 PTL---DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CCc---CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 001 011122346788999999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=302.08 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=202.0
Q ss_pred cCccccceeeeecceeEEEEEECC----CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
++|.+.+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 568889999999999999998643 2468999887654 4456789999999999999999999998875 567899
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999998432 335889999999999999999999988 99999999999999999999999999987654
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
..... .....++..|+|||.+....++.++||||||++++||++ |+.||....... .. .........
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~---~~~~~~~~~------ 227 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VI---GRIENGERL------ 227 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HH---HHHHcCCcC------
Confidence 32211 112234568999999988889999999999999999986 999986443211 11 111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
. .....+..+.+++.+|+..+|++|||+.++++.|+++.
T Consensus 228 ~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 P-----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred C-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 01112346788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.37 Aligned_cols=198 Identities=25% Similarity=0.415 Sum_probs=160.4
Q ss_pred cceeeeecceeEEEEEEC---CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEe--cCeEEEEEeecC
Q 003280 518 QCKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--QGEKILILEYMP 592 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~ 592 (834)
.++||+|+||+||+|+.. .++.||+|++.... ....+.+|+.++++++||||+++++++.. ....++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 358999999999999864 46789999986542 23567889999999999999999999864 446889999987
Q ss_pred CCCccccccCC------CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE----cCCCCceeeeecce
Q 003280 593 NKSLDVFLFDP------TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL----DMDMNPKISDFGLA 662 (834)
Q Consensus 593 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla 662 (834)
+ +|..++... .....+++..+..++.||+.||+|||+++ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 665554321 12235888999999999999999999998 9999999999999 45678999999999
Q ss_pred eecCCCccc-cccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCC
Q 003280 663 RMFGGDELQ-GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN 721 (834)
Q Consensus 663 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~ 721 (834)
+........ .......+|+.|+|||++.+. .++.++||||+||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876543211 122345789999999999774 58999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.30 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=205.2
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|++.++.++|+|++++++.+......++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999864 57899999986542 33567899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865433456889999999999999999999998 99999999999999999999999999887654322
Q ss_pred cc--ccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 671 QG--NTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 671 ~~--~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. ......++..|+|||++... .++.++|+|||||+++||++|+.|+........ + .+..... .+.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~----~~~~~~~------~~~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-L----MLTLQND------PPS 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-H----HHHhcCC------CCC
Confidence 21 22334688999999999877 789999999999999999999999864332110 1 1111110 011
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+............+.+++..|++.+|++||+++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1011101123456789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.04 Aligned_cols=240 Identities=25% Similarity=0.414 Sum_probs=189.7
Q ss_pred ceeeeecceeEEEEEECC--------CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 519 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+.||+|+||.||+|.... ...||+|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997642 234888988766555667899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC--------ceeeeecce
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN--------PKISDFGLA 662 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Dfgla 662 (834)
+++|+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998543 235789999999999999999999998 999999999999987765 589999988
Q ss_pred eecCCCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCC-CCCCCCCCCcccHhHHHHhHhcCCcc
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGK-KNTGVYNADSFNLLGYAWDLWKDDKF 740 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~ 740 (834)
...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+....... .. .....
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~----~~~~~--- 220 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KL----QFYED--- 220 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HH----HHHHc---
Confidence 654322 234678899999999874 5799999999999999999985 4443221110 00 00000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 741 ~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ---------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00111112246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=312.15 Aligned_cols=254 Identities=20% Similarity=0.246 Sum_probs=195.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+++.. .++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999875 4788999998653 2223456888999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|..++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998532 346788999999999999999999998 999999999999999999999999999876443
Q ss_pred ccccccceecccccccccccccC-----CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
.. .......||+.|+|||++.+ +.++.++|||||||++|||++|+.||....... .............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~~~~i~~~~~~~~- 228 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHEERFQ- 228 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-----HHHHHHcCCCccc-
Confidence 22 11223568999999999875 568899999999999999999999986432111 1111111100000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHH
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAAD--RPTMSDVVS 784 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 784 (834)
+... ......++.+++.+|+..++++ |++++++++
T Consensus 229 ~p~~------~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 FPSH------ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CCCc------cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0000 0112346778888888865544 467888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=304.36 Aligned_cols=251 Identities=32% Similarity=0.485 Sum_probs=197.8
Q ss_pred ceeeeecceeEEEEEECC-------CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 519 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+.||+|+||.||+|+..+ ++.+|||.+.... .....++.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2579999886543 23467889999999999999999999999999999999999
Q ss_pred cCCCCccccccCCC----CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC-----Cceeeeecc
Q 003280 591 MPNKSLDVFLFDPT----KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-----NPKISDFGL 661 (834)
Q Consensus 591 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfgl 661 (834)
+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986432 2244788999999999999999999987 99999999999999877 899999999
Q ss_pred eeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcc
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKF 740 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 740 (834)
++...............++..|+|||++.++.++.++|||||||++|||++ |+.|+...... ..... ...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~----~~~~~- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQH----VTAGG- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHH----HhcCC-
Confidence 987644332222223345678999999999999999999999999999998 99887533211 11111 11100
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 741 ~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
.. ......+..+.+++.+||+.+|++||++.++++.|++
T Consensus 231 ------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ------RL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------cc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 1111234567899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=303.71 Aligned_cols=262 Identities=24% Similarity=0.326 Sum_probs=199.8
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999886 48899999986542 2234668899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++++|..++. ....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998887763 3345889999999999999999999988 9999999999999999999999999998765432
Q ss_pred cccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHH----------hHhcCC
Q 003280 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAW----------DLWKDD 738 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~----------~~~~~~ 738 (834)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ +..... ..+...
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhcccc
Confidence 1 1223457889999999876 5688999999999999999999999865432211 100000 000000
Q ss_pred cc-ccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 739 KF-HELIDPVITQDEIS-----LPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 739 ~~-~~lid~~l~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. .....+.. ..... ......+.+++.+||+.+|++||++.|+++
T Consensus 232 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEP-ETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCc-ccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 00000000 00000 012356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=310.77 Aligned_cols=264 Identities=19% Similarity=0.243 Sum_probs=193.4
Q ss_pred ccceeeee--cceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 517 MQCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 517 ~~~~LG~G--~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++++||+| +|++||++... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999875 58999999987542 233457788999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc-
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL- 670 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~- 670 (834)
++++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+++.||+..........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999884322 234789999999999999999999998 99999999999999999999999986544321110
Q ss_pred ----ccccceecccccccccccccC--CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHh-----------
Q 003280 671 ----QGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWD----------- 733 (834)
Q Consensus 671 ----~~~~~~~~gt~~y~aPE~l~~--~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~----------- 733 (834)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||................
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 001122356778999999976 458999999999999999999999986433211100000000
Q ss_pred --HhcCCccccccccccc----------------cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 734 --LWKDDKFHELIDPVIT----------------QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 734 --~~~~~~~~~lid~~l~----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...........+..+. ...........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000000000000000 00111123457889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=327.89 Aligned_cols=262 Identities=20% Similarity=0.242 Sum_probs=191.0
Q ss_pred HHHHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCC------CcceEEeEEEe
Q 003280 508 VAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHR------NLVKLLGCCVE 580 (834)
Q Consensus 508 ~~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp------nIv~l~~~~~~ 580 (834)
+....++|++.++||+|+||+||+|.+. .++.||||+++... ....++..|+.+++.++|. +++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3345688999999999999999999875 47889999996532 2334567788888877654 58888888876
Q ss_pred c-CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcCCC------
Q 003280 581 Q-GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDM------ 652 (834)
Q Consensus 581 ~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~------ 652 (834)
. .+.++|||++ +++|.+++. +.+.+++..+..++.||+.||+|||++ + ||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 5 4788999988 566777663 335688999999999999999999974 6 99999999999998765
Q ss_pred ----------CceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCC
Q 003280 653 ----------NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA 722 (834)
Q Consensus 653 ----------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~ 722 (834)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 499999998764321 22346789999999999999999999999999999999999999975443
Q ss_pred CcccHhHHHHhHh-------c----CCcccccc------ccccc--------cCC--CCHHHHHHHHHHHHhccccCCCC
Q 003280 723 DSFNLLGYAWDLW-------K----DDKFHELI------DPVIT--------QDE--ISLPVLVRYINVALLCVQDNAAD 775 (834)
Q Consensus 723 ~~~~l~~~~~~~~-------~----~~~~~~li------d~~l~--------~~~--~~~~~~~~l~~li~~cl~~dP~~ 775 (834)
.. ......... . .....++. ++... ... ........+.+|+.+||+.||++
T Consensus 351 ~~--~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 351 LE--HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred HH--HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 11 110000000 0 00000000 00000 000 00011245779999999999999
Q ss_pred CCCHHHHHH
Q 003280 776 RPTMSDVVS 784 (834)
Q Consensus 776 RPs~~evl~ 784 (834)
|||++|+++
T Consensus 429 R~ta~e~L~ 437 (467)
T PTZ00284 429 RLNARQMTT 437 (467)
T ss_pred CCCHHHHhc
Confidence 999999997
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=304.80 Aligned_cols=239 Identities=23% Similarity=0.341 Sum_probs=187.3
Q ss_pred eeeeecceeEEEEEECC-------------------------CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceE
Q 003280 520 KLGEGGFGPVYKGRLLN-------------------------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574 (834)
Q Consensus 520 ~LG~G~~G~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 574 (834)
.||+|+||.||+|.+.. ...|++|++.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999876555556678899999999999999999
Q ss_pred EeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC--
Q 003280 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-- 652 (834)
Q Consensus 575 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-- 652 (834)
++++.+....++||||+++|+|+.++.. ....+++..+..++.||++||+|||+.+ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999988843 2346789999999999999999999987 99999999999997654
Q ss_pred -----CceeeeecceeecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhh-cCCCCCCCCCCCcc
Q 003280 653 -----NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETL-SGKKNTGVYNADSF 725 (834)
Q Consensus 653 -----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~ell-tG~~p~~~~~~~~~ 725 (834)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 3799999998654221 12356788999998875 56899999999999999995 6888875432211
Q ss_pred cHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 726 NLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 726 ~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
.... .... ..+ +.+....+.+++.+||+.+|++||++.++++.|.
T Consensus 230 -~~~~----~~~~-------~~~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 -KERF----YEKK-------HRL-----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHH----HHhc-------cCC-----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1110 0000 001 1111235789999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=316.91 Aligned_cols=261 Identities=23% Similarity=0.254 Sum_probs=195.2
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEec------
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------ 581 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 581 (834)
..++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3478999999999999999999865 4889999999754 233456788899999999999999999988643
Q ss_pred CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecc
Q 003280 582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 661 (834)
...++||||++++ |...+. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~~-l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhccc-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 3579999999764 444442 24788889999999999999999998 99999999999999999999999999
Q ss_pred eeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHH-----------
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGY----------- 730 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~----------- 730 (834)
++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 241 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEF 241 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHH
Confidence 98654322 12235789999999999999999999999999999999999999865331110 0000
Q ss_pred -------HHhHhc-CCccccccccc------cc-cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 731 -------AWDLWK-DDKFHELIDPV------IT-QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 731 -------~~~~~~-~~~~~~lid~~------l~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...... ......+..+. .. ...........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 000000 00000000000 00 00011112346789999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=311.44 Aligned_cols=255 Identities=20% Similarity=0.241 Sum_probs=194.8
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.++||+|+||.||+++... ++.+|+|++.+. .....+.+.+|+.++..++|++|+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478999999999999999998764 778999998643 2223455888999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999853 2345888899999999999999999998 999999999999999999999999999765332
Q ss_pred ccccccceeccccccccccccc-----CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-----~~~~~i~~~~~~~-- 227 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHKERF-- 227 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-----HHHHHHhCCCccc--
Confidence 21 1122357899999999986 346889999999999999999999998643211 1111111111000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCC--CCCCHHHHHHH
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAA--DRPTMSDVVSI 785 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~ 785 (834)
.+ ..........+.+++.+|+..+++ .|++++|+++.
T Consensus 228 ---~~--p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ---QF--PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---cC--CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 000111234567888888765444 46899998774
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=295.13 Aligned_cols=248 Identities=24% Similarity=0.389 Sum_probs=208.3
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+-|.++++||+|+||.||||.++. |+.+|||++.-. ...+++..|+.+|++.+.|++|+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 447788999999999999998764 999999998643 45789999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
..|+..+.+. .+++++.++++..+++.-++||+|||... -||||||..||||+.+|.+||+|||.|-.+....
T Consensus 111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-- 183 (502)
T KOG0574|consen 111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-- 183 (502)
T ss_pred CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--
Confidence 9999999884 45678999999999999999999999986 8999999999999999999999999998765433
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc-cc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI-TQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l-~~ 750 (834)
....++.||+.|||||++.+-.|+.++||||||+...||..|++|+....+-. ..-++.... ..
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------------AIFMIPT~PPPT 248 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------------AIFMIPTKPPPT 248 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------------eeEeccCCCCCC
Confidence 23345799999999999999999999999999999999999999975322110 000111111 01
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
-.-+.....++-+++.+||-..|++|-|+.++++
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 1223445678999999999999999999999887
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.03 Aligned_cols=250 Identities=24% Similarity=0.302 Sum_probs=197.2
Q ss_pred ccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
|+..+.||+|+||+||+|... +++.||+|.+.... ......+.+|++++.+++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999875 58899999986542 22335578899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999998887542 2346899999999999999999999998 9999999999999999999999999997654321
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
......|+..|+|||++.+..++.++|+||||+++|||++|+.||........ ....... .... ..
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~-~~~~--~~-------- 222 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRR-VLET--EE-------- 222 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-hhcc--cc--------
Confidence 11234689999999999999999999999999999999999999864332111 0000000 0000 00
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPT-----MSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 784 (834)
.........+.+++..|++.+|++||+ +.++++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 011112345678999999999999999 566655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=306.76 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=197.1
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.++||+|+||.||+|+.. .++.||+|.++... ......+.+|+.++++++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 67999999999999999999875 47899999986543 33345678899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
++ ++|..++.. ....+++..+..++.||++||+|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 477777643 2345788999999999999999999998 99999999999999999999999999976532221
Q ss_pred ccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC---Ccccccc--
Q 003280 671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD---DKFHELI-- 744 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~---~~~~~li-- 744 (834)
......+++.|+|||++.+. .++.++|||||||++|||++|+.||...+... ........... ......+
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCChhhchhhhcc
Confidence 12224568899999998754 57899999999999999999999986543211 11111000000 0000000
Q ss_pred ----cccccc--C----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 745 ----DPVITQ--D----EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 745 ----d~~l~~--~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...... . .........+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 0 000112346789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.60 Aligned_cols=238 Identities=26% Similarity=0.435 Sum_probs=189.0
Q ss_pred ceeeeecceeEEEEEECCCc-----------EEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 519 CKLGEGGFGPVYKGRLLNGQ-----------EVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999886433 5788887655433 6789999999999999999999999988 788999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC-------Cceeeeec
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-------NPKISDFG 660 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~Dfg 660 (834)
|||+++++|..++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999885422 26889999999999999999999988 99999999999999887 79999999
Q ss_pred ceeecCCCccccccceecccccccccccccCC--ccCccCceeehhhhHHHhhcC-CCCCCCCCCCcccHhHHHHhHhcC
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSG-KKNTGVYNADSFNLLGYAWDLWKD 737 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~t~~~DVwSlGvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~ 737 (834)
++..... .....++..|+|||++.+. .++.++||||||+++|||++| ..|+........ .. ....
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~--~~----~~~~ 221 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK--ER----FYQD 221 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH--HH----HHhc
Confidence 9987543 1123566789999999876 789999999999999999994 666543321110 00 0000
Q ss_pred CccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 738 DKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 738 ~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
. .....+....+.+++.+|++.+|.+||++.|+++.|+
T Consensus 222 ~------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 Q------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0001111157789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=322.18 Aligned_cols=251 Identities=30% Similarity=0.423 Sum_probs=206.5
Q ss_pred cccceeeeecceeEEEEEE-CCCc----EEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 516 SMQCKLGEGGFGPVYKGRL-LNGQ----EVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 516 ~~~~~LG~G~~G~Vy~~~~-~~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
+..++||+|+||+||||.+ .+|+ +||||++... ..+..+++.+|+.+|.+++||||++++++|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 4457999999999999975 3443 6899988654 4556789999999999999999999999998776 889999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|||.|.|.+|+.. .+..+..+..+.|..|||+||.|||++. ++||||..+||||.+...+||.|||+++.+..+.
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999965 3456788999999999999999999987 9999999999999999999999999999998776
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.+.......-.+.|||=|.+....|+.++|||||||.+||++| |..|+.....++. .+.++.+ ..+-+
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI------~dlle~g--eRLsq--- 921 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI------PDLLEKG--ERLSQ--- 921 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh------hHHHhcc--ccCCC---
Confidence 6555555566778999999999999999999999999999998 8888765443221 1111111 01222
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
++-...+++.++.+||..|+..||+++++...+.+
T Consensus 922 -----PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 922 -----PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred -----CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 22234578899999999999999999999887654
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.80 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=204.0
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|++++..++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 67889999999999999999875 48899999876543 34457899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
+++++|..++.. .+.+++..+..++.+++.+|.|||+. + ++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999988732 34688999999999999999999974 5 9999999999999999999999999987543221
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcc------cHhHHHHhHhcCCccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF------NLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~------~l~~~~~~~~~~~~~~~l 743 (834)
.....|+..|+|||++.+..++.++|+|||||++|||++|+.||........ .+...........
T Consensus 159 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 159 ----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred ----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 2235789999999999888999999999999999999999999875433210 1111111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
.+.+ ........+.+++.+|++.||++||++.|+++...-
T Consensus 230 -~~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 230 -PPRL----PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred -CCCC----CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 0111 011134568899999999999999999999986433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=296.78 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=200.0
Q ss_pred CccccceeeeecceeEEEEEECC-CcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEe-cCeEEEEEe
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE-QGEKILILE 589 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E 589 (834)
+|++.+.||+|++|.||++.... ++.||+|++... .....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48889999999999999998754 788999998653 23345678999999999999999999988764 446789999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++++|.+++... ....+++..+..++.+++.|+++||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888542 3345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
.......+++.|+|||++.+..++.++||||||++++||++|+.||...+.. ........ +..
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~~-~~~--------- 219 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVYRIIE-GKL--------- 219 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHh-cCC---------
Confidence 1223356889999999999999999999999999999999999997643211 11111111 111
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..........+.+++.+|++.+|++||++.|+++
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0112233457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=294.77 Aligned_cols=250 Identities=22% Similarity=0.354 Sum_probs=203.3
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+|+..+.||+|+||.||.++.. +++.+++|++... .....+++.+|+.++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788899999999999999864 4889999987643 344567789999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|.+++.... ...+++..+..++.|++++|+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999885432 356889999999999999999999988 99999999999999999999999999987644332
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
......+++.|+|||.+.+..++.++||||||++++||++|+.|+...... ........ +...
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~-~~~~--------- 219 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIVQ-GNYT--------- 219 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHc-CCCC---------
Confidence 223356899999999999888999999999999999999999998543211 11111111 1111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
........++.+++.+|++.+|++||+++|+++.
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 -PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0112234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.88 Aligned_cols=240 Identities=23% Similarity=0.285 Sum_probs=185.3
Q ss_pred eeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhh---cCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL---QHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 521 LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
||+|+||+||+|+.. .++.||||++.+.. ......+..|..++.+. +||||++++..+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 48899999986532 12233455566666655 699999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 99988874 3456889999999999999999999998 9999999999999999999999999987643222 12
Q ss_pred cceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCC
Q 003280 674 TKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~ 752 (834)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... + . .....+. ..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--~---~-~~i~~~~------~~~~~~~ 220 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--M---Y-RNIAFGK------VRFPKNV 220 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--H---H-HHHHcCC------CCCCCcc
Confidence 2345799999999998765 48999999999999999999999986432111 1 1 1111110 0110111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCC----CHHHHHH
Q 003280 753 ISLPVLVRYINVALLCVQDNAADRP----TMSDVVS 784 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~ 784 (834)
...++.+++.+||+.+|++|| ++.|+++
T Consensus 221 ----~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 221 ----LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ----CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 234567899999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=304.17 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=199.9
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+.|+..+.||+|+||.||+|... .++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45677789999999999999865 47789999987543 34456789999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|.+++. ...+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999998873 345789999999999999999999988 99999999999999999999999999987643321
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
......++..|+|||++.+..++.++||||||++++||++|+.|+....... ... ..... ..+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~----~~~~~-----~~~---- 219 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLF----LIPKN-----SPP---- 219 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHh----hhhcC-----CCC----
Confidence 1223467889999999999999999999999999999999999975332211 000 00000 011
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.........+.+++.+|++.+|++||++.|+++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 220 -TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111223456789999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.10 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=203.1
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.+.||+|++|.||++... +++.+|+|++.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999886 48899999987653 34456789999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
+++++|.+++.... ..++...+..++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999885322 568889999999999999999999 77 9999999999999999999999999987653221
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
.....++..|+|||.+.+..++.++||||||+++++|++|+.|+..................... .+.+
T Consensus 156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~- 224 (265)
T cd06605 156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP------PPRL- 224 (265)
T ss_pred ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC------CCCC-
Confidence 11256788999999999999999999999999999999999998654322222221111111110 0011
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
........+.+++.+|+..+|++|||+.|+++
T Consensus 225 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 225 ---PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ---ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 01113456789999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=300.16 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=202.5
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
..|+..+.||+|+||.||+|... .++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45777889999999999999875 48899999987543 34467889999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|.+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999883 235788899999999999999999987 99999999999999999999999999987654322
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
......++..|+|||++.+..++.++|+|||||++|||++|+.|+........ . . .+.... .
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~---~----------~~~~~~-~ 218 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--L---F----------LIPKNN-P 218 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--h---h----------hhhcCC-C
Confidence 12234678899999999988999999999999999999999999764322110 0 0 000000 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
..........+.+++.+||+.+|++||+++++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12233445678899999999999999999999773
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=305.27 Aligned_cols=264 Identities=22% Similarity=0.318 Sum_probs=198.8
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc--ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|++.++||+|+||.||+|... .++.||+|++..... ...+.+.+|+++++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999986 488999999865432 235678899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++++|..+... ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999877632 334889999999999999999999998 9999999999999999999999999998764432
Q ss_pred cccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcc--cHhHHHH-------hHhcCCc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF--NLLGYAW-------DLWKDDK 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~--~l~~~~~-------~~~~~~~ 739 (834)
. ......++..|+|||++.+ ..++.++||||||+++|||++|++|+........ .+..... .......
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 1 1223467889999999875 4578899999999999999999988764322110 0000000 0000000
Q ss_pred c-ccccccccccC----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 740 F-HELIDPVITQD----EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 740 ~-~~lid~~l~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. .....+..... .........+.+++.+||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 00000000000 001122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.61 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=210.2
Q ss_pred HHHHhcCccccceeeeecceeEEEEEECC---Cc--EEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEec
Q 003280 508 VAAATENFSMQCKLGEGGFGPVYKGRLLN---GQ--EVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ 581 (834)
Q Consensus 508 ~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~---g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 581 (834)
....++..+..+.||.|-||.||+|...+ |+ .||||..+.. .....+.|+.|..+|+.++|||||+++|+|.+.
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 34455677778899999999999997543 33 5899999874 455678899999999999999999999999764
Q ss_pred CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecc
Q 003280 582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 661 (834)
..++|||.++-|.|..||.. +...++......++.||+.||+|||+.. +|||||..+|||+...--+||+|||+
T Consensus 464 -P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred -ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 68999999999999999953 4456888889999999999999999987 99999999999999999999999999
Q ss_pred eeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcc
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKF 740 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 740 (834)
++.+..+.+.... ...-++.|||||.+.-.+++.++|||-|||++||+++ |..||........ +
T Consensus 538 SR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------------I 602 (974)
T KOG4257|consen 538 SRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------------I 602 (974)
T ss_pred hhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--------------E
Confidence 9998766544332 3455779999999999999999999999999999988 9999865332111 1
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 741 ~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..+-... +-..++..+..++.|+.+||..+|.+||++.|+...|+++
T Consensus 603 ~~iEnGe--RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 603 GHIENGE--RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred EEecCCC--CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 1111000 1123344566788999999999999999999998877654
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=317.81 Aligned_cols=259 Identities=23% Similarity=0.275 Sum_probs=194.9
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEec------C
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------G 582 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 582 (834)
.++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 478999999999999999999865 4889999999753 233456788999999999999999999987543 3
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
..++||||+++ +|...+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 57999999976 4555442 23778889999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHh---------
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWD--------- 733 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~--------- 733 (834)
+...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...+... .......
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPCPEF 248 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHH
Confidence 8654322 1223578999999999999999999999999999999999999986543211 0000000
Q ss_pred ----------HhcC-Ccc-----cccccccccc--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 734 ----------LWKD-DKF-----HELIDPVITQ--DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 734 ----------~~~~-~~~-----~~lid~~l~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.... ... ..+....... ..........+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 000 0000000000 0001112346789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=301.94 Aligned_cols=265 Identities=25% Similarity=0.316 Sum_probs=199.8
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccc-----cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ-----GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
+|++.+.||+|++|.||+|... +++.||||+++..... ....+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999875 5889999999764322 345677899999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+ +++|..++.... ..+++..+..++.||++||+|||+++ ++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999885322 36899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC---------
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD--------- 737 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~--------- 737 (834)
... ......++..|+|||.+.+ ..++.++|||||||+++||++|.+++....+. ............
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI--DQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH--HHHHHHHHHcCCCchhhhhhc
Confidence 321 1222356788999998865 46789999999999999999997776543321 111111000000
Q ss_pred Ccccccccccc----ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhc
Q 003280 738 DKFHELIDPVI----TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI--INS 788 (834)
Q Consensus 738 ~~~~~lid~~l----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~ 788 (834)
........... ............+.+++.+||+.+|++|||++|+++. +.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 00000000000 0000111224578899999999999999999999984 544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=335.36 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=199.3
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 586 (834)
.++|+++++||+|+||+||+++... ++.||+|.+... .......|..|+.++.+++|||||+++++|... ...+|
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 4789999999999999999998754 678999988653 233456789999999999999999999988653 46899
Q ss_pred EEeecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCC----CceEeccCCCCcEEEcCC----------
Q 003280 587 ILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSR----FRIIHRDLKASNVLLDMD---------- 651 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~ivH~Dlkp~NIll~~~---------- 651 (834)
||||+++++|..+|... .....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.+
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 99999999999988542 223568999999999999999999998542 349999999999999642
Q ss_pred -------CCceeeeecceeecCCCccccccceecccccccccccccC--CccCccCceeehhhhHHHhhcCCCCCCCCCC
Q 003280 652 -------MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSGKKNTGVYNA 722 (834)
Q Consensus 652 -------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~t~~~DVwSlGvvl~elltG~~p~~~~~~ 722 (834)
..+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||.....
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred ccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 348999999998764332 1223578999999999864 4589999999999999999999999864321
Q ss_pred CcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 723 DSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 723 ~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
. ...... +... +.+... ....++.+||..||+.+|++||++.|++. .+..
T Consensus 249 ~----~qli~~-lk~~-------p~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 249 F----SQLISE-LKRG-------PDLPIK----GKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred H----HHHHHH-HhcC-------CCCCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 1 111111 1110 001001 12346789999999999999999999984 5543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=298.86 Aligned_cols=254 Identities=22% Similarity=0.352 Sum_probs=188.8
Q ss_pred ceeeeecceeEEEEEECCC---cEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCC
Q 003280 519 CKLGEGGFGPVYKGRLLNG---QEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
++||+|+||.||+|...++ ..+++|.++... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975443 346677766443 334578999999999999999999999999999999999999999
Q ss_pred CccccccCCC-CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 595 SLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 595 sL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
+|.+++.... .....+...+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999986432 2234567778899999999999999988 99999999999999999999999999865322221122
Q ss_pred cceecccccccccccccC-------CccCccCceeehhhhHHHhhcC-CCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 674 TKRIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLSG-KKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~-------~~~t~~~DVwSlGvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+..... ... ...... +....+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~---~~~~~~-~~~~~~~~ 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REV---LNHVIK-DQQVKLFK 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHH---HHHHHh-hcccccCC
Confidence 223467889999999853 2457899999999999999974 556643221 111 111111 11222333
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
+.+. .....++.+++..|+ .+|++||+++||++.|.
T Consensus 232 ~~~~-----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLE-----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccC-----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3331 112345677888899 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.79 Aligned_cols=250 Identities=30% Similarity=0.451 Sum_probs=191.4
Q ss_pred ceeeeecceeEEEEEECC----CcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEe-cCeEEEEEeecC
Q 003280 519 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE-QGEKILILEYMP 592 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~Ey~~ 592 (834)
+.||+|+||.||+|...+ ...||+|++... .....+.+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 478999999999998632 357999998643 33446788999999999999999999998764 556889999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc-
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ- 671 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 671 (834)
+++|..++... ...+.+..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998532 234577788899999999999999987 999999999999999999999999999865432211
Q ss_pred -cccceecccccccccccccCCccCccCceeehhhhHHHhhcCC-CCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 672 -GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK-KNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 672 -~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
.......++..|+|||.+.+..++.++|||||||++|||++|. +|+.... ...+... ...... ...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~---~~~~~~------~~~- 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVY---LLQGRR------LLQ- 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH---HhcCCC------CCC-
Confidence 1112234577899999999889999999999999999999965 4543221 1111111 111100 000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.. ..+..+.+++.+||+.+|++||++.|+++.|+..
T Consensus 224 ~~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 224 PE----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 01 1124678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.82 Aligned_cols=245 Identities=31% Similarity=0.467 Sum_probs=200.0
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
+.|+-++.||.|+||.||.|+.. +.+.||||++.-. +...+..+..|+..|.+++|||+|.+.|+|......+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34667789999999999999864 5788999998754 4455788999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
|||-| +-.+++. ...+++.+.++..|+.+.++||+|||+++ .||||||..||||.+.|.|||+|||.|.+..+
T Consensus 106 EYClG-SAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 106 EYCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHHhc-cHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 99965 4455542 23456888899999999999999999998 99999999999999999999999999987643
Q ss_pred ccccccceeccccccccccccc---CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~---~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
...++|||.|||||++. .+.|+-++||||||+...||.-.++|.-.++. +...+..-..+ .
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----MSALYHIAQNe------s 242 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNE------S 242 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----HHHHHHHHhcC------C
Confidence 33579999999999984 67899999999999999999999998543321 11111111111 1
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
|.+ ...+....+.+++..||+.-|.+|||.+++++
T Consensus 243 PtL----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 PTL----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCC----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 111 24567778899999999999999999998876
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.63 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=200.1
Q ss_pred CccccceeeeecceeEEEEEECC--CcEEEEEEccCc----------ccccHHHHHHHHHHHHh-hcCCCcceEEeEEEe
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQ----------SGQGLEEFKNEMMLIAK-LQHRNLVKLLGCCVE 580 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~--g~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~ 580 (834)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999765 678999987532 22234567788888865 799999999999999
Q ss_pred cCeEEEEEeecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCcEEEcCCCCceeee
Q 003280 581 QGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDMDMNPKISD 658 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D 658 (834)
.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999998887431 234568899999999999999999996 45 99999999999999999999999
Q ss_pred ecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC
Q 003280 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD 738 (834)
Q Consensus 659 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 738 (834)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ........ ..
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~~~~~-~~ 228 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLATKIV-EA 228 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHHHHHh-hc
Confidence 99998765432 22345688999999999998899999999999999999999999753221 11111111 11
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 739 KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 739 ~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
..... . .. .....+.+++.+|++.||++||++.|+.+++++
T Consensus 229 ~~~~~----~-~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 VYEPL----P-EG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cCCcC----C-cc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11100 0 11 123467899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.71 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=198.7
Q ss_pred ccccceeeeecceeEEEEEEC----CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC------
Q 003280 515 FSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------ 582 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 582 (834)
|++.++||+|+||.||+|.+. .++.||||+++.. .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 3688999998654 2344677899999999999999999999886543
Q ss_pred eEEEEEeecCCCCccccccCCC---CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeee
Q 003280 583 EKILILEYMPNKSLDVFLFDPT---KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDF 659 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 659 (834)
..++++||+++|+|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988774321 2235788899999999999999999988 999999999999999999999999
Q ss_pred cceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCC
Q 003280 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDD 738 (834)
Q Consensus 660 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 738 (834)
|+++...............+++.|++||.+....++.++||||||+++|||++ |+.|+..... ..+..+.. ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~---~~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLI---KGN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHH---cCC
Confidence 99987644332222223345678999999999899999999999999999999 8888753321 11111111 110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 739 KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 739 ~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.. .........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 233 ~~-----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RL-----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cC-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00112234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.09 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=208.5
Q ss_pred HhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
...++.+..+||-|.||.||.|.++. .-.||||.++.. ....++|..|..+|+.++|||+|+++|+|......|+|+|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 34567778899999999999999875 668999999654 4457899999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
||..|+|.+||.+.. ...++.-..+.++.||+.|+.||..++ +|||||..+|+|+.++..+||+|||+++++..+.
T Consensus 344 fM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred cccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 999999999996532 334566677899999999999999998 9999999999999999999999999999987765
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
+..-. ...-.+.|.|||-+....++.|+|||+|||+|||+.| |-.|+...+. ..++.++..+- ++
T Consensus 420 YTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------SqVY~LLEkgy-------RM 485 (1157)
T KOG4278|consen 420 YTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYGLLEKGY-------RM 485 (1157)
T ss_pred eeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH------HHHHHHHhccc-------cc
Confidence 43321 1234678999999999999999999999999999998 6667654321 12333333321 11
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
.+ +.-.+..+++|+++||+..|.+||++.|+-+.|+.
T Consensus 486 ~~---PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 486 DG---PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred cC---CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 11 11234578899999999999999999999887653
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=297.88 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=193.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-----cccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-----GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEK 584 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 584 (834)
.+|+..+.||+|+||.||+|... .++.||+|+++... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999875 48899999886432 22345788999999999999999999988763 578
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999988843 345788999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCcc-ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 665 FGGDEL-QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 665 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
+..... ........++..|+|||.+.+..++.++|||||||++|||++|+.||....... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~~~~~~~~~----- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----AIFKIATQP----- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----HHHHHhcCC-----
Confidence 533211 111223467889999999999889999999999999999999999986432110 011111000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+ ..+......+.+++ +|+..+|++||+++|+++
T Consensus 226 ~~~-----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNP-----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCC-----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 011 11122233455565 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=293.57 Aligned_cols=251 Identities=35% Similarity=0.536 Sum_probs=200.1
Q ss_pred ccccceeeeecceeEEEEEECC-----CcEEEEEEccCcccc-cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 515 FSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
|++.+.||.|+||.||+++..+ +..||+|+++..... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999998754 378999999765433 5678999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999998853221 12899999999999999999999998 999999999999999999999999999877554
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
...... ...+++.|+|||.+.+..++.++||||||++++||++ |+.|+...... .+. ... ......
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~---~~~-~~~~~~------ 223 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVL---EYL-KKGYRL------ 223 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH---HHH-hcCCCC------
Confidence 222211 2336789999999988889999999999999999998 77776542211 111 111 111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 786 (834)
........++.+++.+|++.+|++|||+.|+++.|
T Consensus 224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00111345688899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=296.64 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=200.3
Q ss_pred CccccceeeeecceeEEEEEE-CCCcEEEEEEccCcc------cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS------GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
+|+..+.||+|++|.||+|.. .+++.||+|+++... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 458899999986532 1235678999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC-Cceeeeecceeec
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMF 665 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~ 665 (834)
||||+++++|.+++.. .+.+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998843 346789999999999999999999998 99999999999998776 5999999999876
Q ss_pred CCCccc--cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 666 GGDELQ--GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 666 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
...... .......++..|+|||.+.+..++.++||||+|++++||++|+.|+....... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~----- 227 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALIFKIASAT----- 227 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc--hHHHHHHHhccC-----
Confidence 543211 11123467889999999998889999999999999999999999985432211 111111110000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. ....+.....++.+++.+|++.+|++||++.|+++
T Consensus 228 ~-----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 T-----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred C-----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0 11222234457889999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=313.47 Aligned_cols=260 Identities=26% Similarity=0.317 Sum_probs=194.2
Q ss_pred HHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEec-----
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ----- 581 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 581 (834)
...++|++.+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999864 57899999987542 22345678899999999999999999887643
Q ss_pred -CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeec
Q 003280 582 -GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660 (834)
Q Consensus 582 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 660 (834)
...++++|++ +++|..++. ...+++..+..++.||+.||+|||+++ |+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3578999987 678877662 345889999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC--
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD-- 737 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~-- 737 (834)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.. +...........
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~ 236 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVGTPS 236 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCC
Confidence 99875432 223578999999999877 56899999999999999999999998643211 100000000000
Q ss_pred ---------Ccccccccc--ccccCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 ---------DKFHELIDP--VITQDE---ISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 ---------~~~~~lid~--~l~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
......+.. ...... ........+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 000000 00001234678999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.63 Aligned_cols=260 Identities=26% Similarity=0.363 Sum_probs=201.3
Q ss_pred HHHHHHHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEec-
Q 003280 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ- 581 (834)
Q Consensus 505 ~~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~- 581 (834)
+.++..+.++|++.+.||+|+||.||++... +++.+|+|++.... ...+++.+|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3445556789999999999999999999875 58899999986532 2346778899999999 899999999998754
Q ss_pred ----CeEEEEEeecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCcee
Q 003280 582 ----GEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656 (834)
Q Consensus 582 ----~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 656 (834)
...++||||+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence 3589999999999999887532 23456889999999999999999999988 999999999999999999999
Q ss_pred eeecceeecCCCccccccceecccccccccccccCC-----ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHH
Q 003280 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYA 731 (834)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~ 731 (834)
+|||++......... .....++..|+|||.+... .++.++|||||||++|||++|+.|+....... .+
T Consensus 170 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~---- 242 (291)
T cd06639 170 VDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TL---- 242 (291)
T ss_pred eecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HH----
Confidence 999998875432211 1234678899999998644 36899999999999999999999986432111 01
Q ss_pred HhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 732 WDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 732 ~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...... ....+. ........+.+++.+|++.+|++||++.|+++
T Consensus 243 ~~~~~~-~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 243 FKIPRN-PPPTLL--------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHhcC-CCCCCC--------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 000110 11122346889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=294.73 Aligned_cols=247 Identities=28% Similarity=0.424 Sum_probs=199.6
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-----cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-----GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999876 68999999886533 23456799999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999998843 345789999999999999999999998 99999999999999999999999999887644
Q ss_pred CccccccceecccccccccccccCCc-cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
.. ......++..|+|||.+.... ++.++|+||||+++|||++|+.||...... ............
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~------ 220 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-----AAVFKIGRSKEL------ 220 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-----HHHHHHHhcccC------
Confidence 32 123356888999999998776 899999999999999999999998643311 111111110000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...+......+.+++.+|++.+|++||+++++++
T Consensus 221 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0111122356788999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.99 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=200.9
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||++.... ++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468889999999999999998754 7899999987543 233567889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|..++. ..+.+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999984 3346889999999999999999999988 999999999999999999999999998742111
Q ss_pred cc-------------ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh
Q 003280 669 EL-------------QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 669 ~~-------------~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
.. ........++..|+|||.+.+..++.++|+||||+++|||++|+.||...... .+. ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--~~~---~~~~ 229 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELF---GQVI 229 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH---HHHH
Confidence 00 00111245788999999999889999999999999999999999998532211 111 1111
Q ss_pred cCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
... ...+. ........+.+++.+|++.+|++||++.++.++|+..
T Consensus 230 ~~~----~~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 230 SDD----IEWPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred hcc----cCCCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 100 00000 0012234578999999999999999987777777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.81 Aligned_cols=247 Identities=28% Similarity=0.428 Sum_probs=197.6
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|++.+.||+|+||.||++.. .++.||+|+++... ..+.+.+|+.++.+++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688999999999999999975 67889999986532 346789999999999999999999998654 5799999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999998543 2335789999999999999999999988 9999999999999999999999999997643211
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
.....+..|+|||.+.+..++.++|+||||+++|||++ |+.||....... . . ........ .
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~---~-~~~~~~~~---~------- 216 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--V---K-ECVEKGYR---M------- 216 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--H---H-HHHhCCCC---C-------
Confidence 11234568999999998999999999999999999998 888875432211 1 1 11111100 0
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
......+..+.+++.+|++.+|++||+++++++.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0111223567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.52 Aligned_cols=264 Identities=24% Similarity=0.341 Sum_probs=201.4
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|++.+.||+|++|.||+|... +++.||||+++.. .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999876 4789999998653 23345788999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|++++.+..+.. +...+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999988776552 2345789999999999999999999998 9999999999999999999999999998765443
Q ss_pred cccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHH----------hHhc-C
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAW----------DLWK-D 737 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~----------~~~~-~ 737 (834)
. .......++..|+|||++.+. .++.++||||||+++|||++|+.|+....... .+..... ..+. .
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcccC
Confidence 2 122235678899999999888 88999999999999999999999886432211 0000000 0000 0
Q ss_pred Cccc-----cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 DKFH-----ELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~-----~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.... +..+..............++.+++.+||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 0000000000011112467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.97 Aligned_cols=252 Identities=29% Similarity=0.384 Sum_probs=205.3
Q ss_pred cCccccceeeeecceeEEEEEECC--Cc--EEEEEEccCcccc-cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN--GQ--EVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~--g~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
++.++.++||+|.||.|++|.+.. |+ .||||.++..... ..+.|.+|+.+|.+|+|||+++|+|+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 445567899999999999998753 54 5899999876443 67899999999999999999999999988 788999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
||.++.|+|.+.|++ .....+.......++.|||.||.||..++ +|||||..+|+||-....+||+|||+.+.++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999977 45667788889999999999999999997 99999999999999999999999999999865
Q ss_pred Cc-cccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 668 DE-LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 668 ~~-~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
++ .........-...|+|||.+....++-++|||+|||.||||++ |..||...... ++ .+.+|
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--qI-------------L~~iD 329 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--QI-------------LKNID 329 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--HH-------------HHhcc
Confidence 43 2233333455678999999999999999999999999999999 77787543211 11 11122
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
..- .-.-+....+++++++.+||..+|++|||+..+.+.
T Consensus 330 ~~e-rLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 330 AGE-RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccc-cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 100 111123356789999999999999999999999743
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=304.71 Aligned_cols=197 Identities=26% Similarity=0.421 Sum_probs=159.5
Q ss_pred ceeeeecceeEEEEEECC---CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEe--cCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--QGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~---g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~~ 593 (834)
.+||+|+||.||+|+..+ +..||+|.++... ....+.+|+.++++++||||+++++++.. ....++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 589999999999998653 5789999986543 23567889999999999999999999854 4578999999886
Q ss_pred CCccccccC------CCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE----cCCCCceeeeeccee
Q 003280 594 KSLDVFLFD------PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL----DMDMNPKISDFGLAR 663 (834)
Q Consensus 594 gsL~~~l~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~ 663 (834)
+|..++.. ......+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 55554421 112335788999999999999999999998 9999999999999 566789999999998
Q ss_pred ecCCCccc-cccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCC
Q 003280 664 MFGGDELQ-GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN 721 (834)
Q Consensus 664 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~ 721 (834)
........ .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76543221 122345789999999998764 58999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=296.32 Aligned_cols=254 Identities=27% Similarity=0.397 Sum_probs=197.7
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc----------ccHHHHHHHHHHHHhhcCCCcceEEeEEEecC
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG----------QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG 582 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 582 (834)
+|.+.+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|+.++.+++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999764 588999998753211 12356888999999999999999999999999
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999998843 256889999999999999999999988 999999999999999999999999999
Q ss_pred eecCCCccccccceecccccccccccccCCc--cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcc
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKF 740 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 740 (834)
+...............++..|+|||.+.... ++.++|+||||+++|||++|..|+...... ......... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~-~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMFKLGNK-RS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHHHhhcc-cc
Confidence 8654322222223356889999999987655 899999999999999999999997532111 001111111 01
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...+.. .........+.+++.+|++.+|++||+++||++
T Consensus 230 ~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIPP-----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCCc-----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111111 111123456788999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=301.61 Aligned_cols=265 Identities=25% Similarity=0.279 Sum_probs=195.7
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc-ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++++|.+.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.+++.++|+||+++.+++......++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999865 588999999865432 22346788999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+. ++|..++.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 566555532 2245678888899999999999999998 999999999999999999999999998764322
Q ss_pred ccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC----------
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD---------- 737 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~---------- 737 (834)
.. ......+++.|+|||++.+. .++.++|||||||++|||++|+.||.........+ ...+.....
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL-EKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHH-HHHHHHcCCCChhhhhhhh
Confidence 11 11223568899999998764 57899999999999999999999986543321111 111111000
Q ss_pred --CccccccccccccCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 --DKFHELIDPVITQDE-----ISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 --~~~~~lid~~l~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
............... ........+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 00111346778999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.40 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=194.5
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|+||.||+|+.. +|+.||+|+++... ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999875 58899999986532 22335678899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++ +|..++.. ....+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 975 66666532 2345899999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC------------
Q 003280 671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD------------ 737 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~------------ 737 (834)
.......++..|+|||++.+. .++.++|||||||++|||++|+.|+....+....+ .........
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH-HHHHHHhCCCChHHhHHhhhc
Confidence 112224568899999998765 47999999999999999999998854322211111 000000000
Q ss_pred Ccc--ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 DKF--HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~--~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
... ...................++.+++.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 00000000000011122356789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=293.23 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=205.7
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCccc-ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.+.||+|++|.||+|.... ++.|+||++..... ...+.+.+|+..+.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999998865 89999999876544 4467899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
+++++|.+++.. ...+++..+..++.|+++|++|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999843 2568999999999999999999999 87 9999999999999999999999999998765433
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
.. .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+....... ......... .... +
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~-~~~~-----~--- 221 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--FFELMQAIC-DGPP-----P--- 221 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--HHHHHHHHh-cCCC-----C---
Confidence 22 123567889999999999999999999999999999999999986543211 111111111 1100 1
Q ss_pred cCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 750 QDEISLP-VLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..... ....+.+++.+|++.+|++||++.|+++
T Consensus 222 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 222 --SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred --CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 11111 3457889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=305.21 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=199.4
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
.|.....||+|+||.||++... +++.||||++........+.+.+|+..+..++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444568999999999999875 588999999876655566789999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+++|..++. ...+++..+..++.||+.||+|||+++ |+||||||+||++++++.++|+|||++........
T Consensus 103 ~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 103 GGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 999998873 234789999999999999999999998 99999999999999999999999999876543221
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~ 752 (834)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .... . .. ..+...+.
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~---~-~~-----~~~~~~~~--- 239 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMR---R-IR-----DNLPPRVK--- 239 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH---H-HH-----hcCCCccc---
Confidence 123356889999999999889999999999999999999999997643211 1110 0 00 01111110
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 753 ISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
........+.+++.+|++.+|++|||++|+++.
T Consensus 240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011223457789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=297.49 Aligned_cols=260 Identities=26% Similarity=0.342 Sum_probs=201.4
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc-ccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 588 (834)
++|+..+.||.|++|.||++... .++.+|+|.+..... ....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999985 478999999875432 3457799999999999999999999998654 4689999
Q ss_pred eecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 589 EYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
||+++++|.+++... .....++...+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998876432 23455788999999999999999999998 99999999999999999999999999876532
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+................ ........+.+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~- 231 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-IVNMPNPELKDE- 231 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH-HhcCCchhhccC-
Confidence 21 123457889999999999999999999999999999999999987543211111111111 111111111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. .........+.+++.+|++.+|++|||+.|+++
T Consensus 232 ~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 P---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred C---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 111123457889999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=292.14 Aligned_cols=249 Identities=22% Similarity=0.367 Sum_probs=200.9
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|+||.||++... +++.||+|++... .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5788999999999999999865 5889999998643 233456889999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999998887432 2335788999999999999999999988 99999999999999999999999999987644321
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
......+++.|+|||++.+..++.++|+|||||+++||++|+.|+..... ........... .
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~-~---------- 218 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRGS-Y---------- 218 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcCC-C----------
Confidence 12234678899999999999999999999999999999999999753221 11111111110 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.........++.+++.+|++.+|++||++.||++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0111223446789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=295.89 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=195.5
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-----cccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-----GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEK 584 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 584 (834)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999875 48899999875321 22356788999999999999999999998764 467
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+++++|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999988742 245788889999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... .. ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~-~~~~~~~~----- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AA-IFKIATQP----- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HH-HHHHhcCC-----
Confidence 5432111 1223346888999999999888999999999999999999999998532111 00 00111000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. ....+......+.+++.+|+. +|++||+++|+++
T Consensus 226 ~-----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 T-----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred C-----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0 111223334567788888885 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.87 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=198.6
Q ss_pred ccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
|+....||+|+||.||++... +++.||+|++........+.+.+|+.++..++||||+++++++..+...++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334458999999999999875 5889999998765555567789999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
++|..++. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..+..... .
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 173 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 173 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence 99988763 245789999999999999999999998 99999999999999999999999999876543321 1
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
.....++..|+|||++.+..++.++|||||||+++||++|+.||...... .... ....... ... ..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~----~~~~~~~-----~~~---~~ 239 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMK----RLRDSPP-----PKL---KN 239 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH----HHhccCC-----CCc---cc
Confidence 22356889999999999989999999999999999999999998643211 1110 0111000 000 00
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 754 SLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
.......+.+++.+|++.+|++||+++|+++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11123457789999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=298.69 Aligned_cols=244 Identities=27% Similarity=0.359 Sum_probs=199.4
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||++... +++.||+|+++... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999875 48999999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++.. ...++...+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999998843 356889999999999999999999988 999999999999999999999999999876443
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.|+...... .. ........ .
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~----~~~~~~~~------~-- 215 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--QI----YEKILEGK------V-- 215 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HH----HHHHhcCC------c--
Confidence 22346889999999998888999999999999999999999998643311 00 01111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
..+......+.+++.+||+.+|.+|| +++|+++
T Consensus 216 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 ---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11111235678999999999999999 6777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=299.02 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=204.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 68899999999999999999864 57899999987655555678899999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 99999998832 34788899999999999999999998 99999999999999999999999999876543322
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||.......... .....+ .+. .
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-----~~~~~~------~~~---~ 235 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNG------TPE---L 235 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----ehhcCC------CCC---C
Confidence 1223468889999999998889999999999999999999999986433211100 000000 000 0
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhcc
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSI--INSE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 789 (834)
.........+.+++.+||+.+|++||++.+++.. ++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 1111233467899999999999999999999874 4444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=311.44 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=197.4
Q ss_pred cccceeeeecceeEEEEEECC-CcEEEEEEccC----cccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe--EEEEE
Q 003280 516 SMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSS----QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE--KILIL 588 (834)
Q Consensus 516 ~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--~~lV~ 588 (834)
+..++||+|+|-+||||.+.. |-+||--.++. +++...++|..|+.+|+.|+||||++++..+.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 344699999999999998753 76776544322 245556899999999999999999999999987654 88999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC-CCceeeeecceeecCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~ 667 (834)
|.|..|+|..|+. +.+.++.+.+..|++||++||.|||++. +||||||||-+||+|+.+ |.|||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999984 4455788899999999999999999985 799999999999999765 9999999999998765
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. ...+.|||.|||||+.. ..|++.+||||||++|+||+|+..|+..-. -..-.++....+...+.+.
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV~SGiKP~sl~-- 266 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKKVTSGIKPAALS-- 266 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHHHHcCCCHHHhh--
Confidence 43 23479999999999877 789999999999999999999999975321 1112233333222211111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
... ..++.++|..||.. .++|||+.|+|+ +|...
T Consensus 267 ----kV~---dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 267 ----KVK---DPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ----ccC---CHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 111 23567899999999 899999999998 55543
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=292.95 Aligned_cols=252 Identities=28% Similarity=0.455 Sum_probs=201.3
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc--ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|+||.||+|... +++.|++|.++.... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999865 588999999876544 3677899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|.+++.. ...+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999998843 345788999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccc--cceecccccccccccccCCc---cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 671 QGN--TKRIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 671 ~~~--~~~~~gt~~y~aPE~l~~~~---~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
... .....++..|+|||++.+.. ++.++||||||++++||++|+.||........ ....... . ..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~----~~~~~~~-~-----~~ 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ----IMFHVGA-G-----HK 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH----HHHHHhc-C-----CC
Confidence 111 12356788999999998766 89999999999999999999999864321110 1111100 0 01
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+.+.. .......+.+++.+|++.+|++||++.|++.
T Consensus 225 ~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPD---SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCc---ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11100 0111345678999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=296.38 Aligned_cols=254 Identities=27% Similarity=0.425 Sum_probs=199.9
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecC------
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG------ 582 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~------ 582 (834)
.+++|++.+.||+|++|.||+|... .++.+++|++..... ..+++.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4588999999999999999999875 478899999875543 346799999999999 6999999999997654
Q ss_pred eEEEEEeecCCCCccccccCCC-CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecc
Q 003280 583 EKILILEYMPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 661 (834)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999998875422 2456889999999999999999999998 99999999999999999999999999
Q ss_pred eeecCCCccccccceecccccccccccccC-----CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhc
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWK 736 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~ 736 (834)
+....... .......++..|+|||++.. ..++.++||||||++|+||++|+.||....... .+ .....
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~----~~~~~ 232 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-AL----FKIPR 232 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HH----HHhhc
Confidence 88654322 11223568889999998853 346889999999999999999999985322111 01 11111
Q ss_pred CCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 737 DDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 737 ~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. ..+.+ .........+.+++.+||..||++|||+.|+++
T Consensus 233 ~------~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 N------PPPTL---KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred c------CCCCC---CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 00111 111223457889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=297.44 Aligned_cols=262 Identities=25% Similarity=0.359 Sum_probs=200.1
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999875 58899999987643 33457899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+ +++|.+++... ...+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999887532 256899999999999999999999998 99999999999999999999999999987654321
Q ss_pred ccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC-----------
Q 003280 671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD----------- 738 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~----------- 738 (834)
.......++..|+|||.+.+. .++.++||||||++++||++|++++....+. .............
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--EQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--HHHHHHHHHcCCCChHHHhhccCc
Confidence 112235688999999998754 4689999999999999999998777543221 1111111110000
Q ss_pred -cccccccccccc---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 739 -KFHELIDPVITQ---DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 739 -~~~~lid~~l~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
....+..+.... ..........+.+++.+|++.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000000 0000112367889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=292.19 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=199.7
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|+||.||++... .++.+|||++... .......+.+|++++++++|||++++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999874 5889999998654 233467899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC-CceeeeecceeecCCCc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~ 669 (834)
+++++|.+++... ....+++..+..++.+++++|+|||+++ ++|+||+|+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998542 2345789999999999999999999998 99999999999998654 58999999998765432
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
......++..|+|||.+.+..++.++||||||+++|+|++|+.|+...+... ....... .....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~~~~~~~-~~~~~------- 220 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----LVLKIMS-GTFAP------- 220 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----HHHHHHh-cCCCC-------
Confidence 1223467889999999998889999999999999999999999986433211 1111111 00011
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
........+.+++.+||+.+|++|||++|+++
T Consensus 221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11122346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=298.79 Aligned_cols=263 Identities=24% Similarity=0.315 Sum_probs=195.5
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc-ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.+.||+|++|.||+|... +++.||||.+..... .....+.+|++++++++|+||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999875 588999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++ +|..++... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 888877432 236789999999999999999999998 99999999999999999999999999875432111
Q ss_pred ccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC---cc------
Q 003280 671 QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD---KF------ 740 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---~~------ 740 (834)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ......+...... ..
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHhcCCCChhhhhhhhhc
Confidence 1112346788999999875 458999999999999999999999986443211 1111111111000 00
Q ss_pred ---ccc----c-ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 741 ---HEL----I-DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 741 ---~~l----i-d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
... . ...+............+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0 0000000000011246779999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=295.75 Aligned_cols=247 Identities=23% Similarity=0.428 Sum_probs=198.6
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhc---CCCcceEEeEEEecCeEEEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQ---HRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.|++.+.||+|+||.||+|... +++.||+|.++.. .....+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4778889999999999999874 5889999998654 3344577889999999997 999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988732 36889999999999999999999998 999999999999999999999999999877544
Q ss_pred ccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. ......|+..|+|||.+.++ .++.++||||||+++|||++|+.|+....... ... .. .....+.
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~-~~-----~~~~~~~ 221 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMM-LI-----PKSKPPR 221 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhh-cc-----ccCCCCC
Confidence 31 12234688899999998754 47899999999999999999999986432111 000 00 0000111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+... ....++.+++.+|++.+|++||++.|+++
T Consensus 222 ~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LEDN----GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111 13346789999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=296.07 Aligned_cols=251 Identities=25% Similarity=0.323 Sum_probs=207.1
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
.+.|+.-++||+|+||.||-.+.. .|+-+|.|++.+. ..+......+|-.+|.+++.+.||.+-.+|+..+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 367888899999999999998765 4899999988543 334455678899999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
+..|.||+|.-+|++.. .+.++++.++.++.+|+.||.+||... ||.|||||+|||||+.|+++|+|+|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999997643 367999999999999999999999998 99999999999999999999999999998876
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.+.. ...+||.+|||||++.++.|+...|.|||||+||||+.|+.||....+. ...+-+|.+
T Consensus 340 g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK---------------vk~eEvdrr 401 (591)
T KOG0986|consen 340 GKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK---------------VKREEVDRR 401 (591)
T ss_pred CCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh---------------hhHHHHHHH
Confidence 5432 2238999999999999999999999999999999999999998643321 111122222
Q ss_pred cc--cCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 748 IT--QDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 748 l~--~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
+. ...++....+++..+....|+.||++|. .+.+|-+
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 21 2234455566788888999999999996 4556644
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=302.92 Aligned_cols=253 Identities=24% Similarity=0.291 Sum_probs=201.1
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCccc---ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|++|.||++.... ++.||+|.+..... ...+.+.+|++++.+++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468889999999999999998764 89999999876432 24567899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+.+++|.+++.. .....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998743 23456889999999999999999999998 999999999999999999999999998765322
Q ss_pred ccc---------------------------cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCC
Q 003280 669 ELQ---------------------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN 721 (834)
Q Consensus 669 ~~~---------------------------~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~ 721 (834)
... .......|+..|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01112467889999999999899999999999999999999999986433
Q ss_pred CCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 003280 722 ADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPT----MSDVVS 784 (834)
Q Consensus 722 ~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 784 (834)
.... + ... .+..... .........+.+++.+|++.+|++||+ ++|++.
T Consensus 237 ~~~~-~----~~~---------~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET-F----SNI---------LKKEVTF-PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH-H----HHH---------hcCCccC-CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2111 0 000 1111100 001113457889999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=295.62 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=192.4
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHH-HHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMML-IAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|++.+.||+|+||.||+|... +|+.||+|+++... .....++..|+.. ++.++||||+++++++......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999875 58999999987543 2233455566665 556689999999999999999999999
Q ss_pred ecCCCCccccccC-CCCCCcCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 590 YMPNKSLDVFLFD-PTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 590 y~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|++ ++|..++.. ......+++..+..++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 577666643 22345689999999999999999999987 6 99999999999999999999999999986543
Q ss_pred CccccccceecccccccccccccC----CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~----~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+.........+. .....
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~------ 223 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK----QVVEE------ 223 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH----HHHhc------
Confidence 21 1122467889999998865 4568999999999999999999999854322111111 11110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+.+.. ...+.++.+++.+||+.+|++||+++++++
T Consensus 224 ~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PSPQLPA----EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011101 112346789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=294.06 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=200.7
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEe--cCeEEEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--QGEKILIL 588 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~ 588 (834)
+|++.+.||+|+||.||++... +++.+|+|++... .....+++.+|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 5789999998643 23345678899999999999999999998764 44689999
Q ss_pred eecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcC--CCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 589 EYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYS--RFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
||+++++|..++... .....+++..+..++.||+.||+|||..+ ...++|+||+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999888542 22456899999999999999999999332 223999999999999999999999999999887
Q ss_pred CCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
...... .....+++.|+|||.+.+..++.++|+||||+++++|++|+.|+...... .+. ........
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~----~~~~~~~~----- 227 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QLA----SKIKEGKF----- 227 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HHH----HHHhcCCC-----
Confidence 543321 22346889999999999988999999999999999999999998654311 111 11111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
...+......+.+++.+|++.+|++||+++||++.
T Consensus 228 -----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11122334578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.58 Aligned_cols=247 Identities=25% Similarity=0.388 Sum_probs=199.5
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
-|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.+++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4677889999999999999864 57899999886442 334567889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|..++. ...+++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999998873 345789999999999999999999988 99999999999999999999999999987644321
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
......++..|+|||.+.+..++.++|+|||||++|||++|..|+....... . .... .... . .
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~---~~~~-~~~~-~---------~ 219 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--V---LFLI-PKNN-P---------P 219 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--H---HHHH-hcCC-C---------C
Confidence 1223467889999999998889999999999999999999999975432110 0 1110 0000 0 0
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
.........+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1111223467889999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.85 Aligned_cols=266 Identities=22% Similarity=0.321 Sum_probs=196.4
Q ss_pred CccccceeeeecceeEEEEEECC---CcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKI 585 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~---g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 585 (834)
+|++.++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999998754 7899999997633 44456788899999999999999999999988 7899
Q ss_pred EEEeecCCCCccccccC-CC-CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC----CCCceeeee
Q 003280 586 LILEYMPNKSLDVFLFD-PT-KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM----DMNPKISDF 659 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~-~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 659 (834)
+||||+++ +|..++.. .. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 44444422 12 2236889999999999999999999998 999999999999999 899999999
Q ss_pred cceeecCCCcc-ccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccH-------hHH
Q 003280 660 GLARMFGGDEL-QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNL-------LGY 730 (834)
Q Consensus 660 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l-------~~~ 730 (834)
|++........ ........++..|+|||.+.+. .++.++||||||++++||++|+.||.......... ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1122335678899999988764 57999999999999999999999987554332000 000
Q ss_pred HHhHhc------------CCccccccccccccCCCC---H--------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 731 AWDLWK------------DDKFHELIDPVITQDEIS---L--------PVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 731 ~~~~~~------------~~~~~~lid~~l~~~~~~---~--------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
....+. ........+... ....+ . ....++.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFK-TKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhcc-CCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 000000000000 00000 0 12346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=287.39 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=205.0
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc--ccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeEEEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKILIL 588 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 588 (834)
+|++.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999886 588999999876542 4567899999999999999999999999988 8999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999843 237899999999999999999999987 999999999999999999999999999987654
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
..........++..|+|||.+.+..++.++||||||+++++|++|+.|+..... ..............
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~-------- 222 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYKIGSSGEP-------- 222 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHhccccCCC--------
Confidence 321112335688899999999988899999999999999999999999865441 11111111110000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...+......+.+++.+|++.+|++||++.|+++
T Consensus 223 --~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 --PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred --cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1112222457889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=297.35 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=198.6
Q ss_pred HHHHHHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEe---
Q 003280 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVE--- 580 (834)
Q Consensus 506 ~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~--- 580 (834)
.++....+.|++.+.||+|+||.||+|... .++.+|+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 344445678999999999999999999875 47899999886543 3346788899999998 69999999999853
Q ss_pred ---cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceee
Q 003280 581 ---QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS 657 (834)
Q Consensus 581 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 657 (834)
....+++|||+++|+|..++... ....+++..+..++.||+.||+|||+.+ |+|+||+|+||++++++.++|+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence 45789999999999999888532 2345778888999999999999999998 9999999999999999999999
Q ss_pred eecceeecCCCccccccceeccccccccccccc-----CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHH
Q 003280 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAW 732 (834)
Q Consensus 658 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~ 732 (834)
|||++....... .......|+..|+|||++. ...++.++|||||||++|||++|+.||........ . .
T Consensus 164 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-~----~ 236 (282)
T cd06636 164 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-L----F 236 (282)
T ss_pred eCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-h----h
Confidence 999987653221 1123356889999999986 34688899999999999999999999854321110 0 0
Q ss_pred hHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 733 DLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 733 ~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. .....+.+ ........+.+++.+||+.+|.+||++.|+++
T Consensus 237 ~~------~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 LI------PRNPPPKL----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hH------hhCCCCCC----cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 00001111 11123346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=298.20 Aligned_cols=260 Identities=24% Similarity=0.338 Sum_probs=195.9
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|++|.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 58899999986542 23346789999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+. ++|..++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 5787777432 2346889999999999999999999998 99999999999999999999999999876543221
Q ss_pred ccccceecccccccccccccCCc-cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC-----------
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD----------- 738 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~-~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~----------- 738 (834)
......++..|+|||++.+.. ++.++||||||+++|||++|+.||....+.. .+.... ......
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIF-RTLGTPDEVVWPGVTSL 231 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHH-HHhCCCChhhhhhhhHH
Confidence 112235678999999887654 6889999999999999999999986533211 111000 000000
Q ss_pred -----ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 739 -----KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 739 -----~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.+.......+ ..........+.+++.+|++.||++||+++|+++
T Consensus 232 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDF--SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCH--HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 0000112345778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.17 Aligned_cols=249 Identities=30% Similarity=0.457 Sum_probs=203.4
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
+|++.+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+|++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999986 588999999977655566889999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+++|.+++... ...+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999988432 256899999999999999999999987 99999999999999999999999999987654332
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~ 752 (834)
.....++..|+|||.+.+..++.++||||||+++++|++|+.|+....... ... . ...........
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~---~-~~~~~~~~~~~------- 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--ALF---K-IATNGPPGLRN------- 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--HHH---H-HHhcCCCCcCc-------
Confidence 234578889999999998889999999999999999999999976432111 000 0 00000111100
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 753 ISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111356889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=298.47 Aligned_cols=263 Identities=25% Similarity=0.320 Sum_probs=194.6
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 586 (834)
.++|++.+.||+|+||.||+|... +|+.||+|+++... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 368999999999999999999875 48999999986432 22234567899999999999999999998765 46899
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+.+ +|..++... ...+++..+..++.||++||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 677666432 256889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC--Cccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD--DKFHEL 743 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~~~~l 743 (834)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ........... ......
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE--QLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCChhhchh
Confidence 4321 1122345788999999875 458999999999999999999999986433211 11111110000 000000
Q ss_pred c-------ccccccCCC-C-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 744 I-------DPVITQDEI-S-----LPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 744 i-------d~~l~~~~~-~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+ ...+..... . ......+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000000000 0 012346678999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=292.05 Aligned_cols=247 Identities=24% Similarity=0.282 Sum_probs=200.7
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
+|++.+.||.|+||.||+|... .++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999876 48899999987542 2346789999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++++|..++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999998843 256889999999999999999999998 9999999999999999999999999998764432
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+......... ........ .
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~--~--------- 217 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD---QIRAKQET--A--------- 217 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH---HHHHHhcc--c---------
Confidence 122356788999999999888999999999999999999999998754432111 11111110 0
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTM--SDVV 783 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 783 (834)
....+......+.+++.+|++.+|.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111112233678899999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=295.08 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=203.5
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++.|+..+.||+|++|.||+|.+. .++.|++|++..... ..+.+.+|++++++++|+|++++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4467888899999999999999886 588999999976544 56788999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999985422 36899999999999999999999988 9999999999999999999999999987654322
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
. ......++..|+|||++.+..++.++||||||+++|||++|+.|+....... .. .... ...... .
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~---~~~~-~~~~~~-----~- 236 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--AL---FLIT-TKGIPP-----L- 236 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HH---HHHH-hcCCCC-----C-
Confidence 1 1223457889999999998889999999999999999999999975432211 00 0000 000000 0
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.........+.+++.+|++.+|.+||++.++++
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 --KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 001112346789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.22 Aligned_cols=247 Identities=24% Similarity=0.348 Sum_probs=198.5
Q ss_pred ccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444569999999999999864 5889999998765555567789999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
++|.+++.. ..+++..+..++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 999998843 45789999999999999999999998 99999999999999999999999999876543321 1
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... .. ... ..... .+.+ . .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~---~~~-~~~~~-----~~~~-~--~ 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QA---MKR-IRDNL-----PPKL-K--N 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HH---HHH-HHhcC-----CCCC-c--c
Confidence 22346889999999999889999999999999999999999997532211 11 111 11110 0111 0 0
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 754 SLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.......+.+++.+||+.+|++||+++++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1112346889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=293.58 Aligned_cols=263 Identities=25% Similarity=0.366 Sum_probs=198.5
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc-ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+|++.++||+|++|.||+|+.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999985 488999999876532 23567788999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++ +|.+++........+++..+..++.||+.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 77777754444456899999999999999999999998 99999999999999999999999999976533211
Q ss_pred cccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhc---CCccc-----c
Q 003280 672 GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWK---DDKFH-----E 742 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~~~~~-----~ 742 (834)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ......... ..... .
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhHHHHhcCc
Confidence 11224568899999988664 578999999999999999999999865432211 000000000 00000 0
Q ss_pred cccccccc------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 743 LIDPVITQ------DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 743 lid~~l~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
........ ..........+.+++..|++.+|++||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0011122356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=301.31 Aligned_cols=245 Identities=24% Similarity=0.371 Sum_probs=205.6
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
...|.+.++||+|.|++|.+|++. .+..||||.+.+.. ....+.+.+|+++|..++|||||+++.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 367899999999999999999875 48999999997753 333456889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+.+|.+.+++.. .+.+.+.....++.|+..|++|||+++ |+|||||++||||+.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999943 344556888899999999999999998 999999999999999999999999999987533
Q ss_pred ccccccceecccccccccccccCCcc-CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~-t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
......+|++.|.|||++.+..| ++++|+||+|++||-|+.|..||+...-. ++-++.
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk------------------~Lr~rv 267 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK------------------ELRPRV 267 (596)
T ss_pred ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc------------------cccchh
Confidence 33456799999999999998887 68999999999999999999998753321 111111
Q ss_pred cccC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 748 ITQD--EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 748 l~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+ .+ .++.....++.+++.++|-.+|.+|++++++.+
T Consensus 268 l-~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 268 L-RGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred e-eeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 1 11 223333457889999999999999999999976
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=301.77 Aligned_cols=262 Identities=24% Similarity=0.292 Sum_probs=196.4
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEec------
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------ 581 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 581 (834)
..++|++.+.||+|+||.||+|... .++.||||++... .....+++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3478999999999999999999875 5889999998653 233456778899999999999999999988643
Q ss_pred CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecc
Q 003280 582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 661 (834)
...++||||+.+ +|...+.. .++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 357999999965 66666522 2788899999999999999999998 99999999999999999999999999
Q ss_pred eeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcc-------------cHh
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF-------------NLL 728 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~-------------~l~ 728 (834)
++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... .+.
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 987644321 2234678899999999999999999999999999999999999865432100 000
Q ss_pred HH---HHhHhcC-------Ccccccccccccc---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 729 GY---AWDLWKD-------DKFHELIDPVITQ---DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 729 ~~---~~~~~~~-------~~~~~lid~~l~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. ....... ..+.++....+.. ..........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0000000 0001111111100 0001123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=294.23 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=196.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 587 (834)
++|++.+.||+|+||.||+|... +++.+|+|.++... ......+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888999999999999999886 48899999986543 22334677899999999999999999999877 889999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++ +|..++... ...+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999985 887776432 236899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCccc--HhHH-------HHhHhcC
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFN--LLGY-------AWDLWKD 737 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~--l~~~-------~~~~~~~ 737 (834)
.. .......+++.|+|||.+.+. .++.++|+||||++++||++|+.||......... +... .|..+..
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 32 112234578899999998764 4689999999999999999999998654321100 0000 0000000
Q ss_pred ------CccccccccccccCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 ------DKFHELIDPVITQDEISLP-VLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 ------~~~~~lid~~l~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..........+ ....... ....+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000 0011111 2446778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=294.44 Aligned_cols=264 Identities=23% Similarity=0.286 Sum_probs=194.2
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCe-----
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGE----- 583 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~----- 583 (834)
++|++.+.||+|+||.||+|... +++.||||+++... ......+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999875 58899999876542 223467888999999995 6999999999987665
Q ss_pred EEEEEeecCCCCccccccCCCC--CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-CCCceeeeec
Q 003280 584 KILILEYMPNKSLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFG 660 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg 660 (834)
.++||||+++ +|..++..... ...+++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 77777643322 346899999999999999999999998 999999999999998 8999999999
Q ss_pred ceeecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK 739 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 739 (834)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+.... .......
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~-~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIF-KLLGTPT 232 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHH-HHhCCCC
Confidence 9986533211 1112356788999998865 457999999999999999999999986533211 111100 0000000
Q ss_pred ---ccc---ccc----ccccc---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 740 ---FHE---LID----PVITQ---DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 740 ---~~~---lid----~~l~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
... ..+ +.... .........++.+++.+||+.+|.+||+++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 000 00000 0000113456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=301.57 Aligned_cols=268 Identities=22% Similarity=0.321 Sum_probs=198.2
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC-----eE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-----EK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~ 584 (834)
+++|++.++||+|+||.||+|... +++.||||+++.. .......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999864 5889999998653 2334567889999999999999999998876543 57
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++|+||+++ +|..++ ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 666655 3346889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc---
Q 003280 665 FGGDELQ-GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK--- 739 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--- 739 (834)
....... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.. ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCHHH
Confidence 6432211 11223568899999998755 56899999999999999999999998643211 11111111111000
Q ss_pred cccccccc-------c-ccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhcc
Q 003280 740 FHELIDPV-------I-TQDEIS-----LPVLVRYINVALLCVQDNAADRPTMSDVVSI--INSE 789 (834)
Q Consensus 740 ~~~lid~~-------l-~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 789 (834)
...+.+.. . ...... .....++.+++.+||+.+|++|||+.|+++. |+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00000000 0 000001 1123568899999999999999999999884 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-34 Score=305.84 Aligned_cols=251 Identities=24% Similarity=0.416 Sum_probs=204.7
Q ss_pred cCccccceeeeecceeEEEEEECCCc-EEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQ-EVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~-~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.|+|+..||.|+||.||||..++.. .-|.|++...+....+.|+-|+++|+..+||+||++++.|...+.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 56788889999999999999876544 45678887778888899999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
.||-.+..+.. -++.+.+.++.-+++|++.||.|||++. |||||||..|||++-+|.++|+|||.+..... ..
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR 184 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence 99999988743 4567899999999999999999999998 99999999999999999999999998764321 12
Q ss_pred cccceeccccccccccccc-----CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~-----~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
.....+.|||.|||||+.. ..+|+.++||||||+.|.||..+.+|-...+ .+....+.-..+ ...++
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-----pMRVllKiaKSe-PPTLl-- 256 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKSE-PPTLL-- 256 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-----hHHHHHHHhhcC-CCccc--
Confidence 2334579999999999875 5689999999999999999999998854322 111111111111 11111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.+......+.+++..||..||+.||++.++++
T Consensus 257 ------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 ------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 23345677889999999999999999999987
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=295.20 Aligned_cols=246 Identities=30% Similarity=0.443 Sum_probs=194.5
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
+.|++.+.||+|+||.||+|... +++.||+|++.... ....+++.+|+++++.++||||+++.+++.+....++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56888899999999999999875 58899999986432 233467889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++ ++.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 95 e~~~g-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCLG-SASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhCC-CHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99974 55555432 2345889999999999999999999998 999999999999999999999999998765322
Q ss_pred ccccccceeccccccccccccc---CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~---~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
....++..|+|||++. ...++.++||||||+++|||++|+.|+....... ........+ .
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-----~~~~~~~~~-~----- 231 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQND-S----- 231 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-----HHHHHhcCC-C-----
Confidence 2246788999999884 4568899999999999999999999975332111 011111100 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
+.+ ........+.+++.+||+.+|++||++.+++..
T Consensus 232 ~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTL----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCC----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111 111234568899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=286.85 Aligned_cols=242 Identities=26% Similarity=0.368 Sum_probs=194.7
Q ss_pred eeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCc
Q 003280 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
||.|++|.||+++... ++.+|+|++.... ....+.+.+|+.++++++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999854 8899999986542 23456799999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccce
Q 003280 597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (834)
.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999843 345889999999999999999999988 9999999999999999999999999998765432 1223
Q ss_pred ecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHH
Q 003280 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~ 756 (834)
..++..|+|||.+.+..++.++|+||||+++|||++|+.|+.....+..... ........ ....+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~----------~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY---NDILKGNG----------KLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH---HHHhccCC----------CCCCCcc
Confidence 4678899999999888899999999999999999999999875443221111 11110000 0111111
Q ss_pred HHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003280 757 VLVRYINVALLCVQDNAADRPT-----MSDVVS 784 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 784 (834)
...++.+++.+||+.+|++||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2457889999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=287.21 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=199.2
Q ss_pred CccccceeeeecceeEEEEEECC-CcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... ....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47888999999999999998764 7899999986532 23456788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC-ceeeeecceeecCCCc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN-PKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~~~~~~ 669 (834)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988542 2235789999999999999999999988 999999999999988864 6999999998764332
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
. ......|++.|+|||++.+..++.++||||||++++||++|+.|+..... ......... ....
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~-~~~~-------- 220 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKICQ-GYFA-------- 220 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhc-ccCC--------
Confidence 1 12224688899999999988899999999999999999999999754321 111111111 1111
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.........+.+++.+|++.+|++|||+.|+++
T Consensus 221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 --PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111122346789999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-33 Score=278.92 Aligned_cols=247 Identities=24% Similarity=0.302 Sum_probs=201.7
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccccc---HHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQG---LEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
-++|..+++||+|.||.|-+++.+ .++.+|||++++.--.. ...-..|-++|+..+||.+..+...|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 378999999999999999999865 48999999998763332 33445688899999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||..+|.|.-+| .+.+.+++.....+-..|+.||.|||+.+ ||.||||.+|+|||.+|++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999998888 45677888888999999999999999988 99999999999999999999999999986422
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcc-cHhHHHHhHhcCCcccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF-NLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~lid~ 746 (834)
....+++++|||.|+|||++....|..++|.|.+||++|||++|+.||-..+.+.. .+. +-.
T Consensus 321 --~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI---------------l~e 383 (516)
T KOG0690|consen 321 --YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI---------------LME 383 (516)
T ss_pred --ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH---------------Hhh
Confidence 23456678999999999999999999999999999999999999999864433221 111 000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
.-..+.....+...|+...|..||.+|. .++||.+
T Consensus 384 ---d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 384 ---DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ---hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 1112222334567888899999999995 3566544
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=288.62 Aligned_cols=242 Identities=24% Similarity=0.289 Sum_probs=186.1
Q ss_pred eeeeecceeEEEEEEC-CCcEEEEEEccCccc---ccHHHHHHHHHHHHh---hcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAK---LQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 520 ~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~---l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
.||+|+||.||++... +++.+|+|.+.+... .....+.+|..++.. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 488999998865321 122334455444443 479999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999998874 3346899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ...... ... .
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~------~~~-----~ 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTL------TVN-----V 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH---HHHHhh------cCC-----c
Confidence 123468999999999864 568999999999999999999999986433221111 000000 001 1
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRP-----TMSDVVSI 785 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 785 (834)
..+.....++.+++.+||+.||++|| +++|+++.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11222345778999999999999999 59998873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=298.73 Aligned_cols=264 Identities=20% Similarity=0.296 Sum_probs=198.5
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEe----cCeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE----QGEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~ 584 (834)
.++|++.+.||+|++|.||+|... .++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999875 48999999987542 2345678889999999999999999988763 3468
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+. ++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 57877773 3345899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc--cccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHH---------
Q 003280 665 FGGDELQ--GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAW--------- 732 (834)
Q Consensus 665 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~--------- 732 (834)
....... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~--~~~~~~~~~g~~~~~ 234 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--QLKLILSVLGSPSEE 234 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH--HHHHHHHHhCCChhH
Confidence 6433211 11123478889999999865 468999999999999999999999986433211 000000
Q ss_pred --hHhcCCccccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 733 --DLWKDDKFHELIDPVITQDEIS-----LPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 733 --~~~~~~~~~~lid~~l~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.....+...+..+..-...... .....++.+++.+||+.+|++||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0001111111111100011111 123457889999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=292.54 Aligned_cols=262 Identities=23% Similarity=0.318 Sum_probs=194.9
Q ss_pred ccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
|++.+.||+|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|||++++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999875 58999999986543 233467889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
+ ++|..++.... ...+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 68888774322 235899999999999999999999987 99999999999999999999999999976533211
Q ss_pred cccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC-----------Cc
Q 003280 672 GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD-----------DK 739 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~-----------~~ 739 (834)
......++..|+|||++.+. .++.++||||||+++|||++|+.||....... .+.......... ..
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchh
Confidence 11223568899999988764 57899999999999999999999986543211 111100000000 00
Q ss_pred ccccccccc--ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 740 FHELIDPVI--TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 740 ~~~lid~~l--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
....+.... ............+.+++.+|++.+|++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 000001112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=275.34 Aligned_cols=280 Identities=23% Similarity=0.315 Sum_probs=202.2
Q ss_pred HhcCccccceeeeecceeEEEEEECC-----CcEEEEEEccCcccc--cHHHHHHHHHHHHhhcCCCcceEEeEEEe-cC
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQSGQ--GLEEFKNEMMLIAKLQHRNLVKLLGCCVE-QG 582 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~-----g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 582 (834)
....|+....||+|.||.||||.-.+ .+.+|||+++..... ......+|+.+++.++||||+.+..++.+ +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34678999999999999999995432 347999999765332 23567889999999999999999999987 77
Q ss_pred eEEEEEeecCCCCcccccc--CCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC----CCcee
Q 003280 583 EKILILEYMPNKSLDVFLF--DPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD----MNPKI 656 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl 656 (834)
..+|++||.+... ...++ ...+.+.++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+||
T Consensus 102 ~v~l~fdYAEhDL-~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEHDL-WHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhhhH-HHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 8999999998854 44442 2344568999999999999999999999998 9999999999999777 89999
Q ss_pred eeecceeecCCCccc-cccceecccccccccccccCCc-cCccCceeehhhhHHHhhcCCCCCCCCCCC-----cc--cH
Q 003280 657 SDFGLARMFGGDELQ-GNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGKKNTGVYNAD-----SF--NL 727 (834)
Q Consensus 657 ~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~-~t~~~DVwSlGvvl~elltG~~p~~~~~~~-----~~--~l 727 (834)
+|||+++.+...-.. .....++-|..|.|||.+.+.. ||.+.|||+.|||+.||++-++-|.....+ .. +.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999998654222 2344578899999999998864 899999999999999999998877543221 11 11
Q ss_pred hHHHHhHhcCC---cccc---c------ccccccc--CCCCHHH--------HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 728 LGYAWDLWKDD---KFHE---L------IDPVITQ--DEISLPV--------LVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 728 ~~~~~~~~~~~---~~~~---l------id~~l~~--~~~~~~~--------~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
+......+-.. +... + +...-.. ...+... ....++|+..+|+.||.+|.|+++.++-
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 11111111110 0000 0 0000000 0000110 1136789999999999999999999985
Q ss_pred HhcccccCC
Q 003280 786 INSERLELP 794 (834)
Q Consensus 786 L~~~~~~~~ 794 (834)
..-...++|
T Consensus 338 ~yF~~d~lp 346 (438)
T KOG0666|consen 338 PYFTEDPLP 346 (438)
T ss_pred cccccCCCC
Confidence 544333344
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=290.89 Aligned_cols=260 Identities=17% Similarity=0.208 Sum_probs=182.6
Q ss_pred hcCccccceeeeecceeEEEEEECCC----cEEEEEEccCcccccH-----------HHHHHHHHHHHhhcCCCcceEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRLSSQSGQGL-----------EEFKNEMMLIAKLQHRNLVKLLG 576 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g----~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~HpnIv~l~~ 576 (834)
.++|++.++||+|+||.||+|...++ ..+|+|+......... .....++..+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999987543 4566665432221111 11222334455668999999999
Q ss_pred EEEecC----eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC
Q 003280 577 CCVEQG----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM 652 (834)
Q Consensus 577 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 652 (834)
++.... ..++++|++.. ++.+.+. .....++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 776544 34677777644 3433331 2223567888999999999999999998 99999999999999999
Q ss_pred CceeeeecceeecCCCcc-----ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccH
Q 003280 653 NPKISDFGLARMFGGDEL-----QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNL 727 (834)
Q Consensus 653 ~~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l 727 (834)
.++|+|||+++.+..... ........||+.|+|||++.+..++.++|||||||+++||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643211 111223469999999999999999999999999999999999999997553222111
Q ss_pred hHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 728 LGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
.....+.. ..+....+.... ....+.+++..|++.+|++||++.++++.|+
T Consensus 244 ~~~~~~~~-----~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFI-----KRLHEGKIKIKN----ANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHH-----HHhhhhhhccCC----CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 10000000 011111110111 1346789999999999999999999999874
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=285.53 Aligned_cols=247 Identities=22% Similarity=0.265 Sum_probs=191.5
Q ss_pred HHHHhcCcccccee--eeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCe
Q 003280 508 VAAATENFSMQCKL--GEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 508 ~~~~~~~f~~~~~L--G~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 583 (834)
.....++|++.+.+ |+|+||.||++... +++.+|+|.+....... .|+.....+ +||||+++++.+...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 33445677887777 99999999999865 47889999986542211 122222222 79999999999999999
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC-Cceeeeecce
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLA 662 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla 662 (834)
.++||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999998843 237899999999999999999999998 99999999999999998 9999999998
Q ss_pred eecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
+...... ...++..|+|||++.+..++.++||||||+++|||++|+.||............+.... .
T Consensus 158 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~----- 224 (267)
T PHA03390 158 KIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--Q----- 224 (267)
T ss_pred eecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--c-----
Confidence 8654321 24678899999999999999999999999999999999999874433322222221111 0
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPT-MSDVVS 784 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 784 (834)
.. ..........+.+++.+||+.+|.+||+ ++|+++
T Consensus 225 ---~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 ---KK---LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---cc---CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 0111123456889999999999999995 688874
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-33 Score=327.25 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=203.9
Q ss_pred HhcCccccceeeeecceeEEEEEE-CCCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
.+-++.-...||.|.||.||.|.. .+|+-.|+|.++.+ .......+.+|+.++..++|||+|+++|+-.+++..++.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 345666778999999999999975 45889999987654 344556788999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
||||.+|+|.+.+ ..++..++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|++|||.|..+.+
T Consensus 1313 MEyC~~GsLa~ll---~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLL---EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHH---HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999998 34455666677788899999999999999 99999999999999999999999999998865
Q ss_pred Cc--cccccceecccccccccccccCCc---cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 668 DE--LQGNTKRIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 668 ~~--~~~~~~~~~gt~~y~aPE~l~~~~---~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
.. .........||+-|||||++.+.. ..-++||||+|||+.||+||++||...+.+- .++-.+.. +
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-aIMy~V~~----g---- 1457 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-AIMYHVAA----G---- 1457 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-HHHhHHhc----c----
Confidence 42 223334578999999999997654 5678999999999999999999987654331 12111110 1
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
- ..+++.....+-.+++.+||+.||++|.++.|+++.
T Consensus 1458 -h-----~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 -H-----KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -C-----CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1 112233344566789999999999999999888764
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=293.00 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=193.8
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|+..+.||+|+||.||++... .++.||+|++.... ......+.+|+.++.++. |+||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 45667789999999999999875 48899999987543 234567889999999996 9999999999999999999999
Q ss_pred ecCCCCcccc---ccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 590 YMPNKSLDVF---LFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 590 y~~~gsL~~~---l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
|++. ++..+ +.. .....+++..+..++.++++||+|||+. + ++||||||+||+++.++.+||+|||+++.+
T Consensus 84 ~~~~-~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 84 LMDI-SLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred cccC-CHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 9875 44332 221 1235688999999999999999999975 5 999999999999999999999999999765
Q ss_pred CCCccccccceecccccccccccccCC---ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
..... .....++..|+|||++.+. .++.++|||||||++|||++|+.||..... .......... .
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~-~---- 226 (288)
T cd06616 159 VDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVK-G---- 226 (288)
T ss_pred ccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcC-C----
Confidence 43221 1223678899999999876 689999999999999999999999864321 1111111110 0
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+.+ ...........+.+++.+|++.+|++|||++||++
T Consensus 227 -~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 227 -DPPIL-SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred -CCCcC-CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111 11111224457889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=283.82 Aligned_cols=247 Identities=30% Similarity=0.433 Sum_probs=201.8
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc--ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|++|.||++... .++.|++|.+..... ...+.+.+|++++.+++|||++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999875 478999999976543 4567899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999998843 356899999999999999999999998 99999999999999999999999999987754332
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
. .....++..|+|||.+.+..++.++||||||+++++|++|+.|+...... .. .+..... . .
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~-~~~~~~~-~-~--------- 216 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AA-LFRIVQD-D-H--------- 216 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HH-HHHHhcc-C-C---------
Confidence 1 22346788999999998888999999999999999999999997643211 10 1111100 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...+......+.+++.+||+.+|++||++.|++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0111122346789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=289.72 Aligned_cols=261 Identities=25% Similarity=0.371 Sum_probs=196.6
Q ss_pred ccccceeeeecceeEEEEEECC-CcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeEEEEEe
Q 003280 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKILILE 589 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 589 (834)
|++.+.||+|++|.||+|...+ ++.+|+|+++... ....+.+.+|++++++++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5678899999999999998764 8899999997653 33456788999999999999999999999988 89999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++ +|..++... ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 777776432 246889999999999999999999998 9999999999999999999999999998775432
Q ss_pred cccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC---Cccc---c
Q 003280 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD---DKFH---E 742 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~---~~~~---~ 742 (834)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ........... .... .
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchhhcccccc
Confidence 1 11222356788999998765 457999999999999999999999986543211 11111110000 0000 0
Q ss_pred c-----cccccc-----cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 743 L-----IDPVIT-----QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 743 l-----id~~l~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+ ...... ...........+.+++.+|++.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 000000 00000001456789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=290.54 Aligned_cols=243 Identities=23% Similarity=0.344 Sum_probs=195.9
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCcc
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLD 597 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (834)
.+||+|+||.||++... +++.||||++........+.+.+|+.+++.++|+|++++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 58999999999999874 58899999986655555677999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccccccee
Q 003280 598 VFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677 (834)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 677 (834)
+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ .....
T Consensus 106 ~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 106 DIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 8773 235788999999999999999999998 99999999999999999999999999876643221 12235
Q ss_pred cccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHH
Q 003280 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPV 757 (834)
Q Consensus 678 ~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~ 757 (834)
.++..|+|||.+.+..++.++|+||||+++|||++|..|+...... ........ .....+.. ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~---------~~~~~~~~---~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRD---------NLPPKLKN---LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh---------hCCcccCC---cccC
Confidence 6789999999998888999999999999999999999997642211 11111100 00111100 0112
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 758 LVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 758 ~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 335778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=281.32 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=204.0
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc--ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|+||.||++... +++.+++|++..... ...+++.+|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999875 488999999876433 4567789999999999999999999999999999999999
Q ss_pred cCCCCccccccCCC-CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 591 MPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
+++++|.+++.... ....+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999885421 2467899999999999999999999998 9999999999999999999999999998765443
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
.......+++.|+|||.+.+..++.++||||+|+++++|++|+.|+...... ........ ....
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~-------- 221 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELALKILK-GQYP-------- 221 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHHHHhc-CCCC--------
Confidence 1223356888999999999889999999999999999999999997543311 11111111 1111
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+......+.+++.+||..+|++||++.|+++
T Consensus 222 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 --PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111122346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=312.73 Aligned_cols=268 Identities=22% Similarity=0.309 Sum_probs=186.0
Q ss_pred HhcCccccceeeeecceeEEEEEECC--CcEEEEE------------------EccCcccccHHHHHHHHHHHHhhcCCC
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVK------------------RLSSQSGQGLEEFKNEMMLIAKLQHRN 570 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~Hpn 570 (834)
..++|+++++||+|+||+||++.... +...++| ++. ........+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 34789999999999999999986532 2222222 111 12223457889999999999999
Q ss_pred cceEEeEEEecCeEEEEEeecCCCCccccccCCCC--CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE
Q 003280 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648 (834)
Q Consensus 571 Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 648 (834)
|+++++++...+..++|+|++.. +|..++..... ........+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999864 55555533211 122335567789999999999999998 9999999999999
Q ss_pred cCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCC-CCCCCCCc-cc
Q 003280 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN-TGVYNADS-FN 726 (834)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p-~~~~~~~~-~~ 726 (834)
+.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||+||||++|..+ +....... ..
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999877543221 12235789999999999999999999999999999999998754 33222111 11
Q ss_pred HhHHHHhHh-cCCccc-------ccccc-ccccCCCCH-------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 727 LLGYAWDLW-KDDKFH-------ELIDP-VITQDEISL-------PVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 727 l~~~~~~~~-~~~~~~-------~lid~-~l~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+........ ..+.+. +.++. .+....... ....++.+++.+||+.||++|||+.|+++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111110000 000000 00000 000000000 01235677899999999999999999987
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=287.10 Aligned_cols=248 Identities=27% Similarity=0.395 Sum_probs=202.6
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|+||.||+++.. +++.+|+|++.... .....++.+|+++++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999765 57899999986542 33456788999999999999999999999999999999999
Q ss_pred cCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 591 MPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
+++++|..++... .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999988542 22356889999999999999999999998 9999999999999999999999999998775441
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
.....++..|+|||.+.+..++.++|+||||++++||++|+.|+....... +. .. ......
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~---~~-~~~~~~--------- 218 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LR---YK-VQRGKY--------- 218 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH---HH-HhcCCC---------
Confidence 222457889999999999999999999999999999999999986433211 11 11 111111
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.........++.+++.+|++.+|++||++.|+++
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 -PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1122234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=289.14 Aligned_cols=247 Identities=25% Similarity=0.345 Sum_probs=196.8
Q ss_pred eeeecceeEEEEEECC-CcEEEEEEccCccc---ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCc
Q 003280 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
||+|+||.||+++... ++.+++|++..... ...+.+.+|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 89999999875433 4467789999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc------
Q 003280 597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL------ 670 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~------ 670 (834)
.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 998843 236899999999999999999999998 99999999999999999999999999886533211
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
........++..|+|||.+.....+.++||||||++++||++|+.|+....... ..... ..+... . .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~-~~~~~~------~-~ 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-----IFQNI-LNGKIE------W-P 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-hcCCcC------C-C
Confidence 112233567889999999998889999999999999999999999986433211 11111 100000 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
. .......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 222 ~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 222 E--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred c--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0 00124567899999999999999999777777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=288.42 Aligned_cols=258 Identities=21% Similarity=0.287 Sum_probs=191.1
Q ss_pred ccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhc-CCCcceEEeEEEec--CeEEEEEe
Q 003280 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQ--GEKILILE 589 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~E 589 (834)
|++.++||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999865 58899999987642 222234457888888885 99999999999987 88999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ ++||||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9975 66666632 2346899999999999999999999998 999999999999999 999999999998764332
Q ss_pred cccccceeccccccccccccc-CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh-----------cC
Q 003280 670 LQGNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW-----------KD 737 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~-~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~-----------~~ 737 (834)
. .....++..|+|||++. +..++.++|||||||++|||++|+.||...+.. +......... ..
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHHHHhhcc
Confidence 1 12245788999999765 456789999999999999999999998654321 1111111100 00
Q ss_pred CccccccccccccC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 DKFHELIDPVITQD---EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~lid~~l~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
........+..... ......+..+.+++.+||+.+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000000 001123567889999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=296.34 Aligned_cols=265 Identities=25% Similarity=0.324 Sum_probs=196.8
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEec--CeEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ--GEKI 585 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~--~~~~ 585 (834)
.++|++.+.||+|+||.||+|... .++.+|||++... .......+.+|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 478999999999999999999875 4789999988543 233445678899999999 999999999998653 3689
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 488777732 26788899999999999999999988 999999999999999999999999999876
Q ss_pred CCCccc---cccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHH---------
Q 003280 666 GGDELQ---GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAW--------- 732 (834)
Q Consensus 666 ~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~--------- 732 (834)
...... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||........ ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 236 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAED 236 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHH
Confidence 443221 12234568899999998865 4578999999999999999999999864332110 000000
Q ss_pred -hHhcCCccccccccccccCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 733 -DLWKDDKFHELIDPVITQDE-----ISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 733 -~~~~~~~~~~lid~~l~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
..+.......+++....... .......++.+++.+|++.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000011110000000 001124568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=301.21 Aligned_cols=256 Identities=27% Similarity=0.390 Sum_probs=199.2
Q ss_pred ccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecC------eEEE
Q 003280 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKIL 586 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~l 586 (834)
+...+.||+|+||.||+|+.+ .|+.||||.++... ....+...+|+++|++++|+|||++++.-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 455679999999999999964 59999999998753 445678899999999999999999998865543 6789
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc--CCCC--ceeeeecce
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD--MDMN--PKISDFGLA 662 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~--~kl~Dfgla 662 (834)
|||||.+|+|...+...++...+++.+.+.++.+++.||.|||+++ |+||||||.||++- ++|. -||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999999988899999999999999999999999998 99999999999993 3343 799999999
Q ss_pred eecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccc
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH 741 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (834)
+.+..+. ......||..|++||.+.. +.|+..+|.|||||++||.+||..||....... ......|.........
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk-~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK-NNKEIMWHIITKKPSG 247 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc-ccchhhhhhhccCCCc
Confidence 9987655 4556899999999999985 889999999999999999999999986543321 1111122211111110
Q ss_pred c--ccccc----------cc-cCCCCHHHHHHHHHHHHhccccCCCCCC
Q 003280 742 E--LIDPV----------IT-QDEISLPVLVRYINVALLCVQDNAADRP 777 (834)
Q Consensus 742 ~--lid~~----------l~-~~~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
. ..++. ++ ....+.....++.+.+..+|..+|++|-
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0 00110 00 1123334455677778888888888887
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=294.82 Aligned_cols=261 Identities=22% Similarity=0.279 Sum_probs=191.2
Q ss_pred ceeeee--cceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEG--GFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G--~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+| +||+||++++. .++.||||++.... ....+.+.+|+.+++.++||||+++++++..+...++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 89999999875 58999999986532 33457789999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc-
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG- 672 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 672 (834)
++|.+++.... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99998875432 234788999999999999999999988 9999999999999999999999998654332111100
Q ss_pred ----ccceecccccccccccccCC--ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHh-------------
Q 003280 673 ----NTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWD------------- 733 (834)
Q Consensus 673 ----~~~~~~gt~~y~aPE~l~~~--~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~------------- 733 (834)
......++..|+|||++.+. .++.++|||||||++|||++|+.||................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 01112345679999999764 47899999999999999999999986543211100000000
Q ss_pred --HhcC-----------Ccc-----ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 734 --LWKD-----------DKF-----HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 734 --~~~~-----------~~~-----~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.... ... ..+.+..+ ...........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000 000 00000111 11112334567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=284.79 Aligned_cols=250 Identities=26% Similarity=0.363 Sum_probs=195.9
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-----ccccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-----SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEK 584 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 584 (834)
.+|++.+.||+|+||.||+|... +++.||+|++... ..+....+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57899999999999999999874 4889999987432 223456789999999999999999999998764 468
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++++||+++++|.+++. ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999998884 2345788899999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
....... .......++..|+|||++.+..++.++|+|||||+++||++|+.||...... .. ........ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~-~~~~~~~~-~--- 226 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----AA-IFKIATQP-T--- 226 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----HH-HHHHHcCC-C---
Confidence 5332111 1122356889999999999888999999999999999999999998532111 00 01111000 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
....+......+.+++.+|++ +|.+||++.++++
T Consensus 227 ------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 ------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111222334567899999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=270.94 Aligned_cols=273 Identities=22% Similarity=0.336 Sum_probs=206.8
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc-cccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++.+++..||.|..|.|++.+... |..+|||.++... .+..+++...+.++..-+ +|.||+.+|+|......++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 556677899999999999998764 8899999997753 444567777777776664 8999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
.|.- .++.++. ...+++++.-+-++...++.||.||.+++ .|+|||+||+|||+|+.|++|++|||++-.+-...
T Consensus 172 lMs~-C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMST-CAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHH-HHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 8843 2334442 23456888888899999999999999876 59999999999999999999999999998765433
Q ss_pred cccccceecccccccccccccC---CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~---~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
. .....|-+.|||||.+.- ..|+.++||||||+.++||.||+.|+...+.+..-+.. .+.++ ...++.
T Consensus 247 A---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk----vln~e--PP~L~~ 317 (391)
T KOG0983|consen 247 A---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK----VLNEE--PPLLPG 317 (391)
T ss_pred c---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH----HHhcC--CCCCCc
Confidence 2 223578899999999964 46899999999999999999999999876554332222 11111 122222
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCCCCCCCccccccc
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAFIKGIN 806 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~p~~~~~~~ 806 (834)
.. .....+++++..||+.|+.+||...++++-=--...+......+.|++...
T Consensus 318 ----~~---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV~ 370 (391)
T KOG0983|consen 318 ----HM---GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDVM 370 (391)
T ss_pred ----cc---CcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHHH
Confidence 11 134578899999999999999999999883221223344456677777633
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=289.00 Aligned_cols=260 Identities=25% Similarity=0.346 Sum_probs=198.2
Q ss_pred ccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc--ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
|++.+.||+|++|.||++... +++.+++|+++.... .....+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999875 588999999876433 24567889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 86 77766643 2256889999999999999999999998 99999999999999999999999999987755431
Q ss_pred cccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC---Cccccccc--
Q 003280 672 GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD---DKFHELID-- 745 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~---~~~~~lid-- 745 (834)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+... ........... .......+
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCchHhcccchhhh
Confidence 11224577889999999876 78999999999999999999999886433211 11000000000 00000000
Q ss_pred ---------c-ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 746 ---------P-VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 746 ---------~-~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. .............++.+++.+||+.||.+||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 00000111223567889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=286.94 Aligned_cols=244 Identities=26% Similarity=0.335 Sum_probs=191.2
Q ss_pred eeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCc
Q 003280 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
||+|+||+||++... +++.||+|.+.... ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999764 58899999986532 22345677899999999999999999999999999999999999999
Q ss_pred cccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccce
Q 003280 597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (834)
.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 98885432 246889999999999999999999998 9999999999999999999999999987654321 1223
Q ss_pred ecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHH
Q 003280 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~ 756 (834)
..++..|+|||++.+..++.++||||||+++++|++|+.||........ ... ....... . ....+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~-----~~~~~~~----~---~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEE-----LKRRTLE----M---AVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHH-----HHhcccc----c---cccCCcc
Confidence 4678899999999888899999999999999999999999865432111 000 0000000 0 0111112
Q ss_pred HHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 757 VLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
....+.+++.+||+.+|++|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 245678999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=297.95 Aligned_cols=267 Identities=22% Similarity=0.297 Sum_probs=198.3
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEec-----Ce
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-----GE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 583 (834)
.++|.+.+.||+|+||+||+|+.. .++.||||+++.. .......+.+|+.++..++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 367999999999999999999875 4889999998753 233456778899999999999999999988654 35
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.++||||+. ++|..++. ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 57777763 3356899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh-------
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW------- 735 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~------- 735 (834)
...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...+... .........
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH--QLKLITELLGSPSEED 232 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCChHH
Confidence 764332 11223467889999998865 468999999999999999999999986432110 000000000
Q ss_pred ----cCCcccccccccccc-----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhcc
Q 003280 736 ----KDDKFHELIDPVITQ-----DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI--INSE 789 (834)
Q Consensus 736 ----~~~~~~~lid~~l~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 789 (834)
........++..... .........++.+++.+||+.+|++|||++|+++- |+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000000000 00011234567899999999999999999999874 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=291.85 Aligned_cols=264 Identities=23% Similarity=0.330 Sum_probs=192.0
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecC-------
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------- 582 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------- 582 (834)
++|++.++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 67999999999999999999875 58899999886432 222345678999999999999999999987654
Q ss_pred -eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecc
Q 003280 583 -EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 661 (834)
..++||||+.+ +|..++.. ....+++..+..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999975 66666532 2335889999999999999999999998 99999999999999999999999999
Q ss_pred eeecCCCccc--cccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh---
Q 003280 662 ARMFGGDELQ--GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW--- 735 (834)
Q Consensus 662 a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~--- 735 (834)
+..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... .........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~~~~~~~~~ 243 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTLISQLCGSI 243 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCC
Confidence 9876432211 112234578889999988765 47899999999999999999999886433211 111111100
Q ss_pred cCCcc-----cccccc-ccccC---CC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 736 KDDKF-----HELIDP-VITQD---EI-----SLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 736 ~~~~~-----~~lid~-~l~~~---~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+.. ....+. ..... .. .......+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 000000 00000 00 0001235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=292.08 Aligned_cols=249 Identities=30% Similarity=0.437 Sum_probs=195.2
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
+.|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++|||++++++++.+....++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34777889999999999999865 58899999986432 233457889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++ +|.+++.. ....+++..+..++.+|+.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 105 e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 99975 66665532 2345889999999999999999999998 999999999999999999999999998754321
Q ss_pred ccccccceeccccccccccccc---CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~---~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
....++..|+|||++. .+.++.++|||||||++|||++|+.|+....... . .........
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~---~~~~~~~~~------ 241 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A---LYHIAQNES------ 241 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--H---HHHHHhccC------
Confidence 2346788999999974 4568999999999999999999999975432111 0 011111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
+. .........+.+++.+|++.+|++||++.++++.+..
T Consensus 242 ~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 242 PT----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CC----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 00 0111223467899999999999999999999985543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=284.78 Aligned_cols=245 Identities=24% Similarity=0.277 Sum_probs=189.4
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCccc---ccHHHHHHHHHHH-HhhcCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGLEEFKNEMMLI-AKLQHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+|... .++.||||+++.... .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 488999999875432 1223344554444 445899999999999999999999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
++|..++. ....+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999884 3346889999999999999999999998 99999999999999999999999999876432
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
.....++..|+|||.+.+..++.++||||||+++|||++|..|+....... . .......... . ....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~----~~~~~~~~~~------~-~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--V----FDNILSRRIN------W-PEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--H----HHHHHhcccC------C-CCcc
Confidence 123467889999999988889999999999999999999999986433211 1 0111111000 0 0011
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 754 SLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
.......+.+++.+||+.+|++||++.++.+.|..
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 11223567899999999999999988777766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=291.66 Aligned_cols=262 Identities=21% Similarity=0.249 Sum_probs=192.4
Q ss_pred ccceeeeecceeEEEEEECCCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCC
Q 003280 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 517 ~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+.+.+|.|+++.||++.. +++.||||+++.. .....+.+.+|++++++++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 444555556666666554 6899999998754 3445678999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc----
Q 003280 595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---- 670 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~---- 670 (834)
+|.+++.... ...+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+..+.....
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999885432 235788899999999999999999998 99999999999999999999999999876532211
Q ss_pred -ccccceecccccccccccccCC--ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHh----HhcCC-----
Q 003280 671 -QGNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWD----LWKDD----- 738 (834)
Q Consensus 671 -~~~~~~~~gt~~y~aPE~l~~~--~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~----~~~~~----- 738 (834)
........++..|+|||++... .++.++|||||||++|||++|+.||........ +...... .....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhh
Confidence 1112234567889999998763 588999999999999999999999864332111 1000000 00000
Q ss_pred --cccc----cccccc---ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 739 --KFHE----LIDPVI---TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 739 --~~~~----lid~~l---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.... ..++.. ...........++.+++.+||+.+|++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 000000 011112233457889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=288.06 Aligned_cols=256 Identities=25% Similarity=0.338 Sum_probs=200.1
Q ss_pred CccccceeeeecceeEEEEEEC----CCcEEEEEEccCcc----cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 584 (834)
+|++.+.||+|++|.||+++.. +++.||||.+++.. ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999752 46889999986532 22346788999999999 599999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+++++|..++.. ...+++..+..++.|++++|.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999988743 345788999999999999999999988 99999999999999999999999999887
Q ss_pred cCCCccccccceecccccccccccccCCc--cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
+...... ......++..|+|||.+.+.. .+.++||||||+++|||++|..|+....... ............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~----- 227 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKS----- 227 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHcc-----
Confidence 6433211 112346788999999987765 7889999999999999999999986432211 111111111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.+ ..+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 228 --~~-----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 --KP-----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CC-----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00 11111234577899999999999999999998887664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=317.38 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=188.8
Q ss_pred HHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEe-------
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE------- 580 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------- 580 (834)
.-..+|+.++.||+||||.|||++.+ +|+.+|||++... +......+.+|++.+++|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44578999999999999999999865 7999999998765 34456678999999999999999999832100
Q ss_pred -----------------------------------------------------------------------c--------
Q 003280 581 -----------------------------------------------------------------------Q-------- 581 (834)
Q Consensus 581 -----------------------------------------------------------------------~-------- 581 (834)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHh
Q 003280 582 ---------------------------------GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628 (834)
Q Consensus 582 ---------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL 628 (834)
..+|+=||||+..+|+.++..+.-.. .....++++++|+.||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 12467788888888888774432211 3567889999999999999
Q ss_pred hhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC----C------------CccccccceecccccccccccccCC
Q 003280 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG----G------------DELQGNTKRIVGTYGYMSPEYALDG 692 (834)
Q Consensus 629 H~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~l~~~ 692 (834)
|+++ ||||||||.||+|+++..|||+|||+|.... . .......+..+||..|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999999821 0 0011122346899999999999765
Q ss_pred ---ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhcc
Q 003280 693 ---LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCV 769 (834)
Q Consensus 693 ---~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl 769 (834)
.|+.|+|+|||||||+||+. ||+..-+. .. ....++.+.+..- ..+..+....-..+|.+++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER-a~----iL~~LR~g~iP~~-------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER-AS----ILTNLRKGSIPEP-------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHH-HH----HHHhcccCCCCCC-------cccccccchHHHHHHHHHh
Confidence 49999999999999999985 44321111 00 1111222222111 1122333344568999999
Q ss_pred ccCCCCCCCHHHHHH
Q 003280 770 QDNAADRPTMSDVVS 784 (834)
Q Consensus 770 ~~dP~~RPs~~evl~ 784 (834)
+.||.+|||+.|+|.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999986
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=286.65 Aligned_cols=251 Identities=25% Similarity=0.325 Sum_probs=195.6
Q ss_pred CccccceeeeecceeEEEEEE----CCCcEEEEEEccCcc----cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 584 (834)
+|++.+.||+|+||.||+++. .+|+.||+|+++... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 358899999987532 22346788999999999 599999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ ++||||+|+||++++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998843 345788899999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccccccceecccccccccccccCC--ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
....... ......|+..|+|||.+... .++.++||||||+++|||++|+.|+...... ..............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~---- 228 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSE---- 228 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhccC----
Confidence 6433221 12235688999999998753 4788999999999999999999998643221 11111111111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
...+......+.+++.+|++.+|++|| +++++++
T Consensus 229 --------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 --------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 011112234677999999999999997 6666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=289.12 Aligned_cols=263 Identities=24% Similarity=0.326 Sum_probs=193.5
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|++.+.||+|++|.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999875 58899999986542 2334678899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-CCCceeeeecceeecCCC
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~ 668 (834)
|+++ +|..++... ....+++..+..++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9964 666665321 2233578888899999999999999998 999999999999985 567999999999765432
Q ss_pred ccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc------cc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK------FH 741 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~------~~ 741 (834)
. .......+++.|+|||++.+. .++.++||||||+++|||++|+.||....... .+.. ......... ..
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFK-IFRILGTPNEETWPGVT 232 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHHhCCCChhhccccc
Confidence 1 111224568899999988764 57899999999999999999999986432211 1110 000000000 00
Q ss_pred cccc-----cccccC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 742 ELID-----PVITQD---EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 742 ~lid-----~~l~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.+.+ +..... ........++.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000000 001112345788999999999999999999987
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=289.35 Aligned_cols=266 Identities=24% Similarity=0.336 Sum_probs=195.6
Q ss_pred HHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecC----
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG---- 582 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 582 (834)
...++|++.+.||+|+||.||+|... +++.||||+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999986 48899999986542 233456788999999999999999999987655
Q ss_pred ------eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCcee
Q 003280 583 ------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656 (834)
Q Consensus 583 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 656 (834)
..++|+||+++ ++..++.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999987 55555532 2346889999999999999999999998 999999999999999999999
Q ss_pred eeecceeecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh
Q 003280 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
+|||++......... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.|+..... ...........
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--~~~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--LAQLELISRLC 234 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHh
Confidence 999999876443211 1112345778999998865 4578999999999999999999998864321 11111111111
Q ss_pred cCCc---cccc--------ccccccc-C---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 736 KDDK---FHEL--------IDPVITQ-D---EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 736 ~~~~---~~~l--------id~~l~~-~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.... ...+ .+..... . ......+..+.+++.+||+.+|.+||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000 0000000 0 000012346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=290.00 Aligned_cols=251 Identities=23% Similarity=0.385 Sum_probs=192.1
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc-cccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|++.+.||+|++|.||+|.... ++.||||+++... .....++..|+.++.+.. ||||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 678899999999999999999865 8899999997543 233456677887777775 9999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
|+++ +|..++.. ....+++..+..++.||++||+|||+. + |+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9864 55555432 233688999999999999999999974 5 999999999999999999999999998765432
Q ss_pred ccccccceecccccccccccccCCc----cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~----~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
.. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... .. ........ .
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~---~~~~~~~~-~---- 236 (296)
T cd06618 169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EV---LTKILQEE-P---- 236 (296)
T ss_pred Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HH---HHHHhcCC-C----
Confidence 21 12235778999999987554 7899999999999999999999985432211 11 11111111 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
+.+... .....++.+++.+||+.+|++||+++++++.
T Consensus 237 -~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 -PSLPPN---EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001000 0123467899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=295.81 Aligned_cols=262 Identities=26% Similarity=0.354 Sum_probs=194.3
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC------
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------ 582 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 582 (834)
.++|.+.+.||+|+||.||+|... .++.||||+++.. .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999864 5899999998653 2233466889999999999999999999987543
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 555443 235788999999999999999999998 999999999999999999999999998
Q ss_pred eecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhH-------
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDL------- 734 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~------- 734 (834)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+... ........
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 237 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGPE 237 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHH
Confidence 764321 123467889999999876 468999999999999999999999986533111 11000000
Q ss_pred ----hcCCccccccc--cccccCCCC---HHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 735 ----WKDDKFHELID--PVITQDEIS---LPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 735 ----~~~~~~~~lid--~~l~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
.........++ +........ ......+.+++.+||+.||++||+++|++. .++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000000000 000000000 012345789999999999999999999985 46665
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=279.97 Aligned_cols=267 Identities=25% Similarity=0.348 Sum_probs=217.6
Q ss_pred cHHHHHHHhcCccccceeeeecceeEEEEEEC------CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEe
Q 003280 504 SLASVAAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLG 576 (834)
Q Consensus 504 ~~~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 576 (834)
..+++.....+++....+-+|.||.||.|.+. +.+.|.+|.++.. +......+..|-.++..+.|||++.+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 44566677788999999999999999999653 3456888988765 3445678899999999999999999999
Q ss_pred EEEec-CeEEEEEeecCCCCcccccc-----CCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC
Q 003280 577 CCVEQ-GEKILILEYMPNKSLDVFLF-----DPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM 650 (834)
Q Consensus 577 ~~~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 650 (834)
++.+. ...+.+|.++.-|+|..|+. +....+.+...+...++.|++.|++|||.++ +||.||..+|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 98764 57789999999999999997 4455566788889999999999999999998 999999999999999
Q ss_pred CCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhH
Q 003280 651 DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLG 729 (834)
Q Consensus 651 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~ 729 (834)
..++||+|=.+++.+.+.++.........+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+ ...
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--m~~ 509 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--MEH 509 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--HHH
Confidence 99999999999999877766655555566789999999999999999999999999999999 888876544322 111
Q ss_pred HHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 730 YAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 730 ~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
+ +.++ .++ . .+...+.++..++.-||...|++||+++|++.-|.+-
T Consensus 510 y----lkdG-------yRl-a--QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 510 Y----LKDG-------YRL-A--QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred H----Hhcc-------cee-c--CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1 1111 111 1 1223345788999999999999999999999988764
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=282.38 Aligned_cols=260 Identities=24% Similarity=0.340 Sum_probs=193.3
Q ss_pred ccccceeeeecceeEEEEEECC-CcEEEEEEccCccc--ccHHHHHHHHHHHHhh---cCCCcceEEeEEEecCe-----
Q 003280 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG--QGLEEFKNEMMLIAKL---QHRNLVKLLGCCVEQGE----- 583 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~----- 583 (834)
|++.+.||+|+||.||+|+... ++.||+|+++.... .....+.+|+.++.++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999865 89999999974322 2234566788877766 59999999999988776
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.+++|||+++ +|.+++.... ...+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 9999999975 7777764322 235899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc----
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK---- 739 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~---- 739 (834)
.+..... .....++..|+|||++.+..++.++|+|||||++|||++|+.|+....... .+... ........
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKI-FDVIGLPSEEEW 230 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHH-HHHcCCCChHhc
Confidence 7643321 122357889999999999999999999999999999999998876433211 11111 00000000
Q ss_pred --c----ccccccccc--cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 740 --F----HELIDPVIT--QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 740 --~----~~lid~~l~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. ......... ...........+.+++.+||+.||++||+++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000000 00111123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=289.36 Aligned_cols=265 Identities=25% Similarity=0.333 Sum_probs=192.6
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecC------
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------ 582 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 582 (834)
.++|++.++||+|+||.||+|... +++.+|||++.... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999875 48899999886432 222346788999999999999999999875543
Q ss_pred --eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeec
Q 003280 583 --EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660 (834)
Q Consensus 583 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 660 (834)
..++||||+.+ +|...+.. ....+++..+..++.||++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999976 45554432 2346899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCccc---------cccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHH
Q 003280 661 LARMFGGDELQ---------GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGY 730 (834)
Q Consensus 661 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~ 730 (834)
+++........ .......+++.|+|||.+.+. .++.++|||||||++|||++|++||....... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~--~~~~ 238 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID--QLHL 238 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence 99876432211 111234678889999988654 58999999999999999999999986433211 1000
Q ss_pred HHhHhcC---------Ccccccccccc-ccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 731 AWDLWKD---------DKFHELIDPVI-TQDEIS-----LPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 731 ~~~~~~~---------~~~~~lid~~l-~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
....... .......+... ...... ......+.+++.+||+.+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 00000000000 000000 011246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=285.48 Aligned_cols=249 Identities=26% Similarity=0.361 Sum_probs=201.2
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV 587 (834)
++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++.+++ ||||+++++.+...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999875 5899999998653 2233567889999999998 99999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|.+++. +.+.+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999884 3346899999999999999999999998 99999999999999999999999999987654
Q ss_pred Cccc------------------cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhH
Q 003280 668 DELQ------------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729 (834)
Q Consensus 668 ~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~ 729 (834)
.... .......++..|+|||++....++.++||||||++++|+++|+.|+....... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~- 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--TF- 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--HH-
Confidence 3221 12223467889999999998889999999999999999999999986443110 00
Q ss_pred HHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 003280 730 YAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTM----SDVVS 784 (834)
Q Consensus 730 ~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 784 (834)
..... . ....+......+.+++.+||+.+|.+||++ +++++
T Consensus 232 --~~~~~-------~-----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 --QKILK-------L-----EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHHh-------c-----CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00000 0 011112224567899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=282.75 Aligned_cols=241 Identities=24% Similarity=0.301 Sum_probs=185.6
Q ss_pred eeeeecceeEEEEEEC-CCcEEEEEEccCccc---ccHHHHHHHHHHH---HhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGLEEFKNEMMLI---AKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 520 ~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l---~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
.||+|+||.||++... .++.||+|.+.+... .....+..|..++ ....||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 488999999865421 1122344454443 44579999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999988873 3456899999999999999999999988 9999999999999999999999999987653321
Q ss_pred ccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........... . .... .....+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~--~-~~~~------~~~~~~--- 218 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--D-RMTL------TMAVEL--- 218 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH--H-HHhh------ccCCCC---
Confidence 2234689999999999754 689999999999999999999999865422111000 0 0000 001111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
+.....++.+++.+|++.+|.+|| ++.++++
T Consensus 219 --~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred --CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111235678999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=295.19 Aligned_cols=266 Identities=23% Similarity=0.311 Sum_probs=197.3
Q ss_pred HHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC----
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG---- 582 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 582 (834)
...++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34578999999999999999999864 5889999998643 2233457889999999999999999999987654
Q ss_pred --eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeec
Q 003280 583 --EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660 (834)
Q Consensus 583 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 660 (834)
..++||||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999998 678877763 345889999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHH--------
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYA-------- 731 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~-------- 731 (834)
++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... .+....
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCH
Confidence 99865332 223467889999999876 458899999999999999999999986433211 000000
Q ss_pred --HhHhcCCcccccccc--ccccC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 732 --WDLWKDDKFHELIDP--VITQD---EISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 732 --~~~~~~~~~~~lid~--~l~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
...+........+.. ..... .........+.+++.+|++.||++|||+.++++ .++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000000000000000 00000 000112335789999999999999999999984 55554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=294.28 Aligned_cols=267 Identities=24% Similarity=0.314 Sum_probs=202.8
Q ss_pred CccccceeeeecceeEEEEEECC-CcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecC-----eEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-----EKI 585 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 585 (834)
+|++.+.||+|++|.||+|+... ++.||||++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 57888999999999999998754 8899999987643 344578899999999999999999999998775 789
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+||||+++ +|..++. ....+++..+..++.+|+.||+|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 7777773 3347899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccc-cccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh--------
Q 003280 666 GGDELQ-GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW-------- 735 (834)
Q Consensus 666 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~-------- 735 (834)
...... .......++..|+|||++.+. .++.++|+||||+++|+|++|+.||........ ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ--LNLIVEVLGTPSEEDL 231 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHhcCCCChhHh
Confidence 543210 112234678899999999888 789999999999999999999999865442110 00000000
Q ss_pred ---cCCccccccccccccCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 736 ---KDDKFHELIDPVITQDE-----ISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 736 ---~~~~~~~lid~~l~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
........+........ ........+.+++.+||+.+|++||+++++++ .|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 00000000000000000 01113456789999999999999999999998 45554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=283.71 Aligned_cols=262 Identities=25% Similarity=0.287 Sum_probs=194.3
Q ss_pred ccccceeeeecceeEEEEEECC-CcEEEEEEccCccc-ccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEEEEeec
Q 003280 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
|++.+.||+|++|+||+|...+ ++.|+||++..... .......+|+..+.+++ |+||+++++++......++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5678899999999999999864 78899999865432 22234567899999999 999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 788887774322 346899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCccc--Hh---------HHHHhHhcCCc
Q 003280 672 GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFN--LL---------GYAWDLWKDDK 739 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~--l~---------~~~~~~~~~~~ 739 (834)
.....++..|+|||++.. ..++.++|+||||++++||++|+.||......... .. .|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 123467889999998854 45799999999999999999999888644321100 00 00000000000
Q ss_pred ccccccccccc--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 740 FHELIDPVITQ--DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 740 ~~~lid~~l~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
....+...... .........++.+++.+|++.+|++||+++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000000 0000011356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=293.40 Aligned_cols=266 Identities=24% Similarity=0.291 Sum_probs=196.8
Q ss_pred HHHHHHHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEec
Q 003280 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ 581 (834)
Q Consensus 505 ~~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 581 (834)
..++...+++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3455667799999999999999999999864 58899999987532 22346788899999999999999999988643
Q ss_pred ------CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCce
Q 003280 582 ------GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPK 655 (834)
Q Consensus 582 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 655 (834)
...+++++++ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467888876 678877663 235889999999999999999999998 99999999999999999999
Q ss_pred eeeecceeecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHH--
Q 003280 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAW-- 732 (834)
Q Consensus 656 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~-- 732 (834)
|+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.....
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~ 234 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLV 234 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 9999998765322 223467889999999876 568899999999999999999999985433211 0000000
Q ss_pred --------hHhcCCccccccc--cccccCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 733 --------DLWKDDKFHELID--PVITQDEI---SLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 733 --------~~~~~~~~~~lid--~~l~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...........+. +....... ......++.+++.+|++.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000000000000 00000000 0012346789999999999999999999987
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=287.58 Aligned_cols=248 Identities=31% Similarity=0.432 Sum_probs=194.1
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45777889999999999999875 4788999988642 2233567889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+. ++|...+.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 566665532 2345788999999999999999999988 999999999999999999999999998765432
Q ss_pred ccccccceeccccccccccccc---CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~---~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
....++..|+|||.+. ...++.++|||||||++|||++|+.|+....... . ..... ....
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~---~~~~~-~~~~----- 231 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A---LYHIA-QNES----- 231 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--H---HHHHh-hcCC-----
Confidence 2346788999999975 3568899999999999999999999875332111 0 00000 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
+.. ........+.+++.+||+.+|++||++.++++...
T Consensus 232 ~~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 PAL----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred CCc----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 111 11123345789999999999999999999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=290.16 Aligned_cols=263 Identities=23% Similarity=0.323 Sum_probs=196.1
Q ss_pred HHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEe-cCeEE
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE-QGEKI 585 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~ 585 (834)
..+++|++.+.||+|+||.||++... +++.||||++.+. .....+.+.+|+.++.+++||||+++.+++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45688999999999999999999865 5889999988643 22345678899999999999999999999876 55789
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+|+||+. ++|..++. ...+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||++...
T Consensus 87 lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELLG-TDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehhc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 9999984 57877763 335788888899999999999999998 999999999999999999999999998754
Q ss_pred CCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCccc--HhHH-------HHhHh
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFN--LLGY-------AWDLW 735 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~--l~~~-------~~~~~ 735 (834)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... +... .....
T Consensus 159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 321 122456889999998866 56899999999999999999999998644321100 0000 00000
Q ss_pred cCCccccccccccccCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 736 KDDKFHELIDPVITQDEISLP-----VLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
..+...+.+.........+.. ....+.+++.+|++.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000101111110001111111 23578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=286.47 Aligned_cols=244 Identities=30% Similarity=0.420 Sum_probs=190.8
Q ss_pred ccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc---ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
|...++||+|+||.||+|+.. .++.|++|++..... ...+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666678999999999999875 588999999865322 3345788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+.+ ++.+++.. ....+++..+..++.||+.+|+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 975 56555532 2345889999999999999999999998 99999999999999999999999999864321
Q ss_pred ccccceeccccccccccccc---CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~---~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.....++..|+|||++. ...++.++|||||||++|||++|+.|+....... . ....... ......
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--~---~~~~~~~-~~~~~~--- 241 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A---LYHIAQN-DSPTLQ--- 241 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--H---HHHHHhc-CCCCCC---
Confidence 22356888999999984 4568899999999999999999999975432111 0 1111111 011110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
.......+.+++.+||+.+|++||++.++++.
T Consensus 242 ------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 ------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122357789999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=294.57 Aligned_cols=267 Identities=22% Similarity=0.277 Sum_probs=194.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEec----------
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ---------- 581 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---------- 581 (834)
.+|++.+.||+|+||.||+|... .++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 68999999999999999999875 4889999998766666677889999999999999999999776543
Q ss_pred ----CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-CCCcee
Q 003280 582 ----GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKI 656 (834)
Q Consensus 582 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl 656 (834)
...++||||++ ++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 47777662 335889999999999999999999998 999999999999974 567899
Q ss_pred eeecceeecCCCccc-cccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhH
Q 003280 657 SDFGLARMFGGDELQ-GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDL 734 (834)
Q Consensus 657 ~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~ 734 (834)
+|||+++.+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+... ........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~ 235 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESV 235 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhc
Confidence 999999876432111 11122357889999998754 5688999999999999999999999864332110 00000000
Q ss_pred h--cC---Ccc----ccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 735 W--KD---DKF----HELIDPVITQDEIS-----LPVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 735 ~--~~---~~~----~~lid~~l~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
. .. ... .............+ .....++.+++.+||+.||++|||+.|+++ .++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 0 00 000 00000000000001 112346789999999999999999999985 4543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=284.38 Aligned_cols=241 Identities=26% Similarity=0.383 Sum_probs=195.6
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCC
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 595 (834)
++||+|.||+||-|+++ .|+.||||++.+. ......++.+|+.+|+.++||.||.+...|+..+..++|||-+.+.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 78999999999999875 5999999998764 33445789999999999999999999999999999999999997766
Q ss_pred ccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC---CCCceeeeecceeecCCCcccc
Q 003280 596 LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
|.-.|. ...+.+++.....++.||+.||.|||.++ |+|+||||+||||.+ ...+||+|||+|++++....+
T Consensus 650 LEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR- 723 (888)
T KOG4236|consen 650 LEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR- 723 (888)
T ss_pred HHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh-
Confidence 655552 34456888888899999999999999998 999999999999954 457999999999999876543
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc-ccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP-VITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~-~l~~~ 751 (834)
..++||+.|+|||++.++.|...-|+||.|||+|--++|..||....+-. +.++. .....
T Consensus 724 --rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-----------------dQIQNAaFMyP 784 (888)
T KOG4236|consen 724 --RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-----------------DQIQNAAFMYP 784 (888)
T ss_pred --hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-----------------HHhhccccccC
Confidence 34689999999999999999999999999999999999999986432211 11111 00011
Q ss_pred CCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 752 EISL-PVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+. +.....+++|...||..-++|.|..+.+.
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1122 23346788999999999999999877654
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=288.49 Aligned_cols=263 Identities=24% Similarity=0.319 Sum_probs=194.3
Q ss_pred cCcc-ccceeeeecceeEEEEEEC-CCcEEEEEEccCccccc--------------HHHHHHHHHHHHhhcCCCcceEEe
Q 003280 513 ENFS-MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQG--------------LEEFKNEMMLIAKLQHRNLVKLLG 576 (834)
Q Consensus 513 ~~f~-~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~ 576 (834)
++|. +.+.||+|+||+||+|... .++.||||+++...... ...+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 4467999999999999875 58899999986542211 125788999999999999999999
Q ss_pred EEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCcee
Q 003280 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656 (834)
Q Consensus 577 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 656 (834)
++......++||||++ ++|.+++. ....+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 57877773 3345889999999999999999999998 999999999999999999999
Q ss_pred eeecceeecCCCcc------------ccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCC
Q 003280 657 SDFGLARMFGGDEL------------QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNAD 723 (834)
Q Consensus 657 ~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~ 723 (834)
+|||++........ ........++..|+|||.+.+. .++.++|||||||++|||++|+.||...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999987652110 1111123467889999998764 4689999999999999999999998654321
Q ss_pred cccHhHHHHhHhcCCc---ccccc-----ccccccCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 724 SFNLLGYAWDLWKDDK---FHELI-----DPVITQDE-----ISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 724 ~~~l~~~~~~~~~~~~---~~~li-----d~~l~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.............. ..... .+...... .......++.+++..||+.+|++||+++|++.
T Consensus 241 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 --DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred --HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111111000 00000 00000000 00112346789999999999999999999987
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=270.89 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=198.8
Q ss_pred ceeeeecceeEEEEE-ECCCcEEEEEEccCcccccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEEEEeecCCCCc
Q 003280 519 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
+.||+|+|+.|--+. +..|.++|||++.++......++.+|++++.+.+ |+||++++.+|+++...|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 589999999999885 5679999999999998888899999999999995 99999999999999999999999999999
Q ss_pred cccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC---ceeeeecceeecCC--Cc--
Q 003280 597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN---PKISDFGLARMFGG--DE-- 669 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~~~~--~~-- 669 (834)
..+|. +.+.+++.++.++..+|+.||.+||.++ |.||||||+|||...... +||+||.+..-... +-
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 98884 5567899999999999999999999999 999999999999976654 79999988764321 11
Q ss_pred -cccccceeccccccccccccc-----CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccc--
Q 003280 670 -LQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH-- 741 (834)
Q Consensus 670 -~~~~~~~~~gt~~y~aPE~l~-----~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~-- 741 (834)
......+.+|+..|||||+.. ...|+.+.|.||||||||-|++|.+||........ .|.++..=
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------GWdrGe~Cr~ 309 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------GWDRGEVCRV 309 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------CccCCCccHH
Confidence 112223468889999999863 23589999999999999999999999976543221 11111110
Q ss_pred --cccccccccCCC--CH----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 742 --ELIDPVITQDEI--SL----PVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 742 --~lid~~l~~~~~--~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+.+-..+..+.+ +. ....+..+++...+..++.+|.++.+++.
T Consensus 310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 000011112221 21 23456778999999999999999999987
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=308.89 Aligned_cols=261 Identities=31% Similarity=0.448 Sum_probs=206.0
Q ss_pred HhcCccccceeeeecceeEEEEEECC--------CcEEEEEEccCccc-ccHHHHHHHHHHHHhh-cCCCcceEEeEEEe
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQSG-QGLEEFKNEMMLIAKL-QHRNLVKLLGCCVE 580 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~--------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 580 (834)
..++..+.+.||+|.||.|++|.... ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 34556677799999999999997531 34799999986533 4567899999999999 69999999999999
Q ss_pred cCeEEEEEeecCCCCccccccCCC-----CC--------CcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEE
Q 003280 581 QGEKILILEYMPNKSLDVFLFDPT-----KK--------RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVL 647 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 647 (834)
++..++|+||+..|+|..++...+ .. ..+...+.+.++.|||.|++||++.. +|||||..+|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999996544 00 23888999999999999999999987 999999999999
Q ss_pred EcCCCCceeeeecceeecCCCcccc-ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcc
Q 003280 648 LDMDMNPKISDFGLARMFGGDELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSF 725 (834)
Q Consensus 648 l~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~ 725 (834)
+.++..+||+|||+++......... ....-.-...|||||.+....|+.++|||||||+||||++ |..|+..... ..
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-~~ 529 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-TE 529 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-HH
Confidence 9999999999999999765543322 1111113557999999999999999999999999999999 7777654211 11
Q ss_pred cHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 726 NLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 726 ~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
++ .+.++.+...+ .+.....++++++..||+.+|++||++.|+++.|+..
T Consensus 530 ~l----~~~l~~G~r~~----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 530 EL----LEFLKEGNRME----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HH----HHHHhcCCCCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11 11222221111 1122245788999999999999999999999999884
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=288.85 Aligned_cols=262 Identities=24% Similarity=0.284 Sum_probs=191.1
Q ss_pred CccccceeeeecceeEEEEEECC---CcEEEEEEccCcc--cccHHHHHHHHHHHHhh-cCCCcceEEeEEEec----Ce
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRLSSQS--GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ----GE 583 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~---g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~----~~ 583 (834)
+|++.+.||+|+||.||++.... ++.||||+++... ....+.+.+|+.++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47888999999999999998753 6789999986532 22356788899999999 599999999875433 35
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.++++||+. ++|..++. ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788889886 57877773 3456889999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccc--cccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHh-------
Q 003280 664 MFGGDELQ--GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWD------- 733 (834)
Q Consensus 664 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~------- 733 (834)
.+...... .......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD--QLNQILQVLGTPDE 231 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH--HHHHHHHHhCCCCH
Confidence 76433211 11223578999999998765 468999999999999999999999986533211 0000000
Q ss_pred ----HhcCCcccccccc-----ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 734 ----LWKDDKFHELIDP-----VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 734 ----~~~~~~~~~lid~-----~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..........+.. ..............+.+++.+|++.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 00000000111346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=310.70 Aligned_cols=259 Identities=23% Similarity=0.255 Sum_probs=205.6
Q ss_pred HHHHHHHhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEe
Q 003280 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580 (834)
Q Consensus 505 ~~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 580 (834)
...++...++|+++++||+|+||.|..++++. ++.+|+|++.+. ......-|..|-.+|..-+.+=|+.+..+|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34556667899999999999999999999865 788999999873 34455779999999999999999999999999
Q ss_pred cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeec
Q 003280 581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 660 (834)
..++|||||||+||+|-.++. +...+++..+..++..|+-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999998883 3336899999999999999999999999 9999999999999999999999999
Q ss_pred ceeecCCCccccccceeccccccccccccc----C-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYAL----D-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
.+-.+..+.. ......+|||.|++||++. + +.|++.+|.||+||++|||+.|..||-.. .++.-..+..
T Consensus 221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIM 294 (1317)
T ss_pred hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHh
Confidence 9887764332 2334469999999999995 3 67999999999999999999999998432 1221111122
Q ss_pred cCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 003280 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPT---MSDVVS 784 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 784 (834)
+......+. .....+.++.+||...+. +|+.|.. ++++-.
T Consensus 295 ~hk~~l~FP--------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 295 NHKESLSFP--------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred chhhhcCCC--------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 211111111 112244567788877665 7788887 888765
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=276.94 Aligned_cols=249 Identities=25% Similarity=0.348 Sum_probs=194.0
Q ss_pred CccccceeeeecceeEEEEEECC-CcEEEEEEccCc-----ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ-----SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998754 445666655432 222344677899999999999999999999999999999
Q ss_pred EeecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 588 LEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
|||+++++|..++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887542 23456899999999999999999999998 999999999999975 569999999998764
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+.... .......... .. .
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~-~~-----~- 222 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIVE-GP-----T- 222 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHc-CC-----C-
Confidence 3321 1223467889999999988889999999999999999999999975321 1111111111 00 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...+.....++.+++.+|++.+|++||++.|+++
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 ----PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1112233457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=279.88 Aligned_cols=261 Identities=27% Similarity=0.355 Sum_probs=196.8
Q ss_pred ccccceeeeecceeEEEEEECC-CcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
|+..+.||+|++|.||+|+... ++.+|+|++.... ....+.+..|+.++++++|+|++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5567899999999999998764 8999999987653 334567889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
+ ++|.+++.... ..+++..+..++.+++.||+|||+.+ |+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58888884321 46889999999999999999999998 99999999999999999999999999987643321
Q ss_pred cccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcc--cHhH-------HHHhHhcCCc-c
Q 003280 672 GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSF--NLLG-------YAWDLWKDDK-F 740 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~--~l~~-------~~~~~~~~~~-~ 740 (834)
......++..|+|||.+.+. .++.++||||||++++||++|+.|+........ .+.. ..+....... .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 11223457789999998776 789999999999999999999988864332110 0000 0000000000 0
Q ss_pred ccccccccccCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 741 HELIDPVITQDEI---SLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~lid~~l~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
........ .... .......+.+++.+||+.+|++||++++++.
T Consensus 233 ~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFP-PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccC-ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000 0000 0011456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=290.45 Aligned_cols=259 Identities=25% Similarity=0.325 Sum_probs=195.3
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe----
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE---- 583 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~---- 583 (834)
..++|++.+.||+|++|.||+|+.. +++.||||++... .....+.+.+|+.++++++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3578999999999999999999885 4789999998653 22334667889999999999999999988866554
Q ss_pred --EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecc
Q 003280 584 --KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 584 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 661 (834)
.++|+||+ +++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 568888773 245899999999999999999999998 99999999999999999999999999
Q ss_pred eeecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhH------
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDL------ 734 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~------ 734 (834)
+...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ........
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~--~~~~i~~~~~~~~~ 237 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID--QLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHhcCCCCH
Confidence 9865432 223467889999999865 367899999999999999999999986433211 00000000
Q ss_pred -----hcCCccccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 735 -----WKDDKFHELIDPVITQDEIS-----LPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 735 -----~~~~~~~~lid~~l~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+........+.......... ......+.+++.+||+.+|++|||+.||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000000000000000 012457889999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=310.43 Aligned_cols=145 Identities=29% Similarity=0.416 Sum_probs=130.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.++||+|+||.||+|... .++.||||+++... ......+..|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 68999999999999999999876 58899999987542 233467889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
||+++++|..++.. ...+++..++.++.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998843 345788899999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=271.25 Aligned_cols=236 Identities=28% Similarity=0.353 Sum_probs=191.5
Q ss_pred eeeecceeEEEEEEC-CCcEEEEEEccCccc---ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCc
Q 003280 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
||+|+||.||++... +++.+|+|++..... ...+.+.+|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 488999999876432 2456889999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccce
Q 003280 597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (834)
.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 998843 335889999999999999999999987 9999999999999999999999999998764432 12233
Q ss_pred ecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHH
Q 003280 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~ 756 (834)
..++..|+|||.+.+...+.++|+||||+++|||++|+.||...+.. .. ...... . ....+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~---~~~~~~-~-----------~~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--EI---YEKILK-D-----------PLRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HH---HHHHhc-C-----------CCCCCCC
Confidence 56788999999999888999999999999999999999998643321 11 111111 0 0011111
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHH
Q 003280 757 VLVRYINVALLCVQDNAADRPTMSD 781 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPs~~e 781 (834)
....+.+++.+|+..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1346789999999999999999965
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=291.09 Aligned_cols=240 Identities=23% Similarity=0.277 Sum_probs=194.9
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.++.|++...+|.|+|+.|-.+.+. .++..++|++.+...+ -.+|+.++.+. +||||+++.+.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4678899999999999999999765 4889999999776322 34566565555 7999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE-cCCCCceeeeecceeecCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL-DMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfgla~~~~~ 667 (834)
|.+.++-+.+.+.. .+... ..+..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999888776632 22223 677789999999999999998 9999999999999 6899999999999998765
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
. ....+-|..|.|||++....|++++|+||||++||+|++|+.|+.....+ .++. ..
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~-----------------~~ 525 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIH-----------------TR 525 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHH-----------------Hh
Confidence 4 23346688999999999999999999999999999999999998755433 1111 11
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+..+..+...+....+|+.+||+.||.+||+|.++..
T Consensus 526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred hcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1123333444567889999999999999999999976
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=275.36 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=194.1
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 586 (834)
..+|..+.+||+|+||.|.+|..+. .+.+|||++++.- ....+--+.|-++|+.. +-|.++++..+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3578889999999999999997654 5679999998752 22334446677788777 57889999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+.+|+|-.++ ++-+.+.+..+..++..||-||-+||+++ ||.||||.+||+||.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999997776 44456778888899999999999999999 9999999999999999999999999998632
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
-+ ...+.+.+||+.|+|||++...+|+..+|.|||||+||||+.|++||+..++++.. ..+.+.
T Consensus 502 ~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF--------------~aI~eh 565 (683)
T KOG0696|consen 502 FD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF--------------QAIMEH 565 (683)
T ss_pred cC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH--------------HHHHHc
Confidence 22 23456789999999999999999999999999999999999999999876654321 111122
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCC
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRP 777 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
.. .++...+.+...+....+...|.+|.
T Consensus 566 nv---syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 NV---SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cC---cCcccccHHHHHHHHHHhhcCCcccc
Confidence 11 22333345666778888899999984
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=262.68 Aligned_cols=247 Identities=22% Similarity=0.290 Sum_probs=193.9
Q ss_pred HhcCcccc-ceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEe----cCe
Q 003280 511 ATENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVE----QGE 583 (834)
Q Consensus 511 ~~~~f~~~-~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~----~~~ 583 (834)
.+++|++. ++||-|-.|.|-....+ .++.+|+|++... ....+|+++--+. .|||||.++++|++ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35677765 57999999999998775 4889999999643 3446788776555 69999999999865 447
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC---CCCceeeeec
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFG 660 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg 660 (834)
+.+|||.|+||.|...+.+ .....+.+.++..|+.||..|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 8899999999999888754 23456899999999999999999999998 999999999999954 4568999999
Q ss_pred ceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcc
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKF 740 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 740 (834)
+|+.... .....+.+-|+.|.|||++...+|+...|+||+||++|-|++|.+||-.... ..+
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~ai------------- 271 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAI------------- 271 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccC-------------
Confidence 9997543 2234456889999999999999999999999999999999999999853222 111
Q ss_pred ccccccccccC--CCCHH----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 741 HELIDPVITQD--EISLP----VLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~lid~~l~~~--~~~~~----~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..-+..++..+ .++.+ .++...++|+.+|..+|.+|.|++|+..
T Consensus 272 spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 272 SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11111111111 12222 3456789999999999999999999987
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=286.56 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=208.6
Q ss_pred HHHHHHHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEe--
Q 003280 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVE-- 580 (834)
Q Consensus 505 ~~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~-- 580 (834)
++.+...++.|++.++||.|.+|.||+++.. +++..|||++..... ..++++.|..+++.. .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3444455678999999999999999999864 588999999866543 336778899999888 69999999999875
Q ss_pred ---cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceee
Q 003280 581 ---QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS 657 (834)
Q Consensus 581 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 657 (834)
+++++||||||.+|+.-+++.... +..+.|..+..|++.++.|+.+||... ++|||||-.|||++.++.+||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 458999999999999999886544 778999999999999999999999987 9999999999999999999999
Q ss_pred eecceeecCCCccccccceecccccccccccccC-----CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHH
Q 003280 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAW 732 (834)
Q Consensus 658 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~ 732 (834)
|||.+..+... .....+..||+.|||||++.. ..|+.++|+||||++..||--|.+|+..+.+- .
T Consensus 166 DFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------r 235 (953)
T KOG0587|consen 166 DFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------R 235 (953)
T ss_pred eeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------h
Confidence 99999887543 334455799999999999964 34788999999999999999999997533211 1
Q ss_pred hHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 733 DLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 733 ~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.++.. ....-..-.-+.....++.++|..||..|.++||++.++++
T Consensus 236 aLF~I------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 ALFLI------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hhccC------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111 00000011123456778999999999999999999999876
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-32 Score=266.06 Aligned_cols=256 Identities=26% Similarity=0.341 Sum_probs=194.7
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCccc-ccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG-QGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++.+-+..||.|+||+|+|-.++. |+..|||+++.... ...+++..|.+...+- +.||||+++|++..++..++.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 344455789999999999998754 99999999987643 5567888888866555 79999999999999999999999
Q ss_pred ecCCCCccccc---cCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 590 YMPNKSLDVFL---FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
.|. .+|+.+- +. .+...++++-+-+|....+.||.||...- .|||||+||+||||+..|.+||+|||++-.+.
T Consensus 144 LMd-~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHh-hhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 995 3554432 22 23456788888888889999999998765 59999999999999999999999999998765
Q ss_pred CCccccccceecccccccccccccC--CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
.... ...-.|-..|||||.+.. ..|+.++||||||+.|+|+.||+.|+...+.-..++. . ...++...+.
T Consensus 220 ~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~----~-Vv~gdpp~l~ 291 (361)
T KOG1006|consen 220 DSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC----Q-VVIGDPPILL 291 (361)
T ss_pred HHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH----H-HHcCCCCeec
Confidence 4321 112367778999999964 3499999999999999999999999765443211111 1 1112222221
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
......+....+.+++..|+..|..+||...++.++
T Consensus 292 -----~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 -----FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -----CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 222223345578899999999999999999999874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=258.78 Aligned_cols=247 Identities=23% Similarity=0.379 Sum_probs=201.3
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 586 (834)
.++|.++++||+|+|..|..+++.. .+.+|+|++++. ..+..+-.+.|-.+..+. +||.+|.+..+|+....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4789999999999999999998864 788999999874 445566677888887776 79999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
|.||+++|+|--++ .+.+.++++.+..+...|.-||.|||+.+ ||.||||.+|+|+|..|++||+|+|+++.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999985555 56677999999999999999999999999 9999999999999999999999999998642
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCC--cccHhHHHHhHhcCCcccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD--SFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~li 744 (834)
.. ...+.+++||+.|+|||++.+..|...+|.|+|||+++||+.|+.||+....+ ..+...+..+...+.
T Consensus 403 ~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek------ 474 (593)
T KOG0695|consen 403 GP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK------ 474 (593)
T ss_pred CC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh------
Confidence 22 23456789999999999999999999999999999999999999999765432 223333333333221
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCC
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRP 777 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
.+ .++.....+...++..-|..||.+|.
T Consensus 475 --qi---riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 475 --QI---RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --cc---cccceeehhhHHHHHHhhcCCcHHhc
Confidence 11 12233334556788888999999985
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=266.97 Aligned_cols=221 Identities=19% Similarity=0.116 Sum_probs=175.2
Q ss_pred ecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCccccccC
Q 003280 524 GGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD 602 (834)
Q Consensus 524 G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 602 (834)
|.+|.||+++.. +++.+|+|+++... .+..|...+....||||+++++++.+....++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999875 58899999997643 234455555566799999999999999999999999999999888843
Q ss_pred CCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccceeccccc
Q 003280 603 PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682 (834)
Q Consensus 603 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 682 (834)
...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 335889999999999999999999998 999999999999999999999999988665432 112345678
Q ss_pred ccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHH
Q 003280 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYI 762 (834)
Q Consensus 683 y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~ 762 (834)
|+|||.+.+..++.++||||+|+++|||++|+.|+....... ...... ..+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------~~~~~~-----~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------NTHTTL-----NIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------cccccc-----CCcccCCHHHH
Confidence 999999988889999999999999999999998754221100 000000 01111234678
Q ss_pred HHHHhccccCCCCCCCHHH
Q 003280 763 NVALLCVQDNAADRPTMSD 781 (834)
Q Consensus 763 ~li~~cl~~dP~~RPs~~e 781 (834)
+++.+|++.||++||++.+
T Consensus 207 ~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 207 SLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHccCCHHHhcCCCc
Confidence 8999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=267.09 Aligned_cols=258 Identities=28% Similarity=0.373 Sum_probs=197.9
Q ss_pred hcCccccceeeeecceeEEEEEE-CCCcEEEEEEccCc--c-----cccHHHHHHHHHHHHhhcCCCcceEEeEEEec-C
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--S-----GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-G 582 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~--~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~ 582 (834)
.++|-++.+||+|+|+.||||.+ ...+.||||+-... - ....+...+|.++-+.|.||.||+++++|.-+ .
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 35788889999999999999974 45788999975322 1 11234467899999999999999999999654 5
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC---CCCceeeee
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDF 659 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 659 (834)
..+-|+||+++.+|+-|| ...+.+++.++..|+.||+.||.||.+.. +||||-||||.||||.+ -|.+||+||
T Consensus 542 sFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 678999999999999999 45567899999999999999999999875 78999999999999954 478999999
Q ss_pred cceeecCCCcccc-----ccceecccccccccccccCC----ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHH
Q 003280 660 GLARMFGGDELQG-----NTKRIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGY 730 (834)
Q Consensus 660 gla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~----~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~ 730 (834)
|+++++..+.+.. .+....||..|++||.+.-+ .++.|+||||.|||+|..+.|+.||+..... .+++
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-QdIL-- 694 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-QDIL-- 694 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-HHHH--
Confidence 9999987654331 23346899999999988533 4789999999999999999999999854322 1221
Q ss_pred HHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 731 AWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 731 ~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.+..+...-.- .-...+....+...+|.+||+.--++|....++..
T Consensus 695 -----qeNTIlkAtEV---qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 -----QENTILKATEV---QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -----hhhchhcceec---cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 12111111111 11112223446778999999999999988877754
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=238.36 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=192.2
Q ss_pred CccccceeeeecceeEEEEEECC-CcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+|...++||+|.||+||||+..+ ++.||+|+++.. ++.......+|+-+++.++|.|||++++....+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45567899999999999998654 789999988754 233345678999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
|.. +|..+. ..-++.++.+....++.|+++||.++|+++ +.||||||+|+||+.+|++|++|||+++.++-...
T Consensus 83 cdq-dlkkyf--dslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYF--DSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHH--HhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 954 455444 234566888999999999999999999998 99999999999999999999999999998754321
Q ss_pred ccccceecccccccccccccCCc-cCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHH--hHhcCCc---cccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAW--DLWKDDK---FHEL 743 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~-~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~--~~~~~~~---~~~l 743 (834)
.....+-|..|.+|.++.+.. |+...|+||.|||+.|+.. |++.|+..+-+. ++...-+ ....++. +..+
T Consensus 157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd-qlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH-HHHHHHHHhCCCccccCCccccC
Confidence 122245688999999998764 8999999999999999998 555455433221 2221111 1111111 2223
Q ss_pred ccccccc---CCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 744 IDPVITQ---DEIS-----LPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 744 id~~l~~---~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
-|...-. ...+ +.....=.+++...+.-+|.+|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2322200 0011 111122356777888889999999998765
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=263.94 Aligned_cols=262 Identities=21% Similarity=0.245 Sum_probs=198.1
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhc-C-CC----cceEEeEEEecCeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-H-RN----LVKLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-pn----Iv~l~~~~~~~~~~ 584 (834)
+++|.+..++|+|.||.|-...+.. +..||||+++... ...+..+-|+++++++. + |+ +|.+.++|.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6899999999999999999997654 6889999997543 23455677999999994 2 32 78888899999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC--------------
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-------------- 650 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------------- 650 (834)
++|+|.+ |-++.+++..+ +..+++...+..|+.|+++++++||+.+ ++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999988 45778888442 3456888999999999999999999998 999999999999832
Q ss_pred ------CCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCc
Q 003280 651 ------DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS 724 (834)
Q Consensus 651 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~ 724 (834)
+..+||+|||.|....... ..++.|..|.|||++.+-.++..+||||+||||+||.+|..-|...+..+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 2348999999998754332 45788999999999999999999999999999999999998887655322
Q ss_pred -ccHhHH--------------HHhHhcCCccc-----------cccccc---cccCCCCHHHHHHHHHHHHhccccCCCC
Q 003280 725 -FNLLGY--------------AWDLWKDDKFH-----------ELIDPV---ITQDEISLPVLVRYINVALLCVQDNAAD 775 (834)
Q Consensus 725 -~~l~~~--------------~~~~~~~~~~~-----------~lid~~---l~~~~~~~~~~~~l~~li~~cl~~dP~~ 775 (834)
..++.. +.+.+..+++. ...++. -..-....++..++.+|+..||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 111110 11111111110 000000 0001123345668999999999999999
Q ss_pred CCCHHHHHH
Q 003280 776 RPTMSDVVS 784 (834)
Q Consensus 776 RPs~~evl~ 784 (834)
|+|+.|++.
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=257.62 Aligned_cols=238 Identities=28% Similarity=0.359 Sum_probs=192.3
Q ss_pred cceeEEEEEECC-CcEEEEEEccCccccc-HHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCccccccC
Q 003280 525 GFGPVYKGRLLN-GQEVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD 602 (834)
Q Consensus 525 ~~G~Vy~~~~~~-g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 602 (834)
+||.||+|.... ++.+|+|++....... .+.+.+|++.+++++|+|++++++.+......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8999999998765544 78999999999999999999999999999999999999999999998843
Q ss_pred CCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccceeccccc
Q 003280 603 PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682 (834)
Q Consensus 603 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 682 (834)
. ..+++..+..++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 2 22789999999999999999999997 9999999999999999999999999998875432 2233567889
Q ss_pred ccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHH
Q 003280 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYI 762 (834)
Q Consensus 683 y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~ 762 (834)
|+|||.+.+..++.++||||||+++++|++|..|+....... ... ......... ..........++.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~----~~~~~~~~~--------~~~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELF----KKIGKPKPP--------FPPPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHH----HHHhccCCC--------CccccccCCHHHH
Confidence 999999998889999999999999999999999875422111 111 111111000 0000000335688
Q ss_pred HHHHhccccCCCCCCCHHHHHH
Q 003280 763 NVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 763 ~li~~cl~~dP~~RPs~~evl~ 784 (834)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=288.60 Aligned_cols=260 Identities=21% Similarity=0.244 Sum_probs=167.3
Q ss_pred HhcCccccceeeeecceeEEEEEECC-----CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeE------EE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGC------CV 579 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~------~~ 579 (834)
..++|++.++||+|+||.||+|++.+ ++.||||++...... +...+| .+.+..+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999998754 689999998643221 111111 1122222223222221 24
Q ss_pred ecCeEEEEEeecCCCCccccccCCCC-----------------CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCC
Q 003280 580 EQGEKILILEYMPNKSLDVFLFDPTK-----------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLK 642 (834)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 642 (834)
.....++||||+++++|.+++..... ........+..++.||+.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 55689999999999999888753211 011123345679999999999999998 9999999
Q ss_pred CCcEEEcC-CCCceeeeecceeecCCCccccccceecccccccccccccCC----------------------ccCccCc
Q 003280 643 ASNVLLDM-DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG----------------------LFSIKSD 699 (834)
Q Consensus 643 p~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~t~~~D 699 (834)
|+|||+++ ++.+||+|||+++.+..... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 58999999999986543221 122346789999999976432 2345679
Q ss_pred eeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC-cc---ccccccccccC-----CCCHHHHHHHHHHHHhccc
Q 003280 700 VFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD-KF---HELIDPVITQD-----EISLPVLVRYINVALLCVQ 770 (834)
Q Consensus 700 VwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-~~---~~lid~~l~~~-----~~~~~~~~~l~~li~~cl~ 770 (834)
||||||+||||+++..+.... +..+.......+ .. ...+.+..... ...........+|+.+||+
T Consensus 362 VwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999999976653211 111100000000 00 00011100000 0000112234589999999
Q ss_pred cCCCCCCCHHHHHH
Q 003280 771 DNAADRPTMSDVVS 784 (834)
Q Consensus 771 ~dP~~RPs~~evl~ 784 (834)
.||++|||++|+++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=279.49 Aligned_cols=261 Identities=20% Similarity=0.276 Sum_probs=179.8
Q ss_pred HhcCccccceeeeecceeEEEEEE-----------------CCCcEEEEEEccCcccccHHH--------------HHHH
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRL-----------------LNGQEVAVKRLSSQSGQGLEE--------------FKNE 559 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E 559 (834)
..++|++.++||+|+||+||+|.+ ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 235679999986543322233 3447
Q ss_pred HHHHHhhcCCCc-----ceEEeEEEe--------cCeEEEEEeecCCCCccccccCCCC---------------------
Q 003280 560 MMLIAKLQHRNL-----VKLLGCCVE--------QGEKILILEYMPNKSLDVFLFDPTK--------------------- 605 (834)
Q Consensus 560 ~~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------- 605 (834)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788877654 667777753 3568999999999999998864211
Q ss_pred CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccceecccccccc
Q 003280 606 KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685 (834)
Q Consensus 606 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 685 (834)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123467778899999999999999998 99999999999999999999999999976543221 11112344789999
Q ss_pred cccccCCc--------------------c--CccCceeehhhhHHHhhcCCC-CCCCCCCCcccHhH-----HHHhHhcC
Q 003280 686 PEYALDGL--------------------F--SIKSDVFSFGILMLETLSGKK-NTGVYNADSFNLLG-----YAWDLWKD 737 (834)
Q Consensus 686 PE~l~~~~--------------------~--t~~~DVwSlGvvl~elltG~~-p~~~~~~~~~~l~~-----~~~~~~~~ 737 (834)
||.+.... + ..+.||||+||+++||++|.. |+.........+.. ..|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99886432 1 134799999999999999875 54321110000100 01111111
Q ss_pred CccccccccccccCCCCHHHHHHHHHHHHhccccCC---CCCCCHHHHHH
Q 003280 738 DKFHELIDPVITQDEISLPVLVRYINVALLCVQDNA---ADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 784 (834)
... + + ...........+++.++|..+| .+|+|++|+++
T Consensus 459 ~~~----~--~---~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKY----D--F---SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCC----C--c---ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 110 0 0 0111123467789999998765 78999999986
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=273.31 Aligned_cols=249 Identities=24% Similarity=0.312 Sum_probs=203.6
Q ss_pred hcCccccceeeeecceeEEEEEECCCc-EEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQ-EVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~-~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
..+++.+..||-|+||.|-+++.+..+ .+|+|++++. .....+.+..|-.+|...+.|.||+++-.|.+....||+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 356777789999999999999875544 3889988764 334456678899999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
||-|-||.|...+ +.++.++......++..+.+|++|||.++ ||.|||||+|++|+.+|-+||.|||+|+.+..
T Consensus 499 mEaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999988 45567888888999999999999999998 99999999999999999999999999999866
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. .+-+++||+.|.|||++.+...+.++|.||||+++|||++|.+||...++-.. +.. .++ -+|
T Consensus 573 g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt----Yn~-ILk------Gid-- 636 (732)
T KOG0614|consen 573 GR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT----YNL-ILK------GID-- 636 (732)
T ss_pred CC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH----HHH-HHh------hhh--
Confidence 53 45568999999999999999999999999999999999999999976553211 100 011 111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPT-----MSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 784 (834)
.-..+........+++...+..+|.+|.- +.++-+
T Consensus 637 --~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 637 --KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred --hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 11223333446678999999999999975 566654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=267.68 Aligned_cols=208 Identities=23% Similarity=0.354 Sum_probs=176.0
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.-|..++.||-|+||+|.+++..+ ...+|+|.|++.+ +.....++.|-.||+..+.+=||+|+..|++.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 357788999999999999997544 5678999998763 344567889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC--
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-- 666 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~-- 666 (834)
+|++||++-.+|. +-+.+++..+..++..+..|+++.|..| +|||||||+|||||.+|++||+||||+.-+.
T Consensus 709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999988873 4567889999999999999999999999 9999999999999999999999999987541
Q ss_pred -------CCccc-------------------------------cccceecccccccccccccCCccCccCceeehhhhHH
Q 003280 667 -------GDELQ-------------------------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708 (834)
Q Consensus 667 -------~~~~~-------------------------------~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ 708 (834)
..... ......+||+.|+|||++....|+..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 10000 0011247999999999999999999999999999999
Q ss_pred HhhcCCCCCCCCCCCccc
Q 003280 709 ETLSGKKNTGVYNADSFN 726 (834)
Q Consensus 709 elltG~~p~~~~~~~~~~ 726 (834)
||+.|+.||-.....+.+
T Consensus 863 em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred HHhhCCCCccCCCCCcce
Confidence 999999999765544433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=281.00 Aligned_cols=246 Identities=27% Similarity=0.397 Sum_probs=188.4
Q ss_pred ccccceeeeeccee-EEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEeecC
Q 003280 515 FSMQCKLGEGGFGP-VYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 515 f~~~~~LG~G~~G~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
|.-.+.+|.|+.|+ ||+|.. +|+.||||++-.. ..+-..+|+..|+.- +|||||++++.-.+++.+|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44456789998875 789988 7899999998533 334567899999888 69999999999999999999999994
Q ss_pred CCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC---C--CCceeeeecceeecC
Q 003280 593 NKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---D--MNPKISDFGLARMFG 666 (834)
Q Consensus 593 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~Dfgla~~~~ 666 (834)
.+|++++... ...........+.+..|++.||++||+.+ ||||||||+||||.. + .+++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5889988543 11111111345778899999999999987 999999999999976 2 568999999999987
Q ss_pred CCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhcC-CCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 667 GDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG-KKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 667 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
.+... .......||-+|+|||++....-+.++||||||||+|+.++| .+||+.....+.+++. .......+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~-------~~~~L~~L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT-------GNYTLVHL 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc-------Cccceeee
Confidence 65432 224457899999999999999999999999999999999995 8999854433332221 11111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.+ ..+. +..+||.+|+..+|..||++.+|+.
T Consensus 736 ~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 EP-------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred cc-------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 10 1111 6779999999999999999999975
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=228.66 Aligned_cols=110 Identities=47% Similarity=0.788 Sum_probs=81.9
Q ss_pred CCceEEEecCCCCCCC--CCceEEEeecCceEEecCCCceEEEe-eccccc-CcceEEEccCCCeEEecCCCCCCccccc
Q 003280 70 PDTVVWVANRDRPISD--HNAVLTISNKGNLVLLNQTNGTIWST-NVFSEV-KNPVAQLRDDGNLVIRDNSSGNTTESYL 145 (834)
Q Consensus 70 ~~~~vw~anr~~p~~~--~~~~l~~~~~g~l~l~~~~~~~~w~~-~~~~~~-~~~~~~l~d~Gnlvl~~~~~~~~~~~~~ 145 (834)
++||||+|||+.|+.. ...+|.|+.||+|+|++.+++++|++ ++.+.. .+..|+|+|+|||||++. .+.+|
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-----~~~~l 75 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-----SGNVL 75 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET-----TSEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee-----cceEE
Confidence 4699999999999954 35899999999999999999999999 554333 578999999999999996 45899
Q ss_pred cccccCCchhhccCCccccccccccceEEEEecCCCCCC
Q 003280 146 WQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPS 184 (834)
Q Consensus 146 WqSFd~PtDtlLpg~kl~~~~~t~~~~~l~Sw~s~~dps 184 (834)
||||||||||+||+|+|+.+..++.+..++||++.+|||
T Consensus 76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999999999988888878899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-29 Score=247.07 Aligned_cols=267 Identities=23% Similarity=0.370 Sum_probs=188.7
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEe--------c
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--------Q 581 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--------~ 581 (834)
..|+-..+||+|.||.||+|+..+ ++.||+|++--. .+..-....+|+++|..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345556799999999999998765 778999865321 22223455789999999999999999988753 2
Q ss_pred CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecc
Q 003280 582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 661 (834)
...+|||.+++. +|.-++.+ ....++...+.+++.++..||.|+|... |+|||+|+.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 358999999976 45555532 2245788899999999999999999987 99999999999999999999999999
Q ss_pred eeecCCCc--cccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCc-ccHhHH-------
Q 003280 662 ARMFGGDE--LQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADS-FNLLGY------- 730 (834)
Q Consensus 662 a~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~-~~l~~~------- 730 (834)
++.+.... ........+-|..|.+||.+.+. .|+++.|||..|||+.||.++.+-+....+.. ..+...
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 98774432 22223345669999999998764 69999999999999999999997765432211 111111
Q ss_pred -HHhHhcCCccccccccc-cccCCCC--HHH------HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 731 -AWDLWKDDKFHELIDPV-ITQDEIS--LPV------LVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 731 -~~~~~~~~~~~~lid~~-l~~~~~~--~~~------~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
+|.....-.+.+.+... +..+... .+. ..+..+|+.+++..||.+|+.+.+++.-
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11111110010111000 1111100 001 1256789999999999999999999863
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=236.14 Aligned_cols=259 Identities=21% Similarity=0.313 Sum_probs=196.5
Q ss_pred HhcCccccceeeeecceeEEEEEE-CCCcEEEEEEccCcccccHHHHHHHHHHHHhhc-CCCcceEEeEEEecC--eEEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQG--EKIL 586 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~--~~~l 586 (834)
..++|++.+++|+|.|++||.|.. .+.+.++||++++. ..+.+.+|+++|..+. ||||+++++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 347899999999999999999974 56889999999765 3467889999999997 999999999987754 6789
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC-CCceeeeecceeec
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMF 665 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~ 665 (834)
|+||+.+.+...+. +.+....+..++.+++.||.|+|+.| |.|||+||.|++||.. ..++|+|+|+|..+
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998865543 34677788999999999999999999 9999999999999865 56999999999987
Q ss_pred CCCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh---------
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW--------- 735 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~--------- 735 (834)
...... ...+.+..|..||.+..- .|+..-|+|||||+|.+|+..+.||-...+...+++..+.-+-
T Consensus 184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 554321 123556778999999764 5899999999999999999999998655554444444332111
Q ss_pred -----cCCccccccccccccC------CCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 736 -----KDDKFHELIDPVITQD------EISLP-VLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 736 -----~~~~~~~lid~~l~~~------~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.+.++..++....... ..+.. ...+.++++...|..|-.+|||++|...
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111111111100000 00000 1257788999999999999999999865
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-29 Score=244.48 Aligned_cols=267 Identities=21% Similarity=0.277 Sum_probs=194.6
Q ss_pred CccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC-----eEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-----EKI 585 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 585 (834)
+.+-.+.||.|+||.||.+.+. +|+.||+|++... .-...+++-+|+++|.-.+|.|++..++..+-.. ++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3445579999999999999874 5999999998653 2234567889999999999999999888766543 567
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+++|.|.. +|...+ .....++...+.-++.||++||+|||+.+ |.||||||.|+|++.+..+||+|||+++.-
T Consensus 134 V~TELmQS-DLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQS-DLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHh-hhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 88888854 566666 34456778888889999999999999998 999999999999999999999999999987
Q ss_pred CCCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCc-ccHhHH--------HHhHh
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADS-FNLLGY--------AWDLW 735 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~-~~l~~~--------~~~~~ 735 (834)
..++....+. .+-|..|.|||++++. .|+.+.||||.|||+.||+..+..|...++-+ .++..- +.+.-
T Consensus 207 e~d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 DQRDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred chhhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 6665544443 4568999999999986 48999999999999999999888776544321 111110 00111
Q ss_pred cCCccccccccccccC------CC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 736 KDDKFHELIDPVITQD------EI--SLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~------~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
-++....+++...... .+ ......+...+..+++..||++|.+.++.+.-+..
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 1111111111111000 00 11122345677888999999999999998875543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=231.47 Aligned_cols=212 Identities=27% Similarity=0.378 Sum_probs=172.0
Q ss_pred HHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEE
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 586 (834)
...++..-++.||+|++|.|-+-++. +|+..|+|+++.. ..+..++...|+.+..+. .+|.+|+++|.+.+....++
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 34456666789999999999998874 6999999999765 344556778888876655 79999999999999999999
Q ss_pred EEeecCCCCccccccC-CCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 587 ILEYMPNKSLDVFLFD-PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
.||.|. .+|+.+-.+ ..++..+++..+-+|+..+++||.|||++- .+||||+||+||||+.+|++|++|||++-.+
T Consensus 123 cME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999994 466655422 245677899999999999999999999975 5999999999999999999999999999887
Q ss_pred CCCccccccceecccccccccccccC----CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccH
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNL 727 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l 727 (834)
.+.-.. ..-.|-..|||||.+.. ..|+.++||||||+.+.||.+++.|++.......++
T Consensus 200 ~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL 262 (282)
T KOG0984|consen 200 VDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL 262 (282)
T ss_pred hhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence 543211 11356778999999853 368999999999999999999999987665544433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=231.58 Aligned_cols=210 Identities=37% Similarity=0.595 Sum_probs=183.2
Q ss_pred eeeecceeEEEEEECC-CcEEEEEEccCcccc-cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCccc
Q 003280 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDV 598 (834)
Q Consensus 521 LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 598 (834)
||+|.+|.||++.... ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 899999999765433 35789999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-CCCceeeeecceeecCCCcccccccee
Q 003280 599 FLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGGDELQGNTKRI 677 (834)
Q Consensus 599 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~ 677 (834)
++.... ..+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 884321 35789999999999999999999998 999999999999999 89999999999987654321 12234
Q ss_pred cccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHH
Q 003280 678 VGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLP 756 (834)
Q Consensus 678 ~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~ 756 (834)
.+...|++||.+... .++.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577899999999887 889999999999999998
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 757 VLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
..+.+++..|++.+|++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 356789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=254.36 Aligned_cols=195 Identities=26% Similarity=0.363 Sum_probs=167.5
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc--------cccHHHHHHHHHHHHhhc---CCCcceEEeEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS--------GQGLEEFKNEMMLIAKLQ---HRNLVKLLGCCVE 580 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~ 580 (834)
.+|+.++.+|+|+||.|+.+.++. ...|+||.+.+.. ....-.+.-|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468999999999999999998864 6689999886542 111223567999999997 9999999999999
Q ss_pred cCeEEEEEeecC-CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeee
Q 003280 581 QGEKILILEYMP-NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDF 659 (834)
Q Consensus 581 ~~~~~lV~Ey~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 659 (834)
.+..||+||-.. +.+|.+++ +..+.+++.+...|++||+.|+++||+++ |||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999764 45666776 44566899999999999999999999999 999999999999999999999999
Q ss_pred cceeecCCCccccccceecccccccccccccCCcc-CccCceeehhhhHHHhhcCCCCC
Q 003280 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNT 717 (834)
Q Consensus 660 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-t~~~DVwSlGvvl~elltG~~p~ 717 (834)
|.+...... ....++||..|.|||++.+..| ...-|||++|++||.++....|+
T Consensus 715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 999876543 3456899999999999999887 56789999999999999888775
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=209.69 Aligned_cols=109 Identities=38% Similarity=0.801 Sum_probs=103.8
Q ss_pred EeeCCCCCceeeeeec-cccceeeEEEeeeCceeEEEEeccCCCeeeEEEECcCCcEEEEEeecCCCceEEEEecccCcC
Q 003280 210 ACSGQWNGAAFVSAIS-YTNFLYEQYLVENQDEISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYC 288 (834)
Q Consensus 210 ~~sg~w~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~~G~l~~~~w~~~~~~W~~~~~~p~~~C 288 (834)
||+|+|||..|.+.|+ ....++.+.|+.+++|.+|+|...+.+.++|++|+++|+++++.|++..+.|.++|++|.++|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 8999999999999998 556778889999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccCCCCCCccccccCcccCC
Q 003280 289 GKYGYCGANTICSPDQKPICECLEGFKLKS 318 (834)
Q Consensus 289 ~~~g~CG~~giC~~~~~~~C~C~~Gf~~~~ 318 (834)
|+|+.||+||+|+.+..+.|+||+||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 999999999999988889999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-27 Score=246.62 Aligned_cols=205 Identities=22% Similarity=0.263 Sum_probs=172.9
Q ss_pred HHHHhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhc------CCCcceEEeEEEe
Q 003280 508 VAAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ------HRNLVKLLGCCVE 580 (834)
Q Consensus 508 ~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~~~~~~ 580 (834)
-+....+|.+....|+|-|++|..|.... |+.||||+++.+... .+.=+.|+++|++|+ --+.++++-.|..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 34456789999999999999999998754 889999999875332 234467999999996 2479999999999
Q ss_pred cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC-CCceeeee
Q 003280 581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDF 659 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 659 (834)
.++++||+|-+ ..+|.+.|......-.|....+..++.|+.-||..|...+ |+|.||||.|||+++. ..+|||||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence 99999999976 5578888877666777888999999999999999999988 9999999999999876 55899999
Q ss_pred cceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCC
Q 003280 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN 721 (834)
Q Consensus 660 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~ 721 (834)
|.|-....++.. .+.-+..|.|||++.+.+|+...|+||.||.||||.||+..|+...
T Consensus 582 GSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 582 GSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 999877655432 2344668999999999999999999999999999999998886543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-27 Score=254.79 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=203.7
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|+.+..+|.|.||.|||++.. .++..|+|+++-.......-+..|+.+++..+||||+.++|-+......+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 378999999999999999999875 4889999999888777778888999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+.+|+|++.-+ -.+++.+.++..+++...+|++|||+++ -+|||||-.||++.+.|.+|++|||.+-.+..-
T Consensus 94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-- 165 (829)
T KOG0576|consen 94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-- 165 (829)
T ss_pred cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--
Confidence 99999998763 4567889999999999999999999998 899999999999999999999999998776432
Q ss_pred ccccceeccccccccccccc---CCccCccCceeehhhhHHHhhcCCCCCC-CCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTG-VYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~---~~~~t~~~DVwSlGvvl~elltG~~p~~-~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
-.+.+.+.||+.|||||+.. .+.|..++|||++|+...|+---++|.. ..... +..+.. ....++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmT----kS~~qp 234 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMT----KSGFQP 234 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhh----ccCCCC
Confidence 23445579999999999874 5679999999999999999877776621 11110 000000 111222
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.-.++ .......+-+++..|+..+|++||+++.++.
T Consensus 235 p~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 21111 2233455678999999999999999988765
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=203.97 Aligned_cols=115 Identities=43% Similarity=0.718 Sum_probs=102.4
Q ss_pred cccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEecCCCceEEEe
Q 003280 32 SFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWST 111 (834)
Q Consensus 32 ~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~ 111 (834)
+.|++|++|+|+++.|++|||.+..+...+.+|||.+.+.++||.||++.| ....+.|.|+.||+|+|+|.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 578899999999999999999998765599999998876889999999998 4457899999999999999999999999
Q ss_pred ecccccCcceEEEccCCCeEEecCCCCCCccccccccccCC
Q 003280 112 NVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYP 152 (834)
Q Consensus 112 ~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~P 152 (834)
++.+.....+|+|+|+|||||++.+ +.+||||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC-----CCEEEcCCCCC
Confidence 9865355678999999999999874 47899999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=237.39 Aligned_cols=133 Identities=28% Similarity=0.332 Sum_probs=108.8
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhc-----CC---CcceEEeEEEe--
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-----HR---NLVKLLGCCVE-- 580 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----Hp---nIv~l~~~~~~-- 580 (834)
..+|.+.++||-|.|++||++.+.. .+.||+|+.+.. ....+..+.||++|++++ |+ .||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3689999999999999999998754 678999998643 334566788999999984 33 59999999976
Q ss_pred --cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc
Q 003280 581 --QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649 (834)
Q Consensus 581 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 649 (834)
+.+.+||+|++....| .+|. ....+.++...+.+|++||+.||.|||.++ .|||-||||+|||+.
T Consensus 156 pNG~HVCMVfEvLGdnLL-klI~-~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGDNLL-KLIK-YSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhhhhHHH-HHHH-HhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4589999999965444 4442 234456889999999999999999999988 699999999999983
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=228.32 Aligned_cols=199 Identities=35% Similarity=0.500 Sum_probs=172.6
Q ss_pred ccccceeeeecceeEEEEEECC-CcEEEEEEccCcccc-cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
|++.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5567899999999999999875 889999999876544 67889999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999998843221 1788999999999999999999997 99999999999999999999999999988754321 1
Q ss_pred ccceecccccccccccc-cCCccCccCceeehhhhHHHhhcCCCCCCC
Q 003280 673 NTKRIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSGKKNTGV 719 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l-~~~~~t~~~DVwSlGvvl~elltG~~p~~~ 719 (834)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22335678899999998 667788899999999999999999999853
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-26 Score=232.11 Aligned_cols=259 Identities=25% Similarity=0.255 Sum_probs=191.1
Q ss_pred cCccccceeeeecceeEEEEEE-CCCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC------e
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------E 583 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~ 583 (834)
.+|.-++.+|.|.- .|..+.+ -.++.||+|++... .....++..+|+..+..++|+|+++++.+|.-.. +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 56777788999988 5655543 25899999988543 3445677889999999999999999999986433 6
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.|+|||+|.. +|...++ -.++...+..++.|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 7999999954 6666664 23667788999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcc-----------------c
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF-----------------N 726 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~-----------------~ 726 (834)
.-... -....++.|..|.|||++.+..|.+.+||||+||++.||++|+.-|.+.+.-.+ +
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 75443 223346788899999999988899999999999999999999987764332110 0
Q ss_pred HhHHHHhHhcC------CccccccccccccC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 727 LLGYAWDLWKD------DKFHELIDPVITQD--EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 727 l~~~~~~~~~~------~~~~~lid~~l~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+...+...... -.+.+++...+-.. +.+......+.+++.+||..+|++|.+++++|+
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 11111111110 01111111111000 011122345678999999999999999999998
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=233.33 Aligned_cols=266 Identities=23% Similarity=0.336 Sum_probs=198.2
Q ss_pred HHHHhcCccccceeeeecceeEEEEEEC----CCcEEEEEEccCcccccHHHHHHHHHHHHhhc-CCCcceEEeEEEecC
Q 003280 508 VAAATENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQG 582 (834)
Q Consensus 508 ~~~~~~~f~~~~~LG~G~~G~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~ 582 (834)
+....+.|...++||+|.|++||++.+. ..+.||+|.+...+. ..++.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3444578899999999999999999764 367899999876543 367899999999994 999999999999999
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC-CCceeeeecc
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGL 661 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgl 661 (834)
...+|+||+++....++.. .++...+..+++.+.+||+++|++| ||||||||.|+|.+.. +.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999998888773 3568889999999999999999999 9999999999999765 7789999999
Q ss_pred eeecCCCc-------------cc-----------------------------cccceecccccccccccccC-CccCccC
Q 003280 662 ARMFGGDE-------------LQ-----------------------------GNTKRIVGTYGYMSPEYALD-GLFSIKS 698 (834)
Q Consensus 662 a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~l~~-~~~t~~~ 698 (834)
|....... .. .......||++|.|||++.. ...++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 98321100 00 00012369999999999875 5679999
Q ss_pred ceeehhhhHHHhhcCCCCCCCCCCCcccHhHHH---------HhHhcCCc--------cccc---------c--ccccc-
Q 003280 699 DVFSFGILMLETLSGKKNTGVYNADSFNLLGYA---------WDLWKDDK--------FHEL---------I--DPVIT- 749 (834)
Q Consensus 699 DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~---------~~~~~~~~--------~~~l---------i--d~~l~- 749 (834)
||||.|||++-+++++.||-...++...+...+ ......+. +..+ + .....
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 999999999999999999865554433322211 00000111 0000 0 00000
Q ss_pred ------cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 750 ------QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 750 ------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
......-....+++++.+|+..||.+|.|++|.|+
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 00001112336889999999999999999999987
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=215.74 Aligned_cols=251 Identities=20% Similarity=0.331 Sum_probs=187.0
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEe-EEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLG-CCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~-~~~~~~~~~lV~E 589 (834)
+.|.+.+.||+|.||.+-+++++. .+.+|+|-++.. ....++|.+|...--.| .|.||+.-++ .|+..+..++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 679999999999999999999875 667899988654 23457888888765555 5899998765 4677778889999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE--cCCCCceeeeecceeecCC
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL--DMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfgla~~~~~ 667 (834)
|+|.|+|..-+ ....+.+....+++.|++.|+.|||+++ +||||||.+|||| .+..++||+|||+.+..+.
T Consensus 103 ~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999998876 3345778888999999999999999998 9999999999999 3345899999999886543
Q ss_pred CccccccceecccccccccccccCC-----ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~-----~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
- .....-+..|.+||..... ...+.+|+|.||++++.+++|+.|+...... +..-|.|..+..+....
T Consensus 176 t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~--d~~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 176 T-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM--DKPYWEWEQWLKRKNPA 248 (378)
T ss_pred e-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc--CchHHHHHHHhcccCcc
Confidence 2 2223456789999987533 2468899999999999999999998733222 22233444444433332
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
+.+. -.+..+.+.++..+-+..+|++|=-..++.++
T Consensus 249 ~P~~-------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 249 LPKK-------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred Cchh-------hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 2111 11223456778888999999999555555443
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=193.19 Aligned_cols=113 Identities=46% Similarity=0.752 Sum_probs=100.5
Q ss_pred cccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEecCCCceEEEe
Q 003280 32 SFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWST 111 (834)
Q Consensus 32 ~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~ 111 (834)
+.|+.|+.|+|+++.|++|||.+..+ ..+.+|||+..+.++||+|||+.|+.+ ++.|.|+.||+|+|++.+|.+||+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 56888999999999999999998754 689999998866889999999999876 5899999999999999999999999
Q ss_pred ecccccCcceEEEccCCCeEEecCCCCCCccccccccccC
Q 003280 112 NVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDY 151 (834)
Q Consensus 112 ~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~ 151 (834)
++..+....+|+|+|+|||||++.. +.+|||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYDSD-----GNFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC-----CCEEeCCCCC
Confidence 9864455678999999999999874 3799999997
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-24 Score=260.98 Aligned_cols=196 Identities=19% Similarity=0.230 Sum_probs=137.8
Q ss_pred hhcC-CCcceEEeEE-------EecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 003280 565 KLQH-RNLVKLLGCC-------VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636 (834)
Q Consensus 565 ~l~H-pnIv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 636 (834)
.++| +||+++++.| .+....++++|++ +++|.+++.. ....+++..+..++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4555 5788888877 2334567888987 5589999853 2355899999999999999999999998 9
Q ss_pred EeccCCCCcEEEcC-------------------CCCceeeeecceeecCCCcc--------------ccccceecccccc
Q 003280 637 IHRDLKASNVLLDM-------------------DMNPKISDFGLARMFGGDEL--------------QGNTKRIVGTYGY 683 (834)
Q Consensus 637 vH~Dlkp~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y 683 (834)
+||||||+||||+. ++.+|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566667776654211000 0001123578889
Q ss_pred cccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHH
Q 003280 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYIN 763 (834)
Q Consensus 684 ~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~ 763 (834)
||||++.+..++.++|||||||+||||++|..|+..... .. ..... ..+.+.. .....+..+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~----~~~~~----~~~~~~~------~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TM----SSLRH----RVLPPQI------LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HH----HHHHH----hhcChhh------hhcCHHHHH
Confidence 999999999999999999999999999998877532110 00 00000 0011100 111234567
Q ss_pred HHHhccccCCCCCCCHHHHHH
Q 003280 764 VALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 764 li~~cl~~dP~~RPs~~evl~ 784 (834)
++.+||+.+|.+||+|.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999976
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-23 Score=203.92 Aligned_cols=167 Identities=20% Similarity=0.143 Sum_probs=124.8
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccc
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (834)
|+|.+++.. .+..+++..+..++.||+.||+|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 577777743 2456899999999999999999999975 999999999999999 99998764322
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~ 753 (834)
..||+.|||||++.+..++.++|||||||++|||++|+.|+.........+.......... ++. ....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~--~~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD-------DPR--DRSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC-------Ccc--cccc
Confidence 2688999999999999999999999999999999999999854332211111111111000 000 0011
Q ss_pred CHHHH--HHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 754 SLPVL--VRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 754 ~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..... .++.+++.+|++.+|++||++.|+++.+...
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11122 2588999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=217.46 Aligned_cols=176 Identities=21% Similarity=0.246 Sum_probs=135.3
Q ss_pred HHhcCccccceeeeecceeEEEEEEC--CCcEEEEEEccCc-----ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQ-----SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG 582 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~--~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 582 (834)
...++|++.+.||+|+||+||+|.+. +++.||||++... .....+.|.+|+++|++++|+|+++.+.. ..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34578999999999999999999875 4777899987533 12235679999999999999999863322 24
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccC-CCCcEEEcCCCCceeeeecc
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDL-KASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfgl 661 (834)
..++||||+++++|.... .. . ...++.+++++|+|||+++ |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 689999999999986321 11 1 1467889999999999998 999999 99999999999999999999
Q ss_pred eeecCCCccc------cccceecccccccccccccCCc------cCccCcee
Q 003280 662 ARMFGGDELQ------GNTKRIVGTYGYMSPEYALDGL------FSIKSDVF 701 (834)
Q Consensus 662 a~~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~------~t~~~DVw 701 (834)
++.+...... .......+++.|+|||.+...+ .+..+|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9987543211 1113467888999999997543 33446767
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-22 Score=198.98 Aligned_cols=247 Identities=22% Similarity=0.354 Sum_probs=188.7
Q ss_pred ccccceeeeecceeEEEEEECCCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
..+.-+|.+...|+.|+|++ .|..+++|++.-. .....+.|..|.-.|+.+.||||+++++.|....++.++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 33455889999999999999 5667788887543 33344679999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEec-cCCCCcEEEcCCCCceee--eecceeecCCCc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR-DLKASNVLLDMDMNPKIS--DFGLARMFGGDE 669 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~-Dlkp~NIll~~~~~~kl~--Dfgla~~~~~~~ 669 (834)
.|+|...++.. ..-..+..+..+++.+|++|++|||+.. +++-| -|..+.+++|++.+++|. |--++....
T Consensus 271 ~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsfqe~--- 344 (448)
T KOG0195|consen 271 FGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV--- 344 (448)
T ss_pred chHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeeeecc---
Confidence 99999999764 3445677889999999999999999986 45443 589999999999988875 322222111
Q ss_pred cccccceecccccccccccccCCcc---CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLF---SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~---t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
...-.+.||+||.++..+- -.++|+|||++++|||.|...||....+-+.... . ..+-++.
T Consensus 345 ------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-----i-----aleglrv 408 (448)
T KOG0195|consen 345 ------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-----I-----ALEGLRV 408 (448)
T ss_pred ------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-----h-----hhccccc
Confidence 1233678999999987654 3579999999999999999999976544222111 0 0111222
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.+ ++-....+.+++.-|+..||.+||.+..++-+|++-
T Consensus 409 ~i-----ppgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 HI-----PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cC-----CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 22 233345677899999999999999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=202.75 Aligned_cols=260 Identities=22% Similarity=0.265 Sum_probs=190.4
Q ss_pred CccccceeeeecceeEEEEEECCC--cEEEEEEccCcccccHHHHHHHHHHHHhhcC----CCcceEEeEE-EecCeEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLNG--QEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH----RNLVKLLGCC-VEQGEKIL 586 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----pnIv~l~~~~-~~~~~~~l 586 (834)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..++... ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999987653 4788888765533333377889999998873 5788888888 47778899
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC-----CCceeeeecc
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-----MNPKISDFGL 661 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfgl 661 (834)
||+.+ +.+|.++..... .+.++......++.|++.+|.+||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99977 667877663333 567899999999999999999999999 9999999999999765 4589999999
Q ss_pred ee--ecCCCcc----cc-c-cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHh
Q 003280 662 AR--MFGGDEL----QG-N-TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWD 733 (834)
Q Consensus 662 a~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~ 733 (834)
++ .+..... .. . .....||..|++++...+...+.+.|+||++.++.|++.|..|+........ ...
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~---- 248 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSK---- 248 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHH----
Confidence 99 4322211 11 1 2235699999999999999999999999999999999999999854332111 000
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
............ ....... .+.++...+-..+..++|....+...|+...
T Consensus 249 -~~~~~~~~~~~~---~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 249 -FEKDPRKLLTDR---FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred -HHHHhhhhcccc---ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 000000001110 0112222 3344444445588999999999999887663
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-19 Score=196.28 Aligned_cols=260 Identities=31% Similarity=0.413 Sum_probs=197.7
Q ss_pred ccccceeeeecceeEEEEEECCCcEEEEEEccCcccc---cHHHHHHHHHHHHhhcCC-CcceEEeEEEecCeEEEEEee
Q 003280 515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ---GLEEFKNEMMLIAKLQHR-NLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~Ey 590 (834)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++...+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999886 88999998765433 367899999999999988 799999999777778999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC-CceeeeecceeecCCCc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~ 669 (834)
+.++++..++........+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966532211136888999999999999999999998 99999999999999998 79999999998665443
Q ss_pred ccc----ccceecccccccccccccC---CccCccCceeehhhhHHHhhcCCCCCCCCCCC--cccHhHHHHhHhcCCcc
Q 003280 670 LQG----NTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYNAD--SFNLLGYAWDLWKDDKF 740 (834)
Q Consensus 670 ~~~----~~~~~~gt~~y~aPE~l~~---~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~--~~~l~~~~~~~~~~~~~ 740 (834)
... ......|+..|+|||.+.+ ..+....|+||+|++++++++|..|+...... .............. ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 221 2355789999999999988 57899999999999999999999996544321 11111111111100 00
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 741 ~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
........ .......+.+++..++..+|..|.++.+....
T Consensus 236 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSN-----PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccc-----cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 01223456788999999999999998887663
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-21 Score=225.27 Aligned_cols=253 Identities=21% Similarity=0.274 Sum_probs=186.1
Q ss_pred ccceeeeecceeEEEEEEC-CCcEEEEEEcc----C-ccccc-HHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 517 MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS----S-QSGQG-LEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 517 ~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~----~-~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
..+.+|.|++|.|+..... ..+..+.|.++ . ..... ...+..|+.+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4568999999988877543 34444455433 1 11111 1226667777888999999988888777776666799
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++ +|..++. ....+...++..++.|+..|++|+|+.+ |.|||||++|+++..++.+||+|||.+..+.-..
T Consensus 402 ~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 9888873 3346788889999999999999999999 9999999999999999999999999998875443
Q ss_pred cc--cccceecccccccccccccCCccCcc-CceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 670 LQ--GNTKRIVGTYGYMSPEYALDGLFSIK-SDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 670 ~~--~~~~~~~gt~~y~aPE~l~~~~~t~~-~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
.. ......+|+..|+|||++.+..|.+. .||||.|+++..|++|+.||.........+.. .....-...
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~--------~~~~~~~~~ 546 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT--------NNYSDQRNI 546 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh--------hcccccccc
Confidence 32 34455789999999999999999765 79999999999999999998654332221100 000000000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
......+....+.+...++..+|+.+|.+|.|+++|++
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00011222334456788999999999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-21 Score=222.01 Aligned_cols=250 Identities=21% Similarity=0.244 Sum_probs=182.1
Q ss_pred CccccceeeeecceeEEEEEECCCcEEEEEEccCcc-cccHHHHHHHHHHH--HhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS-GQGLEEFKNEMMLI--AKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l--~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++...+.||++.|=.|.+|++++|. |+||++-++. ....+.|.++++-+ ..++|||.+++.-.-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777889999999999999998887 9999987765 34456666655444 455899999998887777778888888
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC-Cc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG-DE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~-~~ 669 (834)
+.+ +|++.+ ..++.+...+...|+.|++.||..+|..+ |+|||||.+||||+.-.-+.|+||..-+...- .+
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 866 455555 45666778888999999999999999999 99999999999999999999999988765411 11
Q ss_pred cccc----cceecccccccccccccCC-----------ccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHh
Q 003280 670 LQGN----TKRIVGTYGYMSPEYALDG-----------LFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWD 733 (834)
Q Consensus 670 ~~~~----~~~~~gt~~y~aPE~l~~~-----------~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~ 733 (834)
.... ..+...--.|+|||.+... ..+++.||||+||++.||++ |+++|... ++..|...
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~ 250 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSG 250 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhcc
Confidence 1111 1222334479999987541 26788999999999999998 67777521 12221111
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
.......++ ..+ . ...+.++++.|++.||.+|.++++.++.-.
T Consensus 251 --~~~~~e~~L-e~I-----e---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 251 --NADDPEQLL-EKI-----E---DVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred --CccCHHHHH-HhC-----c---CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 011111111 111 1 114678999999999999999999998633
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=8e-20 Score=184.79 Aligned_cols=171 Identities=14% Similarity=0.157 Sum_probs=134.7
Q ss_pred HhcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHH---H------HHHHHHHHHhhcCCCcceEEeEEEec
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLE---E------FKNEMMLIAKLQHRNLVKLLGCCVEQ 581 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~---~------~~~E~~~l~~l~HpnIv~l~~~~~~~ 581 (834)
..++|+..++||.|+||.||.... +++.+|||.+++....... . +.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 458999999999999999999765 5778999999765332222 2 68999999999999999999886643
Q ss_pred --------CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC
Q 003280 582 --------GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN 653 (834)
Q Consensus 582 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 653 (834)
...+|||||++|.+|.++. .++. ....+++.++..+|..+ ++|||+||.||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 3578999999999997763 1222 24568999999999998 99999999999999988
Q ss_pred ceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhh
Q 003280 654 PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711 (834)
Q Consensus 654 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ell 711 (834)
++|+|||.......+... ..+.....|..++|+|+||+.+.-+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988765322110 11344556778999999999988654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=179.56 Aligned_cols=139 Identities=18% Similarity=0.169 Sum_probs=109.0
Q ss_pred cceeeeecceeEEEEEECCCcEEEEEEccCcccc--c-------HHH-----------------HHHHHHHHHhhcCCCc
Q 003280 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ--G-------LEE-----------------FKNEMMLIAKLQHRNL 571 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~HpnI 571 (834)
.+.||+|++|.||+|...+|+.||||+++..... . ... ...|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999998754211 1 112 2349999999998877
Q ss_pred ceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHh-hhcCCCceEeccCCCCcEEEcC
Q 003280 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL-HQYSRFRIIHRDLKASNVLLDM 650 (834)
Q Consensus 572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlkp~NIll~~ 650 (834)
.....+.. ...++||||++++++..... ....++......++.|++.+|.++ |+.+ |+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 23389999999987765432 234678899999999999999999 6877 99999999999998
Q ss_pred CCCceeeeecceeec
Q 003280 651 DMNPKISDFGLARMF 665 (834)
Q Consensus 651 ~~~~kl~Dfgla~~~ 665 (834)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.6e-19 Score=179.16 Aligned_cols=203 Identities=24% Similarity=0.343 Sum_probs=169.3
Q ss_pred cCccccceeeeecceeEEEEE-ECCCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
-+|++.++||+|.||+++.|+ +-+++.||||.-...++ .-++..|.+..+.| ..++|...+.+-.++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 579999999999999999997 45799999997654332 35677788888888 478999999888999999999998
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC-----Cceeeeecceeec
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-----NPKISDFGLARMF 665 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfgla~~~ 665 (834)
+ +-+|+++.. .-++.++.+.+..++.|++.-++|+|++. +|.|||||+|+||...+ .+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 557776652 24566899999999999999999999998 99999999999996544 4899999999987
Q ss_pred CCCccc-----cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCC
Q 003280 666 GGDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD 723 (834)
Q Consensus 666 ~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~ 723 (834)
...... ...+...||.+||+=....+...+.+.|+=|||-++...+-|..||.....+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 543221 2334568999999999999999999999999999999999999999876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=173.91 Aligned_cols=141 Identities=20% Similarity=0.227 Sum_probs=112.2
Q ss_pred cceeeeecceeEEEEEECCCcEEEEEEccCccccc--------------------------HHHHHHHHHHHHhhcCCCc
Q 003280 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG--------------------------LEEFKNEMMLIAKLQHRNL 571 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~--------------------------~~~~~~E~~~l~~l~HpnI 571 (834)
.+.||+|++|.||+|...+|+.||||+++...... ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 57899999999999998789999999987642110 1234678999999999987
Q ss_pred ceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCcEEEcC
Q 003280 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDM 650 (834)
Q Consensus 572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~ 650 (834)
.....+... ..+|||||++++++..... ....++......++.+++.++.++|+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444333 3489999999886543321 22356778889999999999999999 87 99999999999999
Q ss_pred CCCceeeeecceeecCC
Q 003280 651 DMNPKISDFGLARMFGG 667 (834)
Q Consensus 651 ~~~~kl~Dfgla~~~~~ 667 (834)
++.++|+|||++..+..
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 89999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=168.70 Aligned_cols=261 Identities=20% Similarity=0.286 Sum_probs=192.1
Q ss_pred hcCccccceeeeecceeEEEEEE-CCCcEEEEEEccCcccccHHHHHHHHHHHHhhcC-CCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH-RNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E 589 (834)
...|.++++||.|+||.+|.|.. .+|+.||||.-+..... .++..|.++...++| ..|..+..+..+...-.|||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 36899999999999999999974 57999999987655433 456778888999975 678888888889999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC---CCceeeeecceeecC
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~ 666 (834)
.+ +-+|.++..- -.+.++...++-++-|++.-++|+|.++ +|||||||+|+|..-+ ..+.++|||+++.+.
T Consensus 92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 87 5567665521 2345778889999999999999999998 9999999999999654 458999999999874
Q ss_pred CCcc-----ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccc
Q 003280 667 GDEL-----QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH 741 (834)
Q Consensus 667 ~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (834)
.... ........||.+|.+-....+...+.+.|+=|+|.+|..+.-|..||.......... ..+...+.+..
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q---KyEkI~EkK~s 242 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ---KYEKISEKKMS 242 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH---HHHHHHHhhcC
Confidence 4321 122334689999999988888889999999999999999999999987654322111 11112222211
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 742 ELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 742 ~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..+. .++.+ .+.++...+.-|-..--++-|...-+-+.+.-+
T Consensus 243 ~~ie-~LC~G-----~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 243 TPIE-VLCKG-----FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred CCHH-HHhCC-----CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 1111 11111 123555666777777778888877666655443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.6e-18 Score=188.78 Aligned_cols=218 Identities=26% Similarity=0.332 Sum_probs=164.0
Q ss_pred HHhhcCCCcceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCC
Q 003280 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLK 642 (834)
Q Consensus 563 l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 642 (834)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....+++.-...++++|+.||+|||... --.|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568899999999999999999999999999999999965 3445788889999999999999999875 12999999
Q ss_pred CCcEEEcCCCCceeeeecceeecCCCccccccceecccccccccccccCCc-------cCccCceeehhhhHHHhhcCCC
Q 003280 643 ASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL-------FSIKSDVFSFGILMLETLSGKK 715 (834)
Q Consensus 643 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~t~~~DVwSlGvvl~elltG~~ 715 (834)
+.|.++|....+||+|||+.................-...|.|||.+.+.. .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999988764311111111123355799999997642 4677999999999999999999
Q ss_pred CCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 716 NTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 716 p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
||+........ ...+..... .....+.|.+.... +...++..++.+||..+|++||+++++-..++...
T Consensus 157 ~~~~~~~~~~~-~eii~~~~~--~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDP-DEIILRVKK--GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCCh-HHHHHHHHh--cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 99765443321 111111111 12223333332111 22336888999999999999999999998887763
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-18 Score=203.61 Aligned_cols=199 Identities=22% Similarity=0.244 Sum_probs=159.9
Q ss_pred HHHhcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhc---CCCcceEEeEEEecCeEE
Q 003280 509 AAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ---HRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 509 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~ 585 (834)
..-.+.|.|.+.||+|+||.||+|...+|+.||+|+-+.... -+|.--.+++.+|+ -+.|.++..++.-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 344578999999999999999999988899999998765432 12222233444444 244556666666677889
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-------CCCceeee
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-------DMNPKISD 658 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------~~~~kl~D 658 (834)
||+||.+.|+|.+++- ..+.++|..+..++.|+++.+++||..+ |||+||||+|+||.. ...++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999984 6677999999999999999999999999 999999999999932 34589999
Q ss_pred ecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCC
Q 003280 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716 (834)
Q Consensus 659 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p 716 (834)
||-+..+.--..........+|-.+--+|...+...+.++|.|.|+-+++-|+.|+..
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9998765322222344556889999999999999999999999999999999999853
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.8e-18 Score=177.01 Aligned_cols=233 Identities=20% Similarity=0.255 Sum_probs=149.5
Q ss_pred CccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhhc----------CCCcceEEeEEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQ----------HRNLVKLLGCCV 579 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~----------HpnIv~l~~~~~ 579 (834)
.+...+.||.|+++.||.+++.. ++.+|||++... .....+++++|......+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45567899999999999999865 899999987533 3345677777775555432 222222222221
Q ss_pred ---------ecC--------eEEEEEeecCCCCcccccc---CC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEe
Q 003280 580 ---------EQG--------EKILILEYMPNKSLDVFLF---DP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638 (834)
Q Consensus 580 ---------~~~--------~~~lV~Ey~~~gsL~~~l~---~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 638 (834)
... ..+++|+-+ .++|..++. .. .....+....+..+..|+++.+++||..+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 235677776 556666642 11 11233445566778899999999999999 999
Q ss_pred ccCCCCcEEEcCCCCceeeeecceeecCCCccccccceecccccccccccccC--------CccCccCceeehhhhHHHh
Q 003280 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD--------GLFSIKSDVFSFGILMLET 710 (834)
Q Consensus 639 ~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~t~~~DVwSlGvvl~el 710 (834)
+||+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999988775432211 234578999997744 2578999999999999999
Q ss_pred hcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCC
Q 003280 711 LSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADR 776 (834)
Q Consensus 711 ltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~R 776 (834)
.+++.||+......... .. -.... +.++.+..||..+|+.+|++|
T Consensus 244 WC~~lPf~~~~~~~~~~------------------~~--f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPE------------------WD--FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSG------------------GG--GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccccc------------------cc--chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999987543211100 01 22333 556678899999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=164.46 Aligned_cols=183 Identities=17% Similarity=0.135 Sum_probs=137.4
Q ss_pred ccceeeeecceeEEEEEECCCcEEEEEEccCcccc----cHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEEEEeec
Q 003280 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ----GLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 517 ~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
....|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++++ |+++.+++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999997765 6788888887654321 1235889999999995 5789998886 4569999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccC-CCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDL-KASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
.+.+|...+. . ....++.|++++|.++|+++ |+|||| ||.|||++.++.++|+|||++........
T Consensus 81 ~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9998865431 0 11357789999999999998 999999 79999999999999999999986543221
Q ss_pred c----c--c-----cceecccccccccccccCC-ccC-ccCceeehhhhHHHhhcCCCCC
Q 003280 671 Q----G--N-----TKRIVGTYGYMSPEYALDG-LFS-IKSDVFSFGILMLETLSGKKNT 717 (834)
Q Consensus 671 ~----~--~-----~~~~~gt~~y~aPE~l~~~-~~t-~~~DVwSlGvvl~elltG~~p~ 717 (834)
. . . ......++.|++|+...-- ..+ .+.+.++-|.-+|+++|++.+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0 0 0 0112356777888754332 233 5678889999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.4e-19 Score=195.36 Aligned_cols=225 Identities=26% Similarity=0.337 Sum_probs=178.0
Q ss_pred eeeeecceeEEEEE----ECCCcEEEEEEccCccccc--HHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEEEEeecC
Q 003280 520 KLGEGGFGPVYKGR----LLNGQEVAVKRLSSQSGQG--LEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 520 ~LG~G~~G~Vy~~~----~~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
.+|+|.||.|+.++ .+.+..+|+|.+++..... ......|..++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999864 3347789999887643221 124566788888887 9999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+|.|...+ .....+.+.....+...++-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-....
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 99987777 34445667777788888999999999998 99999999999999999999999999987643322
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~ 752 (834)
.+||..|||||++. ....++|.||||++++||++|..||.. +.. ..++.. .-.
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~------------~~Il~~---~~~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTM------------KRILKA---ELE 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHH------------HHHhhh---ccC
Confidence 28999999999998 678899999999999999999999864 111 111111 223
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCH
Q 003280 753 ISLPVLVRYINVALLCVQDNAADRPTM 779 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPs~ 779 (834)
.+.+....+.+++..++..+|.+|--.
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 445556677788888999999998644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6e-17 Score=163.57 Aligned_cols=135 Identities=20% Similarity=0.268 Sum_probs=105.9
Q ss_pred ccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhh-----cCCCcceEEeEEEecC---eEE-EE
Q 003280 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-----QHRNLVKLLGCCVEQG---EKI-LI 587 (834)
Q Consensus 517 ~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~~~~---~~~-lV 587 (834)
-.+.||+|+||.||. +++....+||++........+.+.+|+.++..+ .||||++++++++++. ..+ +|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 346899999999996 544344479988765555567899999999999 5799999999998874 333 78
Q ss_pred Eee--cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHH-HHhhhcCCCceEeccCCCCcEEEcC----CCCceeeeec
Q 003280 588 LEY--MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL-LYLHQYSRFRIIHRDLKASNVLLDM----DMNPKISDFG 660 (834)
Q Consensus 588 ~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfg 660 (834)
+|| +++++|.+++.. ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 668999999933 224444 35577777777 9999998 999999999999974 3479999944
Q ss_pred ce
Q 003280 661 LA 662 (834)
Q Consensus 661 la 662 (834)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-17 Score=133.97 Aligned_cols=66 Identities=47% Similarity=1.097 Sum_probs=59.5
Q ss_pred ccCCceeEEeccccCCCcceeecccccCHHHHHHHhhccCCeeeeeccccCCCcceeeeccccccc
Q 003280 336 CIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDA 401 (834)
Q Consensus 336 C~~~~~f~~l~~~~~~d~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~~~~~~~g~~C~~w~~~l~~~ 401 (834)
|+.+|+|++|++|++|++....++.+.++++|++.|++||||+||+|.++.++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 555799999999999999877776779999999999999999999998766778999999999984
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.6e-17 Score=170.59 Aligned_cols=197 Identities=18% Similarity=0.280 Sum_probs=134.9
Q ss_pred cCCCcceEEeEEEe---------------------------cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHH
Q 003280 567 QHRNLVKLLGCCVE---------------------------QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE 619 (834)
Q Consensus 567 ~HpnIv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 619 (834)
+|||||+++++|.+ +..+|+||...+. +|.+++.. ...+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence 59999999988753 2367888887654 67777732 2345566677889
Q ss_pred HHHHHHHHhhhcCCCceEeccCCCCcEEE--cCCC--CceeeeecceeecCCC--c--cccccceecccccccccccccC
Q 003280 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLL--DMDM--NPKISDFGLARMFGGD--E--LQGNTKRIVGTYGYMSPEYALD 691 (834)
Q Consensus 620 ~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~Dfgla~~~~~~--~--~~~~~~~~~gt~~y~aPE~l~~ 691 (834)
|+++|+.|||+++ |.|||+|.+|||| |+|+ .+.|+|||.+-.-... + +.......-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 4443 4789999987543221 1 1111112356678999998854
Q ss_pred Cc------cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHH
Q 003280 692 GL------FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVA 765 (834)
Q Consensus 692 ~~------~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li 765 (834)
.+ .-.|+|.|+.|.+.||++....||-...+-..+...+. +..+ ...+...+..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq-----e~qL----------Palp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ-----ESQL----------PALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh-----hhhC----------CCCcccCChHHHHHH
Confidence 32 13689999999999999999999754322222222111 1111 112222344678899
Q ss_pred HhccccCCCCCCCHHHHHHHH
Q 003280 766 LLCVQDNAADRPTMSDVVSII 786 (834)
Q Consensus 766 ~~cl~~dP~~RPs~~evl~~L 786 (834)
...|+.||.+|++..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999977666554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.8e-16 Score=161.73 Aligned_cols=149 Identities=17% Similarity=0.156 Sum_probs=114.3
Q ss_pred HHHHhcCccccceeeeecceeEEEEE--ECCCcEEEEEEccCcccc------------------------cHHHHHHHHH
Q 003280 508 VAAATENFSMQCKLGEGGFGPVYKGR--LLNGQEVAVKRLSSQSGQ------------------------GLEEFKNEMM 561 (834)
Q Consensus 508 ~~~~~~~f~~~~~LG~G~~G~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~E~~ 561 (834)
+..-...|++.+.||+|++|.||+|. ..+|+.||||+++..... ....+..|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33334468899999999999999998 457999999998653210 0123578999
Q ss_pred HHHhhcCCC--cceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEec
Q 003280 562 LIAKLQHRN--LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639 (834)
Q Consensus 562 ~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~ 639 (834)
.+.++.+.. +.++++. ...++||||+++.+|..... ....+.......++.||+.++++||+++ .++||
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~ 173 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHG 173 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence 999997633 3344432 23589999999988876542 2233555667889999999999999986 49999
Q ss_pred cCCCCcEEEcCCCCceeeeecceeecC
Q 003280 640 DLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 640 Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+||+++ ++.++|+|||.+....
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999 8899999999987643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.1e-16 Score=158.24 Aligned_cols=134 Identities=22% Similarity=0.320 Sum_probs=113.8
Q ss_pred ceeeeecceeEEEEEECCCcEEEEEEccCcccc--------cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ--------GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+.||+|++|.||+|.. .|..++||+....... ....+.+|+.++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5899999999999987 7788999986543211 124578899999999999998888888788889999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
+++++|.+++... .. .+..++.+++.+|+++|+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887321 12 77899999999999999998 99999999999999 88999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.3e-15 Score=154.17 Aligned_cols=146 Identities=18% Similarity=0.183 Sum_probs=113.8
Q ss_pred HHHHHHhcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccc----------------------cHHHHHHHHHHH
Q 003280 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ----------------------GLEEFKNEMMLI 563 (834)
Q Consensus 506 ~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~----------------------~~~~~~~E~~~l 563 (834)
.++......|.+.+.||+|+||.||++...+|+.||||+++..... ....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444558888999999999999999888999999987543210 112367789999
Q ss_pred HhhcCCC--cceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccC
Q 003280 564 AKLQHRN--LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDL 641 (834)
Q Consensus 564 ~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 641 (834)
..+.|++ +...++ ....++||||+++++|..... ......++.+++.++.++|+.+ ++||||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 9998874 444443 245689999999999876541 0234678899999999999988 999999
Q ss_pred CCCcEEEcCCCCceeeeecceeecCC
Q 003280 642 KASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 642 kp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
||+||++++++.++|+|||++..+..
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.6e-15 Score=153.56 Aligned_cols=130 Identities=23% Similarity=0.364 Sum_probs=107.1
Q ss_pred eeeeecceeEEEEEECCCcEEEEEEccCccc--------ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG--------QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 520 ~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.||+|++|.||+|.. .+..+++|+...... ....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 678899998654221 11356788999999999988766666666777789999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++++|.+++.... ..++.+++++|++||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988763210 078999999999999998 99999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.5e-15 Score=175.15 Aligned_cols=136 Identities=22% Similarity=0.333 Sum_probs=111.5
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEE-ccCcc-------cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR-LSSQS-------GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~-l~~~~-------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 584 (834)
..|...+.||+|+||.||+|.+... .+++|+ +.+.. ....+++.+|++++.+++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4456678999999999999987543 444443 22211 11235688999999999999999888888887888
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+||++ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999988772 35678999999999999998 9999999999999 678999999999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-16 Score=182.55 Aligned_cols=208 Identities=23% Similarity=0.278 Sum_probs=141.6
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.+|..+++|..|+||.||..+++. .+.+|+|+-+.+ -. .+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-li-----lRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-LI-----LRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccc-hh-----hhc--cccccCCccee-------------------
Confidence 789999999999999999998865 677888543221 10 000 22222333333
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc--
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE-- 669 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-- 669 (834)
|+-...+ ..-+.++.. ++.+++|||+.+ |+|||+||+|.+|..-|++|+.|||+.+......
T Consensus 136 --gDc~tll---k~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLL---KNIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhc---ccCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 2222223 122233332 278999999998 9999999999999999999999999988642111
Q ss_pred -----------cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC
Q 003280 670 -----------LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD 738 (834)
Q Consensus 670 -----------~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 738 (834)
.+...+.++||+.|+|||++....|...+|.|++|+|+||.+.|+.||....+++. ..
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel--fg--------- 268 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FG--------- 268 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH--Hh---------
Confidence 11122346899999999999999999999999999999999999999876433321 10
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCC
Q 003280 739 KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRP 777 (834)
Q Consensus 739 ~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
.++...+...+...+...++.+++.+.|+.+|..|-
T Consensus 269 ---~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 269 ---QVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ---hhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 001111101111222334677899999999999995
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.8e-16 Score=171.66 Aligned_cols=175 Identities=25% Similarity=0.354 Sum_probs=130.7
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
.+++.|+++...+|.+++.........++.....++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999766666667888899999999999999 55 999999999999999999999999998
Q ss_pred eecCCCc----cccccceecccccccccccccCCccCccCceeehhhhHHHhhcC-CCCCCCCCCCcccHhHHHHhHhcC
Q 003280 663 RMFGGDE----LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG-KKNTGVYNADSFNLLGYAWDLWKD 737 (834)
Q Consensus 663 ~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~ 737 (834)
....... .........||..||+||.+.+..|+.++||||||+||+||+.- ...++ ..
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----------------r~ 466 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-----------------RI 466 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----------------HH
Confidence 8765543 22334457899999999999999999999999999999999872 11111 00
Q ss_pred CccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 003280 738 DKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDV 782 (834)
Q Consensus 738 ~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 782 (834)
..+.++-+..+.. . .......-+.++.+++...|.+||++.++
T Consensus 467 ~t~~d~r~g~ip~-~-~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 ATLTDIRDGIIPP-E-FLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HhhhhhhcCCCCh-H-HhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 0111111111100 0 00011123578899999999999944443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.4e-14 Score=135.50 Aligned_cols=135 Identities=23% Similarity=0.245 Sum_probs=115.5
Q ss_pred ccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcC--CCcceEEeEEEecCeEEEEEeecCCC
Q 003280 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH--RNLVKLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 517 ~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+.+.||+|.++.||++...+ +.+++|....... ...+.+|+.++..++| .++.+++.+....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999844 7899999866543 5678999999999987 58999998888888899999999988
Q ss_pred CccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
.+..+ +......++.++++++++||......++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4566678899999999999987545699999999999999989999999999865
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.5e-14 Score=142.25 Aligned_cols=137 Identities=20% Similarity=0.250 Sum_probs=99.6
Q ss_pred cceeeeecceeEEEEEECCCcEEEEEEccCcccc--cHHH----------------------HHHHHHHHHhhcCCC--c
Q 003280 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ--GLEE----------------------FKNEMMLIAKLQHRN--L 571 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~Hpn--I 571 (834)
.+.||+|+||.||+|...+++.||||+++..... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999878999999998653211 1111 135666666665443 4
Q ss_pred ceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCcEEEcC
Q 003280 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDM 650 (834)
Q Consensus 572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~ 650 (834)
.+.+++ ...++||||++++.+......... . ......++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 246899999999654322111100 1 15677899999999999999 77 99999999999999
Q ss_pred CCCceeeeecceeecC
Q 003280 651 DMNPKISDFGLARMFG 666 (834)
Q Consensus 651 ~~~~kl~Dfgla~~~~ 666 (834)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 9999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=4e-15 Score=172.69 Aligned_cols=256 Identities=22% Similarity=0.295 Sum_probs=190.5
Q ss_pred cCccccceeeeecceeEEEEEECC--CcEEEEEEccCcc--cccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~--g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV 587 (834)
..|.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456777889999999999886533 4456777665442 333445556777777776 99999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhh-hcCCCceEeccCCCCcEEEcCCC-Cceeeeecceeec
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH-QYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMF 665 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~ 665 (834)
.||..++++...+... .....+......++.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999998877311 1113455666788999999999999 777 99999999999999999 9999999999988
Q ss_pred CC-Cccccccceecc-cccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 666 GG-DELQGNTKRIVG-TYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 666 ~~-~~~~~~~~~~~g-t~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+............|.... .....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 252 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GRFTQ 252 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---ccccc
Confidence 76 454555556678 9999999999885 457889999999999999999999876544332221111110 00000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. .. .......++...++..+|..|.+.+++..
T Consensus 253 ~~-----~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 253 LP-----WN----SISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred Cc-----cc----cCChhhhhcccccccCCchhccccccccc
Confidence 00 11 11224557778888899999999888754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.8e-13 Score=142.03 Aligned_cols=134 Identities=22% Similarity=0.273 Sum_probs=104.1
Q ss_pred ceee-eecceeEEEEEECCCcEEEEEEccCcc-------------cccHHHHHHHHHHHHhhcCCCc--ceEEeEEEecC
Q 003280 519 CKLG-EGGFGPVYKGRLLNGQEVAVKRLSSQS-------------GQGLEEFKNEMMLIAKLQHRNL--VKLLGCCVEQG 582 (834)
Q Consensus 519 ~~LG-~G~~G~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~~~ 582 (834)
..|| .|+.|+||++.. .+..++||++.... ......+.+|+.++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4787 899999999987 47789999875311 1223567889999999998875 66777654432
Q ss_pred ----eEEEEEeecCC-CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceee
Q 003280 583 ----EKILILEYMPN-KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS 657 (834)
Q Consensus 583 ----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 657 (834)
..++|||++++ .+|.+++.. ..++.. .+.+|+++|++||+.+ |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 688877632 233433 3578999999999998 9999999999999999999999
Q ss_pred eecceee
Q 003280 658 DFGLARM 664 (834)
Q Consensus 658 Dfgla~~ 664 (834)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.8e-13 Score=113.18 Aligned_cols=71 Identities=15% Similarity=0.290 Sum_probs=60.1
Q ss_pred ccCCceeEEeccccCCCcceeecccccCHHHHHHHhhc---cCCeeeeeccccCCCcceeeecccc-cccCCCCCCCCCc
Q 003280 336 CIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLK---NCTCRAYANSNVTEGSGCLMWFGDL-LDANRPTRNFTGQ 411 (834)
Q Consensus 336 C~~~~~f~~l~~~~~~d~~~~~~~~~~s~~~C~~~Cl~---nCsC~A~~~~~~~~g~~C~~w~~~l-~~~~~~~~~~~~~ 411 (834)
|.....|+++.++++|++.. ++++||++.|++ ||||+||+|.+. +.||++|+++| +|+++.. ..+.
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~--~~gC~~W~~~l~~d~~~~~--~~g~ 74 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA--RKQCLWFPFNSMSGVRKEF--SHGF 74 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC--CCCeEEecCcchhhHHhcc--CCCc
Confidence 33457899999999998754 689999999999 999999999753 36899999999 9988775 4578
Q ss_pred eeeec
Q 003280 412 SVYIR 416 (834)
Q Consensus 412 slylr 416 (834)
++|+|
T Consensus 75 ~Ly~r 79 (80)
T cd00129 75 DLYEN 79 (80)
T ss_pred eeEeE
Confidence 99987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.1e-12 Score=145.72 Aligned_cols=141 Identities=22% Similarity=0.275 Sum_probs=100.9
Q ss_pred ceeeeecceeEEEEEECCCcEEEEEEccCcccccH------------------------------H----------HHHH
Q 003280 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGL------------------------------E----------EFKN 558 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~------------------------------~----------~~~~ 558 (834)
+.||.|++|.||+|++.+|+.||||+.++...... + .|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 68999999999999999999999999865421110 0 2445
Q ss_pred HHHHHHhhc----CCCcceEEeEE-EecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHH-HHHHhhhcC
Q 003280 559 EMMLIAKLQ----HRNLVKLLGCC-VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ-GLLYLHQYS 632 (834)
Q Consensus 559 E~~~l~~l~----HpnIv~l~~~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~~ 632 (834)
|...+.+++ |.+-+.+-..+ ...+..+|||||+++++|.++...... .. .+..++..+++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 555555553 33333333333 234567999999999999887632111 11 23456666665 467889887
Q ss_pred CCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 633 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
++|+|+||.||+++.++.++++|||++..+..
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.1e-12 Score=111.06 Aligned_cols=80 Identities=34% Similarity=0.791 Sum_probs=64.4
Q ss_pred CccccCC---ceeEEeccccCCCcceeecccccCHHHHHHHhhccCCeeeeeccccCCCcceeeecccccccCCCCCCCC
Q 003280 333 SSECIGG---HQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFT 409 (834)
Q Consensus 333 ~l~C~~~---~~f~~l~~~~~~d~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~~~~~~~g~~C~~w~~~l~~~~~~~~~~~ 409 (834)
+++|..+ +.|++++++++|++.... .+.++++|++.|++||+|+||+|.+ ++++|.+|.+.+.+.+... ..
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~--~~~~C~~~~~~~~~~~~~~--~~ 75 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN--GSGGCLLWNGLLNNLRSLS--SG 75 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC--CCCeEEEEeceecceEeec--CC
Confidence 3456543 799999999999886543 6789999999999999999999985 3578999999999876543 33
Q ss_pred CceeeeccC
Q 003280 410 GQSVYIRVP 418 (834)
Q Consensus 410 ~~slylrl~ 418 (834)
+..+|+|+|
T Consensus 76 ~~~~yiKv~ 84 (84)
T cd01098 76 GGTLYLRLA 84 (84)
T ss_pred CcEEEEEeC
Confidence 578999985
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.3e-12 Score=131.44 Aligned_cols=202 Identities=20% Similarity=0.236 Sum_probs=139.6
Q ss_pred HHHHHhhcCCCcceEEeEEEecC-----eEEEEEeecCCCCccccccCCC-CCCcCCHHHHHHHHHHHHHHHHHhhhcCC
Q 003280 560 MMLIAKLQHRNLVKLLGCCVEQG-----EKILILEYMPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLYLHQYSR 633 (834)
Q Consensus 560 ~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 633 (834)
+.-|-++.|.|||++..|+.+.+ ...++.|||..|++..+|.+.. ....+......+|+.||..||.|||+- .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 34455667999999998876543 5789999999999999996533 345677888899999999999999986 5
Q ss_pred CceEeccCCCCcEEEcCCCCceeeeecceeec--CCCccccccceecccccccccccccCCccCccCceeehhhhHHHhh
Q 003280 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711 (834)
Q Consensus 634 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~--~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ell 711 (834)
++|+|+++..+.|++..++-+|+.----.... -............+-++|.|||.=.....+.++|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 78999999999999999888887521111110 0001111122235678999999877777888999999999999998
Q ss_pred cCCCCCCCCCCCcccHhHHHHhHhcCCcccc---ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 712 SGKKNTGVYNADSFNLLGYAWDLWKDDKFHE---LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 712 tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~---lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.+..-..... .. ...+..... .+...+ =..++..|++..|..||+|++++.
T Consensus 277 ilEiq~tnse--S~--------~~~ee~ia~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSE--SK--------VEVEENIANVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCc--ce--------eehhhhhhhheeeccCcc------------ccCcCcccccCCCCCCcchhhhhc
Confidence 8775321110 00 000011111 011111 124677899999999999998865
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.8e-11 Score=117.34 Aligned_cols=130 Identities=22% Similarity=0.167 Sum_probs=98.3
Q ss_pred ceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcce-EEeEEEecCeEEEEEeecCCCCcc
Q 003280 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVK-LLGCCVEQGEKILILEYMPNKSLD 597 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~-l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (834)
+.|+.|.++.||+++. .++.+++|....... ....+..|++++..+.+.++++ ++.+ .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 5789999999999987 478899999865432 2235678999999997666554 4433 233468999999998875
Q ss_pred ccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcC--CCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 598 VFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS--RFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
... .....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 431 011245678999999999986 23469999999999999 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.5e-11 Score=136.49 Aligned_cols=249 Identities=23% Similarity=0.295 Sum_probs=178.7
Q ss_pred cCccccceeee--ecceeEEEEEE---CCCcEEEEEEccC--cccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeE
Q 003280 513 ENFSMQCKLGE--GGFGPVYKGRL---LNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 513 ~~f~~~~~LG~--G~~G~Vy~~~~---~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 584 (834)
..|.+.+.+|+ |.+|.||++.. .++..+|+|+-+. ..+.....=.+|+...+++ .|+|.++....+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677789999 99999999986 3478899998433 2223333335666666666 499999988889999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHH----HHHHhhhcCCCceEeccCCCCcEEEcCC-CCceeeee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ----GLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDF 659 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 659 (834)
++-+|++. .+|..+.+. ....++....+....+..+ ||.++|... ++|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999886 566666532 3344677777888888888 999999998 9999999999999999 88999999
Q ss_pred cceeecCCCcccccc---ceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhc
Q 003280 660 GLARMFGGDELQGNT---KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWK 736 (834)
Q Consensus 660 gla~~~~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~ 736 (834)
|+...+......... ....|...|++||.+ .+.++.+.|+|++|.++.|...+-......... .|...+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W~~~r 339 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-------SWSQLR 339 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-------Cccccc
Confidence 999988765432221 223677889999965 457899999999999999999887653221100 111111
Q ss_pred CCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 737 DDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 737 ~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
... + ..++...-..++..++.++++.+|..|++.+.+..
T Consensus 340 ~~~----i-----p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QGY----I-----PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc----C-----chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111 1 11111111234445888999999999998887754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=8.5e-11 Score=134.05 Aligned_cols=144 Identities=17% Similarity=0.242 Sum_probs=95.8
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCccccc----------------------------------HHH--
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQG----------------------------------LEE-- 555 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~----------------------------------~~~-- 555 (834)
..|+. +.||+|++|.||+|++++ |+.||||++++..... .+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 789999999999999987 9999999997542110 111
Q ss_pred ----HHHHHHHHHhhc----CCCcceEEeEEEe-cCeEEEEEeecCCCCccccccCCCCC---CcCCHHHHHHHHHHHHH
Q 003280 556 ----FKNEMMLIAKLQ----HRNLVKLLGCCVE-QGEKILILEYMPNKSLDVFLFDPTKK---RLLGWQARVTIIEGIAQ 623 (834)
Q Consensus 556 ----~~~E~~~l~~l~----HpnIv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~ 623 (834)
|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++..-...+ ..+....+..++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 334444444442 4444444444443 55788999999999997642111111 11222222233333
Q ss_pred HHHHhhhcCCCceEeccCCCCcEEEcCCC----CceeeeecceeecCC
Q 003280 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDM----NPKISDFGLARMFGG 667 (834)
Q Consensus 624 ~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla~~~~~ 667 (834)
++..+ ++|+|+||.||+++.++ .++++|||++..+..
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33455 99999999999999888 999999999988754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.3e-10 Score=124.19 Aligned_cols=166 Identities=20% Similarity=0.245 Sum_probs=125.5
Q ss_pred CCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHH
Q 003280 535 LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614 (834)
Q Consensus 535 ~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~ 614 (834)
.++.+|.|+..+.......+...+-++.|+.++||||++++..++..+..|+|+|.+.- |..++. .+.....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk------~l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLK------ELGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHH------HhHHHHH
Confidence 35888888888766554456677888999999999999999999999999999998743 333331 1235566
Q ss_pred HHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccceecccccccccccccCCcc
Q 003280 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694 (834)
Q Consensus 615 ~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 694 (834)
..-+.||+.||.+||..+ .++|++|....|++++.|+.||++|.++.....-.. ......--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 778899999999999766 599999999999999999999999999865433221 111122233566776554322
Q ss_pred CccCceeehhhhHHHhhcCC
Q 003280 695 SIKSDVFSFGILMLETLSGK 714 (834)
Q Consensus 695 t~~~DVwSlGvvl~elltG~ 714 (834)
...|.|.||++++|++.|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -cchhhhhHHHHHHHHhCcc
Confidence 4579999999999999993
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.9e-09 Score=107.16 Aligned_cols=138 Identities=14% Similarity=0.116 Sum_probs=99.3
Q ss_pred cceeeeecceeEEEEEECC-------CcEEEEEEccCcc----------------------cccHHHHH----HHHHHHH
Q 003280 518 QCKLGEGGFGPVYKGRLLN-------GQEVAVKRLSSQS----------------------GQGLEEFK----NEMMLIA 564 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~-------g~~vavK~l~~~~----------------------~~~~~~~~----~E~~~l~ 564 (834)
...||.|--+.||.|...+ +..+|||+.+... ....+.+. +|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997543 4799999864210 01122333 7999999
Q ss_pred hhcC--CCcceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHh-hhcCCCceEeccC
Q 003280 565 KLQH--RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL-HQYSRFRIIHRDL 641 (834)
Q Consensus 565 ~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dl 641 (834)
++.. -++..++++ ...++||||+.+..+..-.. +...++.+....+..+++.+|..| |+.+ |+|+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9864 455666654 56789999998764422111 112344455677889999999999 7877 999999
Q ss_pred CCCcEEEcCCCCceeeeecceeecC
Q 003280 642 KASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 642 kp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
++.||+++ ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 5789999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.3e-09 Score=110.23 Aligned_cols=142 Identities=20% Similarity=0.272 Sum_probs=110.5
Q ss_pred ceeeeecceeEEEEEECCCcEEEEEEccCccc-ccHHHHHHHHHHHHhhcCC--CcceEEeEEEecC---eEEEEEeecC
Q 003280 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHR--NLVKLLGCCVEQG---EKILILEYMP 592 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~~~---~~~lV~Ey~~ 592 (834)
+.|+.|..+.||++...+|+.+++|....... .....+..|+++++.+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999887678999999765432 2456789999999999763 4566777766542 5689999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS---------------------------------------- 632 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------- 632 (834)
+.++...+.. ..++......++.+++++|++||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988776521 34667777788888888888888521
Q ss_pred -------------CCceEeccCCCCcEEEcC--CCCceeeeecceee
Q 003280 633 -------------RFRIIHRDLKASNVLLDM--DMNPKISDFGLARM 664 (834)
Q Consensus 633 -------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~ 664 (834)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.2e-09 Score=100.13 Aligned_cols=143 Identities=23% Similarity=0.317 Sum_probs=108.5
Q ss_pred ccceeeeecceeEEEEEECCCcEEEEE-EccCccc-------ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 517 MQCKLGEGGFGPVYKGRLLNGQEVAVK-RLSSQSG-------QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 517 ~~~~LG~G~~G~Vy~~~~~~g~~vavK-~l~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.+..|-+|+-+.|+++.. .|+..+|| ++.+..+ -..++.++|++++.+++--.|....-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999987 67777777 4443321 12456788999999998777777777788888889999
Q ss_pred eecCC-CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC---ceeeeecceee
Q 003280 589 EYMPN-KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN---PKISDFGLARM 664 (834)
Q Consensus 589 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~ 664 (834)
||+++ -++.+++........ ..+....++..|-+.+.-||..+ |+|+||..+||+|..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 466777644322222 22333678889999999999998 999999999999966543 58999999854
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.3e-09 Score=99.19 Aligned_cols=131 Identities=21% Similarity=0.320 Sum_probs=103.2
Q ss_pred ceeeeecceeEEEEEECCCcEEEEEE-ccCcccc-------cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 519 CKLGEGGFGPVYKGRLLNGQEVAVKR-LSSQSGQ-------GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~~vavK~-l~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
..+++|+-+.+|.+.+ -|..+++|. +++.... ..++-.+|.+++.+++--.|....-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3678999999999966 344566663 4333211 124567899999999877777777778888899999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
+++..|.+.+... ...++..+-..+.-||..+ |+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998887322 3567778888899999999 99999999999997665 99999999974
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.93 E-value=8.5e-09 Score=112.03 Aligned_cols=169 Identities=20% Similarity=0.274 Sum_probs=130.5
Q ss_pred ceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEe----cCeEEEEEeecCC-CCcccc
Q 003280 526 FGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE----QGEKILILEYMPN-KSLDVF 599 (834)
Q Consensus 526 ~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~Ey~~~-gsL~~~ 599 (834)
-.+.||+... +|..|++|+++....+.......-+++.+++.|+|+|++..++.. ...+++||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4578898754 699999999955433333334556788999999999999998873 3478999999997 667666
Q ss_pred ccCC------------CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 600 LFDP------------TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 600 l~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
.+.. ..+...++..++.++.|+..||.++|+.| +..+-|.+++|+++.+.+++|...|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5432 23345778899999999999999999999 88899999999999999999999998877655
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCC
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p 716 (834)
+... -+. --.+-|.=.||.+++.|.+|...
T Consensus 446 d~~~----------------~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTE----------------PLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCc----------------chh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 4311 011 12345777899999999999754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.4e-09 Score=121.00 Aligned_cols=247 Identities=18% Similarity=0.168 Sum_probs=173.9
Q ss_pred hcCccccceeeeecceeEEEEEEC--CCcEEEEEEccCcccccHHH--HHHHHHHHHhh-cCCCcceEEeEEEecCeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSGQGLEE--FKNEMMLIAKL-QHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~--~g~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 586 (834)
+.+|..+..||.|.|+.|++...+ ++..+++|.+.+......++ -..|+.+...+ .|.++++....+..-...++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 467888899999999999987643 57789999887654333332 23466666666 58899998888887788889
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC-CCceeeeecceeec
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMF 665 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~ 665 (834)
=-||+.++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..+
T Consensus 344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 99999999987665 23344677788999999999999999887 9999999999999876 88899999998753
Q ss_pred CCCccccccceeccccccc--ccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 666 GGDELQGNTKRIVGTYGYM--SPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~--aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
.-.. ......-+++ +|+......+-.++|++|||.-+.|.+++..-..... ....+
T Consensus 418 ~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----------------~~~~i 475 (524)
T KOG0601|consen 418 AFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----------------QSLTI 475 (524)
T ss_pred ceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-----------------cceee
Confidence 2111 1112233444 5555566778899999999999999999886422100 00111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
....+... +. ...++..+..-++..++..||.+.++....+..
T Consensus 476 ~~~~~p~~--~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 476 RSGDTPNL--PG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ecccccCC--Cc-hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 11111011 11 114455667778889999999998887665443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.8e-10 Score=131.39 Aligned_cols=251 Identities=18% Similarity=0.216 Sum_probs=169.7
Q ss_pred HHhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
...+.+.+.+-+-+|.++.++.++-.. |...++|..... .....+....+-.++-..+||-++....-+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 345788888999999999999875432 333344433221 1111222222323333345566666655556677889
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
|+++|..+++|...++.. +..+.+.....+..+.+++.|||... +.|+|++|.|+++..++..++.||+.....
T Consensus 881 L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 999999999998887542 24455555666777899999999976 899999999999999999999999843322
Q ss_pred CC---------------------C----ccc----cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCC
Q 003280 666 GG---------------------D----ELQ----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716 (834)
Q Consensus 666 ~~---------------------~----~~~----~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p 716 (834)
+- . ... .......+|+.|.+||.+.+......+|.|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0 000 112235789999999999999999999999999999999999999
Q ss_pred CCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 003280 717 TGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMS 780 (834)
Q Consensus 717 ~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 780 (834)
|....... .+..++...+...........+..+++...+..+|.+|-.|.
T Consensus 1035 ~na~tpq~--------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQ--------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhh--------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 86432211 112222222222222333344566788888889999997766
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.6e-07 Score=98.79 Aligned_cols=140 Identities=17% Similarity=0.132 Sum_probs=99.7
Q ss_pred eeeeecceeEEEEEECCCcEEEEEEccCcccc-----------cHHHHHHHHHHHHhhcCCC--cceEEeEEEe-----c
Q 003280 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ-----------GLEEFKNEMMLIAKLQHRN--LVKLLGCCVE-----Q 581 (834)
Q Consensus 520 ~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~-----~ 581 (834)
.+-.-....|.+..+ +|+.+.||+....... ....+.+|...+.++...+ ..+++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344333444667665 6789999976433211 1124789999999885444 3445556544 2
Q ss_pred CeEEEEEeecCCC-CccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-------CCC
Q 003280 582 GEKILILEYMPNK-SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-------DMN 653 (834)
Q Consensus 582 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------~~~ 653 (834)
...++|+|++++. +|.+++.... ....+......++.++++.++-||..+ |+|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3578999999986 7888763211 223455677789999999999999999 999999999999975 467
Q ss_pred ceeeeecceee
Q 003280 654 PKISDFGLARM 664 (834)
Q Consensus 654 ~kl~Dfgla~~ 664 (834)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.2e-07 Score=93.86 Aligned_cols=126 Identities=26% Similarity=0.283 Sum_probs=82.7
Q ss_pred eEEEEEECCCcEEEEEEccCcc--------------c------------ccHHHHHHHHHHHHhhcCC--CcceEEeEEE
Q 003280 528 PVYKGRLLNGQEVAVKRLSSQS--------------G------------QGLEEFKNEMMLIAKLQHR--NLVKLLGCCV 579 (834)
Q Consensus 528 ~Vy~~~~~~g~~vavK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~ 579 (834)
-||.|...+|+.+|||+.+... . .......+|++.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998899999999864210 0 0123467899999999766 455555432
Q ss_pred ecCeEEEEEeecC--CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHH-hhhcCCCceEeccCCCCcEEEcCCCCcee
Q 003280 580 EQGEKILILEYMP--NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY-LHQYSRFRIIHRDLKASNVLLDMDMNPKI 656 (834)
Q Consensus 580 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 656 (834)
...+||||++ +..+..+... .++......++.+++..+.. +|..+ |+|+||.+.||+++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4579999999 5555443311 11134456677788885555 56877 9999999999999888 9999
Q ss_pred eeecceeecC
Q 003280 657 SDFGLARMFG 666 (834)
Q Consensus 657 ~Dfgla~~~~ 666 (834)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=6.7e-07 Score=95.09 Aligned_cols=261 Identities=15% Similarity=0.145 Sum_probs=158.9
Q ss_pred cccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeE----E--EecC-eEEEE
Q 003280 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGC----C--VEQG-EKILI 587 (834)
Q Consensus 516 ~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~----~--~~~~-~~~lV 587 (834)
...+.||+|+-+.+|-.- +-...+.|+.+........+. +..|... .||-+-.-+.+ . -+++ .+-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 455789999999999642 222345677766544332222 2223333 45543321111 1 1122 25677
Q ss_pred EeecCCCCccccccC----CCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 588 LEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
|..+++.---..++. ........|.-.+++++.++.+.+.||.+| .+-+|+.++|+|+.+++.+.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 887776532122222 223455789999999999999999999999 9999999999999999999999866554
Q ss_pred ecCCCccccccceeccccccccccccc-----CCccCccCceeehhhhHHHhhcC-CCCCCCCCCCc---ccHh-HHHHh
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSG-KKNTGVYNADS---FNLL-GYAWD 733 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~t~~~DVwSlGvvl~elltG-~~p~~~~~~~~---~~l~-~~~~~ 733 (834)
...++. ...-.+|...|.+||.-. +-.-+...|.|.|||++++|+.| ++|+....... ..+. ..+
T Consensus 166 i~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia-- 240 (637)
T COG4248 166 INANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA-- 240 (637)
T ss_pred eccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh--
Confidence 432221 122347888999999654 33456789999999999999886 89986533211 0010 011
Q ss_pred HhcCCcccccccccc----ccCCCCHHH-HHHHHHHHHhcccc--CCCCCCCHHHHHHHHhccccc
Q 003280 734 LWKDDKFHELIDPVI----TQDEISLPV-LVRYINVALLCVQD--NAADRPTMSDVVSIINSERLE 792 (834)
Q Consensus 734 ~~~~~~~~~lid~~l----~~~~~~~~~-~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~~~~~ 792 (834)
.+.+...-+... .....+... ...+.-+..+|+.. .+.-|||++-.+..|.....+
T Consensus 241 ---~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 241 ---HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred ---cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 111111111100 111222222 24566777888864 367899999998887766444
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=5.7e-07 Score=102.23 Aligned_cols=141 Identities=17% Similarity=0.222 Sum_probs=93.4
Q ss_pred ceeeeecceeEEEEEECCCcEEEEEEccCccccc------------------------------HHH----------HHH
Q 003280 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG------------------------------LEE----------FKN 558 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~------------------------------~~~----------~~~ 558 (834)
+.|+.++-|.||+|++++|+.||||+.++.-... .++ +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5889999999999999999999999986532111 111 333
Q ss_pred HHHHHHhhc----CCCcceEEeEEE-ecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHH-HHHhhhcC
Q 003280 559 EMMLIAKLQ----HRNLVKLLGCCV-EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG-LLYLHQYS 632 (834)
Q Consensus 559 E~~~l~~l~----HpnIv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~-L~yLH~~~ 632 (834)
|...+.+++ +..-+.+-.++. -.+...|+|||++|..+.+...... ..++.+ .++..++++ +..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHHHHHhcC
Confidence 444444442 222333333343 3567899999999999988753322 223322 233333332 22222344
Q ss_pred CCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 633 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
++|.|.+|.||+++.++++.+.|||+...+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999987754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.3e-06 Score=88.90 Aligned_cols=137 Identities=20% Similarity=0.210 Sum_probs=98.0
Q ss_pred CccccceeeeecceeEEEEEECCCcEEEEEEccC----------c----------c--cccHHHHHHHHHHHHhhcCC--
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSS----------Q----------S--GQGLEEFKNEMMLIAKLQHR-- 569 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~----------~----------~--~~~~~~~~~E~~~l~~l~Hp-- 569 (834)
-..+..+||-|--+.||.|...+|.++|||.=+. . + .......++|.++|.+|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3556789999999999999999999999995211 0 0 01123467899999999755
Q ss_pred CcceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc
Q 003280 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649 (834)
Q Consensus 570 nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 649 (834)
.+.+.+++ +...+||||+++-.|...-. +.+..-.++..|++-+..+-..| |||+|+++-||+++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 56666543 45679999999977654321 22233344444555554444556 99999999999999
Q ss_pred CCCCceeeeecceeec
Q 003280 650 MDMNPKISDFGLARMF 665 (834)
Q Consensus 650 ~~~~~kl~Dfgla~~~ 665 (834)
++|.+.++||--+...
T Consensus 237 ~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 237 EDGDIVVIDWPQAVPI 252 (304)
T ss_pred cCCCEEEEeCcccccC
Confidence 9999999999887654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.39 E-value=3e-06 Score=84.48 Aligned_cols=137 Identities=16% Similarity=0.184 Sum_probs=101.3
Q ss_pred eeecceeEEEEEECCCcEEEEEEccCcc------cccHHHHHHHHHHHHhhcCC--CcceEEeEEE-ec----CeEEEEE
Q 003280 522 GEGGFGPVYKGRLLNGQEVAVKRLSSQS------GQGLEEFKNEMMLIAKLQHR--NLVKLLGCCV-EQ----GEKILIL 588 (834)
Q Consensus 522 G~G~~G~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~-~~----~~~~lV~ 588 (834)
|+||-+.|+.-.+ +|+.+-+|+-.... +.....|.+|+..+.++..- .+.++. ++. .. -..+||+
T Consensus 27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 5588888988776 45579999765211 33567899999999999643 344444 332 21 1468999
Q ss_pred eecCC-CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC--ceeeeecceee
Q 003280 589 EYMPN-KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN--PKISDFGLARM 664 (834)
Q Consensus 589 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~ 664 (834)
|-+++ .+|.+++.+. .....+...+..++.++++.++-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 5777776332 1224566777899999999999999999 999999999999986667 99999988765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.8e-06 Score=86.32 Aligned_cols=107 Identities=23% Similarity=0.249 Sum_probs=84.4
Q ss_pred HHHHHHHHHHHHhhcCC--CcceEEeEEEecC----eEEEEEeecCC-CCccccccCCCCCCcCCHHHHHHHHHHHHHHH
Q 003280 553 LEEFKNEMMLIAKLQHR--NLVKLLGCCVEQG----EKILILEYMPN-KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625 (834)
Q Consensus 553 ~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~~~----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L 625 (834)
.....+|...+.+++.. ...+.+++.+... ..++|+|++++ .+|.+++.... ..+......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 34678899988888643 3556667666533 45899999998 47888874311 155667788999999999
Q ss_pred HHhhhcCCCceEeccCCCCcEEEcCCC---Cceeeeecceeec
Q 003280 626 LYLHQYSRFRIIHRDLKASNVLLDMDM---NPKISDFGLARMF 665 (834)
Q Consensus 626 ~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~~ 665 (834)
+-||..+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999998887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.2e-07 Score=105.13 Aligned_cols=153 Identities=21% Similarity=0.363 Sum_probs=103.5
Q ss_pred HHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc-cc------cccceeccccccccccccc
Q 003280 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE-LQ------GNTKRIVGTYGYMSPEYAL 690 (834)
Q Consensus 618 ~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-~~------~~~~~~~gt~~y~aPE~l~ 690 (834)
+.+++.|+.|+|... .+||++|.|++|.++..+..||+.|+++....+.. +. ...........|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999865 69999999999999999999999999887654411 11 0011123456899999999
Q ss_pred CCccCccCceeehhhhHHHhhcCCCC-CCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhcc
Q 003280 691 DGLFSIKSDVFSFGILMLETLSGKKN-TGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCV 769 (834)
Q Consensus 691 ~~~~t~~~DVwSlGvvl~elltG~~p-~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl 769 (834)
+...+.++|+||+|+++|-+..|..+ +...+.. ..+.... ...+.. ...++...+.++.+=+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~----~~~~~~~-------~~~~~~--~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL----LSYSFSR-------NLLNAG--AFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCc----chhhhhh-------cccccc--cccccccCcHHHHHHHHHHh
Confidence 98899999999999999999955544 3322111 0000000 001110 11222334456777788899
Q ss_pred ccCCCCCCCHHHHHHH
Q 003280 770 QDNAADRPTMSDVVSI 785 (834)
Q Consensus 770 ~~dP~~RPs~~evl~~ 785 (834)
..++..||++.++...
T Consensus 250 ~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSI 265 (700)
T ss_pred cCCcccCcchhhhhcc
Confidence 9999999988777654
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.1e-06 Score=73.93 Aligned_cols=72 Identities=33% Similarity=0.753 Sum_probs=53.9
Q ss_pred ceeEEeccccCCCcceeecccccCHHHHHHHhhc-cCCeeeeeccccCCCcceeeec-ccccccCCCCCCCCCceeeec
Q 003280 340 HQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLK-NCTCRAYANSNVTEGSGCLMWF-GDLLDANRPTRNFTGQSVYIR 416 (834)
Q Consensus 340 ~~f~~l~~~~~~d~~~~~~~~~~s~~~C~~~Cl~-nCsC~A~~~~~~~~g~~C~~w~-~~l~~~~~~~~~~~~~slylr 416 (834)
..|++++++.+++..... ....++++|++.|++ +|+|.||+|.. ++.+|.+|. +.+.+..... ..+.++|.+
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~--~~~~C~l~~~~~~~~~~~~~--~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN--GTKGCLLWSESSLGDARLFP--SGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC--CCCEEEEeeCCccccceecc--cCCceeEEe
Confidence 579999999998665433 346799999999999 99999999975 457899999 7776665222 234455543
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.5e-05 Score=79.84 Aligned_cols=138 Identities=16% Similarity=0.180 Sum_probs=95.0
Q ss_pred HhcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHH---------HHHHHHHHhhcCC---CcceEEeEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEF---------KNEMMLIAKLQHR---NLVKLLGCC 578 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~Hp---nIv~l~~~~ 578 (834)
...+|.+.+++-......|.+-.. +|+.+++|..+.......+.| .+++..+.+++.. ....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 347788888888877777777666 679999999876544333332 3344444555432 233333333
Q ss_pred Ee-----cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC
Q 003280 579 VE-----QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN 653 (834)
Q Consensus 579 ~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 653 (834)
+. ....+|+|||++|..|.++.. ++. .+...|++++.-||+.| +.|+|.+|.|+++.+++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 32 235579999999988866541 222 24466788899999999 99999999999998554
Q ss_pred ceeeeecceee
Q 003280 654 PKISDFGLARM 664 (834)
Q Consensus 654 ~kl~Dfgla~~ 664 (834)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999988765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.9e-05 Score=81.34 Aligned_cols=139 Identities=17% Similarity=0.168 Sum_probs=86.8
Q ss_pred ceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCC--cceEEeEEEecCeEEEEEeecCCCC-
Q 003280 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLGCCVEQGEKILILEYMPNKS- 595 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~~gs- 595 (834)
.+||+|..+.||+. .+..+++|..+... ......+|.+++..+..-. +.+.+.+....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 58999999999984 35578889886533 3356788999999987544 4667777777777889999999963
Q ss_pred ccccc---------------------cCCCCCCcCCHHHH-HHHHH----------HHHH-HHHHhhhc-CCCceEeccC
Q 003280 596 LDVFL---------------------FDPTKKRLLGWQAR-VTIIE----------GIAQ-GLLYLHQY-SRFRIIHRDL 641 (834)
Q Consensus 596 L~~~l---------------------~~~~~~~~l~~~~~-~~i~~----------~ia~-~L~yLH~~-~~~~ivH~Dl 641 (834)
+...+ |... ......... ..+.. .+.+ ...+|... ....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 1100 000010000 00000 0001 11222211 2345789999
Q ss_pred CCCcEEEcCCCCceeeeecceee
Q 003280 642 KASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 642 kp~NIll~~~~~~kl~Dfgla~~ 664 (834)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998854
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.18 E-value=3.7e-06 Score=76.90 Aligned_cols=88 Identities=23% Similarity=0.231 Sum_probs=61.9
Q ss_pred EEEee-cCceEEecCC-CceEEEeeccc-ccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCCcccccc
Q 003280 90 LTISN-KGNLVLLNQT-NGTIWSTNVFS-EVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDL 166 (834)
Q Consensus 90 l~~~~-~g~l~l~~~~-~~~~w~~~~~~-~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~ 166 (834)
+.++. ||+||+++.. +.+||++|+.. ......+.|.++|||||++.+ +.++|+|=
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S~----------------- 81 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS-----GTVVWSSN----------------- 81 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC-----CcEEEEec-----------------
Confidence 45565 9999999765 58999999854 234567899999999999864 36789861
Q ss_pred ccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEeeCC
Q 003280 167 KNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQ 214 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~sg~ 214 (834)
...+.+.+.+.|+.+|...++-.+ ..+.|.|..
T Consensus 82 --------------~~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~ 114 (116)
T cd00028 82 --------------TTRVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114 (116)
T ss_pred --------------ccCCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence 111246788889999886654333 355776543
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.1e-05 Score=79.54 Aligned_cols=153 Identities=18% Similarity=0.208 Sum_probs=101.6
Q ss_pred ccHHHHHHHhcCccccce---eeeecceeEEEEEECCCcEEEEEEccCccccc-------------------H-----HH
Q 003280 503 FSLASVAAATENFSMQCK---LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG-------------------L-----EE 555 (834)
Q Consensus 503 ~~~~~~~~~~~~f~~~~~---LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~-------------------~-----~~ 555 (834)
..+..+.....+..+.+. |.+|--+.||+|...++..+|||+++...... . .-
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 344455555555555444 55677889999988789999999986432111 0 11
Q ss_pred HHHHHHHHHhhc--CCCcceEEeEEEecCeEEEEEeecCCCCc-cccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcC
Q 003280 556 FKNEMMLIAKLQ--HRNLVKLLGCCVEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632 (834)
Q Consensus 556 ~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~ 632 (834)
...|+.-|.++. +-.+.+.+++. .-.|||||+..... .-.| +...+.......+..++++.+.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 345777777774 44455555543 45799999976521 1112 1122233356667778888888887733
Q ss_pred CCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 633 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
.+||+||+.-|||+. ++.+.|+|++-|....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 399999999999999 9999999999987654
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.16 E-value=5.6e-06 Score=75.44 Aligned_cols=87 Identities=24% Similarity=0.321 Sum_probs=61.3
Q ss_pred eEEEeecCceEEecCC-CceEEEeeccccc-CcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCCcccccc
Q 003280 89 VLTISNKGNLVLLNQT-NGTIWSTNVFSEV-KNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDL 166 (834)
Q Consensus 89 ~l~~~~~g~l~l~~~~-~~~~w~~~~~~~~-~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~ 166 (834)
++.++.||+||+++.. +.+||++++.... ....+.|.++|||||++.+ +.++|+|
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S------------------ 79 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD-----GRVVWSS------------------ 79 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC-----CCEEEEe------------------
Confidence 3556789999999765 5899999985332 2367899999999999864 3678986
Q ss_pred ccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEee
Q 003280 167 KNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACS 212 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~s 212 (834)
.+....|.+.+.|+.+|...++--++ .+.|.|
T Consensus 80 -------------~t~~~~~~~~~~L~ddGnlvl~~~~~-~~~W~S 111 (114)
T smart00108 80 -------------NTTGANGNYVLVLLDDGNLVIYDSDG-NFLWQS 111 (114)
T ss_pred -------------cccCCCCceEEEEeCCCCEEEECCCC-CEEeCC
Confidence 11123467888999999876443223 466754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=2.1e-05 Score=89.32 Aligned_cols=141 Identities=20% Similarity=0.273 Sum_probs=91.5
Q ss_pred ceeeeecceeEEEEEECCCcEEEEEEccCccccc---------------------------HH----------HHHHHHH
Q 003280 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG---------------------------LE----------EFKNEMM 561 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~---------------------------~~----------~~~~E~~ 561 (834)
+.||.-+.|.||+|++++|+.||||+-++.-... .+ .|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5899999999999999999999999976532111 01 1344444
Q ss_pred HHHhh----cCCCc---ceEEeEEEe-cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhh-hcC
Q 003280 562 LIAKL----QHRNL---VKLLGCCVE-QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH-QYS 632 (834)
Q Consensus 562 ~l~~l----~HpnI---v~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~ 632 (834)
-..+. +|-++ |.+-.++.+ ...+.|+||||+|..+.+...-. ...++.. .++..+.++...+= ..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~---~i~~~l~~~~~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID--KRGISPH---DILNKLVEAYLEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH--HcCCCHH---HHHHHHHHHHHHHHHhcC
Confidence 33333 35551 223333333 45789999999999988775322 2223444 33333443322221 233
Q ss_pred CCceEeccCCCCcEEEcC----CCCceeeeecceeecCC
Q 003280 633 RFRIIHRDLKASNVLLDM----DMNPKISDFGLARMFGG 667 (834)
Q Consensus 633 ~~~ivH~Dlkp~NIll~~----~~~~kl~Dfgla~~~~~ 667 (834)
++|+|=+|.||++.. ++++.+.|||+...+..
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999984 67899999999887644
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.00 E-value=5.7e-05 Score=78.01 Aligned_cols=144 Identities=22% Similarity=0.238 Sum_probs=86.2
Q ss_pred cceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCC--cceEEeEEEe---cCeEEEEEeecC
Q 003280 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLGCCVE---QGEKILILEYMP 592 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~---~~~~~lV~Ey~~ 592 (834)
++.|+.|..+.||+....+ +.+++|..... .....+..|..++..+.... +.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3689999999999999866 69999997654 45577888999998886443 4566654433 235689999999
Q ss_pred CCCccc----------------cc---cCC-CCCCcCCHHH---------HHHH------------HHHHHH-HHHHhhh
Q 003280 593 NKSLDV----------------FL---FDP-TKKRLLGWQA---------RVTI------------IEGIAQ-GLLYLHQ 630 (834)
Q Consensus 593 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH~ 630 (834)
+..+.. .+ +.. .......... .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 111 0111111100 0000 111222 3333332
Q ss_pred ----cCCCceEeccCCCCcEEEc-CCCCceeeeecceee
Q 003280 631 ----YSRFRIIHRDLKASNVLLD-MDMNPKISDFGLARM 664 (834)
Q Consensus 631 ----~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~ 664 (834)
.....++|+|+.|.||+++ +++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1345699999999999999 566668999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.97 E-value=5.4e-05 Score=68.74 Aligned_cols=100 Identities=24% Similarity=0.424 Sum_probs=66.6
Q ss_pred CeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEe-cCCCCCCCCCceEEEeecCceEEecCCCceEEEeecccc
Q 003280 38 EKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVA-NRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSE 116 (834)
Q Consensus 38 ~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~a-nr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~ 116 (834)
+.+.+.+|.+.|-|...|+ |-|. ....++||.+ +...... ..+.+.|+.||||||+|..+.++|++. ..
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~--~~~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf--~~ 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLY--DSNGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSF--DY 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEE--ETTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEEST--TS
T ss_pred cccccccccccceECCCCe-----EEEE--cCCCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeec--CC
Confidence 4565555888888888775 3332 2235679999 4344432 478999999999999999999999994 34
Q ss_pred cCcceEEEcc--CCCeEEecCCCCCCccccccccccCCc
Q 003280 117 VKNPVAQLRD--DGNLVIRDNSSGNTTESYLWQSFDYPT 153 (834)
Q Consensus 117 ~~~~~~~l~d--~Gnlvl~~~~~~~~~~~~~WqSFd~Pt 153 (834)
.....+..++ .||++ +.. ...+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~-----~~~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKN-----DSLTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EES-----TSSEEEESS----
T ss_pred CccEEEeccCcccCCCc-ccc-----ceEEeECCCCCCC
Confidence 4556677777 89998 543 2257898866663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=2.8e-06 Score=95.03 Aligned_cols=185 Identities=16% Similarity=0.117 Sum_probs=133.2
Q ss_pred ccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCC-cceEEeEEEecCeEEEEEeecCC
Q 003280 515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN-LVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.....+++++++.++|.+....+...++.+... ....-++++|.+++||| .+..++-+..+....++++++..
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3344568899999999987654555556655433 34456889999999999 66667766677788899999987
Q ss_pred C-CccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 594 K-SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 594 g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+ +-..-. ....-.+..-+...+.+.-+++++++|+.. =+|+| ||+..+ +..|..||+.+..+....
T Consensus 319 ~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--- 385 (829)
T KOG0576|consen 319 GRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--- 385 (829)
T ss_pred CccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---
Confidence 7 211111 011112333344556666778999999864 48888 666654 788999999998775543
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNT 717 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~ 717 (834)
......+|+.++|||+..+..+..+.|+|++|+--.++--|-+|-
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 344568899999999999999999999999999777777676653
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.93 E-value=8.8e-05 Score=77.54 Aligned_cols=141 Identities=14% Similarity=0.136 Sum_probs=86.4
Q ss_pred eeeeecc-eeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEEEEeecCCCCcc
Q 003280 520 KLGEGGF-GPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYMPNKSLD 597 (834)
Q Consensus 520 ~LG~G~~-G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (834)
.|-.|.. ..||+.... +..++||+..... ...+.+|++++..+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4445555 788998764 4788889886543 345678999998884 444557777777666789999999998876
Q ss_pred ccc-------------------cCCCC-CCcCCH--HHHHHHHH--------------------HHHHHHHHhhh----c
Q 003280 598 VFL-------------------FDPTK-KRLLGW--QARVTIIE--------------------GIAQGLLYLHQ----Y 631 (834)
Q Consensus 598 ~~l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------~ia~~L~yLH~----~ 631 (834)
... |.... ...+.. ........ .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 11000 000100 00000000 01111122211 1
Q ss_pred CCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 632 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
..+.++|+|+.|.||+++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234589999999999999987788999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.88 E-value=6.2e-05 Score=74.94 Aligned_cols=105 Identities=23% Similarity=0.212 Sum_probs=83.9
Q ss_pred HHHHHHHHhhcC-CCcceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCc
Q 003280 557 KNEMMLIAKLQH-RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635 (834)
Q Consensus 557 ~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 635 (834)
.+|..+++.+++ +++.+++|+| ..++|.||.+.+++...-..-..-...+|..+.+|+.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 6999999999 34789999998765421100011224689999999999999999999866556
Q ss_pred eEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 636 IIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 636 ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+...|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999887654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00045 Score=84.99 Aligned_cols=79 Identities=19% Similarity=0.404 Sum_probs=58.7
Q ss_pred cceeeeecceeEEEEEECCC---cEEEEEEccCcc-cccHHHHHHHHHHHHhhc-CCCc--ceEEeEEEec---CeEEEE
Q 003280 518 QCKLGEGGFGPVYKGRLLNG---QEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQ-HRNL--VKLLGCCVEQ---GEKILI 587 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnI--v~l~~~~~~~---~~~~lV 587 (834)
.+.|+.|.+..+|+.....+ ..+++|+..... ......+.+|+++|+.+. |.++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999877554 467888765432 223457889999999995 6664 7777777664 367899
Q ss_pred EeecCCCCc
Q 003280 588 LEYMPNKSL 596 (834)
Q Consensus 588 ~Ey~~~gsL 596 (834)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00033 Score=70.09 Aligned_cols=132 Identities=17% Similarity=0.235 Sum_probs=92.1
Q ss_pred cceeeeecceeEEEEEECCCcEEEEEEccCcc----------------cccHHHHHHHHHHHHhhc------CCCcceEE
Q 003280 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS----------------GQGLEEFKNEMMLIAKLQ------HRNLVKLL 575 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------HpnIv~l~ 575 (834)
...||+|+.-.||. +++....+||+..... ....++..+|+.....+. +..|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35899999999996 5667788999987655 223566777777766665 78899999
Q ss_pred eEEEecCeEEEEEeecCC--CC----ccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc
Q 003280 576 GCCVEQGEKILILEYMPN--KS----LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649 (834)
Q Consensus 576 ~~~~~~~~~~lV~Ey~~~--gs----L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 649 (834)
|..+.....-+|+|.+.+ |. |.+++ ....++. ...+ .+-+-..||-++. |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQ---ALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHH---HHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998754 33 44444 2233444 3333 3344455666666 99999999999995
Q ss_pred CC--C--Cceeee-ecce
Q 003280 650 MD--M--NPKISD-FGLA 662 (834)
Q Consensus 650 ~~--~--~~kl~D-fgla 662 (834)
.. + .+.|+| ||-.
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 43 2 466666 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00077 Score=72.56 Aligned_cols=77 Identities=14% Similarity=0.129 Sum_probs=57.3
Q ss_pred ccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcC---CCcceEEeEEEec---CeEEEEEee
Q 003280 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH---RNLVKLLGCCVEQ---GEKILILEY 590 (834)
Q Consensus 517 ~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~~~~~---~~~~lV~Ey 590 (834)
-.+.||.|..+.||.....++ .+++|..+.. .....|.+|.+.|+.+.- -.+.++++.+... +..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 346899999999999876555 4667775331 123678999999998853 3677888877543 568999999
Q ss_pred cCCCCc
Q 003280 591 MPNKSL 596 (834)
Q Consensus 591 ~~~gsL 596 (834)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00037 Score=72.44 Aligned_cols=74 Identities=12% Similarity=0.184 Sum_probs=47.1
Q ss_pred ceeeeecce-eEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCC---CcceEEeEEEec---CeEEEEEeec
Q 003280 519 CKLGEGGFG-PVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHR---NLVKLLGCCVEQ---GEKILILEYM 591 (834)
Q Consensus 519 ~~LG~G~~G-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~~~---~~~~lV~Ey~ 591 (834)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|.+++..+... .+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777666 48875 345778876542 2345789999999888532 233344333222 1347899999
Q ss_pred CCCCccc
Q 003280 592 PNKSLDV 598 (834)
Q Consensus 592 ~~gsL~~ 598 (834)
+|.++..
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9988753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00089 Score=69.45 Aligned_cols=141 Identities=17% Similarity=0.193 Sum_probs=83.0
Q ss_pred ceeeeecceeEEEEEECC--CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcce-EEeEEEecCeEEEEEeecCCCC
Q 003280 519 CKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVK-LLGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~-l~~~~~~~~~~~lV~Ey~~~gs 595 (834)
+.|..|-...+|+....+ ++.+++|+........ -...+|+.++..+...++++ +++... ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567788888999988654 6789999876543222 23357888999886544443 433322 248999999987
Q ss_pred ccccc-----------------cCCCCC--------CcC-CHHHHHHHHH----------------------HHHHHHHH
Q 003280 596 LDVFL-----------------FDPTKK--------RLL-GWQARVTIIE----------------------GIAQGLLY 627 (834)
Q Consensus 596 L~~~l-----------------~~~~~~--------~~l-~~~~~~~i~~----------------------~ia~~L~y 627 (834)
+.... |..... ... .++.+..+.. .+.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 63220 111100 011 1122111111 11111111
Q ss_pred h----hhc-CCCceEeccCCCCcEEEcC-CCCceeeeecceee
Q 003280 628 L----HQY-SRFRIIHRDLKASNVLLDM-DMNPKISDFGLARM 664 (834)
Q Consensus 628 L----H~~-~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~ 664 (834)
| ... ....++|+|+.+.|||+++ ++.+.|+||..+..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1 111 2345999999999999998 57899999998853
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00071 Score=67.16 Aligned_cols=125 Identities=24% Similarity=0.407 Sum_probs=90.5
Q ss_pred cCccccceeeeecc-eeEEEEEECCCcEEEEEEccC---cc---------c---------ccHHHHHHHHHHHHhhc---
Q 003280 513 ENFSMQCKLGEGGF-GPVYKGRLLNGQEVAVKRLSS---QS---------G---------QGLEEFKNEMMLIAKLQ--- 567 (834)
Q Consensus 513 ~~f~~~~~LG~G~~-G~Vy~~~~~~g~~vavK~l~~---~~---------~---------~~~~~~~~E~~~l~~l~--- 567 (834)
.+++.++.||.|.- |.|||+++ +|+.+|+|.++. .. . ...+-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78999999999999 99999998 778999999432 00 0 11245889999998886
Q ss_pred CCCc--ceEEeEEEecC------------------eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHH
Q 003280 568 HRNL--VKLLGCCVEQG------------------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627 (834)
Q Consensus 568 HpnI--v~l~~~~~~~~------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y 627 (834)
+.++ |+.+|+..-.. ...+|.||++... .....-+.+|.+-+..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 4456 88888874221 2346777665432 1122345567788889
Q ss_pred hhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 628 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99998 999999999876 3588999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00037 Score=66.81 Aligned_cols=130 Identities=21% Similarity=0.253 Sum_probs=89.3
Q ss_pred cccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCCC
Q 003280 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 516 ~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 595 (834)
...+.|++|..|.||+|.+ .|..+|+|+-+..+ ....+..|+++|..++-.++.+=+..+- ..++.|||+.|-.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcc
Confidence 3456899999999999988 45689999865443 3478889999999998777765443332 2345599999887
Q ss_pred ccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCC-CCcEEEcCCCCceeeeecceee
Q 003280 596 LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLK-ASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~Dfgla~~ 664 (834)
|...-... +. +-+..+++.-.-|...+ |-|+.|. |..++|..+..+.|+||..|..
T Consensus 99 L~~~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 76554110 12 22334555544555556 8888886 4455555555999999999974
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.001 Score=70.08 Aligned_cols=139 Identities=14% Similarity=0.085 Sum_probs=80.7
Q ss_pred eeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcc-eEEeEEEecCeEEEEEeecCCCCccc
Q 003280 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV-KLLGCCVEQGEKILILEYMPNKSLDV 598 (834)
Q Consensus 520 ~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~~gsL~~ 598 (834)
.+..|-...+|+... +++.+++|..........-...+|..+++.+....++ +++... . ..+||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 455677888998873 5778889986544322212357899999988654443 333332 1 368999999977653
Q ss_pred c-----------------ccCCC-CCCcCCHHH-HHHHHHH---------HHHHHHHhhhc-----CCCceEeccCCCCc
Q 003280 599 F-----------------LFDPT-KKRLLGWQA-RVTIIEG---------IAQGLLYLHQY-----SRFRIIHRDLKASN 645 (834)
Q Consensus 599 ~-----------------l~~~~-~~~~l~~~~-~~~i~~~---------ia~~L~yLH~~-----~~~~ivH~Dlkp~N 645 (834)
- +|... ....++... ...+..+ +.+.+..+... ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2 11111 111112111 1111111 11112222111 12358999999999
Q ss_pred EEEcCCCCceeeeecceee
Q 003280 646 VLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 646 Ill~~~~~~kl~Dfgla~~ 664 (834)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998854
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0022 Score=69.13 Aligned_cols=143 Identities=19% Similarity=0.164 Sum_probs=87.3
Q ss_pred cceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCC--cceEEeE------EEecCeEEEEEe
Q 003280 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLGC------CVEQGEKILILE 589 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~------~~~~~~~~lV~E 589 (834)
.+.|..|....+|+.... +..+++|+... ...++...|+.++..+.+.. +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456777888899998764 45788898864 23456777888888885433 4444331 223456789999
Q ss_pred ecCCCCcccc----c----------cCCC---C-----CCcCCHHHHH----------HHHHHHHHHHHHhhhc----CC
Q 003280 590 YMPNKSLDVF----L----------FDPT---K-----KRLLGWQARV----------TIIEGIAQGLLYLHQY----SR 633 (834)
Q Consensus 590 y~~~gsL~~~----l----------~~~~---~-----~~~l~~~~~~----------~i~~~ia~~L~yLH~~----~~ 633 (834)
|++|..+... . |... . .....|.... .....+..++.++... ..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9999876431 0 1000 0 0111121110 0111233344454431 12
Q ss_pred CceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 634 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
..++|+|+.|.||+++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3599999999999999887788999998853
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0026 Score=70.60 Aligned_cols=75 Identities=16% Similarity=0.221 Sum_probs=54.4
Q ss_pred ceeeeecceeEEEEEECCC-cEEEEEEccCc------c-cccHHHHHHHHHHHHhhc-C--CCcceEEeEEEecCeEEEE
Q 003280 519 CKLGEGGFGPVYKGRLLNG-QEVAVKRLSSQ------S-GQGLEEFKNEMMLIAKLQ-H--RNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g-~~vavK~l~~~------~-~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~~~~~~~~~lV 587 (834)
+.||.|.+..||++...+| +.|+||.-.+. . +...+++..|.+.|..+. + ..+.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5899999999999998776 58999985421 1 234567788888888763 2 345566655 44567899
Q ss_pred EeecCCCC
Q 003280 588 LEYMPNKS 595 (834)
Q Consensus 588 ~Ey~~~gs 595 (834)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0022 Score=77.30 Aligned_cols=196 Identities=18% Similarity=0.193 Sum_probs=133.3
Q ss_pred HHHHHHHHHhhcCCCcceEEeEEEecCeEE----EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc
Q 003280 556 FKNEMMLIAKLQHRNLVKLLGCCVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631 (834)
Q Consensus 556 ~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~----lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~ 631 (834)
-.-|+..+..+.|+|++.++.|-.+....- +.-|++..-++...+ ..-..++....+.+..++..|++|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 445677788889999999999887655433 334677776666665 3345577888888999999999999998
Q ss_pred CCCceEeccCCCC---cEEEcCCCCceee--eecceeecCCCccccccceecccccccccccccCCccCcc--Cceeehh
Q 003280 632 SRFRIIHRDLKAS---NVLLDMDMNPKIS--DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIK--SDVFSFG 704 (834)
Q Consensus 632 ~~~~ivH~Dlkp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~--~DVwSlG 704 (834)
. ..|.-+..+ +--.+.++.+.+. ||+..+.+....... ...-+..+.+||......++.+ .|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHH
Confidence 5 555555544 4455666777777 898888765433211 1233556888888877665544 7999999
Q ss_pred hhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 705 ILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 705 vvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+..+..|..+.... .....+++. ... ..+.+....|+..++++|+++.+++.
T Consensus 380 ll~~~~~~~~~i~~~~-----------------~~~~~~l~~-----~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKS-----------------AVPVSLLDV-----LST----SELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCcccccc-----------------cchhhhhcc-----ccc----hhhhhhhhhhcchhhhhccchhhhhh
Confidence 9999999887652210 000111111 000 03556778899999999999999988
Q ss_pred HH
Q 003280 785 II 786 (834)
Q Consensus 785 ~L 786 (834)
..
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 53
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0046 Score=66.82 Aligned_cols=141 Identities=26% Similarity=0.309 Sum_probs=84.3
Q ss_pred ceeeeecceeEEEEEECC-------CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcc-eEEeEEEecCeEEEEEee
Q 003280 519 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV-KLLGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey 590 (834)
+.|..|--..+|+....+ ++.+++|+...... ......+|.+++..+....+. ++++++. + .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 456667777899987654 57899999765432 234557888888888644443 4454443 2 368999
Q ss_pred cCCCCccccc-----------------cCCCCCC------cCC--HHHHHH--------------------------HHH
Q 003280 591 MPNKSLDVFL-----------------FDPTKKR------LLG--WQARVT--------------------------IIE 619 (834)
Q Consensus 591 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 619 (834)
++|..+.... |...... ..+ +..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9988764311 1111000 000 111101 111
Q ss_pred HHHHHHHHhhh------cCCCceEeccCCCCcEEEcCC----CCceeeeecceee
Q 003280 620 GIAQGLLYLHQ------YSRFRIIHRDLKASNVLLDMD----MNPKISDFGLARM 664 (834)
Q Consensus 620 ~ia~~L~yLH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~ 664 (834)
.+...+..+.. .....++|+|+.+.||+++++ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22222333432 134568999999999999885 8899999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.001 Score=49.48 Aligned_cols=44 Identities=36% Similarity=0.666 Sum_probs=32.4
Q ss_pred ccCCCCCCCcccccccc-cCCCCCCCCCCCccccCceeecccccC
Q 003280 791 LELPSPKEPAFIKGINV-KNSSHSNDGMSNLCSVNDVTVSLVYPR 834 (834)
Q Consensus 791 ~~~~~p~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (834)
..+|.|++|+|+..-.. ..+++++..+...+|+|+||.|.|+||
T Consensus 4 ~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 4 ATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred ccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 67999999999887333 333332222247899999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.026 Score=61.43 Aligned_cols=142 Identities=20% Similarity=0.209 Sum_probs=79.1
Q ss_pred ceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCC--cceEEe------EEEecCeEEEEEee
Q 003280 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLG------CCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~------~~~~~~~~~lV~Ey 590 (834)
+.|..|....+|+....+| .+++|++.. ...+....|+.++..|...+ +.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4567787789999876554 688998752 12344455666666664222 333332 12234567899999
Q ss_pred cCCCCcccc--------------ccCCCC--------CCcCCH-HHHHH------------HHH-HHHHHHHHhhhc---
Q 003280 591 MPNKSLDVF--------------LFDPTK--------KRLLGW-QARVT------------IIE-GIAQGLLYLHQY--- 631 (834)
Q Consensus 591 ~~~gsL~~~--------------l~~~~~--------~~~l~~-~~~~~------------i~~-~ia~~L~yLH~~--- 631 (834)
++|..+... +|.... ...+.| ..... .+. .+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 999865321 011000 001111 11111 111 111222333211
Q ss_pred -CCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 632 -SRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 632 -~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
-+..++|+|++|.||+++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234599999999999998665568999998853
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0013 Score=54.45 Aligned_cols=49 Identities=16% Similarity=0.300 Sum_probs=35.4
Q ss_pred ccccCCCcceeecccccCHHHHHHHhhccCCeeeeeccccCCCcceeeeccc
Q 003280 346 DNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGD 397 (834)
Q Consensus 346 ~~~~~~d~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~~~~~~~g~~C~~w~~~ 397 (834)
.++.++.+..... ...+.++|++.|+.+|+|.||.|.. +...|+++.+.
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~--~~~~C~lk~~~ 58 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT--KSKKCFLKSSE 58 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC--CCCeEEcccCC
Confidence 4555554433322 2568999999999999999999973 34579988764
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0024 Score=66.95 Aligned_cols=136 Identities=15% Similarity=0.129 Sum_probs=93.7
Q ss_pred CccccceeeeecceeEEEEEECCCcEEEEEEccC-----------------ccccc-----HHHHHHHHHHHHhhcC--C
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSS-----------------QSGQG-----LEEFKNEMMLIAKLQH--R 569 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~-----------------~~~~~-----~~~~~~E~~~l~~l~H--p 569 (834)
-+.+.++||-|--+-||.+-..+|++.++|.=+. ..... .-...+|+..|+.+.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4678899999999999999998899999984210 00111 1134568888888853 2
Q ss_pred CcceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc
Q 003280 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649 (834)
Q Consensus 570 nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 649 (834)
-+.+.+++ +..++|||++.+-.|...-+- .+.. .+...+..-+.-|..+| +||+|..--||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~---~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPP---TLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec------CChH---HHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 34444443 456899999988887654321 1222 23333444455566677 99999999999999
Q ss_pred CCCCceeeeecceeec
Q 003280 650 MDMNPKISDFGLARMF 665 (834)
Q Consensus 650 ~~~~~kl~Dfgla~~~ 665 (834)
+++.++++||--....
T Consensus 237 dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVST 252 (465)
T ss_pred cCCCEEEeechHhhcc
Confidence 9999999999765443
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.025 Score=61.22 Aligned_cols=144 Identities=22% Similarity=0.217 Sum_probs=84.3
Q ss_pred cceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCC--cceEEeE------EEecCeEEEEEe
Q 003280 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLGC------CVEQGEKILILE 589 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~------~~~~~~~~lV~E 589 (834)
.+.++.|....+|+....++ .+++|+.+... ..++...|+.++..|.... +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876444 67789875432 2345566777787775322 3344331 122456789999
Q ss_pred ecCCCCcccc--------------ccCCCCC---------CcCCHHHHH------------HHHHHHHHHHHHhhh----
Q 003280 590 YMPNKSLDVF--------------LFDPTKK---------RLLGWQARV------------TIIEGIAQGLLYLHQ---- 630 (834)
Q Consensus 590 y~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~ia~~L~yLH~---- 630 (834)
|++|..+... +|..... ..-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998665311 1110000 001111110 011123344555542
Q ss_pred cCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 631 ~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
..+..++|+|+++.||++++++...|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2234699999999999999888778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.018 Score=61.77 Aligned_cols=138 Identities=17% Similarity=0.212 Sum_probs=83.4
Q ss_pred cceeeeecceeEEEEEECCCcEEEEEEccC--cccccHHHHHHHHHHHHhhcC--CCcceEEeEEEecC--eEEEEEeec
Q 003280 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQH--RNLVKLLGCCVEQG--EKILILEYM 591 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~--~~~lV~Ey~ 591 (834)
.+.+..|..-.+|..... ++++++. ... ..........+|+.+|+.+.- .-+...++.|.++. ..+.||+|+
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 344433433344444432 7788888 331 223344566778888887743 23445567776666 679999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHH-HHHHHHHHHhh-----------------------------------------
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTII-EGIAQGLLYLH----------------------------------------- 629 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~-~~ia~~L~yLH----------------------------------------- 629 (834)
++..+...+...... .+++ ..++..|+-||
T Consensus 108 eGe~~~~~~~~~~~~--------~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 108 EGEVVWSALPPESLG--------RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred cceeccCcCCcccch--------HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 986543333111100 0111 13333333333
Q ss_pred ---------hc-----CCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 630 ---------QY-----SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 630 ---------~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
.+ +...++|+|+++.||+++.+.-+-|.||+++..-
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 22 3356999999999999999988999999998753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.018 Score=63.38 Aligned_cols=140 Identities=16% Similarity=0.232 Sum_probs=84.0
Q ss_pred eeeeecceeEEEEEECC-----CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcc-eEEeEEEecCeEEEEEeecCC
Q 003280 520 KLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV-KLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 520 ~LG~G~~G~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
.|-.|---.+|+....+ ++.|++|+.........++ .+|..++..+..-++. ++++.+..+ .|.||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 55557777899887532 3689999887655444444 7799999988655544 455555332 58999988
Q ss_pred CCcccc-----------------ccCCC-CC-C-cCCHHHHHHHHHHH-----------------HHHHHHh----hh-c
Q 003280 594 KSLDVF-----------------LFDPT-KK-R-LLGWQARVTIIEGI-----------------AQGLLYL----HQ-Y 631 (834)
Q Consensus 594 gsL~~~-----------------l~~~~-~~-~-~l~~~~~~~i~~~i-----------------a~~L~yL----H~-~ 631 (834)
.+|... +|... .. . ...+..+..+..++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776422 11111 00 0 11223332332111 1112222 21 2
Q ss_pred CCCceEeccCCCCcEEEcC-CCCceeeeecceee
Q 003280 632 SRFRIIHRDLKASNVLLDM-DMNPKISDFGLARM 664 (834)
Q Consensus 632 ~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~ 664 (834)
.+..++|+|+++.||++++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2346899999999999986 47899999998864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.014 Score=62.48 Aligned_cols=142 Identities=18% Similarity=0.178 Sum_probs=97.8
Q ss_pred cccceeeeecceeEEEEEECCCcEEEEEEccCcc------------------------ccc--HHHHHHHHHHHHhhcCC
Q 003280 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS------------------------GQG--LEEFKNEMMLIAKLQHR 569 (834)
Q Consensus 516 ~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~------------------------~~~--~~~~~~E~~~l~~l~Hp 569 (834)
.+...|..|--+.||.+.-.+|..+|||+++... +.. .--...|++-|.+|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3445788899999999999899999999874210 000 01134578888888755
Q ss_pred CcceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc
Q 003280 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649 (834)
Q Consensus 570 nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 649 (834)
.|...--... ...+|||+|+...... .-..+...+....+..+-.++++-+.-|.+.+ ++||.||.--|+|+.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 5432211111 1347999999753321 11223445666677888888999999998887 699999999999985
Q ss_pred CCCCceeeeecceeec
Q 003280 650 MDMNPKISDFGLARMF 665 (834)
Q Consensus 650 ~~~~~kl~Dfgla~~~ 665 (834)
+|.+.|+|-+-+...
T Consensus 300 -dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVEH 314 (520)
T ss_pred -CCEEEEEEccccccC
Confidence 578899998877654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.026 Score=60.06 Aligned_cols=31 Identities=26% Similarity=0.494 Sum_probs=26.0
Q ss_pred CceEeccCCCCcEEEcCCCC-ceeeeecceee
Q 003280 634 FRIIHRDLKASNVLLDMDMN-PKISDFGLARM 664 (834)
Q Consensus 634 ~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~ 664 (834)
..++|+|++|.||++++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999999865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.028 Score=59.85 Aligned_cols=75 Identities=19% Similarity=0.239 Sum_probs=49.0
Q ss_pred cccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhc---CCCcceEEeEEEecCeEEEEEeecC
Q 003280 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ---HRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 516 ~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
+-.+.|+.|....+|+.. .+++.+.||+-.. .....|..|.+-|+.|. --.+.+++++....+..+|||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 334678889999999987 5788999998762 23357888988888883 3457788888877778899999998
Q ss_pred CC
Q 003280 593 NK 594 (834)
Q Consensus 593 ~g 594 (834)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 87
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.096 Score=58.13 Aligned_cols=73 Identities=11% Similarity=0.079 Sum_probs=50.4
Q ss_pred cceeeeecceeEEEEEECCCcEEEEEEccCc----c---cccHHHHHHHHHHHHhhc---CCCcceEEeEEEecCeEEEE
Q 003280 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ----S---GQGLEEFKNEMMLIAKLQ---HRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~----~---~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV 587 (834)
.+.||.|....||+... .++.++||+-... . +...++-..|...|+.+. ...+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46889999999999876 4567999975421 1 123444555667776653 246777887776 456789
Q ss_pred EeecCC
Q 003280 588 LEYMPN 593 (834)
Q Consensus 588 ~Ey~~~ 593 (834)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.051 Score=59.18 Aligned_cols=74 Identities=15% Similarity=0.214 Sum_probs=48.8
Q ss_pred eeeeecceeEEEEEECCC-cEEEEEEccC-------cccccHHHHHHHHHHHHhhc--CCCcceEEeEEEecCeEEEEEe
Q 003280 520 KLGEGGFGPVYKGRLLNG-QEVAVKRLSS-------QSGQGLEEFKNEMMLIAKLQ--HRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 520 ~LG~G~~G~Vy~~~~~~g-~~vavK~l~~-------~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.||.|....||++...+| +.|+||.-.+ .-+-..++..-|...|.... -|..++-+ ++.+++...+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~v-y~~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRI-FHFDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeE-EEEccccceehHh
Confidence 579999999999998654 6899996421 12334566667777776653 35444332 2335556679999
Q ss_pred ecCCC
Q 003280 590 YMPNK 594 (834)
Q Consensus 590 y~~~g 594 (834)
+++..
T Consensus 81 dL~~~ 85 (370)
T TIGR01767 81 DLSHH 85 (370)
T ss_pred hCccc
Confidence 99653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.036 Score=56.38 Aligned_cols=123 Identities=19% Similarity=0.191 Sum_probs=61.1
Q ss_pred CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcc-eEEeEEEecCeEEEEEeecCCCCccccc---------------
Q 003280 537 GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV-KLLGCCVEQGEKILILEYMPNKSLDVFL--------------- 600 (834)
Q Consensus 537 g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~~gsL~~~l--------------- 600 (834)
.+.|+||+........ -.-..|..+++.+...++. ++++.+.. ..|+||+++..|..--
T Consensus 2 ~~~~~~Ri~g~~t~~~-idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENF-IDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCGCSH-HHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccc-cCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 4678888887664433 4557789999988755554 45554432 2577999777653311
Q ss_pred --cC--C--CCCCcCCHHHHHHH----------------------HHHHHHHHHHhh----hcC-CCceEeccCCCCcEE
Q 003280 601 --FD--P--TKKRLLGWQARVTI----------------------IEGIAQGLLYLH----QYS-RFRIIHRDLKASNVL 647 (834)
Q Consensus 601 --~~--~--~~~~~l~~~~~~~i----------------------~~~ia~~L~yLH----~~~-~~~ivH~Dlkp~NIl 647 (834)
|. . .......+..+..+ ...+..-+..+. ... ...++|+|+.+.||+
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 00 0 00111111222111 011111222221 111 234789999999999
Q ss_pred E-cCCCCceeeeecceee
Q 003280 648 L-DMDMNPKISDFGLARM 664 (834)
Q Consensus 648 l-~~~~~~kl~Dfgla~~ 664 (834)
+ +.++.++++||..+..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.038 Score=60.88 Aligned_cols=74 Identities=14% Similarity=0.149 Sum_probs=50.3
Q ss_pred cceeeeecceeEEEEEECC-CcEEEEEEccC------cccccHHHHHHHHHHHHhhc--CCCcce-EEeEEEecCeEEEE
Q 003280 518 QCKLGEGGFGPVYKGRLLN-GQEVAVKRLSS------QSGQGLEEFKNEMMLIAKLQ--HRNLVK-LLGCCVEQGEKILI 587 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~------~~~~~~~~~~~E~~~l~~l~--HpnIv~-l~~~~~~~~~~~lV 587 (834)
.+.||-|.-..||++.... ++.|+||.-.+ .-+-..++..-|.+.|+... .|..++ ++. .++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 3589999999999999743 67899996321 12344677777888887763 454444 443 345566788
Q ss_pred EeecCC
Q 003280 588 LEYMPN 593 (834)
Q Consensus 588 ~Ey~~~ 593 (834)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 834 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-47 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-41 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-32 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-22 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-22 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-20 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-19 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-19 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-19 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-18 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-18 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 398 bits (1026), Expect = e-133
Identities = 102/306 (33%), Positives = 156/306 (50%), Gaps = 19/306 (6%)
Query: 494 KGKDSWLPLFSLASVAAATENFSMQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSS 547
+ D+ FS + T NF + K+GEGGFG VYKG + N VAVK+L++
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 548 ----QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP 603
+ + ++F E+ ++AK QH NLV+LLG + + L+ YMPN SL L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
L W R I +G A G+ +LH+ IHRD+K++N+LLD KISDFGLAR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD 723
T RIVGT YM+PE L G + KSD++SFG+++LE ++G + +
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD-EHRE 239
Query: 724 SFNLLGYAWDLWKDDK-FHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDV 782
LL ++ ++K + ID + ++ + +VA C+ + RP + V
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 783 VSIINS 788
++
Sbjct: 298 QQLLQE 303
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 396 bits (1019), Expect = e-132
Identities = 117/313 (37%), Positives = 178/313 (56%), Gaps = 7/313 (2%)
Query: 484 FGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK 543
F +V + + L FSL + A++NFS + LG GGFG VYKGRL +G VAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 544 RLSSQSGQGLE-EFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD 602
RL + QG E +F+ E+ +I+ HRNL++L G C+ E++L+ YM N S+ L +
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 603 PTKKRL-LGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661
+ + L W R I G A+GL YLH + +IIHRD+KA+N+LLD + + DFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNT---G 718
A++ + T + GT G+++PEY G S K+DVF +G+++LE ++G++
Sbjct: 181 AKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239
Query: 719 VYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPT 778
+ N D LL + L K+ K L+D + Q + + I VALLC Q + +RP
Sbjct: 240 LANDDDVMLLDWVKGLLKEKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPK 298
Query: 779 MSDVVSIINSERL 791
MS+VV ++ + L
Sbjct: 299 MSEVVRMLEGDGL 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 356 bits (915), Expect = e-116
Identities = 101/284 (35%), Positives = 165/284 (58%), Gaps = 6/284 (2%)
Query: 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMML 562
L + AT NF + +G G FG VYKG L +G +VA+KR + +S QG+EEF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-LGWQARVTIIEGI 621
++ +H +LV L+G C E+ E ILI +YM N +L L+ + + W+ R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
A+GL YLH + IIHRD+K+ N+LLD + PKI+DFG+++ + + + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN-ADSFNLLGYAWDLWKDDKF 740
GY+ PEY + G + KSDV+SFG+++ E L + + NL +A + + +
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784
+++DP + D+I L ++ + A+ C+ ++ DRP+M DV+
Sbjct: 266 EQIVDPNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 7e-93
Identities = 69/310 (22%), Positives = 123/310 (39%), Gaps = 32/310 (10%)
Query: 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMML 562
++ + + G FG V+K +L + VAVK Q Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 563 IAKLQHRNLVKLLGCCVE----QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII 618
+ ++H N+++ +G + LI + SL FL K ++ W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 619 EGIAQGLLYLHQ-------YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671
E +A+GL YLH+ + I HRD+K+ NVLL ++ I+DFGLA F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 672 GNTKRIVGTYGYMSPEYALDGL-----FSIKSDVFSFGILMLETLSGKKNTGVYNADSFN 726
G+T VGT YM+PE + ++ D+++ G+++ E S +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE--Y 245
Query: 727 LLGYAWDLWKDDKFHEL--------IDPVITQDEISLPVLVRYINVALLCVQDNAADRPT 778
+L + ++ + ++ PV+ + C +A R +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 779 MSDVVSIINS 788
V I
Sbjct: 306 AGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 264 bits (675), Expect = 2e-81
Identities = 73/334 (21%), Positives = 129/334 (38%), Gaps = 45/334 (13%)
Query: 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNE--M 560
+ + + +N + +G G +G VYKG L + + VAVK S + Q F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 561 MLIAKLQHRNLVKLLGCCVE-----QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARV 615
+ ++H N+ + + + E +L++EY PN SL +L W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114
Query: 616 TIIEGIAQGLLYLHQ------YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG-- 667
+ + +GL YLH + + I HRDL + NVL+ D ISDFGL+ G
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 668 ----DELQGNTKRIVGTYGYMSPEYALDGLFSI--------KSDVFSFGILMLETLSGKK 715
E VGT YM+PE L+G ++ + D+++ G++ E
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 716 NTGVYNADSFNLLGYAWDLWKDDKFHELID--------PVITQDEISLPVLVRYI-NVAL 766
+ + + + ++ F ++ P + + VR +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 767 LCVQDNAADRPTMSDVVSIINSERLELPSPKEPA 800
C +A R T + + K +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 8e-64
Identities = 72/295 (24%), Positives = 138/295 (46%), Gaps = 28/295 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRN 570
+ +++ K+G G FG V++ +G +VAVK L Q + + EF E+ ++ +L+H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+V +G + ++ EY+ SL L + L + R+++ +A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
I+HR+LK+ N+L+D K+ DFGL+R+ L +K GT +M+PE
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLR 212
Query: 691 DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750
D + KSDV+SFG+++ E + ++ W + +++ V +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQ------------------PWGNLNPAQVVAAVGFK 254
Query: 751 D---EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS-ERLELPSPKEPAF 801
EI + + + C + RP+ + ++ ++ + +P P
Sbjct: 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 4e-62
Identities = 73/294 (24%), Positives = 127/294 (43%), Gaps = 37/294 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
+ ++ +G G FG V K + ++VA+K++ S+S + F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
KL G C+ L++EY SL L ++ +QG+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 633 RFRIIHRDLKASNVLLDMDMN-PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
+IHRDLK N+LL KI DFG A ++Q + G+ +M+PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 692 GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD------DKFHELID 745
+S K DVFS+GI++ E ++ +K ++ W + + I+
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234
Query: 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEP 799
++T+ C + + RP+M ++V I+ P EP
Sbjct: 235 SLMTR-----------------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 7e-60
Identities = 74/284 (26%), Positives = 121/284 (42%), Gaps = 42/284 (14%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRL----SSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
+G GGFG VY+ G EVAVK Q +E + E L A L+H N++ L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
G C+++ L++E+ L+ L + + V IA+G+ YLH +
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 636 IIHRDLKASNVLLDMDMNP--------KISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
IIHRDLK+SN+L+ + KI+DFGLAR + G Y +M+PE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPE 184
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747
+FS SDV+S+G+L+ E L+G+ ++ + V
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGE------------------VPFRGIDGLAVAYGV 226
Query: 748 ITQD---EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
I + + C + RP+ ++++ + +
Sbjct: 227 AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-59
Identities = 67/300 (22%), Positives = 114/300 (38%), Gaps = 44/300 (14%)
Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
LG+G FG K G+ + +K L + F E+ ++ L+H N++K +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
+ I EY+ +L + + W RV+ + IA G+ YLH IIH
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR------------IVGTYGYMSP 686
RDL + N L+ + N ++DFGLAR+ ++ Q R +VG +M+P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWK------DDKF 740
E + K DVFSFGI++ E + A +
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVN---------------ADPDYLPRTMDFGLNV 236
Query: 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPA 800
+D + + + + C + RP+ + + + R+ L
Sbjct: 237 RGFLDRYCPPN-----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-58
Identities = 71/294 (24%), Positives = 136/294 (46%), Gaps = 44/294 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQG-------LEEFKNEMMLIA 564
+ ++G+GGFG V+KGRL+ + VA+K L +G +EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
L H N+VKL G +++E++P L L D K + W ++ ++ IA G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDM-----DMNPKISDFGLARMFGGDELQGNTKRIVG 679
+ Y+ I+HRDL++ N+ L + K++DFGL++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 680 TYGYMSPE--YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD 737
+ +M+PE A + ++ K+D +SF +++ L+G+ + D ++ +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PF--DEYSYGKIKF----- 238
Query: 738 DKFHELIDPVITQD---EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
I+ + + I R NV LC + RP S +V ++
Sbjct: 239 ------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 5e-58
Identities = 59/287 (20%), Positives = 109/287 (37%), Gaps = 40/287 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRN 570
+ + KL E G ++KGR G ++ VK L + S + +F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 571 LVKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
++ +LG C I +MP SL L + T + V +A+G+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFL 127
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H I L + +V++D DM +IS + F + + +++PE
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE- 178
Query: 689 ALDG----LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744
AL +D++SF +L+ E ++ + + D E+
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE------------------VPFADLSNMEIG 220
Query: 745 DPVITQD---EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
V + I + + +C+ ++ A RP +V I+
Sbjct: 221 MKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-56
Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 13/207 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRN 570
++ ++G G FG VYKG+ +G +VAVK L+ + Q L+ FKNE+ ++ K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
++ +G I + ++ SL L K + + I A+G+ YLH
Sbjct: 82 ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA 138
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE--- 687
S IIHRDLK++N+ L D KI DFGLA +++ G+ +M+PE
Sbjct: 139 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
+S +SDV++FGI++ E ++G+
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 4e-56
Identities = 68/304 (22%), Positives = 117/304 (38%), Gaps = 38/304 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNE--MMLIAKLQHR 569
+ ++ +G+G +G V++G G+ VAVK SS+ + + E + L+H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62
Query: 570 NLVKLLGCCVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
N++ + + LI Y SL +L + L + + I+ IA GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118
Query: 626 LYLHQYSRFR-----IIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIV 678
+LH I HRDLK+ N+L+ + I+D GLA M ++L V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 679 GTYGYMSPE------YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAW 732
GT YM+PE + D+++FG+++ E + G+ +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK---PPFYD 235
Query: 733 DLWKDDKFHELID--------PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784
+ D F ++ P I S P L + C N + R T +
Sbjct: 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
Query: 785 IINS 788
+
Sbjct: 296 TLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 4e-55
Identities = 70/304 (23%), Positives = 119/304 (39%), Gaps = 40/304 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNE--MMLIAKLQHRN 570
+ M ++G+G +G V+ G+ G++VAVK + + E + ++H N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 571 LVKLLGCCVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
++ + ++ LI +Y N SL +L K L ++ + + GL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 627 YLHQYSRFR-----IIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVG 679
+LH I HRDLK+ N+L+ + I+D GLA F +E+ VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 680 TYGYMSPEYALDGL-------FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAW 732
T YM PE LD I +D++SFG+++ E + G+ L Y
Sbjct: 209 TKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ---LPYHD 264
Query: 733 DLWKDDKFHELID--------PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784
+ D + ++ + P S L + + C N A R T V
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
Query: 785 IINS 788
+
Sbjct: 325 TLAK 328
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-54
Identities = 66/300 (22%), Positives = 119/300 (39%), Gaps = 49/300 (16%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
+G+G FG VY GR +G EVA++ + + + L+ FK E+M + +H N+V +G
Sbjct: 40 LIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
C+ +I ++L + D K +L I + I +G+ YLH I+
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---IL 152
Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI---VGTYGYMSPE------- 687
H+DLK+ NV D + I+DFGL + G + ++ G +++PE
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 688 --YALDGLFSIKSDVFSFGILMLETLSGKK------NTGVYNADSFNLLGYAWDLWKDDK 739
FS SDVF+ G + E + + + +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK----------- 260
Query: 740 FHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEP 799
P ++Q + + ++ L C +RPT + ++ ++ P
Sbjct: 261 ------PNLSQIGMGKEI----SDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 6e-54
Identities = 76/327 (23%), Positives = 125/327 (38%), Gaps = 43/327 (13%)
Query: 490 DGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS 549
D G S LPL ++A +Q +G+G FG V++G+ G+EVAVK SS+
Sbjct: 22 DMTTSGSGSGLPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE 77
Query: 550 GQGLEEFKNE--MMLIAKLQHRNLVKLLGCCVEQGEKI----LILEYMPNKSLDVFLFDP 603
+ E + L+H N++ + + L+ +Y + SL +L
Sbjct: 78 ---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--- 131
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR-----IIHRDLKASNVLLDMDMNPKISD 658
+ + + + + A GL +LH I HRDLK+ N+L+ + I+D
Sbjct: 132 -NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190
Query: 659 FGLARMF--GGDELQGNTKRIVGTYGYMSPEYALDGL-------FSIKSDVFSFGILMLE 709
GLA D + VGT YM+PE LD ++D+++ G++ E
Sbjct: 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE 249
Query: 710 TLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID--------PVITQDEISLPVLVRY 761
G++ L Y + D E+ P I S L
Sbjct: 250 IARRCSIGGIHED---YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM 306
Query: 762 INVALLCVQDNAADRPTMSDVVSIINS 788
+ C N A R T + ++
Sbjct: 307 AKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-48
Identities = 82/309 (26%), Positives = 133/309 (43%), Gaps = 47/309 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQSG-QGLEEFKNEMMLIAKL 566
LGEG FG V G+ VAVK L + +G Q +K E+ ++ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 567 QHRNLVKLLGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
H +++K GCC + G L++EY+P SL +L + +G + + I +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTK---RI 677
+ YLH ++ IHRDL A NVLLD D KI DFGLA+ ++ +
Sbjct: 147 MAYLH--AQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF- 202
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD 737
+ +PE + F SDV+SFG+ + E L+ ++ L+G A
Sbjct: 203 -----WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257
Query: 738 DKFHELID-------PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS----II 786
+ EL++ P E+ Y ++ C + A+ RPT +++ +
Sbjct: 258 LRLTELLERGERLPRPDKCPAEV-------Y-HLMKNCWETEASFRPTFENLIPILKTVH 309
Query: 787 NSERLELPS 795
+ + PS
Sbjct: 310 EKYQGQAPS 318
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-48
Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 41/298 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
+ +LG+G FG V R G+ VAVK+L + + L +F+ E+ ++ LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 568 HRNLVKLLGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
H N+VK G C G + LI+EY+P SL +L K + + I +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTK---RIV 678
YL ++ R IHRDL N+L++ + KI DFGL ++ D+ ++ +
Sbjct: 128 EYLG--TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF-- 182
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYA-WDLWKD 737
+ +PE + FS+ SDV+SFG+++ E + + + A+ ++G
Sbjct: 183 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 738 DKFHELID-------PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
EL+ P DEI Y + C +N RP+ D+ ++
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEI-------Y-MIMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-48
Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 41/298 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
+ +LG+G FG V R G+ VAVK+L + + L +F+ E+ ++ LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 568 HRNLVKLLGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
H N+VK G C G + LI+EY+P SL +L K + + I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTK---RIV 678
YL ++ R IHRDL N+L++ + KI DFGL ++ D+ ++ +
Sbjct: 159 EYLG--TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF-- 213
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYA-WDLWKD 737
+ +PE + FS+ SDV+SFG+++ E + + + A+ ++G
Sbjct: 214 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 738 DKFHELID-------PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
EL+ P DEI Y + C +N RP+ D+ ++
Sbjct: 270 FHLIELLKNNGRLPRPDGCPDEI-------Y-MIMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-48
Identities = 71/284 (25%), Positives = 120/284 (42%), Gaps = 34/284 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRN 570
E+ + ++G G FG V+ GRL + VAVK + +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+V+L+G C ++ +++E + FL T+ L + + ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMSPEY 688
IHRDL A N L+ KISDFG++R G +++ + +PE
Sbjct: 232 K---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEA 286
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKN--TGVYNADSFNLL--GYAWDLWKDDKFHELI 744
G +S +SDV+SFGIL+ ET S + + N + + G L
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-----------RLP 335
Query: 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
P + D + + + C RP+ S + + S
Sbjct: 336 CPELCPDAV-------F-RLMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-48
Identities = 74/302 (24%), Positives = 127/302 (42%), Gaps = 49/302 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKL 566
LGEG FG V R G++VAVK L +SG + + K E+ ++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 567 QHRNLVKLLGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
H N+VK G C E G LI+E++P+ SL +L P K + + ++ I +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTK---RI 677
+ YL + +HRDL A NVL++ + KI DFGL + D+ ++ +
Sbjct: 139 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF- 194
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWK 736
+ +PE + F I SDV+SFG+ + E L+ ++ + +
Sbjct: 195 -----WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM-- 247
Query: 737 DDKFHELID----------PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
L++ P DE+ Y + C + ++R + +++
Sbjct: 248 --TVTRLVNTLKEGKRLPCPPNCPDEV-------Y-QLMRKCWEFQPSNRTSFQNLIEGF 297
Query: 787 NS 788
+
Sbjct: 298 EA 299
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-46
Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 57/297 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKL 566
F LG G FG VYKG + E VA+K L + S + +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGIA 622
+ ++ +LLG C+ ++ I + MP L ++ + + LL W IA
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
+G+ YL R++HRDL A NVL+ + KI+DFGLA++ G +E Y
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYH 175
Query: 683 Y---------MSPEYALDGLFSIKSDVFSFGILMLETLS-GKK-NTGVYNADSFNLLGYA 731
M+ E L +++ +SDV+S+G+ + E ++ G K G+ ++ ++L
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--- 232
Query: 732 WDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
+K L P I ++ Y + C +A RP +++ +
Sbjct: 233 ------EKGERLPQPPICTIDV-------Y-MIMRKCWMIDADSRPKFRELIIEFSK 275
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-46
Identities = 80/315 (25%), Positives = 138/315 (43%), Gaps = 50/315 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
+ +LG+G FG V R G VAVK+L +F+ E+ ++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 568 HRNLVKLLGCCVEQGEK--ILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGI 621
+VK G G + L++EY+P+ L FL RLL + + I
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QI 136
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTK-- 675
+G+ YL SR R +HRDL A N+L++ + + KI+DFGLA++ D+ ++ +
Sbjct: 137 CKGMEYLG--SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 676 -RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWD 733
+ +PE D +FS +SDV+SFG+++ E + K+ A+ ++G D
Sbjct: 194 IF------WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS-AEFLRMMGCERD 246
Query: 734 LWKDDKFHELID-------PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
+ + EL++ P E+ + + LC + DRP+ S + +
Sbjct: 247 VPALSRLLELLEEGQRLPAPPACPAEV-------H-ELMKLCWAPSPQDRPSFSALGPQL 298
Query: 787 NSERLELPSPKEPAF 801
+ + AF
Sbjct: 299 DMLWSGSRGCETHAF 313
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-46
Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 573 KLLGCCVEQGEKILI-LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
+LLG VE+ + I EYM SL +L + +LG + + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------YMS 685
+HRDL A NVL+ D K+SDFGL + + + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EA-------SSTQDTGKLPVKWTA 182
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
PE + FS KSDV+SFGIL+ E S
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 67/202 (33%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
+ ++G G FG V+ G LN +VA+K + + E+F E ++ KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 66
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+L G C+EQ L+ E+M + L +L T++ L + + + + +G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMSPEYAL 690
+IHRDL A N L+ + K+SDFG+ R D+ TK V + SPE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFS 178
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
+S KSDV+SFG+LM E S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS 200
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-46
Identities = 80/311 (25%), Positives = 132/311 (42%), Gaps = 55/311 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRLSSQSGQGLEEFKNEMMLIAKL 566
+ ++ +LGEG FG V+ N VAVK L + ++F+ E L+ L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLLGWQA 613
QH ++VK G C + I++ EYM + L+ FL K LG
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--EL 670
+ I IA G++YL + +HRDL N L+ ++ KI DFG++R ++ D +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 671 QGNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN--TGVYNADSF 725
G+T R +M PE + F+ +SDV+SFG+++ E + K + N +
Sbjct: 192 GGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 245
Query: 726 NLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785
+ + L P + E+ Y +V L C Q R + ++ I
Sbjct: 246 ECI---------TQGRVLERPRVCPKEV-------Y-DVMLGCWQREPQQRLNIKEIYKI 288
Query: 786 INSERLELPSP 796
+ L +P
Sbjct: 289 L--HALGKATP 297
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-46
Identities = 84/324 (25%), Positives = 137/324 (42%), Gaps = 47/324 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRL--SSQSGQGLEEFKNEMMLIAKL 566
+ F++ LG+G FG V + +L +VAVK L + +EEF E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 567 QHRNLVKLLGCCVEQGEKI------LILEYMPNKSLDVFLFD---PTKKRLLGWQARVTI 617
H ++ KL+G + K +IL +M + L FL L Q V
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--ELQGNT 674
+ IA G+ YL S IHRDL A N +L DM ++DFGL+R ++ GD +
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL--GY 730
K V +++ E D L+++ SDV++FG+ M E T G+ NA+ +N L G
Sbjct: 200 KLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256
Query: 731 AWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790
L P +E+ Y ++ C + RP+ + + + +
Sbjct: 257 -----------RLKQPPECMEEV-------Y-DLMYQCWSADPKQRPSFTCLRMELENIL 297
Query: 791 LELPSPKEPAFIKGINVKNSSHSN 814
L IN++ + H +
Sbjct: 298 GHLSVLSTSQDPLYINIERAHHHH 321
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 91/304 (29%), Positives = 132/304 (43%), Gaps = 54/304 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SSQSGQGLEEFKNEMMLIAK 565
+LGE FG VYKG L Q VA+K L G EEF++E ML A+
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLLGWQ 612
LQH N+V LLG + +I Y + L FL D T K L
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--E 669
V ++ IA G+ YL S ++H+DL NVL+ +N KISD GL R ++ D +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 670 LQGNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKN-TGVYNADS 724
L GN+ R +M+PE + G FSI SD++S+G+++ E S G + G N D
Sbjct: 186 LLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239
Query: 725 FNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784
++ L P + Y + + C + + RP D+ S
Sbjct: 240 VEMI---------RNRQVLPCPDDCPAWV-------Y-ALMIECWNEFPSRRPRFKDIHS 282
Query: 785 IINS 788
+ +
Sbjct: 283 RLRA 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 52/300 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRLSSQSGQGLEEFKNEMMLIAKL 566
+ ++ +LGEG FG V+ N VAVK L S ++F+ E L+ L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL------------FDPTKKRLLGWQAR 614
QH+++V+ G C E +++ EYM + L+ FL + LG
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--ELQ 671
+ + +A G++YL + +HRDL N L+ + KI DFG++R ++ D +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 672 GNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFN 726
G T R +M PE L F+ +SDV+SFG+++ E T + + N ++ +
Sbjct: 218 GRTMLPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271
Query: 727 LLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
+ + EL P E+ Y + C Q R ++ DV + +
Sbjct: 272 CI---------TQGRELERPRACPPEV-------Y-AIMRGCWQREPQQRHSIKDVHARL 314
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-45
Identities = 66/201 (32%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 573 KLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
+LLG VE+ + ++ EYM SL +L + +LG + + + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
+HRDL A NVL+ D K+SDFGL + Q K V + +PE +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 360
Query: 692 GLFSIKSDVFSFGILMLETLS 712
FS KSDV+SFGIL+ E S
Sbjct: 361 KKFSTKSDVWSFGILLWEIYS 381
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 76/304 (25%), Positives = 121/304 (39%), Gaps = 48/304 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQ 567
+G+G FG VY G ++ + A+K L Q +E F E +L+ L
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 568 HRNLVKLLGCCVEQGEKILI-LEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIA 622
H N++ L+G + + L YM + L F+ +PT K L+ + +A
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL------QVA 134
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY- 681
+G+ YL + + +HRDL A N +LD K++DFGLAR E +
Sbjct: 135 RGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 682 -GYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLLGYAWDLWKDD 738
+ + E F+ KSDV+SFG+L+ E T + D + L
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL---------A 242
Query: 739 KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII--------NSER 790
+ L P D + Y V C + + A RPT +V +
Sbjct: 243 QGRRLPQPEYCPDSL-------Y-QVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294
Query: 791 LELP 794
++LP
Sbjct: 295 VQLP 298
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 11/203 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
+ +M+ KLG G +G VY+G VAVK L + + +EEF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
V+LLG C + +I E+M +L +L + ++ + + + I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMSPEYA 689
+ IHRDL A N L+ + K++DFGL+R+ GD K + + +PE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 184
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
FSIKSDV++FG+L+ E +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 66/202 (32%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
E ++ +LG G FG V G+ +VAVK + S +EF E + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLV 66
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
K G C ++ ++ EY+ N L +L + + L + + + +G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMSPEYAL 690
+ IHRDL A N L+D D+ K+SDFG+ R D+ TK V + +PE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV---KWSAPEVFH 178
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
+S KSDV++FGILM E S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
++ + +LG G FG V G+ +VA+K + S +EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 82
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+L G C +Q +I EYM N L +L + Q + + + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMSPEYAL 690
+ +HRDL A N L++ K+SDFGL+R DE +K V + PE +
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLM 194
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
FS KSD+++FG+LM E S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 72/202 (35%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
E + +LG G FG V+ G +VAVK L S + F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+L ++ I I EYM N SL FL P L + + IA+G+ ++
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY--MSPEYAL 690
IHRDL+A+N+L+ ++ KI+DFGLAR+ +E T R + +PE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 183
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
G F+IKSDV+SFGIL+ E ++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-45
Identities = 83/286 (29%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 520 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
+G G FG VY G LL+ AVK L + +F E +++ H N++ L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 575 LGCCVEQGEKIL-ILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
LG C+ L +L YM + L F+ +PT K L+G +A+G+ YL
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQVAKGMKYL- 144
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------Y 683
+ + +HRDL A N +LD K++DFGLAR D + G +
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKW 198
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLS-GKKN-TGVYNADSFNLLGYAWDLWKDDKFH 741
M+ E F+ KSDV+SFG+L+ E ++ G V D L +
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---------LQGR 249
Query: 742 ELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787
L+ P D + Y V L C A RP+ S++VS I+
Sbjct: 250 RLLQPEYCPDPL-------Y-EVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-45
Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 38/283 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
+ +M+ KLG G +G VY+G VAVK L + + +EEF E ++ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 278
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
V+LLG C + +I E+M +L +L + ++ + + + I+ + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY--MSPEYA 689
+ IHR+L A N L+ + K++DFGL+R+ GD T + +PE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESL 391
Query: 690 LDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL--GYAWDLWKD--DKFHEL 743
FSIKSDV++FG+L+ E T G+ + + LL Y + + +K +EL
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451
Query: 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
+ C Q N +DRP+ +++
Sbjct: 452 M---------------------RACWQWNPSDRPSFAEIHQAF 473
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-45
Identities = 84/324 (25%), Positives = 145/324 (44%), Gaps = 63/324 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKL 566
F LG G FG VYKG + E VA+K L + S + +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
+ ++ +LLG C+ ++ I + MP L ++ + K +G Q + IA+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY--- 683
YL R++HRDL A NVL+ + KI+DFGLA++ G +E Y
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYHAEGG 179
Query: 684 ------MSPEYALDGLFSIKSDVFSFGILMLETLS-GKK-NTGVYNADSFNLLGYAWDLW 735
M+ E L +++ +SDV+S+G+ + E ++ G K G+ ++ ++L
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL------- 232
Query: 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS----------- 784
+K L P I ++ Y + + C +A RP +++
Sbjct: 233 --EKGERLPQPPICTIDV-------Y-MIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 282
Query: 785 ---IINSERLELPSPKEPAFIKGI 805
I ER+ LPSP + F + +
Sbjct: 283 YLVIQGDERMHLPSPTDSNFYRAL 306
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 7e-45
Identities = 81/302 (26%), Positives = 136/302 (45%), Gaps = 57/302 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SSQSGQGLEEFKNEMMLIAKL-Q 567
+ Q +GEG FG V K R+ A+KR+ S +F E+ ++ KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------FDPTKKRLLGWQARVTIIE- 619
H N++ LLG C +G L +EY P+ +L FL DP + ++ +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 620 -----GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT 674
+A+G+ YL S+ + IHRDL A N+L+ + KI+DFGL+R G + T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 199
Query: 675 K-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
R +M+ E +++ SDV+S+G+L+ E +L G G+ A+ +
Sbjct: 200 MGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253
Query: 728 L--GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785
L GY L P+ DE+ Y ++ C ++ +RP+ + ++
Sbjct: 254 LPQGY-----------RLEKPLNCDDEV-------Y-DLMRQCWREKPYERPSFAQILVS 294
Query: 786 IN 787
+N
Sbjct: 295 LN 296
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-44
Identities = 83/293 (28%), Positives = 137/293 (46%), Gaps = 37/293 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG G FG V+ +VAVK + +E F E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
KL ++ I I E+M SL FL + + IA+G+ ++
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY--MSPEYAL 690
+ IHRDL+A+N+L+ + KI+DFGLAR+ +E T R + +PE
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAIN 358
Query: 691 DGLFSIKSDVFSFGILMLETLS-GKK-NTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748
G F+IKSDV+SFGIL++E ++ G+ G+ N + L ++ + + P
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERGYRMPRPEN 409
Query: 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII-------NSERLELP 794
+E+ Y N+ + C ++ +RPT + S++ S+ E+P
Sbjct: 410 CPEEL-------Y-NIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-44
Identities = 81/299 (27%), Positives = 131/299 (43%), Gaps = 52/299 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL--SSQSGQGLEEFKNEMMLIAKL 566
+ LGEG FG V +G L VAVK + + S + +EEF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 567 QHRNLVKLLGCCVEQG-----EKILILEYMPNKSLDVFL---FDPTKKRLLGWQARVTII 618
H N+++LLG C+E + ++IL +M L +L T + + Q + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--ELQGNTK 675
IA G+ YL S +HRDL A N +L DM ++DFGL++ ++ GD K
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 676 ---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL-- 728
+ +++ E D +++ KSDV++FG+ M E T GV N + ++ L
Sbjct: 211 MPVK------WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264
Query: 729 GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787
G+ L P DE+ Y + C + + DRPT S + +
Sbjct: 265 GH-----------RLKQPEDCLDEL-------Y-EIMYSCWRTDPLDRPTFSVLRLQLE 304
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-44
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSG-QGLEEFKNEMMLIAKL 566
LG G FG V+KG + E V +K + +SG Q + + M+ I L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGIA 622
H ++V+LLG C ++ + +Y+P SL + + LL W IA
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIA 125
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVG 679
+G+ YL ++HR+L A NVLL +++DFG+A + D+ K +
Sbjct: 126 KGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI- 181
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+ E G ++ +SDV+S+G+ + E ++
Sbjct: 182 --KWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 86/327 (26%), Positives = 142/327 (43%), Gaps = 69/327 (21%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SSQSGQGLEEFKNEMMLI 563
+ ++ LGEG FG V + VAVK L + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
+ +H+N++ LLG C + G +I+EY +L +L + + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD 668
++ V+ +A+G+ YL + + IHRDL A NVL+ + KI+DFGLAR + D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 669 ELQGNTK-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
+ T + +M+PE D +++ +SDV+SFG+LM E TL G G+
Sbjct: 212 YYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265
Query: 722 ADSFNLL--GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTM 779
+ F LL G+ + P +E+ Y + C + RPT
Sbjct: 266 EELFKLLKEGH-----------RMDKPANCTNEL-------Y-MMMRDCWHAVPSQRPTF 306
Query: 780 SDVVSII--------NSERLELPSPKE 798
+V + N E L+L P E
Sbjct: 307 KQLVEDLDRILTLTTNEEYLDLSQPLE 333
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-44
Identities = 82/302 (27%), Positives = 123/302 (40%), Gaps = 54/302 (17%)
Query: 520 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
+G G FG VY G LL+ AVK L + +F E +++ H N++ L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 575 LGCCVEQGEKIL-ILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
LG C+ L +L YM + L F+ +PT K L+G +A+G+ +L
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQVAKGMKFL- 208
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG-----YM 684
+ + +HRDL A N +LD K++DFGLAR E + T +M
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWM 263
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742
+ E F+ KSDV+SFG+L+ E T V D L +
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---------LQGRR 314
Query: 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII--------NSERLELP 794
L+ P D + Y V L C A RP+ S++VS I + +
Sbjct: 315 LLQPEYCPDPL-------Y-EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 366
Query: 795 SP 796
+
Sbjct: 367 AT 368
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 77/298 (25%), Positives = 128/298 (42%), Gaps = 52/298 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SSQSGQGLEEFKNEMMLIAK 565
E +M +LG+G FG VY+G + VA+K + + S + EF NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------FDPTKKRLLGWQARVTII 618
++V+LLG + ++I+E M L +L + + +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--ELQGNTK 675
IA G+ YL + + +HRDL A N ++ D KI DFG+ R ++ D G
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 676 ---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL-- 728
R +MSPE DG+F+ SDV+SFG+++ E TL+ + G+ N +
Sbjct: 202 LPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 729 GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
G D P D + + + +C Q N RP+ +++S I
Sbjct: 256 GGLLDK-----------PDNCPDML-------F-ELMRMCWQYNPKMRPSFLEIISSI 294
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-44
Identities = 80/306 (26%), Positives = 136/306 (44%), Gaps = 57/306 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SSQSGQGLEEFKNEMMLI 563
+ ++ LGEG FG V + VAVK L + + L + +EM ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
+ +H+N++ LLG C + G +I+EY +L +L + + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD 668
++ V+ +A+G+ YL + + IHRDL A NVL+ + KI+DFGLAR + D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 669 ELQGNTK-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
+ T + +M+PE D +++ +SDV+SFG+LM E TL G G+
Sbjct: 258 YYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311
Query: 722 ADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSD 781
+ F LL + H + P +E+ Y + C + RPT
Sbjct: 312 EELFKLL---------KEGHRMDKPANCTNEL-------Y-MMMRDCWHAVPSQRPTFKQ 354
Query: 782 VVSIIN 787
+V ++
Sbjct: 355 LVEDLD 360
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 77/315 (24%), Positives = 128/315 (40%), Gaps = 57/315 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SSQSGQGLEEFKNEMMLIAK 565
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGI 621
H+N+V+ +G ++ + +++E M L FL P++ L + + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLAR-MFGGD--ELQGNTK 675
A G YL IHRD+ A N LL KI DFG+AR ++ G
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 676 ---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL-- 728
+ +M PE ++G+F+ K+D +SFG+L+ E +L N + +
Sbjct: 207 LPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260
Query: 729 GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII-- 786
G + P + Y + C Q DRP + ++ I
Sbjct: 261 GG-----------RMDPPKNCPGPV-------Y-RIMTQCWQHQPEDRPNFAIILERIEY 301
Query: 787 ---NSERLELPSPKE 798
+ + + P E
Sbjct: 302 CTQDPDVINTALPIE 316
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-44
Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 57/315 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SSQSGQGLEEFKNEMMLIAK 565
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGI 621
H+N+V+ +G ++ + ++LE M L FL P++ L + + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLAR-MFGGD--ELQGNTK 675
A G YL IHRD+ A N LL KI DFG+AR ++ G
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 676 ---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL-- 728
+ +M PE ++G+F+ K+D +SFG+L+ E +L N + +
Sbjct: 248 LPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301
Query: 729 GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII-- 786
G + P + Y + C Q DRP + ++ I
Sbjct: 302 GG-----------RMDPPKNCPGPV-------Y-RIMTQCWQHQPEDRPNFAIILERIEY 342
Query: 787 ---NSERLELPSPKE 798
+ + + P E
Sbjct: 343 CTQDPDVINTALPIE 357
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 6e-44
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQ 567
++ +G G G V GRL VA+K L + + + +F +E ++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
H N+++L G +++ EYM N SLD FL + V ++ G+ G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRY 166
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY---- 683
L S +HRDL A NVL+D ++ K+SDFGL+R+ D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTT 212
Query: 684 --------MSPEYALDGLFSIKSDVFSFGILMLETLS 712
+PE FS SDV+SFG++M E L+
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 520 KLGEGGFGPVYKGRLLNG---QEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
+LG G FG V KG + VAVK L + +E E ++ +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
+G C + E L++E L+ +L + R + + + ++ ++ G+ YL
Sbjct: 84 IGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EE 135
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEYA 689
+HRDL A NVLL KISDFGL++ DE Q + K V + +PE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---KWYAPECI 192
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
FS KSDV+SFG+LM E S
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-43
Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKL 566
+ Q +G G FG VYKG L VA+K L + + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
H N+++L G + ++I EYM N +LD FL K V ++ GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG---- 682
YL + +HRDL A N+L++ ++ K+SDFGL+R+ D T G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIP 213
Query: 683 --YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +PE F+ SDV+SFGI+M E ++
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 5e-43
Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 34/282 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + E F E ++ KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 242
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+L E+ I + EYM SL FL + L V + IA G+ Y+
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
R +HRDL+A+N+L+ ++ K++DFGLAR+ +E + +PE AL G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 693 LFSIKSDVFSFGILMLETLSGKKN--TGVYNADSFNLL--GYAWDLWKD--DKFHELIDP 746
F+IKSDV+SFGIL+ E + + G+ N + + + GY + + H+L+
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM-- 414
Query: 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
C + +RPT + + +
Sbjct: 415 -------------------CQCWRKEPEERPTFEYLQAFLED 437
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-43
Identities = 66/234 (28%), Positives = 100/234 (42%), Gaps = 43/234 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SSQSGQGLEEFKNEMMLIAK 565
N +GEG FG V++ R VAVK L S +F+ E L+A+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL---------------------FDPT 604
+ N+VKLLG C L+ EYM L+ FL
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 605 KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR- 663
L ++ I +A G+ YL S + +HRDL N L+ +M KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 664 MFGGD--ELQGNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
++ D + GN R +M PE ++ +SDV+++G+++ E S
Sbjct: 224 IYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 7e-43
Identities = 84/322 (26%), Positives = 134/322 (41%), Gaps = 82/322 (25%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SSQSGQGLEEFKNEMMLIAK 565
+N + LGEG FG V K + VAVK L + S L + +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL------------------------- 600
+ H +++KL G C + G +LI+EY SL FL
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 601 --FDPTKKRLL--GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656
T L+ WQ I+QG+ YL + +++HRDL A N+L+ KI
Sbjct: 143 DERALTMGDLISFAWQ--------ISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKI 191
Query: 657 SDFGLAR-MFGGDELQGNTK-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE- 709
SDFGL+R ++ D ++ + +M+ E D +++ +SDV+SFG+L+ E
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 710 -TLSGKKNTGVYNADSFNLL--GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVAL 766
TL G G+ FNLL G+ + P +E+ Y + L
Sbjct: 246 VTLGGNPYPGIPPERLFNLLKTGH-----------RMERPDNCSEEM-------Y-RLML 286
Query: 767 LCVQDNAADRPTMSDVVSIINS 788
C + RP +D+ +
Sbjct: 287 QCWKQEPDKRPVFADISKDLEK 308
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
+LG G FG V +G ++ VA+K L EE E ++ +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 573 KLLGCCVEQGEKILI-LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
+L+G C Q E +++ +E L FL K+ + ++ ++ G+ YL
Sbjct: 74 RLIGVC--QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL--- 126
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL----QGNTKRIVGTYGYMSPE 687
+HRDL A NVLL KISDFGL++ G D+ + K + + +PE
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPE 183
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
FS +SDV+S+G+ M E LS
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 7e-43
Identities = 78/278 (28%), Positives = 129/278 (46%), Gaps = 26/278 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + E F E ++ KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 325
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+L E+ I + EYM SL FL + L V + IA G+ Y+
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
R +HRDL+A+N+L+ ++ K++DFGLAR+ +E + +PE AL G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 693 LFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750
F+IKSDV+SFGIL+ E T G+ N + + + ++ + + P
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMPCPPECP 490
Query: 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
+ + + ++ C + +RPT + + +
Sbjct: 491 ESL-------H-DLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 8e-43
Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 18/210 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRL---SSQSGQGLEEFKNEMMLIAK 565
++ + KLG+G FG V +G VAVK L + +++F E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
L HRNL++L G + K+ + E P SL L + +A+G+
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGM 134
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YG 682
YL R IHRDL A N+LL KI DFGL R ++ + +
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFA 189
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +PE FS SD + FG+ + E +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQ 567
E + +GEG FG V++G ++ + VA+K + S E+F E + + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQ 623
H ++VKL+G E I I+E L FL + L+ + ++
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKYSLDLASLILYAY------QLST 127
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTKRIVGTY 681
L YL R +HRD+ A NVL+ + K+ DFGL+R K +
Sbjct: 128 ALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI--- 181
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE F+ SDV+ FG+ M E L
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-42
Identities = 86/323 (26%), Positives = 142/323 (43%), Gaps = 62/323 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRL-SSQSGQGLEEFKNEMMLI 563
+ + LGEG FG V + +VAVK L S + + L + +EM ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
+ +H+N++ LLG C + G +I+EY +L +L + L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD 668
+ V+ +A+G+ YL + + IHRDL A NVL+ D KI+DFGLAR + D
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 669 --ELQGNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
+ N + + +M+PE D +++ +SDV+SFG+L+ E TL G GV
Sbjct: 246 YYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299
Query: 722 ADSFNLL--GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTM 779
+ F LL G+ + P +E+ Y + C + RPT
Sbjct: 300 EELFKLLKEGH-----------RMDKPSNCTNEL-------Y-MMMRDCWHAVPSQRPTF 340
Query: 780 SDVVSIINSERLELPSPKEPAFI 802
+V ++ + L S +E +
Sbjct: 341 KQLVEDLDRI-VALTSNQEMGYY 362
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 38/222 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL--------LNGQEVAVKRLSSQSGQGLEEFKNEMMLIA 564
E+ LG+G F ++KG L+ EV +K L E F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
KL H++LV G CV E IL+ E++ SLD +L K + ++ + + +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAA 125
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNP--------KISDFGLARMFGGDELQGNTKR 676
+ +L +IH ++ A N+LL + + K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 677 IVGTYGY-----MSPEYALDG-LFSIKSDVFSFGILMLETLS 712
+ PE + ++ +D +SFG + E S
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQ 567
E+ + LGEG FG VY+G N + VAVK + E+F +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQ 623
H ++VKL+G E+ I I+E P L +L L+ + I +
Sbjct: 72 HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNSLKVLTLVLYSL------QICK 124
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTK---RIV 678
+ YL +HRD+ N+L+ K+ DFGL+R ++ T+ +
Sbjct: 125 AMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-- 179
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+MSPE F+ SDV+ F + M E LS
Sbjct: 180 ----WMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-42
Identities = 85/339 (25%), Positives = 137/339 (40%), Gaps = 65/339 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQ 567
N S+ +G G FG V GRL + VA+K L + + +F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
H N+++L G + +++ EYM N SLD FL V ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY---- 683
L S +HRDL A N+L++ ++ K+SDFGL R+ D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----------EAAYTTR 208
Query: 684 --------MSPEYALDGLFSIKSDVFSFGILMLETLS-GKKN-TGVYNADSFNLL--GYA 731
SPE F+ SDV+S+GI++ E +S G++ + N D + GY
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY- 267
Query: 732 WDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSII----- 786
L P+ + Y + L C Q + +RP +VSI+
Sbjct: 268 ----------RLPPPMDCPAAL-------Y-QLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 787 NSERLELPSPKEPAFIKGINVKNSSHSNDGMSNLCSVND 825
N L++ + + SN ++ + D
Sbjct: 310 NPGSLKIITSAAA----RPSNLLLDQSNVDITTFRTTGD 344
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRL-SSQSGQGLEEFKNEMMLIAK 565
+ + LG G FG V + + VAVK L + +E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 566 L-QHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFL-------------FDPTKKRLLG 610
+ H N+V LLG C + G + +I+E+ +L +L + K L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 611 WQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDE 669
+ + +A+G+ +L + + IHRDL A N+LL KI DFGLAR ++ +
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 670 LQGNTK-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 204 YVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-42
Identities = 61/224 (27%), Positives = 93/224 (41%), Gaps = 28/224 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SSQSGQGLEEFKNEMMLIAK 565
S LG G FG V + + VAVK L S E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 566 L-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG---- 620
L H N+V LLG C G ++I EY L FL + + + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 621 -----------IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD 668
+A+G+ +L + IHRDL A N+LL KI DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +M+PE + +++ +SDV+S+GI + E S
Sbjct: 200 NYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-41
Identities = 67/225 (29%), Positives = 100/225 (44%), Gaps = 34/225 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SSQSGQGLEEFKNEMMLIAK 565
N LG G FG V + + VAVK L S+ E +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 566 L-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTKKRLLGWQA 613
L QH N+V LLG C G ++I EY L FL +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDE--L 670
+ +AQG+ +L + IHRD+ A NVLL KI DFGLAR + +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 671 QGNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+GN + + +M+PE D +++++SDV+S+GIL+ E S
Sbjct: 223 KGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 28/220 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
+F +G GGFG V+K + ++G+ +KR+ + E+ + E+ +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 572 VKLLGCCVEQGEKI----------------LILEYMPNKSLDVFLFDPTKKRLLGWQARV 615
V GC + +E+ +L+ ++ ++L A
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
+ I +G+ Y+H ++I+RDLK SN+ L KI DFGL D G
Sbjct: 127 LFEQ-ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
R GT YMSPE + + D+++ G+++ E L
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-40
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
+LG G FG V +G ++ VA+K L EE E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+L+G C + + ++E L FL K+ + ++ ++ G+ YL
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEY 688
+HR+L A NVLL KISDFGL++ G D+ + K + + +PE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 510
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
FS +SDV+S+G+ M E LS
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-39
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQ 567
E + +GEG FG V++G ++ + VA+K + S E+F E + + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
H ++VKL+G E I I+E L FL +K L + + ++ L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMS 685
L R +HRD+ A NVL+ + K+ DFGL+R K + +M+
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 560
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
PE F+ SDV+ FG+ M E L
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILM 587
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-39
Identities = 62/277 (22%), Positives = 117/277 (42%), Gaps = 33/277 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
E + K+GEG FG + +G++ +K +S S + EE + E+ ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
N+V+ E G ++++Y L + Q ++ I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ-ICLALKHVH 142
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+I+HRD+K+ N+ L D ++ DFG+AR+ +GT Y+SPE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 690 LDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749
+ ++ KSD+++ G ++ E + K + A S L I
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKH---AFEAGSMKNLVLK----------------II 238
Query: 750 QDEISLPVLVRY----INVALLCVQDNAADRPTMSDV 782
PV + Y ++ + N DRP+++ +
Sbjct: 239 SGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 68/242 (28%), Positives = 95/242 (39%), Gaps = 59/242 (24%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SSQSGQGLEEFKNEMMLIAK 565
EN LG G FG V + VAVK L E +E+ ++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 566 L-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL------------------------ 600
L H N+V LLG C G LI EY L +L
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 601 --FDPTKKRLL--GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656
T + LL +Q +A+G+ +L +HRDL A NVL+ KI
Sbjct: 165 DLNVLTFEDLLCFAYQ--------VAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKI 213
Query: 657 SDFGLAR-MFGGDELQGNTK-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 710
DFGLAR + + +M+PE +G+++IKSDV+S+GIL+ E
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEI 267
Query: 711 LS 712
S
Sbjct: 268 FS 269
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 27/221 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
+F LG GGFG V++ + ++ A+KR+ E+ E+ +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 571 LVKLLGCCVEQGEKI------------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTII 618
+V+ +E+ + ++ ++L ++ + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR-- 676
IA+ + +LH ++HRDLK SN+ MD K+ DFGL DE +
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 677 --------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
VGT YMSPE +S K D+FS G+++ E
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-39
Identities = 70/305 (22%), Positives = 127/305 (41%), Gaps = 31/305 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SSQSGQGLEEFKNEMMLIAKLQH 568
NF ++ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARV-TIIEGIAQGLLY 627
N++K +E E ++LE L + K++ L + V + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
+H R++HRD+K +NV + K+ D GL R F ++ +VGT YMSPE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747
+ ++ KSD++S G L+ E + + + D NL + + D P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLCKKIEQCD-----YPP- 257
Query: 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAFIKGINV 807
+ D S + + +C+ + RP ++ V ++ +
Sbjct: 258 LPSDHYSEEL----RQLVNMCINPDPEKRPDVTYV--------YDVAKRMHACTASSLEH 305
Query: 808 KNSSH 812
+ H
Sbjct: 306 HHHHH 310
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-39
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKLQHRN 570
+S+ ++G GG V++ Q A+K L Q L+ ++NE+ + KLQ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 571 L--VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
++L + +++E N L+ +L KK + W+ + + + + +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK--KKSIDPWERKSYWKN-MLEAVHTI 143
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE- 687
HQ+ I+H DLK +N L+ D K+ DFG+A D VGT YM PE
Sbjct: 144 HQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 688 ----------YALDGLFSIKSDVFSFGILMLETLSGK 714
S KSDV+S G ++ GK
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
++G G F VYKG EVA + + + FK E ++ LQH N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 577 CCVEQGEK----ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+ +L+ E M + +L +L + +++ + + I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148
Query: 633 RFRIIHRDLKASNVLLD-MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
IIHRDLK N+ + + KI D GLA + K ++GT +M+PE +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE 204
Query: 692 GLFSIKSDVFSFGILMLETLSGK 714
+ DV++FG+ MLE + +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 4e-38
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 23/210 (10%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKLQHRNL--VKLL 575
++G GG V++ Q A+K L Q L+ ++NE+ + KLQ + ++L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
+ +++E N L+ +L KK + W+ + + + + +HQ+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKN-MLEAVHTIHQH---G 175
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE-------- 687
I+H DLK +N L+ D K+ DFG+A D VG YM PE
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 688 ---YALDGLFSIKSDVFSFGILMLETLSGK 714
S KSDV+S G ++ GK
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKLQHRN 570
+S+ ++G GG V++ Q A+K L Q L+ ++NE+ + KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 571 L--VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
++L + +++E N L+ +L KK + W+ + + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKN-MLEAVHTI 124
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE- 687
HQ+ I+H DLK +N L+ D K+ DFG+A D VGT YM PE
Sbjct: 125 HQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 688 ----------YALDGLFSIKSDVFSFGILMLETLSGK 714
S KSDV+S G ++ GK
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 10/210 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
E++ + +G G +G K R +G+ + K S + + +E+ L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 570 NLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARV-TIIEGIAQGLL 626
N+V+ +++ L ++EY L + TK+R + V ++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 627 YLHQ--YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
H+ ++HRDLK +NV LD N K+ DFGLAR+ D T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
SPE ++ KSD++S G L+ E +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
LG+G +G VY GR L N +A+K + + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
E G + +E +P SL L Q + I +GL YLH +I+HR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 640 DLKASNVLLDMDM-NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE---YALDGLFS 695
D+K NVL++ KISDFG ++ G + T+ GT YM+PE G +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRG-YG 203
Query: 696 IKSDVFSFGILMLETLSGK 714
+D++S G ++E +GK
Sbjct: 204 KAADIWSLGCTIIEMATGK 222
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 37/231 (16%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
+F LG+G FG V K R L+ + A+K++ + L +E+ML+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 571 LVKLLGCCVEQGEKI-------------LILEYMPNKSLDVFLFD--PTKKRLLGWQARV 615
+V+ +E+ + + +EY N +L +D ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF---------- 665
+ I + L Y+H IIHRDLK N+ +D N KI DFGLA+
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 666 --GGDELQGNTKRIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLETLSG 713
N +GT Y++ E G ++ K D++S GI+ E +
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 67/317 (21%), Positives = 123/317 (38%), Gaps = 63/317 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
+++ KLGEGGF V L +G A+KR+ Q EE + E + H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 572 VKLLGCCVEQGEK----ILILEYMPNKSLDVFLFDPTKKRLLGWQARVT------IIEGI 621
++L+ C+ + L+L + +L + +RL +T ++ GI
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLGI 143
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-----MFGGDELQGNTKR 676
+GL +H HRDLK +N+LL + P + D G + G +
Sbjct: 144 CRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 677 I--VGTYGYMSPE------YALDGLFSIKSDVFSFGILMLETLSGKK--NTGVYNADSFN 726
T Y +PE + + ++DV+S G ++ + G+ + DS
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257
Query: 727 LLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRY----INVALLCVQDNAADRPTMSDV 782
L Q+++S+P R+ + + + RP + +
Sbjct: 258 L--------------------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297
Query: 783 VSIINSERLELPSPKEP 799
+S + E L+ P+P +
Sbjct: 298 LSQL--EALQPPAPGQH 312
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 54/207 (26%), Positives = 82/207 (39%), Gaps = 14/207 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKL-QH 568
++F +LG G +G V+K R +G+ AVK + + E+ K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
V+L E G L E SL L Q + + L +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA-WGASLPEAQVWGYLRD-TLLALAHL 173
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H ++H D+K +N+ L K+ DFGL G + G YM+PE
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPE- 226
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKK 715
L G + +DVFS G+ +LE +
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 56/204 (27%), Positives = 106/204 (51%), Gaps = 10/204 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
+ ++ K+G+G G VY + GQEVA+++++ Q E NE++++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+V L + E +++EY+ SL D + + + Q L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
++IHRD+K+ N+LL MD + K++DFG ++ + +T +VGT +M+PE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 691 DGLFSIKSDVFSFGILMLETLSGK 714
+ K D++S GI+ +E + G+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-36
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK---RLSSQSGQGLEEFKNEMMLIAKLQH 568
+ LG+GGF ++ + A K + E+ E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGL 625
+++V G E + + ++LE +SL + +K L +AR + I G
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGC 154
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
YLH+ R+IHRDLK N+ L+ D+ KI DFGLA D + + GT Y++
Sbjct: 155 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIA 209
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
PE S + DV+S G +M L GK
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVK---RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
LG+GGF ++ + A K + E+ E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 577 CCVEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
E + + ++LE +SL + +K L +AR + I G YLH+
Sbjct: 83 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN-- 134
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
R+IHRDLK N+ L+ D+ KI DFGLA D + + GT Y++PE
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 191
Query: 694 FSIKSDVFSFGILMLETLSGK 714
S + DV+S G +M L GK
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
K+GEG G V R +G++VAVK + + Q E NE++++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+V++ + E +++E++ +L D + L + T+ E + Q L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+IHRD+K+ ++LL +D K+SDFG D + + +VGT +M+PE
Sbjct: 160 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214
Query: 691 DGLFSIKSDVFSFGILMLE 709
L++ + D++S GI+++E
Sbjct: 215 RSLYATEVDIWSLGIMVIE 233
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-35
Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIA 564
+ Q ++G G FG V++ + G + AVK++ + + E++ A
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACA 105
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
L +V L G E + +E + SL + + L + + +G
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEG 162
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKR---IVGT 680
L YLH RI+H D+KA NVLL D + + DFG A D L + I GT
Sbjct: 163 LEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
+M+PE + K D++S +ML L+G
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 60/209 (28%), Positives = 111/209 (53%), Gaps = 13/209 (6%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
E + + +LG+G FG VYK + G A K + ++S + LE++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+VKLLG G+ +++E+ P ++D + + L Q +V + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE--- 687
RIIHRDLKA NVL+ ++ + +++DFG++ + ++ +GT +M+PE
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 688 --YALDGLFSIKSDVFSFGILMLETLSGK 714
D + K+D++S GI ++E +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG---LEEFKNEMMLIAKLQHRNLVKLL 575
KLG GG VY + +VA+K + + L+ F+ E+ ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
E L++EY+ +L ++ L + I G+ + H R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
I+HRD+K N+L+D + KI DFG+A+ L T ++GT Y SPE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATD 190
Query: 696 IKSDVFSFGILMLETLSGK 714
+D++S GI++ E L G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
++ +LG G +G V K R + +GQ +AVKR+ + +E K +M + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDISMRTVD 64
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT------IIEGI 621
V G +G+ + +E M + SLD F K+++ + I I
Sbjct: 65 CPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSI 118
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
+ L +LH S+ +IHRD+K SNVL++ K+ DFG++ D++ + G
Sbjct: 119 VKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AGCK 173
Query: 682 GYMSPE----YALDGLFSIKSDVFSFGILMLETLSGK 714
YM+PE +S+KSD++S GI M+E +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 11/205 (5%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHR 569
E F+ K+G+G FG V+KG + VA+K + + + +E+ + E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
+ K G ++ + +I+EY+ S D + L TI+ I +GL YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+ IHRD+KA+NVLL K++DFG+A +++ NT VGT +M+PE
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 191
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
+ K+D++S GI +E G+
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGE 216
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEE-FKNEMMLIAKLQH 568
E+F + LG+G F VY+ + G EVA+K + + G+ + +NE+ + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTK---KRLLGWQARVTIIEGIAQG 624
++++L E + L+LE N + K K +AR + I G
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEAR-HFMHQIITG 124
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
+LYLH I+HRDL SN+LL +MN KI+DFGLA + T + GT Y+
Sbjct: 125 MLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYI 179
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
SPE A ++SDV+S G + L G+
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-34
Identities = 57/238 (23%), Positives = 105/238 (44%), Gaps = 19/238 (7%)
Query: 483 EFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVA 541
+ E+ D + + + ++F +LG G G V+K +G +A
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62
Query: 542 VKRLSSQSGQGLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDV 598
K + + E+ ++ + +V G GE + +E+M SLD
Sbjct: 63 RKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 599 FL--FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656
L +++LG + + +GL YL + +I+HRD+K SN+L++ K+
Sbjct: 121 VLKKAGRIPEQILG-----KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKL 173
Query: 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
DFG++ + N+ VGT YMSPE +S++SD++S G+ ++E G+
Sbjct: 174 CDFGVSGQL--IDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 12/205 (5%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
E F + KLGEG +G VYK GQ VA+K++ + L+E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
+VK G + + +++EY S+ D + K L + TI++ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD--IIRLRNKTLTEDEIA-TILQSTLKGLEYLH 142
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
R IHRD+KA N+LL+ + + K++DFG+A + NT ++GT +M+PE
Sbjct: 143 F---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
+ ++ +D++S GI +E GK
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGK 222
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
+ + LG+G V++GR G A+K + + ++ E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 571 LVKLLGC--CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
+VKL K+LI+E+ P SL L +P+ L + ++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 629 HQYSRFRIIHRDLKASNVLL----DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
+ I+HR++K N++ D K++DFG AR DE + GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL 182
Query: 685 SPE--------YALDGLFSIKSDVFSFGILMLETLSGK 714
P+ + D++S G+ +G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 27/217 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
E+ ++G G +G V K +GQ +AVKR+ S + +E K +M ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSD 79
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT------IIEGI 621
+V+ G +G+ + +E M + S D F K + I
Sbjct: 80 CPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLAT 134
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
+ L +L +IIHRD+K SN+LLD N K+ DFG++ + G
Sbjct: 135 VKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCR 189
Query: 682 GYMSPE----YALDGLFSIKSDVFSFGILMLETLSGK 714
YM+PE A + ++SDV+S GI + E +G+
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 45/228 (19%), Positives = 84/228 (36%), Gaps = 34/228 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKL-Q 567
T F K+G G FG V+K L+G A+KR + E+ A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARV-TIIEGIAQGLL 626
H ++V+ E ++ EY SL + + + +A + ++ + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNP-------------------KISDFGLARMFGG 667
Y+H ++H D+K SN+ + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 668 DELQGNTKRIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLETLSGK 714
+ + G +++ E + K+D+F+ + ++ +
Sbjct: 185 ----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
+ + LG+G V++GR G A+K + + ++ E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 571 LVKLLGC--CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
+VKL K+LI+E+ P SL L +P+ L + ++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 629 HQYSRFRIIHRDLKASNVLL----DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
+ I+HR++K N++ D K++DFG AR DE + GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL 182
Query: 685 SPE--------YALDGLFSIKSDVFSFGILMLETLSGK 714
P+ + D++S G+ +G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 47/200 (23%), Positives = 83/200 (41%), Gaps = 13/200 (6%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG---LEEFKNEMMLIAKLQHRNLVKLL 575
+G GG G VY+ + + VA+K +S + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
G+ + + + L L ++ L V I+ I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL-QGNTKRIVGTYGYMSPEYALDGLF 694
HRD+K N+L+ D + DFG+A ++L Q VGT YM+PE +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--TVGTLYYMAPERFSESHA 212
Query: 695 SIKSDVFSFGILMLETLSGK 714
+ ++D+++ ++ E L+G
Sbjct: 213 TYRADIYALTCVLYECLTGS 232
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-32
Identities = 39/203 (19%), Positives = 76/203 (37%), Gaps = 24/203 (11%)
Query: 520 KLGEGGFGPVYKGR--LLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHRNLVKLLG 576
+ GG G +Y +NG+ V +K L + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 577 CCVEQGEKI-----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
+++EY+ +SL L + + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
+++ DLK N++L + K+ D G + GT G+ +PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRT 251
Query: 692 GLFSIKSDVFSFGILMLETLSGK 714
G ++ +D+++ G +
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDL 273
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 73/295 (24%), Positives = 121/295 (41%), Gaps = 33/295 (11%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG---LEEFKNEMMLIAKLQHRNLVKLL 575
LG GG V+ R L + ++VAVK L + + F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 576 --GCCVEQGEKI--LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
G + +++EY+ +L + + + + + +I Q L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG-NTKRIVGTYGYMSPEYAL 690
+ IIHRD+K +N+++ K+ DFG+AR T ++GT Y+SPE A
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 691 DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750
+SDV+S G ++ E L+G+ + DS + Y E P +
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQ-------HVREDPIPPSAR 242
Query: 751 DEISLPVLVRYINVALLCVQDNAADRPT-----MSDVVSIINSERLELPSPKEPA 800
E L + V L + N +R +D+V + N E E P A
Sbjct: 243 HE-GLSADLD--AVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDA 294
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 59/243 (24%), Positives = 101/243 (41%), Gaps = 30/243 (12%)
Query: 485 GEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVK 543
G GK G + A + ++G G G V+K R G +AVK
Sbjct: 1 GSSGSSGKQTGYLT----IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56
Query: 544 RLSSQSGQGLEEFKNEMM----LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVF 599
++ + EE K +M ++ +V+ G + + + +E M +
Sbjct: 57 QMRRSGNK--EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKL 113
Query: 600 ---LFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656
+ P +R+LG + I + L YL + +IHRD+K SN+LLD K+
Sbjct: 114 KKRMQGPIPERILG-----KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKL 166
Query: 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLETL 711
DFG++ D+ + G YM+PE + I++DV+S GI ++E
Sbjct: 167 CDFGISGRL-VDDKAKDR--SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223
Query: 712 SGK 714
+G+
Sbjct: 224 TGQ 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQ 567
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
H N ++ GC + + L++EY + D L + KK L + + G QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AVTHGALQGLAY 169
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL-ARMFGGDELQGNTKR--IVGTYGYM 684
LH + +IHRD+KA N+LL K+ DFG + M VGT +M
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM---------APANSFVGTPYWM 217
Query: 685 SPE---YALDGLFSIKSDVFSFGILMLETLSGK 714
+PE +G + K DV+S GI +E K
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 14/213 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
+++ +Q +G G V ++VA+KR++ + ++E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSL-----DVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
+V V + E L+++ + S+ + K +L TI+ + +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL-ARMFGGDELQGNTKR--IVGTYG 682
YLH + IHRD+KA N+LL D + +I+DFG+ A + G ++ N R VGT
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 683 YMSPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
+M+PE + K+D++SFGI +E +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS----SQSGQGLEEFKNEMMLIAKLQ 567
E+F + LG+G FG VY R + +A+K L ++G + + E+ + + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
H N+++L G + LILEY P ++ + + + T I +A L Y
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTV--YRELQKLSKFDEQRTA-TYITELANALSY 124
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLPPE 177
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
+ K D++S G+L E L GK
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 50/212 (23%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEM-MLIAKLQHRNLV 572
+F + LG G G + + + ++VAVKR+ + E+ +L +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 573 KLLGCCVEQGEKI--LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+ C E+ + + +E +L ++ LG + T+++ GL +LH
Sbjct: 82 RYF--CTEKDRQFQYIAIELCA-ATLQEYVEQK-DFAHLGLEPI-TLLQQTTSGLAHLHS 136
Query: 631 YSRFRIIHRDLKASNVLLDM-----DMNPKISDFGLARMFGGDEL-QGNTKRIVGTYGYM 684
I+HRDLK N+L+ M + ISDFGL + + GT G++
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 685 SPEY---ALDGLFSIKSDVFSFGILMLETLSG 713
+PE + D+FS G + +S
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (324), Expect = 5e-31
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHRNL 571
+ M+ +LG GGFG V + G++VA+K+ + E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 572 VKLLGCCVEQGEKI-------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
V + +K+ L +EY L +L L T++ I+
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
L YLH+ RIIHRDLK N++L + KI D G A+ EL VGT
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTL 187
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
Y++PE +++ D +SFG L E ++G
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 6e-31
Identities = 48/224 (21%), Positives = 87/224 (38%), Gaps = 18/224 (8%)
Query: 504 SLASVAAATENFSMQCKLGEG--GFGPVYKGR-LLNGQEVAVKR--LSSQSGQGLEEFKN 558
++S + + +G+G V R G+ V V+R L + S + + +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARVTI 617
E+ + H N+V + E ++ +M S D L + A I
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYI 133
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT--- 674
++G+ + L Y+H +HR +KAS++L+ +D +S +
Sbjct: 134 LQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 675 --KRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSGK 714
K V ++SPE L + KSD++S GI E +G
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHR 569
F + +G G +G VYKGR + GQ A+K + +G EE K E+ ++ K HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 570 NLVKLLGCCVEQGEKI------LILEYMPNKSL-DVFLFDPTKKRLLGWQARVTIIEGIA 622
N+ G +++ L++E+ S+ D L TK L + I I
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLKEEWIAYICREIL 139
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
+GL +LHQ ++IHRD+K NVLL + K+ DFG++ + NT +GT
Sbjct: 140 RGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 194
Query: 683 YMSPE-----YALDGLFSIKSDVFSFGILMLETLSGK 714
+M+PE D + KSD++S GI +E G
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 50/230 (21%), Positives = 90/230 (39%), Gaps = 39/230 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-----------------SQSGQGLEE 555
++ + L +G F + + + A+K+ ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 556 FKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLL 609
FKNE+ +I +++ + G E +I EYM N S+ L +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
+ II+ + Y+H + I HRD+K SN+L+D + K+SDFG + +
Sbjct: 150 IQVIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 670 LQGNTKRIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLETLSGK 714
++G GTY +M PE + +G K D++S GI +
Sbjct: 207 IKG----SRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYNV 249
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 4e-30
Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 25/218 (11%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGC 577
L EGGF VY+ + + +G+E A+KRL S + E+ + KL H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 578 CVEQGEK-------ILILEYMPNKSL-DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
E+ L+L + L + ++ L I + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL-KIFYQTCRAVQHMH 153
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI----------VG 679
+ IIHRDLK N+LL K+ DFG A + +
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 680 TYGYMSPE-YALDGLFSI--KSDVFSFGILMLETLSGK 714
T Y +PE L F I K D+++ G ++ +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 67/301 (22%), Positives = 105/301 (34%), Gaps = 67/301 (22%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEM-MLIAKLQHRNLVKLLGCC 578
LG G G V G+ VAVKR+ + E+ +L H N+++ C
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY--C 76
Query: 579 VEQGEK--ILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
E ++ + LE N +L + D K + +++ IA G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLHSL 134
Query: 632 SRFRIIHRDLKASNVLLDM-------------DMNPKISDFGLARMFGGDE--LQGNTKR 676
+IIHRDLK N+L+ ++ ISDFGL + + + N
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 677 IVGTYGYMSPEYALDGLFSI-------KSDVFSFGILMLETLS------GKKNTGVYN-- 721
GT G+ +PE + D+FS G + LS G K + N
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 722 ADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSD 781
F+L E D L+ ++ + RPT
Sbjct: 252 RGIFSLDEMKCLHD-RSLIAEATD------------LIS----QMIDH--DPLKRPTAMK 292
Query: 782 V 782
V
Sbjct: 293 V 293
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 35/223 (15%), Positives = 66/223 (29%), Gaps = 24/223 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR------LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAK 565
++ + LGEG F VY+ N Q+ +K + M +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLD---VFLFDPTKKRLLGWQARVTIIEGIA 622
+K + Q +L+ E +L + +K + + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR-ML 182
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLL-----------DMDMNPKISDFGLARMFGGDELQ 671
+ +H IIH D+K N +L D+ + D G +
Sbjct: 183 YMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
T G+ E + ++ + D F + L G
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 39/303 (12%), Positives = 81/303 (26%), Gaps = 66/303 (21%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH-------- 568
LG+ + G+ V +++ K E++ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 569 --------RNLVKLLGCC-----VEQGEKILILEY---MPNKSLDVFLF------DPTKK 606
+LVK + +L P ++ F +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 607 RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666
+ L AR+ + + + L LH Y ++H L+ +++LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 667 GDELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYN 721
G R + L + D ++ G+ +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD------- 314
Query: 722 ADSFNLLGYAWDL-WKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMS 780
L DD + + + ++P VR + L DR
Sbjct: 315 ------------LPNTDDAALGGSEWIF-RSCKNIPQPVRALLEGFLRY--PKEDRLLPL 359
Query: 781 DVV 783
+
Sbjct: 360 QAM 362
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 25/249 (10%), Positives = 56/249 (22%), Gaps = 43/249 (17%)
Query: 501 PLFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SSQSGQGLEEF 556
+ ++ + L G V+ R + ++ A+K + S LE
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 557 KNEMMLIAKLQHRNLVKLLGCC--------------------------VEQGEKILILEY 590
A+L + + +L++
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 591 MP---NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVL 647
F + G A + + + L ++H N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLF 226
Query: 648 LDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGI 705
+ D + D G Y E+ F+ + + G+
Sbjct: 227 IMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 706 LMLETLSGK 714
+
Sbjct: 282 SIYRVWCLF 290
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS----SQSGQGLEEFKNEMMLIAKLQ 567
++F + LG+G FG VY R N +A+K L + G + + E+ + + L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLR 72
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK--RLLGWQARVTIIEGIAQGL 625
H N++++ ++ L+LE+ P L + +K R ++ T +E +A L
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSA-TFMEELADAL 127
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
Y H ++IHRD+K N+L+ KI+DFG + T + GT Y+
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RT--MCGTLDYLP 180
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
PE K D++ G+L E L G
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 33/216 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKN--------EMMLIA 564
E + K+GEG +G VYK + G+ VA+KR+ L+ E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPN---KSLDVF--LFDPTKKRLLGWQARVTIIE 619
+L H N+V L+ + L+ E+M K LD ++ ++ +Q
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ------- 127
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
+ +G+ + HQ+ RI+HRDLK N+L++ D K++DFGLAR F G ++ T +V
Sbjct: 128 -LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV- 181
Query: 680 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
T Y +P+ + +S D++S G + E ++GK
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-29
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQH 568
+E + KLG G +G V R + E A+K + +S S + E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLL 626
N++KL ++ L++E LFD + + A II+ + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAA-VIIKQVLSGVT 150
Query: 627 YLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
YLH+++ I+HRDLK N+LL + D KI DFGL+ +F + K +GT Y
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYY 204
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
++PE L + K DV+S G+++ L+G
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQH 568
E +++ C LG+G FG V K + + QE AVK + +S + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLL 626
N++KL + ++ E LFD +KR A II+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 627 YLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
Y+H++ I+HRDLK N+LL + D + KI DFGL+ F + K +GT Y
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYY 189
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
++PE L G + K DV+S G+++ LSG
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQ 567
++ + Q LG+G FG V + + GQE AVK +S + E E+ L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGL 625
H N++KL ++G L+ E LFD ++KR A II + G+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAA-RIIRQVLSGI 139
Query: 626 LYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
Y+H+ I+HRDLK N+LL D N +I DFGL+ F + K +GT
Sbjct: 140 TYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAY 193
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
Y++PE L G + K DV+S G+++ LSG
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 34/218 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN--------EMMLI 563
+ + K+GEG +G V+K + + VA+KR+ L++ E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPN---KSLDV--FLFDPTKKRLLGWQARVTII 618
+L+H+N+V+L + L+ E+ K D DP + +Q
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ------ 109
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ +GL + H ++HRDLK N+L++ + K+++FGLAR F G ++ + +V
Sbjct: 110 --LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163
Query: 679 GTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGKK 715
T Y P+ L+S D++S G + E + +
Sbjct: 164 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKN--------EMMLIA 564
E + K+GEG +G VYK + G+ A+K++ LE+ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPN---KSLDV--FLFDPTKKRLLGWQARVTIIE 619
+L+H N+VKL + +L+ E++ K LDV + + Q
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ------- 108
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
+ G+ Y H R++HRDLK N+L++ + KI+DFGLAR F G ++ T IV
Sbjct: 109 -LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV- 162
Query: 680 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
T Y +P+ + +S D++S G + E ++G
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 68/210 (32%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQH 568
E +++ C LG+G FG V K + + QE AVK + +S + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLL 626
N++KL + ++ E LFD +KR A II+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 627 YLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
Y+H+++ I+HRDLK N+LL + D + KI DFGL+ F + K +GT Y
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYY 189
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
++PE L G + K DV+S G+++ LSG
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS----SQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
LGEG +G V + AVK L + G K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 576 G-CCVEQGEKI-LILEYMPNKSLDVFLFD-PTKKRLLGWQARVT---IIEGIAQGLLYLH 629
E+ +K+ +++EY + + D +KR QA +I+G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
I+H+D+K N+LL KIS G+A + G+ + PE A
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 690 L-----DGLFSIKSDVFSFGILMLETLSGK 714
G K D++S G+ + +G
Sbjct: 184 NGLDTFSGF---KVDIWSAGVTLYNITTGL 210
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 39/310 (12%), Positives = 83/310 (26%), Gaps = 77/310 (24%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSS---QSGQGLEEFKNEMMLIAKLQ--------- 567
LG+ + G+ V +++ K E++ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 568 ----------------HRNLVKLLGCC-VEQGEKILILEYMPNKSLDVF---LFD-PTKK 606
+ ++++ L +L F L +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 607 RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666
+ L AR+ + + + L LH Y ++H L+ +++LD ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 667 GDELQGNTKRIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSGKK 715
G + G+ PE L + D ++ G+++
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD- 310
Query: 716 NTGVYNADSFNLLGYAWDL-WKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAA 774
L D + I + ++P VR + L
Sbjct: 311 ------------------LPITKDAALGGSEW-IFRSCKNIPQPVRALLEGFLRY--PKE 349
Query: 775 DRPTMSDVVS 784
DR +
Sbjct: 350 DRLLPLQAME 359
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 23/213 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHR 569
+ F + KLG G FG V+ +G E +K ++ +S +E+ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGW----QARVTIIEGIAQ 623
N++K+ + +++E L + + + +++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVA-ELMKQMMN 135
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
L Y H ++H+DLK N+L KI DFGLA +F DE GT
Sbjct: 136 ALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
YM+PE + K D++S G++M L+G
Sbjct: 190 ALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
+ ++++ +G G +G V A K++ + ++ FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYL 628
+++L + + L++E LF+ K+ A I++ + + Y
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122
Query: 629 HQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
H+ + HRDLK N L D K+ DFGLA F ++ + VGT Y+S
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVS 176
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSG 713
P+ L+GL+ + D +S G++M L G
Sbjct: 177 PQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN--------EMMLI 563
+ + KLGEG +G VYK + + VA+KR+ LE + E+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTII 618
+LQHRN+++L LI EY L ++ + +Q
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQ------ 140
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFGGDELQGN 673
+ G+ + H R +HRDLK N+LL + KI DFGLAR F G ++
Sbjct: 141 --LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 674 TKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
T I+ T Y PE L +S D++S + E L
Sbjct: 195 THEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG-----LEEFKNEMMLI 563
+++ F KLG G + VYKG G VA+K + S +G + E L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPN---KSLDVFLFDPTKKRLLGWQARVTIIEG 620
+L+H N+V+L + + L+ E+M N K +D T + L + +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ- 116
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ QGL + H+ +I+HRDLK N+L++ K+ DFGLAR F G + + +V T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-T 171
Query: 681 YGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
Y +P+ + +S D++S G ++ E ++GK
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-27
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-------------SQSGQGLEEFK 557
E++ KLG G +G V + E A+K + + EE
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 558 NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARV 615
NE+ L+ L H N++KL ++ L+ E+ L F+ + + A
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA- 149
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQG 672
I++ I G+ YLH+++ I+HRD+K N+LL + +N KI DFGL+ F D
Sbjct: 150 NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
+ +GT Y++PE L ++ K DV+S G++M L G
Sbjct: 206 --RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 45/224 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKN--------EMM 561
+ + LGEG F VYK R Q VA+K +L + E K+ E+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHR-----SEAKDGINRTALREIK 64
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPN------KSLDVFLFDPTKKRLLGWQARV 615
L+ +L H N++ LL + L+ ++M K + L K +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM-LM--- 120
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
QGL YLHQ+ I+HRDLK +N+LLD + K++DFGLA+ F G + T
Sbjct: 121 -----TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTH 171
Query: 676 RIVGTYGYMSPEYALDGLFSIKS-----DVFSFGILMLETLSGK 714
++V T Y +PE LF + D+++ G ++ E L
Sbjct: 172 QVV-TRWYRAPEL----LFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKN----EMMLIAK 565
E + +GEG +G V K R G+ VA+K S + K E+ L+ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPN---KSLDVF--LFDPTKKRLLGWQARVTIIEG 620
L+H NLV LL C ++ L+ E++ + L++F D + +Q
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ-------- 132
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I G+ + H + IIHRD+K N+L+ K+ DFG AR + + T
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-T 187
Query: 681 YGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
Y +PE + D + DV++ G L+ E G+
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-26
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG-----LEEFKNEMMLIAKL 566
E + KLGEG + VYKG+ L VA+K + + +G + E L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPN---KSLDV--FLFDPTKKRLLGWQARVTIIEGI 621
+H N+V L + L+ EY+ + LD + + +L +Q +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------L 109
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
+GL Y H+ +++HRDLK N+L++ K++DFGLAR + +V T
Sbjct: 110 LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TL 164
Query: 682 GYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
Y P+ L +S + D++ G + E +G+
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 29/206 (14%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
LGEG +G V + + VAVK + ++ E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 579 VEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVT---IIEGIAQGLLYLHQYSR 633
E + L LEY L FD + A+ ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE------ 687
I HRD+K N+LLD N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 688 YALDGLFSIKSDVFSFGILMLETLSG 713
+ DV+S GI++ L+G
Sbjct: 184 F--HAE---PVDVWSCGIVLTAMLAG 204
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 34/217 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN--------EMMLI 563
E + K+GEG +G V+K R GQ VA+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPN---KSLDVF--LFDPTKKRLLGWQARVTII 618
+L+H NLV LL + L+ EY + LD + + + WQ
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ------ 110
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
Q + + H++ IHRD+K N+L+ K+ DFG AR+ +
Sbjct: 111 --TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA 164
Query: 679 GTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
T Y SPE + D + DV++ G + E LSG
Sbjct: 165 -TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
+ + + +LG G FG V++ G+ K +++ KNE+ ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYL 628
L+ L ++ E +LILE++ LFD + + + + +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
H++ I+H D+K N++ + KI DFGLA DE K T + +P
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
E +D+++ G+L LSG
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 54/217 (24%), Positives = 86/217 (39%), Gaps = 25/217 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSSQSGQGLEEFKNEMMLIAK 565
+ + + +G+G F V + GQ+ AVK + +S G E+ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGW----QARVTIIE 619
L+H ++V+LL G ++ E+M L + A +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVAS-HYMR 137
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKR 676
I + L Y H IIHRD+K VLL + K+ FG+A G
Sbjct: 138 QILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGG 192
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
VGT +M+PE + DV+ G+++ LSG
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
S LG G FG V+K G ++A K + ++ + EE KNE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+L + + +L++EY+ LFD + L + ++ I +G+ ++HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 631 YSRFRIIHRDLKASNVLL-DMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
I+H DLK N+L + D KI DFGLAR + E K GT +++PE
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEV 259
Query: 689 ALDGLFSIKSDVFSFGIL--MLETLSG 713
S +D++S G++ ML LSG
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYML--LSG 284
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 29/206 (14%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
LGEG +G V + + VAVK + ++ E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 579 VEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVT---IIEGIAQGLLYLHQYSR 633
E + L LEY L FD + A+ ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE------ 687
I HRD+K N+LLD N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 688 YALDGLFSIKSDVFSFGILMLETLSG 713
+ DV+S GI++ L+G
Sbjct: 184 F--HAE---PVDVWSCGIVLTAMLAG 204
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 58/263 (22%), Positives = 86/263 (32%), Gaps = 66/263 (25%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
+F +G GGFG V++ + ++ A+KR+ E+ E+ +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI------------- 617
+V+ +E + E D P V I
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 618 --IEGIAQGLLY----------LHQYSRFRI-----------------------IH---- 638
+ LY L + R +H
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 639 --RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK----------RIVGTYGYMSP 686
RDLK SN+ MD K+ DFGL DE + VGT YMSP
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 687 EYALDGLFSIKSDVFSFGILMLE 709
E +S K D+FS G+++ E
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFE 268
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 46/229 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN--------EMMLI 563
+ K+G+G FG V+K R GQ+VA+K++ +E K E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 564 AKLQHRNLVKLLGCCVEQGEKI--------LILEYMPN------KSLDVFLFDPTKKRLL 609
L+H N+V L+ C + L+ ++ + ++ V KR++
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG--- 666
+ GL Y+H+ +I+HRD+KA+NVL+ D K++DFGLAR F
Sbjct: 131 -QM--------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 667 GDELQGNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
+ T R+V T Y PE L + + D++ G +M E +
Sbjct: 179 NSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 67/353 (18%), Positives = 117/353 (33%), Gaps = 41/353 (11%)
Query: 383 SNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGKRKLLWILVILVLPLVLLP 442
N+ + + L W LD T ++ R + W
Sbjct: 19 ENILDEAVILSWKPPALDGGSLV---TNYTIEKREAMGGS------WSPCAKSRYTYTTI 69
Query: 443 SF------YIFCRRRRNCKEKETENMETDQDLLAFDINMGITTRTNEFGEVNGDGK---- 492
Y F N + T L+ D + GK
Sbjct: 70 EGLRAGKQYEFRIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVS 129
Query: 493 ---DKGKDSWLPLFSLASVAAATENFS----MQCKLGEGGFGPVYKGR-LLNGQEVAVKR 544
D + V ++ + +LG G FG V++ G A K
Sbjct: 130 SNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF 189
Query: 545 LSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD-- 602
+ + E + E+ ++ L+H LV L + E ++I E+M LF+
Sbjct: 190 VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE----LFEKV 245
Query: 603 PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP--KISDFG 660
+ + V + + +GL ++H+ + +H DLK N++ + K+ DFG
Sbjct: 246 ADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFG 302
Query: 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
L + + K GT + +PE A +D++S G+L LSG
Sbjct: 303 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 48/198 (24%)
Query: 519 CKLGEGGFGPVYKGR---LLNGQEVAVKRLS----SQSGQGLEEFKNEMMLIAKLQHRNL 571
CK+G G +G VYK + + ++ A+K++ S S E+ L+ +L+H N+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNV 80
Query: 572 VKLLGCCVEQGEKI--LILEYM--------------PNKSLDVFLFDPTKKRLLGWQARV 615
+ L + ++ L+ +Y V L K LL +Q
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL-YQ--- 136
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP----KISDFGLARMFG--GDE 669
I G+ YLH ++HRDLK +N+L+ + KI+D G AR+F
Sbjct: 137 -----ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 670 LQGNTKRIVGTYGYMSPE 687
L +V T+ Y +PE
Sbjct: 189 LADLDPVVV-TFWYRAPE 205
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 49/256 (19%), Positives = 86/256 (33%), Gaps = 60/256 (23%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSSQSGQGLEEFKNEMMLIAK 565
+ + ++ +G+G +G V A+K ++ + + +E K E+ L+ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT--------- 616
L H N+ +L ++ L++E L D + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHL----LDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 617 --------------------------------IIEGIAQGLLYLHQYSRFRIIHRDLKAS 644
I+ I L YLH I HRD+K
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPE 197
Query: 645 NVLL--DMDMNPKISDFGLARMFGGDELQGNT--KRIVGTYGYMSPE--YALDGLFSIKS 698
N L + K+ DFGL++ F GT +++PE + + K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 699 DVFSFGILMLETLSGK 714
D +S G+L+ L G
Sbjct: 258 DAWSAGVLLHLLLMGA 273
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRN 570
++ +G G FG V++ +L+ EVA+K++ + FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 571 LVKLLGCCVEQGEKI------LILEYMP---NKSLDVFL-----FDPTKKRLLGWQARVT 616
+V L G+K L+LEY+P ++ + +L +Q
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ---- 149
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTK 675
+ + L Y+H I HRD+K N+LLD K+ DFG A++ + N
Sbjct: 150 ----LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200
Query: 676 RIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGK 714
I Y Y +PE ++ D++S G +M E + G+
Sbjct: 201 YICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 35/209 (16%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
+G+G F V R +L G+EVA+K + + + L++ E+ ++ L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 578 CVEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARVT---IIEGIAQGLLYLHQY 631
+E + + LI+EY + FD R+ +AR I+ + Y H
Sbjct: 83 -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH-- 131
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE---- 687
+ RI+HRDLKA N+LLD DMN KI+DFG + F G Y +PE
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQG 187
Query: 688 --YALDGLFSIKSDVFSFGILMLETLSGK 714
Y DG + DV+S G+++ +SG
Sbjct: 188 KKY--DGP---EVDVWSLGVILYTLVSGS 211
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSSQS---GQGLEEFKNEMMLIA 564
+S LG G FG V+ +EV VK ++ L + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
+++H N++K+L QG L++E + LD+F F RL A I +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLAS-YIFRQLVSA 142
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
+ YL IIHRD+K N+++ D K+ DFG A +L GT Y
Sbjct: 143 VGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYC 196
Query: 685 SPE------YALDGLFSIKSDVFSFGILM 707
+PE Y G + +++S G+ +
Sbjct: 197 APEVLMGNPY--RGP---ELEMWSLGVTL 220
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
+ F LG G F V+ + L G+ A+K + +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYL 628
+V L L+++ + L FD + A +I+ + + YL
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDAS-LVIQQVLSAVKYL 122
Query: 629 HQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
H+ I+HRDLK N+L + + I+DFGL++M + GT GY++
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYVA 175
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSG 713
PE +S D +S G++ L G
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 32/237 (13%)
Query: 496 KDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--------RLS 546
+D+ LP S EN+ + LG G V + +E AVK S
Sbjct: 2 RDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59
Query: 547 SQSGQGLEE-FKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD-- 602
++ Q L E E+ ++ K+ H N+++L L+ + M L FD
Sbjct: 60 AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYL 115
Query: 603 PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662
K L + R I+ + + + LH+ I+HRDLK N+LLD DMN K++DFG +
Sbjct: 116 TEKVTLSEKETR-KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 663 RMFGGDELQGNTKRIVGTYGYMSPE------YALDGLFSIKSDVFSFGILMLETLSG 713
E + + GT Y++PE + + D++S G++M L+G
Sbjct: 172 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 55/224 (24%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS-----------------SQSGQGLEEFKNEMML 562
+G+G +G V + A+K LS + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 563 ------IA---KLQHRNLVKLLGCCVEQGEK---ILILEYMPNKSLDVFLFD-PTKKRLL 609
IA KL H N+VKL+ ++ + ++ E + + + PT K L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 610 GWQARVT---IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF- 665
QAR +I+GI YLH +IIHRD+K SN+L+ D + KI+DFG++ F
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSI----KSDVFSFGI 705
G D L VGT +M+PE +L I DV++ G+
Sbjct: 189 GSDAL---LSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGV 228
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 47/209 (22%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
E + + LG G FG V++ + + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYL 628
++ L E ++I E++ +F+ T L + V+ + + + L +L
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
H ++ I H D++ N++ + KI +FG AR + + + Y +P
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAP 172
Query: 687 EYALDGLFSIKSDVFSFGIL--MLETLSG 713
E + S +D++S G L +L LSG
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVL--LSG 199
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQH 568
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLL 626
N+V+L E+ L+ + + LF+ ++ A I+ I + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS-HCIQQILESIA 119
Query: 627 YLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
Y H I+HR+LK N+LL K++DFGLA E GT GY
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 173
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
+SPE +S D+++ G+++ L G
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS--------SQSGQGLEEFKNEMML 562
+ + M LG G G V ++VA++ +S ++ + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEG 620
+ KL H ++K+ + + ++LE M L FD KRL +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 247
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRI 677
+ + YLH+ IIHRDLK NVLL + D KI+DFG +++ G L + +
Sbjct: 248 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301
Query: 678 VGTYGYMSPE---YALDGLFSIKSDVFSFGILMLETLSG 713
GT Y++PE ++ D +S G+++ LSG
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 37/221 (16%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHR 569
+++ +G G FG VY+ +L +G+ VA+K++ + FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 570 NLVKLLGCCVEQGEKI------LILEYMP---NKSLDVFL-----FDPTKKRLLGWQARV 615
N+V+L GEK L+L+Y+P + + +L +Q
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--- 164
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNT 674
+ + L Y+H F I HRD+K N+LLD D K+ DFG A+ E N
Sbjct: 165 -----LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NV 214
Query: 675 KRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGK 714
I Y Y +PE ++ DV+S G ++ E L G+
Sbjct: 215 SYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK------RLSSQSGQGLEEFKNEMMLIA 564
+ + + +LG G F V K R G E A K +S+ G EE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQ 623
++ H N++ L + + +LILE + LFD +K L + + I+ I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNP----KISDFGLARMFGGDELQGNTKRIVG 679
G+ YLH I H DLK N++L P K+ DFGLA K I G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
T +++PE +++D++S G++ LSG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 26/216 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK------RLSSQSGQGLEEFKNEMMLIA 564
+ + + +LG G F V K R G E A K +S+ G EE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQ 623
++ H N++ L + + +LILE + LFD +K L + + I+ I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNP----KISDFGLARMFGGDELQGNTKRIVG 679
G+ YLH I H DLK N++L P K+ DFGLA K I G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGIL--MLETLSG 713
T +++PE +++D++S G++ +L LSG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYIL--LSG 214
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKN----EMMLI 563
AT + ++G G +G VYK R +G VA+K R+ + G G E+ L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVALL 65
Query: 564 AKLQ---HRNLVKLLGCCVEQGEKI-----LILEYMPN------KSLDVFLFDPTKKRLL 609
+L+ H N+V+L+ C L+ E++ + L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
Q +GL +LH I+HRDLK N+L+ K++DFGLAR++
Sbjct: 126 MRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ- 173
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
T +V T Y +PE L ++ D++S G + E K
Sbjct: 174 -MALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 14/208 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQH 568
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 569 RNLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
VKL Q ++ L L Y N L + R E I L
Sbjct: 90 PFFVKLYFTF--QDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTAE-IVSALE 144
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
YLH IIHRDLK N+LL+ DM+ +I+DFG A++ + Q VGT Y+SP
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
E + SD+++ G ++ + ++G
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK------RLSSQSGQGLEEFKNEMMLIA 564
+++ M +LG G F V K R G+E A K SS+ G EE + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIA 622
+++H N++ L + + +LILE + L FD K+ L +A ++ I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEAT-QFLKQIL 118
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLL----DMDMNPKISDFGLARMFGGDELQGNTKRIV 678
G+ YLH RI H DLK N++L + K+ DFG+A K I
Sbjct: 119 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIF 172
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGIL--MLETLSG 713
GT +++PE +++D++S G++ +L LSG
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYIL--LSG 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 51/190 (26%), Positives = 83/190 (43%), Gaps = 26/190 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS--------SQSGQGLEEFKNEMML 562
+ + M LG G G V ++VA+K +S ++ + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEG 620
+ KL H ++K+ + + ++LE M L FD KRL +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 122
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRI 677
+ + YLH+ IIHRDLK NVLL + D KI+DFG +++ G L + +
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 176
Query: 678 VGTYGYMSPE 687
GT Y++PE
Sbjct: 177 CGTPTYLAPE 186
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-------RLSSQSGQGLEE-FKNEMML 562
+ + + +G G V + G E AVK RLS + + + E + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 563 IAKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIE 619
+ ++ H +++ L+ L+ + M L FD K L + R +I+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMR 207
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
+ + + +LH I+HRDLK N+LLD +M ++SDFG + E + + G
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCG 261
Query: 680 TYGYMSPE------YALDGLFSIKSDVFSFGILMLETLSG 713
T GY++PE + + D+++ G+++ L+G
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL------SSQSGQGLEEFKNEMMLIA 564
+ + +LG G F V K R G + A K + SS+ G E+ + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQ 623
++QH N++ L + + ILILE + L FD +K L + ++ I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILN 125
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLL----DMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
G+ YLH I H DLK N++L KI DFGLA K I G
Sbjct: 126 GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFG 179
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGIL--MLETLSG 713
T +++PE +++D++S G++ +L LSG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYIL--LSG 213
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 26/215 (12%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL------SSQSGQGLEEFKNEMMLIAKL 566
+ + LG GGFG VY G + + VA+K + E++L+ K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 567 QHR--NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
+++LL +LILE P D+F F + L AR + + +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 161
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
+ + H ++HRD+K N+L+D++ K+ DFG + GT Y
Sbjct: 162 VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVY 214
Query: 684 MSPEYAL----DGLFSIKSDVFSFGILMLETLSGK 714
PE+ G + V+S GIL+ + + G
Sbjct: 215 SPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGD 246
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 46/227 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR--LLNGQEVAVKRLSSQSGQGLEEFKN--------EMML 562
+ + ++GEG +G V+K R G+ VA+KR+ ++ + E+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 563 IAKLQ---HRNLVKLLGCCV----EQGEKI-LILEYMPN--KSL-----DVFLFDPTKKR 607
+ L+ H N+V+L C ++ K+ L+ E++ + + + T K
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 608 LLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667
++ +Q + +GL +LH + R++HRDLK N+L+ K++DFGLAR++
Sbjct: 125 MM-FQ--------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172
Query: 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
T +V T Y +PE L ++ D++S G + E K
Sbjct: 173 Q--MALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQH 568
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLL 626
N+V+L E+ L+ + + LF+ ++ A I+ I + +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS-HCIQQILESIA 142
Query: 627 YLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
Y H I+HR+LK N+LL K++DFGLA E GT GY
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 196
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
+SPE +S D+++ G+++ L G
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 36/210 (17%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVK---RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
LG G FG V G L G +VAVK R +S + + K E+ + +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 577 CCVEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARVT---IIEGIAQGLLYLHQ 630
+ +++EY+ L FD R+ +AR I+ + Y H
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCH- 128
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE--- 687
R ++HRDLK NVLLD MN KI+DFGL+ M E + G+ Y +PE
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVIS 183
Query: 688 ---YALDGLFSIKSDVFSFGILMLETLSGK 714
Y G + D++S G+++ L G
Sbjct: 184 GRLY--AGP---EVDIWSCGVILYALLCGT 208
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 22/199 (11%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRL------SSQSGQGLEEFKNE----MMLIAKLQHR 569
LG+GGFG V+ G L + +VA+K + E + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
+++LL Q +L+LE P + D+F + K L +R + + + H
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRC-FFGQVVAAIQHCH 156
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
++HRD+K N+L+D+ K+ DFG + + GT Y PE+
Sbjct: 157 SR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEW 209
Query: 689 ALDGLFS-IKSDVFSFGIL 706
+ + + V+S GIL
Sbjct: 210 ISRHQYHALPATVWSLGIL 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 36/210 (17%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
LG G FG V G+ L G +VAVK L+ Q S + + + E+ + +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 577 CCVEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARVT---IIEGIAQGLLYLHQ 630
+ I +++EY+ L FD RL ++R I+ G+ Y H
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD----YCH- 133
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE--- 687
R ++HRDLK NVLLD MN KI+DFGL+ M E + G+ Y +PE
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVIS 188
Query: 688 ---YALDGLFSIKSDVFSFGILMLETLSGK 714
Y G + D++S G+++ L G
Sbjct: 189 GRLY--AGP---EVDIWSSGVILYALLCGT 213
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 24/206 (11%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR-NLVKLL 575
+LG G F V + GQE A K + + E +E+ ++ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW---QARVTIIEGIAQGLLYLHQYS 632
E ILILEY + F L + +I+ I +G+ YLHQ
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN- 150
Query: 633 RFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
I+H DLK N+LL + KI DFG++R G + I+GT Y++PE
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEIL 205
Query: 690 LDGLFSIKSDVFSFGIL--MLETLSG 713
+ +D+++ GI+ ML L+
Sbjct: 206 NYDPITTATDMWNIGIIAYML--LTH 229
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 37/210 (17%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVK---RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
LGEG FG V Q+VA+K R + + E+ + L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 577 CCVEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARVT---IIEGIAQGLLYLHQ 630
+ I +++EY + LFD KKR+ + R II I Y H
Sbjct: 77 V-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH- 125
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE--- 687
R +I+HRDLK N+LLD ++N KI+DFGL+ + K G+ Y +PE
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVIN 180
Query: 688 ---YALDGLFSIKSDVFSFGILMLETLSGK 714
Y G + DV+S GI++ L G+
Sbjct: 181 GKLY--AGP---EVDVWSCGIVLYVMLVGR 205
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 47/229 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKN----EMMLIAKL 566
+ F ++ G+G FG V G+ G VA+K++ F+N M +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVL 76
Query: 567 QHRNLVKLLGCCVEQGEK-------ILILEYMP---NKSLDVFLFDPTK-----KRLLGW 611
H N+V+L GE+ +++EY+P ++ + ++ +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 612 QARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDEL 670
Q + + + LH S + HRD+K NVL++ K+ DFG A+ E
Sbjct: 137 Q--------LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKS-----DVFSFGILMLETLSGK 714
N I Y Y +PE +F + D++S G + E + G+
Sbjct: 188 --NVAYICSRY-YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 22/186 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQH 568
TE + + +LG+G F V + +L GQE A + S + ++ + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW----QARVTIIEGIAQG 624
N+V+L E+G LI + + LF+ R + A I+ I +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAR--EYYSEADAS-HCIQQILEA 122
Query: 625 LLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
+L+ HQ ++HR+LK N+LL K++DFGLA G+ Q GT
Sbjct: 123 VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTP 177
Query: 682 GYMSPE 687
GY+SPE
Sbjct: 178 GYLSPE 183
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
F LG+GGFG V ++ ++ A K+L + +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
R +V L E + + L+L M L ++ + +A E I GL
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLED 301
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
LH R RI++RDLK N+LLD + +ISD GLA + K VGT GYM+PE
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE 355
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
+ ++ D ++ G L+ E ++G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 25/210 (11%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCC 578
LGEG V L+ QE AVK + Q G E+ ++ + Q HRN+++L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 579 VEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
E+ L+ E M S+ K+R +++ +A L +LH I
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIA 133
Query: 638 HRDLKASNVLL---DMDMNPKISDFGLARMF-----GGDELQGNTKRIVGTYGYMSPEYA 689
HRDLK N+L + KI DF L G+ YM+PE
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE-V 192
Query: 690 LDGLFSI------KSDVFSFGILMLETLSG 713
++ + D++S G+++ LSG
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 9e-22
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
+ F LG GGFG V+ ++ ++ A K+L+ + +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKK--RLLGWQARVTIIEGIAQGL 625
R +V L E + L++ M + +++ + +A + I GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGL 302
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
+LHQ II+RDLK NVLLD D N +ISD GLA + TK GT G+M+
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMA 357
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
PE L + D F+ G+ + E ++ +
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 3e-21
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQ---SGQGLEEFKNE---MMLIAK 565
+FS+ +G GGFG VY R + ++ A+K L + QG NE + L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 566 LQHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
+V + +K+ IL+ M L L R E I G
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAE-IILG 304
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
L ++H +++RDLK +N+LLD + +ISD GLA F + VGT+GYM
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYM 357
Query: 685 SPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
+PE G+ S D FS G ++ + L G
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 20/209 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
T+ + ++ +G G + + E AVK + EE +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYL 628
++ L + ++ E M L D +K +A ++ I + + YL
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVLFTITKTVEYL 132
Query: 629 HQYSRFRIIHRDLKASNVLL-DMDMNP---KISDFGLARMFGGDELQGNTKRIVGTYGYM 684
H ++HRDLK SN+L D NP +I DFG A+ + G T ++
Sbjct: 133 HAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYTANFV 187
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSG 713
+PE + D++S G+L+ L+G
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-21
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
++ F ++ +LG G VY+ + + A+K L + + + E+ ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYL 628
++KL E L+LE + LFD K A ++ I + + YL
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGE----LFDRIVEKGYYSERDAA-DAVKQILEAVAYL 164
Query: 629 HQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
H+ I+HRDLK N+L D KI+DFGL+++ L K + GT GY +
Sbjct: 165 HEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCA 218
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSG 713
PE + + D++S GI+ L G
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 22/200 (11%), Positives = 59/200 (29%), Gaps = 43/200 (21%)
Query: 520 KLGEGGFGPVYKGR--LLNGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHRNLVKL 574
G ++ L ++VA+ + Q L+E + + ++++ + ++
Sbjct: 38 FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
L + +++ E++ SL A + ++ +A H R
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGA-IRAMQSLAAAADAAH---RA 148
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
+ S V + +D + ++ M
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA------- 179
Query: 695 SIKSDVFSFGILMLETLSGK 714
+ + D+ G + L +
Sbjct: 180 NPQDDIRGIGASLYALLVNR 199
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 20/201 (9%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGC 577
LGEG F K + Q AVK +S + + E+ + + H N+VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 578 CVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
+Q L++E + L F+ KK +A I+ + + ++H
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEAS-YIMRKLVSAVSHMHDVG--- 126
Query: 636 IIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
++HRDLK N+L + ++ KI DFG AR+ D K T Y +PE
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQN 184
Query: 693 LFSIKSDVFSFGILMLETLSG 713
+ D++S G+++ LSG
Sbjct: 185 GYDESCDLWSLGVILYTMLSG 205
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 30/207 (14%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGC 577
LG G G V + GQ+ A+K L + + E+ + ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90
Query: 578 CVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGW----QARVTIIEGIAQGLLYLH 629
+I+E M L F ++R +A I+ I + +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAA-EIMRDIGTAIQFLH 145
Query: 630 QYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
++ I HRD+K N+L + D K++DFG A+ + LQ T Y++P
Sbjct: 146 SHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYTPYYVAP 198
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
E + D++S G++M L G
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 36/208 (17%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHRNLVKLLGCC 578
+G G FG R L + VAVK + G ++E + E++ L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 579 VEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVT---IIEGIAQGLLYLHQYSR 633
+ +I+EY L ++ R +AR ++ G++ Y H
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH---S 134
Query: 634 FRIIHRDLKASNVLLD--MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE---- 687
+I HRDLK N LLD KI DFG ++ K VGT Y++PE
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLR 191
Query: 688 --YALDGLFSIKSDVFSFGILMLETLSG 713
Y DG +DV+S G+ + L G
Sbjct: 192 QEY--DGK---IADVWSCGVTLYVMLVG 214
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-18
Identities = 43/207 (20%), Positives = 81/207 (39%), Gaps = 29/207 (14%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGC 577
LG G G V + ++ A+K L + + E+ L + ++V+++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 123
Query: 578 CVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGW----QARVTIIEGIAQGLLYLH 629
+++E + L F + R +A I++ I + + YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 178
Query: 630 QYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
+ I HRD+K N+L + K++DFG A+ + T Y++P
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAP 232
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
E + D++S G++M L G
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 17/211 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEE---FKNEMMLIAKLQH 568
E+F + +G G FG V +L N +V A+K L+ E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
+ + L + + L+++Y L + L + RL AR + E + +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDS 190
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
+HQ +HRD+K N+L+DM+ + +++DFG D + VGT Y+SPE
Sbjct: 191 VHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPE 246
Query: 688 YALDGLFSIKS-----DVFSFGILMLETLSG 713
D +S G+ M E L G
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 7e-18
Identities = 52/253 (20%), Positives = 100/253 (39%), Gaps = 69/253 (27%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHR 569
++ +S+ LG G FG V + + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHV 60
Query: 570 NLVKLLGCCVEQGEKI--------------------------------------LILEYM 591
N++KL+ G++ +I+EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 592 P---NKSLDVFLFDPTK-----KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKA 643
P +K L F+ + +Q + + + ++H I HRD+K
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQ--------LFRAVGFIHS---LGICHRDIKP 169
Query: 644 SNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVF 701
N+L++ N K+ DFG A+ + + I + Y +PE L ++ D++
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLW 226
Query: 702 SFGILMLETLSGK 714
S G + E + GK
Sbjct: 227 SIGCVFGELILGK 239
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-18
Identities = 47/212 (22%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HR 569
+++ + KLG G + V++ + N ++V VK L + + K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91
Query: 570 NLVKLLGCCVEQGEK--ILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGL 625
N++ L + + L+ E++ N R ++ I + L
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE--------ILKAL 143
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
Y H S I+HRD+K NV++D + ++ D+GLA Q R+ Y +
Sbjct: 144 DYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FK 197
Query: 685 SPEYALDGLFSIKS-DVFSFGILMLETLSGKK 715
PE +D S D++S G ++ + K+
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 46/199 (23%), Positives = 90/199 (45%), Gaps = 41/199 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
+ + ++ +G G +G V + L + VA+K++ F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 562 LIAKLQHRNLVKLLGCCV----EQGEKI-LILEYMPN------KSLDVFLFDPTKKRLLG 610
++ +L H ++VK+L + E+ +++ ++LE + ++ V+L + K LL
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLL- 162
Query: 611 WQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670
+ + G+ Y+H S I+HRDLK +N L++ D + K+ DFGLAR E
Sbjct: 163 YN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 671 QGNTKRIVGTYGYMSPEYA 689
+ I M+
Sbjct: 212 GNSQLPISPREDDMNLVTF 230
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 19/213 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
++F + +G G F V ++ +V A+K ++ + F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
R + +L + + L++EY L + L +R+ AR + E I +
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAE-IVMAIDS 177
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
+H+ +HRD+K N+LLD + +++DFG D + VGT Y+SPE
Sbjct: 178 VHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPE 233
Query: 688 -------YALDGLFSIKSDVFSFGILMLETLSG 713
G + + D ++ G+ E G
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 562 LIAKLQHRNLVKLL-----GCCVEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQ 612
L+ + H+N++ LL +E+ + + +++E M + + + L LL +Q
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL-YQ 135
Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672
+ G+ +LH IIHRDLK SN+++ D KI DFGLAR G +
Sbjct: 136 --------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184
Query: 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
V T Y +PE L + D++S G +M E + G
Sbjct: 185 PY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 36/95 (37%), Positives = 56/95 (58%), Gaps = 9/95 (9%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRI 677
+A+G+ +L + + IHRDL A N+LL KI DFGLAR D +G+ +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 259 L---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 34/160 (21%), Positives = 56/160 (35%), Gaps = 19/160 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQG-LEEFKNEM-MLIA 564
+ + LG G FG V + + VAVK L + +E+ +LI
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 565 KLQHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
H N+V LLG C + G + +I+E+ +L +L R + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
G + I DLK + + S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 51/226 (22%), Positives = 84/226 (37%), Gaps = 38/226 (16%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEE--FKN---------EM 560
+++Q + G +G V G G VA+KR+ + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 561 MLIAKLQHRNLVKLLGC----CVEQGEKI-LILEYMPN------KSLDVFLFDPTKKRLL 609
L+ H N++ L K+ L+ E M + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
+ I GL LH+ ++HRDL N+LL + + I DF LAR D
Sbjct: 141 -YH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
N V Y +PE + F+ D++S G +M E + K
Sbjct: 189 ---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 17/206 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLS----SQSGQGLEEFKNEMMLIAKLQ 567
+ F LG G FG V + +G A+K L + Q +E NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
LVKL + +++EY+ + L R AR + I Y
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQ-IVLTFEY 156
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
LH +I+RDLK N+L+D +++DFG A+ ++G T + GT ++PE
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPE 208
Query: 688 YALDGLFSIKSDVFSFGILMLETLSG 713
L ++ D ++ G+L+ E +G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 3e-16
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 562 LIAKLQHRNLVKLL------GCCVEQGEKILILEYMP---NKSLDVFLFDPTKKRLLGWQ 612
L+ + H+N++ LL E + L++E M + + + L LL +Q
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL-YQ 172
Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672
+ G+ +LH S IIHRDLK SN+++ D KI DFGLAR G +
Sbjct: 173 --------MLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-- 219
Query: 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
V T Y +PE L + D++S G +M E + K
Sbjct: 220 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEE---FKNEMMLIAKLQH 568
E++ + +G G FG V R + ++V A+K LS + F E ++A
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
+V+L + +++EYMP L + + + AR E + L +
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAE-VVLALDAI 184
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE- 687
H IHRD+K N+LLD + K++DFG + + VGT Y+SPE
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEV 240
Query: 688 ---YALDGLFSIKSDVFSFGILMLETLSG 713
DG + + D +S G+ + E L G
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 44/223 (19%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
+ + +G G +G V +G++VA+K+LS F++ E++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 562 LIAKLQHRNLVKLL-----GCCVEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQ 612
L+ +QH N++ LL + L++ +M K + + + + L+ +Q
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-YQ 134
Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672
+ +GL Y+H ++HRDLK N+ ++ D KI DFGLAR E+ G
Sbjct: 135 --------MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMTG 182
Query: 673 NTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
V T Y +PE L ++ D++S G +M E L+GK
Sbjct: 183 Y----VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 61/252 (24%), Positives = 112/252 (44%), Gaps = 29/252 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
++F + +G G + V RL + A+K + + E+
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
H LV L C + ++ ++EY+ D+ +++L AR E I+ L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALN 124
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
YLH+ II+RDLK NVLLD + + K++D+G+ + + GD T GT Y+
Sbjct: 125 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYI 177
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744
+PE + D ++ G+LM E ++G+ F+++G + + ++ + L
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRS--------PFDIVGSSDNPDQNTE-DYLF 228
Query: 745 DPVITQDEISLP 756
VI + +I +P
Sbjct: 229 Q-VILEKQIRIP 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 17/209 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEF---KNEMMLIAKLQH 568
F LG+G FG V + A+K L + +E E ++ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
L L + +++ ++EY ++F ++ +AR E I L Y
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRARFYGAE-IVSALDY 263
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMS 685
LH S +++RDLK N++LD D + KI+DFGL + + G K GT Y++
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT----MKTFCGTPEYLA 317
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
PE D + D + G++M E + G+
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKN---EMMLIAKLQH 568
++F + +G+G FG V + + +++ A+K ++ Q E +N E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 569 RNLVKLLGCCVEQ-GEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
LV L Q E + ++++ + D+ ++ I E + L
Sbjct: 75 PFLVNLWYSF--QDEEDMFMVVDLLLGG--DLRYHLQQNVHFKEETVKLFICE-LVMALD 129
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
YL RIIHRD+K N+LLD + I+DF +A M + + GT YM+P
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAP 183
Query: 687 EYALDGLFSIKS---DVFSFGILMLETLSGK 714
E + S D +S G+ E L G+
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 43/225 (19%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
++ +GEG +G V LN VA+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 562 LIAKLQHRNLVKLLGC----CVEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQA 613
++ + +H N++ + +EQ + + ++ + M K L +Q
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136
Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673
I +GL Y+H S ++HRDLK SN+LL+ + KI DFGLAR+ D +
Sbjct: 137 -------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDH 184
Query: 674 TKRI---VGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
T + V T Y +PE L+ ++ D++S G ++ E LS +
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEF---KNEMMLIAKLQH 568
++F + LG G FG V+ R + A+K L + L++ +E ++++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
++++ G + + +I++Y+ L F +R A+ E + L YL
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAE-VCLALEYL 122
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H II+RDLK N+LLD + + KI+DFG A+ + T + GT Y++PE
Sbjct: 123 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSG 713
++ D +SFGIL+ E L+G
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 52/234 (22%), Positives = 92/234 (39%), Gaps = 52/234 (22%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
+ LG GG G V+ + VA+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------------FDPT 604
+I +L H N+VK+ G ++ + V++
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 605 KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD-MDMNPKISDFGLAR 663
RL +Q + +GL Y+H + ++HRDLK +N+ ++ D+ KI DFGLAR
Sbjct: 121 HARLFMYQ--------LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 664 MFGGDELQGN--TKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
+ ++ +V T Y SP L ++ D+++ G + E L+GK
Sbjct: 170 IMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 60/252 (23%), Positives = 112/252 (44%), Gaps = 29/252 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
++F + +G G + V RL + A++ + + E+
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
H LV L C + ++ ++EY+ D+ +++L AR E I+ L
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALN 167
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
YLH+ II+RDLK NVLLD + + K++D+G+ + + GD T GT Y+
Sbjct: 168 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYI 220
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744
+PE + D ++ G+LM E ++G+ F+++G + + ++ + L
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRS--------PFDIVGSSDNPDQNTE-DYLF 271
Query: 745 DPVITQDEISLP 756
VI + +I +P
Sbjct: 272 Q-VILEKQIRIP 282
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 75.7 bits (185), Expect = 7e-15
Identities = 37/203 (18%), Positives = 61/203 (30%), Gaps = 46/203 (22%)
Query: 507 SVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRL--------SSQSGQGLEEFKN 558
S TE K+GEG FG V++ + VA+K + + + EE
Sbjct: 14 SHCLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 559 EMMLIAKLQ---------HRNLVKLLGCCVEQGE--KILILEYM--------PNKSLDVF 599
E+++ +L + L QG +L+ + N D F
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 600 ----------------LFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKA 643
+ + +L +I+ + L R HRDL
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 644 SNVLLDMDMNPKISDFGLARMFG 666
NVLL K+ +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSST 213
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 1e-14
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
+F+ LG+G FG V E+ AVK L ++ + M+ L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
L +L C + +++ ++EY+ D+ R A E IA GL
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGG--DLMYHIQQVGRFKEPHAVFYAAE-IAIGLF 456
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
+L II+RDLK NV+LD + + KI+DFG+ + ++ G TK GT Y+
Sbjct: 457 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYI 509
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
+PE + D ++FG+L+ E L+G+
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEM----MLIAKLQ 567
E+F + LG+G FG V+ + A+K L ++ + M +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
H L + C + E + ++EY+ D+ + + +A E I GL
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGG--DLMYHIQSCHKFDLSRATFYAAE-IILGLQ 132
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
+LH I++RDLK N+LLD D + KI+DFG+ + M G T GT Y+
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFCGTPDYI 185
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSG 713
+PE L ++ D +SFG+L+ E L G
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEF---KNEMMLIAKLQH 568
+F LG+G FG V R A+K L + +E E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
L L + +++ ++EY ++F ++ +AR E I L Y
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAE-IVSALEY 120
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMS 685
LH +++RD+K N++LD D + KI+DFGL + + G K GT Y++
Sbjct: 121 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLA 173
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
PE D + D + G++M E + G+
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLS----SQSGQGLEEFKNEMMLIA 564
E F + LG+GG+G V++ R + G A+K L ++ + K E ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 565 KLQHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
+++H +V L+ + G K+ LILEY+ L F+ + + A + E I+
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISM 132
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTY 681
L +LHQ II+RDLK N++L+ + K++DFGL + + G T GT
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV----THTFCGTI 185
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
YM+PE + + D +S G LM + L+G
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSSQS--GQGLEEFKNEMMLIAKL 566
F + LG+G FG V+ + ++G + A+K L + + K E ++ ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 567 QHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
H +VKL + K+ LIL+++ L F + + + E +A L
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAE-LALAL 139
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGY 683
+LH II+RDLK N+LLD + + K++DFGL++ + + GT Y
Sbjct: 140 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK----AYSFCGTVEY 192
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
M+PE + +D +SFG+LM E L+G
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
+F+ LG+G FG V E+ AVK L ++ + M+ L +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSL-------DVFLFDPTKKRLLGWQARVTIIE 619
L +L C + +++ ++EY+ L F A E
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---------HAVFYAAE 129
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRI 677
IA GL +L II+RDLK NV+LD + + KI+DFG+ + ++ G TK
Sbjct: 130 -IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTF 181
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
GT Y++PE + D ++FG+L+ E L+G+
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
+F +G+G FG V R + AVK L ++ +E K+ M L+ ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
H LV L + +K+ +L+Y+ ++F ++ L +AR E IA L
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAE-IASALG 153
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
YLH + I++RDLK N+LLD + ++DFGL + + T GT Y+
Sbjct: 154 YLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFCGTPEYL 206
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
+PE + D + G ++ E L G
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 43/223 (19%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
+ +G G +G V G +VA+K+L F++ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76
Query: 562 LIAKLQHRNLVKLL-----GCCVEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQ 612
L+ ++H N++ LL ++ L++ +M K + + + L +Q
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672
+ +GL Y+H IIHRDLK N+ ++ D KI DFGLAR E+ G
Sbjct: 137 --------MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA-DSEMTG 184
Query: 673 NTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
V T Y +PE L+ ++ D++S G +M E ++GK
Sbjct: 185 Y----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 41/202 (20%), Positives = 81/202 (40%), Gaps = 41/202 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
+N+ ++ +G G +G VY + VA+K+++ F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKI-----LILEYMPN------KSLDVFLFDPTKKRLLG 610
++ +L+ +++L + ++LE + K+ +FL + K +L
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTIL- 135
Query: 611 WQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670
+ + G ++H IIHRDLK +N LL+ D + K+ DFGLAR ++
Sbjct: 136 YN--------LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 671 QGNTKRIVGTYGYMSPEYALDG 692
+ L
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKK 206
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
+NF LG+G FG V R+ ++ AVK L ++ + M L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
H L +L CC + +++ ++E++ D+ +R +AR E I L+
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAE-IISALM 138
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA--RMFGGDELQGNTKRIVGTYGYM 684
+LH II+RDLK NVLLD + + K++DFG+ + G T GT Y+
Sbjct: 139 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFCGTPDYI 191
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
+PE + L+ D ++ G+L+ E L G
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 43/223 (19%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
E + +G G +G V G VAVK+LS F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 562 LIAKLQHRNLVKLL-----GCCVEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQ 612
L+ ++H N++ LL +E+ + L+ M N + + L +Q
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672
I +GL Y+H IIHRDLK SN+ ++ D KI DFGLAR DE+ G
Sbjct: 141 --------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT-ADEMTG 188
Query: 673 NTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
V T Y +PE L+ ++ D++S G +M E L+G+
Sbjct: 189 Y----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 50/230 (21%), Positives = 93/230 (40%), Gaps = 46/230 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
+ +F ++ LGEG +G V G+ VA+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 562 LIAKLQHRNLVKLLGC----CVEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQA 613
++ +H N++ + E ++ +I E M ++ + + + +Q
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ- 120
Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673
+ + LH + +IHRDLK SN+L++ + + K+ DFGLAR+ +
Sbjct: 121 -------TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 674 TKRI--------VGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
V T Y +PE L +S DV+S G ++ E +
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 34/156 (21%), Positives = 63/156 (40%), Gaps = 26/156 (16%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGC 577
LG G G V + ++ A+K L + + E+ L + Q ++V+++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 578 CVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGW----QARVTIIEGIAQGLLYLH 629
+++E + L F + R +A I++ I + + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 134
Query: 630 QYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLA 662
+ I HRD+K N+L + K++DFG A
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 3e-13
Identities = 22/126 (17%), Positives = 46/126 (36%), Gaps = 19/126 (15%)
Query: 26 DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISD 85
+ +T + G+ L + + L ++ T VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYDH---STSVWASNTGIL-GK 50
Query: 86 HNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYL 145
+ + GN V+ + ++W+++ N V L++DGN+VI + +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------I 102
Query: 146 WQSFDY 151
W + Y
Sbjct: 103 WSTGTY 108
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLS----SQSGQGLEEFKNEMMLIA 564
ENF + LG G +G V+ R ++G + A+K L Q + E + E ++
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 565 KLQHRN-LVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA 622
++ LV L + K+ LIL+Y+ L F ++R + ++ + E I
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGE-IV 169
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
L +LH+ II+RD+K N+LLD + + ++DFGL++ F DE + GT
Sbjct: 170 LALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIE 225
Query: 683 YMSPEYALDGLFSIKSDV--FSFGILMLETLSGK 714
YM+P+ G V +S G+LM E L+G
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 34/198 (17%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
+ + KLG+G +G V+K G+ VAVK++ + F+N E+M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 562 LIAKLQ-HRNLVKLLGCCV-EQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQARV 615
++ +L H N+V LL + + L+ +YM + + + +P K+ + +Q
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ--- 117
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
+ + + YLH S ++HRD+K SN+LL+ + + K++DFGL+R F N
Sbjct: 118 -----LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 676 RIVGTYGYMSPEYALDGL 693
+ + + L
Sbjct: 170 PLSINENTENFDDDQPIL 187
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 39/201 (19%), Positives = 75/201 (37%), Gaps = 48/201 (23%)
Query: 520 KLGEGGFGPVYKGRLLNGQ------EVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVK 573
+G+GGFG +Y + + + VK S +G E K Q + ++
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 574 LL-------------GCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRL-------LGW 611
G + G+ +I++ L +++ KR L
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ-KIYEANAKRFSRKTVLQLSL 159
Query: 612 QARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI--SDFGLARMFGGDE 669
+ + I+E Y+H++ +H D+KASN+LL+ ++ D+GLA + +
Sbjct: 160 RI-LDILE-------YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 670 L-----QGNTKRIVGTYGYMS 685
+ + GT + S
Sbjct: 209 VHKAYAADPKRCHDGTIEFTS 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 42/192 (21%), Positives = 73/192 (38%), Gaps = 36/192 (18%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
NF + K+G G FG + G+ L + VA+K +S + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARVTIIEGIAQGL 625
++ ++LE + SL+ LFD + + Q ++ +E
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRTFSLKTVLMIAIQL-ISRME------ 119
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPK-----ISDFGLARMFGGDELQGNT------ 674
Y+H + +I+RD+K N L+ N I DF LA+ + + +
Sbjct: 120 -YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY--IDPETKKHIPYRE 173
Query: 675 -KRIVGTYGYMS 685
K + GT YMS
Sbjct: 174 HKSLTGTARYMS 185
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 41/194 (21%), Positives = 83/194 (42%), Gaps = 38/194 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
++ + ++GEG FG +++G LLN Q+VA+K S + Q +E++ +L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARVTIIEGIA 622
+ + E +L+++ + SL+ L D ++ Q + ++
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLG-PSLE-DLLDLCGRKFSVKTVAMAAKQM-LARVQ--- 120
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPK-----ISDFGLARMFGGDELQGN---- 673
+H+ S +++RD+K N L+ + + DFG+ + + D +
Sbjct: 121 ----SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPY 172
Query: 674 --TKRIVGTYGYMS 685
K + GT YMS
Sbjct: 173 REKKNLSGTARYMS 186
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-11
Identities = 26/124 (20%), Positives = 49/124 (39%), Gaps = 18/124 (14%)
Query: 25 ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPIS 84
+D + + G L + + L ++ + VW + +
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN---NRAVWASGTNGK-- 48
Query: 85 DHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESY 144
VL + N GNLV+ + + IW++N + N L+ D N+VI DNS+ +
Sbjct: 49 ASGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 145 LWQS 148
+W +
Sbjct: 103 IWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-05
Identities = 18/65 (27%), Positives = 31/65 (47%), Gaps = 1/65 (1%)
Query: 87 NAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLW 146
+ I N NLVL + N +W++ + V ++++DGNLVI S +
Sbjct: 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWASNTNR 78
Query: 147 QSFDY 151
Q+ +Y
Sbjct: 79 QNGNY 83
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 45/192 (23%), Positives = 80/192 (41%), Gaps = 36/192 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH-RN 570
+ + K+G G FG +Y G + G+EVA+K ++ E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARVTIIEGIAQ 623
+ + C E ++++E + SL+ LF+ ++ L Q ++ IE
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFCSRKFSLKTVLLLADQM-ISRIE---- 119
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPK---ISDFGLARMFGGDELQGNT------ 674
Y+H + IHRD+K N L+ + I DFGLA+ + + + +
Sbjct: 120 ---YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY--RDARTHQHIPYRE 171
Query: 675 -KRIVGTYGYMS 685
K + GT Y S
Sbjct: 172 NKNLTGTARYAS 183
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 3e-11
Identities = 25/123 (20%), Positives = 44/123 (35%), Gaps = 19/123 (15%)
Query: 26 DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISD 85
++++ + + G L + L ++ VW +N S
Sbjct: 2 NSLSSPNSLFTGHSLEV-GPSYRLIMQGDCN-----FVLYDS---GKPVWASNTGGLGSG 52
Query: 86 HNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYL 145
L N GNLV+ +Q+N IW T + + V L+ D N+VI +
Sbjct: 53 CRLTLH--NNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV--------V 102
Query: 146 WQS 148
W +
Sbjct: 103 WAT 105
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 30/216 (13%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSG---QGLEEFK-------NEMMLIAKLQH 568
KLG G F V+ + ++N VA+K + +E K + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 569 RNLVKLLGCCVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
+++KLL +G ++ E + ++L + + + + I + + G
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK-QISKQLLLG 143
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNP------KISDFGLARMFGGDELQGNTKRIV 678
L Y+H R IIH D+K NVL+++ +P KI+D G A + + +
Sbjct: 144 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY----TNSI 196
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
T Y SPE L + +D++S L+ E ++G
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 5e-11
Identities = 22/123 (17%), Positives = 40/123 (32%), Gaps = 20/123 (16%)
Query: 26 DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISD 85
+ + + L + + L + L + +W +N DR
Sbjct: 3 NVLLSGQTLHADHSLQA--GAYTLTIQNKCN-----LVKYQN---GRQIWASNTDR--RG 50
Query: 86 HNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYL 145
LT+ + GNLV+ + N +W + + + L+ DG VI L
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV--------L 102
Query: 146 WQS 148
W
Sbjct: 103 WSL 105
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 32/201 (15%), Positives = 68/201 (33%), Gaps = 48/201 (23%)
Query: 520 KLGEGGFGPVYKGR---------LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
G +Y+ Q+ ++K L ++ G+ E LQ
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 571 LVKL-----------LGCCVEQGE-KILILEYMPNKSL-DVFLFDPTKK------RLLGW 611
KL +G V Q + + L+L + +SL P +
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVAC 166
Query: 612 QARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI--SDFGLARMF--GG 667
+ + +E +LH+ +H ++ A N+ +D + ++ + +G A + G
Sbjct: 167 RL-LDALE-------FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 668 DEL---QGNTKRIVGTYGYMS 685
+ +G+ G ++S
Sbjct: 216 KHVAYVEGSRSPHEGDLEFIS 236
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 1e-10
Identities = 17/78 (21%), Positives = 32/78 (41%), Gaps = 10/78 (12%)
Query: 71 DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNL 130
+ +W N + + G LV++ N T+W + V + + V L+ D N+
Sbjct: 48 NNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNV 105
Query: 131 VIRDNSSGNTTESYLWQS 148
VI ++ LW +
Sbjct: 106 VIYGDA--------LWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 8e-08
Identities = 21/88 (23%), Positives = 32/88 (36%), Gaps = 6/88 (6%)
Query: 61 YLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNP 120
+ P + + + H + NLVL + N IW+TN
Sbjct: 5 FSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGC 63
Query: 121 VAQLRDDGNLVIRDNSSGNTTESYLWQS 148
A L+ DG LV+ N + +WQS
Sbjct: 64 RAVLQPDGVLVVITNEN-----VTVWQS 86
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 38/186 (20%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLV-KLL 575
K+G G FG +Y G + +EVA+K + ++ Q L E K + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGGTGIPNVR 69
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARVTIIEGIAQGLLYL 628
VE +L+++ + SL+ LF+ ++L L Q + +E ++
Sbjct: 70 WFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQM-INRVE-------FV 119
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPK---ISDFGLARMFGGDELQG------NTKRIVG 679
H S +HRD+K N L+ + I DFGLA+ + D K + G
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNLTG 175
Query: 680 TYGYMS 685
T Y S
Sbjct: 176 TARYAS 181
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 39/198 (19%), Positives = 73/198 (36%), Gaps = 45/198 (22%)
Query: 520 KLGEGGFGPVYKG-RLLNGQEVA---VKRLSSQSGQGLEEFKNEMML-----IAKLQHRN 570
K+G GGFG +Y ++ A VK ++G E K + I K R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 571 LVKLLG----------CCVEQGEKILILEYMPNKSLDVFLFDPTKK------RLLGWQAR 614
+ LG + + +++E + L + LG +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISGQNGTFKKSTVLQLGIRM- 160
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI--SDFGLARMFGGDEL-- 670
+ ++E Y+H+ +H D+KA+N+LL ++ +D+GL+ + +
Sbjct: 161 LDVLE-------YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 671 ---QGNTKRIVGTYGYMS 685
+ K GT + S
Sbjct: 211 QYQENPRKGHNGTIEFTS 228
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 4e-10
Identities = 27/123 (21%), Positives = 46/123 (37%), Gaps = 20/123 (16%)
Query: 26 DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISD 85
+ + + GE L + R+ L ++ D +W N D
Sbjct: 2 NILYSGETLSPGEFLNN--GRYVFIMQEDCN-----LVLYDV---DKPIWATNTGGL--D 49
Query: 86 HNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYL 145
L++ + GNLV+ + N IW++N E N V L+ D N+VI +
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA--------R 101
Query: 146 WQS 148
W +
Sbjct: 102 WAT 104
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 4e-09
Identities = 21/112 (18%), Positives = 43/112 (38%), Gaps = 13/112 (11%)
Query: 21 VSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRD 80
+ + + + +L + + +L L ++ W +N
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVLY----GGKYGWQSNTH 50
Query: 81 RPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVI 132
+ + L +++KG L++ + TIWS+ S+ V L+DDG VI
Sbjct: 51 G--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-06
Identities = 16/71 (22%), Positives = 27/71 (38%), Gaps = 7/71 (9%)
Query: 78 NRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSS 137
D ++ N L + NLVL W +N ++ +L G L+I+D+
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYGGK--YGWQSNTHGNGEHCFLRLNHKGELIIKDDDF 73
Query: 138 GNTTESYLWQS 148
+W S
Sbjct: 74 KT-----IWSS 79
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-08
Identities = 24/126 (19%), Positives = 42/126 (33%), Gaps = 23/126 (18%)
Query: 23 LAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRP 82
L + + + L + F+L Y G W + R
Sbjct: 1 LGTNYLLSGQTLDTEGHLKN--GDFDLVMQDDCNL-VLYNGNW-----QSNTANNGR--- 49
Query: 83 ISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTE 142
+ LT+++ G LV+ N T+W + S N A + DG LV+ S
Sbjct: 50 ----DCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPS------ 99
Query: 143 SYLWQS 148
+++
Sbjct: 100 --VFKI 103
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-08
Identities = 14/117 (11%), Positives = 42/117 (35%), Gaps = 10/117 (8%)
Query: 24 AADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPI 83
+ + + + D +L + + + L + + +VW +
Sbjct: 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKGSKTNIVWESGTSG-- 54
Query: 84 SDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNT 140
+ + + + G L + + T++ +N + + V L+ +G V+ + +T
Sbjct: 55 RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGPAVWST 111
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 50/223 (22%), Positives = 85/223 (38%), Gaps = 46/223 (20%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHR- 569
+ + +G+G FG V K + + VA+K + ++ Q E + L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMNKHD 111
Query: 570 -----NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-----------RLLGWQA 613
+V L + + L+ E L L+D + R Q
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQ- 165
Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQ 671
+ LL+L IIH DLK N+LL KI DFG + G +
Sbjct: 166 -------MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRI- 215
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
+ I + Y SPE L + + D++S G +++E +G+
Sbjct: 216 --YQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 6e-08
Identities = 60/495 (12%), Positives = 140/495 (28%), Gaps = 153/495 (30%)
Query: 395 FGDLLDANRPTRNFTGQSV--YIRVPASETGKRKLLWIL-------VILVLPLVLLPSF- 444
D+ D + + + + I + +G +L W L V + VL ++
Sbjct: 35 CKDVQDMPKSI--LSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK 92
Query: 445 YIFCRRRRNCKEKE--TENMETDQDLLAFDINMGIT----TRTNEFGEVN---------- 488
++ + ++ T +D L ++ N +R + ++
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDRL-YNDNQVFAKYNVSRLQPYLKLRQALLELRPAK 151
Query: 489 --------GDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEV 540
G GK +W+ ++ +QCK+ F + +
Sbjct: 152 NVLIDGVLGSGK-----TWV-------ALDVCLSYKVQCKMDFKIF---W---------L 187
Query: 541 AVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL 600
+K +S ++ LQ L+ + ++ N L
Sbjct: 188 NLKNCNS-----------PETVLEMLQ--KLLYQIDPNWTSRS-----DHSSNIKLR--- 226
Query: 601 FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI---- 656
+ L + LL Y ++ +++ + +++ KI
Sbjct: 227 IHSIQAEL--------------RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT 272
Query: 657 SDFGLARMFGGDELQGNTK---RIVGTYGYMSPEYALDGLFS--IKSDVFS--------- 702
+ D L T + ++P+ L +
Sbjct: 273 RFKQVT-----DFLSAATTTHISLDHHSMTLTPDEVK-SLLLKYLDCRPQDLPREVLTTN 326
Query: 703 -FGILML-ETLSGKKNTGVYNADSFNLLGYAWDLWKD---DKFHELIDPVITQDEISLPV 757
+ ++ E++ T WD WK DK +I+ + E P
Sbjct: 327 PRRLSIIAESIRDGLAT--------------WDNWKHVNCDKLTTIIESSLNVLE---PA 369
Query: 758 LVR--YINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAFIKGINVKNSSHSND 815
R + +++ +A + ++S+I + + + K S
Sbjct: 370 EYRKMFDRLSVF--PPSA---HIPTILLSLIWFD----VIKSDVMVVVNKLHKYSLVEKQ 420
Query: 816 GMSNLCSVNDVTVSL 830
+ S+ + + L
Sbjct: 421 PKESTISIPSIYLEL 435
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 2e-04
Identities = 97/716 (13%), Positives = 186/716 (25%), Gaps = 251/716 (35%)
Query: 165 DLKNRLERYLSSWQSDD---DPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAA-F 220
D+++ + LS + D T RL + S Q F
Sbjct: 37 DVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTL--------------LSKQEEMVQKF 82
Query: 221 VSAISYTN--FLYEQYLVENQD----EISYWY---------EPF-----NRPSIMT---- 256
V + N FL E + Y + F +R
Sbjct: 83 VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ 142
Query: 257 --LKLNPSGLLTRQIWNNNG--------------NDWDLVFSFPDE-YCGKYGYCGANTI 299
L+L P+ + G + + + + C
Sbjct: 143 ALLELRPAKNVLID-----GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNC----- 192
Query: 300 CSPDQKPICECLEGFKLKSKFNQTGPIKCERSHSSECI---------------GGHQFIK 344
SP+ LE L+ Q P RS S I +
Sbjct: 193 NSPE-----TVLE--MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245
Query: 345 ----LDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLD 400
L N++ F NL C+ +T
Sbjct: 246 CLLVLLNVQNAKAWNAF-----NLS-----------CKIL----LT-------------- 271
Query: 401 ANRPTRNFTGQSVYIRVPASETGKRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETE 460
TR + V + A+ T L + +
Sbjct: 272 ----TRF---KQVTDFLSAATTTHISL----------------------------DHHSM 296
Query: 461 NMETDQ--DLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQ 518
+ D+ LL ++ E N P L+ +A + +
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPREVLTTN------------PR-RLSIIAESIRDGLAT 343
Query: 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKN--EMMLI----AKLQHRNLV 572
+ V +L E ++ L E++ + + + A + L
Sbjct: 344 WD----NWKHVNCDKLTTIIESSLNVLEP------AEYRKMFDRLSVFPPSAHIPTILLS 393
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+ ++ + ++++ + SL + TI +
Sbjct: 394 LIWFDVIKS-DVMVVVNKLHKYSL-----------VEKQPKESTI---------SIPS-- 430
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISD-FGLARMFGGDELQGNTKRIVGTY-----GYMSP 686
I+ +LK + + ++ I D + + + F D+L + Y G+
Sbjct: 431 ----IYLELKV-KLENEYALHRSIVDHYNIPKTFDSDDL---IPPYLDQYFYSHIGHHLK 482
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK-KNTGVYNADSFNLLGYAWDLWKDDKFHELID 745
++ VF L L K ++ ++N G + + KF++
Sbjct: 483 NIEHPERMTLFRMVF----LDFRFLEQKIRHDST----AWNASGSILNTLQQLKFYK--- 531
Query: 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAF 801
P I ++ P R +N A+L + S ++ R+ L + E F
Sbjct: 532 PYICDND---PKYERLVN-AILDFLPKIEENLICSKYTDLL---RIALMAEDEAIF 580
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 1e-07
Identities = 16/79 (20%), Positives = 25/79 (31%), Gaps = 10/79 (12%)
Query: 70 PDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGN 129
D VW N + G + +L N +W++ V L+ D N
Sbjct: 167 RDDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 224
Query: 130 LVIRDNSSGNTTESYLWQS 148
L I + LW +
Sbjct: 225 LAIYGGA--------LWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 6e-05
Identities = 17/90 (18%), Positives = 35/90 (38%), Gaps = 6/90 (6%)
Query: 65 WFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQL 124
+ Q D + + + L++ NLVL + + +WSTN + A L
Sbjct: 129 YSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFD-RDDRVWSTNTAGKGTGCRAVL 187
Query: 125 RDDGNLVIRDNSSGNTTESYLWQSFDYPTD 154
+ +G + + N + +W S + +
Sbjct: 188 QPNGRMDVLTNQN-----IAVWTSGNSRSA 212
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 4e-04
Identities = 21/109 (19%), Positives = 33/109 (30%), Gaps = 3/109 (2%)
Query: 71 DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNL 130
D VW +N + + G LV+L N WS+ + N V L+ D +
Sbjct: 44 DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTV 100
Query: 131 VIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQS 179
I ++ S + G D + S Q
Sbjct: 101 TIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQL 149
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 48/217 (22%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHR------N 570
+G+G FG V K Q VA+K + ++ Q EE + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-----------RLLGWQARVTIIE 619
++ +L + + E L + L++ KK R
Sbjct: 161 VIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHS------- 208
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRI 677
I Q L LH + RIIH DLK N+LL K+ DFG + + +
Sbjct: 209 -ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVY----TY 259
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
+ + Y +PE L + + D++S G ++ E L+G
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 52/264 (19%), Positives = 88/264 (33%), Gaps = 86/264 (32%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ--------HRN 570
KLG G F V+ + + VA+K + S E +E+ L+ ++
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREM 102
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR-----------VTIIE 619
+V+LL G N + +F+ LL W + II+
Sbjct: 103 VVQLLDDFKISG---------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD---------------------------- 651
+ QGL YLH ++ RIIH D+K N+LL ++
Sbjct: 154 QVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 652 ---------------------MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+ KI+D G A + + T Y S E +
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC-WVHKHFTE----DIQTRQYRSLEVLI 266
Query: 691 DGLFSIKSDVFSFGILMLETLSGK 714
++ +D++S + E +G
Sbjct: 267 GSGYNTPADIWSTACMAFELATGD 290
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.5 bits (114), Expect = 4e-06
Identities = 13/66 (19%), Positives = 25/66 (37%), Gaps = 8/66 (12%)
Query: 87 NAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLW 146
GNLV+ N +W ++ + V +L+ +G++ I D +W
Sbjct: 196 AVRAVFQGDGNLVVYGAGNAVLWHSHTGG-HASAVLRLQANGSIAILDEKP-------VW 247
Query: 147 QSFDYP 152
F +
Sbjct: 248 ARFGFQ 253
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.1 bits (100), Expect = 2e-04
Identities = 34/171 (19%), Positives = 60/171 (35%), Gaps = 20/171 (11%)
Query: 22 SLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDR 81
+ + + G+ L+S +QRF+L G L I VWVAN +
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQD---NGATVWVANEQQ 62
Query: 82 PIS------DHNAVLTISNKGNLVLLNQTNGTIW-----STNVFSEVKNPVAQLRDDGNL 130
P S + A L + L + + +W + + L+DDGN+
Sbjct: 63 PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122
Query: 131 VIRDNSSG-NTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSD 180
V+ D+ + N T + + L G ++ + +Q D
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGD 173
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-05
Identities = 12/53 (22%), Positives = 20/53 (37%), Gaps = 2/53 (3%)
Query: 87 NAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGN 139
+A + NLVL N + +N + +L + G L I +S
Sbjct: 21 SAAFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNT 71
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 1e-04
Identities = 13/73 (17%), Positives = 31/73 (42%), Gaps = 5/73 (6%)
Query: 71 DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGT---IWSTNVFSEVKNPVAQLRDD 127
+ + +N + L ++N+G L + + + T ++ +V + N A L D
Sbjct: 37 EAGGFQSNTHG--RGVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPD 94
Query: 128 GNLVIRDNSSGNT 140
++ I + +T
Sbjct: 95 QHVTIYGPAIWST 107
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 47/241 (19%), Positives = 80/241 (33%), Gaps = 66/241 (27%)
Query: 515 FSMQCKLGEGGFGPVYKG--RLLNGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHR 569
+ + LGEG FG V + +VA+K + + E ++ K++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN----VLKKIKEK 76
Query: 570 ------NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-----------RLLGWQ 612
V + G + E L F+ K+ R + +Q
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP------------------ 654
+ L +LH ++ H DLK N+L
Sbjct: 132 --------LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 655 -KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
+++DFG A F + IV T Y PE L+ ++ DV+S G ++ E G
Sbjct: 181 IRVADFGSA-TFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
Query: 714 K 714
Sbjct: 236 F 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 53/240 (22%), Positives = 86/240 (35%), Gaps = 60/240 (25%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHR- 569
F + K+G+G FG V + + N + AVK + + E ++ K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDD 92
Query: 570 ----NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-----------RLLGWQAR 614
N+VK G + LI E L L++ + +L +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIE-- 145
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT 674
I + L YL + + H DLK N+LLD K G T
Sbjct: 146 ------ILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 675 KR--------------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
K I+ T Y +PE L+ + + SD++SFG ++ E +G
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 834 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.85 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.83 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.82 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.8 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.79 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.71 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.69 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.65 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.64 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.54 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.53 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.51 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.25 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.22 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.01 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.97 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.93 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.89 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.69 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.68 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.63 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.38 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.22 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.18 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.12 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.11 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.8 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.68 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.29 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.26 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.04 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.03 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.0 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.99 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.66 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.65 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.53 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.15 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.76 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.57 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.97 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.12 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 90.84 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=439.19 Aligned_cols=260 Identities=26% Similarity=0.427 Sum_probs=215.3
Q ss_pred cCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 67899999999999999999864 367899999988777778899999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCC----------CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCcee
Q 003280 587 ILEYMPNKSLDVFLFDP----------TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 656 (834)
|||||++|+|.++|+.. .....++|..+..++.||++||+|||+++ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999642 23456999999999999999999999998 999999999999999999999
Q ss_pred eeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHh
Q 003280 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...... ++... ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~---i~ 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIEC---IT 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHH---HH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH---HH
Confidence 99999997755443333444679999999999999999999999999999999999 89998654321 12111 11
Q ss_pred cCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 003280 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERL 791 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 791 (834)
. +... ..+...+.++.+|+.+||+.||++|||++||++.|+.+..
T Consensus 245 ~-~~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 245 Q-GRVL----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp H-TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c-CCCC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 1110 0111223468899999999999999999999999998743
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=439.66 Aligned_cols=259 Identities=26% Similarity=0.426 Sum_probs=207.5
Q ss_pred cCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 67888999999999999999864 367899999988777778899999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCC------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCc
Q 003280 587 ILEYMPNKSLDVFLFDPT------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP 654 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 654 (834)
|||||++|+|.++++... ....++|..++.++.||++||+|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999986532 2346899999999999999999999988 9999999999999999999
Q ss_pred eeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHh
Q 003280 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWD 733 (834)
Q Consensus 655 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~ 733 (834)
||+|||+++.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||...... ++...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~--- 272 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDC--- 272 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHHH---
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHHH---
Confidence 9999999998755444444445689999999999999999999999999999999999 89998654321 11111
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.....+ .. .+...+.++.+|+.+||+.||++||||+||++.|+.+.
T Consensus 273 i~~g~~------~~-----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 273 ITQGRE------LE-----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHTCC------CC-----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHcCCC------CC-----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 111110 01 11122346889999999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=433.66 Aligned_cols=263 Identities=26% Similarity=0.425 Sum_probs=205.1
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.++||+|+||+||+|++. ..||||+++.. ..+..++|.+|+.+|++++|||||++++++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 367889999999999999999864 36999998754 34456789999999999999999999998864 56899999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
||++|+|.++++. ....+++..+..++.||++||+|||+++ ||||||||+||||++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999954 3346899999999999999999999998 9999999999999999999999999998775443
Q ss_pred cccccceecccccccccccccC---CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~---~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
.........||+.|||||++.+ +.|+.++|||||||+||||+||+.||....... .+. .....+. ..+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~----~~~~~~~----~~p 257 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QII----FMVGRGY----ASP 257 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHH----HHHHTTC----CCC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHH----HHHhcCC----CCC
Confidence 3334455789999999999964 468999999999999999999999986543221 111 1111111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccC
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLEL 793 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 793 (834)
.+ .......+..+.+|+.+||+.||++||||.||++.|+.++-++
T Consensus 258 ~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 258 DL--SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CS--TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred Cc--ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 11 1111223356889999999999999999999999998875444
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=437.64 Aligned_cols=258 Identities=30% Similarity=0.446 Sum_probs=212.5
Q ss_pred cCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
.++++.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45778899999999999999863 46789999997653 344678999999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCC-------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC
Q 003280 586 LILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM 652 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 652 (834)
||||||++|+|.++|.... ....+++..+..++.||++||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999996432 1346899999999999999999999998 99999999999999999
Q ss_pred CceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHH
Q 003280 653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYA 731 (834)
Q Consensus 653 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~ 731 (834)
.+||+|||+++.+.............||+.|||||++.++.|+.++|||||||+||||+| |+.||..... .++...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~~~- 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVVEM- 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHHHH-
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHHHH-
Confidence 999999999998755444444455689999999999999999999999999999999998 8999865432 122211
Q ss_pred HhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 732 WDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 732 ~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
...+... ..+...+.++.+|+.+||+.||++||||+||++.|+..
T Consensus 260 ---i~~~~~~----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 ---IRNRQVL----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---HHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---HHcCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111111 11122345688999999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=427.12 Aligned_cols=262 Identities=24% Similarity=0.272 Sum_probs=209.1
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.|++.++||+|+||.||+|++. .|+.||||+++.... ..+|+.++++++|||||++++++.+++..+|||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56888999999999999999975 489999999975432 246999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC-CceeeeecceeecCCCcc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMFGGDEL 670 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~ 670 (834)
++|+|.+++. +.+.+++..+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999994 3456999999999999999999999998 99999999999999987 699999999998754332
Q ss_pred cc---ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 671 QG---NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 671 ~~---~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.......... .........
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-----~i~~~~~~~------ 275 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-----KIASEPPPI------ 275 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH-----HHHHSCCGG------
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-----HHHcCCCCc------
Confidence 11 2234689999999999999999999999999999999999999997544332211 111111000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCCCCCCC
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEP 799 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~p 799 (834)
...+......+.+++.+||+.||++|||+.|+++.|.....+...-+.|
T Consensus 276 ---~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP 324 (336)
T 4g3f_A 276 ---REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324 (336)
T ss_dssp ---GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred ---hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence 0111122346789999999999999999999999887764444443333
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=428.35 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=208.4
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999986 58999999997665556677899999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999998842 45899999999999999999999998 99999999999999999999999999998754322
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+. ..+.... ... ..+.+
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i---~~~------~~~~~--- 290 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMI---RDN------LPPRL--- 290 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHH---HHS------SCCCC---
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHH---HcC------CCCCC---
Confidence 23457899999999999999999999999999999999999999864322 1111111 111 00111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
........++.+|+.+||+.||++|||++|+++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011122346789999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=422.17 Aligned_cols=248 Identities=25% Similarity=0.343 Sum_probs=209.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.++||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+++|++++|||||++++++++.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 67999999999999999999875 5899999999753 2345678999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|.+++. +.+.+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999984 3456999999999999999999999998 999999999999999999999999999988655
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.........+||+.|||||++.+..|+.++|||||||+||||++|+.||...+. ..+. ....... . .+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~---~~i~~~~-~------~~ 253 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--GLIF---AKIIKLE-Y------DF 253 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHHTC-C------CC
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHH---HHHHcCC-C------CC
Confidence 444455567999999999999999999999999999999999999999964322 1111 1111110 0 11
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVV 783 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 783 (834)
... ...++.+|+.+||+.||++|||++|++
T Consensus 254 -p~~----~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 -PEK----FFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CTT----CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -Ccc----cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 111 234678999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=423.24 Aligned_cols=268 Identities=24% Similarity=0.294 Sum_probs=204.9
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC----eEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG----EKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lV~ 588 (834)
++|.+.++||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||++++++.+.+ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5688899999999999999998 6899999999754322 223445666677889999999999998764 579999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-----CCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-----SRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
|||++|+|.+++.. ..++++.+.+++.|+++||+|||++ ..++|+||||||+||||+.++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999943 4589999999999999999999986 13359999999999999999999999999999
Q ss_pred ecCCCcc--ccccceecccccccccccccCC------ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccH--------
Q 003280 664 MFGGDEL--QGNTKRIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNL-------- 727 (834)
Q Consensus 664 ~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~------~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l-------- 727 (834)
....... ........||+.|||||++.+. .++.++|||||||+||||+||+.|+..........
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 8754322 1223346899999999999764 47889999999999999999998875443321111
Q ss_pred -hHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 728 -LGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 728 -~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
......... ...+++.+.....+.+....+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 237 ~~~~~~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 237 SVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 001111111 11223333222233456678899999999999999999999999998863
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=425.40 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=202.2
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|+++++||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++|++++|||||++++++.+.+..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 78999999999999999999875 5899999999754 33446789999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++|+|.+++... +...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999998532 3445789999999999999999999998 9999999999999999999999999998764321
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+.. .+ ........ ..
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~---~~~i~~~~-~~-------- 243 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--NL---VLKIISGS-FP-------- 243 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH---HHHHHHTC-CC--------
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HH---HHHHHcCC-CC--------
Confidence 1233468999999999999999999999999999999999999999653321 11 11111111 10
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
......+.++.+|+.+||+.||++|||++|+++
T Consensus 244 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122346889999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=429.58 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=208.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 57999999999999999999985 48999999997766666678999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++|+|.+++. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~- 302 (423)
T 4fie_A 231 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 302 (423)
T ss_dssp TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred CCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence 9999999883 345899999999999999999999998 99999999999999999999999999998754322
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ..+.... ... ..+.+
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i---~~~------~~~~~--- 367 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMI---RDN------LPPRL--- 367 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHH---HHS------CCCCC---
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHH---HcC------CCCCC---
Confidence 23457899999999999999999999999999999999999999864321 1111111 111 01111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
........++.+|+.+||+.||++|||++|+++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001112346789999999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=424.38 Aligned_cols=266 Identities=27% Similarity=0.385 Sum_probs=215.1
Q ss_pred HHHHHHhcCccccceeeeecceeEEEEEECC------CcEEEEEEccCccc-ccHHHHHHHHHHHHhhcC-CCcceEEeE
Q 003280 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQH-RNLVKLLGC 577 (834)
Q Consensus 506 ~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H-pnIv~l~~~ 577 (834)
...+...++|++.++||+|+||+||+|++.. ++.||||+++.... ...++|.+|+++|.+++| ||||+++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3344456899999999999999999998643 35799999976543 345789999999999965 899999999
Q ss_pred EEec-CeEEEEEeecCCCCccccccCCC-------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCC
Q 003280 578 CVEQ-GEKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKA 643 (834)
Q Consensus 578 ~~~~-~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp 643 (834)
|.+. +.+++|||||++|+|.++|.... ....+++..+..++.||++||+|||+++ ||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCc
Confidence 9765 56899999999999999996432 1345899999999999999999999998 99999999
Q ss_pred CcEEEcCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCC
Q 003280 644 SNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNA 722 (834)
Q Consensus 644 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~ 722 (834)
+||||++++.+||+|||+|+.+..+..........||+.|||||++.+..|+.++|||||||+||||+| |+.||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999998765544444455789999999999999999999999999999999998 8999875443
Q ss_pred CcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 723 DSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 723 ~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
... +.. ....+. .... +...+.++.+++.+||+.||++|||+.||++.|+.+
T Consensus 294 ~~~-~~~----~i~~g~-----~~~~-----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 294 DEE-FCR----RLKEGT-----RMRA-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp SHH-HHH----HHHHTC-----CCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH-HHH----HHHcCC-----CCCC-----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 221 111 111111 0111 111234688999999999999999999999999876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=406.93 Aligned_cols=247 Identities=25% Similarity=0.399 Sum_probs=197.4
Q ss_pred ccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEe----cCeEEEE
Q 003280 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE----QGEKILI 587 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV 587 (834)
|++.++||+|+||+||+|.+. .++.||||++... .....++|.+|+.+|++++|||||++++++.+ ...++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 366778999999999999875 4889999998654 33446789999999999999999999999876 3468999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-CCCceeeeecceeecC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~ 666 (834)
||||++|+|.+++. +.+.+++..+..++.||+.||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999994 3456899999999999999999999875 35999999999999974 7999999999998643
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
.. .....+||+.|||||++.+ .|+.++|||||||+||||++|+.||....... .+ ......+.....++
T Consensus 184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~----~~~i~~~~~~~~~~- 252 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QI----YRRVTSGVKPASFD- 252 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HH----HHHHTTTCCCGGGG-
T ss_pred CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HH----HHHHHcCCCCCCCC-
Confidence 32 2345689999999998865 69999999999999999999999986432211 11 11111111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
... +.++.+|+.+||+.||++|||++|+++
T Consensus 253 ----~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 ----KVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----ccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 235789999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=402.97 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=189.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999875 5899999999654 2334578999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+ +|+|.+++. +.+.+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 678888874 3456999999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccceecccccccccccccCCcc-CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~-t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
. ......||+.|||||++.+..| +.++||||+||++|||++|+.||..... ..+.. .... ... .
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~~---~i~~-~~~------~ 230 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLFK---NISN-GVY------T 230 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH---HHHH-TCC------C
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHH---HHHc-CCC------C
Confidence 2 2334689999999999998876 5899999999999999999999964321 11111 1111 100 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+ ... ...++.+++.+||+.||++|||++|+++
T Consensus 231 ~-p~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 L-PKF----LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp C-CTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-CCC----CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 111 2346789999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=409.03 Aligned_cols=247 Identities=26% Similarity=0.327 Sum_probs=195.9
Q ss_pred cCccccceeeeecceeEEEEEEC----CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
++|++++.||+|+||+||+|+.. .++.||||++++.. .....++.+|+++|++++|||||++++++.+.+..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 67999999999999999999863 36789999997642 2234578899999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++|+|.+++. +.+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999984 3456899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+.. .+.. ..... ..
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~---~i~~~-~~------ 243 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--ETMT---MILKA-KL------ 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---HHHHC-CC------
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--HHHH---HHHcC-CC------
Confidence 332 2233468999999999999999999999999999999999999999643321 1111 11111 00
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPT-----MSDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 784 (834)
. .+...+.++.+|+.+||+.||++||| ++|+++
T Consensus 244 ~-----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 G-----MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp C-----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred C-----CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0 11112346789999999999999998 467664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=397.33 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=189.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecC--------
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-------- 582 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-------- 582 (834)
++|++++.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 56999999999999999999875 58999999986543 334578999999999999999999999997654
Q ss_pred ----eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeee
Q 003280 583 ----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISD 658 (834)
Q Consensus 583 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 658 (834)
..++||||+++|+|.+++.........++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999965444445667778899999999999999998 99999999999999999999999
Q ss_pred ecceeecCCCcccc----------ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHh
Q 003280 659 FGLARMFGGDELQG----------NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLL 728 (834)
Q Consensus 659 fgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~ 728 (834)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||... .+..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~----~~~~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ----MERV 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH----HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc----cHHH
Confidence 99999875432211 1233579999999999999999999999999999999996 55321 1111
Q ss_pred HHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 729 GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 729 ~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
... ......... .........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~-~~~~~~~~p----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTL-TDVRNLKFP----------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH-HHHHTTCCC----------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH-HHHhcCCCC----------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001 111111110 001122345678999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=394.38 Aligned_cols=267 Identities=20% Similarity=0.290 Sum_probs=203.1
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEe------cCe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE------QGE 583 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~ 583 (834)
++|+++++||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 68999999999999999999875 58999999997543 3345678999999999999999999998764 357
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
+|||||||+ |+|..++. +.+.+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 67888884 4567999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcc--ccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc-
Q 003280 664 MFGGDEL--QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK- 739 (834)
Q Consensus 664 ~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~- 739 (834)
.+..... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...+.. +.............
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~--~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV--HQLQLIMMVLGTPSP 284 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHHHHHHCCCCG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhcCCCCh
Confidence 7644321 2233457899999999998875 5699999999999999999999999754321 11111111110000
Q ss_pred ----------cccccccccccCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 740 ----------FHELIDPVITQDEISLP-----VLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 740 ----------~~~lid~~l~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
....+.........+.. ...++.+|+.+||+.||++|||++|+++ .|.+
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 00000000001111111 1346789999999999999999999987 4544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=389.03 Aligned_cols=201 Identities=24% Similarity=0.359 Sum_probs=172.0
Q ss_pred HHhcCccccceeeeecceeEEEEEEC----CCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeE
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 584 (834)
...++|++.++||+|+||+||+|+.+ .++.||||++.+.. ...++.+|+++|..+ +||||+++++++.+.++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34578999999999999999999753 36789999986543 346788999999998 699999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC-CCceeeeeccee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLAR 663 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~ 663 (834)
++||||+++|+|.+++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999882 3889999999999999999999998 9999999999999877 799999999998
Q ss_pred ecCCCccc--------------------------cccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCC
Q 003280 664 MFGGDELQ--------------------------GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKN 716 (834)
Q Consensus 664 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p 716 (834)
........ ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 76432211 112235799999999999876 589999999999999999999999
Q ss_pred CCCCC
Q 003280 717 TGVYN 721 (834)
Q Consensus 717 ~~~~~ 721 (834)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 86443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=380.63 Aligned_cols=278 Identities=36% Similarity=0.631 Sum_probs=239.3
Q ss_pred HHHHhcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 508 VAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 508 ~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
+...+++|++.+.||+|+||.||+|++.+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 34467899999999999999999999888999999999877777788999999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCC-CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 588 LEYMPNKSLDVFLFDPTK-KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
|||+++++|.+++..... ...+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999999865332 345899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCC-CcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA-DSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~-~~~~l~~~~~~~~~~~~~~~lid 745 (834)
............||+.|+|||++.+..++.++||||||+++|||++|+.||..... +......+.......+.....++
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 43333333445789999999999999999999999999999999999999876543 23345555555555666666676
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
+.+ ...........+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 271 ~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 271 PNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSC-TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhh-ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 665 4456777888999999999999999999999999999886
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=378.75 Aligned_cols=288 Identities=39% Similarity=0.653 Sum_probs=243.8
Q ss_pred cCcccHHHHHHHhcCccccceeeeecceeEEEEEECCCcEEEEEEccCccc-ccHHHHHHHHHHHHhhcCCCcceEEeEE
Q 003280 500 LPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCC 578 (834)
Q Consensus 500 ~~~~~~~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 578 (834)
+..+++.++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456888999999999999999999999999999987899999999976532 2234789999999999999999999999
Q ss_pred EecCeEEEEEeecCCCCccccccCCC-CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceee
Q 003280 579 VEQGEKILILEYMPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS 657 (834)
Q Consensus 579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 657 (834)
......++||||+++|+|.+++.... ....+++..+..++.||+.||+|||++...+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999986543 34458999999999999999999999922239999999999999999999999
Q ss_pred eecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCC---CCCCcccHhHHHHhH
Q 003280 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGV---YNADSFNLLGYAWDL 734 (834)
Q Consensus 658 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~---~~~~~~~l~~~~~~~ 734 (834)
|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.. ..........+....
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999987754322 122335699999999999999999999999999999999999999863 223344556666666
Q ss_pred hcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 735 WKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 735 ~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
........+.+..+ ......+....+.+++.+||+.||++|||++||++.|++.
T Consensus 256 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTC-TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhh-ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 66667777777666 4566788889999999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=401.97 Aligned_cols=251 Identities=23% Similarity=0.334 Sum_probs=208.4
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|++.+.||+|+||+||+|+.. .|+.||||++........+.+.+|+.+|+.++|||||++++++.+...++||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999875 58999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC--CCceeeeecceeecCCCc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD--MNPKISDFGLARMFGGDE 669 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~~~~~~~ 669 (834)
++|+|.+++.. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999998843 3356899999999999999999999998 9999999999999854 899999999999875433
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||...+.. .... ..... .. . +....
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~---~i~~~-~~-~-~~~~~- 379 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLR---NVKSC-DW-N-MDDSA- 379 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHH---HHHTT-CC-C-CCSGG-
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHH---HHHhC-CC-C-CCccc-
Confidence 234568999999999999999999999999999999999999998654321 1111 11111 00 0 00000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.... ..++.+|+.+||+.||++|||+.|+++
T Consensus 380 ~~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 FSGI----SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112 346789999999999999999999987
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=363.94 Aligned_cols=233 Identities=18% Similarity=0.189 Sum_probs=181.7
Q ss_pred hhcccccccCCcccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCC----CceEEEeecC
Q 003280 21 VSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDH----NAVLTISNKG 96 (834)
Q Consensus 21 ~~~~~~~~~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~----~~~l~~~~~g 96 (834)
++++.|+|++||+|++|++|+|++|.|+||||+++ ++|| |+ ..+ |||+|||++|+.++ +++|+|+.||
T Consensus 10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G 81 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV 81 (276)
T ss_dssp CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence 46678999999999999999999999999999543 6777 76 445 99999999999885 7899999999
Q ss_pred ceEE--ecCCCceEEEeecccc-----cCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCCccccccccc
Q 003280 97 NLVL--LNQTNGTIWSTNVFSE-----VKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNR 169 (834)
Q Consensus 97 ~l~l--~~~~~~~~w~~~~~~~-----~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~~t~ 169 (834)
+|+| .|++|.+||+|+++.. ..+.+|+|+|+|||||++ +.+|||| |||||||||||+|.++++|
T Consensus 82 ~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~-------~~~lWqS--~ptdtlLpg~~~~~~l~~g 152 (276)
T 3m7h_A 82 QYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD-------SLALWNG--TPAIPLVPGAIDSLLLAPG 152 (276)
T ss_dssp SSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE-------EEEEEES--CTTSCCCCSCTTCEEECSS
T ss_pred cEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC-------CceeeCc--ccccccccccccccccccC
Confidence 9999 7888999999997542 345789999999999997 2689999 9999999999999999888
Q ss_pred cceEEEEecCCCCCCCCceEEeeeecCCceEEEEc-CCeeeEeeCCCCCceeeeeeccccceeeEEEeeeCceeEEEEec
Q 003280 170 LERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFN-GSVKFACSGQWNGAAFVSAISYTNFLYEQYLVENQDEISYWYEP 248 (834)
Q Consensus 170 ~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~-~~~~~~~sg~w~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (834)
.. | ++.+||++|.|+++++++|. +++++ ++.+||++|.|++.... ..-.... .+.+. +.+...+.++.
T Consensus 153 ~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~-l~l~~dG--nLvl~-d~~~~~vWsS~ 221 (276)
T 3m7h_A 153 SE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVR-AVFQGDG--NLVVY-GAGNAVLWHSH 221 (276)
T ss_dssp EE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCE-EEECTTS--CEEEE-CTTSCEEEECS
T ss_pred cc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEE-EEEcCCC--eEEEE-eCCCcEEEEec
Confidence 65 5 67899999999999999985 45565 46899999999864321 1111111 11222 22223444444
Q ss_pred cCCCeeeEEEECcCCcEEEEEeecCCCceEEEEecc
Q 003280 249 FNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFP 284 (834)
Q Consensus 249 ~~~~~~~rl~L~~~G~l~~~~w~~~~~~W~~~~~~p 284 (834)
.......|++|+.||++++|.| ...|..++.+|
T Consensus 222 t~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P 254 (276)
T 3m7h_A 222 TGGHASAVLRLQANGSIAILDE---KPVWARFGFQP 254 (276)
T ss_dssp CTTCTTCEEEECTTSCEEEEEE---EEEEESSSCCT
T ss_pred CCCCCCEEEEEcCCccEEEEcC---CCeEEccCccC
Confidence 3333458999999999999998 23465555444
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=398.62 Aligned_cols=248 Identities=25% Similarity=0.293 Sum_probs=199.2
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHH---HHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNE---MMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E---~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
++|+++++||+|+||.||+|+.. +|+.||||++++.. ......+.+| +.++..++|||||+++++|++.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 78999999999999999999986 48999999996531 2223334444 55666778999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
|||||++||+|..++. +.+.+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999984 3456899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
.... ....+||+.|||||++.. ..|+.++|+|||||+||||++|+.||........ ...........
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~~i~~~~------ 410 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMA------ 410 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHHHHHHCC------
T ss_pred CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhhcCCC------
Confidence 5432 334689999999999975 5799999999999999999999999965332211 11111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPT-----MSDVVS 784 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 784 (834)
...+.....++.+|+.+||+.||++|++ ++||++
T Consensus 411 ------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0111122346789999999999999998 788875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=359.34 Aligned_cols=284 Identities=35% Similarity=0.541 Sum_probs=232.0
Q ss_pred CcCcccHHHHHHHhcCcccc------ceeeeecceeEEEEEECCCcEEEEEEccCc----ccccHHHHHHHHHHHHhhcC
Q 003280 499 WLPLFSLASVAAATENFSMQ------CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ----SGQGLEEFKNEMMLIAKLQH 568 (834)
Q Consensus 499 ~~~~~~~~~~~~~~~~f~~~------~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H 568 (834)
..+.|++.++..++++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34568999999999998877 8999999999999987 6889999998653 23446789999999999999
Q ss_pred CCcceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE
Q 003280 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648 (834)
Q Consensus 569 pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 648 (834)
|||+++++++.+.+..++||||+++++|.+++........+++..+..++.||+.||+|||+++ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999865555567899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHh
Q 003280 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLL 728 (834)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~ 728 (834)
+.++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|||++|+.||........ +.
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~ 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LL 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HH
Confidence 9999999999999987654332223334578999999998865 589999999999999999999999875443321 11
Q ss_pred HHHHhHhc-CCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 729 GYAWDLWK-DDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 729 ~~~~~~~~-~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.+...... ...+.+.+++.+ ..........+.+++.+||+.+|++|||++|+++.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111111 122233344433 2345667788999999999999999999999999999863
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=366.16 Aligned_cols=268 Identities=26% Similarity=0.428 Sum_probs=205.1
Q ss_pred HhcCccccceeeeecceeEEEEEECCCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
..++|++.+.||+|+||.||+|+. .++.||||++.... ....+++.+|++++++++||||+++++++.+....++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 347899999999999999999987 68899999987653 334568999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++........+++..+..++.||+.||+|||+++ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999965443445899999999999999999999975 34999999999999999999999999999865433
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ... .......
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~---~~~~~~~--------- 256 (309)
T 3p86_A 193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVA---AVGFKCK--------- 256 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHH---HHHHSCC---------
T ss_pred c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH---HHHhcCC---------
Confidence 2 12234578999999999999999999999999999999999999986543211 111 1100000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCCCCC
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPK 797 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~ 797 (834)
....+......+.+++.+||+.+|++|||++|+++.|+.......+|+
T Consensus 257 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 257 -RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred -CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 011111223467899999999999999999999999998855544433
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=363.63 Aligned_cols=262 Identities=25% Similarity=0.418 Sum_probs=213.8
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 68999999999999999999985 48899999997777777889999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999854 2456899999999999999999999998 999999999999999999999999999886443221
Q ss_pred c------------ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc
Q 003280 672 G------------NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK 739 (834)
Q Consensus 672 ~------------~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 739 (834)
. ......||+.|+|||++.+..++.++||||||+++|||++|..|+...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~------- 237 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR------- 237 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH-------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh-------
Confidence 1 111457999999999999999999999999999999999999987654332211100000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccC
Q 003280 740 FHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLEL 793 (834)
Q Consensus 740 ~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 793 (834)
...+... +...+..+.+++.+||+.||++|||++|+++.|+.+...+
T Consensus 238 --~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 238 --GFLDRYC-----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp --HHHHHTC-----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --ccccccC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0011100 1111235778999999999999999999999999886543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=365.01 Aligned_cols=266 Identities=26% Similarity=0.342 Sum_probs=210.2
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC----eEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG----EKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lV 587 (834)
.++|++.++||+|+||.||+|+.. ++.||||+++.... ....+..|+.++.+++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 378999999999999999999874 79999999965432 3345677999999999999999999998855 47999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc----------CCCceEeccCCCCcEEEcCCCCceee
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY----------SRFRIIHRDLKASNVLLDMDMNPKIS 657 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------~~~~ivH~Dlkp~NIll~~~~~~kl~ 657 (834)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999999843 3589999999999999999999998 6 9999999999999999999999
Q ss_pred eecceeecCCCccccccceecccccccccccccC-----CccCccCceeehhhhHHHhhcCCCCCCCCCCCccc-HhH--
Q 003280 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFN-LLG-- 729 (834)
Q Consensus 658 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~-l~~-- 729 (834)
|||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999988765544333444679999999999987 35678899999999999999999998764432211 100
Q ss_pred -------HHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 730 -------YAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 730 -------~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.......... ..+.+............+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CSSCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0001111111 11111111112345567899999999999999999999999998863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.34 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=207.7
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|++.+.||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 368999999999999999999864 5899999999776666678899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999998843 35889999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ........ ...
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~---~~~~~~~~-~~~------- 236 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--AL---YLIATNGT-PEL------- 236 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH---HHHHHHCS-CCC-------
T ss_pred --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HH---HHHHhCCC-CCC-------
Confidence 2334579999999999999999999999999999999999999986433211 11 11110000 000
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+......+.+++.+||+.||++|||++|+++
T Consensus 237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011122346789999999999999999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=369.02 Aligned_cols=259 Identities=28% Similarity=0.440 Sum_probs=212.0
Q ss_pred hcCccccceeeeecceeEEEEEEC--------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ 581 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 581 (834)
.++|++.+.||+|+||.||+|+.. .+..||||+++... ....+++.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 378999999999999999999862 34579999997653 34467899999999999 899999999999999
Q ss_pred CeEEEEEeecCCCCccccccCCC-------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE
Q 003280 582 GEKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 648 (834)
+..++||||+++|+|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999986432 1245789999999999999999999998 9999999999999
Q ss_pred cCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccH
Q 003280 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l 727 (834)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--~ 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence 9999999999999998765443333344567889999999999999999999999999999999 999986543221 1
Q ss_pred hHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 728 LGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.. ....+.. . ..+.....++.+++.+||+.+|++||++.|+++.|+.+
T Consensus 315 ~~----~~~~~~~-----~-----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 315 FK----LLKEGHR-----M-----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HH----HHHTTCC-----C-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----HHhcCCC-----C-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 1111110 0 11112234688999999999999999999999999886
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=355.55 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=214.1
Q ss_pred cccHHHHHHHhcC----------ccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCC
Q 003280 502 LFSLASVAAATEN----------FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570 (834)
Q Consensus 502 ~~~~~~~~~~~~~----------f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn 570 (834)
.++.+++..+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4677777776654 777889999999999999986 69999999998776677788999999999999999
Q ss_pred cceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC
Q 003280 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM 650 (834)
Q Consensus 571 Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 650 (834)
|+++++++...+..++||||+++++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 9999999999999999999999999999883 345899999999999999999999998 999999999999999
Q ss_pred CCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHH
Q 003280 651 DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGY 730 (834)
Q Consensus 651 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~ 730 (834)
++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ....
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~- 251 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMK- 251 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH-
T ss_pred CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH-
Confidence 99999999999987654322 223457999999999999999999999999999999999999998643211 1111
Q ss_pred HHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 731 AWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 731 ~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
..... ..+.+ .........+.+++.+||+.||++|||++|+++-
T Consensus 252 --~~~~~------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 252 --RLRDS------PPPKL---KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --HHHHS------SCCCC---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHhcC------CCCCc---CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11110 00111 0011123467899999999999999999999873
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=347.77 Aligned_cols=262 Identities=26% Similarity=0.327 Sum_probs=204.3
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHh--hcCCCcceEEeEEEec----CeEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAK--LQHRNLVKLLGCCVEQ----GEKI 585 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~----~~~~ 585 (834)
.++|++.+.||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 47899999999999999999988 6899999999654 33556667777766 7999999999997653 4589
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhh--------hcCCCceEeccCCCCcEEEcCCCCceee
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH--------QYSRFRIIHRDLKASNVLLDMDMNPKIS 657 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 657 (834)
+||||+++|+|.+++. ...+++..+..++.||+.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999983 346899999999999999999999 666 9999999999999999999999
Q ss_pred eecceeecCCCccc--cccceecccccccccccccCC------ccCccCceeehhhhHHHhhcC----------CCCCCC
Q 003280 658 DFGLARMFGGDELQ--GNTKRIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSG----------KKNTGV 719 (834)
Q Consensus 658 Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~------~~t~~~DVwSlGvvl~elltG----------~~p~~~ 719 (834)
|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999876443221 112334799999999999877 566899999999999999999 677654
Q ss_pred CCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 720 YNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 720 ~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
................... ..+.+............+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3332222221111111111 1111111222334667899999999999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=354.65 Aligned_cols=253 Identities=26% Similarity=0.341 Sum_probs=204.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 78999999999999999999876 58899999986543 23346788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999984 3456899999999999999999999998 99999999999999999999999999987644333
Q ss_pred ccccceecccccccccccccCCcc-CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~-t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||............+... . . ...+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----~-~--~~~~--- 230 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----K-T--YLNP--- 230 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT----C-T--TSTT---
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc----c-c--cCCc---
Confidence 333345689999999999988775 789999999999999999999997654433222211110 0 0 0000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
.......+.+++.+||+.||++|||++|+++-
T Consensus 231 ----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 ----WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01123456789999999999999999999873
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=359.05 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=207.9
Q ss_pred hcCccccceeeeecceeEEEEEEC----CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+|++. .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 368999999999999999999874 3446999999765 34456789999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999843 3346899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCcccc-ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 667 GDELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 667 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+. ........
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~---~~~~~~~~----- 272 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVI---SSVEEGYR----- 272 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHH---HHHHTTCC-----
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHH---HHHHcCCC-----
Confidence 432211 1222356778999999999999999999999999999999 99998543221 111 11111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERL 791 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 791 (834)
...+......+.+++.+||+.||++|||++|++++|+.+..
T Consensus 273 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 273 ------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 01111223467899999999999999999999999998743
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=369.65 Aligned_cols=258 Identities=26% Similarity=0.361 Sum_probs=210.2
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.+.||+|+||.||+|++. +++.||||+++... ....++|.+|++++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 478999999999999999999986 58899999997643 3334578999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999853 2345889999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.........+++.|+|||++.+..++.++|||||||++|||++ |+.|+...... .... ....+.. .
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~----~~~~~~~-----~-- 334 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTRE----FVEKGGR-----L-- 334 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHH----HHHTTCC-----C--
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcCCC-----C--
Confidence 2222223346788999999999999999999999999999998 99888643321 1111 1111100 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
..+...+..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 335 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 335 ---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 011112346789999999999999999999999998874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.06 Aligned_cols=247 Identities=27% Similarity=0.402 Sum_probs=204.8
Q ss_pred hcCccccceeeeecceeEEEEEE-CCCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.++|++.+.||+|+||.||+|++ .+|+.||||++... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 36899999999999999999997 46899999998654 3345677899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999998843 345899999999999999999999998 999999999999999999999999999876443
Q ss_pred ccccccceecccccccccccccCCccC-ccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t-~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
. ......||+.|+|||++.+..+. .++|||||||++|||++|+.||...+.. .+ ........ .
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~---~~~i~~~~-~------- 231 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--EL---RERVLRGK-Y------- 231 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH---HHHHHHCC-C-------
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HH---HHHHHhCC-C-------
Confidence 2 23346799999999999988875 8999999999999999999998643321 11 11111110 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+.....++.+++.+||+.||++|||++|+++
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111112346789999999999999999999987
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.99 Aligned_cols=256 Identities=29% Similarity=0.421 Sum_probs=210.5
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|++.+.||+|+||.||+|+..+++.||||+++... ...+++.+|+.++.+++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 47899999999999999999999888899999997543 34577999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999843 2345899999999999999999999998 999999999999999999999999999876544322
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
. .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... . ........ .... .
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~---~~~~~~~~---~~~~----~ 227 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--V---VLKVSQGH---RLYR----P 227 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--H---HHHHHTTC---CCCC----C
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--H---HHHHHcCC---CCCC----C
Confidence 1 222456778999999999999999999999999999999 999986433211 1 11111110 0000 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.. ....+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 228 ~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 HL----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TT----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred Cc----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11 1236789999999999999999999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=362.49 Aligned_cols=269 Identities=26% Similarity=0.393 Sum_probs=213.9
Q ss_pred ccHHHHHHHhcCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceE
Q 003280 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKL 574 (834)
Q Consensus 503 ~~~~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l 574 (834)
+.........++|++.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 344455556789999999999999999999742 35789999997643 33456799999999999 79999999
Q ss_pred EeEEEecCe-EEEEEeecCCCCccccccCCCC------------------------------------------------
Q 003280 575 LGCCVEQGE-KILILEYMPNKSLDVFLFDPTK------------------------------------------------ 605 (834)
Q Consensus 575 ~~~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------ 605 (834)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999988654 8999999999999999865432
Q ss_pred ---------------CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 606 ---------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 606 ---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999998 99999999999999999999999999987654433
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||........ +. .........
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~----~~~~~~~~~-------- 315 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FC----RRLKEGTRM-------- 315 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HH----HHHHHTCCC--------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HH----HHHHcCCCC--------
Confidence 333444678999999999999999999999999999999998 9999865443221 11 111111000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..+.....++.+++.+||+.||++|||++|+++.|+.+
T Consensus 316 --~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 316 --RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 01111234678999999999999999999999999876
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=364.68 Aligned_cols=267 Identities=28% Similarity=0.410 Sum_probs=215.4
Q ss_pred hcCccccceeeeecceeEEEEEEC--------CCcEEEEEEccCc-ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ 581 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 581 (834)
.++|.+.++||+|+||.||+|+.. .+..||||+++.. .....+++.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 478999999999999999999862 2357999999765 334457899999999999 999999999999999
Q ss_pred CeEEEEEeecCCCCccccccCCCC-------------CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE
Q 003280 582 GEKILILEYMPNKSLDVFLFDPTK-------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 648 (834)
+..++||||+++|+|.+++..... ...+++..+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999854321 245899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccH
Q 003280 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l 727 (834)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~~ 302 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL 302 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 9999999999999987755443333444567899999999999999999999999999999999 99998643321 11
Q ss_pred hHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCCCCC
Q 003280 728 LGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPK 797 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~ 797 (834)
. ......... .. +.....++.+++.+||+.||++|||++|+++.|+.+.......+
T Consensus 303 ~----~~~~~~~~~-----~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 303 F----KLLKEGHRM-----DK-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp H----HHHHTTCCC-----CC-----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred H----HHHHcCCCC-----CC-----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 1 111111100 00 11123467899999999999999999999999999854444333
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=357.67 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=201.1
Q ss_pred cCccccceeeeecceeEEEEEECC-Cc----EEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
++|++.+.||+|+||.||+|++.. ++ .||+|+++.. .....+++.+|+.++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 679999999999999999998643 44 4688888654 3445678999999999999999999999998754 789
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
|+||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999854 2356899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +.. .......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~----~~~~~~~----- 237 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS----ILEKGER----- 237 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH----HHHTTCC-----
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHH----HHHcCCC-----
Confidence 5544333444567889999999999999999999999999999999 999986543322 111 1111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
...+......+.+++.+||+.+|++||+++|+++.|+..
T Consensus 238 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 238 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011112234678999999999999999999999998765
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.35 Aligned_cols=271 Identities=21% Similarity=0.289 Sum_probs=215.7
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecC--eEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG--EKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~ 588 (834)
++|++.+.||+|+||.||+|+... ++.||||+++... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 689999999999999999999864 8999999997543 344678899999999999999999999998765 789999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE----cCCCCceeeeecceee
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL----DMDMNPKISDFGLARM 664 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~~ 664 (834)
||+++++|.+++........+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976555555899999999999999999999998 9999999999999 7778899999999988
Q ss_pred cCCCccccccceeccccccccccccc--------CCccCccCceeehhhhHHHhhcCCCCCCCCCCCccc--HhHHHHhH
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYAL--------DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFN--LLGYAWDL 734 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~--l~~~~~~~ 734 (834)
...... .....||+.|+|||++. +..++.++|||||||++|||++|+.||......... ........
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 754332 22357899999999986 578899999999999999999999998654432211 11111111
Q ss_pred hcCCccccc---cc-------cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 735 WKDDKFHEL---ID-------PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 735 ~~~~~~~~l---id-------~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
........+ .. ...............+.+++.+||+.||++|||++|+++-..+.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 111100000 00 00112234566777889999999999999999999999988876
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=346.63 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=209.4
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|++.+.||+|+||.||+|+..+++.||||++.... ...+++.+|+.++++++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 6899999999999999999999889999999997643 334779999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 162 (269)
T 4hcu_A 89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 162 (269)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc-
Confidence 9999999853 3346899999999999999999999998 999999999999999999999999999876443211
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... . ........ ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~---~~~~~~~~------~~~---- 227 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--V---VEDISTGF------RLY---- 227 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H---HHHHHTTC------CCC----
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--H---HHHHhcCc------cCC----
Confidence 1223456788999999999999999999999999999999 899986433211 1 11111110 000
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.+......+.+++.+||+.+|++||+++|+++.|+++
T Consensus 228 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 228 -KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 0111234678999999999999999999999999886
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=353.82 Aligned_cols=247 Identities=22% Similarity=0.298 Sum_probs=204.8
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|+.. +++.||||++++. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 68999999999999999999876 5899999999754 2345678899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|..++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999998884 3456899999999999999999999998 999999999999999999999999999864322
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+. ....... .
T Consensus 159 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~---~~i~~~~-~-------- 222 (337)
T 1o6l_A 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLF---ELILMEE-I-------- 222 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HHHHHCC-C--------
T ss_pred C--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HHH---HHHHcCC-C--------
Confidence 2 1234468999999999999999999999999999999999999998643211 111 1111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
..+.....++.+++.+||+.||++|| +++|+++
T Consensus 223 ---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 01111234678999999999999999 8999976
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.66 Aligned_cols=260 Identities=26% Similarity=0.393 Sum_probs=205.5
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
.++|++.+.||+|+||.||+|+.. .++.||+|++... .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 368999999999999999999875 5889999998543 233457899999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|.+++. ..+.+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999984 3346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......... .... ...
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~-~~~~-~~~ 235 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-----IAIKHIQDS-VPNV-TTD 235 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-----HHHHHHSSC-CCCH-HHH
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhhcc-CCCc-chh
Confidence 321 22334579999999999999999999999999999999999999986533211 111111111 1000 000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhccc
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRP-TMSDVVSIINSER 790 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~ 790 (834)
.....+..+.+++.+|++.||++|| +++++.+.|+...
T Consensus 236 -----~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 236 -----VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp -----SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred -----cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0111234678999999999999998 9999999998873
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=347.56 Aligned_cols=267 Identities=27% Similarity=0.406 Sum_probs=207.0
Q ss_pred hcCccccceeeeecceeEEEEEE-----CCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 584 (834)
.++|++.+.||+|+||.||+|++ .+++.||||+++.......+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 37899999999999999999984 25889999999877777778899999999999999999999998654 568
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998542 335899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcc----------cHhHHHHh
Q 003280 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF----------NLLGYAWD 733 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~----------~l~~~~~~ 733 (834)
....... .......++..|+|||++.+..++.++||||||+++|||++|..|+........ ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543221 122234577789999999999999999999999999999999988753211000 00000011
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccC
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLEL 793 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 793 (834)
...... ....+...+.++.+++.+||+.||++|||++|+++.|+.+...+
T Consensus 244 ~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 244 LLKNNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHTTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHhccC----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 111100 01111223356889999999999999999999999999875544
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=363.88 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=197.2
Q ss_pred cCccccceeeeecceeEEEEEEC----CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
++|++.+.||+|+||.||+|++. .+..||||+++.. .....++|.+|+.++++++||||+++++++.+....++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 68999999999999999999875 4678999999764 334567899999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 125 ~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999853 3346899999999999999999999998 99999999999999999999999999987754
Q ss_pred Ccccc-ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 668 DELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 668 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .+... .....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~~----i~~~~------ 267 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKA----VDEGY------ 267 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHHH----HHTTE------
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcCC------
Confidence 32211 1222345778999999999999999999999999999998 99998643221 11111 11110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
...........+.+++.+||+.||++||+++|++++|+.+.
T Consensus 268 ----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 268 ----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp ----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 00111122356889999999999999999999999998763
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.05 Aligned_cols=259 Identities=29% Similarity=0.443 Sum_probs=212.0
Q ss_pred hcCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 584 (834)
.++|.+.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 478999999999999999999862 35789999997643 34567899999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCC---------------------CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCC
Q 003280 585 ILILEYMPNKSLDVFLFDPTK---------------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKA 643 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp 643 (834)
++||||+++++|.+++..... ...+++..+..++.||++||+|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999864322 234889999999999999999999998 99999999
Q ss_pred CcEEEcCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCC
Q 003280 644 SNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNA 722 (834)
Q Consensus 644 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~ 722 (834)
+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999988755443333334567889999999999999999999999999999999 9999865433
Q ss_pred CcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 723 DSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 723 ~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.. +. ......... .........+.+++.+||+.||++||++.|+++.|+.+
T Consensus 259 ~~--~~----~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 ER--LF----NLLKTGHRM----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GG--HH----HHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH--HH----HHhhcCCcC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 21 11 111111100 01112234688999999999999999999999999876
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=352.40 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=204.7
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc------ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG------QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+++.. +|+.||||+++.... ...+.+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 368999999999999999999886 489999999875432 2357899999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC----Cceeeeec
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM----NPKISDFG 660 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg 660 (834)
++||||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999984 3456899999999999999999999998 99999999999998877 79999999
Q ss_pred ceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcc
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKF 740 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 740 (834)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ... ....
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--~~~~---~i~-~~~~ 235 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLA---NIT-AVSY 235 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHH---HHH-TTCC
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHH---HHH-hcCC
Confidence 998875432 223457999999999999999999999999999999999999998643221 1111 111 0000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..++.. ... ....+.+++.+||+.||++|||+.|+++
T Consensus 236 --~~~~~~-~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 --DFDEEF-FSQ----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --CCCHHH-HTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --CCCchh-ccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 011 1346789999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=348.11 Aligned_cols=266 Identities=27% Similarity=0.447 Sum_probs=207.4
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|++.+.||+|+||.||+|+. .++.||||++... ...+.|.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 6799999999999999999988 4789999999643 34578999999999999999999999886 35799999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC-ceeeeecceeecCCCccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN-PKISDFGLARMFGGDELQ 671 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~~~~~~~~ 671 (834)
+++|.+++........+++..++.++.||++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976554456788999999999999999999943234999999999999998887 799999999765432
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........... +..... .. +.. ..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~~-~~-----~~~-~~ 227 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHNG-TR-----PPL-IK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH---HHHHTT-CC-----CCC-BT
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH---HHHhcC-CC-----CCc-cc
Confidence 2234689999999999999999999999999999999999999875433322111 111111 11 111 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCCCCCCCccc
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAFI 802 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~p~~~ 802 (834)
. ....+.+++.+||+.||++|||++|+++.|+.+....+.+..|...
T Consensus 228 ~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~ 274 (307)
T 2eva_A 228 N----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274 (307)
T ss_dssp T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCCC
T ss_pred c----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcccc
Confidence 1 2245789999999999999999999999999987666666555543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=355.36 Aligned_cols=262 Identities=28% Similarity=0.415 Sum_probs=209.1
Q ss_pred hcCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 583 (834)
.++|++.+.||+|+||.||+|+.. .++.||||+++... ....+.+.+|+.++.++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 478999999999999999999862 35689999997542 33457899999999999 89999999999999999
Q ss_pred EEEEEeecCCCCccccccCCCC--------------------CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCC
Q 003280 584 KILILEYMPNKSLDVFLFDPTK--------------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKA 643 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp 643 (834)
.++||||+++|+|.+++..... ...+++..+..++.||+.||+|||+++ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 9999999999999999865322 134789999999999999999999998 99999999
Q ss_pred CcEEEcCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCC
Q 003280 644 SNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNA 722 (834)
Q Consensus 644 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~ 722 (834)
+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987654433223334567889999999999999999999999999999998 9999865433
Q ss_pred CcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 003280 723 DSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERL 791 (834)
Q Consensus 723 ~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 791 (834)
... +. ....... .. ..+......+.+++.+||+.||++|||+.|+++.|+....
T Consensus 281 ~~~-~~----~~~~~~~-----~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 281 DAN-FY----KLIQNGF-----KM-----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp SHH-HH----HHHHTTC-----CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHH-HH----HHHhcCC-----CC-----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 211 11 1111110 00 0111123467899999999999999999999999998743
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=353.43 Aligned_cols=264 Identities=27% Similarity=0.426 Sum_probs=213.1
Q ss_pred HHHhcCccccceeeeecceeEEEEEECC------CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEec
Q 003280 509 AAATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ 581 (834)
Q Consensus 509 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 581 (834)
....++|++.+.||+|+||.||+|+... ++.||||+++... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 3455889999999999999999998742 4789999997653 33467899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCccccccCCCC---------------------CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEecc
Q 003280 582 GEKILILEYMPNKSLDVFLFDPTK---------------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRD 640 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 640 (834)
+..++||||+++++|.+++..... ...+++..++.++.||++||+|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999854321 256899999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCC
Q 003280 641 LKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGV 719 (834)
Q Consensus 641 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~ 719 (834)
|||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987654433333344578899999999999999999999999999999999 9999864
Q ss_pred CCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 003280 720 YNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERL 791 (834)
Q Consensus 720 ~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 791 (834)
.... .+. . ....+.... .+.....++.+++.+||+.||++||++.|+++.|+.+..
T Consensus 280 ~~~~--~~~---~-~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAHE--EVI---Y-YVRDGNILA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCHH--HHH---H-HHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CChH--HHH---H-HHhCCCcCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 3221 111 1 111111110 111123467899999999999999999999999998743
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=357.70 Aligned_cols=266 Identities=25% Similarity=0.359 Sum_probs=210.2
Q ss_pred cCccccceeeeecceeEEEEEE-----CCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEE--ecCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV--EQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~~ 585 (834)
++|++.+.||+|+||.||+|++ ..++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6899999999999999999984 357899999998877667788999999999999999999999987 455789
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999998432 345899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcc---------cHhHHHHhHh
Q 003280 666 GGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF---------NLLGYAWDLW 735 (834)
Q Consensus 666 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~---------~l~~~~~~~~ 735 (834)
...... .......+|+.|+|||++.+..++.++||||||+++|||++|+.|+........ ..........
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 543221 122334678889999999999999999999999999999999998753221100 0000000111
Q ss_pred cCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccC
Q 003280 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLEL 793 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 793 (834)
... . ....+......+.+++.+||+.||++|||++|+++.|+.+....
T Consensus 258 ~~~---------~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 258 EEG---------Q-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HTT---------C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hcc---------c-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 110 0 01112223456889999999999999999999999999875443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=354.77 Aligned_cols=272 Identities=28% Similarity=0.381 Sum_probs=207.9
Q ss_pred CccccceeeeecceeEEEEEEC-----CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeEE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKI 585 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 585 (834)
.|++.++||+|+||.||++... +++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3499999999999999998642 57889999997653 34467899999999999999999999999884 5789
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+||||+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 112 lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999843 34899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 666 GGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 666 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
...... .......+|..|+|||++.+..++.++||||||+++|||++|+.|+............+...........+.+
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 543221 1223356788899999999999999999999999999999999987542211100000000000000011111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccC
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLEL 793 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 793 (834)
+... ....+......+.+++.+||+.||++|||++|+++.|+.+....
T Consensus 265 ~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 265 ERGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hccc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 1111 11112223457889999999999999999999999998875443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=346.09 Aligned_cols=263 Identities=25% Similarity=0.324 Sum_probs=201.4
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.++||+|+||+||+|+..+++.||||+++... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 37899999999999999999999889999999987542 2335678999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++ +|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 66666643 3345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccc---ccc-
Q 003280 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH---ELI- 744 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~---~li- 744 (834)
.......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .............. ...
T Consensus 174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHHHHCCCCTTTSGGGTT
T ss_pred --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHCCCChHHhhhhhc
Confidence 12233578999999999876 5689999999999999999999999975443321 11111111110000 000
Q ss_pred -----ccccc-cCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 745 -----DPVIT-QDEISL-----PVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 745 -----d~~l~-~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+.... ...... ....++.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 000011 11246789999999999999999999987
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.02 Aligned_cols=255 Identities=20% Similarity=0.298 Sum_probs=206.6
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|++.+.||+|+||.||++.... ++.||+|.++.. ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 3789999999999999999998764 789999998654 33456789999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC--CCCceeeeecceeecCCC
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM--DMNPKISDFGLARMFGGD 668 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~ 668 (834)
+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999998843 3346899999999999999999999998 999999999999987 789999999999887543
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ....... .. .+...
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~---~~i~~~~-~~--~~~~~ 226 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QII---ENIMNAE-YT--FDEEA 226 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH---HHHHHTC-CC--CCHHH
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHH---HHHHcCC-CC--CChhh
Confidence 2 233467899999999999999999999999999999999999998643221 111 1111110 00 00000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
... ...++.+++.+||+.||++|||+.|+++ .+.+
T Consensus 227 -~~~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 227 -FKE----ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp -HTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred -hcc----CCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 001 1346789999999999999999999998 4444
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=341.19 Aligned_cols=252 Identities=29% Similarity=0.482 Sum_probs=196.5
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcc----cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|.. .++.||||+++... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 6899999999999999999997 48899999987543 233578999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC--------CCCceeeeec
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM--------DMNPKISDFG 660 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~Dfg 660 (834)
||+++++|.+++. ...+++..+..++.|++.||+|||+++..+|+||||||+||+++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999883 446899999999999999999999987666999999999999986 7789999999
Q ss_pred ceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcc
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKF 740 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 740 (834)
+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ......... .
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~-~ 231 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-----VAYGVAMNK-L 231 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHHHHTSC-C
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHhhhcCC-C
Confidence 998664332 223578999999999999999999999999999999999999986433211 111111111 0
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 741 ~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
. ...+......+.+++.+||+.||++|||+.|+++.|+.
T Consensus 232 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 232 A---------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred C---------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0 01111223468899999999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.16 Aligned_cols=262 Identities=20% Similarity=0.209 Sum_probs=208.6
Q ss_pred hcCccccceeeeecceeEEEEEE-CCCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++++ +||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36899999999999999999987 4688999999865432 24688999999999 99999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC-----ceeeeecceee
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN-----PKISDFGLARM 664 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgla~~ 664 (834)
|+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998532 456899999999999999999999998 999999999999998887 99999999998
Q ss_pred cCCCcccc-----ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcc-cHhHHHHhHhcCC
Q 003280 665 FGGDELQG-----NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF-NLLGYAWDLWKDD 738 (834)
Q Consensus 665 ~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~ 738 (834)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 64432211 12356899999999999999999999999999999999999999976543321 1111000000000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 003280 739 KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLE 792 (834)
Q Consensus 739 ~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 792 (834)
....+ ... .+ ++.+++..|++.+|.+||++.+|++.|++....
T Consensus 240 -----~~~~~-~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 240 -----PIEVL-CEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp -----CHHHH-TTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----CHHHH-hcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 00000 000 12 788999999999999999999999999876433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.06 Aligned_cols=263 Identities=21% Similarity=0.283 Sum_probs=200.8
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|++.++||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999986 48899999987543 3345788999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|++++.+..+. ...+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99875444443 23456899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccceecccccccccccccCCc-cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc---c---cc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK---F---HE 742 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~-~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~---~---~~ 742 (834)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.|+....... .............. . ..
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHCCCCTTTCTTGGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhhhhhhcc
Confidence 1223357899999999998766 8999999999999999999988854322211 11111111111100 0 00
Q ss_pred cccc--------ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 743 LIDP--------VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 743 lid~--------~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+. ..............+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 00000111123456789999999999999999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=351.34 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=193.7
Q ss_pred hcCccccceeeeecceeEEEEEECCCc----EEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeE-
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQ----EVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK- 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~----~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~- 584 (834)
.++|++.+.||+|+||.||+|+..... .||||+++.. .....+++.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 478999999999999999999875432 7999999764 344567899999999999999999999999887655
Q ss_pred -----EEEEeecCCCCccccccCCC---CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCcee
Q 003280 585 -----ILILEYMPNKSLDVFLFDPT---KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656 (834)
Q Consensus 585 -----~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 656 (834)
++||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 99999999999999885422 2235899999999999999999999998 999999999999999999999
Q ss_pred eeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHh
Q 003280 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... +.. ...
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~---~~~ 253 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--IYN---YLI 253 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH---HHH
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--HHH---HHh
Confidence 99999987655443333334567889999999999999999999999999999999 899886543221 111 111
Q ss_pred cCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
... . ..........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 254 ~~~-~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 254 GGN-R----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp TTC-C----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC-C----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 0 0111122346889999999999999999999999999873
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=354.54 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=201.8
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 586 (834)
.++|++.++||+|+||.||+|+... ++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 3789999999999999999999864 7889999997642 22345688899999887 89999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++|+|..++. +.+.+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999998884 3356899999999999999999999998 9999999999999999999999999998632
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCc---ccHhHHHHhHhcCCccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS---FNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~l 743 (834)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...............
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 278 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 278 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----
T ss_pred cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----
Confidence 221 22345689999999999999999999999999999999999999996433211 011111111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTM------SDVVS 784 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 784 (834)
+ ..+.....++.+|+.+||+.||++||++ +|+++
T Consensus 279 ----~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 279 ----I---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp ----C---CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ----c---CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 0 1111223467899999999999999985 56665
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=344.59 Aligned_cols=248 Identities=22% Similarity=0.322 Sum_probs=195.5
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc--------------------------ccHHHHHHHHHHHHh
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--------------------------QGLEEFKNEMMLIAK 565 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~~ 565 (834)
++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 78999999999999999999875 488999999865421 123568999999999
Q ss_pred hcCCCcceEEeEEEe--cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCC
Q 003280 566 LQHRNLVKLLGCCVE--QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKA 643 (834)
Q Consensus 566 l~HpnIv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp 643 (834)
++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||+.||+|||+++ |+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 999999999999987 56899999999999998875 3456899999999999999999999998 99999999
Q ss_pred CcEEEcCCCCceeeeecceeecCCCccccccceecccccccccccccCCc---cCccCceeehhhhHHHhhcCCCCCCCC
Q 003280 644 SNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSGKKNTGVY 720 (834)
Q Consensus 644 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~t~~~DVwSlGvvl~elltG~~p~~~~ 720 (834)
+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999988654322 123357899999999998765 478899999999999999999998643
Q ss_pred CCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 721 NADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 721 ~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. ......... .... . + . ... ....+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~-----~~~~~~~~~-~~~~-~--~-~-~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RI-----MCLHSKIKS-QALE-F--P-D-QPD----IAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SH-----HHHHHHHHH-CCCC-C--C-S-SSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cH-----HHHHHHHhc-ccCC-C--C-C-ccc----cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 111111111 1000 0 0 0 111 2246789999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=340.49 Aligned_cols=265 Identities=18% Similarity=0.225 Sum_probs=211.0
Q ss_pred hcCccccceeeeecceeEEEEEE-CCCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 36899999999999999999986 4689999999865432 24678899999999 79999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC-----ceeeeecceee
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN-----PKISDFGLARM 664 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgla~~ 664 (834)
|+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998532 345899999999999999999999998 999999999999987776 99999999998
Q ss_pred cCCCccc-----cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcc-cHhHHHHhHhcCC
Q 003280 665 FGGDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF-NLLGYAWDLWKDD 738 (834)
Q Consensus 665 ~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~ 738 (834)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 7543221 123346799999999999999999999999999999999999999976543221 1111111100000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCC
Q 003280 739 KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELP 794 (834)
Q Consensus 739 ~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 794 (834)
...+ + ... .+..+.+++.+||+.||++||++++|++.|+.+...+.
T Consensus 241 ~~~~-----~-~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 241 PLRE-----L-CAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp CHHH-----H-TTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cHHH-----H-Hhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 0000 0 011 13467899999999999999999999999998754443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=345.27 Aligned_cols=255 Identities=28% Similarity=0.409 Sum_probs=206.6
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|++.+.||+|+||.||+|+..+++.||||+++.... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 478999999999999999999998888999999976433 3477999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999998542 345899999999999999999999998 999999999999999999999999999876443211
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... . ....... ..... .
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~---~~~~~~~------~~~~~-~ 243 (283)
T 3gen_A 177 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--T---AEHIAQG------LRLYR-P 243 (283)
T ss_dssp -STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--H---HHHHHTT------CCCCC-C
T ss_pred -cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--H---HHHHhcc------cCCCC-C
Confidence 1222456788999999999999999999999999999998 999986533211 1 1111111 00000 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.. ....+.+++.+||+.+|++|||++|+++.|+++
T Consensus 244 ~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 244 HL----ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp TT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred Cc----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11 124678999999999999999999999999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=349.46 Aligned_cols=262 Identities=27% Similarity=0.390 Sum_probs=212.4
Q ss_pred hcCccccceeeeecceeEEEEEE------CCCcEEEEEEccCccc-ccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 583 (834)
.++|++.+.||+|+||.||+|+. ..++.||||+++.... ...+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 47899999999999999999985 2467899999976533 3457899999999999 99999999999999999
Q ss_pred EEEEEeecCCCCccccccCCCC---------------CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE
Q 003280 584 KILILEYMPNKSLDVFLFDPTK---------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 648 (834)
.++||||+++|+|.+++..... ...+++..+..++.||+.||+|||+++ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999854322 225899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccH
Q 003280 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l 727 (834)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||........ .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-F 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-H
Confidence 9999999999999988765433323334567889999999999999999999999999999999 9999865443221 1
Q ss_pred hHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 003280 728 LGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERL 791 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 791 (834)
...... . .... ........+.+++.+||+.||++|||+.|+++.|++...
T Consensus 258 ~~~~~~----~-----~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 258 YKMIKE----G-----FRML-----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHHH----T-----CCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcc----C-----CCCC-----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 111110 0 0000 011123467899999999999999999999999988743
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=362.05 Aligned_cols=260 Identities=28% Similarity=0.418 Sum_probs=208.4
Q ss_pred hcCccccceeeeecceeEEEEEEC------CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+|+.. .++.||||+++.. ......++.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 368999999999999999999853 3668999999754 344556789999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCC----CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC---Cceee
Q 003280 585 ILILEYMPNKSLDVFLFDPT----KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM---NPKIS 657 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 657 (834)
++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999985432 2345889999999999999999999998 99999999999998555 59999
Q ss_pred eecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhc
Q 003280 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWK 736 (834)
Q Consensus 658 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 736 (834)
|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. ....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~~---~i~~ 301 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLE---FVTS 301 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHH---HHHT
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH---HHHc
Confidence 9999986533322233334567899999999999999999999999999999998 99998643321 1111 1111
Q ss_pred CCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 737 DDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 737 ~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
... . .........+.+++.+||+.+|++|||+.|+++.|+...
T Consensus 302 ~~~------~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 302 GGR------M-----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TCC------C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC------C-----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 110 0 011112345789999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=349.55 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=200.6
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecC-------
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------- 582 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------- 582 (834)
.++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 468999999999999999999986 68999999997543 345678999999999999999999999986654
Q ss_pred --------------------------------------------------eEEEEEeecCCCCccccccCCCCCCcCCHH
Q 003280 583 --------------------------------------------------EKILILEYMPNKSLDVFLFDPTKKRLLGWQ 612 (834)
Q Consensus 583 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 612 (834)
..++||||+++++|.+++..........+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999999999766555666777
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc----------cccceeccccc
Q 003280 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ----------GNTKRIVGTYG 682 (834)
Q Consensus 613 ~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~~ 682 (834)
.+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 999999999999999999999999999987554211 11233579999
Q ss_pred ccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHH
Q 003280 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYI 762 (834)
Q Consensus 683 y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~ 762 (834)
|+|||++.+..++.++|||||||++|||++|..|+.. ..... ........ ..........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~~~-~~~~~~~~----------~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVRII-TDVRNLKF----------PLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHHHH-HHHHTTCC----------CHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHHHH-HHhhccCC----------CcccccCChhHH
Confidence 9999999999999999999999999999998766310 00000 00111000 001122335678
Q ss_pred HHHHhccccCCCCCCCHHHHHH
Q 003280 763 NVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 763 ~li~~cl~~dP~~RPs~~evl~ 784 (834)
+++.+||+.||++|||++|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 9999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=343.19 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=195.3
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.++||+|+||.||+|+.. ..||||+++.. .....+.+.+|+.++++++||||++++++. .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 478999999999999999999863 46999998754 334467899999999999999999999965 5567899999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999998843 3456899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccceeccccccccccccc---CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~---~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
.........||+.|+|||++. +..++.++||||||+++|||++|+.||........ +... ..........
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~~~~~~~~~~-- 247 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIEM----VGRGSLSPDL-- 247 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HHHH----HHHTSCCCCT--
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HHHH----hcccccCcch--
Confidence 333334467899999999986 66789999999999999999999999865433211 1111 1111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.......+.++.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 248 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 248 ----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0111122356889999999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=369.46 Aligned_cols=257 Identities=29% Similarity=0.435 Sum_probs=209.5
Q ss_pred HhcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
..++|++.+.||+|+||.||+|.+.+++.||||+++... ...++|.+|+.+|++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 347899999999999999999999888999999997643 45788999999999999999999999986 6678999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999999998532 2235788899999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
.. .....+|+.|+|||++....++.++|||||||+||||++ |+.||...... .+.. ......+.
T Consensus 340 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~---~i~~~~~~--------- 404 (454)
T 1qcf_A 340 TA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIR---ALERGYRM--------- 404 (454)
T ss_dssp HT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHH---HHHHTCCC---------
T ss_pred ec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHH---HHHcCCCC---------
Confidence 11 122356788999999999999999999999999999999 99998643321 1111 11111000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
..+...+.++.+++.+||+.||++|||+++|++.|+...
T Consensus 405 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 001112346889999999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=367.73 Aligned_cols=260 Identities=28% Similarity=0.433 Sum_probs=205.5
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|++.++||+|+||.||+|.+..+..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 47899999999999999999999888889999997643 345789999999999999999999999876 6789999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 261 ~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 999999998432 2345889999999999999999999998 999999999999999999999999999876543221
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .... . ...+. ..
T Consensus 337 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~---~-i~~~~-----~~---- 400 (452)
T 1fmk_A 337 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLD---Q-VERGY-----RM---- 400 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH---H-HHTTC-----CC----
T ss_pred -cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHH---H-HHcCC-----CC----
Confidence 1223456789999999999999999999999999999999 89998643321 1111 1 11110 00
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCC
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELP 794 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 794 (834)
..+...+..+.+++.+||+.||++|||++++++.|+.......
T Consensus 401 -~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 401 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 1111223467899999999999999999999999998754433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=355.39 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=199.9
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+|+.. +++.||||++++. .....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999876 4889999999754 234456788999999988 79999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++|+|..++. +.+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999884 3356899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+. .......
T Consensus 176 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~---~~i~~~~-------- 240 (353)
T 3txo_A 176 CNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLF---EAILNDE-------- 240 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HHHHHCC--------
T ss_pred cCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HHH---HHHHcCC--------
Confidence 222 2234468999999999999999999999999999999999999998653321 111 1111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTM------SDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 784 (834)
. ..+......+.+++.+||+.||++||++ +|+++
T Consensus 241 -~---~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 -V---VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -C---CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -C---CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0 0111123467889999999999999998 77766
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=369.92 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=211.4
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|++.++||+|+||.||+|.+.. ++.||||+++... ...++|.+|+.+|++++||||+++++++.+....++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4679999999999999999999865 8899999997643 3468899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999998542 2345889999999999999999999998 99999999999999999999999999998754332
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
.. .....+++.|+|||++.+..++.++|||||||+||||++ |+.|+....... +.. ....+. ..
T Consensus 374 ~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~-----~~--- 438 (495)
T 1opk_A 374 TA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYE----LLEKDY-----RM--- 438 (495)
T ss_dssp EC-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHH----HHHTTC-----CC---
T ss_pred ee-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcCC-----CC---
Confidence 21 222456789999999999999999999999999999999 888886543221 111 111110 00
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
..+......+.+|+.+||+.||++|||+.||++.|+...
T Consensus 439 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111122346789999999999999999999999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=346.02 Aligned_cols=250 Identities=25% Similarity=0.335 Sum_probs=203.8
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc------ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG------QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
++|++.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 67999999999999999999986 488999999865422 24678999999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC----Cceeeeecc
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM----NPKISDFGL 661 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgl 661 (834)
+||||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999984 3456899999999999999999999998 99999999999998887 899999999
Q ss_pred eeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccc
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH 741 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (834)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ...... .
T Consensus 165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~---~~~~~~-~- 234 (326)
T 2y0a_A 165 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLA---NVSAVN-Y- 234 (326)
T ss_dssp CEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHH---HHHHTC-C-
T ss_pred CeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHH---HHHhcC-C-
Confidence 98875432 223457999999999999999999999999999999999999998643211 1111 000000 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 742 ELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 742 ~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. ..... ... ....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~-~~~~~-~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 E-FEDEY-FSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C-CCHHH-HTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-cCccc-ccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00000 001 1246789999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=352.75 Aligned_cols=272 Identities=18% Similarity=0.214 Sum_probs=207.2
Q ss_pred hcCccccceeeeecceeEEEEEECC------CcEEEEEEccCcccccH-----------HHHHHHHHHHHhhcCCCcceE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQGL-----------EEFKNEMMLIAKLQHRNLVKL 574 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~------g~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~HpnIv~l 574 (834)
.++|++.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999998764 47899999876532211 123445556677789999999
Q ss_pred EeEEEec----CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc-
Q 003280 575 LGCCVEQ----GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD- 649 (834)
Q Consensus 575 ~~~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~- 649 (834)
++++... ...++||||+ +++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9999875 4589999999 9999999853 3356899999999999999999999998 99999999999999
Q ss_pred -CCCCceeeeecceeecCCCcccc-----ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCC
Q 003280 650 -MDMNPKISDFGLARMFGGDELQG-----NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD 723 (834)
Q Consensus 650 -~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~ 723 (834)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999998865432211 112346999999999999999999999999999999999999999753332
Q ss_pred cccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCCC
Q 003280 724 SFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPS 795 (834)
Q Consensus 724 ~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 795 (834)
.... ....... .....+++++.+..... +.++.+++..|++.+|++||++.+++++|+........
T Consensus 268 ~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 268 PKYV-RDSKIRY-RENIASLMDKCFPAANA----PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp HHHH-HHHHHHH-HHCHHHHHHHHSCTTCC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHH-HHHHHHh-hhhHHHHHHHhcccccC----HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 2111 1111111 11223333333322222 24678899999999999999999999999887544433
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=351.27 Aligned_cols=272 Identities=17% Similarity=0.207 Sum_probs=203.4
Q ss_pred cCccccceeeeecceeEEEEEEC----CCcEEEEEEccCccccc-----------HHHHHHHHHHHHhhcCCCcceEEeE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQSGQG-----------LEEFKNEMMLIAKLQHRNLVKLLGC 577 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~----~g~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~HpnIv~l~~~ 577 (834)
++|++.+.||+|+||.||+|... .+..+|||++....... ...+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 68999999999999999999985 46789999987543221 1346678888999999999999999
Q ss_pred EEe----cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC-
Q 003280 578 CVE----QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM- 652 (834)
Q Consensus 578 ~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~- 652 (834)
+.. ....++||||+ +++|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 988 67899999999 9999999843 337899999999999999999999998 99999999999998887
Q ss_pred -CceeeeecceeecCCCccc-----cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCccc
Q 003280 653 -NPKISDFGLARMFGGDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFN 726 (834)
Q Consensus 653 -~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~ 726 (834)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999887433211 1123457999999999999999999999999999999999999998643322222
Q ss_pred HhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCCCCC
Q 003280 727 LLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPK 797 (834)
Q Consensus 727 l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~ 797 (834)
.......... .....+........ .+.++.+++..||+.||++||++++|++.|+....++....
T Consensus 270 ~~~~~~~~~~--~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d 334 (345)
T 2v62_A 270 VQTAKTNLLD--ELPQSVLKWAPSGS----SCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLD 334 (345)
T ss_dssp HHHHHHHHHH--TTTHHHHHHSCTTS----CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCC
T ss_pred HHHHHHhhcc--cccHHHHhhccccc----cHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCC
Confidence 2111111110 01111111110011 23468899999999999999999999999998754443333
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=351.02 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=204.2
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+++... ++.||||++.+. .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 789999999999999999998764 789999998653 2345678899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 95 e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999884 3456899999999999999999999998 999999999999999999999999999986543
Q ss_pred ccccccceecccccccccccccC---CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~---~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||........... .......
T Consensus 169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~--~~~~~~~-------- 235 (384)
T 4fr4_A 169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI--VHTFETT-------- 235 (384)
T ss_dssp C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH--HHHHHHC--------
T ss_pred C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH--HHHHhhc--------
Confidence 2 2344689999999999974 4589999999999999999999999875443221111 1110000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPT-MSDVVS 784 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 784 (834)
....+......+.+++.+||+.||++||+ ++++++
T Consensus 236 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00111122346789999999999999998 777765
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=348.82 Aligned_cols=245 Identities=23% Similarity=0.353 Sum_probs=200.9
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|.+. .++.||||++.... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 68999999999999999999974 58899999986531 223467899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+ +|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 6788777743 346899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccceecccccccccccccCCcc-CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~-t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ...+...
T Consensus 162 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~ 223 (336)
T 3h4j_B 162 NF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSC 223 (336)
T ss_dssp BT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSS
T ss_pred cc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcC
Confidence 22 234579999999999998876 7899999999999999999999864322110 0000000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
....+......+.+++.+||+.||++|||++|+++
T Consensus 224 --~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 224 --VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp --CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred --CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00111122346789999999999999999999987
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=350.64 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=203.0
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-----ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-----SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 67999999999999999999875 5899999998542 12246789999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC---ceeeeecce
Q 003280 587 ILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN---PKISDFGLA 662 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla 662 (834)
||||+++++|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998777432 23345889999999999999999999998 999999999999987655 999999999
Q ss_pred eecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+. ...... ...
T Consensus 181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~---~~i~~~-~~~- 250 (351)
T 3c0i_A 181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RLF---EGIIKG-KYK- 250 (351)
T ss_dssp EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HHH---HHHHHT-CCC-
T ss_pred eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HHH---HHHHcC-CCC-
Confidence 88754322 12345799999999999999999999999999999999999999864211 111 011110 000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+.. ... ...++.+++.+||+.||++|||+.|+++
T Consensus 251 -~~~~~-~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 -MNPRQ-WSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -CCHHH-HTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCccc-ccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 011 1346789999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=349.43 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=210.3
Q ss_pred hcCccccceeeeecceeEEEEEEC--------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ 581 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 581 (834)
.++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999863 46789999997653 34467899999999999 899999999999999
Q ss_pred CeEEEEEeecCCCCccccccCCCC-------------CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE
Q 003280 582 GEKILILEYMPNKSLDVFLFDPTK-------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 648 (834)
+..++||||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999865322 234889999999999999999999998 9999999999999
Q ss_pred cCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccH
Q 003280 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l 727 (834)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~ 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--HH
Confidence 9999999999999998765433333334567889999999999999999999999999999999 99998643221 11
Q ss_pred hHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 728 LGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.. ...... . . .........+.+++.+||+.+|++|||++|+++.|+.+.
T Consensus 269 ~~---~~~~~~-~-----~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 269 FK---LLKEGH-R-----M-----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HH---HHHHTC-C-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HHhcCC-C-----C-----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 111110 0 0 011112346789999999999999999999999998874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=352.24 Aligned_cols=274 Identities=18% Similarity=0.261 Sum_probs=206.9
Q ss_pred hcCccccceeeee--cceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 512 TENFSMQCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G--~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
.++|++.++||+| +||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4789999999999 99999999986 58999999997543 3445778899999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999998543 2345899999999999999999999998 9999999999999999999999999987653
Q ss_pred CCc-----cccccceecccccccccccccC--CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhH---hc
Q 003280 667 GDE-----LQGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDL---WK 736 (834)
Q Consensus 667 ~~~-----~~~~~~~~~gt~~y~aPE~l~~--~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~---~~ 736 (834)
... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||................. ..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 211 1112223478999999999987 6799999999999999999999999975443221110000000 00
Q ss_pred -----CCc-------------ccccccc--------ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 737 -----DDK-------------FHELIDP--------VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 737 -----~~~-------------~~~lid~--------~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
... ....+.. ..............+.+|+.+||+.||++|||++|+++ .|+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 000 0000000 00000011122356889999999999999999999986 3554
Q ss_pred c
Q 003280 789 E 789 (834)
Q Consensus 789 ~ 789 (834)
.
T Consensus 340 ~ 340 (389)
T 3gni_B 340 I 340 (389)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=353.34 Aligned_cols=261 Identities=28% Similarity=0.396 Sum_probs=209.2
Q ss_pred HhcCccccceeeeecceeEEEEEECC------CcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecC
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG 582 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 582 (834)
..++|++.+.||+|+||.||+|.... .+.||+|+++... ....+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 34789999999999999999998743 2479999997653 33457799999999999 8999999999999999
Q ss_pred eEEEEEeecCCCCccccccCCC-----------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC
Q 003280 583 EKILILEYMPNKSLDVFLFDPT-----------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 651 (834)
..++||||+++|+|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 9999999999999999885321 1345789999999999999999999998 9999999999999999
Q ss_pred CCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHH
Q 003280 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGY 730 (834)
Q Consensus 652 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~ 730 (834)
+.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||........ +...
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKL 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HHHH
Confidence 9999999999987644332222334567889999999999999999999999999999999 8888865432211 1111
Q ss_pred HHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 731 AWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 731 ~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
... . .... .+......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 280 ~~~----~-----~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 280 VKD----G-----YQMA-----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHH----T-----CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hhc----C-----CCCC-----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111 0 0000 0111134678999999999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=350.46 Aligned_cols=252 Identities=23% Similarity=0.304 Sum_probs=206.4
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 368999999999999999999875 5889999999776555667899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC--CCCceeeeecceeecCCC
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM--DMNPKISDFGLARMFGGD 668 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~ 668 (834)
+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998843 2346899999999999999999999998 999999999999974 477999999999987543
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... ...... . ..+.
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~---~i~~~~-~--~~~~-- 271 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQ---NVKRCD-W--EFDE-- 271 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHH---HHHHCC-C--CCCS--
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHH---HHHhCC-C--CCCc--
Confidence 2 22345799999999999999999999999999999999999999864322 11111 111110 0 0000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
........++.+++.+||+.||++|||+.|+++
T Consensus 272 ---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 272 ---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 001112346789999999999999999999987
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=362.20 Aligned_cols=251 Identities=29% Similarity=0.408 Sum_probs=205.4
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC-eEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-EKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~Ey 590 (834)
.++|++.+.||+|+||.||+|.. .++.||||+++... ..+.|.+|+.+|++++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 47899999999999999999988 47899999997653 4578999999999999999999999987765 78999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999543 2234789999999999999999999998 999999999999999999999999999865322
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... .... ...+. ..
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~----i~~~~-----~~--- 405 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPR----VEKGY-----KM--- 405 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHH----HHTTC-----CC---
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HHcCC-----CC---
Confidence 122356889999999999999999999999999999998 999987543322 1111 11110 00
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
..+...+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 406 --~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 406 --DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 011122346789999999999999999999999998863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.62 Aligned_cols=244 Identities=25% Similarity=0.339 Sum_probs=203.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+++.. +|+.||||++++.. ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 68999999999999999999886 58999999997542 234677889999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999999843 346889999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .. ........ +
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~---~~~i~~~~---------~ 220 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KT---YEKILNAE---------L 220 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HH---HHHHHHCC---------C
T ss_pred -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HH---HHHHHhCC---------C
Confidence 23467999999999999999999999999999999999999998643211 11 11111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
..+.....++.+++.+||+.||++|| +++|+++
T Consensus 221 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 01111234678999999999999999 8999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=351.03 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=203.2
Q ss_pred cCccccceeeeecceeEEEEEECC-CcE----EEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQE----VAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
++|++.+.||+|+||.||+|++.. ++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 679999999999999999998753 443 8888875432 333456788999999999999999999886 567899
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999854 2456889999999999999999999998 9999999999999999999999999999876
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
............+|..|+|||++.+..++.++||||||+++|||++ |+.||....... +.. ....... ...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~~--~~~ 238 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPD----LLEKGER--LAQ 238 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHH----HHHTTCB--CCC
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHH----HHHcCCC--CCC
Confidence 5544434445678889999999999999999999999999999999 999987543322 111 1111100 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
+ ......+.+++.+||+.||++||+++|+++.|+...
T Consensus 239 ~--------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 239 P--------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp C--------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred C--------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 001224678999999999999999999999998763
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=349.33 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=203.4
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 478999999999999999999875 4889999998654 2334577899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC---CCceeeeecceeec
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMF 665 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~ 665 (834)
||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++...
T Consensus 108 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999988884 3456899999999999999999999998 9999999999999765 45999999999876
Q ss_pred CCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. .... +... ...
T Consensus 182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~---~i~~-~~~~-~~~ 251 (362)
T 2bdw_A 182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYA---QIKA-GAYD-YPS 251 (362)
T ss_dssp TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH---HHHH-TCCC-CCT
T ss_pred cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHH---HHHh-CCCC-CCc
Confidence 5332 12345799999999999999999999999999999999999999864321 11111 1111 1000 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+. ......++.+++.+||+.||++||++.|+++
T Consensus 252 ~~------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 252 PE------WDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp TG------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0112346789999999999999999999976
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=344.74 Aligned_cols=252 Identities=24% Similarity=0.350 Sum_probs=204.1
Q ss_pred hcCccccceeeeecceeEEEEEECC-C-------cEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-G-------QEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 583 (834)
.++|++.+.||+|+||.||+|.... + ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3689999999999999999998653 3 4799999987777778899999999999999999999999999999
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC--------ce
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN--------PK 655 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~k 655 (834)
.++||||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999853 2334889999999999999999999998 999999999999998887 99
Q ss_pred eeeecceeecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhH
Q 003280 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDL 734 (834)
Q Consensus 656 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~ 734 (834)
|+|||++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|..|+........ .. ...
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~---~~~ 231 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KL---QFY 231 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HH---HHH
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HH---HHh
Confidence 999999865432 223468899999999987 7799999999999999999996655332211110 10 000
Q ss_pred hcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 003280 735 WKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERL 791 (834)
Q Consensus 735 ~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 791 (834)
...... .. ....++.+++.+||+.||++|||++|+++.|+.+..
T Consensus 232 ~~~~~~----~~---------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 EDRHQL----PA---------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HTTCCC----CC---------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hccCCC----CC---------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 000000 00 112346789999999999999999999999998743
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=332.07 Aligned_cols=253 Identities=27% Similarity=0.349 Sum_probs=206.5
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 368999999999999999999886 58899999986543 3445789999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999884 3456899999999999999999999998 9999999999999999999999999998764333
Q ss_pred cccccceecccccccccccccCCcc-CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~-t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||............+.. ... ....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~--~~~~-- 230 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-----KKT--YLNP-- 230 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT-----TCT--TSTT--
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh-----ccc--ccCc--
Confidence 2223344678999999999988765 78999999999999999999998765443322221111 000 0000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.......+.+++.+||+.||++|||++|+++
T Consensus 231 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 -----WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0112346778999999999999999999976
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.00 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=199.2
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.+.||+|+||.||+|+...++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999999779999999986543 23347788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++ +|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 78777743 2356889999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc------ccc-
Q 003280 671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK------FHE- 742 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~------~~~- 742 (834)
......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....... ............. ..+
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHHCCCChhhchhhhcc
Confidence 12235789999999999764 58999999999999999999999986543211 1111111111000 000
Q ss_pred -cccccccc------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 743 -LIDPVITQ------DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 743 -lid~~l~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..++.... .........++.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01111100 0001112346789999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=348.34 Aligned_cols=262 Identities=26% Similarity=0.386 Sum_probs=205.0
Q ss_pred cCccccceeeeecceeEEEEEE-----CCCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEK 584 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~-----~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 584 (834)
++|++.+.||+|+||.||+|++ ..++.||||+++.. .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5689999999999999999984 35889999999754 334567899999999999999999999999876 678
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999843 2345899999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCC---------CcccHhHHHHhH
Q 003280 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA---------DSFNLLGYAWDL 734 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~---------~~~~l~~~~~~~ 734 (834)
....... .......+|..|+|||++.+..++.++||||||+++|||++|+.|+..... ............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 7544321 222335678889999999999999999999999999999999987532110 000000000011
Q ss_pred hcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 735 WKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 735 ~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..... ....+......+.+++.+||+.||++|||++|+++.|+.+
T Consensus 256 ~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKEGK----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccC----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 11100 0111122335688999999999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=346.05 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=202.4
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 587 (834)
++|++.+.||+|+||.||+|+... ++.||||++++.. ....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 689999999999999999999864 8899999997642 33456788999999988 899999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++|+|..++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999988843 346899999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcc---cHhHHHHhHhcCCcccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF---NLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~---~l~~~~~~~~~~~~~~~li 744 (834)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..............
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 235 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 235 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----
Confidence 21 123446899999999999999999999999999999999999999864322110 01111111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTM------SDVVS 784 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 784 (834)
+ ..+.....++.+++.+||+.||++||++ +|+++
T Consensus 236 ---~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 236 ---I---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ---C---CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ---C---CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 0 1111223467899999999999999995 56655
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=348.66 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=188.5
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|++.+.||+|+||.||+|+... ++.||||+++... ..+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 4789999999999999999999864 7899999997543 346788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC---CCCceeeeecceeecCC
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLARMFGG 667 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~ 667 (834)
+++++|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999884 3456899999999999999999999998 999999999999975 88999999999987643
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+ .... ..... ...+
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----~~i~-~~~~~-~~~~- 273 (349)
T 2w4o_A 204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF----RRIL-NCEYY-FISP- 273 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH----HHHH-TTCCC-CCTT-
T ss_pred cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH----HHHH-hCCCc-cCCc-
Confidence 32 2234578999999999999999999999999999999999999986433221111 1111 11100 0000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.......++.+++.+||+.||++|||+.|+++
T Consensus 274 -----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 -----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01122346789999999999999999999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=357.01 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=203.0
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
..++|++.+.||+|+||.||++... .|+.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999875 58899999986543 33456789999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc---CCCCceeeeecceee
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD---MDMNPKISDFGLARM 664 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~ 664 (834)
|||+++|+|.+.+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999888843 356899999999999999999999998 99999999999998 467899999999987
Q ss_pred cCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. . ...+.. ...
T Consensus 163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--~~~~---~-i~~~~~-~~~ 233 (444)
T 3soa_A 163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--RLYQ---Q-IKAGAY-DFP 233 (444)
T ss_dssp CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH---H-HHHTCC-CCC
T ss_pred ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--HHHH---H-HHhCCC-CCC
Confidence 654322 223357999999999999999999999999999999999999998543211 1111 1 111100 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.+. ......++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 SPE------WDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTT------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccc------cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 0112346789999999999999999999988
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.89 Aligned_cols=259 Identities=31% Similarity=0.456 Sum_probs=208.7
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|++.+.||+|+||.||+|...+++.||||+++... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 37899999999999999999998888899999997543 34678999999999999999999999886 45689999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||++++++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999998432 1235889999999999999999999998 999999999999999999999999999887543322
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
. .....++..|+|||++.+..++.++||||||+++|||++ |+.||...... .+. ... .... .... .
T Consensus 166 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~---~~~-~~~~-----~~~~-~ 232 (279)
T 1qpc_A 166 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVI---QNL-ERGY-----RMVR-P 232 (279)
T ss_dssp C-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH---HHH-HTTC-----CCCC-C
T ss_pred c-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHH---HHH-hccc-----CCCC-c
Confidence 1 223456788999999998999999999999999999999 88888643221 111 111 1110 0000 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccC
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLEL 793 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 793 (834)
. .....+.+++.+|++.+|++|||+.++++.|++.....
T Consensus 233 ~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 233 D----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred c----cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 1 12346789999999999999999999999998874443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=335.42 Aligned_cols=254 Identities=27% Similarity=0.525 Sum_probs=203.2
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccc-------cHHHHHHHHHHHHhhcCCCcceEEeEEEecCe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ-------GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 583 (834)
.++|++.+.||+|+||.||+|++. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 378999999999999999999875 5889999998654321 1267899999999999999999999987655
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC-----ceeee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN-----PKISD 658 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~D 658 (834)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+++ .+|+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 699999999999888754 3456899999999999999999999975 34999999999999988776 99999
Q ss_pred ecceeecCCCccccccceecccccccccccc--cCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhc
Q 003280 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYA--LDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWK 736 (834)
Q Consensus 659 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~ 736 (834)
||+++.... ......||+.|+|||++ ....++.++||||||+++|||++|+.||............... .
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~ 244 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR---E 244 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH---H
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh---c
Confidence 999975432 23345789999999998 4556899999999999999999999998765443322221111 1
Q ss_pred CCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 737 DDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 737 ~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
.. . .+. ........+.+++.+||+.||++|||++|+++.|++
T Consensus 245 ~~-~----~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 245 EG-L----RPT-----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp SC-C----CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cC-C----CCC-----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11 1 111 111223468899999999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=346.71 Aligned_cols=244 Identities=22% Similarity=0.263 Sum_probs=204.0
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+++.. +++.||||++++.. ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999986 58999999986542 344678899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999843 345899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ....... .. .
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~---~~~i~~~-~~------~- 256 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QI---YEKIVSG-KV------R- 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH---HHHHHHC-CC------C-
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH--HH---HHHHHcC-CC------C-
Confidence 23468999999999999999999999999999999999999998643211 11 1111111 00 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPT-----MSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 784 (834)
.+.....++.+++.+||+.||++||+ ++|+++
T Consensus 257 ----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 ----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11112346789999999999999998 888876
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=350.86 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=195.8
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcC--CCcceEEeEEEecCeEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQH--RNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV 587 (834)
.++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| |||+++++++.+....++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999888999999998654 33445789999999999986 9999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|| +.+++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 578899998843 456889999999999999999999998 99999999999997 67899999999987755
Q ss_pred CccccccceecccccccccccccC-----------CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWK 736 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~ 736 (834)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~ 235 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----LHAIID 235 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----HHHHHC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH----HHHHhc
Confidence 433333345679999999999865 67899999999999999999999998643221111 111111
Q ss_pred CCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 737 DDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 737 ~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. . ....+.....++.+++.+||+.||++|||+.|+++
T Consensus 236 ~~---------~-~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 236 PN---------H-EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp TT---------S-CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC---------c-ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 10 0 00011111245789999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.80 Aligned_cols=268 Identities=24% Similarity=0.305 Sum_probs=201.0
Q ss_pred HHhcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhh--cCCCcceEEeEEEec----Ce
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL--QHRNLVKLLGCCVEQ----GE 583 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~HpnIv~l~~~~~~~----~~ 583 (834)
...++|++.+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++..+ +||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34478999999999999999999884 8999999985432 24445566665554 899999999999887 78
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcC-----CCceEeccCCCCcEEEcCCCCceeee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS-----RFRIIHRDLKASNVLLDMDMNPKISD 658 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~D 658 (834)
.++||||+++|+|.+++. ...+++..+..++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 999999999999999983 235899999999999999999999880 11299999999999999999999999
Q ss_pred ecceeecCCCcccc--ccceecccccccccccccCCccCcc------CceeehhhhHHHhhcC----------CCCCCCC
Q 003280 659 FGLARMFGGDELQG--NTKRIVGTYGYMSPEYALDGLFSIK------SDVFSFGILMLETLSG----------KKNTGVY 720 (834)
Q Consensus 659 fgla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~t~~------~DVwSlGvvl~elltG----------~~p~~~~ 720 (834)
||+++.+....... ......||+.|+|||++.+...+.+ +|||||||++|||++| +.|+...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99998765432221 1223579999999999988766655 9999999999999999 4454332
Q ss_pred CCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 721 NADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 721 ~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.......... ........ ..+.+...........++.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 266 ~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 266 VPSDPSYEDM-REIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp SCSSCCHHHH-HHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCchhhh-HHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 2222111111 11111111 11111111112355678899999999999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=356.37 Aligned_cols=257 Identities=21% Similarity=0.263 Sum_probs=204.8
Q ss_pred HHHHHhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC
Q 003280 507 SVAAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG 582 (834)
Q Consensus 507 ~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 582 (834)
.+....++|++.++||+|+||.||+|+... ++.||||++++. .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 344456899999999999999999999864 889999998653 1223345889999999999999999999999999
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
..++||||+++|+|..++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999998842 35889999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceecccccccccccccCCc----cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD 738 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 738 (834)
+....... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+... .. .......
T Consensus 216 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~---~~i~~~~ 289 (410)
T 3v8s_A 216 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--TY---SKIMNHK 289 (410)
T ss_dssp EECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH---HHHHTHH
T ss_pred EeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh--HH---HHHHhcc
Confidence 87654322 1223468999999999998765 8899999999999999999999986433211 11 1111000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHH
Q 003280 739 KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAAD--RPTMSDVVS 784 (834)
Q Consensus 739 ~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 784 (834)
. .+.-+. ... ...++.+|+.+||+.+|++ ||+++|+++
T Consensus 290 ~--~~~~p~--~~~----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 290 N--SLTFPD--DND----ISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp H--HCCCCT--TCC----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred c--cccCCC--ccc----ccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 0 000000 011 2346789999999999988 999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=343.21 Aligned_cols=267 Identities=21% Similarity=0.242 Sum_probs=207.5
Q ss_pred HhcCccccceeeeecceeEEEEEE-CCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEe----cCeEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE----QGEKI 585 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~ 585 (834)
..++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 347899999999999999999987 4689999999977666677889999999999999999999999873 34789
Q ss_pred EEEeecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 586 LILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
+||||+++++|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999988542 23466899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCccc-------cccceecccccccccccccCCc---cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhH
Q 003280 665 FGGDELQ-------GNTKRIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDL 734 (834)
Q Consensus 665 ~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~---~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~ 734 (834)
....... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.........+....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--- 260 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV--- 260 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH---
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh---
Confidence 5321110 0112245799999999987654 78999999999999999999999853211111111000
Q ss_pred hcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCC
Q 003280 735 WKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELP 794 (834)
Q Consensus 735 ~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 794 (834)
.. .. ...........+.+++.+||+.||++|||++|+++.|+.+..+.+
T Consensus 261 -~~---------~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 261 -QN---------QL-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp -HC---------C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred -hc---------cC-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 00 00 000111223468899999999999999999999999998743333
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=350.69 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=203.7
Q ss_pred HHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeE
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 584 (834)
...++|++.+.||+|+||.||+|+.. +++.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34589999999999999999999986 48899999997542 34456788899999887 999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+++|+|..++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999998843 346899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+. .......
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~---~~i~~~~------ 234 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELF---HSIRMDN------ 234 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HHHHHCC------
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHH---HHHHhCC------
Confidence 43222 1234568999999999999999999999999999999999999998643221 111 1111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMS-DVVS 784 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 784 (834)
..+ +.....++.+++.+||+.||++||++. |+++
T Consensus 235 -~~~-----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 -PFY-----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -CCC-----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCC-----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 011 111234678999999999999999998 7753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=360.07 Aligned_cols=262 Identities=20% Similarity=0.266 Sum_probs=206.9
Q ss_pred HHHHHHHhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEe
Q 003280 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580 (834)
Q Consensus 505 ~~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 580 (834)
+..+....++|++.++||+|+||+||+|++.. ++.||||++++.. ....+.+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44455567899999999999999999999865 7889999986532 2223448899999999999999999999999
Q ss_pred cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeec
Q 003280 581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 660 (834)
.+..++||||+++|+|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999954 2356899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCccccccceeccccccccccccc-----CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
+++........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ... ...
T Consensus 221 la~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~--~~~---~i~ 294 (437)
T 4aw2_A 221 SCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TYG---KIM 294 (437)
T ss_dssp TCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH---HHH
T ss_pred hhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH--HHH---hhh
Confidence 99876543221 223358999999999997 5679999999999999999999999986433211 111 111
Q ss_pred cCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHH
Q 003280 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAAD--RPTMSDVVS 784 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 784 (834)
.... .. .+ .........++.+++.+||+.+|++ ||+++|+++
T Consensus 295 ~~~~--~~---~~--p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 295 NHKE--RF---QF--PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp THHH--HC---CC--CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hccc--cc---cC--CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0000 00 00 0000112346788999999888888 999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.93 Aligned_cols=268 Identities=26% Similarity=0.379 Sum_probs=213.0
Q ss_pred cHHHHHHHhcCccccceeeeecceeEEEEEE------CCCcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEE
Q 003280 504 SLASVAAATENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLL 575 (834)
Q Consensus 504 ~~~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~ 575 (834)
.........++|++.+.||+|+||.||+|+. ..++.||||+++... ....+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344444568999999999999999999974 246789999997653 33456799999999999 799999999
Q ss_pred eEEEecC-eEEEEEeecCCCCccccccCCCC-------------CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccC
Q 003280 576 GCCVEQG-EKILILEYMPNKSLDVFLFDPTK-------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDL 641 (834)
Q Consensus 576 ~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 641 (834)
+++...+ ..++||||+++++|.+++..... ...+++..+..++.||+.||+|||+++ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9998765 58999999999999999865332 223789999999999999999999998 999999
Q ss_pred CCCcEEEcCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCC
Q 003280 642 KASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVY 720 (834)
Q Consensus 642 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~ 720 (834)
||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987654433333344578899999999999999999999999999999998 99998654
Q ss_pred CCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 721 NADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 721 ~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..... +.. ....... ... +......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 255 ~~~~~-~~~----~~~~~~~-----~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 255 KIDEE-FCR----RLKEGTR-----MRA-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCSHH-HHH----HHHHTCC-----CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhHH-HHH----HhccCcc-----CCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 33221 111 1111100 000 111234678999999999999999999999999876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=338.84 Aligned_cols=265 Identities=27% Similarity=0.395 Sum_probs=211.7
Q ss_pred cCccccc-eeeeecceeEEEEEEC---CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~-~LG~G~~G~Vy~~~~~---~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
++|.+.+ .||+|+||.||+|... .++.||||+++.. .....+++.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 5677776 9999999999999864 4778999999765 334567899999999999999999999999 55679999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999853 3456899999999999999999999998 99999999999999999999999999998754
Q ss_pred Cccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 668 DELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 668 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+... ......
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~----i~~~~~----- 231 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAF----IEQGKR----- 231 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHH----HHTTCC-----
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHH----HhcCCc-----
Confidence 3221 12223456889999999998899999999999999999998 99998654321 11111 111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCCCCCCC
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEP 799 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~p 799 (834)
. ..+......+.+++.+||+.+|++||++.|+++.|+....+...+..+
T Consensus 232 ~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 232 M-----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp C-----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred C-----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 0 111122346889999999999999999999999999885554444333
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=347.33 Aligned_cols=271 Identities=24% Similarity=0.346 Sum_probs=200.5
Q ss_pred hcCccccceeeeecceeEEEEEE-CCCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe----
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE---- 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~---- 583 (834)
.++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 37899999999999999999997 458899999997642 3335678999999999999999999999876553
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.++||||+++++|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 4999999999999999843 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 664 MFGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 664 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~- 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQHVREDPIP- 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHCCCCC-
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCCCCC-
Confidence 76543221 22334578999999999999999999999999999999999999986433211 111111111100
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHH-HHHHhcccccCCCCCCCccc
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDV-VSIINSERLELPSPKEPAFI 802 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev-l~~L~~~~~~~~~p~~p~~~ 802 (834)
+...... ...++.+++.+||+.||++||++.++ ...|... .....|..|...
T Consensus 239 ---~~~~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~-~~~~~~~~~~~~ 291 (311)
T 3ork_A 239 ---PSARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV-HNGEPPEAPKVL 291 (311)
T ss_dssp ---HHHHSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH-HTTCCCSSCCCC
T ss_pred ---cccccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH-hcCCCCCCCccc
Confidence 0000011 23467899999999999999965554 4555554 233344444443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=337.45 Aligned_cols=256 Identities=28% Similarity=0.416 Sum_probs=209.4
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|++.+.||+|+||.||+|...+++.||+|+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 368999999999999999999998889999999976533 3478999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999853 2346889999999999999999999998 999999999999999999999999999876432211
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .. ........ ...
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~---~~~i~~~~------~~~--- 225 (267)
T 3t9t_A 161 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EV---VEDISTGF------RLY--- 225 (267)
T ss_dssp -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH---HHHHHTTC------CCC---
T ss_pred -ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HH---HHHHhcCC------cCC---
Confidence 1223456788999999999999999999999999999999 89887643211 11 11111110 000
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.+......+.+++.+||+.||++||+++|+++.|+++.
T Consensus 226 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 226 --KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01112346789999999999999999999999998863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=349.47 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=199.3
Q ss_pred cCccccceeeeecceeEEEEEECC-Cc----EEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
++|++.+.||+|+||.||+|.+.. ++ .||+|.++.. .....+++.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 689999999999999999998643 44 3588877543 3456788999999999999999999999998754 889
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
|+||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999998854 2346889999999999999999999998 9999999999999999999999999998875
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +... ......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~----~~~~~~----- 237 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI----LEKGER----- 237 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH----HHTTCC-----
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHH----HHcCCC-----
Confidence 5433333334567889999999999999999999999999999999 999986543322 1111 111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
...+.....++.+++.+||+.||++||++.|+++.|+...
T Consensus 238 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 238 -----LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0111112346789999999999999999999999998874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.70 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=210.6
Q ss_pred HHhcCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecC
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG 582 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 582 (834)
...++|++.+.||+|+||.||+|... .++.||||++.... .....++.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 44588999999999999999999764 36789999997543 334567899999999999999999999999999
Q ss_pred eEEEEEeecCCCCccccccCCC-------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCce
Q 003280 583 EKILILEYMPNKSLDVFLFDPT-------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPK 655 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 655 (834)
..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 9999999999999999985321 1245689999999999999999999998 99999999999999999999
Q ss_pred eeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhH
Q 003280 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDL 734 (834)
Q Consensus 656 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~ 734 (834)
|+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+.. .
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~----~ 252 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLR----F 252 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHHH----H
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HHHH----H
Confidence 999999987644333233334567889999999999999999999999999999999 88887643211 1111 1
Q ss_pred hcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 735 WKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 735 ~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
........ ........+.+++.+||+.||++|||+.|+++.|++.
T Consensus 253 ~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 253 VMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 11111100 1112234678999999999999999999999999886
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=349.22 Aligned_cols=271 Identities=21% Similarity=0.302 Sum_probs=214.7
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecC--eEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG--EKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV 587 (834)
.++|++.+.||+|+||.||+|+... ++.||||+++... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3689999999999999999999864 8999999997543 344678889999999999999999999998765 78999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE----cCCCCceeeeeccee
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL----DMDMNPKISDFGLAR 663 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~ 663 (834)
|||+++|+|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999966544455899999999999999999999998 9999999999999 777889999999998
Q ss_pred ecCCCccccccceecccccccccccccC--------CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALD--------GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... .......
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~-~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKII 240 (396)
T ss_dssp ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH-HHHHHHH
T ss_pred EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH-HHHHHHh
Confidence 8754332 223578999999999875 568899999999999999999999986543322111 1111111
Q ss_pred cCCc---cccc---c-------ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 736 KDDK---FHEL---I-------DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 736 ~~~~---~~~l---i-------d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.... .... . ................+.+++.+||+.||++||++.|+++.++.+
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 1110 0000 0 000112234566777889999999999999999999999988765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=339.02 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=195.2
Q ss_pred hcCccccceeeeecceeEEEEEECC----CcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+|.... +..||||+++.. .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3789999999999999999998743 457999998764 3344678999999999999999999999984 567899
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999853 2345889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... .... .. .....
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~---i~-~~~~~---- 236 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGR---IE-NGERL---- 236 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH---HH-TTCCC----
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHH---HH-cCCCC----
Confidence 43221 1223456789999999999999999999999999999997 898986543221 1111 11 11000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..+......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 237 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01112234678999999999999999999999999876
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=340.04 Aligned_cols=266 Identities=23% Similarity=0.288 Sum_probs=209.0
Q ss_pred HHHhcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHh--hcCCCcceEEeEEEecC----
Q 003280 509 AAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAK--LQHRNLVKLLGCCVEQG---- 582 (834)
Q Consensus 509 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~~---- 582 (834)
....++|++.+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34457899999999999999999998 5899999999643 34677889998887 78999999999998876
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhh--------hcCCCceEeccCCCCcEEEcCCCCc
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH--------QYSRFRIIHRDLKASNVLLDMDMNP 654 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~~ 654 (834)
..++||||+++|+|.+++.. ..+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999843 35899999999999999999999 666 9999999999999999999
Q ss_pred eeeeecceeecCCCcccc--ccceecccccccccccccCC------ccCccCceeehhhhHHHhhcC----------CCC
Q 003280 655 KISDFGLARMFGGDELQG--NTKRIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSG----------KKN 716 (834)
Q Consensus 655 kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~t~~~DVwSlGvvl~elltG----------~~p 716 (834)
||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765433211 22345789999999999876 345789999999999999999 566
Q ss_pred CCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 717 TGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 717 ~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
|............+... .... ...+.+............+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKV-VCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TTTTSCSSCCHHHHHHH-HTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCcCcccHHHHHHH-HHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 65433222222221111 1111 111222111123456678899999999999999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=353.63 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=196.1
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCc--ccccHHHHHHHHHHHHhhc--CCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQ--HRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||++....++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 569999999999999999999888999999998654 3445678999999999996 599999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
| +.+++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 678899998853 346788899999999999999999998 99999999999995 589999999999877544
Q ss_pred ccccccceecccccccccccccC-----------CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD 737 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~-----------~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 737 (834)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ........
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~----~~~~~~~~ 283 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KLHAIIDP 283 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH----HHHHHHCT
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH----HHHHHhCc
Confidence 33323344679999999999875 4689999999999999999999999864322111 11111111
Q ss_pred CccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 DKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
... ... ... ...++.+++.+||+.||++|||+.|+++
T Consensus 284 ~~~-----~~~-~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 284 NHE-----IEF-PDI----PEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp TSC-----CCC-CCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccc-----CCC-Ccc----chHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 100 000 011 1246789999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=342.37 Aligned_cols=265 Identities=27% Similarity=0.414 Sum_probs=199.6
Q ss_pred HhcCccccceeeeecceeEEEEEECC----CcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC--
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-- 582 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~----g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-- 582 (834)
..++|.+.+.||+|+||.||+|.... ++.||||+++.. .....+.+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45789999999999999999997643 457999998754 3344578999999999999999999999998765
Q ss_pred ---eEEEEEeecCCCCccccccCC---CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCcee
Q 003280 583 ---EKILILEYMPNKSLDVFLFDP---TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656 (834)
Q Consensus 583 ---~~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 656 (834)
..++||||+++++|..++... .....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 359999999999999988432 23456899999999999999999999998 999999999999999999999
Q ss_pred eeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHh
Q 003280 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ... ...
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~---~~~ 263 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MYD---YLL 263 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHH---HHH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHH---HHH
Confidence 99999987654433333334567889999999999999999999999999999999 888876543221 111 111
Q ss_pred cCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCC
Q 003280 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELP 794 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 794 (834)
... . .. ........+.+++.+||+.||++|||+.++++.|+.+...++
T Consensus 264 ~~~-~-----~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 264 HGH-R-----LK-----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp TTC-C-----CC-----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred cCC-C-----CC-----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 110 0 00 111123467899999999999999999999999998755444
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.91 Aligned_cols=252 Identities=22% Similarity=0.281 Sum_probs=193.2
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|++.+.||+|+||.||+++.. .++.||||++..... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 478999999999999999999986 588999999975432 236788999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC--ceeeeecceeecCCC
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN--PKISDFGLARMFGGD 668 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~~~~~ 668 (834)
+++|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999998843 345899999999999999999999998 999999999999987765 999999999754222
Q ss_pred ccccccceecccccccccccccCCccCcc-CceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIK-SDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~-~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ............ . .
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~-~------~ 240 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVK-Y------S 240 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTC-C------C
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCC-C------C
Confidence 12234579999999999988887655 8999999999999999999875433221 111111111110 0 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 241 IPD---DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCT---TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCC---cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 000 0012346789999999999999999999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=341.49 Aligned_cols=244 Identities=24% Similarity=0.281 Sum_probs=192.2
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.++||+|+||+||+|+.. +++.||||++.... .....++..|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 68999999999999999999986 58999999986542 23334556666666665 8999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 66887777432 346899999999999999999999998 999999999999999999999999999876443
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..++.... .+......... +.+
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~~~~~~~~~~----~~~ 273 (311)
T 3p1a_A 211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQLRQGYLP----PEF 273 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HHHHHTTTCCC----HHH
T ss_pred C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHHhccCCC----ccc
Confidence 2 2233568999999999876 79999999999999999999977653210 11111111111 111
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. ....++.+++.+||+.||++|||++|+++
T Consensus 274 -~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 -TA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -HT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -cc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 01 12346889999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=344.04 Aligned_cols=248 Identities=27% Similarity=0.346 Sum_probs=193.4
Q ss_pred hcCccccceeeeecceeEEEEEE----CCCcEEEEEEccCcc----cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 583 (834)
.++|++.+.||+|+||.||+++. ..++.||||++++.. ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 37899999999999999999987 368999999997642 2344668899999999999999999999999999
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.++||||+++++|.+++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999884 3346889999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .......
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~---~~i~~~~----- 237 (327)
T 3a62_A 170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--KTI---DKILKCK----- 237 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH---HHHHHTC-----
T ss_pred ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--HHH---HHHHhCC-----
Confidence 6433221 123357899999999999999999999999999999999999998643221 111 1111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
. ..+......+.+++.+||+.||++|| ++.|+++
T Consensus 238 ----~---~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 ----L---NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----C---CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----C---CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 01111234678999999999999999 7888876
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=344.92 Aligned_cols=266 Identities=20% Similarity=0.217 Sum_probs=203.0
Q ss_pred HHHHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-----ccccHHHHHHHHHHHHhhcCCCcceEEeEEEec
Q 003280 508 VAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-----SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ 581 (834)
Q Consensus 508 ~~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 581 (834)
+....++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3445689999999999999999999875 4789999998653 345567899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCccccccCCC-------------------------------------CCCcCCHHHHHHHHHHHHHH
Q 003280 582 GEKILILEYMPNKSLDVFLFDPT-------------------------------------KKRLLGWQARVTIIEGIAQG 624 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~ 624 (834)
+..++||||+++|+|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999998884210 02234567788999999999
Q ss_pred HHHhhhcCCCceEeccCCCCcEEEcCCC--CceeeeecceeecCCCcc--ccccceecccccccccccccC--CccCccC
Q 003280 625 LLYLHQYSRFRIIHRDLKASNVLLDMDM--NPKISDFGLARMFGGDEL--QGNTKRIVGTYGYMSPEYALD--GLFSIKS 698 (834)
Q Consensus 625 L~yLH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~--~~~t~~~ 698 (834)
|+|||+++ |+||||||+||+++.++ .+||+|||+++.+..... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 899999999987643211 112334679999999999975 6789999
Q ss_pred ceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC
Q 003280 699 DVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPT 778 (834)
Q Consensus 699 DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 778 (834)
|||||||++|||++|+.||....... . .......... ...+.. ......+.+++.+||+.||++||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~--~---~~~~~~~~~~--~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDAD--T---ISQVLNKKLC--FENPNY------NVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH--H---HHHHHHCCCC--TTSGGG------GGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHH--H---HHHHHhcccc--cCCccc------ccCCHHHHHHHHHHcCCChhHCCC
Confidence 99999999999999999986433211 1 1111111100 000000 012346789999999999999999
Q ss_pred HHHHHH--HHhcc
Q 003280 779 MSDVVS--IINSE 789 (834)
Q Consensus 779 ~~evl~--~L~~~ 789 (834)
+.|+++ .+++.
T Consensus 325 ~~~~l~hp~~~~~ 337 (345)
T 3hko_A 325 AMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHSHHHHTT
T ss_pred HHHHhcChhhccC
Confidence 999987 45443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=356.42 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=206.8
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 68999999999999999999986 58999999996542 234568999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|.+++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999984 3456899999999999999999999998 999999999999999999999999999987543
Q ss_pred ccccccceecccccccccccccCCcc-CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~-t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .+. ... ..+.. .
T Consensus 170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~---~~i-~~~~~------~ 234 (476)
T 2y94_A 170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLF---KKI-CDGIF------Y 234 (476)
T ss_dssp C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHH---HHH-HTTCC------C
T ss_pred c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHH---HHH-hcCCc------C
Confidence 2 2234579999999999998776 78999999999999999999998643221 111 111 11110 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
. ... ...++.+++.+||+.||++|||++|+++ .+...
T Consensus 235 ~-p~~----~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 235 T-PQY----LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp C-CTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred C-Ccc----CCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0 111 1246789999999999999999999997 55543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=342.05 Aligned_cols=265 Identities=26% Similarity=0.364 Sum_probs=188.9
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999875 48899999986543 3344778899999999999999999999999999999999
Q ss_pred ecCCCCccccccCC---CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 590 YMPNKSLDVFLFDP---TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
|++ ++|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5888877432 12245889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC--cc---
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD--KF--- 740 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~--- 740 (834)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ............ ..
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--QLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCTTTCGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChhHhhh
Confidence 3221 2233578999999999976 468999999999999999999999987543221 111111110000 00
Q ss_pred -ccc--cccccc-----------cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 741 -HEL--IDPVIT-----------QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 741 -~~l--id~~l~-----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+ ..+.+. ..........++.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 000000 00000012346889999999999999999999876
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=347.12 Aligned_cols=248 Identities=24% Similarity=0.318 Sum_probs=203.1
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+|+... ++.||||++++. .....+.+..|..++..+ +||+|+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4789999999999999999999865 789999999754 234567788999999988 89999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++|+|..++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999998843 346899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+. ...... .
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~---~~i~~~-~------- 237 (353)
T 2i0e_A 173 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELF---QSIMEH-N------- 237 (353)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HHHHHC-C-------
T ss_pred cCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--HHH---HHHHhC-C-------
Confidence 222 1234468999999999999999999999999999999999999998643221 111 111111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPT-----MSDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 784 (834)
+ ..+.....++.+++.+||+.||++||+ ++|+++
T Consensus 238 -~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 -V---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -C---CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -C---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 011122346789999999999999995 577765
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=332.15 Aligned_cols=248 Identities=27% Similarity=0.446 Sum_probs=183.2
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 67999999999999999999874 68999999986532 233578999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 91 EMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp ECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999998853 2356899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .........
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~ 229 (278)
T 3cok_A 166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------------LNKVVLADY 229 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSSCC
T ss_pred CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------------HHHHhhccc
Confidence 21 12235789999999999999999999999999999999999999865332110 000000000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+.....++.+++.+||+.||++|||++|+++
T Consensus 230 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 ---EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 111112346789999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.59 Aligned_cols=250 Identities=21% Similarity=0.309 Sum_probs=204.2
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|++.+.||+|+||.||+|.... ++.||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4679999999999999999998765 778999999877666778999999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE---cCCCCceeeeecceeecCC
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~ 667 (834)
+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999888743 345899999999999999999999998 9999999999999 7889999999999987654
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. ......||+.|+|||++.+. ++.++||||||+++|||++|+.||....... . ...... .... .....
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~---~~~~~~-~~~~-~~~~~ 230 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--V---MLKIRE-GTFT-FPEKD 230 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---HHHHHH-CCCC-CCHHH
T ss_pred cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH--H---HHHHHh-CCCC-CCchh
Confidence 32 22335789999999988654 9999999999999999999999986433211 1 111111 0000 00000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. .....+.+++.+||+.||++|||+.|+++
T Consensus 231 --~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 --WL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --HT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --hh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 11346789999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=338.90 Aligned_cols=262 Identities=24% Similarity=0.293 Sum_probs=198.6
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCccc--ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|++.+.||+|+||.||+|+... ++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 689999999999999999999864 89999999865432 335678899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++++|..++. ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999988873 3455899999999999999999999998 9999999999999999999999999998765332
Q ss_pred cccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhH-----------hcC
Q 003280 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDL-----------WKD 737 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~-----------~~~ 737 (834)
. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ....... +..
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHT
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhccccccccccccc
Confidence 1 1233578999999999976 6789999999999999999999999865433211 1111110 000
Q ss_pred CccccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 DKFHELIDPVITQDEIS-----LPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~lid~~l~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
................. ......+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000000000000 112345789999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=347.45 Aligned_cols=252 Identities=26% Similarity=0.322 Sum_probs=198.7
Q ss_pred cccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCCC
Q 003280 516 SMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 516 ~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
...+.||+|+||.||+|... +|+.||||+++.......+++.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33578999999999999875 58999999998766666788999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE--cCCCCceeeeecceeecCCCcccc
Q 003280 595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL--DMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 172 ~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 172 ELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred cHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 99888753 3345889999999999999999999998 9999999999999 5678899999999998754332
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~ 752 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ........ ...... ...
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~---~~i~~~~~--~~~~~~--~~~ 314 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--TL---NNILACRW--DLEDEE--FQD 314 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH---HHHHHTCC--CSCSGG--GTT
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HH---HHHHhccC--CCChhh--hcc
Confidence 223469999999999999999999999999999999999999986533211 11 11111100 000000 011
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 753 ISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
...++.+++.+||+.||++|||++|+++ .|.+
T Consensus 315 ----~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 315 ----ISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred ----CCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 2346789999999999999999999998 4443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=331.56 Aligned_cols=264 Identities=20% Similarity=0.263 Sum_probs=207.4
Q ss_pred hcCccccceeeeecceeEEEEEE-CCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEE-EecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC-VEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lV~E 589 (834)
.++|++.+.||+|+||.||+|+. .+++.||||++...... +++.+|+.++.+++|++++..+..+ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47899999999999999999997 46899999998654332 4688999999999998877666655 56678899999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE---cCCCCceeeeecceeecC
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~ 666 (834)
|+ +++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999998842 2346899999999999999999999998 9999999999999 588999999999999875
Q ss_pred CCccc-----cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCc-ccHhHHHH-hHhcCCc
Q 003280 667 GDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS-FNLLGYAW-DLWKDDK 739 (834)
Q Consensus 667 ~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~-~~l~~~~~-~~~~~~~ 739 (834)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........ ......
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-
Confidence 54321 11234679999999999999999999999999999999999999997644322 11111111 111000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCC
Q 003280 740 FHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELP 794 (834)
Q Consensus 740 ~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 794 (834)
. +.+ ... .+.++.+++.+||+.||++|||++|+++.|+.......
T Consensus 239 ~-----~~~-~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 239 I-----EVL-CKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp H-----HHH-TTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred h-----HHH-Hhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 0 000 011 12467899999999999999999999999998754443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=355.10 Aligned_cols=261 Identities=20% Similarity=0.244 Sum_probs=205.4
Q ss_pred HHHHHHHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEe
Q 003280 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580 (834)
Q Consensus 505 ~~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 580 (834)
+.+.....++|++.+.||+|+||.||+++.. +++.||||++++.. ....+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444456689999999999999999999985 58999999996532 2233458899999999999999999999999
Q ss_pred cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeec
Q 003280 581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 660 (834)
.+..++||||+++|+|..++... +..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999998532 246899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCccccccceeccccccccccccc-------CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHh
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYAL-------DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWD 733 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~ 733 (834)
+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .. ..
T Consensus 208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~---~~ 281 (412)
T 2vd5_A 208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE--TY---GK 281 (412)
T ss_dssp TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH---HH
T ss_pred hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--HH---HH
Confidence 9988754322 1122358999999999997 4678999999999999999999999986533211 11 01
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCC---CCHHHHHH
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADR---PTMSDVVS 784 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~ 784 (834)
..... ....-+.. ......++.+++.+||+ +|++| |+++|+++
T Consensus 282 i~~~~--~~~~~p~~-----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 282 IVHYK--EHLSLPLV-----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHTHH--HHCCCC---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHhcc--cCcCCCcc-----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 11000 00000000 11123467899999999 99998 68999977
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.13 Aligned_cols=269 Identities=21% Similarity=0.232 Sum_probs=195.5
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhc-CCCcceEEeEEEe--------c
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVE--------Q 581 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~--------~ 581 (834)
..+|++.++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 468999999999999999999975 58899999997766666788999999999996 9999999999953 3
Q ss_pred CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecc
Q 003280 582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 661 (834)
...++||||+. |+|.+++........+++..+..++.||+.||+|||+++ .+|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 35799999996 788888755444567999999999999999999999874 3599999999999999999999999999
Q ss_pred eeecCCCcccc----------ccceecccccccccccc---cCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHh
Q 003280 662 ARMFGGDELQG----------NTKRIVGTYGYMSPEYA---LDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLL 728 (834)
Q Consensus 662 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~l---~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~ 728 (834)
++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||....... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~- 261 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--I- 261 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--h-
Confidence 98765432111 11134689999999998 56778999999999999999999999986422110 0
Q ss_pred HHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCCCCCCCcc
Q 003280 729 GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAF 801 (834)
Q Consensus 729 ~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~p~~ 801 (834)
+.... ...........+.+++.+||+.||++|||+.|+++.|+.+......++.+..
T Consensus 262 ---------------~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~ 318 (337)
T 3ll6_A 262 ---------------VNGKY-SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPI 318 (337)
T ss_dssp -------------------C-CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred ---------------hcCcc-cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccH
Confidence 00000 0000001112467899999999999999999999999988655444444433
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=334.16 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=204.5
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEec--CeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|+. .++.||||+++... ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 6899999999999999999998 48899999997643 34457899999999999999999999999887 7889999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|.+++... ....+++..+..++.||+.||+|||+++ .+|+||||||+||+++.++.++|.|||++.....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999999642 2335899999999999999999999864 3599999999999999999999999998764322
Q ss_pred ccccccceecccccccccccccCCccCc---cCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSI---KSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~---~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
....||+.|+|||++.+..++. ++||||||+++|||++|+.||....... ......... ..
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~-----~~ 229 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IGMKVALEG-----LR 229 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-----HHHHHHHSC-----CC
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-----HHHHHHhcC-----CC
Confidence 2246899999999998766544 7999999999999999999986433211 111111111 11
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
+.+ +......+.+++..||+.||++|||++|+++.|+.+.
T Consensus 230 ~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 230 PTI-----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111 1122346789999999999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=338.11 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=211.3
Q ss_pred HhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
..++|++.+.||+|+||.||+|.... ++.||||+++.. ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 34789999999999999999999865 788999999754 3456789999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999998542 3355899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
. .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ... ..... ...
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~----~~~~~-----~~~-- 231 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYE----LLEKD-----YRM-- 231 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHH----HHHTT-----CCC--
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHhcc-----CCC--
Confidence 2 12223467889999999999999999999999999999999 888886543221 111 11111 000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
..+...+..+.+++.+||+.||++|||++|+++.|+...
T Consensus 232 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 232 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 011112346789999999999999999999999998763
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=334.94 Aligned_cols=261 Identities=21% Similarity=0.258 Sum_probs=199.1
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 378999999999999999999975 58899999997543 22357899999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999843 346899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||...... . ......... . .+.
T Consensus 187 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~---~~~~~~~~~-~---~~~ 255 (309)
T 2h34_A 187 EKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---V---MGAHINQAI-P---RPS 255 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---H---HHHHHHSCC-C---CGG
T ss_pred cccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---H---HHHHhccCC-C---Ccc
Confidence 3221 222357899999999999999999999999999999999999998643211 0 111111110 0 000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcccccC
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRP-TMSDVVSIINSERLEL 793 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 793 (834)
......+..+.+++.+||+.||++|| +++++++.|+......
T Consensus 256 ----~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 256 ----TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp ----GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ----ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 00111223678899999999999999 9999999999874333
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=369.63 Aligned_cols=259 Identities=29% Similarity=0.437 Sum_probs=209.5
Q ss_pred HhcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
..++|++.++||+|+||.||+|.+..++.||||+++... ...++|.+|+++|++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 347899999999999999999999888889999997643 345789999999999999999999999876 678999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999998432 2345889999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
. ......++..|+|||++.+..++.++|||||||+||||++ |+.||...... .+.. . ...+. ..
T Consensus 419 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~---~-i~~~~-----~~--- 483 (535)
T 2h8h_A 419 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLD---Q-VERGY-----RM--- 483 (535)
T ss_dssp H-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHH---H-HHTTC-----CC---
T ss_pred e-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH---H-HHcCC-----CC---
Confidence 1 1122356788999999999999999999999999999999 89998643321 1111 1 11110 00
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLE 792 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 792 (834)
.........+.+|+.+||+.||++|||+++|+++|+.....
T Consensus 484 --~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 01112234678999999999999999999999999987433
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=337.77 Aligned_cols=267 Identities=24% Similarity=0.378 Sum_probs=200.9
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|... +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 67999999999999999999874 6899999998753 2344577899999999999999999999999999999999
Q ss_pred eecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 589 EYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
||+++++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999988532 23456889999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
... ......|++.|+|||++.+..++.++||||||+++|||++|+.||.........+. .. ..........
T Consensus 189 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~-~~~~~~~~~~--- 259 (310)
T 2wqm_A 189 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC---KK-IEQCDYPPLP--- 259 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH---HH-HHTTCSCCCC---
T ss_pred CCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH---HH-hhcccCCCCc---
Confidence 321 12235789999999999999999999999999999999999999864332211111 11 1111111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCCCCC
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPK 797 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~ 797 (834)
.. ....++.+++.+||+.||++|||++|+++.|+.+......|+
T Consensus 260 --~~----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 260 --SD----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp --TT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred --cc----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 11 123467899999999999999999999999998855444443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=341.66 Aligned_cols=264 Identities=26% Similarity=0.368 Sum_probs=196.5
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHH--HHhhcCCCcceEEeEEEe-----cCeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMML--IAKLQHRNLVKLLGCCVE-----QGEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~HpnIv~l~~~~~~-----~~~~ 584 (834)
.++|++.+.||+|+||.||+|+. +++.||||+++... .+.+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 37899999999999999999987 68999999996543 2344444444 445899999999986643 2257
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc---------CCCceEeccCCCCcEEEcCCCCce
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY---------SRFRIIHRDLKASNVLLDMDMNPK 655 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------~~~~ivH~Dlkp~NIll~~~~~~k 655 (834)
++||||+++|+|.+++.. ...++..+..++.||++||+|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 899999999999999832 3458899999999999999999998 6 99999999999999999999
Q ss_pred eeeecceeecCCCcc------ccccceecccccccccccccC-------CccCccCceeehhhhHHHhhcCCCCCCCCCC
Q 003280 656 ISDFGLARMFGGDEL------QGNTKRIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLSGKKNTGVYNA 722 (834)
Q Consensus 656 l~Dfgla~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~-------~~~t~~~DVwSlGvvl~elltG~~p~~~~~~ 722 (834)
|+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999988754321 111223469999999999987 4677899999999999999999877533222
Q ss_pred CcccHhHH------------HHhHhcCCcccccccccccc-CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 723 DSFNLLGY------------AWDLWKDDKFHELIDPVITQ-DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 723 ~~~~l~~~------------~~~~~~~~~~~~lid~~l~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.......+ .......... .+.+.. ..........+.+++.+||+.||++|||++|+++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 11100000 0000111111 111111 111233556789999999999999999999999999987
Q ss_pred c
Q 003280 790 R 790 (834)
Q Consensus 790 ~ 790 (834)
.
T Consensus 317 l 317 (336)
T 3g2f_A 317 M 317 (336)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=331.86 Aligned_cols=263 Identities=20% Similarity=0.271 Sum_probs=203.0
Q ss_pred HhcCccccceeeeecceeEEEEEE-CCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEE-EecCeEEEEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC-VEQGEKILIL 588 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lV~ 588 (834)
..++|++.+.||+|+||.||+|+. ..++.||||++...... +++.+|++++.+++|++++..+..+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 347899999999999999999987 45889999987554322 4578899999999988877766665 5677889999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE---cCCCCceeeeecceeec
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMF 665 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~ 665 (834)
||+ +++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999998843 2345899999999999999999999998 9999999999999 78999999999999987
Q ss_pred CCCccc-----cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcc-cHhHHH-HhHhcCC
Q 003280 666 GGDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF-NLLGYA-WDLWKDD 738 (834)
Q Consensus 666 ~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~-~l~~~~-~~~~~~~ 738 (834)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 544321 122346789999999999999999999999999999999999999976543221 111111 1111000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 003280 739 KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLE 792 (834)
Q Consensus 739 ~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 792 (834)
. .. + .... +..+.+++.+||+.||++|||++|+++.|+.+..+
T Consensus 239 -~-~~----~-~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 239 -I-EV----L-CKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp -H-HH----H-TTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -h-hh----h-hccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 0 00 0 0111 24688999999999999999999999999887443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=335.48 Aligned_cols=261 Identities=28% Similarity=0.411 Sum_probs=203.8
Q ss_pred cCccccceeeeecceeEEEEEECC----CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEE-ecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCV-EQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~l 586 (834)
.+|++.+.||+|+||.||+|...+ ...||+|++.... ....+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 578899999999999999998643 2358999987643 344678999999999999999999999865 4557899
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999853 3456789999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc--cccceecccccccccccccCCccCccCceeehhhhHHHhhcCC-CCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 667 GDELQ--GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK-KNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 667 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++|. +|+....... .... ..... . .
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~---~~~~~-~--~ 251 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVY---LLQGR-R--L 251 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHH---HHTTC-C--C
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHH---HhcCC-C--C
Confidence 43321 1223356788999999999999999999999999999999954 5554332221 1111 11110 0 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCC
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELP 794 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 794 (834)
.. ... ....+.+++.+||+.+|++|||++|+++.|+.+...+.
T Consensus 252 ~~----~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 252 LQ----PEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp CC----CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CC----Ccc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00 111 12467899999999999999999999999998755443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=336.62 Aligned_cols=263 Identities=26% Similarity=0.332 Sum_probs=206.2
Q ss_pred cCccccceeeeecceeEEEEEECC-C---cEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeE-EE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK-IL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~-~l 586 (834)
..|++.++||+|+||.||+|...+ + ..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 356677899999999999998643 2 379999987643 34567899999999999999999999999877665 99
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+.+++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999854 3456789999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcc--ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 667 GDEL--QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 667 ~~~~--~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
.... ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+..... ...+..... ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~----~~~~---- 246 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLA----QGRR---- 246 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHH----TTCC----
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhh----cCCC----
Confidence 4321 1223345778999999999999999999999999999999996665432211 111111111 1100
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCCC
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPS 795 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 795 (834)
...+......+.+++.+||+.||++|||++|+++.|+++...+..
T Consensus 247 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 247 ------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 001111234678999999999999999999999999988555443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=335.98 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=204.3
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc------ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG------QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+|+.. +++.||||+++.... ...+++.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 367999999999999999999976 488999999865422 2467899999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC----Cceeeeec
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM----NPKISDFG 660 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg 660 (834)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999843 456889999999999999999999998 99999999999999887 79999999
Q ss_pred ceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcc
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKF 740 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 740 (834)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ..... ...
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~---~~i~~-~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETL---ANITS-VSY 235 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHH---HHHHT-TCC
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHH---HHHHh-ccc
Confidence 998775432 123357899999999999999999999999999999999999998643211 111 11110 000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..++.. ... ....+.+++.+||+.||++|||+.|+++
T Consensus 236 --~~~~~~-~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 --DFDEEF-FSH----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCCHHH-HTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --ccChhh-hcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000 011 1246789999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=346.49 Aligned_cols=252 Identities=16% Similarity=0.150 Sum_probs=204.4
Q ss_pred HhcCccccceeeeecceeEEEEE------ECCCcEEEEEEccCcccccHHHHHHHHHHHHhhc---CCCcceEEeEEEec
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGR------LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ---HRNLVKLLGCCVEQ 581 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~ 581 (834)
..++|++.++||+|+||.||+|. ...++.||||+++.. ...++..|++++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34789999999999999999994 345889999999754 3457788888888886 99999999999999
Q ss_pred CeEEEEEeecCCCCccccccCC--CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC---------
Q 003280 582 GEKILILEYMPNKSLDVFLFDP--TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM--------- 650 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--------- 650 (834)
+..++||||+++|+|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 9999999999999999998532 23456999999999999999999999998 999999999999998
Q ss_pred --CCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHh
Q 003280 651 --DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLL 728 (834)
Q Consensus 651 --~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~ 728 (834)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 899999999999876432222233446799999999999999999999999999999999999999753221110
Q ss_pred HHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHHhcc
Q 003280 729 GYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADR-PTMSDVVSIINSE 789 (834)
Q Consensus 729 ~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~ 789 (834)
.+...+ ... +....+.+++..|++.+|.+| |+++++.+.|++.
T Consensus 294 --------------~~~~~~-~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 294 --------------KPEGLF-RRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp --------------EECSCC-TTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred --------------eechhc-ccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 011111 111 123456788999999999999 6888888888776
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=341.16 Aligned_cols=255 Identities=23% Similarity=0.300 Sum_probs=198.5
Q ss_pred cCcccc-ceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~-~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
+.|++. +.||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 678885 78999999999999864 5899999999877666678899999999985 79999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC---ceeeeecceeecC
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN---PKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~~~ 666 (834)
|+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999843 346889999999999999999999998 999999999999988776 9999999998654
Q ss_pred CCcc-----ccccceecccccccccccccC-----CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccH---------
Q 003280 667 GDEL-----QGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNL--------- 727 (834)
Q Consensus 667 ~~~~-----~~~~~~~~gt~~y~aPE~l~~-----~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l--------- 727 (834)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 111223468999999999975 568999999999999999999999987654322100
Q ss_pred hHHHHhHhcCCccccccccccccCCCCHH----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 728 LGYAWDLWKDDKFHELIDPVITQDEISLP----VLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~lid~~l~~~~~~~~----~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
............ ...+.. ....+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 246 QNMLFESIQEGK-----------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHCC-----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhccC-----------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000001110000 011111 2346789999999999999999999988
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=343.55 Aligned_cols=243 Identities=22% Similarity=0.323 Sum_probs=201.5
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc--------ccHHHHHHHHHHHHhhcCCCcceEEeEEEec
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--------QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ 581 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 581 (834)
..++|++.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999864 588999999875421 1334678899999999999999999999999
Q ss_pred CeEEEEEeecCCC-CccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeec
Q 003280 582 GEKILILEYMPNK-SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660 (834)
Q Consensus 582 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 660 (834)
+..++||||+.+| +|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999877 8888884 3446899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecCCCccccccceecccccccccccccCCcc-CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc
Q 003280 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK 739 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 739 (834)
+++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------- 235 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------- 235 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence 998875432 2234679999999999988877 8899999999999999999999853110
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 740 FHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 740 ~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
.+....... .....++.+++.+||+.||++|||++|+++-
T Consensus 236 ---~~~~~~~~~---~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ---TVEAAIHPP---YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---GTTTCCCCS---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---HHhhccCCC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111000 0123467899999999999999999999883
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=359.74 Aligned_cols=248 Identities=22% Similarity=0.282 Sum_probs=194.0
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
.++|++.+.||+|+||.||+|+.. +++.||||+++.. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 368999999999999999999875 5889999999753 333456788899999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
|||+++|+|..++. ....+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999998884 34568999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ......
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~---~i~~~~-------- 365 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFE---LILMEE-------- 365 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---HHHHCC--------
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHH---HHHhCC--------
Confidence 322 1233468999999999999999999999999999999999999998643221 1111 111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
...+.....++.+++.+||+.||++|| +++|+++
T Consensus 366 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 ----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 001111234678999999999999999 9999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=333.26 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=199.6
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
.++|++.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4789999999999999999998764 7789999986532 23356789999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999988843 345889999999999999999999998 99999999999999999999999999865433
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ..... . ..
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~---~~~~~-~------~~- 224 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETY---KRISR-V------EF- 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH---HHHHH-T------CC-
T ss_pred cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHH---HHHHh-C------CC-
Confidence 22 23357899999999999999999999999999999999999998643211 111 01000 0 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+......+.+++.+||+.||++|||++|+++
T Consensus 225 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 225 ----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 011112346779999999999999999999997
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=340.14 Aligned_cols=247 Identities=23% Similarity=0.262 Sum_probs=178.4
Q ss_pred ceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEEEEeecCCCCc
Q 003280 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
+.||+|+||.||+|... +++.||||++... ....+.+|+.++.+++ ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999985 4889999999643 3467789999999997 99999999999999999999999999999
Q ss_pred cccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC---CceeeeecceeecCCCccccc
Q 003280 597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM---NPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~~~~~~~~~~ 673 (834)
.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....... .
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~ 165 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--P 165 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--c
Confidence 999843 456899999999999999999999998 99999999999997765 799999999987654322 2
Q ss_pred cceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCc--ccHhHHHHhHhcCCccccccccccccC
Q 003280 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS--FNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... .......+... . ..
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~~------~-~~ 237 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDFS------F-EG 237 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCCC------C-CS
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCCC------C-Cc
Confidence 234578999999999999999999999999999999999999987543321 11111 11111111110 0 00
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
........++.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 000112356889999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=329.75 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=203.1
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999875 4889999998654 3344577899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC---ceeeeecceeec
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN---PKISDFGLARMF 665 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~~ 665 (834)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888743 356899999999999999999999998 999999999999987655 999999999876
Q ss_pred CCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .... .... .... ...
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~---~~~~-~~~~-~~~ 228 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYA---QIKA-GAYD-YPS 228 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---HHHH-TCCC-CCT
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHH---HHHh-cccc-CCc
Confidence 54322 22357899999999999999999999999999999999999998543221 1111 1100 0000 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+ ........+.+++.+||+.||++|||++|+++
T Consensus 229 ~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 P------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp T------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred h------hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 00112346789999999999999999999987
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=355.94 Aligned_cols=253 Identities=25% Similarity=0.305 Sum_probs=206.6
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+. .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999885 5899999998653 233456789999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++|+|..++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999885432 335899999999999999999999998 99999999999999999999999999988754
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........... .
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~i~~~i~~~-------~-- 405 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKEV-------P-- 405 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHHHHHHHHHC-------C--
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHHHHHHhhcc-------c--
Confidence 32 12335899999999999999999999999999999999999999975433211 10000010000 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
...+.....++.+|+.+||+.||++|| +++|+++
T Consensus 406 ---~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 ---EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 011112234678999999999999999 7888876
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=344.43 Aligned_cols=266 Identities=15% Similarity=0.173 Sum_probs=208.1
Q ss_pred cCccccceeeeecceeEEEEEECC---------CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcce----------
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN---------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVK---------- 573 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~---------- 573 (834)
++|++.+.||+|+||.||+|+... ++.||||++... +.+.+|+.++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 689999999999999999998764 789999998654 46789999999999999987
Q ss_pred -----EEeEEEe-cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEE
Q 003280 574 -----LLGCCVE-QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVL 647 (834)
Q Consensus 574 -----l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 647 (834)
+++++.. ....++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 6777776 67899999999 99999999532 2356899999999999999999999998 999999999999
Q ss_pred EcCCC--CceeeeecceeecCCCccc-----cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCC
Q 003280 648 LDMDM--NPKISDFGLARMFGGDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY 720 (834)
Q Consensus 648 l~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~ 720 (834)
++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999876533211 1112347899999999999999999999999999999999999998765
Q ss_pred CCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCC
Q 003280 721 NADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELP 794 (834)
Q Consensus 721 ~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 794 (834)
......+......... ....+.+........ ..++.+++.+||+.||++||+++|+++.|+.+..+..
T Consensus 272 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVD--KPGPFVGPCGHWIRP----SETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TTCHHHHHHHHHHHHH--SCCCEECTTSCEECC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CcCHHHHHHHHHhccC--ChhhhhhhccccCCC----cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 4332222222111111 111111111101111 2467899999999999999999999999988754443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=334.65 Aligned_cols=255 Identities=27% Similarity=0.388 Sum_probs=202.1
Q ss_pred hcCccccceeeeecceeEEEEEECC----CcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+|+... +..||||+++.. .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4789999999999999999998643 236999999765 33456789999999999999999999999865 45789
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999853 2345889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ...... .....
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~---~~~~~----- 233 (281)
T 3cc6_A 165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLE---KGDRL----- 233 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHH---HTCCC-----
T ss_pred ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHh---cCCCC-----
Confidence 43221 1223456889999999999999999999999999999998 999986433221 111111 11000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 234 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 ------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 00111234678999999999999999999999999876
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=333.57 Aligned_cols=264 Identities=25% Similarity=0.358 Sum_probs=198.2
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-----cccHHHHHHHHHHHHhhc---CCCcceEEeEEEec
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-----GQGLEEFKNEMMLIAKLQ---HRNLVKLLGCCVEQ 581 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~ 581 (834)
..++|++.++||+|+||+||+|+.. +++.||||+++... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3579999999999999999999974 58899999986432 122356677888877775 99999999999876
Q ss_pred C-----eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCcee
Q 003280 582 G-----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656 (834)
Q Consensus 582 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 656 (834)
. ..++||||++ ++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5799999997 5888888543 2234899999999999999999999998 999999999999999999999
Q ss_pred eeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhc
Q 003280 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWK 736 (834)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~ 736 (834)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~ 236 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIG 236 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHHHHC
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhC
Confidence 9999998764322 2234678999999999999999999999999999999999999986543221 1111111111
Q ss_pred C---Ccccc---ccccccc-cCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 737 D---DKFHE---LIDPVIT-QDEISL-----PVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 737 ~---~~~~~---lid~~l~-~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. ..... +.+.... ...... .....+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0 00000 0000000 000011 12346789999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=342.94 Aligned_cols=249 Identities=19% Similarity=0.249 Sum_probs=190.6
Q ss_pred cCcccc-ceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHh-hcCCCcceEEeEEEe----cCeEE
Q 003280 513 ENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAK-LQHRNLVKLLGCCVE----QGEKI 585 (834)
Q Consensus 513 ~~f~~~-~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~----~~~~~ 585 (834)
++|.+. +.||+|+||.||++... +++.||||+++.. ..+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 567776 68999999999999876 4889999999642 456788888754 489999999999876 56789
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC---CCCceeeeecce
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLA 662 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla 662 (834)
+||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999998542 2345899999999999999999999998 999999999999988 789999999999
Q ss_pred eecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcc--cHhHHHHhHhcCCcc
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF--NLLGYAWDLWKDDKF 740 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~ 740 (834)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... ..+..
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~ 284 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQY 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCC
T ss_pred cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCcc
Confidence 8764322 22346789999999999999999999999999999999999999865443221 111100 00000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
....+ .......++.+|+.+||+.||++|||+.|+++
T Consensus 285 -~~~~~------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 285 -EFPNP------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp -CCCTT------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cCCCc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 00112346789999999999999999999998
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=342.08 Aligned_cols=257 Identities=30% Similarity=0.443 Sum_probs=200.5
Q ss_pred cCccccceeeeecceeEEEEEECC-----CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
++|++.+.||+|+||.||+|.... +..||||+++... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 678889999999999999998643 2359999997643 3345679999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999853 2356899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 667 GDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 667 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+.. ....+..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~----~~~~~~~---- 268 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMK----AINDGFR---- 268 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH----HHHTTCC----
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHH----HHHCCCc----
Confidence 43211 11222356788999999999999999999999999999999 99998543221 1111 1111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
. .........+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus 269 -~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 269 -L-----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp -C-----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -C-----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 011122346789999999999999999999999998863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=330.79 Aligned_cols=253 Identities=28% Similarity=0.430 Sum_probs=200.1
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|.....||+|+||.||+|... +++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555569999999999999874 57899999998776666788999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-CCCceeeeecceeecCCCcc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~ 670 (834)
++++|.+++........+++..+..++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999865444445678899999999999999999998 999999999999987 89999999999987654321
Q ss_pred ccccceecccccccccccccCCc--cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~--~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||........... ...... ..+.+
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~-------~~~~~ 247 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--KVGMFK-------VHPEI 247 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--HHHHHC-------CCCCC
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--hhcccc-------ccccc
Confidence 123457899999999997654 88999999999999999999999864322111110 000000 01111
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+.....++.+++.+||+.||++||+++|+++
T Consensus 248 -----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 -----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1122346789999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=343.45 Aligned_cols=206 Identities=27% Similarity=0.312 Sum_probs=177.6
Q ss_pred cHHHHHHHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhc-----CCCcceEEeE
Q 003280 504 SLASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-----HRNLVKLLGC 577 (834)
Q Consensus 504 ~~~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~l~~~ 577 (834)
++.......++|++.++||+|+||.||+|+.. +++.||||+++.. ....+.+..|+.+++.++ ||||++++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 33333345689999999999999999999884 5889999999643 334567788999999997 9999999999
Q ss_pred EEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-------
Q 003280 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM------- 650 (834)
Q Consensus 578 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~------- 650 (834)
+...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccc
Confidence 99999999999999 99999988543 2235889999999999999999999998 999999999999975
Q ss_pred ------------------CCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc
Q 003280 651 ------------------DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712 (834)
Q Consensus 651 ------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt 712 (834)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 789999999999875432 223578999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 003280 713 GKKNTGVY 720 (834)
Q Consensus 713 G~~p~~~~ 720 (834)
|+.||...
T Consensus 255 g~~pf~~~ 262 (360)
T 3llt_A 255 GSLLFRTH 262 (360)
T ss_dssp SSCSCCCS
T ss_pred CCCCCCCC
Confidence 99998654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=334.94 Aligned_cols=256 Identities=27% Similarity=0.384 Sum_probs=203.6
Q ss_pred hcCccccc-eeeeecceeEEEEEEC---CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 512 TENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~f~~~~-~LG~G~~G~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
.++|++.+ .||+|+||.||+|... .++.||||+++... ....+++.+|+.++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 36788888 9999999999999642 36789999997653 23367899999999999999999999999 667889
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999843 345889999999999999999999998 999999999999999999999999999887
Q ss_pred CCCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 666 GGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 666 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
...... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....... +. ........
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~----~~~~~~~~--- 238 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VT----AMLEKGER--- 238 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH----HHHHTTCC---
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HH----HHHHcCCC---
Confidence 543321 11222356788999999999899999999999999999999 999986533211 11 11111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
. ..+......+.+++.+||+.||++||++.|+++.|+..-
T Consensus 239 --~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 239 --M-----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp --C-----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --C-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 111122346889999999999999999999999998763
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=341.05 Aligned_cols=253 Identities=24% Similarity=0.315 Sum_probs=201.9
Q ss_pred cCccccceeeeecceeEEEEEE----CCCcEEEEEEccCcc----cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 583 (834)
++|++.+.||+|+||.||+++. ..++.||||+++... ....+.+.+|+.++.++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6899999999999999999987 368999999987532 23345678899999999 69999999999999999
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999843 346889999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceecccccccccccccC--CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccc
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH 741 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (834)
.+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ............
T Consensus 208 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~--- 282 (355)
T 1vzo_A 208 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE--- 282 (355)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCC---
T ss_pred ecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhccC---
Confidence 76433221 2234579999999999986 3478999999999999999999999875433221 111111111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003280 742 ELIDPVITQDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVSI 785 (834)
Q Consensus 742 ~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 785 (834)
...+......+.+++.+||+.||++|| +++|+++.
T Consensus 283 ---------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 ---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ---------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 011112234678999999999999999 99999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=346.97 Aligned_cols=261 Identities=28% Similarity=0.435 Sum_probs=196.1
Q ss_pred cCccccceeeeecceeEEEEEECC--C--cEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEe-cCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN--G--QEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE-QGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~--g--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~l 586 (834)
..|++.+.||+|+||.||+|+..+ + ..||||.++... ....++|.+|+.++++++||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 457788999999999999998642 2 368999987543 3456789999999999999999999998765 457899
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999853 3345788999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc--cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 667 GDELQ--GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 667 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||....... ..... ..... .
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~---~~~~~---~ 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL---LQGRR---L 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHH---HTTCC---C
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHH---HcCCC---C
Confidence 43221 11223467789999999999999999999999999999999 666665433221 21111 11110 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCC
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELP 794 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 794 (834)
.. ... ....+.+++.+||+.||++|||++|+++.|+.+...+.
T Consensus 316 ~~----p~~----~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 316 LQ----PEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CC----CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CC----CCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 111 22467899999999999999999999999998754443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.15 Aligned_cols=203 Identities=28% Similarity=0.438 Sum_probs=163.9
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhc-CCCcceEEeEEEecC--eE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQG--EK 584 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~--~~ 584 (834)
..++|++.+.||+|+||.||+|.+. +++.||||++... .....+++.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3578999999999999999999875 5899999998653 3344567889999999997 999999999998654 78
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||++ ++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHH----HTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 57887773 246889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCc-------------------cccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCC
Q 003280 665 FGGDE-------------------LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN 721 (834)
Q Consensus 665 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~ 721 (834)
+.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 64311 0111234579999999999986 678999999999999999999999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=336.79 Aligned_cols=250 Identities=20% Similarity=0.274 Sum_probs=199.1
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.+.||+|+||.||++... +++.||||++.+.... ..+|++++.++ +||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 478999999999999999999886 4889999999765432 35688888888 79999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC-C---Cceeeeecceeec
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-M---NPKISDFGLARMF 665 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~---~~kl~Dfgla~~~ 665 (834)
|+++|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||+.++ + .+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999998843 456899999999999999999999998 9999999999998443 3 4999999999976
Q ss_pred CCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcc-cHhHHHHhHhcCCcccccc
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF-NLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~li 744 (834)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+.. . ...+...
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~-i~~~~~~--- 241 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---R-IGSGKFS--- 241 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH---H-HHHCCCC---
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH---H-HccCCcc---
Confidence 54322 22345789999999999988899999999999999999999999875432211 1111 1 1111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+ ...........+.+++.+||+.||++||++.|+++
T Consensus 242 ---~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ---L-SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---C-CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---c-CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00011122346789999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.96 Aligned_cols=258 Identities=28% Similarity=0.429 Sum_probs=203.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcE--EEEEEccCc-ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQE--VAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 587 (834)
++|++.+.||+|+||.||+|+.. +++. +|||+++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999875 3554 499988753 334456789999999999 899999999999999999999
Q ss_pred EeecCCCCccccccCCC-------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCc
Q 003280 588 LEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP 654 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 654 (834)
|||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986432 2346899999999999999999999998 9999999999999999999
Q ss_pred eeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHh
Q 003280 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWD 733 (834)
Q Consensus 655 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~ 733 (834)
||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....... +. .
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~----~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LY----E 252 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH----H
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HH----H
Confidence 99999999753221 11223456889999999999999999999999999999998 999986433211 11 1
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLE 792 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 792 (834)
..... ... .........+.+++.+||+.+|++|||++|+++.|+....+
T Consensus 253 ~~~~~-----~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 253 KLPQG-----YRL-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HGGGT-----CCC-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhhcC-----CCC-----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 000 01112234678999999999999999999999999887443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=352.84 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=206.4
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 68999999999999999999986 58999999996542 234578899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCC-CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 589 EYMPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
||+++|+|..++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999886532 2456899999999999999999999998 99999999999999999999999999998654
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............
T Consensus 342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~~~~--------- 409 (543)
T 3c4z_A 342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVLEQA--------- 409 (543)
T ss_dssp TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHHHCC---------
T ss_pred CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHhhcc---------
Confidence 332 22345899999999999999999999999999999999999999975432211 111111111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTM-----SDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 784 (834)
. ..+......+.+++.+||+.||++||++ +|+++
T Consensus 410 ~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 V---TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp C---CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred c---CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0 1111223467899999999999999975 56654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=328.37 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=204.4
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEe---------
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--------- 580 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--------- 580 (834)
..++|++.+.||+|+||.||+|+.. +++.||||+++... +.+.+|++++.+++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3468999999999999999999986 68999999997543 356789999999999999999998864
Q ss_pred -------cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC
Q 003280 581 -------QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN 653 (834)
Q Consensus 581 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 653 (834)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 44589999999999999998542 2356889999999999999999999998 999999999999999999
Q ss_pred ceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHh
Q 003280 654 PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWD 733 (834)
Q Consensus 654 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~ 733 (834)
+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|..|+... .. ...
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~-~~~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SK-FFT 229 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HH-HHH
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HH-HHH
Confidence 99999999988754321 22356899999999999999999999999999999999999875210 00 111
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccccc
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLE 792 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 792 (834)
...... + ... ....+.+++.+||+.||++|||+.|+++.|+.....
T Consensus 230 ~~~~~~--------~-~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 DLRDGI--------I-SDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHTTC--------C-CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred Hhhccc--------c-ccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 111111 1 111 223577899999999999999999999999987543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=337.32 Aligned_cols=264 Identities=27% Similarity=0.415 Sum_probs=208.2
Q ss_pred cCccccceeeeecceeEEEEEE-----CCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC--eEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG--EKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~ 585 (834)
++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 6799999999999999999984 358899999998776667788999999999999999999999987654 789
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 121 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 999999999999998542 345889999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCC---------cccH-hHHHHhH
Q 003280 666 GGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD---------SFNL-LGYAWDL 734 (834)
Q Consensus 666 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~---------~~~l-~~~~~~~ 734 (834)
...... .......++..|+|||++.+..++.++||||||+++|||++|+.|+...... .... .......
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 543221 1122345677899999999999999999999999999999999886532100 0000 0000011
Q ss_pred hcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 003280 735 WKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERL 791 (834)
Q Consensus 735 ~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 791 (834)
..... ....+...+.++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 276 ~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 276 LKNNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHTTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCC----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11100 001111223568899999999999999999999999988743
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=349.55 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=191.2
Q ss_pred HhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc--------cccHHHHHHHHHHHHhhcCCCcceEEeEEEec
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS--------GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ 581 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 581 (834)
..++|.+.+.||+|+||.||+|.... ++.||||++.... ......+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 45899999999999999999998754 7899999986532 112235889999999999999999999975 5
Q ss_pred CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC---CCceeee
Q 003280 582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISD 658 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~D 658 (834)
+..++||||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 56899999999999998884 3456899999999999999999999998 9999999999999654 4599999
Q ss_pred ecceeecCCCccccccceecccccccccccccC---CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh
Q 003280 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 659 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.. ..
T Consensus 286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~----~i 357 (419)
T 3i6u_A 286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKD----QI 357 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHH----HH
T ss_pred cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHH----HH
Confidence 99998764322 2234679999999999863 678899999999999999999999986543221 1111 11
Q ss_pred cCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
....... . +.. ... ....+.+++.+||+.||++|||++|+++
T Consensus 358 ~~~~~~~-~-~~~-~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 TSGKYNF-I-PEV-WAE----VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HTTCCCC-C-HHH-HTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCCC-C-chh-hcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1111000 0 000 001 1346789999999999999999999987
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=328.37 Aligned_cols=251 Identities=22% Similarity=0.346 Sum_probs=197.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 68999999999999999999875 48899999987643 34568899999999999999999999999999999999999
Q ss_pred cCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE---cCCCCceeeeecceeecC
Q 003280 591 MPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFG 666 (834)
Q Consensus 591 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~ 666 (834)
+++++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999888542 23356899999999999999999999998 9999999999999 456789999999998764
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
... ......||+.|+|||++. ..++.++||||||+++|||++|+.||....... . ...........
T Consensus 179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~---~~~~~~~~~~~----- 244 (285)
T 3is5_A 179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--V---QQKATYKEPNY----- 244 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---HHHHHHCCCCC-----
T ss_pred Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--H---HhhhccCCccc-----
Confidence 432 123457899999999886 568999999999999999999999986433211 1 11111000000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...... ...++.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 AVECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC--CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000011 1346778999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=351.20 Aligned_cols=259 Identities=23% Similarity=0.262 Sum_probs=194.2
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEec------C
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------G 582 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 582 (834)
.++|++.++||+|+||.||+|... .++.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 378999999999999999999875 4889999999754 334467889999999999999999999999654 3
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
..++||||++++ |...+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 679999999876 444442 23889999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh-------
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW------- 735 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~------- 735 (834)
+...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+... .........
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEF 286 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHH
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHH
Confidence 8764432 2334689999999999999999999999999999999999999997543211 111000000
Q ss_pred ------------cCC------ccccccccccccCCC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 736 ------------KDD------KFHELIDPVITQDEI--SLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 736 ------------~~~------~~~~lid~~l~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
... .+.......+..... ......++.+|+.+||+.||++|||++|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000000000000000 0112457889999999999999999999988
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=326.64 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=205.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 68999999999999999999886 4778999998653 2234578999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999998843 345889999999999999999999998 999999999999999999999999999775432
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
. .....|++.|+|||++.+..++.++||||||+++|||++|+.||....... . ...... . +..+
T Consensus 168 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~---~~~~~~-~------~~~~ 231 (284)
T 2vgo_A 168 R----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--T---HRRIVN-V------DLKF 231 (284)
T ss_dssp C----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--H---HHHHHT-T------CCCC
T ss_pred c----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--H---HHHHhc-c------ccCC
Confidence 2 233578999999999999999999999999999999999999986432211 1 111111 0 0001
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
+......+.+++.+||+.||++||+++|+++ .+...
T Consensus 232 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 232 -----PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp -----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred -----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 1112346789999999999999999999987 55554
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=348.15 Aligned_cols=245 Identities=22% Similarity=0.276 Sum_probs=190.6
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHH-HHhhcCCCcceEEeEEEecCeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMML-IAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+|+... ++.||||++++.. ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 3789999999999999999999864 7889999997643 2234456667766 567899999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++|+|..++. +.+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999998884 3346889999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+ ....... .
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~---~~~i~~~-~------- 255 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EM---YDNILNK-P------- 255 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--HH---HHHHHHS-C-------
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HH---HHHHHhc-c-------
Confidence 222 1234468999999999999999999999999999999999999998643211 11 1111111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSD 781 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 781 (834)
+ ..+......+.+++.+||+.||++||++.+
T Consensus 256 -~---~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 256 -L---QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp -C---CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred -c---CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 0 001112346789999999999999999853
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=366.56 Aligned_cols=256 Identities=27% Similarity=0.391 Sum_probs=201.8
Q ss_pred cCccccc-eeeeecceeEEEEEEC---CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~-~LG~G~~G~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
+++.+.+ .||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4455555 7999999999999864 35679999997653 3457889999999999999999999999976 569999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999853 3456899999999999999999999998 99999999999999999999999999987644
Q ss_pred Cccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 668 DELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 668 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
.... .......+++.|+|||++.+..++.++|||||||+||||++ |+.||....... +.. ....+...
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~----~i~~~~~~---- 558 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMA----FIEQGKRM---- 558 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHH----HHHTTCCC----
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHH----HHHcCCCC----
Confidence 3211 11122345689999999999999999999999999999998 999987543321 111 11111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
..+.....++.+|+.+||+.+|++||++++|++.|+...
T Consensus 559 ------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 559 ------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp ------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111122356889999999999999999999999998864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=341.72 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=203.7
Q ss_pred hcCccccceeeeecceeEEEEEE------CCCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+|+. ..++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 37899999999999999999984 24678999999754 344566899999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCC----CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC---CCCceee
Q 003280 585 ILILEYMPNKSLDVFLFDPT----KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKIS 657 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 657 (834)
++||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999986432 1245889999999999999999999998 999999999999984 4569999
Q ss_pred eecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhc
Q 003280 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWK 736 (834)
Q Consensus 658 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 736 (834)
|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+.. ...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~----~~~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLE----FVT 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHH----HHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHHH----HHh
Confidence 9999986644333233334567889999999999999999999999999999998 88887643211 1111 111
Q ss_pred CCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 737 DDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 737 ~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.... . .........+.+++.+||+.||++||++.|+++.|+...
T Consensus 260 ~~~~-----~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 260 SGGR-----M-----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TTCC-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCC-----C-----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 1100 0 011112346789999999999999999999999998764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=337.64 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=206.2
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
.++|.+.+.||+|+||.||++.... ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4789999999999999999999864 789999998654 234457789999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999998874 2356899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... . ....... . ..
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~---~~~~~~~-~------~~ 259 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--T---YLRIKKN-E------YS 259 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H---HHHHHHT-C------CC
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--H---HHHHhcC-C------CC
Confidence 321 2233578999999999999999999999999999999999999986432111 1 1111110 0 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
+ +......+.+++.+||+.||++|||++|+++ .+..
T Consensus 260 ~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 260 I-----PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp C-----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred C-----CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1 1112245778999999999999999999987 4544
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=329.75 Aligned_cols=246 Identities=20% Similarity=0.300 Sum_probs=198.5
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 586 (834)
..++|++.+.||+|+||.||+|... +++.||||+++.. ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3478999999999999999999986 6899999998754 233456788999999999 99999999999999999999
Q ss_pred EEeecCCCCccccccCCC-CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC--------------
Q 003280 587 ILEYMPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-------------- 651 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-------------- 651 (834)
||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999985422 1256899999999999999999999998 9999999999999844
Q ss_pred -----CCceeeeecceeecCCCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcc
Q 003280 652 -----MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSF 725 (834)
Q Consensus 652 -----~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~ 725 (834)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|||++|.+++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 479999999998865432 23589999999999876 56789999999999999999987753211
Q ss_pred cHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 726 NLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 726 ~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. .......... .+ ... ....+.+++.+||+.||++|||+.|+++
T Consensus 236 -~----~~~~~~~~~~-----~~-~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 -Q----WHEIRQGRLP-----RI-PQV----LSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -H----HHHHHTTCCC-----CC-SSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -H----HHHHHcCCCC-----CC-Ccc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0 1111111111 11 111 2346789999999999999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=330.81 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=205.4
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
+.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 67999999999999999999875 58899999986543 34568899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 102 ~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 102 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 99999999883 346899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
......||+.|+|||++.+..++.++||||||+++|||++|+.|+....... .. ..... .. .+.+ .
T Consensus 175 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~---~~~~~-~~-----~~~~-~ 240 (303)
T 3a7i_A 175 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VL---FLIPK-NN-----PPTL-E 240 (303)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH---HHHHH-SC-----CCCC-C
T ss_pred --ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HH---HHhhc-CC-----CCCC-c
Confidence 2234578999999999999999999999999999999999999986432211 11 11111 00 0111 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
... ...+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 GNY----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 112 2457899999999999999999999873
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.92 Aligned_cols=246 Identities=30% Similarity=0.447 Sum_probs=198.6
Q ss_pred cCccccceeeeecceeEEEEEE-CCCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
+.|++.+.||+|+||.||+|+. .+++.||||++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5699999999999999999987 468899999986542 233567899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||++ |+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9998 567666632 2356899999999999999999999998 999999999999999999999999999875432
Q ss_pred ccccccceeccccccccccccc---CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~---~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
....||+.|+|||++. +..++.++|||||||++|||++|+.||...... .......... .
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-----~~~~~~~~~~------~ 270 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQNE------S 270 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSC------C
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhcC------C
Confidence 2357899999999985 567899999999999999999999998543211 1111111111 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
+...... ....+.+++.+||+.||++|||++|+++.
T Consensus 271 ~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 PALQSGH----WSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCC----CCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111111 23457789999999999999999999873
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=331.55 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=204.1
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
.++|.+.+.||+|+||.||++.... ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 3789999999999999999999864 788999998654 233457789999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999998873 3346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... . .... ..... .
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~---~~~~-~~~~~------~ 233 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--T---YLRI-KKNEY------S 233 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H---HHHH-HTTCC------C
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--H---HHHH-hhccC------C
Confidence 221 2233578999999999999999999999999999999999999986432211 0 1111 11100 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+ +......+.+++.+||+.||++|||++|+++
T Consensus 234 ~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 234 I-----PKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp C-----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred C-----ccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1 1112246788999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.26 Aligned_cols=264 Identities=23% Similarity=0.290 Sum_probs=192.6
Q ss_pred HHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc--ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
...++|++.++||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999865 588999999975432 234678899999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc-----CCCCceeeeecc
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD-----MDMNPKISDFGL 661 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~Dfgl 661 (834)
||||+++ +|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 8888874 3345899999999999999999999998 99999999999994 445599999999
Q ss_pred eeecCCCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC---
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD--- 737 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~--- 737 (834)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...........
T Consensus 184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCT
T ss_pred ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHHhCCCch
Confidence 987643321 22335789999999999875 48999999999999999999999986533211 11111111000
Q ss_pred Cccccc---c--cccc-ccCCCCHH------HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 DKFHEL---I--DPVI-TQDEISLP------VLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~l---i--d~~l-~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...... . .... ........ ...++.+++.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000 0 0000 00000111 2346789999999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=339.66 Aligned_cols=268 Identities=23% Similarity=0.335 Sum_probs=196.5
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccccc-HHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.+.||+|+||.||+|+.. +++.||||+++...... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999986 58899999987543221 12456799999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
++ ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 98 477777743 3446889999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC---ccccccc-
Q 003280 671 QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD---KFHELID- 745 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---~~~~lid- 745 (834)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ............ .......
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGC
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHhchhhhcc
Confidence 12233578999999999876 568999999999999999999999986543221 111111111110 0000000
Q ss_pred --------cccccCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhccc
Q 003280 746 --------PVITQDE---ISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSER 790 (834)
Q Consensus 746 --------~~l~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 790 (834)
+...... .......++.+++.+||+.||++|||++|+++ .+.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 0000000 00012346789999999999999999999988 555543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=345.08 Aligned_cols=199 Identities=26% Similarity=0.402 Sum_probs=167.2
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEec-----Ce
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-----GE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 583 (834)
.++|++.+.||+|+||.||+|+... ++.||||+++.. .....+++.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 3789999999999999999998754 788999999764 334457899999999999999999999999876 57
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.++||||++ ++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 58888884 3456899999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCccc--------------------cccceecccccccccccc-cCCccCccCceeehhhhHHHhhcCCCCC
Q 003280 664 MFGGDELQ--------------------GNTKRIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSGKKNT 717 (834)
Q Consensus 664 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~l-~~~~~t~~~DVwSlGvvl~elltG~~p~ 717 (834)
........ .......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 87543211 123456899999999986 5667999999999999999999865554
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=332.83 Aligned_cols=257 Identities=24% Similarity=0.304 Sum_probs=202.6
Q ss_pred HHHHhcCcccc-ceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhc-CCCcceEEeEEEecC
Q 003280 508 VAAATENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQG 582 (834)
Q Consensus 508 ~~~~~~~f~~~-~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~ 582 (834)
.....++|.+. +.||+|+||.||+|... +++.||||+++... .....++.+|+.++.+++ ||||+++++++.+..
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34455778887 89999999999999876 48999999987642 344678999999999994 699999999999999
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC---CCCceeeee
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDF 659 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 659 (834)
..++||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred eEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999999988432 3456899999999999999999999998 999999999999987 789999999
Q ss_pred cceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc
Q 003280 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK 739 (834)
Q Consensus 660 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 739 (834)
|+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....... ....
T Consensus 179 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~-~~~~- 251 (327)
T 3lm5_A 179 GMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYLNISQ-VNVD- 251 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-TCCC-
T ss_pred ccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHHHh-cccc-
Confidence 9998765432 1233579999999999999999999999999999999999999986433211 1100000 0000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 740 FHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 740 ~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. ...........+.+++.+||+.||++|||++|+++
T Consensus 252 ~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 252 Y---------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp C---------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c---------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 00111112346789999999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=341.27 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=203.1
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.+.||+|+||.||+|... +++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 68999999999999999999986 5889999998765 334457899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
+++++|.+++.. ...+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999843 34588999999999999999999986 7 999999999999999999999999998765321
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHH-------------------
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGY------------------- 730 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~------------------- 730 (834)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 1233578999999999999999999999999999999999999987543221110000
Q ss_pred -----HHhHhcCCccccccccccc---cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 731 -----AWDLWKDDKFHELIDPVIT---QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 731 -----~~~~~~~~~~~~lid~~l~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...........+.++.... ..........++.+++.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000000000010000 00001112346889999999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=325.93 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=202.8
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc------cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS------GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 67999999999999999999986 58999999986542 124678999999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC----Cceeeeecc
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM----NPKISDFGL 661 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgl 661 (834)
+||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999843 346899999999999999999999998 99999999999998877 899999999
Q ss_pred eeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccc
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH 741 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (834)
+....... ......+++.|+|||++.+..++.++||||||+++|||++|+.||...... .... . ......
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~---~-~~~~~~- 228 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLT---N-ISAVNY- 228 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH---H-HHTTCC-
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHH---H-hHhccc-
Confidence 98764432 123356899999999999999999999999999999999999998643211 1110 0 100000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 742 ELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 742 ~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
...... ... ....+.+++.+||+.||++||++.|+++ .++..
T Consensus 229 -~~~~~~-~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 229 -DFDEEY-FSN----TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp -CCCHHH-HTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred -CCcchh-ccc----CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 000000 011 1246789999999999999999999987 44443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.27 Aligned_cols=251 Identities=28% Similarity=0.410 Sum_probs=197.4
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEec-CeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-GEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~Ey 590 (834)
.++|++.+.||+|+||.||+|+. .++.||||+++... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 37899999999999999999987 58899999997543 457899999999999999999999997654 478999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|.+++... ....+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 9999999998432 1223788999999999999999999998 9999999999999999999999999998654321
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
....+++.|+|||++.+..++.++||||||+++|||++ |+.||....... +.. ...... ..
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~----~~~~~~-----~~--- 233 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP----RVEKGY-----KM--- 233 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHH----HHTTTC-----CC---
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHhcCC-----CC---
Confidence 22357889999999999999999999999999999998 999986543211 111 111110 01
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.........+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 234 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 234 --DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 111122346789999999999999999999999998863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=331.17 Aligned_cols=255 Identities=21% Similarity=0.331 Sum_probs=203.7
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|++.+.||+|+||.||+++.. +++.||||+++.......+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 368999999999999999999875 5899999999866555557789999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE---cCCCCceeeeecceeecCC
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~ 667 (834)
+++++|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999888843 346889999999999999999999998 9999999999999 7889999999999976533
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+.. ... .... .. .
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~---~i~-~~~~-~~-~-- 227 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFE---KIK-EGYY-EF-E-- 227 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH---HHH-HCCC-CC-C--
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHH---HHH-cCCC-CC-C--
Confidence 2 123356899999999999999999999999999999999999998643221 1111 111 1100 00 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
..........+.+++.+||+.||++|||++|+++ .+++.
T Consensus 228 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 228 ---SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ---TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 0111122346789999999999999999999987 55543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=352.72 Aligned_cols=194 Identities=26% Similarity=0.389 Sum_probs=154.3
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEec-----CeE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-----GEK 584 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~ 584 (834)
++|++.+.||+|+||.||+|+.. +++.||||++... .....+++.+|+++|++++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 68999999999999999999875 5889999998654 333457899999999999999999999999543 578
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+. ++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 133 ~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 99999985 67887773 3456899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-------------------------cccceecccccccccccc-cCCccCccCceeehhhhHHHhhcC
Q 003280 665 FGGDELQ-------------------------GNTKRIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSG 713 (834)
Q Consensus 665 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~l-~~~~~t~~~DVwSlGvvl~elltG 713 (834)
....... .......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 6432110 122345789999999986 566799999999999999999994
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=336.61 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=203.9
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccc-----------------cHHHHHHHHHHHHhhcCCCcceEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ-----------------GLEEFKNEMMLIAKLQHRNLVKLL 575 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~-----------------~~~~~~~E~~~l~~l~HpnIv~l~ 575 (834)
++|++.+.||+|+||.||+|.. +++.||||++...... ..+.+.+|+.++.+++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 6899999999999999999999 8999999998653211 127899999999999999999999
Q ss_pred eEEEecCeEEEEEeecCCCCcccc------ccCCCCCCcCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCcEEE
Q 003280 576 GCCVEQGEKILILEYMPNKSLDVF------LFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLL 648 (834)
Q Consensus 576 ~~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll 648 (834)
+++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||+|||+ .+ |+||||||+||++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 999999999999999999999998 422 225678999999999999999999999 87 9999999999999
Q ss_pred cCCCCceeeeecceeecCCCccccccceecccccccccccccCC-ccCc-cCceeehhhhHHHhhcCCCCCCCCCCCccc
Q 003280 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSI-KSDVFSFGILMLETLSGKKNTGVYNADSFN 726 (834)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~-~~DVwSlGvvl~elltG~~p~~~~~~~~~~ 726 (834)
+.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||....... .
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~ 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-E 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-H
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-H
Confidence 99999999999999876443 22345789999999999887 6766 9999999999999999999987543321 1
Q ss_pred HhHHHHhHhcCCcccc------cccccccc--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 727 LLGYAWDLWKDDKFHE------LIDPVITQ--DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 727 l~~~~~~~~~~~~~~~------lid~~l~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+.. ......... ...+.... ..........+.+++.+||+.||++|||++|+++
T Consensus 261 ~~~----~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFN----NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHH----HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH----HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 111111000 00000000 0000123357889999999999999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=335.90 Aligned_cols=256 Identities=21% Similarity=0.335 Sum_probs=204.2
Q ss_pred HHHHHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc--------ccHHHHHHHHHHHHhh-cCCCcceEEe
Q 003280 507 SVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--------QGLEEFKNEMMLIAKL-QHRNLVKLLG 576 (834)
Q Consensus 507 ~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~HpnIv~l~~ 576 (834)
......++|++.+.||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34445678999999999999999999986 589999999865431 1245688999999999 7999999999
Q ss_pred EEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCcee
Q 003280 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656 (834)
Q Consensus 577 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 656 (834)
++......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999998843 346899999999999999999999998 999999999999999999999
Q ss_pred eeecceeecCCCccccccceecccccccccccccC------CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHH
Q 003280 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGY 730 (834)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~ 730 (834)
+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......
T Consensus 242 ~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~ 316 (365)
T 2y7j_A 242 SDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLRM 316 (365)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH
T ss_pred EecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHHH
Confidence 9999998875432 2234679999999999863 3588999999999999999999999854321 111111
Q ss_pred HHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 731 AWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 731 ~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. .. .... ...+.. .. ....+.+++.+||+.||++|||++|+++
T Consensus 317 i---~~-~~~~-~~~~~~--~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 I---ME-GQYQ-FSSPEW--DD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp H---HH-TCCC-CCHHHH--SS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H---Hh-CCCC-CCCccc--cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00 0000 000000 01 1245789999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=349.48 Aligned_cols=242 Identities=14% Similarity=0.160 Sum_probs=189.4
Q ss_pred hcCccccceeeeecceeEEEEEE-CCCcEEEEEEccCc---ccccHHHHHHHHH---HHHhhcCCCcceEE-------eE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ---SGQGLEEFKNEMM---LIAKLQHRNLVKLL-------GC 577 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~---~l~~l~HpnIv~l~-------~~ 577 (834)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+. ++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 36899999999999999999996 45899999998743 3445678999994 55556899999998 66
Q ss_pred EEecC-----------------eEEEEEeecCCCCccccccCCC----CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 003280 578 CVEQG-----------------EKILILEYMPNKSLDVFLFDPT----KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636 (834)
Q Consensus 578 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 636 (834)
+...+ ..++||||+ +|+|.+++.... ....+++..+..++.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 66553 278999999 689999885321 1223446888899999999999999998 9
Q ss_pred EeccCCCCcEEEcCCCCceeeeecceeecCCCccccccceecccccccccccccCC-----------ccCccCceeehhh
Q 003280 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-----------LFSIKSDVFSFGI 705 (834)
Q Consensus 637 vH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~t~~~DVwSlGv 705 (834)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2233567 999999999887 8999999999999
Q ss_pred hHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 706 LMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 706 vl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
++|||++|+.||........ ...+... .... ..++.+++.+||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~--------------~~~~~~~---~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG--------------SEWIFRS---CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC--------------SGGGGSS---CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc--------------hhhhhhh---ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999864332110 0011110 0112 246789999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=335.80 Aligned_cols=265 Identities=26% Similarity=0.315 Sum_probs=196.5
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccc-----cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ-----GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 584 (834)
..++|++.+.||+|+||.||+|+.. +++.||||+++..... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3478999999999999999999975 4899999998753221 124688999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+++ +|..++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 77777643 3346888999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc---c
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK---F 740 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~---~ 740 (834)
+..... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||...... .............. .
T Consensus 162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 162 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTS
T ss_pred ccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHcCCCChhhh
Confidence 643321 22335789999999999764 5899999999999999999999987643321 11111111111100 0
Q ss_pred c---cccccccc--cCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003280 741 H---ELIDPVIT--QDEIS-----LPVLVRYINVALLCVQDNAADRPTMSDVVSI 785 (834)
Q Consensus 741 ~---~lid~~l~--~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 785 (834)
. .+.+.... ....+ .....++.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00000000 00111 1123578899999999999999999999984
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=338.92 Aligned_cols=262 Identities=26% Similarity=0.369 Sum_probs=199.2
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCccc--ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|++.+.||+|+||.||+|+... ++.||||++..... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 789999999999999999999864 88999999865432 335668899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999988763 3345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHH----------HhHhc-C
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYA----------WDLWK-D 737 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~----------~~~~~-~ 737 (834)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +.... ...+. .
T Consensus 179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHHC
T ss_pred c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhhc
Confidence 1 22335789999999999875 789999999999999999999999865432211 10000 00000 0
Q ss_pred CccccccccccccCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 DKFHELIDPVITQDEISL-----PVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~lid~~l~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
........+.+ ...... .....+.+++.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEI-KEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCC-SSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccc-cccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00011111111 001111 12456889999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=342.10 Aligned_cols=253 Identities=11% Similarity=0.103 Sum_probs=182.8
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc---ccHHHHHHHHHHHHhh--cCCCcceEE-------eEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKL--QHRNLVKLL-------GCCV 579 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~HpnIv~l~-------~~~~ 579 (834)
.+|++.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+.++..+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 56899999999999999999975 588999999977532 3456788886666666 599988755 4444
Q ss_pred ec-----------------CeEEEEEeecCCCCccccccCCCCCCcCCHHHH------HHHHHHHHHHHHHhhhcCCCce
Q 003280 580 EQ-----------------GEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR------VTIIEGIAQGLLYLHQYSRFRI 636 (834)
Q Consensus 580 ~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~i 636 (834)
.. ...++||||++ ++|.+++... ...+++..+ ..++.||+.||+|||+++ |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 33 33799999999 8999998542 223455556 778899999999999998 9
Q ss_pred EeccCCCCcEEEcCCCCceeeeecceeecCCCccccccceecccccccccccccC--CccCccCceeehhhhHHHhhcCC
Q 003280 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSGK 714 (834)
Q Consensus 637 vH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~t~~~DVwSlGvvl~elltG~ 714 (834)
+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999764321 13466799999999987 67999999999999999999999
Q ss_pred CCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 715 KNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 715 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.||.......... +............. ...........+.+++.+||+.||++|||+.|+++
T Consensus 291 ~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS-------WKRPSLRVPGTDSL-AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC-------CCBCCTTSCCCCSC-CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc-------hhhhhhhhcccccc-chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9987653321110 00000000000000 00000122456889999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=333.78 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=198.3
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEe--------c
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--------Q 581 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--------~ 581 (834)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 68999999999999999999984 58999999986543 2334678899999999999999999999987 4
Q ss_pred CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecc
Q 003280 582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 661 (834)
+..++||||+++ +|...+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999986 55555532 2345899999999999999999999998 99999999999999999999999999
Q ss_pred eeecCCCcc--ccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC-
Q 003280 662 ARMFGGDEL--QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD- 737 (834)
Q Consensus 662 a~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~- 737 (834)
++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...........
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~ 248 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--QLALISQLCGSI 248 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCC
Confidence 987653221 122234578999999999876 458999999999999999999999987543211 11111111000
Q ss_pred --Cccc--------cccccccccCCCCHH-H------HHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 --DKFH--------ELIDPVITQDEISLP-V------LVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 --~~~~--------~lid~~l~~~~~~~~-~------~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.... +.+.... ....... . ...+.+|+.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCS-SCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Chhhccccccchhhccccccc-ccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000 0000000 0111111 1 235789999999999999999999988
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.82 Aligned_cols=256 Identities=20% Similarity=0.288 Sum_probs=199.5
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhc-CCCcceEEeEEEe--cCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVE--QGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~--~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|+.. +++.||||+++.. ..+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 78999999999999999999874 5889999999743 3477899999999997 9999999999998 66789999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC-CceeeeecceeecCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~ 667 (834)
||+++++|..++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999988872 3788999999999999999999998 99999999999999776 899999999987654
Q ss_pred CccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHh--------HhcCC
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWD--------LWKDD 738 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~--------~~~~~ 738 (834)
... .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.........+...... .....
T Consensus 184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 322 233578999999999987 678999999999999999999999985433322111111000 00000
Q ss_pred ------cc--------ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 739 ------KF--------HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 739 ------~~--------~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. ........ ..........++.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFV-HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGC-CTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhc-cccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 00000000 01111112457889999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.61 Aligned_cols=258 Identities=26% Similarity=0.363 Sum_probs=197.5
Q ss_pred hcCccccceeeeecceeEEEEEEC--CCc--EEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL--NGQ--EVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~--~g~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+|++. +++ .||||+++.. .....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 368999999999999999999863 233 6899998754 2345678999999999999999999999998765 8
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999988532 345889999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
....... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||...... .+ ...........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~---~~~~~~~~~~~- 244 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QI---LHKIDKEGERL- 244 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH---HHHHHTSCCCC-
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HH---HHHHHccCCCC-
Confidence 7543321 12233467888999999999999999999999999999999 99998644321 11 11111111000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.........+.+++.+||+.||++|||+.++++.|++..
T Consensus 245 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 ---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 011122346889999999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=365.77 Aligned_cols=249 Identities=27% Similarity=0.382 Sum_probs=197.4
Q ss_pred ceeeeecceeEEEEEEC---CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|+++|++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 36789999997643 344688999999999999999999999986 4568999999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc-c
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ-G 672 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 672 (834)
|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999984 3456899999999999999999999998 999999999999999999999999999877543221 1
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +. .....+...
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~----~~i~~~~~~---------- 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VT----AMLEKGERM---------- 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH----HHHHTTCCC----------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHHcCCCC----------
Confidence 2223456789999999999999999999999999999998 999986543221 11 111111100
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
..+.....++.+++.+||+.||++||++++|++.|+...
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111122356889999999999999999999999998763
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=323.58 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=197.8
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEe----cCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE----QGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~ 585 (834)
+.|++.+.||+|+||.||+|... .+..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45888899999999999999875 4788999998654 34456789999999999999999999999876 34689
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc-CCCCceeeeecceee
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD-MDMNPKISDFGLARM 664 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~ 664 (834)
+||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ .+|+||||||+||+++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999843 356889999999999999999999875 3499999999999997 789999999999976
Q ss_pred cCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
.... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||........ .. ............
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~-~~~~~~~~~~~~ 251 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IY-RRVTSGVKPASF 251 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HH-HHHTTTCCCGGG
T ss_pred cccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH----HH-HHHhccCCcccc
Confidence 4332 2234578999999998874 599999999999999999999999864332111 11 111111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+ ... ..++.+++.+||+.||++|||++|+++
T Consensus 252 ~-----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 D-----KVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G-----GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-----CCC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 111 235789999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.49 Aligned_cols=252 Identities=26% Similarity=0.439 Sum_probs=198.5
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|++.+.||+|+||.||+|+... ++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 3789999999999999999999864 889999999877777788999999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++++|..++.. ....+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 999999988743 2345899999999999999999999998 9999999999999999999999999976432111
Q ss_pred ccccceecccccccccccc-----cCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYA-----LDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l-----~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
.......||+.|+|||++ .+..++.++||||||+++|||++|+.|+....... ........... ...
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~-~~~- 243 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSDPP-TLL- 243 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCC-CCS-
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-----HHHHHhccCCc-ccC-
Confidence 112235789999999998 36678999999999999999999999986533211 11111111110 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.+......+.+++.+||+.||++|||+.|+++
T Consensus 244 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 -------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01112346789999999999999999999876
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=339.27 Aligned_cols=261 Identities=25% Similarity=0.312 Sum_probs=196.6
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC------
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------ 582 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 582 (834)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 368999999999999999999875 5899999999653 3334577899999999999999999999998763
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 7899888843 45889999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC---
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD--- 738 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--- 738 (834)
+..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.. +............
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMKVTGTPPAE 248 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHH
Confidence 876432 223578999999999987 67999999999999999999999998654321 1111110000000
Q ss_pred --------c-------cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 739 --------K-------FHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 739 --------~-------~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
. ........+ ..........+.+++.+||+.||++|||++|+++ .++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDF--ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCG--GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCH--HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0 000000000 0011112346789999999999999999999998 45544
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=311.38 Aligned_cols=216 Identities=15% Similarity=0.164 Sum_probs=165.6
Q ss_pred cccccccCCcccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEec
Q 003280 23 LAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLN 102 (834)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~ 102 (834)
++.|+|.+||+|++|++| ++|.|+|||+.+++ +.+ |.. +|+||+|||+.| ..+.|+|+.||||||+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~~--~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FDS--DVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EES--SSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEE-EEC--CEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 567999999999999999 49999999997765 334 432 799999999988 47899999999999999
Q ss_pred CCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhh-ccCCcccccc-cccc-----ceEEE
Q 003280 103 QTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTL-LQGMKMGWDL-KNRL-----ERYLS 175 (834)
Q Consensus 103 ~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtl-Lpg~kl~~~~-~t~~-----~~~l~ 175 (834)
.+|.+||+|++.......+|+|+|+|||||++. ++||||||||||+ ||+| |.|. .+|+ ++.|+
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~--------~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS--------EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEecC--------CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE
Confidence 999999999986444456899999999999852 6999999999877 5665 5554 4554 56787
Q ss_pred EecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEeeCCCCCceeeeeecc-ccceeeEEEeeeCceeEEEEeccCCCee
Q 003280 176 SWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISY-TNFLYEQYLVENQDEISYWYEPFNRPSI 254 (834)
Q Consensus 176 Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~sg~w~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (834)
+ .+||++|.|+++++++| ++++++++.+||++++|++. +...+.. ... ....+-.++++....|.... ...
T Consensus 143 s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~G-nl~ly~~~~~~vw~s~~~~~-~~~ 214 (236)
T 1dlp_A 143 A---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNG-RMDVLTNQNIAVWTSGNSRS-AGR 214 (236)
T ss_dssp S---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTT-EEEEEETTTEEEEECCCCCS-SSC
T ss_pred c---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCC-cEEEEeCCCcEEEEeCCCCC-CCC
Confidence 4 78999999999999998 67889988999999999753 3333331 122 11222223334444444333 346
Q ss_pred eEEEECcCCcEEEEE
Q 003280 255 MTLKLNPSGLLTRQI 269 (834)
Q Consensus 255 ~rl~L~~~G~l~~~~ 269 (834)
.|++|++||++++|.
T Consensus 215 ~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 215 YVFVLQPDRNLAIYG 229 (236)
T ss_dssp CEEEECSSSCEEEEC
T ss_pred EEEEEcCCCcEEEeC
Confidence 899999999999984
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=344.50 Aligned_cols=260 Identities=21% Similarity=0.293 Sum_probs=204.4
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcC-CCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH-RNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.++||+|+||.||+|+.. +++.||||++...... +++..|++++..++| +++..+..++.+....++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 378999999999999999999874 5899999987654332 457889999999987 556666667778888999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE---cCCCCceeeeecceeecC
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~ 666 (834)
|+ +++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999998843 2346899999999999999999999998 9999999999999 688999999999999875
Q ss_pred CCccc-----cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcc-cHhHHHHhHhcCCcc
Q 003280 667 GDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF-NLLGYAWDLWKDDKF 740 (834)
Q Consensus 667 ~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~~~ 740 (834)
..... .......||+.|+|||++.+..++.++|||||||+||||++|+.||........ ......... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----KV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH----HH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc----cc
Confidence 43321 122256899999999999999999999999999999999999999976544321 111111110 00
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 741 ~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
...++. + .... ..++.+++..||+.+|++||++++|+++|+.+
T Consensus 234 ~~~~~~-l-~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 234 ATSIEA-L-CRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HSCHHH-H-HTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccHHH-H-hcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 011100 0 0111 24688999999999999999999999998776
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=328.90 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=203.5
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEe--cCeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--QGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l 586 (834)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 378999999999999999999885 5899999998654 33446789999999999999999999998854 568999
Q ss_pred EEeecCCCCccccccCCC-CCCcCCHHHHHHHHHHHHHHHHHhhhcC--CCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 587 ILEYMPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLYLHQYS--RFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
||||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999985432 2345899999999999999999999986 2349999999999999999999999999998
Q ss_pred ecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||...... .+. .. ...+...
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~---~~-i~~~~~~-- 234 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELA---GK-IREGKFR-- 234 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HH-HHHTCCC--
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHH---HH-Hhhcccc--
Confidence 7643321 122357899999999999999999999999999999999999998643211 111 11 1111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
. .+.....++.+++.+||+.||++||+++|+++.+..
T Consensus 235 ---~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 ---R-----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ---C-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---c-----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1 111223467899999999999999999999987654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=337.92 Aligned_cols=262 Identities=21% Similarity=0.273 Sum_probs=201.1
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhc--------CCCcceEEeEEE---
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ--------HRNLVKLLGCCV--- 579 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------HpnIv~l~~~~~--- 579 (834)
.++|++.++||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 378999999999999999999875 4789999999753 344577899999999996 788999999998
Q ss_pred -ecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcCCC-----
Q 003280 580 -EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDM----- 652 (834)
Q Consensus 580 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~----- 652 (834)
.....++||||+.+ +|.+++.. .....+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVLGH-HLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCCCC-BHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEeccCc-cHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 45689999999955 44444432 2234689999999999999999999998 7 99999999999998775
Q ss_pred --------------------------------------------CceeeeecceeecCCCccccccceeccccccccccc
Q 003280 653 --------------------------------------------NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688 (834)
Q Consensus 653 --------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~ 688 (834)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999876432 223578999999999
Q ss_pred ccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCccc----HhHHHHhHhcC---------Ccccccccc---------
Q 003280 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFN----LLGYAWDLWKD---------DKFHELIDP--------- 746 (834)
Q Consensus 689 l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~----l~~~~~~~~~~---------~~~~~lid~--------- 746 (834)
+.+..++.++|||||||++|||++|+.||......... ........... ....+....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999765433211 11111110000 000000000
Q ss_pred ---------ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 747 ---------VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 747 ---------~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..............+.+|+.+||+.||++|||++|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00111234566778999999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.01 Aligned_cols=265 Identities=25% Similarity=0.391 Sum_probs=187.0
Q ss_pred HHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34588999999999999999999864 58899999986543 33457788999999999999999999999999999999
Q ss_pred EeecCCCCccccccC-----CCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 588 LEYMPNKSLDVFLFD-----PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
|||+++++|.+++.. ......+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999998853 123456899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcc---ccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC
Q 003280 663 RMFGGDEL---QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD 738 (834)
Q Consensus 663 ~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 738 (834)
........ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .. ......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~---~~~~~~ 243 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LM---LTLQND 243 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HH---HHHTSS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HH---HHhccC
Confidence 87643211 111234578999999999876 5689999999999999999999999875443221 10 111110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 739 KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 739 ~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.... ................+.+++.+||+.||++||++.|+++
T Consensus 244 -~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 -PPSL-ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -CCCT-TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -CCcc-ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0000 0000000111112346789999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.78 Aligned_cols=246 Identities=25% Similarity=0.403 Sum_probs=194.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 68999999999999999999986 58999999986532 334578899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999843 345889999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccceecccccccccccccCCcc-CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~-t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. .....+++.|+|||++.+..+ +.++||||||+++|||++|+.||...... .+. .. ...... .
T Consensus 165 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~---~~-~~~~~~------~ 229 (276)
T 2h6d_A 165 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLF---KK-IRGGVF------Y 229 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HH-HHHCCC------C
T ss_pred cc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHH---HH-hhcCcc------c
Confidence 21 223578999999999988765 68999999999999999999998643211 111 11 111100 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+ ... ....+.+++.+||+.||++|||++|+++
T Consensus 230 ~-~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 230 I-PEY----LNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp C-CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-chh----cCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0 111 1245788999999999999999999998
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=322.90 Aligned_cols=256 Identities=21% Similarity=0.264 Sum_probs=200.0
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc----cccHHHHHHHHHHHHhhcCCCcceEEeEEE--ecCeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKLQHRNLVKLLGCCV--EQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~ 584 (834)
.++|++.+.||+|+||.||++... +++.||||+++... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 378999999999999999999875 58899999997542 334678999999999999999999999984 45588
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||++++ |.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 55555332 3456899999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCccccccceecccccccccccccCCc--cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
..............||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... .. ...... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~---~~~i~~-~~~-- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KL---FENIGK-GSY-- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH---HHHHHH-CCC--
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HH---HHHHhc-CCC--
Confidence 75433333334467899999999997644 478999999999999999999998643211 11 111111 100
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
.+ .. .....+.+++.+||+.||++|||++|+++ .+.+.
T Consensus 231 ----~~-~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 231 ----AI-PG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ----CC-CS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ----CC-CC----ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 01 11 12346778999999999999999999997 45543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=364.31 Aligned_cols=249 Identities=24% Similarity=0.312 Sum_probs=204.2
Q ss_pred HhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCc---ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 585 (834)
..++|+++++||+|+||.||+|+... ++.||||++++. .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 34789999999999999999999764 788999999753 233456788899999987 7999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+||||+++|+|..++.. .+.+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999843 346899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
.... .......||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.. .+ ...... ..
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--~~---~~~i~~-~~------ 558 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--EL---FQSIME-HN------ 558 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH---HHHHHS-SC------
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--HH---HHHHHh-CC------
Confidence 3322 2234568999999999999999999999999999999999999998653321 11 111111 10
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTM-----SDVVS 784 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 784 (834)
+ ..+.....++.+|+.+||+.||++||++ +||++
T Consensus 559 --~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 --V---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --C---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --C---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 0 1111233567899999999999999997 77765
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.76 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=195.5
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc--------cccHHHHHHHHHHHHhhcCCCcceEEeEEEecC
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS--------GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG 582 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 582 (834)
.++|++.+.||+|+||.||+|.... ++.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 4789999999999999999998754 7899999986532 122345889999999999999999999987654
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC---ceeeee
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN---PKISDF 659 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df 659 (834)
.++||||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 899999999999998884 3456899999999999999999999998 999999999999987654 999999
Q ss_pred cceeecCCCccccccceeccccccccccccc---CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhc
Q 003280 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWK 736 (834)
Q Consensus 660 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~ 736 (834)
|+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+.....
T Consensus 162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~---- 233 (322)
T 2ycf_A 162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQIT---- 233 (322)
T ss_dssp TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHH----
T ss_pred ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHH----
Confidence 9998765432 122357899999999974 5678999999999999999999999986543321 1111110
Q ss_pred CCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 737 DDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 737 ~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.+... . .+.. .. .....+.+++.+||+.||++||++.|+++
T Consensus 234 ~~~~~-~-~~~~-~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKYN-F-IPEV-WA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCCC-C-CHHH-HT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCccc-c-Cchh-hh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 0 0000 00 11346789999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=328.79 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=199.6
Q ss_pred HhcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
..++|++.+.||+|+||.||+|.... ++.||||++.... ..+++.+|+.++.+++||||+++++++.+....++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 34789999999999999999998864 8999999997543 34778999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999998842 2456899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... . ........ ... .
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~---~~~~~~~~-~~~-----~- 245 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--A---IFMIPTNP-PPT-----F- 245 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--H---HHHHHHSC-CCC-----C-
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--H---HHHHhcCC-Ccc-----c-
Confidence 2 2233578999999999999999999999999999999999999986432211 0 11111110 000 0
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.........+.+++.+||+.||++|||+.|+++
T Consensus 246 --~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 --RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 001112346789999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=336.49 Aligned_cols=258 Identities=25% Similarity=0.327 Sum_probs=183.8
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEec------C
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------G 582 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 582 (834)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 378999999999999999999864 5889999999653 333457888999999999999999999999754 5
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
..++|+|++ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 688988873 246899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC---
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD--- 738 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--- 738 (834)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.. +............
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGAE 252 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHH
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence 875432 233578999999999987 67899999999999999999999998654321 1111111111000
Q ss_pred --------ccccccccccccCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 739 --------KFHELIDPVITQDEISLP-----VLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 739 --------~~~~lid~~l~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.....++........... ....+.+|+.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000000000000111111 1346789999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=341.34 Aligned_cols=265 Identities=21% Similarity=0.302 Sum_probs=197.8
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe------EEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE------KIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------~~l 586 (834)
.+|++.+.||+|+||.||+|+...+..||+|++...... ..+|+++++.++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 579999999999999999999988778999988654322 2369999999999999999999976543 789
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc-CCCCceeeeecceeec
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD-MDMNPKISDFGLARMF 665 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~ 665 (834)
||||++++.+............+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999998765544432234557899999999999999999999998 99999999999999 7899999999999986
Q ss_pred CCCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC-------
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD------- 737 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~------- 737 (834)
..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.. .......
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~-i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVE-IIKVLGTPSREQIK 267 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH-HHHHHCCCCHHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHHhCCCCHHHHH
Confidence 44332 2235789999999998765 58999999999999999999999987543211 1111 1110000
Q ss_pred ---CccccccccccccC----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 738 ---DKFHELIDPVITQD----EISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 738 ---~~~~~lid~~l~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
....+..-+.+... ........++.+|+.+||+.||++|||+.|+++ .+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 00000000000000 001112347889999999999999999999987 35444
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=348.13 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=202.4
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.++|++.++||+|+||+||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999875 5889999998643 2345678999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc---CCCCceeeeecceeec
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD---MDMNPKISDFGLARMF 665 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~ 665 (834)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999888743 346899999999999999999999998 99999999999995 4567999999999876
Q ss_pred CCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .+.. .... ...... .
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~---~i~~-~~~~~~-~ 243 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILK---RVET-GKYAFD-L 243 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---HHHH-TCCCSC-S
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH---HHHh-CCCCCC-C
Confidence 4432 2234579999999999876 5999999999999999999999998643221 1111 1111 100000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
+.. .....++.+++.+||+.||++|||+.|+++ .++.
T Consensus 244 ~~~------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 244 PQW------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp GGG------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred ccc------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 000 112346789999999999999999999998 3444
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=348.69 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=197.0
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.++|++.++||+|+||+||+|+.. .++.||||+++... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 367999999999999999999986 58899999987642 334578899999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC---CCceeeeecceeec
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMF 665 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~ 665 (834)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.. +.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999888743 345889999999999999999999998 9999999999999764 55999999999887
Q ss_pred CCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||...... .+.. ..... ... ...
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~---~i~~~-~~~-~~~ 258 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILR---KVEKG-KYT-FDS 258 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---HHHHT-CCC-CCS
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH---HHHhC-CCC-CCc
Confidence 5432 223457999999999886 56999999999999999999999998653321 1111 11111 000 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+.. .. ....+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~--~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 259 PEW--KN----VSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGG--TT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhc--cc----CCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000 11 1246789999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=327.84 Aligned_cols=252 Identities=26% Similarity=0.386 Sum_probs=186.4
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc--ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.++|++.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 478999999999999999999974 588999999976422 22334455555678889999999999999999999999
Q ss_pred eecCCCCccccccC-CCCCCcCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 589 EYMPNKSLDVFLFD-PTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 589 Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||+++ +|.+++.. ......+++..+..++.||+.||+|||++ + |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99985 77666633 12345789999999999999999999998 7 9999999999999999999999999998764
Q ss_pred CCccccccceecccccccccccc----cCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYA----LDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l----~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
.... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.........+. .......
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~--- 231 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK----QVVEEPS--- 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH----HHHHSCC---
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH----HHhccCC---
Confidence 4321 2234789999999996 566789999999999999999999999864332211111 1111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+...... ...++.+++.+||+.||++|||+.|+++
T Consensus 232 ---~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 ---PQLPADK----FSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---CCCCTTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCccccc----CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1110111 2346789999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=349.89 Aligned_cols=255 Identities=28% Similarity=0.366 Sum_probs=205.4
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 368999999999999999999986 58999999986542 34568899999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE---cCCCCceeeeecceee
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARM 664 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~ 664 (834)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999888843 356899999999999999999999998 9999999999999 5678999999999987
Q ss_pred cCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
+.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .+.. ..... .... .
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~---~i~~~-~~~~-~ 247 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILK---KVEKG-KYTF-E 247 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---HHHHC-CCCC-C
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHH---HHHcC-CCCC-C
Confidence 65432 2234579999999999876 6999999999999999999999998653321 1111 11111 0000 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
.+.. ......+.+++.+||+.+|++|||+.|+++ .+...
T Consensus 248 ~~~~------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 248 LPQW------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp SGGG------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred Cccc------ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 0000 112346789999999999999999999987 44443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.01 Aligned_cols=254 Identities=23% Similarity=0.309 Sum_probs=196.2
Q ss_pred HHHhcCccccceeeeecceeEEEEEECCCcEEEEEEccCc--ccccHHHHHHHHHHHHhhc--CCCcceEEeEEEecCeE
Q 003280 509 AAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQ--HRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 509 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~ 584 (834)
....++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++.+....
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3445789999999999999999999888999999998653 3345678999999999997 59999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||| +.+++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+||+++ ++.+||+|||+++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeecccccc
Confidence 99999 678899998843 346889999999999999999999998 99999999999996 48999999999987
Q ss_pred cCCCccccccceecccccccccccccC-----------CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHh
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWD 733 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~ 733 (834)
..............||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ...
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----~~~ 251 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----LHA 251 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----HHH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH----HHH
Confidence 654433223334578999999999875 46889999999999999999999998643221111 111
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
....... ... +......+.+++.+||+.||++||++.|+++
T Consensus 252 ~~~~~~~-----~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 252 IIDPNHE-----IEF-----PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHCTTSC-----CCC-----CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhcccc-----cCC-----cccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1111100 000 1111246788999999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=348.34 Aligned_cols=254 Identities=27% Similarity=0.378 Sum_probs=201.1
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCccc-------------ccHHHHHHHHHHHHhhcCCCcceEEeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG-------------QGLEEFKNEMMLIAKLQHRNLVKLLGC 577 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~l~~~ 577 (834)
.++|++.++||+|+||+||+|+... ++.||||++..... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4789999999999999999999864 78999999865421 345789999999999999999999999
Q ss_pred EEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC---Cc
Q 003280 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM---NP 654 (834)
Q Consensus 578 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~ 654 (834)
+.+....++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999888843 356899999999999999999999998 99999999999998776 69
Q ss_pred eeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhH
Q 003280 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDL 734 (834)
Q Consensus 655 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~ 734 (834)
||+|||+++...... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||...... .+.. ..
T Consensus 189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~---~i 259 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIK---KV 259 (504)
T ss_dssp EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---HH
T ss_pred EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHH---HH
Confidence 999999998875432 223457999999999987 46999999999999999999999998653321 1111 11
Q ss_pred hcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 735 WKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 735 ~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
.. .... .+... ... ...++.+++.+||+.||++|||++|+++ .+.+
T Consensus 260 ~~-~~~~--~~~~~-~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 260 EK-GKYY--FDFND-WKN----ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp HH-CCCC--CCHHH-HTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred Hc-CCCC--CCccc-cCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 11 1000 00000 011 1246789999999999999999999987 4444
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=340.47 Aligned_cols=199 Identities=23% Similarity=0.280 Sum_probs=172.1
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhh------cCCCcceEEeEEEecCeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKL------QHRNLVKLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~~~~~~~~~~ 584 (834)
..+|++.++||+|+||.||+|.... ++.||||+++.. ....+++.+|+.++..+ .|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 3679999999999999999998754 889999999753 33446788899998888 467999999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC--ceeeeecce
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN--PKISDFGLA 662 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla 662 (834)
++||||+. ++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 5888777542 2234899999999999999999999998 999999999999999987 999999999
Q ss_pred eecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCC
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN 721 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~ 721 (834)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 865432 223578999999999999999999999999999999999999986543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=334.71 Aligned_cols=258 Identities=23% Similarity=0.272 Sum_probs=190.9
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC------e
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------E 583 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~ 583 (834)
++|++.+.||+|+||.||+|... .++.||||++... .....+.+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 68999999999999999999875 5889999998653 3344567899999999999999999999997665 7
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.++||||+++ +|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred eEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 8999999985 5666663 24789999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhH---------
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDL--------- 734 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~--------- 734 (834)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ........
T Consensus 176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 176 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHC-CCCCCHHHH
T ss_pred cccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHH
Confidence 764322 1233578999999999999999999999999999999999999986543211 00000000
Q ss_pred ----------hcC-C-----ccccccccccccCC--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 735 ----------WKD-D-----KFHELIDPVITQDE--ISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 735 ----------~~~-~-----~~~~lid~~l~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
... . .............. ........+.+|+.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000 0 00000000000000 01123567889999999999999999999988
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=331.55 Aligned_cols=266 Identities=26% Similarity=0.392 Sum_probs=199.2
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.+.||+|+||.||+|+... .+|+|+++... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4789999999999999999998743 59999986542 3334567889999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999999843 2346889999999999999999999998 99999999999998 6899999999987653221
Q ss_pred ---cccccceecccccccccccccC---------CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC
Q 003280 670 ---LQGNTKRIVGTYGYMSPEYALD---------GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD 737 (834)
Q Consensus 670 ---~~~~~~~~~gt~~y~aPE~l~~---------~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 737 (834)
.........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .......
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~- 257 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-----IIWQMGT- 257 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-----HHHHHHT-
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHhcc-
Confidence 1122233568999999999874 457899999999999999999999986433211 1111111
Q ss_pred CccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCCCCCCCc
Q 003280 738 DKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPA 800 (834)
Q Consensus 738 ~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~p~ 800 (834)
....... ... ...++.+++.+||+.||++|||+.|++++|+.+.........|.
T Consensus 258 ~~~~~~~-----~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~ 311 (319)
T 2y4i_B 258 GMKPNLS-----QIG----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPG 311 (319)
T ss_dssp TCCCCCC-----CSS----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----------
T ss_pred CCCCCCC-----cCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCc
Confidence 1111111 111 12357799999999999999999999999999865544444443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=331.28 Aligned_cols=263 Identities=21% Similarity=0.292 Sum_probs=200.5
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEec-----CeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-----GEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~ 584 (834)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 368999999999999999999875 57889999997543 33457889999999999999999999999765 368
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+++ +|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~~-~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCSE-EHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccCc-CHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 999999984 8888773 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccc-
Q 003280 665 FGGDELQ-GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH- 741 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~- 741 (834)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...............
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQED 255 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG--HHHHHHHHHCSCCHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH--HHHHHHHHhCCCCHHH
Confidence 6543221 12234589999999998765 458999999999999999999999986543221 111111111000000
Q ss_pred ----------cccccccccCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 742 ----------ELIDPVITQDEISL-----PVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 742 ----------~lid~~l~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.............. ....++.+++.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000011111 12346789999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=322.12 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=202.5
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---------cccHHHHHHHHHHHHhhc-CCCcceEEeEEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---------GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCV 579 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 579 (834)
..++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++.+++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3478999999999999999999986 48899999986542 123467889999999996 999999999999
Q ss_pred ecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeee
Q 003280 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDF 659 (834)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 659 (834)
.....++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999843 346899999999999999999999998 999999999999999999999999
Q ss_pred cceeecCCCccccccceeccccccccccccc------CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHh
Q 003280 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYAL------DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWD 733 (834)
Q Consensus 660 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~ 733 (834)
|++....... ......+++.|+|||++. ...++.++||||||+++|||++|+.||...... ... ..
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~---~~ 240 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LML---RM 240 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HH
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--HHH---HH
Confidence 9998765432 223357899999999985 456889999999999999999999998543211 111 11
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.... ... ...+ ........+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~-~~~-~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMSG-NYQ-FGSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHT-CCC-CCTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhcC-Ccc-cCcc------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111 000 0000 00122346889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=335.75 Aligned_cols=271 Identities=22% Similarity=0.260 Sum_probs=199.0
Q ss_pred ccHHHHHHHhcCccccceeeeecceeEEEEEECCCcEEEEEEccCccc-----------ccHHHHHHHHHHHHhhcCCCc
Q 003280 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG-----------QGLEEFKNEMMLIAKLQHRNL 571 (834)
Q Consensus 503 ~~~~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~HpnI 571 (834)
....++....++|++.+.||+|+||.||+|...+++.||||++..... ...+.+.+|+.++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 345667788899999999999999999999988899999999864321 124789999999999999999
Q ss_pred ceEEeEEEec-----CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcE
Q 003280 572 VKLLGCCVEQ-----GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNV 646 (834)
Q Consensus 572 v~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 646 (834)
+++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 9999998553 36899999998 577766643 3446899999999999999999999998 99999999999
Q ss_pred EEcCCCCceeeeecceeecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcc
Q 003280 647 LLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF 725 (834)
Q Consensus 647 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~ 725 (834)
+++.++.+||+|||+++...... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-- 240 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-- 240 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred EEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--
Confidence 99999999999999998653322 2233578999999999887 67899999999999999999999998653321
Q ss_pred cHhHHHHhHhcCCc-----------cccccccccccC-C-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 726 NLLGYAWDLWKDDK-----------FHELIDPVITQD-E-----ISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 726 ~l~~~~~~~~~~~~-----------~~~lid~~l~~~-~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.............. ....+...+... . ........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111111110000 000000000000 0 00112346789999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=343.13 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=194.4
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC------eEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~ 585 (834)
.+|++.+.||+|+||.||+|++. .++.||||++..... .+.+|++++++++||||+++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 57999999999999999999986 489999999865422 2346999999999999999999986422 367
Q ss_pred EEEeecCCCCccccccC-CCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC-CCceeeeeccee
Q 003280 586 LILEYMPNKSLDVFLFD-PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLAR 663 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~ 663 (834)
+||||++++ |...+.. ......+++..+..++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhccccc-HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 999999874 4444321 223456899999999999999999999998 9999999999999965 568999999999
Q ss_pred ecCCCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhc------
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWK------ 736 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~------ 736 (834)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.... ....
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~-~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEII-KVLGTPTREQ 280 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH-HHHCSCCHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HHhCCCCHHH
Confidence 7644322 2235789999999999765 79999999999999999999999987543211 111111 1100
Q ss_pred ----CCccccccccccccCC----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 737 ----DDKFHELIDPVITQDE----ISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 737 ----~~~~~~lid~~l~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
.....+..-+.+.... .......++.+|+.+||+.||++|||+.|+++ .+++.
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0011111111110000 01112357889999999999999999999986 44443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.95 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=196.0
Q ss_pred HHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEe------c
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVE------Q 581 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~------~ 581 (834)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++.++ +||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 34688999999999999999999975 58899999986543 3347889999999999 89999999999987 4
Q ss_pred CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecc
Q 003280 582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 661 (834)
...++||||+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 6889999999999999998543 2356889999999999999999999998 99999999999999999999999999
Q ss_pred eeecCCCccccccceeccccccccccccc-----CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhc
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWK 736 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~ 736 (834)
+........ ......||+.|+|||++. +..++.++|||||||++|||++|+.||....... . ......
T Consensus 176 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~---~~~~~~ 248 (326)
T 2x7f_A 176 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--A---LFLIPR 248 (326)
T ss_dssp TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--H---HHHHHH
T ss_pred ceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--H---HHHhhc
Confidence 987643221 123357899999999997 5678999999999999999999999985432111 1 111111
Q ss_pred CCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 737 DDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 737 ~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. . +....... ...+.+++.+||+.||++||+++|+++
T Consensus 249 ~~-~-----~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 249 NP-A-----PRLKSKKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp SC-C-----CCCSCSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cc-c-----ccCCcccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 10 1 11101111 246789999999999999999999988
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=326.65 Aligned_cols=265 Identities=21% Similarity=0.264 Sum_probs=204.6
Q ss_pred hcCccccceeeeecceeEEEEEE-C-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCC------cceEEeEEEecCe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRL-L-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN------LVKLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~-~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~~~~~~~~~ 583 (834)
.++|++.+.||+|+||.||+|.. . +++.||||+++.. ....+.+.+|+.+++.++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36899999999999999999987 3 5889999999754 334577899999999997665 9999999999999
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-------------
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM------------- 650 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~------------- 650 (834)
.++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88998888532 2235889999999999999999999998 999999999999987
Q ss_pred ------CCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCc
Q 003280 651 ------DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS 724 (834)
Q Consensus 651 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~ 724 (834)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999875432 223578999999999999999999999999999999999999987543321
Q ss_pred ccHhHHHHhHhcC-----------Ccc------------------ccccccccccCCCCHHHHHHHHHHHHhccccCCCC
Q 003280 725 FNLLGYAWDLWKD-----------DKF------------------HELIDPVITQDEISLPVLVRYINVALLCVQDNAAD 775 (834)
Q Consensus 725 ~~l~~~~~~~~~~-----------~~~------------------~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~ 775 (834)
........... ... .....+.............++.+++.+||+.||++
T Consensus 242 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 242 --HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp --HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred --HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 11111000000 000 00000000011123345667899999999999999
Q ss_pred CCCHHHHHH--HHhcc
Q 003280 776 RPTMSDVVS--IINSE 789 (834)
Q Consensus 776 RPs~~evl~--~L~~~ 789 (834)
|||++|+++ .|+..
T Consensus 320 Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 320 RITLREALKHPFFDLL 335 (339)
T ss_dssp SCCHHHHTTSGGGGGG
T ss_pred ccCHHHHhcCHHHHHH
Confidence 999999985 34443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=327.29 Aligned_cols=266 Identities=23% Similarity=0.299 Sum_probs=195.9
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEE------------
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV------------ 579 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------------ 579 (834)
++|++.+.||+|+||.||+|.... ++.||||++........+++.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 689999999999999999999865 8899999998776667788999999999999999999999874
Q ss_pred --ecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc-CCCCcee
Q 003280 580 --EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD-MDMNPKI 656 (834)
Q Consensus 580 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl 656 (834)
+....++||||++ |+|.+++. .+.+++..+..++.||+.||+|||+++ |+||||||+||+++ +++.+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999998 68988883 346889999999999999999999998 99999999999997 5679999
Q ss_pred eeecceeecCCCcc-ccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhH
Q 003280 657 SDFGLARMFGGDEL-QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDL 734 (834)
Q Consensus 657 ~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~ 734 (834)
+|||+++....... ........+|..|+|||++.+ ..++.++||||||+++|||++|+.||....... ........
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~ 240 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE--QMQLILES 240 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHh
Confidence 99999987643221 112233467899999998875 678999999999999999999999987543211 11100000
Q ss_pred hcCC----------ccccccccccccCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 735 WKDD----------KFHELIDPVITQDEISL-----PVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 735 ~~~~----------~~~~lid~~l~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
.... .....+........... ....++.+++.+||+.||++|||++|+++ .+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 0000 00000000000011111 12356889999999999999999999987 4544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=337.49 Aligned_cols=262 Identities=21% Similarity=0.276 Sum_probs=194.5
Q ss_pred HHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEec-------
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------- 581 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------- 581 (834)
...++|++.+.||+|+||.||+|+.. +++.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 45688999999999999999999874 5899999998654322 24799999999999999999998543
Q ss_pred -------------------------------CeEEEEEeecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhh
Q 003280 582 -------------------------------GEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLH 629 (834)
Q Consensus 582 -------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH 629 (834)
...++||||+++ +|.+.+... .....+++..+..++.||++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 348899999984 776666431 23457899999999999999999999
Q ss_pred hcCCCceEeccCCCCcEEEc-CCCCceeeeecceeecCCCccccccceecccccccccccccCC-ccCccCceeehhhhH
Q 003280 630 QYSRFRIIHRDLKASNVLLD-MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILM 707 (834)
Q Consensus 630 ~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl 707 (834)
+++ |+||||||+|||++ .++.+||+|||+++.+..... .....+|+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 99999999999998 688999999999997654332 2235789999999998875 489999999999999
Q ss_pred HHhhcCCCCCCCCCCCcccHhHHHHhHhcCC----------ccccccccccccC----CCCHHHHHHHHHHHHhccccCC
Q 003280 708 LETLSGKKNTGVYNADSFNLLGYAWDLWKDD----------KFHELIDPVITQD----EISLPVLVRYINVALLCVQDNA 773 (834)
Q Consensus 708 ~elltG~~p~~~~~~~~~~l~~~~~~~~~~~----------~~~~lid~~l~~~----~~~~~~~~~l~~li~~cl~~dP 773 (834)
|||++|+.||....... ............ ...+..-+.+... ..+.....++.+|+.+||+.||
T Consensus 233 ~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 233 GELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 99999999987543211 111111110000 0000000000000 0111123468899999999999
Q ss_pred CCCCCHHHHHH
Q 003280 774 ADRPTMSDVVS 784 (834)
Q Consensus 774 ~~RPs~~evl~ 784 (834)
++|||+.|+++
T Consensus 311 ~~R~t~~e~l~ 321 (383)
T 3eb0_A 311 DLRINPYEAMA 321 (383)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhc
Confidence 99999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=333.22 Aligned_cols=274 Identities=20% Similarity=0.229 Sum_probs=191.7
Q ss_pred HHHHHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe--
Q 003280 507 SVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE-- 583 (834)
Q Consensus 507 ~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-- 583 (834)
......++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+|++.+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34556689999999999999999999985 58999999986543 223456778888999999999999999976543
Q ss_pred -----EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhh--hcCCCceEeccCCCCcEEEcC-CCCce
Q 003280 584 -----KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH--QYSRFRIIHRDLKASNVLLDM-DMNPK 655 (834)
Q Consensus 584 -----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivH~Dlkp~NIll~~-~~~~k 655 (834)
.++||||++++.+..+.........+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999997543332222234566889999999999999999999 777 999999999999997 89999
Q ss_pred eeeecceeecCCCccccccceecccccccccccccCCc-cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhH
Q 003280 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDL 734 (834)
Q Consensus 656 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~ 734 (834)
|+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... ........
T Consensus 173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~~~~~ 247 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHEIVRV 247 (360)
T ss_dssp ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHH
T ss_pred EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHHHHHH
Confidence 999999987654332 22356899999999987654 8999999999999999999999986543211 11111110
Q ss_pred hcC-----------C-cccccccc-cc----ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 735 WKD-----------D-KFHELIDP-VI----TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 735 ~~~-----------~-~~~~lid~-~l----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
... . ......+. .. ...........++.+|+.+||+.||++|||+.|+++ .+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 000 0 00000000 00 000111123467889999999999999999999987 45443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=321.28 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=191.6
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEe----------
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE---------- 580 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---------- 580 (834)
.++|++.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 468999999999999999999975 6899999999643 3445788999999999999999999998865
Q ss_pred ---cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceee
Q 003280 581 ---QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS 657 (834)
Q Consensus 581 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 657 (834)
....++||||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3568999999999999999853 2345778899999999999999999998 9999999999999999999999
Q ss_pred eecceeecCCCcc------------ccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCc
Q 003280 658 DFGLARMFGGDEL------------QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADS 724 (834)
Q Consensus 658 Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~ 724 (834)
|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++ |+....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--- 232 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--- 232 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---
Confidence 9999987643210 1122345789999999999864 78999999999999999998 332110
Q ss_pred ccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 725 FNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...... ....... ..+ ...........+.+++.+||+.||++|||++|+++
T Consensus 233 -~~~~~~-~~~~~~~------~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 -ERVNIL-KKLRSVS------IEF-PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHHH-HHHHSTT------CCC-CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hHHHHH-Hhccccc------ccc-CccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 001111 1111100 001 11122233446789999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=327.30 Aligned_cols=201 Identities=24% Similarity=0.340 Sum_probs=170.2
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhc-CC-----CcceEEeEEEecCeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HR-----NLVKLLGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-Hp-----nIv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+|... +++.||||+++.. ....+++..|+.++..++ |+ +|+++++++......
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 478999999999999999999876 4789999999753 334567888999999885 55 499999999999999
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc--CCCCceeeeecce
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD--MDMNPKISDFGLA 662 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla 662 (834)
++||||+++ +|.+++... ....+++..+..++.||+.||+|||.+. .+|+||||||+|||++ .++.+||+|||++
T Consensus 132 ~lv~e~~~~-~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEECCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEecCCC-CHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999964 888887543 2245899999999999999999999521 2399999999999994 4788999999999
Q ss_pred eecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCC
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN 721 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~ 721 (834)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 886432 223578999999999999999999999999999999999999987543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=335.66 Aligned_cols=265 Identities=22% Similarity=0.334 Sum_probs=181.8
Q ss_pred cCccc-cceeeeecceeEEEEEEC---CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEe--cCeEEE
Q 003280 513 ENFSM-QCKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--QGEKIL 586 (834)
Q Consensus 513 ~~f~~-~~~LG~G~~G~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l 586 (834)
+.|++ .++||+|+||.||+|+.. .++.||||++..... .+.+.+|+.++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45666 458999999999999975 478999999975432 3578899999999999999999999965 668999
Q ss_pred EEeecCCCCccccccCC------CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE----cCCCCcee
Q 003280 587 ILEYMPNKSLDVFLFDP------TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL----DMDMNPKI 656 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl 656 (834)
||||+++ +|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 666555311 12235899999999999999999999998 9999999999999 77899999
Q ss_pred eeecceeecCCCcc-ccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCc-------ccH
Q 003280 657 SDFGLARMFGGDEL-QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADS-------FNL 727 (834)
Q Consensus 657 ~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~-------~~l 727 (834)
+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....+. .+.
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987654321 1223346889999999999874 58999999999999999999999996544321 011
Q ss_pred hHHHHhHhcCCc---cccc------------cccccccCCCCH---------HHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003280 728 LGYAWDLWKDDK---FHEL------------IDPVITQDEISL---------PVLVRYINVALLCVQDNAADRPTMSDVV 783 (834)
Q Consensus 728 ~~~~~~~~~~~~---~~~l------------id~~l~~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl 783 (834)
.......+.... ...+ +.... ...... .....+.+|+.+||+.||++|||++|++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNT-YTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGG-GTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccC-CCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 111111110000 0000 00000 000000 0123678999999999999999999999
Q ss_pred H
Q 003280 784 S 784 (834)
Q Consensus 784 ~ 784 (834)
+
T Consensus 333 ~ 333 (405)
T 3rgf_A 333 Q 333 (405)
T ss_dssp T
T ss_pred c
Confidence 8
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=324.32 Aligned_cols=264 Identities=25% Similarity=0.366 Sum_probs=198.6
Q ss_pred HhcCccccceeeeecceeEEEEEEC--CCcEEEEEEccCcc--cccHHHHHHHHHHHHhh---cCCCcceEEeEEE----
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKL---QHRNLVKLLGCCV---- 579 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~---- 579 (834)
+.++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999983 57899999986432 12224566777777766 7999999999987
Q ss_pred -ecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeee
Q 003280 580 -EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISD 658 (834)
Q Consensus 580 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 658 (834)
.....++||||++ ++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 6898887543 2335889999999999999999999998 99999999999999999999999
Q ss_pred ecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC
Q 003280 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD 738 (834)
Q Consensus 659 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 738 (834)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .............
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCC
Confidence 99998764322 223457899999999999999999999999999999999999998654321 1111111110000
Q ss_pred ---cccc---cccccc------ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 739 ---KFHE---LIDPVI------TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 739 ---~~~~---lid~~l------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.... ...... ............+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 000000 000011122346789999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=329.36 Aligned_cols=268 Identities=22% Similarity=0.302 Sum_probs=200.5
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEec-----CeE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-----GEK 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~ 584 (834)
.++|++.+.||+|+||.||+|... +|+.||||++.... .....++.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 378999999999999999999976 58899999997543 33456788999999999999999999988764 678
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+. ++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 588887732 46899999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCcccc--------ccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh
Q 003280 665 FGGDELQG--------NTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 665 ~~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~ 239 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH--QLLLIFGII 239 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHh
Confidence 75332111 1223578999999998765 678999999999999999999999987543211 111111111
Q ss_pred cCCc----cc--------cccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 736 KDDK----FH--------ELIDPVITQDEIS-----LPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 736 ~~~~----~~--------~lid~~l~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
.... .. +.+.......... .....++.+++.+||+.||++|||++|+++ .|+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0000 00 0000000000000 112346789999999999999999999987 45443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.91 Aligned_cols=257 Identities=23% Similarity=0.306 Sum_probs=194.6
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeE----
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK---- 584 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~---- 584 (834)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 378999999999999999999875 5889999999764 333457889999999999999999999999887654
Q ss_pred --EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 585 --ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 585 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
++||||+. ++|..++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 57776652 23889999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC---
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD--- 738 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--- 738 (834)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ............
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTE 264 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCHH
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCcHH
Confidence 865432 223578999999999987 789999999999999999999999986533211 111110000000
Q ss_pred --------ccccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 739 --------KFHELIDPVITQDEIS-----LPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 739 --------~~~~lid~~l~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.....+.......... ......+.+|+.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000000000000000 112356889999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=334.80 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=187.9
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+....++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445667889999999998776678999999998643 345678999999887 8999999999999999999999999
Q ss_pred CCCCccccccCCCCCC----cCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC-------------CCc
Q 003280 592 PNKSLDVFLFDPTKKR----LLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-------------MNP 654 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-------------~~~ 654 (834)
+ |+|.+++....... ...+..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999885432211 1233456789999999999999998 9999999999999754 479
Q ss_pred eeeeecceeecCCCccc--cccceecccccccccccccC-------CccCccCceeehhhhHHHhhc-CCCCCCCCCCCc
Q 003280 655 KISDFGLARMFGGDELQ--GNTKRIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLS-GKKNTGVYNADS 724 (834)
Q Consensus 655 kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-------~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~ 724 (834)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999987554321 12234579999999999976 678999999999999999999 899986433221
Q ss_pred ccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 725 FNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+ ...... .. .. ..........++.+++.+||+.||++|||+.|+++
T Consensus 248 ~~i---~~~~~~---~~-----~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SNI---IRGIFS---LD-----EM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH---HHTCCC---CC-----CC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH---hcCCCC---cc-----cc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111 000000 00 00 11123455678899999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=354.31 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=202.6
Q ss_pred HhcCccccceeeeecceeEEEEEECC----CcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
..++|++.+.||+|+||.||+|.+.. +..||||+++.. .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34789999999999999999998743 457999998764 3344578999999999999999999999985 46789
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+||||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 99999999999999853 2345889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... +... .......
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~---~i~~~~~----- 610 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIG---RIENGER----- 610 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH---HHHHTCC-----
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHH---HHHcCCC-----
Confidence 543221 1223456789999999999999999999999999999997 89898643321 1111 1111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
. ..+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 611 -~-----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 611 -L-----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C-----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 01112234678999999999999999999999999876
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=327.59 Aligned_cols=265 Identities=21% Similarity=0.309 Sum_probs=200.9
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhc-----------CCCcceEEeEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-----------HRNLVKLLGCCVE 580 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~~ 580 (834)
++|++.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+.++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 68999999999999999999874 5889999999753 334567889999999886 8999999999986
Q ss_pred cC----eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcC-----
Q 003280 581 QG----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDM----- 650 (834)
Q Consensus 581 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~----- 650 (834)
.. ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ + |+||||||+|||++.
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 54 789999999 88998888542 234588999999999999999999998 7 999999999999953
Q ss_pred -CCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcc----
Q 003280 651 -DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF---- 725 (834)
Q Consensus 651 -~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~---- 725 (834)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 447999999999876432 2234789999999999999999999999999999999999999975442211
Q ss_pred cHhHHHHhHh------------------cCCcccccccc---------ccccCCCCHHHHHHHHHHHHhccccCCCCCCC
Q 003280 726 NLLGYAWDLW------------------KDDKFHELIDP---------VITQDEISLPVLVRYINVALLCVQDNAADRPT 778 (834)
Q Consensus 726 ~l~~~~~~~~------------------~~~~~~~lid~---------~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 778 (834)
.......... ........+.. .......+.....++.+|+.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 0110000000 00000000000 00112345566778999999999999999999
Q ss_pred HHHHHH--HHhc
Q 003280 779 MSDVVS--IINS 788 (834)
Q Consensus 779 ~~evl~--~L~~ 788 (834)
++|+++ .+.+
T Consensus 328 ~~ell~hp~f~~ 339 (373)
T 1q8y_A 328 AGGLVNHPWLKD 339 (373)
T ss_dssp HHHHHTCGGGTT
T ss_pred HHHHhhChhhhc
Confidence 999988 4544
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.84 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=201.4
Q ss_pred HHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34478999999999999999999986 58899999986542 3456789999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC---CCceeeeeccee
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLAR 663 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~ 663 (834)
||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999888743 345889999999999999999999998 9999999999999764 469999999998
Q ss_pred ecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
...... ......+|+.|+|||++.+ .++.++||||||+++|||++|+.||...... .+.. .... +.....
T Consensus 173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~---~~~~-~~~~~~ 242 (287)
T 2wei_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILK---RVET-GKYAFD 242 (287)
T ss_dssp TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---HHHH-CCCCCC
T ss_pred eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHH---HHHc-CCCCCC
Confidence 764432 1223468999999998875 4899999999999999999999998643211 1111 1111 110000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. +. .... ..++.+++.+||+.||++|||+.|+++
T Consensus 243 ~-~~--~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 L-PQ--WRTI----SDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp S-GG--GTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c-hh--hhhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 00 0111 346789999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.16 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=194.8
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe------
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE------ 583 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------ 583 (834)
++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 68999999999999999999875 5899999999754 23345788999999999999999999999987654
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.++||||++ ++|..++. ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999998 57877762 24889999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC-----
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD----- 737 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~----- 737 (834)
..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...........
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTEF 247 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHHHHHCBCCHHH
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHH
Confidence 65332 223578999999999887 678999999999999999999999987543211 11111000000
Q ss_pred ------C-------ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 ------D-------KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 ------~-------~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. .........+ ..........+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDF--TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCT--TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccH--HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0000000000 0111223457889999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=321.49 Aligned_cols=257 Identities=19% Similarity=0.210 Sum_probs=175.0
Q ss_pred hcCccccc-eeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEe----cCeEE
Q 003280 512 TENFSMQC-KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE----QGEKI 585 (834)
Q Consensus 512 ~~~f~~~~-~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~ 585 (834)
.++|.+.+ .||+|+||.||+|... +++.||||++.... ....+....+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 47899865 6999999999999986 58999999986531 222223334566799999999999976 44589
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC---CCCceeeeecce
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLA 662 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla 662 (834)
+||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999998643 2346899999999999999999999998 999999999999976 455999999999
Q ss_pred eecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
+...... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||........... ........
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~---- 248 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRIRLG---- 248 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhhhcc----
Confidence 8764322 2335789999999999999999999999999999999999999865432211000 00000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
.... ..........++.+++.+||+.||++|||++|+++ .+.+.
T Consensus 249 --~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 249 --QYGF-PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ----CC-CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred --cccc-CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0000 00001122346789999999999999999999998 55554
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.40 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=177.0
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHH-HHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMM-LIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|++.+.||+|+||.||+|... +++.||||+++... .....++..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 78999999999999999999985 58899999997653 233445666665 6777899999999999999999999999
Q ss_pred ecCCCCccccccC--CCCCCcCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 590 YMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
|+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9986 66666532 11245688999999999999999999998 8 9999999999999999999999999998764
Q ss_pred CCccccccceecccccccccccc----cCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYA----LDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l----~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.........+. . ...
T Consensus 178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~------~~~ 244 (327)
T 3aln_A 178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT----Q------VVK 244 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C----C------CCC
T ss_pred ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH----H------Hhc
Confidence 332 12234789999999998 466789999999999999999999999865332111000 0 000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
...+.+ ...........+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPPQL-SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCC-CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCC-CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000111 00001112346889999999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=321.55 Aligned_cols=260 Identities=22% Similarity=0.277 Sum_probs=198.7
Q ss_pred hcCccccceeeeecceeEEEEEECC-C-cEEEEEEccCcccccHHHHHHHHHHHHhhcCCC------cceEEeEEEecCe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-G-QEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN------LVKLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~~~~~~~~~ 583 (834)
.++|++.+.||+|+||.||+|.... + +.||||+++.. ....+.+.+|+.++++++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 3789999999999999999998753 4 68999999753 334577889999999998766 8999999999999
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE---------------
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL--------------- 648 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--------------- 648 (834)
.++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 55555555332 2346899999999999999999999998 9999999999999
Q ss_pred ----cCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCc
Q 003280 649 ----DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS 724 (834)
Q Consensus 649 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~ 724 (834)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 67889999999999875432 223578999999999999999999999999999999999999987543211
Q ss_pred ccHhHHHHhHhcC-----------Ccc------------------ccccccccccCCCCHHHHHHHHHHHHhccccCCCC
Q 003280 725 FNLLGYAWDLWKD-----------DKF------------------HELIDPVITQDEISLPVLVRYINVALLCVQDNAAD 775 (834)
Q Consensus 725 ~~l~~~~~~~~~~-----------~~~------------------~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~ 775 (834)
........... ... .+...+.............++.+|+.+||+.||++
T Consensus 247 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 247 --HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp --HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred --HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 11111111000 000 00000000001112334567889999999999999
Q ss_pred CCCHHHHHH
Q 003280 776 RPTMSDVVS 784 (834)
Q Consensus 776 RPs~~evl~ 784 (834)
|||+.|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=323.25 Aligned_cols=242 Identities=23% Similarity=0.392 Sum_probs=190.4
Q ss_pred HHhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccc------cHHHHHHHHHHHHhh----cCCCcceEEeEE
Q 003280 510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ------GLEEFKNEMMLIAKL----QHRNLVKLLGCC 578 (834)
Q Consensus 510 ~~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l----~HpnIv~l~~~~ 578 (834)
...++|++.+.||+|+||.||+|+.. +++.||||+++..... ....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34578999999999999999999874 5889999999754321 233466799999999 899999999999
Q ss_pred EecCeEEEEEee-cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc-CCCCcee
Q 003280 579 VEQGEKILILEY-MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD-MDMNPKI 656 (834)
Q Consensus 579 ~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl 656 (834)
...+..++|||| +++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++ .++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999 789999999843 345899999999999999999999998 99999999999999 8899999
Q ss_pred eeecceeecCCCccccccceecccccccccccccCCcc-CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh
Q 003280 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
+|||+++...... .....||..|+|||++.+..+ +.++||||||+++|||++|+.||.... . ..
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~-------~~ 246 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----E-------IL 246 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----H-------HH
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----H-------Hh
Confidence 9999998875432 233568999999999987766 458999999999999999999985311 0 00
Q ss_pred cCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. .. ........++.+++.+||+.||++|||++|+++
T Consensus 247 ~~---------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 EA---------EL---HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HT---------CC---CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hh---------cc---CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00 011112346789999999999999999999998
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=329.71 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=186.5
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
..+|++.+.||+|+||+|+.....+++.||||++...... .+.+|+.+++++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3578999999999999976655568999999999654332 356799999999 799999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-----CCCceeeeecceeec
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-----DMNPKISDFGLARMF 665 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~~~ 665 (834)
++ |+|.+++.... ....+..+..++.||+.||+|||+++ |+||||||+|||++. ...+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 97 58888885432 23445567789999999999999998 999999999999943 235789999999877
Q ss_pred CCCcc-ccccceeccccccccccccc---CCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcc
Q 003280 666 GGDEL-QGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKF 740 (834)
Q Consensus 666 ~~~~~-~~~~~~~~gt~~y~aPE~l~---~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 740 (834)
..... ........||+.|+|||++. ...++.++|||||||++|||++ |+.||......... ...... .
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~------~~~~~~-~ 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN------ILLGAC-S 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH------HHTTCC-C
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH------HHhccC-C
Confidence 54321 12233467999999999997 4567889999999999999999 88888543221110 011100 0
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. ...........+.+++.+||+.||++|||++|+++
T Consensus 247 ~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 LD-------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CT-------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc-------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 01112234456789999999999999999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=324.05 Aligned_cols=241 Identities=22% Similarity=0.365 Sum_probs=197.4
Q ss_pred HhcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccc------cHHHHHHHHHHHHhhc--CCCcceEEeEEEec
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ------GLEEFKNEMMLIAKLQ--HRNLVKLLGCCVEQ 581 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~ 581 (834)
..++|++.+.||+|+||.||+|+.. +++.||||+++..... ..+.+.+|+.++++++ ||||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 4478999999999999999999864 5889999998654221 2245678999999996 59999999999999
Q ss_pred CeEEEEEeecCC-CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc-CCCCceeeee
Q 003280 582 GEKILILEYMPN-KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD-MDMNPKISDF 659 (834)
Q Consensus 582 ~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Df 659 (834)
+..++|||++.+ ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999986 899988843 456889999999999999999999998 99999999999999 7899999999
Q ss_pred cceeecCCCccccccceecccccccccccccCCcc-CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC
Q 003280 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD 738 (834)
Q Consensus 660 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 738 (834)
|+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ......
T Consensus 195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----------~~~~~~ 259 (320)
T 3a99_A 195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------EIIRGQ 259 (320)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HHHHCC
T ss_pred cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----------hhhccc
Confidence 9998875432 223568999999999987765 788999999999999999999985311 000000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 739 KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 739 ~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
... .... ..++.+++.+||+.||++|||++|+++
T Consensus 260 ---~~~-----~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 ---VFF-----RQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---CCC-----SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---ccc-----cccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 1112 246789999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=316.62 Aligned_cols=251 Identities=21% Similarity=0.360 Sum_probs=178.2
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc--ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 378999999999999999999985 589999999976432 22334455556788889999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
||+ ++.+..+.. .....+++..+..++.||++||+|||++ + |+||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 444444332 1235688999999999999999999995 7 99999999999999999999999999977644
Q ss_pred Cccccccceeccccccccccccc-----CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~-----~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
.. ......+|+.|+|||++. ...++.++||||||+++|||++|+.||........ . .........
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~---~~~~~~~~~--- 247 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-V---LTKVLQEEP--- 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-H---HHHHHHSCC---
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-H---HHHHhccCC---
Confidence 32 122357899999999994 55689999999999999999999999864332211 1 111111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+.+... .....++.+++.+||+.||++||+++|+++
T Consensus 248 ---~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 ---PLLPGH---MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ---CCCCSS---SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCCCcc---CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 001000 012246789999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=343.54 Aligned_cols=260 Identities=26% Similarity=0.335 Sum_probs=199.9
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEe------cCeE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE------QGEK 584 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~~ 584 (834)
++|++.+.||+|+||.||+|... +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 78999999999999999999874 5889999998764 34456789999999999999999999998765 6678
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCC---ceeeeecc
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN---PKISDFGL 661 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgl 661 (834)
++||||+++++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999976555557899999999999999999999998 999999999999997765 89999999
Q ss_pred eeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh------
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW------ 735 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~------ 735 (834)
+........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..|.....
T Consensus 171 a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC------
T ss_pred ccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhhcccchh
Confidence 987654322 23457899999999999999999999999999999999999998643110 00000000
Q ss_pred --cCCccccc--ccccc-ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 003280 736 --KDDKFHEL--IDPVI-TQDEISLPVLVRYINVALLCVQDNAADRPTMSDV 782 (834)
Q Consensus 736 --~~~~~~~l--id~~l-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 782 (834)
........ ....+ ............+.+++..||+.||++|||++|+
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00000000 00010 1122334456788999999999999999999773
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=342.01 Aligned_cols=238 Identities=19% Similarity=0.300 Sum_probs=192.8
Q ss_pred cCccccceeeeecceeEEEEEEC--CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCe-----E
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE-----K 584 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~--~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-----~ 584 (834)
++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 78999999999999999999975 5889999998654 33445678999999999999999999999988765 7
Q ss_pred EEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
++||||+++++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999887632 6899999999999999999999998 9999999999999885 999999999987
Q ss_pred cCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
.... ....||+.|+|||++.+.. +.++|||||||++|||++|..|+...... .+.
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------~~~ 285 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------------GLP 285 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------------SCC
T ss_pred cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------------ccc
Confidence 6443 3357999999999987654 89999999999999999998875421100 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcc
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRP-TMSDVVSIINSE 789 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~ 789 (834)
...........+.+++.+||+.||++|| +++++...|...
T Consensus 286 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 -----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0111112235688999999999999999 566666666543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=303.39 Aligned_cols=231 Identities=12% Similarity=0.078 Sum_probs=182.5
Q ss_pred cCccccceeeeecceeEEEEEECC-CcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+|+... ++.||||+++... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 679999999999999999999864 8999999997653 233578999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++.. + .....+.+++.||+.||+|||+++ |+||||||+|||++.++.+||+++
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~--------- 173 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP--------- 173 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC---------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec---------
Confidence 99999999999832 2 345578889999999999999998 999999999999999999999743
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.|++| ++.++|||||||++|||++|+.||........... +. .........
T Consensus 174 -------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--~~-----~~~~~~~~~-- 224 (286)
T 3uqc_A 174 -------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--AE-----RDTAGQPIE-- 224 (286)
T ss_dssp -------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--CC-----BCTTSCBCC--
T ss_pred -------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--HH-----HHhccCCCC--
Confidence 34443 68999999999999999999999875433210000 00 000000000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERL 791 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 791 (834)
...........+.+++.+||+.||++| |+.|+++.|+....
T Consensus 225 -~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 225 -PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp -HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred -hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 000001123467899999999999999 99999999988743
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=296.74 Aligned_cols=231 Identities=19% Similarity=0.251 Sum_probs=180.3
Q ss_pred cCcccc-ceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHH-HhhcCCCcceEEeEEEe----cCeEE
Q 003280 513 ENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLI-AKLQHRNLVKLLGCCVE----QGEKI 585 (834)
Q Consensus 513 ~~f~~~-~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~----~~~~~ 585 (834)
++|.+. +.||+|+||.||++... +++.||||+++.. ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 677777 78999999999999874 5889999999643 4567888888 55589999999999987 67889
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC---CCCceeeeecce
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLA 662 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla 662 (834)
+||||+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999998542 2346899999999999999999999998 999999999999998 788999999998
Q ss_pred eecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
.... +..++.++|||||||++|||++|+.||........ .......
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~~~~~~~ 213 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------SPGMKTR 213 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CCSCCS
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------hHHHHHH
Confidence 7542 24577899999999999999999999864332110 0000000
Q ss_pred ccccccccCCCCHH----HHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 743 LIDPVITQDEISLP----VLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 743 lid~~l~~~~~~~~----~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
.... ....+.+ ...++.+++.+||+.||++|||+.|+++ .+...
T Consensus 214 ~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 214 IRMG---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp SCTT---CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred Hhhc---cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 0000 0111111 2356889999999999999999999998 45544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.50 Aligned_cols=242 Identities=17% Similarity=0.165 Sum_probs=184.6
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcc--------cccHHHHHHHHHHHHhhc---------CCCcceE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--------GQGLEEFKNEMMLIAKLQ---------HRNLVKL 574 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------HpnIv~l 574 (834)
.++|++.++||+|+||+||+|+. +|+.||||+++... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 36799999999999999999998 78999999997542 234578999999999986 7777777
Q ss_pred EeEEE------------------------------ecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHH
Q 003280 575 LGCCV------------------------------EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624 (834)
Q Consensus 575 ~~~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 624 (834)
.+.+. .....++||||+++|++.+.+. ...+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 76643 2678999999999997666662 2458999999999999999
Q ss_pred HHHhh-hcCCCceEeccCCCCcEEEcCCC--------------------CceeeeecceeecCCCccccccceecccccc
Q 003280 625 LLYLH-QYSRFRIIHRDLKASNVLLDMDM--------------------NPKISDFGLARMFGGDELQGNTKRIVGTYGY 683 (834)
Q Consensus 625 L~yLH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y 683 (834)
|+||| +++ |+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 888 99999999999999887 8999999999876432 35899999
Q ss_pred cccccccCCccCccCceeehhhh-HHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHH
Q 003280 684 MSPEYALDGLFSIKSDVFSFGIL-MLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYI 762 (834)
Q Consensus 684 ~aPE~l~~~~~t~~~DVwSlGvv-l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~ 762 (834)
+|||++.+.. +.++|||||+++ .+++++|..||.... ................. ............++.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~----~~~~~~~~~~~~~~~~~-----~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL----WLHYLTDKMLKQMTFKT-----KCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH----HHHHHHHHHHHTCCCSS-----CCCSHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh----hhhHHHHhhhhhhccCc-----ccchhhhhhcCHHHH
Confidence 9999998766 899999998766 788899998863100 00000001110100000 001111234567899
Q ss_pred HHHHhccccCCCCCCCHHHHH
Q 003280 763 NVALLCVQDNAADRPTMSDVV 783 (834)
Q Consensus 763 ~li~~cl~~dP~~RPs~~evl 783 (834)
+|+.+||+.| |++|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999966 899888
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-33 Score=314.11 Aligned_cols=242 Identities=14% Similarity=0.156 Sum_probs=179.2
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcC-CCc---------ceEE--
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQH-RNL---------VKLL-- 575 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H-pnI---------v~l~-- 575 (834)
...|...+.||+|+||.||+|++. +|+.||||+++... ....+.+.+|+.+++.++| +|. +...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 356888899999999999999964 58999999987432 2335789999999999977 221 1111
Q ss_pred ----------eEEEe-----cCeEEEEEeecCCCCccccccC----CCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 003280 576 ----------GCCVE-----QGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636 (834)
Q Consensus 576 ----------~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 636 (834)
.++.. ....+++|+++ +++|.+++.. ......+++..++.++.||++||+|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111 12356666654 6788887731 223456788899999999999999999998 9
Q ss_pred EeccCCCCcEEEcCCCCceeeeecceeecCCCccccccceecccccccccccc----------cCCccCccCceeehhhh
Q 003280 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA----------LDGLFSIKSDVFSFGIL 706 (834)
Q Consensus 637 vH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~t~~~DVwSlGvv 706 (834)
+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999875432 233567 999999999 56678999999999999
Q ss_pred HHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 707 MLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 707 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+|||++|+.||........ ...++.. .... +..+.+++.+||+.||++||++.|+++
T Consensus 307 l~elltg~~Pf~~~~~~~~--------------~~~~~~~---~~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG--------------SEWIFRS---CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC--------------SGGGGSS---CCCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchhhh--------------HHHHHhh---cccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999864322110 0111110 0112 246889999999999999999777643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=276.94 Aligned_cols=185 Identities=16% Similarity=0.136 Sum_probs=131.3
Q ss_pred eeeeecceeEEEEEE-CCCcEEEEEEccCcc----------cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEE
Q 003280 520 KLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS----------GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 520 ~LG~G~~G~Vy~~~~-~~g~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 587 (834)
.++.|+.|.+..++. --|+.+|||.+.+.. ....++|.+|+++|+++ .|+||+++++++++.+..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456777777766543 248999999986531 23356799999999999 799999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||++|++|.++|. ..+.++.. +|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999994 33455554 58899999999999999 99999999999999999999999999997654
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCC
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p 716 (834)
... .....+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 332 2334689999999999875 467789999999999998776544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-24 Score=250.54 Aligned_cols=184 Identities=18% Similarity=0.184 Sum_probs=146.2
Q ss_pred ccceeeeecceeEEEEEECCCcEEEEEEccCccc--------ccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG--------QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 517 ~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
..++||+|+||.||+|.. .++.+++|+...... ...+++.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999954 678899998643211 12356899999999999999997777777888889999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++++|.+++.. +..++.||++||+|||+++ |+||||||+|||++. .+||+|||+++.....
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999843 4689999999999999998 999999999999998 9999999999987553
Q ss_pred cccc-----ccceecccccccccccccC--CccCccCceeehhhhHHHhhcCCCCC
Q 003280 669 ELQG-----NTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSGKKNT 717 (834)
Q Consensus 669 ~~~~-----~~~~~~gt~~y~aPE~l~~--~~~t~~~DVwSlGvvl~elltG~~p~ 717 (834)
.... ......||+.|||||++.. ..|+..+|+||..+-..+-+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 1235689999999999987 66888999999998888887766553
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.6e-22 Score=208.83 Aligned_cols=164 Identities=18% Similarity=0.137 Sum_probs=129.1
Q ss_pred HHHHHHHhcCccccceeeeecceeEEEEEECCCcEEEEEEccCccc------------------ccHHHHHHHHHHHHhh
Q 003280 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG------------------QGLEEFKNEMMLIAKL 566 (834)
Q Consensus 505 ~~~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l 566 (834)
...+......|++.+.||+|+||.||+|...+|+.||||+++.... .....+.+|+.+++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3445555667888899999999999999997799999999964321 1346789999999999
Q ss_pred cCCCcceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcE
Q 003280 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNV 646 (834)
Q Consensus 567 ~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 646 (834)
+ | +++.+++.. +..++||||+++++|.+ +. ......++.||+.||+|||+++ |+||||||+||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 9 4 566665543 55699999999999988 41 1234579999999999999998 99999999999
Q ss_pred EEcCCCCceeeeecceeecCCCccccccceecccccccccccccC----------CccCccCcee
Q 003280 647 LLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD----------GLFSIKSDVF 701 (834)
Q Consensus 647 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----------~~~t~~~DVw 701 (834)
|++ ++.+||+|||+++. +..++|||++.. ..|...+|+|
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~ 273 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDIN 273 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChH
Confidence 999 99999999999964 345789998754 3455556655
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.4e-21 Score=170.32 Aligned_cols=105 Identities=17% Similarity=0.366 Sum_probs=92.5
Q ss_pred cccccCCcccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEecCC
Q 003280 25 ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQT 104 (834)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
.|+|.+||.|.+|++|.| |.|.|.|...++ |.++. ..++||+|||+.|... .+.|+|+.||||||+|++
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~---~~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD---HSTSTWASNTEIGGKS-GCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCC-SCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE---CCEEEEEecCCCCCCc-cEEEEEeCCccEEEECCC
Confidence 478999999999999998 889999998886 67754 3589999999999765 689999999999999999
Q ss_pred CceEEEeecccccCcceEEEccCCCeEEecCCCCCCcccccccc
Q 003280 105 NGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQS 148 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqS 148 (834)
|.+||+|++.......+|+|+|+|||||++. .||||
T Consensus 70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S 105 (105)
T 4h3o_A 70 GRSLWASHSTRGSGNYILILQDDGNVIIYGS--------DIWST 105 (105)
T ss_dssp CCEEEECCCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred cEEEEEecCCCCCCCEEEEEeCCCeEEEECC--------cEecC
Confidence 9999999987666667899999999999964 49998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=2.8e-20 Score=169.14 Aligned_cols=108 Identities=18% Similarity=0.309 Sum_probs=94.8
Q ss_pred cccccccCCcccCCCCeee--eCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEE
Q 003280 23 LAADTVTPASFIRDGEKLV--SFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVL 100 (834)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~--s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l 100 (834)
++.|+|.+|++|.+|++|+ |++|.|+|+|+.+|+ -+||++ .++||+||++.| +.++.|+|+.||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn------lvly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN------LVLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC------EEEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC------EEEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 5679999999999999999 999999999999875 257876 799999999877 3468999999999999
Q ss_pred ecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCcccccccc
Q 003280 101 LNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQS 148 (834)
Q Consensus 101 ~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqS 148 (834)
+|.++.+||+|++....+...++|+|+|||||++. ++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~~--------~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEECc--------cEeCC
Confidence 99999999999976444566899999999999972 59998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=5e-20 Score=165.35 Aligned_cols=110 Identities=24% Similarity=0.392 Sum_probs=95.5
Q ss_pred cccccCCcccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEecCC
Q 003280 25 ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQT 104 (834)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
+|+|.+||.|.+|++|+ ++|.|.|+|+..|+ -++|+ ..++||.||++.|. .++.|+|+.||||||+|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn------lvl~~--~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN------FVLYD--SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC------EEEEE--TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc------EEEEE--CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECCC
Confidence 48999999999999999 99999999998876 36676 47999999998773 4689999999999999999
Q ss_pred CceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCc
Q 003280 105 NGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPT 153 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~Pt 153 (834)
|.+||+|++....+..+++|+|+|||||++. ++||||+||.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~ 110 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP--------VVWATGSGPA 110 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEECSCCC-
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEECC--------CEecCCCcCC
Confidence 9999999986555566899999999999863 5999999983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2e-19 Score=163.02 Aligned_cols=110 Identities=20% Similarity=0.394 Sum_probs=93.8
Q ss_pred cccccCCcccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEecCC
Q 003280 25 ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQT 104 (834)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
.|+|.+||+|.+|++|+ +|.|+|+|+.+++ | ++|+ ..++||+||++.|. .++.|+|+.||||||.|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----l-vly~--~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----L-VKYQ--NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----E-EEEE--TTEEEEECSCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----E-EEEe--CCEEEEeCCCCCCC--CceEEEECCCCcEEEECCC
Confidence 58999999999999998 7999999988774 2 2355 47999999999883 4689999999999999998
Q ss_pred CceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCch
Q 003280 105 NGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTD 154 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtD 154 (834)
+.++|+|++.......+++|+|+|||||++. ++||||.+++.
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYGP--------VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEECC--------CEEECCCCCCc
Confidence 9999999986444567899999999999852 69999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.9e-19 Score=160.39 Aligned_cols=110 Identities=23% Similarity=0.408 Sum_probs=93.2
Q ss_pred cccccCCcccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEecCC
Q 003280 25 ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQT 104 (834)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
+|+|.+||.|.+|++| .+|.|+|+|+.+++ -+||++ .++||+||++.+ +.++.|+|+.||||||+| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn------lvl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN------LVLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC------EEEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc------EEEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 4899999999999999 47999999999886 245765 689999999764 346899999999999999 8
Q ss_pred CceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCC
Q 003280 105 NGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYP 152 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~P 152 (834)
+.++|+|++....+..+++|+++|||||++.. +.++||||++.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~-----~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEECCC-----CceEEECCCcc
Confidence 89999998764445678999999999999742 36899999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.6e-18 Score=154.00 Aligned_cols=104 Identities=26% Similarity=0.435 Sum_probs=88.5
Q ss_pred cccccCCcccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEecCC
Q 003280 25 ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQT 104 (834)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
+++|.|||.|.+|++|+ +|.|.|+|+.+|+ |-+ |.. .++||++|++.+ +.++.|.|+.||||||+|.+
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence 47899999999999997 6999999998875 333 554 689999999876 34689999999999999999
Q ss_pred CceEEEeecccccCcceEEEccCCCeEEecCCCCCCcccccccc
Q 003280 105 NGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQS 148 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqS 148 (834)
+.++|++++.+.....+|+|+|+|||||++. ++|||
T Consensus 69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~--------~~W~s 104 (109)
T 3dzw_A 69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT--------ARWAT 104 (109)
T ss_dssp SCEEEECCCCCSSSCEEEEECTTSCEEEEES--------CCCCC
T ss_pred CCEEEECCCCCCCCCEEEEEeCCCEEEEECC--------CEEeC
Confidence 9999999986544456899999999999974 49998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=8.1e-18 Score=176.27 Aligned_cols=138 Identities=15% Similarity=0.175 Sum_probs=106.9
Q ss_pred cCccccceeeeecceeEEEEEE-CCCcE--EEEEEccCcccc------------------------cHHHHHHHHHHHHh
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQE--VAVKRLSSQSGQ------------------------GLEEFKNEMMLIAK 565 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~ 565 (834)
.-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999988 67888 999987543111 12368899999999
Q ss_pred hcCCCc--ceEEeEEEecCeEEEEEeecCC-C----CccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhh-hcCCCceE
Q 003280 566 LQHRNL--VKLLGCCVEQGEKILILEYMPN-K----SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH-QYSRFRII 637 (834)
Q Consensus 566 l~HpnI--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iv 637 (834)
++|+++ ..++.. ...+|||||+.+ | +|.++... .++..+..++.||+.+|.||| +.+ |+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 998864 333432 356899999952 4 44443311 234567889999999999999 887 99
Q ss_pred eccCCCCcEEEcCCCCceeeeecceeec
Q 003280 638 HRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 638 H~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
||||||+|||++. .++|+|||++...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999865
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.3e-17 Score=147.70 Aligned_cols=105 Identities=20% Similarity=0.339 Sum_probs=87.4
Q ss_pred cccccccCCcccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEec
Q 003280 23 LAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLN 102 (834)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~ 102 (834)
++.|+|.+||.|.+|+.|+| |.|.|.|...|+ |.+ |.. ++||.+|++.. +.++.|.|+.||||||+|
T Consensus 4 ~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp CBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred cccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEEe
Confidence 57899999999999999998 559997776664 555 544 58999999863 346899999999999999
Q ss_pred CCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCcccccccc
Q 003280 103 QTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQS 148 (834)
Q Consensus 103 ~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqS 148 (834)
.+|.++|++++.......+|+|+|+|||||++. .+|+|
T Consensus 71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~~--------~~W~t 108 (110)
T 3r0e_B 71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGP--------AIFET 108 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred CCCCEEEEcCCcCCCCCEEEEEcCCccEEEecC--------CEecC
Confidence 999999999985444457899999999999973 59987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-16 Score=144.01 Aligned_cols=108 Identities=14% Similarity=0.308 Sum_probs=90.5
Q ss_pred cccccccCCcccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEec
Q 003280 23 LAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLN 102 (834)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~ 102 (834)
++.|+|.+||.|.+|+.|.+ |.|.|.|...|+ |.++ .....++||.+|+..+ +.++.|.|+.||||||+|
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~-~~~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLT-KGSKTNIVWESGTSGR--GQHCFMRLGHSGELDITD 73 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEE-ETTTTEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEE-ECCCCEEEEECCcccC--CcCEEEEEeCCCcEEEEC
Confidence 46799999999999999985 889999988776 6664 3224689999999876 346899999999999999
Q ss_pred CCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCcccccccc
Q 003280 103 QTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQS 148 (834)
Q Consensus 103 ~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqS 148 (834)
.++.++|++++.......+|+|+|+|||||++. .+|+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~~--------~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYGP--------AVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEecC--------CEecC
Confidence 999999999986444457899999999999973 59997
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.3e-16 Score=139.93 Aligned_cols=103 Identities=21% Similarity=0.358 Sum_probs=86.0
Q ss_pred cccccccCCcccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEec
Q 003280 23 LAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLN 102 (834)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~ 102 (834)
+|+|+|.|||.|.+|+.| .+|.|.|.|...|+ |-+ |.. +|.+|+..+ +.++.|+|+.||||||+|
T Consensus 1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG-----NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT-----TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 478999999999999999 46999999988776 333 432 699998865 346899999999999999
Q ss_pred CCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCcccccccc
Q 003280 103 QTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQS 148 (834)
Q Consensus 103 ~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqS 148 (834)
.++.++|++++.+.....+|+|+|+|||||++. .+|+|
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~~--------~~W~s 103 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGP--------SVFKI 103 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEECS--------EEEEE
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEec--------CEECC
Confidence 999999999986444456899999999999973 59997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.64 E-value=4.9e-16 Score=140.02 Aligned_cols=96 Identities=23% Similarity=0.414 Sum_probs=78.8
Q ss_pred CCCCCCceEEEeecCceEEecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCCc
Q 003280 82 PISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMK 161 (834)
Q Consensus 82 p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~k 161 (834)
|+.+...+|.|+.||||+|++. +.+||++++.....+.+|+|+++|||||++ ++ .++||||+
T Consensus 15 ~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~-----~~~W~S~~----------- 76 (112)
T 1xd5_A 15 SLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GS-----RAIWASNT----------- 76 (112)
T ss_dssp EEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TT-----EEEEECCC-----------
T ss_pred EEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CC-----EEEEECCc-----------
Confidence 3334478899999999999987 789999998643345789999999999998 32 68999993
Q ss_pred cccccccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEc-CCeeeEeeCCCCC
Q 003280 162 MGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFN-GSVKFACSGQWNG 217 (834)
Q Consensus 162 l~~~~~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~-~~~~~~~sg~w~g 217 (834)
+|++|.|++.|+++|. ++++. +..+||+|++|+|
T Consensus 77 --------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 --------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp --------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred --------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567899999999998 55665 5689999999987
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-15 Score=136.42 Aligned_cols=89 Identities=21% Similarity=0.333 Sum_probs=74.2
Q ss_pred CCceEEEeecCceEEecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCCccccc
Q 003280 86 HNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWD 165 (834)
Q Consensus 86 ~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~ 165 (834)
...+|.|+.||||||++ .+.+||++++.....+.+++|+|+|||||++.+ +.++||||
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~-----~~~~W~S~---------------- 77 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS-----NRVIWQTK---------------- 77 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECC----------------
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC-----CcEEEecC----------------
Confidence 36889999999999998 589999999864444578999999999999863 37899999
Q ss_pred cccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEeeCCC
Q 003280 166 LKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQW 215 (834)
Q Consensus 166 ~~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~sg~w 215 (834)
++|++|.|+++++.+|. ++++++ .||+|+.+
T Consensus 78 ---------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ---------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ---------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ---------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 34577999999999998 556665 89999875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=8e-16 Score=167.64 Aligned_cols=145 Identities=13% Similarity=0.149 Sum_probs=104.8
Q ss_pred HHHHHhcCccccceeeeecceeEEEEEECCCcEEEEEEccCccc--------------ccHHH--------HHHHHHHHH
Q 003280 507 SVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG--------------QGLEE--------FKNEMMLIA 564 (834)
Q Consensus 507 ~~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~--------------~~~~~--------~~~E~~~l~ 564 (834)
.+.....-|++.+.||+|++|.||+|...+|+.||||+++.... ..... ...|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33433345999999999999999999998899999998753210 00111 234666777
Q ss_pred hhcCCCcceEEeEEEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCC
Q 003280 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKAS 644 (834)
Q Consensus 565 ~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~ 644 (834)
++.+.++....-+... ..+|||||+++++|..+.. ......++.||+.+|.|||+.+ ||||||||.
T Consensus 169 rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~ 234 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEF 234 (397)
T ss_dssp HHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred HHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence 7765544322222222 2379999999988876541 1234567899999999999998 999999999
Q ss_pred cEEEcCCCC----------ceeeeecceeec
Q 003280 645 NVLLDMDMN----------PKISDFGLARMF 665 (834)
Q Consensus 645 NIll~~~~~----------~kl~Dfgla~~~ 665 (834)
|||+++++. +.|+||+-+...
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999988773 789999988654
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.54 E-value=1.7e-14 Score=130.97 Aligned_cols=87 Identities=25% Similarity=0.315 Sum_probs=72.6
Q ss_pred CceEEEeecCceEEecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCCcccccc
Q 003280 87 NAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDL 166 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~ 166 (834)
..+|.|+.||||+|++. +.+||++++.....+.+++|+|+|||||++.+ +.++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~-----~~~lW~S~----------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSP----------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECS-----------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCC-----CcEEEcCC-----------------
Confidence 46699999999999987 89999999864444578999999999999863 47899999
Q ss_pred ccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEeeCC
Q 003280 167 KNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQ 214 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~sg~ 214 (834)
+||++|.|+++|+.+|. +++++ ..||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 45678999999999998 55665 38999886
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2.8e-14 Score=129.02 Aligned_cols=91 Identities=29% Similarity=0.350 Sum_probs=75.5
Q ss_pred CceEEEeecCceEEecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCCcccccc
Q 003280 87 NAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDL 166 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~ 166 (834)
...|.|+.||||+|++ .+.+||++++........++|+++|||||++.+ +.++|||||+|
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~-----~~~vW~S~~~~-------------- 80 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN-----NNDVWGSACWG-------------- 80 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC-----ceEEEEcCCCC--------------
Confidence 5679999999999998 588999999864444578999999999999863 36899999983
Q ss_pred ccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEeeCCCCCc
Q 003280 167 KNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGA 218 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~sg~w~g~ 218 (834)
++|.|++.|+.+|. ++++++ .||+|++|...
T Consensus 81 -----------------~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 81 -----------------DNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp -----------------SSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred -----------------CCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 56789999999997 556655 89999999754
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.51 E-value=4.7e-14 Score=126.40 Aligned_cols=103 Identities=15% Similarity=0.269 Sum_probs=83.3
Q ss_pred cccccCCcccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEecCC
Q 003280 25 ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQT 104 (834)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
+|+|.+||.|.+|+.|. +|.|.|.|...|+ |.+ |.. .. ||.+|+..+ +..+.|.|+.||||||+|.+
T Consensus 2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-~~~--~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN-----LVL-YNE--AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-ECS--SC-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe-----EEE-ECC--CC-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence 58999999999999994 6899999988776 444 432 23 999999876 33689999999999999988
Q ss_pred Cc-eEEEeecc--cccCcceEEEccCCCeEEecCCCCCCcccccccc
Q 003280 105 NG-TIWSTNVF--SEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQS 148 (834)
Q Consensus 105 ~~-~~w~~~~~--~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqS 148 (834)
+. ++|+|++. ......+++|+++|||||++ ..+|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG--------PAIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC--------SEEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEec--------cCEEcc
Confidence 76 59999963 22345689999999999997 258997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.5e-11 Score=110.54 Aligned_cols=95 Identities=16% Similarity=0.244 Sum_probs=71.6
Q ss_pred CCCCCCCCceEEEeecCceEEecC-CCceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhcc
Q 003280 80 DRPISDHNAVLTISNKGNLVLLNQ-TNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQ 158 (834)
Q Consensus 80 ~~p~~~~~~~l~~~~~g~l~l~~~-~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLp 158 (834)
+.|+.....+|.|+.||||||++. .+.++|++++.....+..++|+++|||||++.+ +.++|||-.+
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~-----~~~iW~S~t~------- 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR-----LNTVFVSNTV------- 85 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEECSCC-------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC-----CCEEEECCCc-------
Confidence 345555578899999999999998 589999999864444578999999999999863 3679997211
Q ss_pred CCccccccccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEeeCC
Q 003280 159 GMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQ 214 (834)
Q Consensus 159 g~kl~~~~~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~sg~ 214 (834)
-..|.|.+.|+.+|...++ . .+.|.||+
T Consensus 86 ------------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 86 ------------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp ------------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred ------------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 0135588899999986543 3 57888774
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=1.7e-11 Score=128.24 Aligned_cols=113 Identities=19% Similarity=0.357 Sum_probs=86.1
Q ss_pred cccccccCCcc----cCCCCeeeeCCCeeEEEEEcCC--CCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecC
Q 003280 23 LAADTVTPASF----IRDGEKLVSFSQRFELGFFSPG--KSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKG 96 (834)
Q Consensus 23 ~~~~~~~~~~~----l~~~~~l~s~~~~f~~gf~~~~--~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g 96 (834)
..+|++.||+. |..|+.|.|+ ..++.|+|... ...+.+ +| .+ ..+++|.+++..+ + .+.|.++.||
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlv--Ly-~~-~~~~yW~Sgt~~~--~-~~~l~l~~dG 205 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLV--AY-GP-NGAATWNAGTQGK--G-AVRAVFQGDG 205 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEE--EE-CT-TSSEEEECCCTTT--T-CCEEEECTTS
T ss_pred ccccccccccccccccccCcccccC-CCCCCceEEEeecCCceEE--EE-eC-CCeEEEECCCCCC--c-cEEEEEcCCC
Confidence 35799999999 8899998654 45555555331 222333 33 22 3589999999876 3 2789999999
Q ss_pred ceEEecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccC
Q 003280 97 NLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDY 151 (834)
Q Consensus 97 ~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~ 151 (834)
+|+++|.++.++|++++... ...+|+|+++|||||++. .++||||||
T Consensus 206 nLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~-------~~~Wqsf~~ 252 (276)
T 3m7h_A 206 NLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE-------KPVWARFGF 252 (276)
T ss_dssp CEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE-------EEEEESSSC
T ss_pred eEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC-------CCeEEccCc
Confidence 99999998899999997533 457899999999999974 469999998
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=4.4e-11 Score=125.09 Aligned_cols=145 Identities=17% Similarity=0.093 Sum_probs=114.3
Q ss_pred HhcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEEEEe
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 589 (834)
....|++...++.|+.+.||++.. .++.+++|+...........+.+|+.+++.+. |..+.++++++...+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 346788888899899999999975 47899999987532223346889999999985 6778899999998889999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------------
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS------------------------------------- 632 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------- 632 (834)
|++|.+|...+. +......++.+++++|+.||+..
T Consensus 91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999876531 11223477889999999999811
Q ss_pred -------------------CCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 633 -------------------RFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 633 -------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998765667999998754
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.14 E-value=1e-10 Score=104.51 Aligned_cols=93 Identities=17% Similarity=0.235 Sum_probs=69.5
Q ss_pred CCCCCceEEEeecCceEEecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCCcc
Q 003280 83 ISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKM 162 (834)
Q Consensus 83 ~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl 162 (834)
+......|.|+.||||||++.++ +|++++........++|+++|||||++.++ +.++|||.-+
T Consensus 17 L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~----~~~vW~S~t~----------- 79 (111)
T 3mez_A 17 LSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS----NTPVWVYPRS----------- 79 (111)
T ss_dssp EEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC----SSCSEEESSS-----------
T ss_pred EecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC----CEEEEEeccc-----------
Confidence 33446789999999999999877 999998644445789999999999998642 2359998521
Q ss_pred ccccccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEeeCC
Q 003280 163 GWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQ 214 (834)
Q Consensus 163 ~~~~~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~sg~ 214 (834)
.....|.|.+.|+.+|...++ . .++|.++.
T Consensus 80 ------------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 80 ------------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp ------------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred ------------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 011347799999999986644 3 67887764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=2.2e-10 Score=119.25 Aligned_cols=138 Identities=18% Similarity=0.180 Sum_probs=102.3
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCC--cceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey 590 (834)
.++.+....+.|..+.||++...+|+.+++|+.... ....+..|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345553333455669999998767888999997654 2245788999999997555 45588888887889999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcC--------------------------------------
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS-------------------------------------- 632 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------- 632 (834)
+++.+|. .. . . ....++.++++.|+.||+..
T Consensus 97 i~G~~l~--~~-~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SS-H-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TS-C-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cC-c-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 21 1 1 12356778888888888743
Q ss_pred -----------------CCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 633 -----------------RFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 633 -----------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999999864
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.01 E-value=6.5e-10 Score=99.15 Aligned_cols=85 Identities=20% Similarity=0.328 Sum_probs=64.3
Q ss_pred CceEEEeecCceEEecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCCcccccc
Q 003280 87 NAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDL 166 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~ 166 (834)
+..|.|+.||||||++. .++|++++........++|+++|||||++.+ +.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~-----~~~iW~S~t~~-------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD-----FKTIWSSRSSS-------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTT-----CCEEEECCCCC--------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC-----CCEEEEcCCcC--------------
Confidence 57799999999999976 6999999864444568999999999999863 36899983210
Q ss_pred ccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEeeC
Q 003280 167 KNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSG 213 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~sg 213 (834)
..|.|.+.|+.+|...+ ++ .+.|.+|
T Consensus 84 -----------------~~~~~~~~L~~dGNlvl--y~--~~~W~t~ 109 (110)
T 3r0e_B 84 -----------------KQGEYVLILQDDGFGVI--YG--PAIFETS 109 (110)
T ss_dssp -----------------SSSCCEEEECTTSCEEE--EC--SEEEESC
T ss_pred -----------------CCCCEEEEEcCCccEEE--ec--CCEecCC
Confidence 13458888998887654 33 4778766
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=1.4e-09 Score=97.04 Aligned_cols=86 Identities=22% Similarity=0.331 Sum_probs=64.8
Q ss_pred CceEEEeecCceEEecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCCcccccc
Q 003280 87 NAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDL 166 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~ 166 (834)
...|.|+.||||||++. +.++|++++........++|+++|||||++.+ +.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~-----~~~~W~S~t~~-------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR-----NNPIWASNTGG-------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTT-----SCEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCC-----CCEEEECCCCC--------------
Confidence 57799999999999987 78999999864444578999999999999863 36899974221
Q ss_pred ccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEeeC
Q 003280 167 KNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSG 213 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~sg 213 (834)
..+.|.+.|+.+|...+ ++. ..|.|+
T Consensus 80 -----------------~~~~~~~~L~ddGNlvl--y~~--~~W~s~ 105 (109)
T 3dzw_A 80 -----------------ENGNYVCVLQKDRNVVI--YGT--ARWATG 105 (109)
T ss_dssp -----------------SSSCEEEEECTTSCEEE--EES--CCCCCC
T ss_pred -----------------CCCCEEEEEeCCCEEEE--ECC--CEEeCC
Confidence 12467888988887654 332 567655
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.93 E-value=2.3e-09 Score=95.42 Aligned_cols=91 Identities=22% Similarity=0.357 Sum_probs=68.1
Q ss_pred CCCCCCCceEEEeecCceEEecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCC
Q 003280 81 RPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGM 160 (834)
Q Consensus 81 ~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~ 160 (834)
.|+......|.|+.||||||+++ +|+|++........++|+++|||||++.+ +.++|+|-.
T Consensus 16 ~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~-----~~~vWss~t---------- 76 (109)
T 3r0e_A 16 GHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGD-----GSTVWKSGA---------- 76 (109)
T ss_dssp CEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEECCC----------
T ss_pred CEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC-----CCEEEcCCC----------
Confidence 34444577899999999999984 79999865444678999999999999863 367897511
Q ss_pred ccccccccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEeeCCC
Q 003280 161 KMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQW 215 (834)
Q Consensus 161 kl~~~~~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~sg~w 215 (834)
....+.|.+.|+.+|...+ +. .+.|.++.|
T Consensus 77 ---------------------~~~~~~~~~~L~~dGNlvl--y~--~~~W~s~t~ 106 (109)
T 3r0e_A 77 ---------------------QSVKGNYAAVVHPDGRLVV--FG--PSVFKIDPW 106 (109)
T ss_dssp ---------------------CCSSSCCEEEEETTTEEEE--EC--SEEEEECTT
T ss_pred ---------------------cCCCcCEEEEEcCCCeEEE--Ee--cCEECCCCc
Confidence 0123568899999987654 33 688999987
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.89 E-value=7e-09 Score=113.62 Aligned_cols=142 Identities=15% Similarity=0.239 Sum_probs=107.2
Q ss_pred ccceeeeecceeEEEEEECCCcEEEEEEcc--Ccc-cccHHHHHHHHHHHHhhc--CCCcceEEeEEEec---CeEEEEE
Q 003280 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLS--SQS-GQGLEEFKNEMMLIAKLQ--HRNLVKLLGCCVEQ---GEKILIL 588 (834)
Q Consensus 517 ~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~---~~~~lV~ 588 (834)
..+.|+.|.++.||+.... ++.+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3468999999999998874 4688899876 322 123457888999999997 45578888888776 3589999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS------------------------------------ 632 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------ 632 (834)
||+++..+.+.. ...++...+..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998875422 123567788899999999999999731
Q ss_pred -------------------CCceEeccCCCCcEEEcCCCC--ceeeeecceee
Q 003280 633 -------------------RFRIIHRDLKASNVLLDMDMN--PKISDFGLARM 664 (834)
Q Consensus 633 -------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~ 664 (834)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987753 68999999875
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.69 E-value=6.1e-08 Score=85.47 Aligned_cols=77 Identities=25% Similarity=0.366 Sum_probs=58.4
Q ss_pred CceEEEeecCceEEecCCCceEEEeecccc-cCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCCccccc
Q 003280 87 NAVLTISNKGNLVLLNQTNGTIWSTNVFSE-VKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWD 165 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~ 165 (834)
.-+|.|+.||||||++. +.+||++|+... ..+..++|.++|||||+|.+ ++++|+|-
T Consensus 20 ~y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~-----~~~vWss~---------------- 77 (105)
T 4h3o_A 20 PYHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS-----GRSLWASH---------------- 77 (105)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTT-----CCEEEECC----------------
T ss_pred CEEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCC-----cEEEEEec----------------
Confidence 35699999999999974 689999998533 33567899999999999874 36789861
Q ss_pred cccccceEEEEecCCCCCCCCceEEeeeecCCceE
Q 003280 166 LKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKM 200 (834)
Q Consensus 166 ~~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~ 200 (834)
+....+.+.+.|+.+|...+
T Consensus 78 ---------------t~~~~~~~~l~L~ddGNlVl 97 (105)
T 4h3o_A 78 ---------------STRGSGNYILILQDDGNVII 97 (105)
T ss_dssp ---------------CCCCSSCEEEEECTTSCEEE
T ss_pred ---------------CCCCCCCEEEEEeCCCeEEE
Confidence 11234668888988887653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.68 E-value=8e-09 Score=110.39 Aligned_cols=187 Identities=18% Similarity=0.186 Sum_probs=121.2
Q ss_pred cceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhc-CCC--cceEEeEEEecC---eEEEEEeec
Q 003280 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRN--LVKLLGCCVEQG---EKILILEYM 591 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~Ey~ 591 (834)
.+.++.|....||+.. +.+++|+.... .....+.+|+.+++.+. +.. +.+++....... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3578999999999863 56899986533 34567899999999884 433 334444433332 347899999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc----------------------------------------
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY---------------------------------------- 631 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------- 631 (834)
+|..|..... ..++..++..++.++++.++.||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865331 2356667778888888888888851
Q ss_pred ---------------CCCceEeccCCCCcEEEcC--CCCceeeeecceeecCCCccccccc------------eeccccc
Q 003280 632 ---------------SRFRIIHRDLKASNVLLDM--DMNPKISDFGLARMFGGDELQGNTK------------RIVGTYG 682 (834)
Q Consensus 632 ---------------~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~------------~~~gt~~ 682 (834)
....++|+|++|.||++++ ...+.|+||+.+..-....-..... ......+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1245899999999999988 4567899999987643211000000 0000111
Q ss_pred ccc-cccccCCccCccCceeehhhhHHHhhcCCCCC
Q 003280 683 YMS-PEYALDGLFSIKSDVFSFGILMLETLSGKKNT 717 (834)
Q Consensus 683 y~a-PE~l~~~~~t~~~DVwSlGvvl~elltG~~p~ 717 (834)
... |+... ......+.|+++.++|++.+|..++
T Consensus 254 ~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 22211 1122358899999999999998653
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.63 E-value=4.1e-08 Score=100.55 Aligned_cols=92 Identities=21% Similarity=0.280 Sum_probs=67.6
Q ss_pred CCCCCCCCceEEEeecCceEEecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccC
Q 003280 80 DRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQG 159 (834)
Q Consensus 80 ~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg 159 (834)
+.|..+ .-+|.|+.||+|+|.+++ .++|++++.+.....+++|+++||||+++.+ +..+||||.+.
T Consensus 145 ~d~s~G-~~~l~l~~dG~LvL~~~~-~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~-----~~~vw~s~~~~------- 210 (236)
T 1dlp_A 145 QSLQLS-PYRLSMETDCNLVLFDRD-DRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ-----NIAVWTSGNSR------- 210 (236)
T ss_dssp CCCBCS-SCEEEEETTTEEEEEBTT-BCCSCCCCCSSCSSCEEEEETTTEEEEEETT-----TEEEEECCCCC-------
T ss_pred cEeecC-cEEEEECCCCcEEEEcCC-EeEEeCCCcCCCCceEEEECCCCcEEEEeCC-----CcEEEEeCCCC-------
Confidence 344433 667999999999998764 6899998754334467899999999999753 36899999431
Q ss_pred CccccccccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEeeC
Q 003280 160 MKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSG 213 (834)
Q Consensus 160 ~kl~~~~~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~sg 213 (834)
++|.|++.|+++|..+++ . ..||.+|
T Consensus 211 ------------------------~~~~~rl~Ld~dG~l~ly--~--~~~W~sg 236 (236)
T 1dlp_A 211 ------------------------SAGRYVFVLQPDRNLAIY--G--GALWTTG 236 (236)
T ss_dssp ------------------------SSSCCEEEECSSSCEEEE--C--CCCCBC-
T ss_pred ------------------------CCCCEEEEEcCCCcEEEe--C--CCCccCC
Confidence 236789999999987654 3 3788654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=9e-06 Score=86.63 Aligned_cols=135 Identities=21% Similarity=0.198 Sum_probs=94.2
Q ss_pred ceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCC---CcceEEeEEE-ecCeEEEEEeecCCC
Q 003280 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHR---NLVKLLGCCV-EQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~-~~~~~~lV~Ey~~~g 594 (834)
+.++.|....||+. ++.+++|+-+. ......+..|..+|..+.+. .+.+++.+.. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 56888888899987 67788998532 23456889999999999753 2556666664 344578999999998
Q ss_pred CccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-------------------------------------------
Q 003280 595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY------------------------------------------- 631 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------- 631 (834)
.+...... .++......++.++++.|+.||+.
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88653211 123444455555555555555532
Q ss_pred --------------CCCceEeccCCCCcEEEcC---CCCc-eeeeecceee
Q 003280 632 --------------SRFRIIHRDLKASNVLLDM---DMNP-KISDFGLARM 664 (834)
Q Consensus 632 --------------~~~~ivH~Dlkp~NIll~~---~~~~-kl~Dfgla~~ 664 (834)
....++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 4554 8999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=7.8e-06 Score=85.24 Aligned_cols=136 Identities=18% Similarity=0.160 Sum_probs=96.8
Q ss_pred ceeeeecce-eEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEEEEeecCCCC
Q 003280 519 CKLGEGGFG-PVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 519 ~~LG~G~~G-~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 595 (834)
+.+..|..+ .||+..... +..+++|+-... ....+.+|...|+.+. +-.+.+++.++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 355566665 589877643 668999986533 3467888999998884 3346788899999999999999999987
Q ss_pred ccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc--------------------------------------------
Q 003280 596 LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-------------------------------------------- 631 (834)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------------------------------------------- 631 (834)
+.+.... .......+..++++.|+.||..
T Consensus 107 ~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7654311 1122334555666666666631
Q ss_pred -----------CCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 632 -----------SRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 632 -----------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
....++|+|+.+.||++++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112379999999999999877777999999864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=6.2e-06 Score=89.89 Aligned_cols=81 Identities=6% Similarity=-0.000 Sum_probs=57.6
Q ss_pred ccee-eeecceeEEEEEEC-------CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhc-C--CCcceEEeEEEec--
Q 003280 518 QCKL-GEGGFGPVYKGRLL-------NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQ-H--RNLVKLLGCCVEQ-- 581 (834)
Q Consensus 518 ~~~L-G~G~~G~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~~~~~-- 581 (834)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998764 26789999875432 111245778999998885 3 3466778777655
Q ss_pred -CeEEEEEeecCCCCccc
Q 003280 582 -GEKILILEYMPNKSLDV 598 (834)
Q Consensus 582 -~~~~lV~Ey~~~gsL~~ 598 (834)
+..++||||+++..+..
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999988764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.80 E-value=6.6e-05 Score=80.91 Aligned_cols=141 Identities=15% Similarity=0.159 Sum_probs=82.2
Q ss_pred ceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcC--CCcceEEe------EEEecCeEEEEEee
Q 003280 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH--RNLVKLLG------CCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~------~~~~~~~~~lV~Ey 590 (834)
+.|+.|..+.||+....+| .+++|+.... .+++..|+.++..+.. -.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987544 5999998752 2344556666666631 12333332 22346678999999
Q ss_pred cCCCCccc--------------cccCCCC-----------CCcCCHHHH-------------------------------
Q 003280 591 MPNKSLDV--------------FLFDPTK-----------KRLLGWQAR------------------------------- 614 (834)
Q Consensus 591 ~~~gsL~~--------------~l~~~~~-----------~~~l~~~~~------------------------------- 614 (834)
++|..+.. .+|.... .....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876531 0111000 001122211
Q ss_pred HHHHHHHHHHHHHhhh----------cCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 615 VTIIEGIAQGLLYLHQ----------YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 615 ~~i~~~ia~~L~yLH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
..+...+..++.+|++ .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223445666663 1235699999999999998888999999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=7e-05 Score=82.82 Aligned_cols=75 Identities=11% Similarity=0.196 Sum_probs=50.6
Q ss_pred cceeeeecceeEEEEEEC-CCcEEEEEEccCccc-------ccHHHHHHHHHHHHhhcC--CCcc-eEEeEEEecCeEEE
Q 003280 518 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-------QGLEEFKNEMMLIAKLQH--RNLV-KLLGCCVEQGEKIL 586 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--pnIv-~l~~~~~~~~~~~l 586 (834)
.+.||.|..+.||++... .++.++||....... ...+++..|.+++..+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 368999999999999754 468899998653221 234567889999988853 3333 44433 4556789
Q ss_pred EEeecCCC
Q 003280 587 ILEYMPNK 594 (834)
Q Consensus 587 V~Ey~~~g 594 (834)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999863
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00017 Score=75.92 Aligned_cols=80 Identities=16% Similarity=0.253 Sum_probs=60.4
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCC---CcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHR---NLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~~~~~~~lV~E 589 (834)
....-.+.+|.|..+.||+.++.+|+.|++|+...........|..|...|+.+.-. .+.+++++ . ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEE
Confidence 455666889999999999999999999999997665555556788999999988422 24444443 2 3478999
Q ss_pred ecCCCCc
Q 003280 590 YMPNKSL 596 (834)
Q Consensus 590 y~~~gsL 596 (834)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00034 Score=74.33 Aligned_cols=138 Identities=21% Similarity=0.117 Sum_probs=92.4
Q ss_pred cceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhc---CCCcceEEeEEEecCeEEEEEeecCCC
Q 003280 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ---HRNLVKLLGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
.+.|+.|....+|+... +++.+++|+.... ....+..|...|+.+. ...+.+++.+....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999876 5778999987543 3567889999999884 256788888888788899999999998
Q ss_pred Ccccc-----------ccCCCC-C------------------CcCCHHHHH---HHHH----------------HHHH-H
Q 003280 595 SLDVF-----------LFDPTK-K------------------RLLGWQARV---TIIE----------------GIAQ-G 624 (834)
Q Consensus 595 sL~~~-----------l~~~~~-~------------------~~l~~~~~~---~i~~----------------~ia~-~ 624 (834)
.+..- +|.... . -.-+|.... ++.. .++. .
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 76321 121111 0 011343321 1111 1111 1
Q ss_pred HHHhhh-cCCCceEeccCCCCcEEEcCCCCceeeeec
Q 003280 625 LLYLHQ-YSRFRIIHRDLKASNVLLDMDMNPKISDFG 660 (834)
Q Consensus 625 L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 660 (834)
...|.. ...+.++|+|+.+.|++++.++ +.|+|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223322 2346799999999999999887 8888873
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0012 Score=70.50 Aligned_cols=158 Identities=15% Similarity=0.128 Sum_probs=87.4
Q ss_pred cHHHHHHHhcCccc-----cceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCC--cceEEe
Q 003280 504 SLASVAAATENFSM-----QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLG 576 (834)
Q Consensus 504 ~~~~~~~~~~~f~~-----~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~ 576 (834)
+.+.+......|.+ .+.|+.|....+|+....+| .+++|+..... ..+.+..|+.++..+.... +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 33444444444544 24566788889999987555 68899886531 1235567888887774322 233332
Q ss_pred E------EEecCeEEEEEeecCCCCcccc--------------ccCCC----CC-----CcCCHHHHHH-----------
Q 003280 577 C------CVEQGEKILILEYMPNKSLDVF--------------LFDPT----KK-----RLLGWQARVT----------- 616 (834)
Q Consensus 577 ~------~~~~~~~~lV~Ey~~~gsL~~~--------------l~~~~----~~-----~~l~~~~~~~----------- 616 (834)
. ....+..+++|+|++|..+... +|... .. ....|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 1234567899999998765321 11100 00 0011222110
Q ss_pred -HHHHHHHHHHHhhhc----CCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 617 -IIEGIAQGLLYLHQY----SRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 617 -i~~~ia~~L~yLH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
+...+.+.++.++.. ....++|+|+++.||+++++..+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001134445555532 234589999999999998876668999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00086 Score=74.60 Aligned_cols=78 Identities=10% Similarity=0.026 Sum_probs=47.1
Q ss_pred CCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccccccceec--ccccccccccccCC---ccCccCceeehhhhH
Q 003280 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV--GTYGYMSPEYALDG---LFSIKSDVFSFGILM 707 (834)
Q Consensus 633 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~---~~t~~~DVwSlGvvl 707 (834)
...++|+|++|.|||++.++ ++|+||+.+..-.... . ..... -...|++|+..... .-....++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-D--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-H--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-H--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 34699999999999998776 9999999987642110 0 00001 12346666654311 112234455677777
Q ss_pred HHhhcCC
Q 003280 708 LETLSGK 714 (834)
Q Consensus 708 ~elltG~ 714 (834)
|+.+.++
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7776654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0029 Score=67.54 Aligned_cols=142 Identities=14% Similarity=0.158 Sum_probs=83.4
Q ss_pred ceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCC--cceEEeE-----EEecCeEEEEEeec
Q 003280 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLGC-----CVEQGEKILILEYM 591 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~-----~~~~~~~~lV~Ey~ 591 (834)
+.|+ |....||+....+|+.+++|+.+... ...+.+..|..++..+.... +.+++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 78889999877677789999986432 23456777888888875322 3444432 22345668899999
Q ss_pred CCCCcccc--------------ccC----C--CCCCcCCHHHH----HHH---------------HHHHHHHHHHhhhc-
Q 003280 592 PNKSLDVF--------------LFD----P--TKKRLLGWQAR----VTI---------------IEGIAQGLLYLHQY- 631 (834)
Q Consensus 592 ~~gsL~~~--------------l~~----~--~~~~~l~~~~~----~~i---------------~~~ia~~L~yLH~~- 631 (834)
++..+... +|. . ......++... ..+ ...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 98665310 110 0 00111121110 000 11111222333221
Q ss_pred ---CCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 632 ---SRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 632 ---~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234589999999999999 4 899999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0026 Score=70.79 Aligned_cols=73 Identities=21% Similarity=0.302 Sum_probs=51.1
Q ss_pred ceeeeecceeEEEEEECC--------CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCc-ceEEeEEEecCeEEEEEe
Q 003280 519 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL-VKLLGCCVEQGEKILILE 589 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E 589 (834)
+.|+.|....+|+....+ ++.+++|+.... ...+.+.+|..++..+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 578888889999998753 478999988442 122456689999998854444 556665532 38999
Q ss_pred ecCCCCcc
Q 003280 590 YMPNKSLD 597 (834)
Q Consensus 590 y~~~gsL~ 597 (834)
|+++.+|.
T Consensus 153 ~l~G~~l~ 160 (429)
T 1nw1_A 153 YIPSRPLS 160 (429)
T ss_dssp CCCEEECC
T ss_pred EeCCcccC
Confidence 99875553
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0024 Score=67.44 Aligned_cols=128 Identities=14% Similarity=0.152 Sum_probs=77.4
Q ss_pred cceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcc-eEEeEEEecCeEEEEEeec-CCCC
Q 003280 518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV-KLLGCCVEQGEKILILEYM-PNKS 595 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~-~~gs 595 (834)
.+.|+.|....+|+. +.+++|+........ ....+|+.+++.+....+. +++++ +.+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 568999999999998 678999886542221 1235688888887543443 44443 344457899999 6655
Q ss_pred ccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhh---------------------------------------------
Q 003280 596 LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ--------------------------------------------- 630 (834)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~--------------------------------------------- 630 (834)
+....... +..++.++++.|+-||+
T Consensus 95 l~~~~~~~----------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 95 MSPEKFKT----------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp CCHHHHHH----------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred CCHhhHhh----------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 53210000 00011222222222221
Q ss_pred -----cCCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 631 -----YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 631 -----~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
.....++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 12345899999999999 6677889999998865
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0034 Score=68.43 Aligned_cols=141 Identities=18% Similarity=0.224 Sum_probs=83.9
Q ss_pred ceeeeecceeEEEEEEC--------CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCC-cceEEeEEEecCeEEEEEe
Q 003280 519 CKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN-LVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~E 589 (834)
+.|..|-...+|+.... +++.+++|+.... ......+.+|..+++.+.-.+ ..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46777888899998864 2478999986432 234566778999999885333 3456665543 29999
Q ss_pred ecCCCCccccc-----------------cCC--CCCCcCC--HHHHHHHHHHHHH-------------------HHHHhh
Q 003280 590 YMPNKSLDVFL-----------------FDP--TKKRLLG--WQARVTIIEGIAQ-------------------GLLYLH 629 (834)
Q Consensus 590 y~~~gsL~~~l-----------------~~~--~~~~~l~--~~~~~~i~~~ia~-------------------~L~yLH 629 (834)
|+++..|..-- |.. .-.+... +..+.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99987764211 111 0011122 3444444443321 222332
Q ss_pred ----hc-CCCceEeccCCCCcEEEcCC----CCceeeeecceee
Q 003280 630 ----QY-SRFRIIHRDLKASNVLLDMD----MNPKISDFGLARM 664 (834)
Q Consensus 630 ----~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~ 664 (834)
.. ....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 23458999999999999876 7899999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0094 Score=66.72 Aligned_cols=74 Identities=14% Similarity=0.123 Sum_probs=49.3
Q ss_pred ceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCc-ceEEeEEEecCeEEEEEeecCCCCc
Q 003280 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL-VKLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
+.|+.|-...+|+....+ ++.+++|+.........+ ..+|..++..+...++ .++++.+. + .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN-REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 578888889999998765 478999987543322211 2578999999865555 45666652 2 259999998665
Q ss_pred c
Q 003280 597 D 597 (834)
Q Consensus 597 ~ 597 (834)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.006 Score=65.30 Aligned_cols=142 Identities=14% Similarity=0.130 Sum_probs=72.6
Q ss_pred ceeeeeccee-EEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCC--CcceEEeEEEecCeEEEEEeecCCCC
Q 003280 519 CKLGEGGFGP-VYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHR--NLVKLLGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 519 ~~LG~G~~G~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~~~~~~lV~Ey~~~gs 595 (834)
+.|+.|.... +|+....+++.+++|....... +.+..|+.++..+... .+.+++.+..+. -+++||++++..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4565554444 6676654467788886544321 2345577777777432 345566653332 378999998765
Q ss_pred cccccc---------------------CCCC--CCcCCHHHHH-------H-H------------HHHHHHHHHHhh---
Q 003280 596 LDVFLF---------------------DPTK--KRLLGWQARV-------T-I------------IEGIAQGLLYLH--- 629 (834)
Q Consensus 596 L~~~l~---------------------~~~~--~~~l~~~~~~-------~-i------------~~~ia~~L~yLH--- 629 (834)
+...+. .... ...++..... . + ...+.+.+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 533221 1000 0111111000 0 0 001112222221
Q ss_pred hcCCCceEeccCCCCcEEEcCC----CCceeeeecceeec
Q 003280 630 QYSRFRIIHRDLKASNVLLDMD----MNPKISDFGLARMF 665 (834)
Q Consensus 630 ~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~~ 665 (834)
......++|+|+.+.||+++.+ +.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123469999999999999874 67899999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.53 E-value=0.006 Score=66.39 Aligned_cols=73 Identities=12% Similarity=0.103 Sum_probs=45.7
Q ss_pred ceeeeecceeEEEEEECC---------CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCc-ceEEeEEEecCeEEEEE
Q 003280 519 CKLGEGGFGPVYKGRLLN---------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL-VKLLGCCVEQGEKILIL 588 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~ 588 (834)
+.|+.|....+|+....+ ++.+++|+........ .....|..++..+...++ .++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 467888888999988654 2688999876533221 224678888888854443 3566543 2 36899
Q ss_pred eecCCCCc
Q 003280 589 EYMPNKSL 596 (834)
Q Consensus 589 Ey~~~gsL 596 (834)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.15 E-value=0.025 Score=60.70 Aligned_cols=68 Identities=10% Similarity=0.074 Sum_probs=44.1
Q ss_pred eeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcC---CCcceEEeE------EEecCeEEEEEeecC
Q 003280 522 GEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH---RNLVKLLGC------CVEQGEKILILEYMP 592 (834)
Q Consensus 522 G~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~------~~~~~~~~lV~Ey~~ 592 (834)
|.|....||+....+| .+++|+...... ..|+..+..+.. |.+.+++.. ....+..++||||++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3334678999987666 899998765432 356666666632 224444432 233567899999999
Q ss_pred CCCc
Q 003280 593 NKSL 596 (834)
Q Consensus 593 ~gsL 596 (834)
+..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8776
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.57 E-value=0.19 Score=55.44 Aligned_cols=73 Identities=14% Similarity=0.178 Sum_probs=49.2
Q ss_pred ceeeeecceeEEEEEECC--------CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCc-ceEEeEEEecCeEEEEEe
Q 003280 519 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL-VKLLGCCVEQGEKILILE 589 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E 589 (834)
+.|..|-...+|+....+ ++.+++|+......... ...+|..+++.+...++ .++++.+ . -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 567778888999998753 57899998755432222 23678888888853333 4455433 2 378999
Q ss_pred ecCCCCc
Q 003280 590 YMPNKSL 596 (834)
Q Consensus 590 y~~~gsL 596 (834)
|+++..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9999775
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.97 E-value=0.087 Score=51.83 Aligned_cols=102 Identities=13% Similarity=0.050 Sum_probs=63.4
Q ss_pred CccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccccc
Q 003280 595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT 674 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (834)
+|.+.|. ..+.++++++++.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 34 SL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 4555552 345689999999999999999877621110 1 1233457899999999988764 1110
Q ss_pred ceecccccccccccccCCccCccCceeehhhhHHHhhcCCCC
Q 003280 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716 (834)
Q Consensus 675 ~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p 716 (834)
.....+.|||... ...+.+.=|||||++||.-+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122466888653 3456788899999999998864433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.12 E-value=0.37 Score=52.78 Aligned_cols=29 Identities=24% Similarity=0.391 Sum_probs=24.9
Q ss_pred eEeccCCCCcEEE------cCCCCceeeeecceee
Q 003280 636 IIHRDLKASNVLL------DMDMNPKISDFGLARM 664 (834)
Q Consensus 636 ivH~Dlkp~NIll------~~~~~~kl~Dfgla~~ 664 (834)
++|+|+.+.||++ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4467799999998864
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=90.84 E-value=15 Score=37.21 Aligned_cols=66 Identities=12% Similarity=0.257 Sum_probs=40.7
Q ss_pred CCceEEEecCCCC--CC----CCCceEEEeecCceEEecCCCceEEEeecccccCcceEEEccCCCeEEecC
Q 003280 70 PDTVVWVANRDRP--IS----DHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDN 135 (834)
Q Consensus 70 ~~~~vw~anr~~p--~~----~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~ 135 (834)
..+++|...+..+ +. .+++.+-++.++.+..+|++|..+|.-..........+..+.+||+++-+.
T Consensus 24 tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~ 95 (276)
T 3no2_A 24 TKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC 95 (276)
T ss_dssp TTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred CCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence 4577888876542 11 123444445555566677889999998753222334567778888888654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 834 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-69 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-25 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 4e-22 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 4e-15 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-09 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 4e-15 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-14 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 2e-13 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 6e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 2e-69
Identities = 68/285 (23%), Positives = 130/285 (45%), Gaps = 20/285 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
++ ++G G FG VYKG+ V + +++ + Q L+ FKNE+ ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+G + ++ ++ SL L + + I AQG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL-- 690
IIHRDLK++N+ L D+ KI DFGLA + +++ G+ +M+PE
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 691 -DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749
+S +SDV++FGI++ E ++G+ + N + + P ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIFMVG----RGYLSPDLS 232
Query: 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELP 794
+ + P ++ + C++ +RP +++ I LP
Sbjct: 233 KVRSNCPKAMK--RLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 5e-65
Identities = 63/291 (21%), Positives = 115/291 (39%), Gaps = 28/291 (9%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
+G+G FG V++G+ G+EVAVK SS+ + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 580 EQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ----- 630
+ L+ +Y + SL +L + + + + + A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEY 688
+ I HRDLK+ N+L+ + I+D GLA D + VGT YM+PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 689 ALDGL------FSIKSDVFSFGILMLETLSGKKNTGVYNADSF-----NLLGYAWDLWKD 737
D + ++D+++ G++ E G++ + + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 738 DKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
+ + P I S L + C N A R T + ++
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-64
Identities = 79/274 (28%), Positives = 132/274 (48%), Gaps = 22/274 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
E + +LG G FG V+ G +VAVK L Q + F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+L Q +I EYM N SL FL P+ +L + + IA+G+ ++ + +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
IHRDL+A+N+L+ ++ KI+DFGLAR+ +E + +PE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 693 LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752
F+IKSDV+SFGIL+ E ++ + + + + ++ + ++ P +E
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI-------PYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 753 ISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
+ + LC ++ DRPT + S++
Sbjct: 239 L--------YQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 2e-64
Identities = 73/276 (26%), Positives = 125/276 (45%), Gaps = 26/276 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
+ ++G G FG V+ G LN +VA+K + + E+F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+L G C+EQ L+ E+M + L +L ++ L + + + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA- 120
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
+IHRDL A N L+ + K+SDFG+ R D+ ++ + SPE
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 693 LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752
+S KSDV+SFG+LM E S K +++ E+++ + T
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKI-----------------PYENRSNSEVVEDISTGFR 220
Query: 753 ISLPVLV--RYINVALLCVQDNAADRPTMSDVVSII 786
+ P L + C ++ DRP S ++ +
Sbjct: 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 5e-63
Identities = 78/290 (26%), Positives = 126/290 (43%), Gaps = 26/290 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + E F E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+L + ++ EYM SL FL T K L V + IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
+HRDL+A+N+L+ ++ K++DFGLAR+ +E + +PE AL G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189
Query: 693 LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752
F+IKSDV+SFGIL+ E + + + E++D V
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV-----------------PYPGMVNREVLDQVERGYR 232
Query: 753 ISLP--VLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPA 800
+ P ++ C + +RPT + + + +P
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-62
Identities = 67/301 (22%), Positives = 119/301 (39%), Gaps = 38/301 (12%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQH 568
++F +LG G G V+K +G +A K + + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
+V G GE + +E+M SLD L K + Q + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
+ +I+HRD+K SN+L++ K+ DFG++ VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK------------------------KNTGVYNADS 724
+S++SD++S G+ ++E G+ +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 725 FNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLV---RYINVALLCVQDNAADRPTMSD 781
L Y D EL+D ++ + LP V + + C+ N A+R +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 782 V 782
+
Sbjct: 295 L 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 6e-62
Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 26/276 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
++ + +LG G FG V G+ +VA+K + S +EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+L G C +Q +I EYM N L +L + + Q + + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES-- 118
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
+ +HRDL A N L++ K+SDFGL+R DE + + PE +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYS 176
Query: 693 LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752
FS KSD+++FG+LM E S K ++ E + +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMP-----------------YERFTNSETAEHIAQGLR 219
Query: 753 ISLPVLV--RYINVALLCVQDNAADRPTMSDVVSII 786
+ P L + + C + A +RPT ++S I
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-60
Identities = 72/299 (24%), Positives = 119/299 (39%), Gaps = 31/299 (10%)
Query: 511 ATENFSMQ-CKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQG-LEEFKNEMMLIAK 565
+N + +LG G FG V +G +VA+K L + + EE E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
L + +V+L+G C + +L++E L FL K+ + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYM 684
YL + +HRDL A NVLL KISDFGL++ G D+ + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744
+PE FS +SDV+S+G+ M E LS + +K K E++
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQK-----------------PYKKMKGPEVM 222
Query: 745 DPVITQDEISLP--VLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAF 801
+ + P + C DRP V + + L S E
Sbjct: 223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 4e-60
Identities = 72/277 (25%), Positives = 117/277 (42%), Gaps = 32/277 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
+ + +G+G FG V G G +VAVK + + + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 573 KLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
+LLG VE+ + ++ EYM SL +L + +LG + + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
+HRDL A NVL+ D K+SDFGL + E + +PE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174
Query: 692 GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751
FS KSDV+SFGIL+ E S + + +++ V
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVP-----------------YPRIPLKDVVPRVEKGY 217
Query: 752 EISLP--VLVRYINVALLCVQDNAADRPTMSDVVSII 786
++ P V C +AA RP+ + +
Sbjct: 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (516), Expect = 9e-60
Identities = 74/304 (24%), Positives = 127/304 (41%), Gaps = 41/304 (13%)
Query: 503 FSLASVAAATENFS---------MQCKLGEGGFGPVYKGRLL----NGQEVAVKRL-SSQ 548
F+ A F+ ++ +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 549 SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL 608
+ + +F +E ++ + H N++ L G + ++I E+M N SLD FL +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 609 LGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668
V ++ GIA G+ YL +HRDL A N+L++ ++ K+SDFGL+R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 669 ELQGNTKRIVG---TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF 725
+G + +PE F+ SDV+S+GI+M E
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE---------------- 225
Query: 726 NLLGYAWDLWKDDKFHELIDPVITQDEISLPVLV--RYINVALLCVQDNAADRPTMSDVV 783
++ Y + D ++I+ + + P+ + L C Q + RP +V
Sbjct: 226 -VMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 784 SIIN 787
+ ++
Sbjct: 285 NTLD 288
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (513), Expect = 3e-59
Identities = 73/309 (23%), Positives = 124/309 (40%), Gaps = 52/309 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQGLE-EFKNEMMLIAK 565
N +GEG FG V++ R VAVK L ++ ++ +F+ E L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL----------------- 608
+ N+VKLLG C L+ EYM L+ FL + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 609 ----LGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
L ++ I +A G+ YL + + +HRDL N L+ +M KI+DFGL+R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS 724
+ +M PE ++ +SDV+++G+++ E S
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP------- 242
Query: 725 FNLLGYAWDLWKDDKFHELIDPVITQDEISLP--VLVRYINVALLCVQDNAADRPTMSDV 782
+ E+I V + ++ P + N+ LC ADRP+ +
Sbjct: 243 ----------YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292
Query: 783 VSIINSERL 791
I+ +R+
Sbjct: 293 HRIL--QRM 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (511), Expect = 3e-59
Identities = 72/277 (25%), Positives = 129/277 (46%), Gaps = 22/277 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
+ +M+ KLG G +G VY+G VAVK L + + +EEF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
V+LLG C + +I E+M +L +L + ++ + + + I+ + YL +
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKK 134
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
IHRDL A N L+ + K++DFGL+R+ GD + + +PE
Sbjct: 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 692 GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751
FSIKSDV++FG+L+ E + + + + +EL++ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQVYELLEKDY-RM 235
Query: 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
E + + C Q N +DRP+ +++ +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 6e-59
Identities = 64/281 (22%), Positives = 124/281 (44%), Gaps = 35/281 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
+ + + +LG+G FG VYK + A K + ++S + LE++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+VKLL + +++E+ ++D + + +R L + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+IIHRDLKA N+L +D + K++DFG++ + ++ +GT +M+PE +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 691 -----DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745
D + K+DV+S GI ++E + + ++
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEP------------------PHHELNPMRVLL 225
Query: 746 PVITQDEISLPVLVRY----INVALLCVQDNAADRPTMSDV 782
+ + +L R+ + C++ N R T S +
Sbjct: 226 KIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-58
Identities = 66/281 (23%), Positives = 117/281 (41%), Gaps = 30/281 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHR 569
E++ + +G G +G K R +G+ + K L S + + +E+ L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 570 NLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKR-LLGWQARVTIIEGIAQGLL 626
N+V+ +++ L ++EY L + TK+R L + + ++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 627 YLHQYSR--FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
H+ S ++HRDLK +NV LD N K+ DFGLAR+ D K VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYM 181
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744
SPE ++ KSD++S G L+ E + + EL
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP------------------PFTAFSQKELA 223
Query: 745 DPVITQDEISLPVLV--RYINVALLCVQDNAADRPTMSDVV 783
+ +P + + RP++ +++
Sbjct: 224 GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (509), Expect = 1e-58
Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQ 567
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
H N ++ GC + + L++EY + D+ K+ L + G QGL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
LH + +IHRD+KA N+LL K+ DFG A + VGT +M+PE
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 688 YAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744
L +G + K DV+S GI +E K ++N ++ + L ++ L
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSAL----YHIAQNESPALQ 235
Query: 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784
++ + N C+Q DRPT ++
Sbjct: 236 SGHWSEY---------FRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-58
Identities = 73/275 (26%), Positives = 118/275 (42%), Gaps = 23/275 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
E++ + LGEG +G V + VAVK + ++ E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+VK G E + L LEY L + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
I HRD+K N+LLD N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 691 DGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749
F + DV+S GI++ L+G+ ++ S + Y+ WK+ K + I
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEYS--DWKEKKTYLNPWKKID 233
Query: 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784
++L + +N + R T+ D+
Sbjct: 234 SAPLAL---------LHKILVENPSARITIPDIKK 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 6e-58
Identities = 69/277 (24%), Positives = 120/277 (43%), Gaps = 32/277 (11%)
Query: 520 KLGEGGFGPVYKGRLLN---GQEVAVKRLSSQSGQG--LEEFKNEMMLIAKLQHRNLVKL 574
+LG G FG V KG + VAVK L +++ +E E ++ +L + +V++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
+G C E +L++E L+ +L + R + + + ++ ++ G+ YL +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK-RIVGTYGYMSPEYALDGL 693
+HRDL A NVLL KISDFGL++ DE + + +PE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 694 FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDEI 753
FS KSDV+SFG+LM E S + ++ K E+ + + +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQK-----------------PYRGMKGSEVTAMLEKGERM 229
Query: 754 SLPVLV--RYINVALLCVQDNAADRPTMSDVVSIINS 788
P ++ LC + +RP + V + +
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-57
Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 32/279 (11%)
Query: 520 KLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKL 574
+G G FG VY G LL+ AVK L+ + G + +F E +++ H N++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 575 LGCCVE-QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
LG C+ +G +++L YM + L F+ + T + + + +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLAS 148
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR--IVGTYGYMSPEYALD 691
+ +HRDL A N +LD K++DFGLAR E + +M+ E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 692 GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751
F+ KSDV+SFG+L+ E ++ + D ++ ++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP-----------------PYPDVNTFDITVYLLQGR 251
Query: 752 EISLPVLV--RYINVALLCVQDNAADRPTMSDVVSIINS 788
+ P V L C A RP+ S++VS I++
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 1e-57
Identities = 60/273 (21%), Positives = 114/273 (41%), Gaps = 31/273 (11%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
++G G F VYKG EVA L + + + FK E ++ LQH N+V+
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 577 CCVEQGEK----ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
+ +L+ E M + +L +L + +++ + + I +GL +LH +
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 633 RFRIIHRDLKASNVLL-DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
IIHRDLK N+ + + KI D GLA + K ++GT +M+PE +
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YE 186
Query: 692 GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751
+ DV++FG+ MLE + + + + + + +
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPY--------------SECQNAAQIYRRVTSGVKPA 232
Query: 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784
+ + C++ N +R ++ D+++
Sbjct: 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 3e-57
Identities = 73/308 (23%), Positives = 114/308 (37%), Gaps = 51/308 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQG-LEEFKNEMMLIAK 565
EN LG G FG V +VAVK L ++ E +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 566 L-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK------------------ 606
L H N+V LLG C G LI EY L +L +K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 607 --RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
+L ++ + +A+G+ +L +HRDL A NVL+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS 724
D +M+PE +G+++IKSDV+S+GIL+ E S N
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-------- 265
Query: 725 FNLLGYAWDLWKDDKFHELIDPVITQD---EISLPVLVRYINVALLCVQDNAADRPTMSD 781
+ +I + + C ++ RP+ +
Sbjct: 266 ---------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 782 VVSIINSE 789
+ S + +
Sbjct: 317 LTSFLGCQ 324
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 1e-56
Identities = 79/335 (23%), Positives = 143/335 (42%), Gaps = 51/335 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLS-SQSGQGLEEFKNEMMLIAKL 566
F LG G FG VYKG + E VA+K L + S + +E +E ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
+ ++ +LLG C+ LI + MP L + K +G Q + IA+G+
Sbjct: 69 DNPHVCRLLGICLT-STVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
YL R++HRDL A NVL+ + KI+DFGLA++ G +E + + + +M+
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746
E L +++ +SDV+S+G+ + E L+ + + E+
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWE-----------------LMTFGSKPYDGIPASEISSI 225
Query: 747 VITQDEISLPVLV--RYINVALLCVQDNAADRPTMSDVVS--------------IINSER 790
+ + + P + + + C +A RP +++ I ER
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDER 285
Query: 791 LELPSPKEPAFIKGINVKNSSHSNDGMSNLCSVND 825
+ LPSP + F + + + M ++ ++
Sbjct: 286 MHLPSPTDSNFYR------ALMDEEDMDDVVDADE 314
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 1e-56
Identities = 71/278 (25%), Positives = 118/278 (42%), Gaps = 35/278 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQH 568
E+F + LG+G FG VY R + +A+K L + + + E+ + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
N+++L G + LILEY P ++ L +K Q T I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748
+ K D++S G+L E L GK ++ + + E I
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP------------------PFEANTYQETYK-RI 216
Query: 749 TQDEISLPVLV--RYINVALLCVQDNAADRPTMSDVVS 784
++ E + P V ++ ++ N + RP + +V+
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-56
Identities = 72/300 (24%), Positives = 113/300 (37%), Gaps = 40/300 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQG-LEEFKNEMMLIAK 565
S LG G FG V + VAVK L + E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 566 L-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL---------------L 609
L H N+V LLG C G ++I EY L FL + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
+ ++ +A+G+ +L IHRDL A N+LL KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
+M+PE + +++ +SDV+S+GI + E S +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 730 YAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789
+ D KF+++I + ++ C + RPT +V +I +
Sbjct: 247 PYPGMPVDSKFYKMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 2e-55
Identities = 63/284 (22%), Positives = 123/284 (43%), Gaps = 32/284 (11%)
Query: 504 SLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMML 562
S+ SV + ++ K+G+G G VY + GQEVA+++++ Q E NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA 622
+ + ++ N+V L + E +++EY+ S L D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECL 126
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
Q L +LH ++IHRD+K+ N+LL MD + K++DFG + Q +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742
+M+PE + K D++S GI+ +E + G+ + ++
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP------------------PYLNENPLR 223
Query: 743 LIDPVITQDEISLPVLVRY----INVALLCVQDNAADRPTMSDV 782
+ + T L + + C+ + R + ++
Sbjct: 224 ALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-55
Identities = 73/305 (23%), Positives = 130/305 (42%), Gaps = 38/305 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLS-SQSGQGLEEFKNEMMLIAK 565
E +M +LG+G FG VY+G VA+K ++ + S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARVTII 618
++V+LLG + ++I+E M L +L + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
IA G+ YL+ + +HRDL A N ++ D KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD 738
+MSPE DG+F+ SDV+SFG+++ E + + ++
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----------------YQGL 239
Query: 739 KFHELIDPVITQDEISLP--VLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSP 796
+++ V+ + P + +C Q N RP+ +++S I E +E P
Sbjct: 240 SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE-ME-PGF 297
Query: 797 KEPAF 801
+E +F
Sbjct: 298 REVSF 302
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 7e-55
Identities = 77/283 (27%), Positives = 125/283 (44%), Gaps = 27/283 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSGQG-LEEFKNEMMLIAKL 566
+ Q +G G FG VYKG L VA+K L + + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
H N+++L G + ++I EYM N +LD FL + K V ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMS 685
YL +HRDL A N+L++ ++ K+SDFGL+R+ D T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745
PE F+ SDV+SFGI+M E ++ + W+L + + D
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGER-------------PYWELSNHEVMKAIND 228
Query: 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
+ + + + C Q A RP +D+VSI++
Sbjct: 229 GF--RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 9e-55
Identities = 70/285 (24%), Positives = 110/285 (38%), Gaps = 34/285 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAK 565
++ + KLG+G FG V +G VAVK L + +++F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
L HRNL++L G ++ E P SL L LLG +R + +A+G+
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG-NTKRIVGTYGYM 684
YL R IHRDL A N+LL KI DFGL R ++ + + +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744
+PE FS SD + FG+ + E + Y + W +++
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWE-----------------MFTYGQEPWIGLNGSQIL 224
Query: 745 DPVITQD---EISLPVLVRYINVALLCVQDNAADRPTMSDVVSII 786
+ + NV + C DRPT + +
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-54
Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG---QEVAVKRLS-SQSGQGLEEFKNEMMLIAKL-Q 567
+ Q +GEG FG V K R+ + A+KR+ S +F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLLGWQAR 614
H N++ LLG C +G L +EY P+ +L FL + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT 674
+ +A+G+ YL Q + IHRDL A N+L+ + KI+DFGL+R
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDL 734
+M+ E +++ SDV+S+G+L+ E +S
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----------------GTP 226
Query: 735 WKDDKFHELIDPVITQDEISLPVLV--RYINVALLCVQDNAADRPTMSDVVSIIN 787
+ EL + + + P+ ++ C ++ +RP+ + ++ +N
Sbjct: 227 YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-51
Identities = 64/300 (21%), Positives = 108/300 (36%), Gaps = 39/300 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQH 568
E+F LGEG F V R L +E A+K L + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
VKL + + L Y N L ++ R A+ + L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTR----FYTAEIVSAL 121
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
IIHRDLK N+LL+ DM+ +I+DFG A++ + Q VGT Y+SPE
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748
+ SD+++ G ++ + ++G ++ + + I
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLP------------------PFRAGNEYLIFQK-I 222
Query: 749 TQDEISLP--VLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELPSPKEPAFIKGIN 806
+ E P + ++ + +A R E K F + +
Sbjct: 223 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGC--------EEMEGYGPLKAHPFFESVT 274
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-51
Identities = 61/283 (21%), Positives = 116/283 (40%), Gaps = 31/283 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQ 567
E + +GEG FG V++G ++ VA+K + + + E+F E + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
H ++VKL+G E +I+E L FL L + + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
L R +HRD+ A NVL+ + K+ DFGL+R + +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747
F+ SDV+ FG+ M E L ++ K +++I +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV-----------------KPFQGVKNNDVIGRI 222
Query: 748 ITQDEISLP--VLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
+ + +P ++ C + + RP +++ + +++
Sbjct: 223 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 180 bits (457), Expect = 6e-51
Identities = 60/310 (19%), Positives = 115/310 (37%), Gaps = 33/310 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
+++ + +LG G FG V++ G A K + + E + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
V L + E ++I E+M L + D + + V + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 632 SRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+H DLK N++ + K+ DFGL + + K GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197
Query: 690 LDGLFSIKSDVFSFGILMLETLSGKK-NTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748
+D++S G+L LSG G + ++ + D + I
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-----KSCDWNMDDSAFSGI 252
Query: 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDV-----VSIIN--SERLELPSPKEPAF 801
++D + + R T+ ++ N ++PS +
Sbjct: 253 SEDGKDF---------IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 303
Query: 802 IKGINVKNSS 811
I K +
Sbjct: 304 RDSIKTKYDA 313
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 70/298 (23%), Positives = 111/298 (37%), Gaps = 39/298 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQG--LEEFKNEMMLIA 564
+ + LG G FG V + + VAVK L + +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 565 KLQHRNLVKLLGCCVEQGEKILIL-EYMPNKSLDVFLF-------------DPTKKRLLG 610
H N+V LLG C + G ++++ E+ +L +L + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 611 WQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670
+ + +A+G+ +L + IHRDL A N+LL KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGY 730
+M+PE D +++I+SDV+SFG+L+ E S +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA----SPYPGVKIDEE 245
Query: 731 AWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
K+ D + L C + RPT S++V + +
Sbjct: 246 FCRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-50
Identities = 73/300 (24%), Positives = 122/300 (40%), Gaps = 45/300 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLI 563
+ + LGEG FG V + +VAVK L S + + L + +EM ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLF-------------DPTKKRLL 609
+ +H+N++ LLG C + G +I+EY +L +L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
+ V+ +A+G+ YL + IHRDL A NVL+ D KI+DFGLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
T +M+PE D +++ +SDV+SFG+L+ E + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------- 236
Query: 730 YAWDLWKDDKFHELIDPVITQDEISLP--VLVRYINVALLCVQDNAADRPTMSDVVSIIN 787
+ EL + + P + C + RPT +V ++
Sbjct: 237 ----PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (440), Expect = 1e-48
Identities = 55/278 (19%), Positives = 103/278 (37%), Gaps = 34/278 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
+ + + +LG G FG V++ G+ K +++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
+ L ++ E +LILE++ L + + + + + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 632 SRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
I+H D+K N++ + KI DFGLA DE+ K T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 690 LDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749
+D+++ G+L LSG + + E + V
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS------------------PFAGEDDLETLQNVKR 242
Query: 750 QDEISLPVLVRYINVALL-----CVQDNAADRPTMSDV 782
D ++ +Q R T+ D
Sbjct: 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-45
Identities = 63/289 (21%), Positives = 115/289 (39%), Gaps = 21/289 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHR 569
++ +GEG +G V +N VA+K++S Q + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
N++ + + + Y+ + L+ K + L + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEY 688
++HRDLK SN+LL+ + KI DFGLAR+ D V T Y +PE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 689 ALDGLFSIKS-DVFSFGILMLETLSGK-----KNTGVYNADSFNLLG----YAWDLWKDD 738
L+ KS D++S G ++ E LS + K+ +LG + +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 739 KFHELIDPVITQDEISLPVLVRYINVALL-----CVQDNAADRPTMSDV 782
K + + ++++ L + L + N R +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 9e-45
Identities = 51/278 (18%), Positives = 106/278 (38%), Gaps = 35/278 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
E + + LG G FG V++ + + K + + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
+ L E ++I E++ + + T L + V+ + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 632 SRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
I H D++ N++ + KI +FG AR + N + + Y +PE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 690 LDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749
+ S +D++S G L+ LSG + + ++I+ ++
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGIN------------------PFLAETNQQIIENIMN 217
Query: 750 QDEISLPVLVRYINVALL-----CVQDNAADRPTMSDV 782
+ + I++ + + R T S+
Sbjct: 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 159 bits (403), Expect = 2e-44
Identities = 62/286 (21%), Positives = 113/286 (39%), Gaps = 39/286 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQ 567
++ + + LG GG V+ R L ++VAVK L ++ F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 568 HRNLVKLLGCCVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
H +V + + +++EY+ +L + + + + +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGNTKRIVGTYG 682
L + H + IIHRD+K +N+++ K+ DFG+AR T ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742
Y+SPE A +SDV+S G ++ E L+G+ + D
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP------------------PFTGDSPVS 221
Query: 743 LIDPVITQDEISLPVLVRYI-----NVALLCVQDNAADRP-TMSDV 782
+ + +D I + V L + N +R T +++
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 4e-44
Identities = 54/273 (19%), Positives = 100/273 (36%), Gaps = 21/273 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
+ + + LG G F V + VA+K ++ ++ +G E +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
N+V L G LI++ + L + +K + +I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+ LD D ISDFGL++M + GT GY++PE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181
Query: 690 LDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749
+S D +S G++ L G + ++ L + L + +F I+
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKL-FEQILKAEYEFDSPYWDDIS 237
Query: 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDV 782
++ + R T
Sbjct: 238 DSAKDF---------IRHLMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 158 bits (400), Expect = 6e-44
Identities = 61/292 (20%), Positives = 112/292 (38%), Gaps = 49/292 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGL---------EEFKNEMML 562
EN+ + LG G V + +E AVK + G E E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 563 IAKLQ-HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
+ K+ H N+++L L+ + M L +L T+K L + I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
+ + LH + I+HRDLK N+LLD DMN K++DFG + E + + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 682 GYMSPEYALDGL------FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW 735
Y++PE + + + D++S G++M L+G +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP------------------PF 215
Query: 736 KDDKFHELIDPVITQD-EISLPVLVRY----INVALLCVQDNAADRPTMSDV 782
K ++ +++ + + P Y ++ + R T +
Sbjct: 216 WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (404), Expect = 1e-43
Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNE---MMLIAK 565
+FS+ +G GGFG VY R G+ A+K L + QG NE + L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
+V + + IL+ M L L + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
++H +++RDLK +N+LLD + +ISD GLA F + VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 686 PEYALDGL-FSIKSDVFSFGILMLETLSGK 714
PE G+ + +D FS G ++ + L G
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (398), Expect = 3e-43
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQH 568
++F + LG G FG V+ R NG+ A+K L + +E +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
++++ G + + +I++Y+ L F +R A+ A+ L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYA----AEVCLAL 117
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
II+RDLK N+LLD + + KI+DFG A+ + T + GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKK 715
++ D +SFGIL+ E L+G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 1e-42
Identities = 52/278 (18%), Positives = 97/278 (34%), Gaps = 25/278 (8%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
K+G G FG +Y G + G+EVA+K ++ + E + +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
+G+ +++ + SL+ R + + + + + + Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIH 126
Query: 639 RDLKASNVL---LDMDMNPKISDFGLARMFGGDELQGN-----TKRIVGTYGYMSPEYAL 690
RD+K N L I DFGLA+ + + K + GT Y S L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 691 DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750
S + D+ S G +++ G A + K E++
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPS 246
Query: 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
+ + C D+P S + + +
Sbjct: 247 E---------FATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-42
Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 13/207 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS---SQSGQGLEEFKNE-MMLIAKLQ 567
E+F + LG+G FG V+ Q A+K L +E E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
H L + + ++EY+ L + I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
LH I++RDLK N+LLD D + KI+DFG+ + + + NT GT Y++PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
L ++ D +SFG+L+ E L G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (383), Expect = 1e-41
Identities = 62/285 (21%), Positives = 115/285 (40%), Gaps = 23/285 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRN 570
E + K+GEG +G VYK + G+ A+K RL + E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
+VKL + +L+ E++ + + L + + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
R++HRDLK N+L++ + KI+DFGLAR FG + + T Y +P+ +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
Query: 691 -DGLFSIKSDVFSFGILMLETLSGK------KNTGVYNADSFNLLGYAWDLWKDDKFHEL 743
+S D++S G + E ++G L W +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 744 IDPVITQDE-ISLPVLVRYINVALL-----CVQDNAADRPTMSDV 782
DP T E + ++ ++ + + ++ + R T
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 70/300 (23%), Positives = 112/300 (37%), Gaps = 28/300 (9%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEE-----FKNEMMLIAKLQHRNLVK 573
LGEG F VYK R N Q VA+K++ ++ E+ L+ +L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
LL + L+ ++M +L + QGL YLHQ+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-G 692
I+HRDLK +N+LLD + K++DFGLA+ FG V T Y +PE
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGAR 176
Query: 693 LFSIKSDVFSFGILMLETLSGK------KNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746
++ + D+++ G ++ E L + L + W D
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 747 VITQDEISLPVLVRYINVALL-----CVQDNAADRPTMSDVVS--IINSERLELPSPKEP 799
+ I L + LL N R T + + ++ P + P
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 150 bits (380), Expect = 4e-41
Identities = 47/287 (16%), Positives = 103/287 (35%), Gaps = 27/287 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
++ + ++GEG FG +++G LLN Q+VA+K +S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
+ + ++G +++ + SL+ L R + + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFGGDELQGN-----TKRIVGTY 681
+++RD+K N L+ + + DFG+ + + + + K + GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH 741
YMS L S + D+ + G + + L G A + + K ++
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT--------NKQKYERIG 229
Query: 742 ELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788
E E+ + P + + +
Sbjct: 230 EKKQS-TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 5e-41
Identities = 72/289 (24%), Positives = 123/289 (42%), Gaps = 29/289 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
ENF K+GEG +G VYK R L G+ VA+K RL +++ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
N+VKLL + + L+ E++ D + + + + + QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE-Y 688
+ R++HRDLK N+L++ + K++DFGLAR FG V T Y +PE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS--------FNLLG----YAWDLWK 736
+S D++S G + E ++ + ++ DS F LG W
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA---LFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 737 DDKFHELIDPVITQDEISL---PVLVRYINVALLCVQDNAADRPTMSDV 782
++ P + + S P+ ++ + + R +
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 9e-41
Identities = 61/292 (20%), Positives = 114/292 (39%), Gaps = 26/292 (8%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSGQGLEEFK-----NEMMLI 563
A + + ++GEG +G V+K R L G+ VA+KR+ Q+G+ + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLD---VFLFDPTKKRLLGWQARVTIIEG 620
+H N+V+L C + + +D D + + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ +GL +LH R++HRDLK N+L+ K++DFGLAR++ Q +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK-----KNTGVYNADSFNLLGYAWDLW 735
Y +PE L ++ D++S G + E K + +++G +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 736 KDDKFHELIDPVITQDEISLPVLVRYINVALL-----CVQDNAADRPTMSDV 782
++ + V I+ C+ N A R +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 64/310 (20%), Positives = 114/310 (36%), Gaps = 48/310 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL------SSQSGQGLEEFKNEMMLIAK 565
+ + +LG G F V K R G + A K + SS+ G E+ + E+ ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
+QH N++ L + + ILILE + L +K L + ++ I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNG- 125
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNP----KISDFGLARMFGGDELQGNTKRIVGTY 681
++ +I H DLK N++L P KI DFGLA K I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH 741
+++PE +++D++S G++ LSG + D
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------------------SPFLGDTKQ 222
Query: 742 ELIDPVITQDEISLPVLVRYINVALL-----CVQDNAADRPTMSDV-----VSIINSERL 791
E + V + + + + R T+ D + ++++
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282
Query: 792 ELPSPKEPAF 801
+ P F
Sbjct: 283 LSSAWSHPQF 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 6e-40
Identities = 66/290 (22%), Positives = 115/290 (39%), Gaps = 31/290 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
+++ +G G FG VY+ +L +G+ VA+K++ E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 573 KLLGCCVEQGEK------ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
+L GEK L+L+Y+P V K+ L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
Y+H + I HRD+K N+LLD D K+ DFG A+ E + + + Y +
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 686 PEYALDGL-FSIKSDVFSFGILMLETLSGK-----KNTGVYNADSFNLLG---YAWDLWK 736
PE ++ DV+S G ++ E L G+ + + +LG
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 737 DDKFHELIDPVITQDEISLPVLVRYINVAL----LCVQDNAADRPTMSDV 782
+ + E P I + R A+ ++ R T +
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-38
Identities = 55/279 (19%), Positives = 104/279 (37%), Gaps = 43/279 (15%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEE------FKNEMMLIAKLQ 567
+ + LG GGFG VY G + + VA+K + E E++L+ K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 568 --HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
+++LL +LILE T++ L + + + + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAV 123
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
+ H ++HRD+K N+L+D++ K+ DFG + GT Y
Sbjct: 124 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYS 176
Query: 685 SPEYAL-DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743
PE+ + V+S GIL+ + + G ++ D+ +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDE-EII 217
Query: 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDV 782
V + +S ++ C+ +DRPT ++
Sbjct: 218 RGQVFFRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 3e-38
Identities = 66/299 (22%), Positives = 117/299 (39%), Gaps = 35/299 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHR 569
+ K+G+G FG V+K R GQ+VA+K++ ++ E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 570 NLVKLLGCCVEQGEKI--------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
N+V L+ C + L+ ++ + + K +++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR--IVG 679
GL Y+H+ +I+HRD+KA+NVL+ D K++DFGLAR F + + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 680 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK-----KNTGVYNADSFNLLG---- 729
T Y PE L + + D++ G +M E + A L G
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 730 YAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALL------CVQDNAADRPTMSDV 782
W + + +E ++ V Q L Y+ + + A R D
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 57/286 (19%), Positives = 109/286 (38%), Gaps = 23/286 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
+ + K+GEG +G V+K + + VA+K RL E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
N+V+L + L+ E+ F G + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
++HRDLK N+L++ + K+++FGLAR F G ++ + +V +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 690 LDGLFSIKSDVFSFGILMLETLSGKK--NTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747
L+S D++S G + E + + G D + ++++ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 748 ITQDEISLPVLVRYINVA---------LL--CVQDNAADRPTMSDV 782
+ P +NV LL ++ N R + +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-37
Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 12/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
+F LG+G FG V R G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
L L ++EY L L + + + R A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFY--GAEIVSAL 118
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
+++RD+K N++LD D + KI+DFGL + D K GT Y++PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
D + D + G++M E + G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-36
Identities = 47/271 (17%), Positives = 98/271 (36%), Gaps = 30/271 (11%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCC 578
LG G G V + ++ A+K L + + E+ L + Q ++V+++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 579 ----VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
+ ++++E + L + D + +A I++ I + + YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHSI--- 130
Query: 635 RIIHRDLKASNVLLDMDMNP---KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
I HRD+K N+L K++DFG A+ T Y++PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187
Query: 692 GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751
+ D++S G++M L G + + + +F ++++
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 752 EISLPVLVRYINVALLCVQDNAADRPTMSDV 782
L ++ R T+++
Sbjct: 248 VKML---------IRNLLKTEPTQRMTITEF 269
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 8e-36
Identities = 61/294 (20%), Positives = 114/294 (38%), Gaps = 37/294 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHR 569
+ +G G +G V G +VA+K+L QS + E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 570 NLVKLLGCCVEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
N++ LL + L++ +M + K LG ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
GL Y+H IIHRDLK N+ ++ D KI DFGLAR + V T Y
Sbjct: 133 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184
Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLETLSGK-----KNTGVYNADSFNLLG----YAWD 733
+PE L+ + ++ D++S G +M E ++GK + + + G
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALL-----CVQDNAADRPTMSDV 782
+ D+ + + ++ ++ + + + +A R T +
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 2e-35
Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 15/206 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
+ F LG G FG V + +G A+K L Q + +E NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
LVKL + +++EY+ + L + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H +I+RDLK N+L+D +++DFG A+ +G T + GT ++PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEI 209
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
L ++ D ++ G+L+ E +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-33
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 18/213 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLS----SQSGQGLEEFKNEMMLIA 564
ENF + LG G +G V+ R + G+ A+K L Q + E + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 565 KLQHR-NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
++ LV L + + LIL+Y+ L L + Q + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
+L L + II+RD+K N+LLD + + ++DFGL++ F DE + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 684 MSPEYALDGL--FSIKSDVFSFGILMLETLSGK 714
M+P+ G D +S G+LM E L+G
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (320), Expect = 8e-33
Identities = 54/297 (18%), Positives = 113/297 (38%), Gaps = 42/297 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRN 570
+++ + KLG G + V++ + N ++V VK L ++ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 571 LVKLLGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
++ L + + L+ E++ N + L + R + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIR-FYMYEILKALDYC 145
Query: 629 HQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
H I+HRD+K NV++D + ++ D+GLA + + V + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK------KNTGVYNADSFNLLGYAWDLWKDDKF 740
+D ++ D++S G ++ + K + +LG DK+
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 741 HELIDPVITQ--DEISLPVLVRYINVALL-------------CVQDNAADRPTMSDV 782
+ +DP S R+++ ++ + R T +
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-31
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS--SQSGQGLEEFKNEMMLIAKLQHR 569
+ + +G G G V + + VA+K+LS Q+ + E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 570 NLVKLLGCCVEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
N++ LL Q + L++E M V + + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
G+ +LH IIHRDLK SN+++ D KI DFGLAR G + V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
+PE L + D++S G +M E + K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-30
Identities = 66/294 (22%), Positives = 114/294 (38%), Gaps = 35/294 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS--SQSGQGLEEFKNEMMLIAKLQH 568
E + +G G +G V G VAVK+LS QS + E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 569 RNLVKLLGCCVEQ-----GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
N++ LL + ++ ++ L+ + K + L +I I +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILR 132
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
GL Y+H IIHRDLK SN+ ++ D KI DFGLAR V T Y
Sbjct: 133 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWY 184
Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLETLSGK-----KNTGVYNADSFNLLGY----AWD 733
+PE L+ + ++ D++S G +M E L+G+ + L+G
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALL-----CVQDNAADRPTMSDV 782
+ I + +++ + N + + ++ R T +
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (287), Expect = 3e-28
Identities = 45/210 (21%), Positives = 85/210 (40%), Gaps = 18/210 (8%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
KLG G F V+ + ++N VA+K + E ++E+ L+ ++ + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 579 VEQGEKIL-------------ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
K+L ++ + + L + R + I + + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
Y+H+ R IIH D+K NVL+++ D + +A + + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
SPE L + +D++S L+ E ++G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (252), Expect = 3e-25
Identities = 38/205 (18%), Positives = 71/205 (34%), Gaps = 35/205 (17%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVK--RLSSQSGQ--------GLEEFKNEMMLIAKLQHR 569
+GEG V+ E VK ++ S + G F + A+ + R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 570 NLVKLLGCCV----EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
L KL G V +++E + K + + + +++ I + +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEEV 116
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYM 684
+ I+H DL NVL+ + I DF + G + + +R + Y
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
S Y + D+ S +L+
Sbjct: 173 SRTY------RTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 90.0 bits (223), Expect = 4e-22
Identities = 23/118 (19%), Positives = 48/118 (40%), Gaps = 13/118 (11%)
Query: 34 IRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTIS 93
+ +GE L + Q ++ + + L ++ T VW +N +
Sbjct: 4 LTNGEGLYA-GQSLDVEPYHFIMQEDCNLVLYDH---STSVWASNTGILG-KKGCKAVLQ 58
Query: 94 NKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDY 151
+ GN V+ + ++W+++ N V L++DGN+VI + +W + Y
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------IWSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 70.3 bits (172), Expect = 4e-15
Identities = 17/97 (17%), Positives = 36/97 (37%), Gaps = 9/97 (9%)
Query: 64 IWFRQVP-DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVA 122
I + D + + + L++ NLVL ++ + +WSTN + A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA 70
Query: 123 QLRDDGNLVIRDNSSGNTTESYLWQSFD--YPTDTLL 157
L+ +G + + N + +W S + +
Sbjct: 71 VLQPNGRMDVLTNQN-----IAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 54.2 bits (130), Expect = 1e-09
Identities = 18/92 (19%), Positives = 30/92 (32%), Gaps = 5/92 (5%)
Query: 45 QRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQT 104
Q +L + L ++ R D VW N + G + +L
Sbjct: 30 QSLQLSPYRLSMETDCNLVLFDR---DDRVWSTNT--AGKGTGCRAVLQPNGRMDVLTNQ 84
Query: 105 NGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNS 136
N +W++ V L+ D NL I +
Sbjct: 85 NIAVWTSGNSRSAGRYVFVLQPDRNLAIYGGA 116
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 69.7 bits (170), Expect = 4e-15
Identities = 26/126 (20%), Positives = 44/126 (34%), Gaps = 20/126 (15%)
Query: 26 DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISD 85
+ + + GE L F L ++ D +W N
Sbjct: 2 NILYSGETLSTGEFLNY--GSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGLSR- 50
Query: 86 HNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYL 145
+ L++ GNLV+ N +N IW++N + N V L+ D N+VI
Sbjct: 51 -SCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------R 101
Query: 146 WQSFDY 151
W + +
Sbjct: 102 WATGTH 107
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 67.9 bits (165), Expect = 2e-14
Identities = 26/130 (20%), Positives = 48/130 (36%), Gaps = 18/130 (13%)
Query: 25 ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPIS 84
+D + + G L + + + VW + + S
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCNLVLYD--------NNRAVWASGTNGKAS 50
Query: 85 DHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESY 144
VL + N GNLV+ + + IW++N + N L+ D N+VI DNS+ +
Sbjct: 51 --GCVLKMQNDGNLVIYSGSR-AIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 145 LWQSFDYPTD 154
+W + +
Sbjct: 103 IWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 65.4 bits (159), Expect = 2e-13
Identities = 17/82 (20%), Positives = 32/82 (39%), Gaps = 10/82 (12%)
Query: 70 PDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGN 129
+ +W N + + G LV++ N T+W + V + + V L+ D N
Sbjct: 47 NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRN 104
Query: 130 LVIRDNSSGNTTESYLWQSFDY 151
+VI ++ LW +
Sbjct: 105 VVIYGDA--------LWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 55.3 bits (133), Expect = 6e-10
Identities = 17/113 (15%), Positives = 31/113 (27%), Gaps = 34/113 (30%)
Query: 64 IWF-RQVPDTVVWVANRDRPISDHNAVLTISNKGN------------------------- 97
I F + + + + + T+ + N
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62
Query: 98 -----LVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDN---SSGNTTE 142
LV+L N WS+ + N V L+ D + I SG + +
Sbjct: 63 QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNK 115
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 834 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.83 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.83 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.82 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.62 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.55 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.48 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.38 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.14 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.88 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.72 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.66 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.5 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.39 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.69 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.36 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.83 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.31 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.9 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 87.71 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 80.47 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=407.76 Aligned_cols=252 Identities=27% Similarity=0.339 Sum_probs=205.2
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.++||+|+||+||+|++. +|+.||||+++... ....+++.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 68999999999999999999985 58999999986543 33456789999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999984 4457999999999999999999999998 99999999999999999999999999998755443
Q ss_pred ccccceecccccccccccccCCcc-CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~-t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
........||+.|||||++.+..+ +.++|||||||++|||++|+.||............. .......
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-----~~~~~~~------- 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKTYL------- 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-----HTTCTTS-------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-----hcCCCCC-------
Confidence 334455789999999999988876 678999999999999999999997544332222111 1110000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
........++.+|+.+||+.||++|||++|+++
T Consensus 227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 --NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000112346778999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-49 Score=413.13 Aligned_cols=264 Identities=27% Similarity=0.433 Sum_probs=205.1
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.++||+|+||+||+|++. ..||||+++.. .....++|.+|+.+|++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 368999999999999999999863 46999998754 44567889999999999999999999998754 56899999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+++|+|.+++.. ....+++..+..++.||++||+|||+++ ||||||||+||||+.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999854 3346899999999999999999999998 9999999999999999999999999998875544
Q ss_pred cccccceecccccccccccccC---CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~---~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
.........||+.|||||++.+ ..|+.++|||||||+||||++|+.||....... .+......... .+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~~~~~--------~p 229 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGRGYL--------SP 229 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHHTSC--------CC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCC--------CC
Confidence 3344455789999999999864 358999999999999999999999986543221 11111111111 11
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccCC
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLELP 794 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 794 (834)
.+ .......+.++.+|+.+||+.||++|||++||++.|+.+...+|
T Consensus 230 ~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 230 DL--SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CG--GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred cc--hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11 01111223468899999999999999999999999998755443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=404.86 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=199.4
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|++.++||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578999999999999999999988899999999764 3445789999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 9999998854 3456889999999999999999999998 999999999999999999999999999877544322
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCC-CCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN-TGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p-~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
......||+.|+|||++.+..|+.++|||||||++|||+++..| +..... ..+.... .... ....+
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~~i---~~~~---~~~~p----- 224 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDI---STGF---RLYKP----- 224 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHHHH---HHTC---CCCCC-----
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHHHHH---HhcC---CCCCc-----
Confidence 22335789999999999999999999999999999999996544 432211 1111111 1110 01111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.....++.+++.+||+.||++||||+||++.|+++
T Consensus 225 ---~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 225 ---RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11234678999999999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=406.33 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=207.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|++.++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999874 58999999998766666788999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++|+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 9999998773 245899999999999999999999998 99999999999999999999999999998754332
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
......||+.|+|||++.+..|+.++|||||||++|||++|+.||...... ... ......... . +
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~---~~~~~~~~~-~-----~--- 236 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RAL---YLIATNGTP-E-----L--- 236 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH---HHHHHHCSC-C-----C---
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHH---HHHHhCCCC-C-----C---
Confidence 233468999999999999999999999999999999999999998643321 111 111111100 0 0
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+.....++.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011112346789999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=401.83 Aligned_cols=256 Identities=30% Similarity=0.443 Sum_probs=206.9
Q ss_pred hcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|++.++||+|+||.||+|.+++++.||||+++... ...++|.+|++++++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 36899999999999999999999888899999997543 445789999999999999999999998754 5679999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+......
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999887432 2335899999999999999999999998 999999999999999999999999999987654322
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
. .....||+.|||||++.++.++.++|||||||++|||+||..|+...... ..+.. ....+ ..+.. ..
T Consensus 166 ~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~----~i~~~-----~~~~~-p~ 233 (272)
T d1qpca_ 166 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQ----NLERG-----YRMVR-PD 233 (272)
T ss_dssp C-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHH----HHHTT-----CCCCC-CT
T ss_pred c-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHH----HHHhc-----CCCCC-cc
Confidence 2 23357899999999999999999999999999999999976654322211 11111 11111 11111 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
. .+.++.+|+.+||+.||++||||+||+++|++.
T Consensus 234 ~----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 234 N----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c----ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 1 234678999999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=399.95 Aligned_cols=245 Identities=27% Similarity=0.359 Sum_probs=205.5
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 67999999999999999999985 5889999998643 2344678999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|.+++. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999884 3456899999999999999999999998 999999999999999999999999999876443
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
. .....||+.|||||++.+..++.++|||||||+||||++|+.||...... .+. .. ..... ..+
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~---~~-i~~~~------~~~ 223 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETY---KR-ISRVE------FTF 223 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH---HH-HHTTC------CCC
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--HHH---HH-HHcCC------CCC
Confidence 2 33468999999999999999999999999999999999999998643211 111 11 11111 011
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+...+.++.+++.+||+.||++|||++|+++
T Consensus 224 -----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 -----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1112346789999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=396.13 Aligned_cols=253 Identities=28% Similarity=0.426 Sum_probs=211.2
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|++.++||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6899999999999999999999888899999997643 345789999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+|+|..++.. ....+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 9999988743 3456889999999999999999999998 999999999999999999999999999877554332
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ +. ....... ....+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~---~~i~~~~---~~~~p----- 223 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TA---EHIAQGL---RLYRP----- 223 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HH---HHHHTTC---CCCCC-----
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HH---HHHHhCC---CCCCc-----
Confidence 2333578999999999999999999999999999999998 888886543221 11 1111110 01111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINS 788 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 788 (834)
.....++.+++.+||+.||++|||++|+++.|.+
T Consensus 224 ---~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 ---HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1122467899999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-48 Score=409.93 Aligned_cols=258 Identities=28% Similarity=0.412 Sum_probs=211.1
Q ss_pred hcCccccceeeeecceeEEEEEECC-CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|++.++||+|+||+||+|++.. ++.||||+++... ...++|.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 4689999999999999999999864 8899999997543 4567899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+++|+|..++... ....+++..+..++.||++||+|||+++ |+||||||+||||++++.+||+|||+++.......
T Consensus 95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999988543 3456899999999999999999999998 99999999999999999999999999987654432
Q ss_pred ccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
. ......|++.|+|||++.+..|+.++|||||||++|||++|+.|+..... ...+. .....+. ..
T Consensus 171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~----~~i~~~~-----~~---- 235 (287)
T d1opja_ 171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVY----ELLEKDY-----RM---- 235 (287)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHH----HHHHTTC-----CC----
T ss_pred e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHH----HHHhcCC-----CC----
Confidence 2 22235688999999999999999999999999999999998776532221 11111 1111110 01
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
..+...+.++.+|+.+||+.||++|||++||++.|+...
T Consensus 236 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 236 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111122346889999999999999999999999998763
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-47 Score=407.17 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=198.3
Q ss_pred cCccccceeeeecceeEEEEEECC-C---cEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
++|++.++||+|+||+||+|++.. + ..||||++... .....++|.+|+++|++++|||||++++++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 568888999999999999998753 3 25899998664 444567899999999999999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++|+|.+++.. ..+.+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998753 3456899999999999999999999998 99999999999999999999999999998754
Q ss_pred Ccccc---ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 668 DELQG---NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 668 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
..... ......||+.|||||.+.++.++.++|||||||++|||+| |+.||...... ++... .....+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~---i~~~~~---- 251 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINA---IEQDYR---- 251 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH---HHTTCC----
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHH---HHcCCC----
Confidence 43221 1222467899999999999999999999999999999998 89998643321 12111 111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
...+...+..+.+|+.+||+.||++|||+.||++.|+++
T Consensus 252 -------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 252 -------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 011122345688999999999999999999999999876
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=404.14 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=206.4
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.|+++++||+|+||+||+|+.. +++.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999975 58899999998776667788999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++|+|..++.. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 99999998743 2346899999999999999999999998 9999999999999999999999999998653321
Q ss_pred cccceeccccccccccccc-----CCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~-----~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
.......||+.|+|||++. +..|+.++|||||||++|||++|+.||....... .. ....... ...+
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~---~~i~~~~-~~~~--- 235 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VL---LKIAKSE-PPTL--- 235 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HH---HHHHHSC-CCCC---
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HH---HHHHcCC-CCCC---
Confidence 1223468999999999984 4568999999999999999999999986543221 11 1111111 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 236 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 -----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011122346789999999999999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=408.19 Aligned_cols=258 Identities=29% Similarity=0.426 Sum_probs=207.0
Q ss_pred hcCccccceeeeecceeEEEEEECC-C-----cEEEEEEccCc-ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN-G-----QEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~-g-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 583 (834)
.++|++.++||+|+||+||+|++.. + ..||||++... .......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3789999999999999999998643 2 36999998654 333456789999999998 89999999999999999
Q ss_pred EEEEEeecCCCCccccccCCCC--------------------CCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCC
Q 003280 584 KILILEYMPNKSLDVFLFDPTK--------------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKA 643 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp 643 (834)
.++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999865321 245889999999999999999999998 99999999
Q ss_pred CcEEEcCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCC
Q 003280 644 SNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNA 722 (834)
Q Consensus 644 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~ 722 (834)
+|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||++ |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987655443333345678999999999999999999999999999999998 8999875443
Q ss_pred CcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003280 723 DSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIIN 787 (834)
Q Consensus 723 ~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 787 (834)
... +. .....+. .. ..+...+.++.+|+.+||+.||++|||++||++.|.
T Consensus 273 ~~~-~~----~~~~~~~-----~~-----~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DAN-FY----KLIQNGF-----KM-----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHH-HH----HHHHTTC-----CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH-HH----HHHhcCC-----CC-----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 221 11 1111110 00 111122346889999999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=399.06 Aligned_cols=254 Identities=25% Similarity=0.393 Sum_probs=194.8
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEe--cCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--QGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV 587 (834)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. .+...+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 78999999999999999999875 5889999998764 33445779999999999999999999999865 4568999
Q ss_pred EeecCCCCccccccCC-CCCCcCCHHHHHHHHHHHHHHHHHhhhcCC--CceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 588 LEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSR--FRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~--~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
|||+++|+|.+++... .....+++..++.++.||+.||+|||+++. .+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999988543 234578999999999999999999998752 3599999999999999999999999999998
Q ss_pred cCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
+..... ......||+.|||||++.+..|+.++|||||||++|||++|+.||...... ++.. . ........
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~---~-i~~~~~~~-- 233 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAG---K-IREGKFRR-- 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH---H-HHHTCCCC--
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHHH---H-HHcCCCCC--
Confidence 754322 233468999999999999999999999999999999999999998643221 1111 1 11111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.+...+.++.+|+.+||+.||++|||++|+++
T Consensus 234 --------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 --------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11122346889999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=402.02 Aligned_cols=249 Identities=25% Similarity=0.335 Sum_probs=203.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||+||+|+.. +++.||||++++. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999985 5899999998653 2345678999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|.+++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999998874 3456899999999999999999999998 999999999999999999999999999987654
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
..........||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.. .+. ..... ... .+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~---~~i~~-~~~------~~ 229 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--LIF---QKIIK-LEY------DF 229 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HHHHT-TCC------CC
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH--HHH---HHHHc-CCC------CC
Confidence 4444444568999999999999999999999999999999999999998643221 111 11111 110 11
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+.....++.+|+.+||+.||++|||++|+++
T Consensus 230 -----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 -----PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -----CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1112346789999999999999999999754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=397.65 Aligned_cols=259 Identities=28% Similarity=0.417 Sum_probs=204.0
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecC
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|++.+.||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 689999999999999999999988889999999654 3456789999999999999999999999854 56899999999
Q ss_pred CCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcccc
Q 003280 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 672 (834)
+|+|..++... ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 99999888543 2345899999999999999999999998 999999999999999999999999999876543322
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccCC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQDE 752 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~ 752 (834)
......||+.|+|||++.++.++.++|||||||++|||++|+.|+...... ..+.... ..+. .. .
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i----~~~~-----~~-----~ 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQV----ERGY-----RM-----P 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHH----HTTC-----CC-----C
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHH----HhcC-----CC-----C
Confidence 223357899999999999999999999999999999999977665432221 1111111 1110 01 1
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccccC
Q 003280 753 ISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERLEL 793 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 793 (834)
.+.....++.+++.+||+.||++||||++|+++|++.....
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 11122346889999999999999999999999999864433
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=396.92 Aligned_cols=256 Identities=27% Similarity=0.386 Sum_probs=207.3
Q ss_pred hcCccccce-eeeecceeEEEEEEC---CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 512 TENFSMQCK-LGEGGFGPVYKGRLL---NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~-LG~G~~G~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
.++|.+.+. ||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|++++|||||++++++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 356777774 999999999999764 34579999997653 4456789999999999999999999999865 56899
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998743 3456899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 667 GDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 667 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
..... .......||+.|+|||++.++.++.++|||||||++|||++ |+.||...... ++.. ....+...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~----~i~~~~~~--- 231 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMA----FIEQGKRM--- 231 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHH----HHHTTCCC---
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcCCCC---
Confidence 54322 22334578999999999999999999999999999999998 89998754322 1211 11111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
. .+...+.++.+|+.+||+.||++|||+.+|++.|+..
T Consensus 232 --~-----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 232 --E-----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp --C-----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --C-----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 1112235678999999999999999999999999865
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-47 Score=407.96 Aligned_cols=267 Identities=24% Similarity=0.337 Sum_probs=207.2
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|+++++||+|+||+||+|+.. +|+.||||+++.. .....+++.+|+.+|++++|||||+++++|.+.++.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 478999999999999999999975 5889999999764 33445789999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
|+++|+|.+++. +.+.+++..+..++.||+.||.|||++ + |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999984 334689999999999999999999974 6 999999999999999999999999999876332
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh-------------
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW------------- 735 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~------------- 735 (834)
......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..............
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 223468999999999999999999999999999999999999999765433221110000000
Q ss_pred -----------cCCcccccccccccc---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 736 -----------KDDKFHELIDPVITQ---DEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 736 -----------~~~~~~~lid~~l~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
......+..+..... .........++.+++.+||+.||++|||++|+++ .|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000000000000000 0000012346789999999999999999999987 4543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=396.14 Aligned_cols=248 Identities=27% Similarity=0.386 Sum_probs=198.0
Q ss_pred ceeeeecceeEEEEEECC---CcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeecCC
Q 003280 519 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~---g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||+||+|.+.. ++.||||+++.. .....++|.+|+++|++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998643 468999999754 23345789999999999999999999999864 567899999999
Q ss_pred CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc-c
Q 003280 594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ-G 672 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 672 (834)
|+|.+++. ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999884 3456899999999999999999999998 999999999999999999999999999987544322 2
Q ss_pred ccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccccccccC
Q 003280 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~ 751 (834)
......||+.|||||++.+..++.++|||||||++|||++ |+.||...... ++.. ....+.. +
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~----~i~~~~~-----~----- 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTA----MLEKGER-----M----- 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH----HHHTTCC-----C-----
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHH----HHHcCCC-----C-----
Confidence 2334578999999999999999999999999999999998 89998654321 1111 1111110 0
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 752 EISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..+...+.++.+|+.+||+.||++|||++||+++|+..
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 11112234678999999999999999999999988764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=397.06 Aligned_cols=258 Identities=29% Similarity=0.432 Sum_probs=200.0
Q ss_pred cCccccceeeeecceeEEEEEECCC-----cEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
+.|++.++||+|+||+||+|.+... ..||||+++.. .....++|.+|+.++++++|||||++++++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5688899999999999999987542 36999999754 33345679999999999999999999999999999999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+.++++..++.. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999887743 3356899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
..... .......||+.|||||++.++.++.++|||||||++|||++|..|+...... ..+.. ....+. .
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~----~i~~~~-----~ 231 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMK----AINDGF-----R 231 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHH----HHHTTC-----C
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHH----HHhccC-----C
Confidence 43221 2223356899999999999999999999999999999999976664332211 11111 111110 1
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
+ ..+...+.++.+|+.+||+.||++||||.||+++|+.+.
T Consensus 232 ~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 232 L-----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp C-----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred C-----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 1 111123356889999999999999999999999998863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=387.17 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=196.5
Q ss_pred ccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEe----cCeEEEE
Q 003280 515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE----QGEKILI 587 (834)
Q Consensus 515 f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV 587 (834)
|++.++||+|+||+||+|.+. +++.||+|++... .....+.|.+|+++|++++|||||++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 466778999999999999976 4889999998654 34446789999999999999999999999876 3467999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc-CCCCceeeeecceeecC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD-MDMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~ 666 (834)
|||+++|+|.+++. +...+++..+..++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999984 3456899999999999999999999875 3599999999999996 57899999999998643
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
.. ......||+.|||||++.+ .++.++|||||||++|||++|+.||....... .+ ......+.....++
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~----~~~i~~~~~~~~~~- 235 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QI----YRRVTSGVKPASFD- 235 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HH----HHHHTTTCCCGGGG-
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HH----HHHHHcCCCCcccC-
Confidence 32 2335689999999998875 59999999999999999999999986432211 11 11111111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
.. ...++.+|+.+||+.||++|||++|+++
T Consensus 236 ----~~----~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 ----KV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----cc----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11 1235789999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.2e-45 Score=397.64 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=208.1
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 68999999999999999999875 58999999998776666788999999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC--CCCceeeeecceeecCCCc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM--DMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~ 669 (834)
++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999998843 3446899999999999999999999998 999999999999954 6889999999999875433
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
......||+.|||||++.+..++.++|||||||++|||++|+.||...+.. .+.. ........ .....
T Consensus 181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~---~i~~~~~~---~~~~~- 248 (350)
T d1koaa2 181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLR---NVKSCDWN---MDDSA- 248 (350)
T ss_dssp ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---HHHHTCCC---SCCGG-
T ss_pred ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--HHHH---HHHhCCCC---CCccc-
Confidence 234468999999999999999999999999999999999999998643221 1111 11111000 00000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
......++.+|+.+||+.||++|||++|+++
T Consensus 249 ----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 249 ----FSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp ----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112346789999999999999999999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-45 Score=393.94 Aligned_cols=255 Identities=23% Similarity=0.307 Sum_probs=191.4
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
.+.|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 367999999999999999999985 48899999987543 2334678899999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc---CCCCceeeeecceeecC
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD---MDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~ 666 (834)
|+++|+|.+++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999984 3456999999999999999999999998 99999999999994 57899999999998764
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~ 746 (834)
... ......||+.|||||++.+..|+.++|||||||++|||++|+.||...... .+. ....... .. ..
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~---~~i~~~~-~~--~~- 229 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLF---EQILKAE-YE--FD- 229 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH---HHHHTTC-CC--CC-
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHH---HHHhccC-CC--CC-
Confidence 432 223467999999999999999999999999999999999999998643221 111 1111111 00 00
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 747 VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 747 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
.......+.++.+++.+||+.||++|||++|+++ .|.+
T Consensus 230 ----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 230 ----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp ----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 0111122346789999999999999999999988 4543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.4e-45 Score=395.19 Aligned_cols=256 Identities=22% Similarity=0.297 Sum_probs=210.3
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|+++++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 67999999999999999999875 58999999998766566678899999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc--CCCCceeeeecceeecCCCc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD--MDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~~~ 669 (834)
++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999887632 3446899999999999999999999998 99999999999997 57899999999999876543
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ....... . ..
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~---~~i~~~~-~------~~- 247 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETL---QNVKRCD-W------EF- 247 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHH---HHHHHCC-C------CC-
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHH---HHHHhCC-C------CC-
Confidence 234468999999999999999999999999999999999999998643321 111 1111110 0 00
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
..........++.+|+.+||+.||++|||++|+++ .|++.
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 00111122346789999999999999999999987 46544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-46 Score=398.33 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=211.2
Q ss_pred HHHhcCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEec
Q 003280 509 AAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ 581 (834)
Q Consensus 509 ~~~~~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 581 (834)
+...++|++.+.||+|+||+||+|+.. +++.||||+++... ....++|.+|++++++++||||+++++++.+.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 334578999999999999999999864 35689999997653 33457899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCccccccCCC---------------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEecc
Q 003280 582 GEKILILEYMPNKSLDVFLFDPT---------------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRD 640 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 640 (834)
...++||||+++|+|.++++... ....+++..++.++.||+.||+|||+++ |||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrD 165 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 165 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeE
Confidence 99999999999999999885321 1234889999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCC-CCCCC
Q 003280 641 LKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK-KNTGV 719 (834)
Q Consensus 641 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~-~p~~~ 719 (834)
|||+||||+.++.+||+|||+++...............||+.|+|||.+.+..|+.++|||||||++|||++|. +|+..
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999999999999999999998775544444444567899999999999999999999999999999999986 45544
Q ss_pred CCCCcccHhHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 720 YNADSFNLLGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 720 ~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.... .+.. . ...+...+ + +...+.++.+|+.+||+.+|++||||.||+++|+++
T Consensus 246 ~~~~--e~~~---~-v~~~~~~~-----~-----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 246 MAHE--EVIY---Y-VRDGNILA-----C-----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp SCHH--HHHH---H-HHTTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCHH--HHHH---H-HHcCCCCC-----C-----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 3221 1111 1 11221111 1 111234688999999999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-46 Score=396.95 Aligned_cols=245 Identities=30% Similarity=0.464 Sum_probs=200.9
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
+.|+++++||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999875 58899999987543 334567999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999976653 3456899999999999999999999998 99999999999999999999999999986543
Q ss_pred ccccccceecccccccccccccC---CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~---~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
.....||+.|||||++.+ +.|+.++|||||||++|||++|+.||...... .. ........ .
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--~~---~~~i~~~~-~----- 231 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SA---LYHIAQNE-S----- 231 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HH---HHHHHHSC-C-----
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--HH---HHHHHhCC-C-----
Confidence 234579999999999864 46899999999999999999999998643211 11 11111111 1
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+.+.... .+..+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~----~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 PALQSGH----WSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCSCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCC----CCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111111 2346889999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=393.81 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=202.3
Q ss_pred cCccccceeeeecceeEEEEEECC-Cc----EEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
.+|+++++||+|+||+||+|.+.. |+ .||||+++.. .....++|.+|++++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 569999999999999999998753 43 5899998654 445678899999999999999999999999865 5678
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
++||+.+|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999887743 3456899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
............||+.|+|||++.++.++.++|||||||++|||+| |+.||....... +...... ..+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~---~~~------ 231 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEK---GER------ 231 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHH---TCC------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHc---CCC------
Confidence 5544444445678999999999999999999999999999999998 788876543222 2111111 100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
...+...+.++.+|+.+||+.||++|||+.|+++.|+..
T Consensus 232 -----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 011112234678999999999999999999999988765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=383.15 Aligned_cols=250 Identities=25% Similarity=0.333 Sum_probs=204.1
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc------cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS------GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|+.+|++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 67999999999999999999985 58999999986431 234678999999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC----Cceeeeecc
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM----NPKISDFGL 661 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgl 661 (834)
+||||+++|+|.+++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999984 3356899999999999999999999998 99999999999998776 499999999
Q ss_pred eeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccc
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH 741 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (834)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..... ....
T Consensus 164 a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~---~~i~~-~~~~ 234 (293)
T d1jksa_ 164 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETL---ANVSA-VNYE 234 (293)
T ss_dssp CEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HHHHT-TCCC
T ss_pred hhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--HHH---HHHHh-cCCC
Confidence 98875432 223457899999999999999999999999999999999999998643221 111 11111 0000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 742 ELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 742 ~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..... ... .+.++.+|+.+||+.||++|||++|+++
T Consensus 235 --~~~~~-~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 --FEDEY-FSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --CCHHH-HTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCchh-cCC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 011 1346789999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=390.66 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=206.1
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|++++.||+|+||.||+|+.. +|+.||||++++. .....+.+.+|+.+|++++||||+++++++.+....++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 68999999999999999999975 5899999999754 2345678999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|..++. +.+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999884 4456889999999999999999999998 999999999999999999999999999876443
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
. ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+... +.. .... .. .
T Consensus 159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~---~i~~-~~------~-- 222 (337)
T d1o6la_ 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFE---LILM-EE------I-- 222 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---HHHH-CC------C--
T ss_pred C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--HHH---HHhc-CC------C--
Confidence 2 22344689999999999999999999999999999999999999986543211 111 1111 10 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRPT-----MSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 784 (834)
..+.....++.+|+.+||+.||++||+ ++|+++
T Consensus 223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 011112346789999999999999995 888876
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=383.51 Aligned_cols=249 Identities=29% Similarity=0.413 Sum_probs=197.5
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEec-CeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-GEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~Ey~ 591 (834)
++|++.+.||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++||||+++++++.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 6789999999999999999998 5789999999754 3457899999999999999999999998654 5689999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++|+|.+++... ....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 999999998542 2235899999999999999999999988 999999999999999999999999999865432
Q ss_pred cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCcccccccccccc
Q 003280 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVITQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~~ 750 (834)
.....+|..|+|||++.++.++.++|||||||++|||++ |+.|+...... ++.... ..+. .+
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i----~~~~-----~~---- 219 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRV----EKGY-----KM---- 219 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHH----TTTC-----CC----
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HcCC-----CC----
Confidence 223467899999999999999999999999999999998 67776543222 222111 1111 11
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 751 DEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..+.....++.+|+.+||+.||++|||+.|++++|+.+
T Consensus 220 -~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 220 -DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11122234678999999999999999999999999876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=386.88 Aligned_cols=261 Identities=27% Similarity=0.387 Sum_probs=199.4
Q ss_pred HhcCccccceeeeecceeEEEEEECC------CcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecC
Q 003280 511 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG 582 (834)
Q Consensus 511 ~~~~f~~~~~LG~G~~G~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 582 (834)
..++|++.++||+|+||.||+|+... ++.||||+++... ....+++.+|...+.++ +|+||+.+++++.+.+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 34789999999999999999998632 4689999997543 34456788888888887 6899999999987654
Q ss_pred -eEEEEEeecCCCCccccccCCC-------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE
Q 003280 583 -EKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648 (834)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 648 (834)
..++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+||||
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 6899999999999999985432 1345889999999999999999999998 9999999999999
Q ss_pred cCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCC-CCCCCCCCCcccH
Q 003280 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK-KNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~-~p~~~~~~~~~~l 727 (834)
++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. .||....... .+
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~~ 246 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF 246 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 999999999999999876554444445578999999999999999999999999999999999975 4665433221 11
Q ss_pred hHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 728 LGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
.. ....+.. +.+ +...+.++.+++.+||+.||++|||++|+++.|+.+
T Consensus 247 ~~----~~~~~~~-----~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 247 CR----RLKEGTR-----MRA-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HH----HHHHTCC-----CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----HHhcCCC-----CCC-----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 1111111 111 111234678999999999999999999999999876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-44 Score=386.69 Aligned_cols=244 Identities=25% Similarity=0.336 Sum_probs=204.1
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|+++++||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 67999999999999999999975 5899999998653 2345678999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999988874 4455788889999999999999999998 999999999999999999999999999986543
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.....||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. .+ ........
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~---~~~i~~~~---------- 217 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KT---YEKILNAE---------- 217 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HH---HHHHHHCC----------
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--HH---HHHHHcCC----------
Confidence 23468999999999999999999999999999999999999998643221 11 11111110
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
...+.....++.+++.+||+.||.+|| |++|+++
T Consensus 218 --~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 011111234678999999999999996 8999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=383.37 Aligned_cols=256 Identities=26% Similarity=0.360 Sum_probs=197.0
Q ss_pred cCccccceeeeecceeEEEEEECC--C--cEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN--G--QEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~--g--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
++|++.+.||+|+||.||+|++.. + ..||||++.+. ..+..++|.+|+.+|++++|||||++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 679999999999999999998642 3 36899998754 33446789999999999999999999999976 4678
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+||||+++|++.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999887743 3456899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccc-cccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccc
Q 003280 666 GGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHEL 743 (834)
Q Consensus 666 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 743 (834)
...... .......|+..|+|||++.+..++.++|||||||++|||++ |+.||...+... . .......+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~---~~~i~~~~~~~-- 234 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--I---LHKIDKEGERL-- 234 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H---HHHHHTSCCCC--
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--H---HHHHHhCCCCC--
Confidence 554322 22334567889999999999999999999999999999998 899986433221 1 11122221110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 744 IDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 744 id~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..+...+..+.+|+.+||+.||++|||++||+++|++.
T Consensus 235 --------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 01111234678999999999999999999999999874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=382.46 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=196.0
Q ss_pred hcCccccceeeeecceeEEEEEECC----CcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 586 (834)
.++|++.+.||+|+||.||+|++.. +..||||+++... ....+.|.+|+.++++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4689999999999999999998743 3468999987543 344578999999999999999999999986 467899
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecC
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 666 (834)
||||+++|+|..++.. ....+++..++.++.||++||.|||+++ |+||||||+||++++++.+||+|||+++.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999988743 3456899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccHhHHHHhHhcCCccccccc
Q 003280 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYAWDLWKDDKFHELID 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid 745 (834)
..... ......||+.|+|||++.+..++.++|||||||++|||++ |++|+...... .+... ...+...
T Consensus 160 ~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~----i~~~~~~---- 228 (273)
T d1mp8a_ 160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR----IENGERL---- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH----HHTTCCC----
T ss_pred CCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHH----HHcCCCC----
Confidence 43322 2334578999999999999999999999999999999998 88888654332 12111 1111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 746 PVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 746 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
..+...+..+.+|+.+||+.||++|||++||++.|+.+
T Consensus 229 ------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11112234688999999999999999999999998765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=385.17 Aligned_cols=268 Identities=24% Similarity=0.297 Sum_probs=202.7
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC----eEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG----EKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lV~ 588 (834)
++|.+.++||+|+||.||+|++ +|+.||||+++..... ...++.|+..+.+++|||||++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5788899999999999999997 6899999999654321 122334555556789999999999998764 679999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-----CCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-----SRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
||+++|+|..++.. ..+++..++.++.|++.||+|||+. ...+|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999953 3589999999999999999999974 12359999999999999999999999999999
Q ss_pred ecCCCcc--ccccceecccccccccccccCC------ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccH--------
Q 003280 664 MFGGDEL--QGNTKRIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNL-------- 727 (834)
Q Consensus 664 ~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~------~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l-------- 727 (834)
....... ........||+.|+|||++.+. .++.++|||||||+||||++|..|+..........
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 8754322 2233456899999999998764 36789999999999999999998875433221110
Q ss_pred -hHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 728 -LGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 728 -~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.......... ...++.+.......+....+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 237 ~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 237 SVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111111111 1122222222223345567889999999999999999999999998763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=386.36 Aligned_cols=261 Identities=27% Similarity=0.388 Sum_probs=211.0
Q ss_pred hcCccccceeeeecceeEEEEEEC------CCcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 583 (834)
.++|++.++||+|+||.||+|++. .++.||||+++... .....+|.+|+.+++++ +|||||++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 478999999999999999999862 35689999997643 33456799999999999 69999999999999999
Q ss_pred EEEEEeecCCCCccccccCCC---------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE
Q 003280 584 KILILEYMPNKSLDVFLFDPT---------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 648 (834)
.++||||+++|+|..+++... ....+++..+..++.||++||+|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999986432 2335889999999999999999999998 9999999999999
Q ss_pred cCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCC-CCCCCCCCCcccH
Q 003280 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK-KNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~-~p~~~~~~~~~~l 727 (834)
+.++.+|++|||+++...............||+.|+|||++.++.++.++|||||||++|||++++ +|+....... .+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~-~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-KF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-HH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 999999999999999876544434444568999999999999999999999999999999999954 4444333221 11
Q ss_pred hHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003280 728 LGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSER 790 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 790 (834)
.... ..+ ..+ ..+...+.++.+|+.+||+.||++||||+||+++|++..
T Consensus 258 ~~~i----~~~-----~~~-----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 258 YKMI----KEG-----FRM-----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHH----HHT-----CCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH----hcC-----CCC-----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 1111 111 001 111122356889999999999999999999999998763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5e-44 Score=378.01 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=201.4
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHHHHHHHhhcCCCcceEEeEEEecC----e
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG----E 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~ 583 (834)
.++|++.+.||+|+||+||+|++. +|+.||||+++... ....+.|.+|++++++++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 378999999999999999999874 58999999997643 334567999999999999999999999998754 3
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.++||||+++++|..++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999998873 3456899999999999999999999998 9999999999999999999999999988
Q ss_pred ecCCCc-cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 664 MFGGDE-LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 664 ~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~~~~~~~~~- 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQHVREDPIP- 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHCCCCC-
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----HHHHHHHhcCCCC-
Confidence 764332 222334468999999999999999999999999999999999999998643221 1111222221111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcc
Q 003280 743 LIDPVITQDEISLPVLVRYINVALLCVQDNAADRP-TMSDVVSIINSE 789 (834)
Q Consensus 743 lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~ 789 (834)
+...... .+.++.+++.+||+.||++|| |++++++.|..+
T Consensus 234 ---~~~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 234 ---PSARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp ---GGGTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---CchhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 0000111 234678999999999999999 899999888764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=385.56 Aligned_cols=257 Identities=28% Similarity=0.411 Sum_probs=204.2
Q ss_pred cCccccceeeeecceeEEEEEECC-Cc--EEEEEEccCc-ccccHHHHHHHHHHHHhh-cCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 587 (834)
++|++.++||+|+||.||+|++.+ +. .||||+++.. .....++|.+|+++|.++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 689999999999999999998754 33 5788888644 344567899999999998 799999999999999999999
Q ss_pred EeecCCCCccccccCC-------------CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCc
Q 003280 588 LEYMPNKSLDVFLFDP-------------TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP 654 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 654 (834)
|||+++|+|.++++.. .....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998653 23467899999999999999999999998 9999999999999999999
Q ss_pred eeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCC-CCCCCCCCcccHhHHHHh
Q 003280 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK-NTGVYNADSFNLLGYAWD 733 (834)
Q Consensus 655 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~-p~~~~~~~~~~l~~~~~~ 733 (834)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. |+...+. ..+.. .
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--~~~~~---~ 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYE---K 238 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHH---H
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--HHHHH---H
Confidence 999999998653322 2223578999999999999999999999999999999999765 5543221 11111 1
Q ss_pred HhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 003280 734 LWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERL 791 (834)
Q Consensus 734 ~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 791 (834)
..... .+ ..+...+.++.+|+.+||+.||++||||+||++.|+.+..
T Consensus 239 i~~~~------~~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 239 LPQGY------RL-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp GGGTC------CC-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcC------CC-----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111 01 1111223578899999999999999999999999988743
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-43 Score=386.00 Aligned_cols=244 Identities=22% Similarity=0.281 Sum_probs=204.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 588 (834)
++|+++++||+|+||.||+|++. +|+.||||++++. .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 68999999999999999999875 5899999998643 2344678999999999999999999999999999999999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 668 (834)
||+.+|+|..++. +.+.+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999998884 3346899999999999999999999998 999999999999999999999999999987543
Q ss_pred ccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccccccc
Q 003280 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l 748 (834)
.....||+.|||||++.+..++.++|||||||++|||++|+.||..... ..+.. ...... .
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~---~i~~~~-~-------- 255 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYE---KIVSGK-V-------- 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH---HHHHCC-C--------
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--HHHHH---HHhcCC-C--------
Confidence 2346899999999999999999999999999999999999999864321 11111 111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 749 TQDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
..+.....++.+++.+||+.||.+|+ |++|+++
T Consensus 256 ---~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 01111234678999999999999994 8999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=384.00 Aligned_cols=259 Identities=29% Similarity=0.430 Sum_probs=207.8
Q ss_pred hcCccccceeeeecceeEEEEEECC--------CcEEEEEEccCcc-cccHHHHHHHHHHHHhh-cCCCcceEEeEEEec
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ 581 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~~--------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 581 (834)
.++|++.+.||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3789999999999999999998632 2479999997654 34457889999999888 899999999999999
Q ss_pred CeEEEEEeecCCCCccccccCCC-------------CCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEE
Q 003280 582 GEKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 648 (834)
...++||||+++|+|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999995432 2345899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhc-CCCCCCCCCCCcccH
Q 003280 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~l 727 (834)
+.++.+||+|||+++...............+|+.|+|||.+.++.|+.++|||||||++|||++ |+.||...... .+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~~ 246 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL 246 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--HH
Confidence 9999999999999998766554444555789999999999999999999999999999999998 67777543321 11
Q ss_pred hHHHHhHhcCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 728 LGYAWDLWKDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
......+... .. +...+.++.+|+.+||+.||++|||+.||++.|+.+
T Consensus 247 ----~~~i~~~~~~-----~~-----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 247 ----FKLLKEGHRM-----DK-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ----HHHHHTTCCC-----CC-----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHcCCCC-----CC-----CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1122221111 11 111234688999999999999999999999999886
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=379.22 Aligned_cols=254 Identities=19% Similarity=0.290 Sum_probs=205.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEeec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|++.+.||+|+||+||+|... +++.||||+++.... ....+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 78999999999999999999886 588999999976533 3456889999999999999999999999999999999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC--CCceeeeecceeecCCCc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD--MNPKISDFGLARMFGGDE 669 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~~~~~~~ 669 (834)
++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++......
T Consensus 84 ~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999998843 3346899999999999999999999998 9999999999999754 579999999998864432
Q ss_pred cccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+. ....... . .++...
T Consensus 159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~---~~i~~~~-~--~~~~~~- 226 (321)
T d1tkia_ 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QII---ENIMNAE-Y--TFDEEA- 226 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH---HHHHHTC-C--CCCHHH-
T ss_pred ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHH---HHHHhCC-C--CCChhh-
Confidence 233467899999999999999999999999999999999999998653321 111 1111110 0 000000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
... ...++.+|+.+||+.||++|||++|+++ .+.+
T Consensus 227 ~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 227 FKE----ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ccC----CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 001 1346789999999999999999999988 4543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=376.91 Aligned_cols=263 Identities=25% Similarity=0.303 Sum_probs=198.2
Q ss_pred ccceeeeecceeEEEEEEC-CCcEEEEEEccCcccc-----cHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 517 MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ-----GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 517 ~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
.+++||+|+||+||+|++. +|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999975 4899999998654221 134688999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+.++++..+. .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998877665 34556889999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC---Ccc---ccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD---DKF---HEL 743 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~---~~~---~~l 743 (834)
......||+.|+|||++... .|+.++|||||||++|||++|+.||....+. +......+.... ... ...
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--HHHHHHHHhcCCCChhhccchhcc
Confidence 22335799999999998754 6899999999999999999999998643321 111111111100 000 000
Q ss_pred cccc-c-ccCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 744 IDPV-I-TQDEISL-----PVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 744 id~~-l-~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
.... . .....+. ....++.+|+.+||+.||++|||++|+++ .|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0000 0 0001111 12346889999999999999999999987 56554
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=378.85 Aligned_cols=254 Identities=28% Similarity=0.445 Sum_probs=202.1
Q ss_pred cceeeeecceeEEEEEECCC----cEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEec-CeEEEEEeec
Q 003280 518 QCKLGEGGFGPVYKGRLLNG----QEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-GEKILILEYM 591 (834)
Q Consensus 518 ~~~LG~G~~G~Vy~~~~~~g----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~Ey~ 591 (834)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++||||+++++++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999987542 25899999753 445568899999999999999999999998764 5889999999
Q ss_pred CCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCccc
Q 003280 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 671 (834)
++|+|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998854 3445678889999999999999999998 999999999999999999999999999987544322
Q ss_pred c--ccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccccc
Q 003280 672 G--NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPVIT 749 (834)
Q Consensus 672 ~--~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~l~ 749 (834)
. ......||+.|+|||.+....++.++||||||+++|||++|+.|+...... .++... .....+. ..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~---i~~g~~~---~~---- 255 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVY---LLQGRRL---LQ---- 255 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH---HHTTCCC---CC----
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHH---HHcCCCC---CC----
Confidence 1 223357899999999999999999999999999999999988876542211 111111 1111110 11
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccc
Q 003280 750 QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSERL 791 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 791 (834)
... ...++.+|+.+||+.||++||+|.||++.|+.+..
T Consensus 256 p~~----~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 256 PEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccc----CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111 22467899999999999999999999999998843
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.3e-43 Score=370.37 Aligned_cols=250 Identities=23% Similarity=0.284 Sum_probs=202.9
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc---------ccHHHHHHHHHHHHhhc-CCCcceEEeEEEec
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---------QGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQ 581 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~ 581 (834)
++|++.+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999874 588999999865421 12346889999999997 99999999999999
Q ss_pred CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecc
Q 003280 582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 661 (834)
+..++||||+++|+|.+++. ..+.+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999994 3456899999999999999999999998 99999999999999999999999999
Q ss_pred eeecCCCccccccceecccccccccccccC------CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHh
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLW 735 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 735 (834)
++.+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ... ....
T Consensus 157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~--~~~---~~i~ 228 (277)
T d1phka_ 157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LML---RMIM 228 (277)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HHHH
T ss_pred eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH--HHH---HHHH
Confidence 998755332 234679999999999863 34788999999999999999999998754321 111 1111
Q ss_pred cCCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 736 KDDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 736 ~~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
... .. .. .......+.++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~-~~-~~------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGN-YQ-FG------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTC-CC-CC------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hCC-CC-CC------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 10 00 0011122346889999999999999999999865
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-44 Score=383.15 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=209.9
Q ss_pred cCccccceeeeecceeEEEEEEC------CCcEEEEEEccCc-ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
++|++.++||+|+||+||+|.+. .++.||||+++.. .......|.+|+.++++++||||+++++++......+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 78999999999999999999863 2578999999754 3344567999999999999999999999999999999
Q ss_pred EEEeecCCCCccccccCC-------CCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeee
Q 003280 586 LILEYMPNKSLDVFLFDP-------TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISD 658 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 658 (834)
+||||+++|+|..++... .....+++..+.+++.|+++||+|||+++ |+||||||+|||+++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 999999999999988532 12234688999999999999999999997 99999999999999999999999
Q ss_pred ecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCC-CCCCCCCCCcccHhHHHHhHhcC
Q 003280 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK-KNTGVYNADSFNLLGYAWDLWKD 737 (834)
Q Consensus 659 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~-~p~~~~~~~~~~l~~~~~~~~~~ 737 (834)
||+++.+.............||+.|+|||.+.+..++.++||||||+++|||++|+ .|+...... .... ... .
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~--~~~~---~i~-~ 250 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLR---FVM-E 250 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHHH---HHH-T
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH--HHHH---HHH-h
Confidence 99998775544444444567899999999999999999999999999999999985 555432211 1111 111 1
Q ss_pred CccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 738 DKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 738 ~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
+.... .+...+..+.+++.+||+.+|++||||+||+++|++.
T Consensus 251 ~~~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 251 GGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11111 1111234688999999999999999999999999886
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.6e-43 Score=385.85 Aligned_cols=248 Identities=25% Similarity=0.295 Sum_probs=198.3
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc---cccHHHHHHH---HHHHHhhcCCCcceEEeEEEecCeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNE---MMLIAKLQHRNLVKLLGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E---~~~l~~l~HpnIv~l~~~~~~~~~~~ 585 (834)
++|++.++||+|+||.||+|+.. +|+.||||++.+.. ......+.+| +.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999975 58999999986431 2223344444 56666778999999999999999999
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
+||||+++|+|..++. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999984 3456789999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccccc
Q 003280 666 GGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELI 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~li 744 (834)
.... .....||+.|+|||++.. ..|+.++|||||||+||||++|+.||.......... ...... ..
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~~~~~~-~~------ 224 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTL-TM------ 224 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH--HHHHSS-SC------
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhcc-cC------
Confidence 5432 334589999999999975 568999999999999999999999997644332111 010000 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003280 745 DPVITQDEISLPVLVRYINVALLCVQDNAADRPT-----MSDVVS 784 (834)
Q Consensus 745 d~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 784 (834)
.. ..+.....++.+|+.+||+.||++||| ++|+++
T Consensus 225 ~~-----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 AV-----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CC-----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CC-----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00 011112346789999999999999999 688875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-43 Score=377.64 Aligned_cols=250 Identities=18% Similarity=0.208 Sum_probs=197.8
Q ss_pred cCccccc-eeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhh-cCCCcceEEeEEEe----cCeEE
Q 003280 513 ENFSMQC-KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVE----QGEKI 585 (834)
Q Consensus 513 ~~f~~~~-~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~----~~~~~ 585 (834)
++|++.+ .||+|+||+||+|+.. +++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ ....+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 6898875 5999999999999874 5899999998643 5677899987655 89999999999976 45789
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC---CCCceeeeecce
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLA 662 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla 662 (834)
+||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||++
T Consensus 86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 999999999999998542 2346899999999999999999999998 999999999999975 567999999999
Q ss_pred eecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcccc
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHE 742 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (834)
+....... .....||+.|||||++.+..|+.++|||||||+||||++|+.||......... .... ..
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~--~~~~--------~~ 228 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMK--------TR 228 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------C
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH--HHHH--------HH
Confidence 98754432 33468999999999999999999999999999999999999998654322110 0000 00
Q ss_pred ccccccc-cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 743 LIDPVIT-QDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 743 lid~~l~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
+...... ........+.++.+|+.+||+.||++|||+.|+++
T Consensus 229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000000 00011123457889999999999999999999988
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=381.15 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=202.0
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc---ccccHHHHHHHHHHHH-hhcCCCcceEEeEEEecCeEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIA-KLQHRNLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~~~~~~lV 587 (834)
++|++.++||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999986 4889999999753 2344566777777765 68999999999999999999999
Q ss_pred EeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCC
Q 003280 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 667 (834)
|||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999984 3446889999999999999999999998 99999999999999999999999999987644
Q ss_pred CccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccccccccc
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFHELIDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~lid~~ 747 (834)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .... + .+.
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~---~i~~-~------~~~ 221 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFH---SIRM-D------NPF 221 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---HHHH-C------CCC
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHH---HHHc-C------CCC
Confidence 32 2233468999999999999999999999999999999999999999643321 1111 1111 1 011
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 003280 748 ITQDEISLPVLVRYINVALLCVQDNAADRPTMS-DVVS 784 (834)
Q Consensus 748 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 784 (834)
+ +.....++.+|+.+||+.||++||++. |+++
T Consensus 222 ~-----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 Y-----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C-----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C-----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1 111234678999999999999999996 7754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-43 Score=373.82 Aligned_cols=270 Identities=23% Similarity=0.305 Sum_probs=203.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|+++++||+|+||+||+|++. +|+.||||+++... ....+++.+|+++|++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999974 58999999996542 2345789999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
|+.++.+..... .....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 998765544332 23456899999999999999999999998 9999999999999999999999999998775433
Q ss_pred cccccceecccccccccccccCCc-cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC---Ccc---cc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD---DKF---HE 742 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~-~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~---~~~---~~ 742 (834)
. ......||+.|+|||++.... ++.++|||||||++|||++|+.||...+.. +........... ... ..
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHHHHHhcCCCchhhcccccc
Confidence 2 233458999999999887665 588999999999999999999998643321 111111110000 000 00
Q ss_pred ccc--ccc-ccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcccc
Q 003280 743 LID--PVI-TQDEIS-----LPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSERL 791 (834)
Q Consensus 743 lid--~~l-~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~ 791 (834)
..+ ... ...... .....++.+|+.+||+.||++|||++|+++ .|+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 000 000 000001 112346789999999999999999999998 4766533
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-42 Score=368.30 Aligned_cols=262 Identities=23% Similarity=0.319 Sum_probs=201.5
Q ss_pred cCccccceeeeecceeEEEEEECCCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 590 (834)
++|+++++||+|+||+||+|++++|+.||||+++.. .....+++.+|+.+|++++||||+++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999988999999999654 233467899999999999999999999999999999999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCcc
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 670 (834)
+.++.+..+. ...+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9988877776 34567999999999999999999999998 99999999999999999999999999988654322
Q ss_pred ccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc------cccc
Q 003280 671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK------FHEL 743 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~------~~~l 743 (834)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... +............. ....
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCChhhccchhhh
Confidence 22334689999999998764 5699999999999999999999998643321 11111111100000 0000
Q ss_pred c--cccc------ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 744 I--DPVI------TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 744 i--d~~l------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. +... ............+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000 000011112346789999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=364.92 Aligned_cols=239 Identities=22% Similarity=0.375 Sum_probs=194.3
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCccc------ccHHHHHHHHHHHHhhc--CCCcceEEeEEEecCe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG------QGLEEFKNEMMLIAKLQ--HRNLVKLLGCCVEQGE 583 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~ 583 (834)
++|++.++||+|+||+||+|+.. +|+.||||++++... ....++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 67999999999999999999875 589999999865321 11234678999999996 8999999999999999
Q ss_pred EEEEEeecCC-CCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCC-CCceeeeecc
Q 003280 584 KILILEYMPN-KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGL 661 (834)
Q Consensus 584 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgl 661 (834)
.++||||+.+ +++.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 56666663 3456899999999999999999999998 9999999999999854 7899999999
Q ss_pred eeecCCCccccccceecccccccccccccCCcc-CccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCcc
Q 003280 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKF 740 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 740 (834)
++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... . .....
T Consensus 158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~-------i~~~~-- 220 (273)
T d1xwsa_ 158 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----E-------IIRGQ-- 220 (273)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----H-------HHHCC--
T ss_pred ceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----H-------Hhhcc--
Confidence 98764332 234689999999999987765 677999999999999999999986321 0 01100
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
..+ .... +.++.+++.+||+.||++|||++|+++
T Consensus 221 -~~~-----~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 -VFF-----RQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -CCC-----SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cCC-----CCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 001 1122 246789999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=365.48 Aligned_cols=263 Identities=24% Similarity=0.339 Sum_probs=196.4
Q ss_pred hcCccccceeeeecceeEEEEEEC-C-CcEEEEEEccCcc--cccHHHHHHHHHHHHhh---cCCCcceEEeEEEe----
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-N-GQEVAVKRLSSQS--GQGLEEFKNEMMLIAKL---QHRNLVKLLGCCVE---- 580 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~---- 580 (834)
.++|+++++||+|+||+||+|++. + ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999874 3 5679999986532 22233566777777766 79999999999864
Q ss_pred -cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeee
Q 003280 581 -QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDF 659 (834)
Q Consensus 581 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 659 (834)
....+++|||++++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 246899999999987765442 34456889999999999999999999998 999999999999999999999999
Q ss_pred cceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCc
Q 003280 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDK 739 (834)
Q Consensus 660 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 739 (834)
|+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||...... +.............
T Consensus 161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPG 235 (305)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCc
Confidence 9998654322 334568999999999999999999999999999999999999999654321 11111111100000
Q ss_pred ---c---cccccccc------ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 740 ---F---HELIDPVI------TQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 740 ---~---~~lid~~l------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
. ........ ............+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 00000000 000011112346778999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=358.79 Aligned_cols=263 Identities=23% Similarity=0.326 Sum_probs=196.7
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEe--------c
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--------Q 581 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--------~ 581 (834)
++|+++++||+|+||+||+|+.. +|+.||||++... .....+++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 78999999999999999999975 6899999998654 33345778999999999999999999999865 3
Q ss_pred CeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecc
Q 003280 582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 661 (834)
...++||||+.++.+..+. .....++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 4689999999988776554 34456888999999999999999999998 99999999999999999999999999
Q ss_pred eeecCCCccc--cccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC-
Q 003280 662 ARMFGGDELQ--GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD- 737 (834)
Q Consensus 662 a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~- 737 (834)
++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....+.. ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~--~~~~i~~~~~~~ 241 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--QLALISQLCGSI 241 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH--HHHHHHHhcCCC
Confidence 9877543321 122335799999999998765 68999999999999999999999986433211 11111111100
Q ss_pred --Ccc--------ccccccccccCCCCHH-------HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 738 --DKF--------HELIDPVITQDEISLP-------VLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 738 --~~~--------~~lid~~l~~~~~~~~-------~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
... ...+.... ....... ....+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCS-SCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred Chhhccccchhhhhhhhcccc-cccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000 00000000 0011111 1235678999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=363.50 Aligned_cols=265 Identities=23% Similarity=0.286 Sum_probs=197.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcceEEeEEEec------CeEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------GEKI 585 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~ 585 (834)
-+|+.+++||+|+||+||+|++. +|+.||||+++..... +.+|+.+|++++||||+++++++... .+.+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 36888999999999999999985 5899999999754322 34799999999999999999998653 2578
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC-Cceeeeecceee
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARM 664 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~ 664 (834)
+||||++++.+..+.........+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999988765554433344567899999999999999999999998 99999999999999775 899999999988
Q ss_pred cCCCccccccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHH----------Hh
Q 003280 665 FGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYA----------WD 733 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~----------~~ 733 (834)
+..... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+.... +.
T Consensus 173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHH
T ss_pred ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHhhh
Confidence 754432 233579999999998875 568999999999999999999999986543211 111100 00
Q ss_pred Hhc----CCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 734 LWK----DDKFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 734 ~~~----~~~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
... ............ ..........++.+|+.+||+.||++|||++|+++ .|++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPW-TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHCC---CCCCCCCCCCCG-GGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhccchhhccccccccCch-hhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000 000111000000 00011122346789999999999999999999986 45554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-40 Score=353.22 Aligned_cols=258 Identities=20% Similarity=0.277 Sum_probs=195.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcce-EEeEEEecCeEEEEEee
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVK-LLGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~-l~~~~~~~~~~~lV~Ey 590 (834)
++|++.++||+|+||.||+|++. +++.||||++...... +++..|++++++++|+|++. +..+..+....++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999874 5889999988654332 45788999999998776555 45556777889999999
Q ss_pred cCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEc---CCCCceeeeecceeecCC
Q 003280 591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD---MDMNPKISDFGLARMFGG 667 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~ 667 (834)
++++ |...+. ...+.+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~~~-l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LGPS-LEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCCB-HHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cCCc-hhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9554 444432 23456899999999999999999999998 99999999999985 456799999999998754
Q ss_pred Cccc-----cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHh--HHHHhHhcCCcc
Q 003280 668 DELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLL--GYAWDLWKDDKF 740 (834)
Q Consensus 668 ~~~~-----~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~--~~~~~~~~~~~~ 740 (834)
.... .......||+.|||||++.+..++.++|||||||++|||++|+.||........... ......... ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~ 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-Ch
Confidence 3221 223346899999999999999999999999999999999999999876543322111 100000000 00
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 741 HELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 741 ~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
+.+ ... .+.++.+++..|++.+|++||+++++.+.|+..
T Consensus 238 -----~~~-~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 238 -----EVL-CKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -----HHH-TTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -----hHh-ccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 000 011 124678999999999999999999999988765
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=351.44 Aligned_cols=267 Identities=20% Similarity=0.275 Sum_probs=205.5
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecCeEEEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 589 (834)
++|+++++||+|+||+||+|++. +++.||||+++.. .....+++.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999975 5889999998654 33446789999999999999999999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeecCCCc
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 669 (834)
++.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999888773 4456889999999999999999999998 9999999999999999999999999999875433
Q ss_pred cccccceecccccccccccccCCc-cCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC---cc---cc
Q 003280 670 LQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD---KF---HE 742 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~l~~~~-~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---~~---~~ 742 (834)
. ......+++.|+|||.+.... ++.++|||||||++|||++|+.||....... +............ .. ..
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHCCCCTTTCTTGGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH-HHHHHHHhhcCCCChhhhhhhhh
Confidence 2 222346778899999987665 6999999999999999999999964332221 1111111111100 00 00
Q ss_pred --------ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003280 743 --------LIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINS 788 (834)
Q Consensus 743 --------lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 788 (834)
..................+.+|+.+||+.||++|||++|+++ .|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 000000011111222346788999999999999999999986 4543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=362.08 Aligned_cols=261 Identities=25% Similarity=0.311 Sum_probs=194.4
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEecC------
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------ 582 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 582 (834)
.++|+++++||+|+||+||+|... +|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 378999999999999999999975 5899999999754 3344578899999999999999999999998655
Q ss_pred eEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecce
Q 003280 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 662 (834)
+.++||||+ +.+|..+. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHH----HhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 579999999 45666655 3346899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcC----
Q 003280 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKD---- 737 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~---- 737 (834)
+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...+... ...........
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAE 241 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH--HHHHHHhccCCCcHH
Confidence 876433 2345789999999998764 57999999999999999999999986543211 11000000000
Q ss_pred ----C----------ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 738 ----D----------KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 738 ----~----------~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
. ...+.....+ ..........+.+|+.+||+.||++|||++|+++ .|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDF--ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCG--GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHhhhcchhhhhhhccCCcccccch--HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0 0000000000 0011112345778999999999999999999998 46654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-39 Score=347.08 Aligned_cols=260 Identities=18% Similarity=0.231 Sum_probs=204.3
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhcC-CCcceEEeEEEecCeEEEEEe
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH-RNLVKLLGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.++||+|+||+||+|++. +|+.||||+++.... .+.+.+|++.++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 368999999999999999999975 588999999865432 2457789999999975 899999999999999999999
Q ss_pred ecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcC-----CCCceeeeecceee
Q 003280 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-----DMNPKISDFGLARM 664 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~~ 664 (834)
|+ +++|..++.. ....++...+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6788887743 3446899999999999999999999998 999999999999964 57899999999998
Q ss_pred cCCCccc-----cccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccH-hHHHHhHhcCC
Q 003280 665 FGGDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNL-LGYAWDLWKDD 738 (834)
Q Consensus 665 ~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l-~~~~~~~~~~~ 738 (834)
+...... .......||+.|||||++.+..++.++|||||||++|||++|+.||.......... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 7543211 12334689999999999999999999999999999999999999997554332211 11111100000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003280 739 KFHELIDPVITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVSIINSE 789 (834)
Q Consensus 739 ~~~~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 789 (834)
...+ + .... +.++.+++..|++.+|++||+++.+.+.|++.
T Consensus 236 ~~~~-----l-~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 236 PLRE-----L-CAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp CHHH-----H-TTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ChHH-----h-cCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0011 1 0112 24678899999999999999999999988775
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-39 Score=351.84 Aligned_cols=257 Identities=20% Similarity=0.324 Sum_probs=197.4
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhc-CCCcceEEeEEEec--CeEEEEE
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQ--GEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~ 588 (834)
++|+++++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 68999999999999999999974 5899999999754 3467899999999995 99999999999854 4689999
Q ss_pred eecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCC-CceeeeecceeecCC
Q 003280 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~ 667 (834)
||+++++|..+. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987654 34889999999999999999999998 99999999999998765 589999999998754
Q ss_pred CccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHH--------HhH---h
Q 003280 668 DELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYA--------WDL---W 735 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~--------~~~---~ 735 (834)
... .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||.............. ... .
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 332 2345789999999998765 479999999999999999999999865443221111000 000 0
Q ss_pred cCC---cccccccc-------ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 736 KDD---KFHELIDP-------VITQDEISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 736 ~~~---~~~~lid~-------~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
... ........ .............++.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00000000 00001111112346789999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=361.33 Aligned_cols=264 Identities=21% Similarity=0.285 Sum_probs=197.0
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc-cccHHHHHHHHHHHHhhcCCCcceEEeEEEecC----eEE
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG----EKI 585 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~ 585 (834)
+++|+++++||+|+||+||+|+.. +|+.||||++++.. ....+++++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 367999999999999999999874 69999999997543 344578999999999999999999999997654 345
Q ss_pred EEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeecceeec
Q 003280 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 665 (834)
++++|+.+|+|.+++. .+.+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 6667788999999983 235899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cccceecccccccccccccC-CccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccc--
Q 003280 666 GGDELQ-GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH-- 741 (834)
Q Consensus 666 ~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~-- 741 (834)
...... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||....... ...............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQEDL 237 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH--HHHHHhhhccCCChhhh
Confidence 544322 22344679999999999854 567899999999999999999999986433211 111110000000000
Q ss_pred ---------cccccccccCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 742 ---------ELIDPVITQDEISL-----PVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 742 ---------~lid~~l~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
............+. ....++.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000011111 11236789999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-40 Score=353.06 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=200.9
Q ss_pred cCccccceeeeecceeEEEEEEC----CCcEEEEEEccCc----ccccHHHHHHHHHHHHhhcC-CCcceEEeEEEecCe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQ----SGQGLEEFKNEMMLIAKLQH-RNLVKLLGCCVEQGE 583 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~----~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~ 583 (834)
++|+++++||+|+||+||+|+.. .|+.||||++++. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999862 3789999998653 22345678899999999977 899999999999999
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.++||||+.+|+|..++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999884 3345678889999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceecccccccccccccCC--ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCCccc
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDDKFH 741 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (834)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||........... .........
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~-i~~~~~~~~--- 252 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE-ISRRILKSE--- 252 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH-HHHHHHHCC---
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcccCC---
Confidence 76543322 23346799999999999765 468899999999999999999999976543322111 111111100
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003280 742 ELIDPVITQDEISLPVLVRYINVALLCVQDNAADRP-----TMSDVVS 784 (834)
Q Consensus 742 ~lid~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 784 (834)
...+.....++.+++.+||+.||++|| |++|+++
T Consensus 253 ---------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011112345788999999999999999 4889886
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-39 Score=349.08 Aligned_cols=264 Identities=23% Similarity=0.291 Sum_probs=197.6
Q ss_pred hcCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcc--cccHHHHHHHHHHHHhhcCCCcceEEeEEEec-----Ce
Q 003280 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-----GE 583 (834)
Q Consensus 512 ~~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 583 (834)
.++|+++++||+|+||+||+|+.. +|+.||||++++.. ....+++.+|+++|++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 478999999999999999999874 58999999997643 33456789999999999999999999998643 34
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.+++++|+.+|+|.+++. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 577788899999999883 345899999999999999999999998 9999999999999999999999999997
Q ss_pred ecCCCccccccceecccccccccccccCC-ccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHHHHhHhcCC----
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYAWDLWKDD---- 738 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---- 738 (834)
.... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+... ............
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~--~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAEL 242 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCHHH
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCChHH
Confidence 6532 23345789999999987765 46899999999999999999999986543211 110000000000
Q ss_pred -------ccccccccccccCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003280 739 -------KFHELIDPVITQDEISL-----PVLVRYINVALLCVQDNAADRPTMSDVVS--IINSE 789 (834)
Q Consensus 739 -------~~~~lid~~l~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 789 (834)
................. ....++.+|+.+||+.||++|||++|+++ .|.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00000000000011111 11346789999999999999999999998 56554
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-39 Score=351.16 Aligned_cols=259 Identities=23% Similarity=0.251 Sum_probs=190.4
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCc--ccccHHHHHHHHHHHHhhcCCCcceEEeEEEe------cCe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE------QGE 583 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~ 583 (834)
++|+++++||+|+||+||+|++. +|+.||||+++.. .....+++.+|+.++++++||||+++++++.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999976 5899999999754 23445678999999999999999999999964 368
Q ss_pred EEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceeeeeccee
Q 003280 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 663 (834)
.++||||+.++.+.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999877665432 34789999999999999999999998 9999999999999999999999999988
Q ss_pred ecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCcccHhHH-------------
Q 003280 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGY------------- 730 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~~~l~~~------------- 730 (834)
...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||...+.... ....
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH-HHHHHHhccCCCHHHHH
Confidence 764432 23345789999999999999999999999999999999999999864432110 0000
Q ss_pred -----HHhHhcCC------ccccccccccccCC--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003280 731 -----AWDLWKDD------KFHELIDPVITQDE--ISLPVLVRYINVALLCVQDNAADRPTMSDVVS 784 (834)
Q Consensus 731 -----~~~~~~~~------~~~~lid~~l~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 784 (834)
........ .............. .......++.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 00011111110111 11224567899999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-34 Score=317.62 Aligned_cols=263 Identities=20% Similarity=0.249 Sum_probs=193.6
Q ss_pred cCccccceeeeecceeEEEEEEC-CCcEEEEEEccCcccccHHHHHHHHHHHHhhc-----------CCCcceEEeEEEe
Q 003280 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-----------HRNLVKLLGCCVE 580 (834)
Q Consensus 513 ~~f~~~~~LG~G~~G~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~~ 580 (834)
.+|+++++||+|+||+||+|+.. +|+.||||++++.. ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999975 58999999997543 23467888999988875 5789999988765
Q ss_pred --cCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCcEEEcCCCC----
Q 003280 581 --QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDMDMN---- 653 (834)
Q Consensus 581 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~---- 653 (834)
....+++|+++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 34677788877766554444334455678899999999999999999998 66 999999999999987654
Q ss_pred --ceeeeecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhHHHhhcCCCCCCCCCCCc-cc----
Q 003280 654 --PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS-FN---- 726 (834)
Q Consensus 654 --~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl~elltG~~p~~~~~~~~-~~---- 726 (834)
++++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||....... ..
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 899999999865332 234579999999999999999999999999999999999999986543211 00
Q ss_pred HhHHHHh-----------------HhcCCcccccccc---------ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 003280 727 LLGYAWD-----------------LWKDDKFHELIDP---------VITQDEISLPVLVRYINVALLCVQDNAADRPTMS 780 (834)
Q Consensus 727 l~~~~~~-----------------~~~~~~~~~lid~---------~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 780 (834)
+...... .+........+.. .............++.+|+.+||+.||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 0000000 0000000000000 0011233456677899999999999999999999
Q ss_pred HHHH
Q 003280 781 DVVS 784 (834)
Q Consensus 781 evl~ 784 (834)
|+++
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=1.1e-21 Score=193.61 Aligned_cols=169 Identities=18% Similarity=0.166 Sum_probs=121.3
Q ss_pred cccceeeeecceeEEEEEECCCcEEEEEEccCccc------------------ccHHHHHHHHHHHHhhcCCCcceEEeE
Q 003280 516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG------------------QGLEEFKNEMMLIAKLQHRNLVKLLGC 577 (834)
Q Consensus 516 ~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~HpnIv~l~~~ 577 (834)
.+.++||+|+||+||+|+..+|+.||||+++.... .....+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46789999999999999998899999998753210 012335568889999999999988765
Q ss_pred EEecCeEEEEEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcEEEcCCCCceee
Q 003280 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS 657 (834)
Q Consensus 578 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 657 (834)
. ..+++|||+++..+.. ++......++.|++++|+|||+++ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 2379999999876543 234445688999999999999998 99999999999998654 8999
Q ss_pred eecceeecCCCccccccceecccccccccccccCCccCccCceeehhhhH
Q 003280 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707 (834)
Q Consensus 658 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~t~~~DVwSlGvvl 707 (834)
|||+|............. ..... -.|. ....|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~~~l~---rd~~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWREILE---RDVRN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHHHHH---HHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHH---HHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 999998764322110000 00000 0111 235688999999975443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.83 E-value=1.4e-20 Score=167.57 Aligned_cols=112 Identities=24% Similarity=0.413 Sum_probs=95.8
Q ss_pred cccccCCcccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEecCC
Q 003280 25 ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQT 104 (834)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
+|+|.|||.|.+|++|+| |.|.|+|+.+|+ |.|+. ..++||.||++.|.. .+.|.|+.||+|+|++.
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc---CCcEEEEccCccCCC--CcEEEEeccccEEEEec-
Confidence 589999999999999985 999999999886 66654 468999999998854 57899999999999986
Q ss_pred CceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCch
Q 003280 105 NGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTD 154 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtD 154 (834)
+.++|++++.......+|+|+|+|||||++.+ +.++|||+.+|++
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~-----~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECCC-----CcEEecCCCccCC
Confidence 57788888765656678999999999999864 3689999999975
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.83 E-value=1.4e-20 Score=165.89 Aligned_cols=107 Identities=24% Similarity=0.355 Sum_probs=93.4
Q ss_pred cccccCCcccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEecCC
Q 003280 25 ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQT 104 (834)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
+|+|.+||.|.+|+.|. +|.|.|.|+.+|+ |.||. ..++||.||++.|. +.+.|.|+.||+|+|.+++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGLS--RSCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe---CCceeeEeCCCCCC--CccEEEEeccceEEEECCC
Confidence 47899999999999996 5999999999987 77764 45889999999884 4678999999999999999
Q ss_pred CceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccC
Q 003280 105 NGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDY 151 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~ 151 (834)
|.+||++++.......+|+|+|+|||||++. .+||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC--------CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC--------CcccCCCC
Confidence 9999999986565666899999999999964 38999988
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.82 E-value=3.2e-20 Score=163.55 Aligned_cols=108 Identities=20% Similarity=0.364 Sum_probs=93.3
Q ss_pred cccccCCcccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEecCC
Q 003280 25 ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQT 104 (834)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
.|+|.+||.|.+|++|.+ |.|.|+|...++ |.++. ..++||+||++.|... .+.|.|+.||+|+|.|.+
T Consensus 1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECSS
T ss_pred CCCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe---CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeCC
Confidence 478999999999999975 889999998876 55553 4588999999999865 788999999999999999
Q ss_pred CceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccC
Q 003280 105 NGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDY 151 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~ 151 (834)
|.+||+|+++......+|+|+|+|||||+++ .+|||+-|
T Consensus 70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~--------~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY 108 (109)
T ss_dssp SCEEEECCCCCCSSCCEEEECTTSCEEEECC--------EEEECCCC
T ss_pred CcEEEEEeeECCCCCEEEEEeCCCcEEEECC--------CEecCCCc
Confidence 9999999987556667899999999999964 39999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.62 E-value=2.3e-16 Score=140.85 Aligned_cols=101 Identities=20% Similarity=0.296 Sum_probs=85.2
Q ss_pred EEEEecC-CCceEEEecCCCCCCCCCceEEEeecCceEEecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCc
Q 003280 63 GIWFRQV-PDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTT 141 (834)
Q Consensus 63 ~iw~~~~-~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~ 141 (834)
.|||..+ .++.+|++|++.|+....-+|.|+.||||+|.++ +.++|++++.+.....+|+|+++|||||++.+
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~----- 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ----- 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETT-----
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCC-----
Confidence 5788877 6799999999999988778999999999999985 68899999876656678999999999999874
Q ss_pred cccccccccCCchhhccCCccccccccccceEEEEecCCCCCCCCceEEeeeecCCceE
Q 003280 142 ESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKM 200 (834)
Q Consensus 142 ~~~~WqSFd~PtDtlLpg~kl~~~~~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~ 200 (834)
++++||||. +.++|.|.+.|+++|...+
T Consensus 85 ~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvl 112 (120)
T d1dlpa2 85 NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAI 112 (120)
T ss_dssp TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEE
T ss_pred CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEE
Confidence 478999973 3467889999999998764
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.55 E-value=4.3e-15 Score=131.99 Aligned_cols=103 Identities=17% Similarity=0.329 Sum_probs=82.7
Q ss_pred ccccCCcccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEecCCC
Q 003280 26 DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTN 105 (834)
Q Consensus 26 ~~~~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~~ 105 (834)
++|.++|+| .+.+..|.|.|.|...|+ |.++ . ..++||.||+..+.. .+.|.|+.||+|+|.|++|
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVLy-~--~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~g 80 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVLY-D--NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITNEN 80 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEEE-E--TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTTC
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEEE-E--CCeEEEEecCCCCCc--ceEEEEEeCCCEEEECCCC
Confidence 455555554 236679999999999997 5553 2 468899999987743 5889999999999999999
Q ss_pred ceEEEeecccccCcceEEEccCCCeEEecCCCCCCcccccccccc
Q 003280 106 GTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFD 150 (834)
Q Consensus 106 ~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd 150 (834)
.+||++++.+.....+++|+|+|||||++. .+|||-.
T Consensus 81 ~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg~--------~~W~S~T 117 (119)
T d1b2pa_ 81 VTVWQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWATQT 117 (119)
T ss_dssp CEEEECSCCCCSSCEEEEECTTSCEEEEES--------EEEECCC
T ss_pred cEEEECCCcCCCCceEEEEcCCCCEEEECC--------CEeccCC
Confidence 999999986555667899999999999963 4999854
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.48 E-value=9.6e-15 Score=128.74 Aligned_cols=109 Identities=22% Similarity=0.283 Sum_probs=88.1
Q ss_pred EEEecC-CCceEEEecCCCCCCCCCceEEEeecCceEEecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCcc
Q 003280 64 IWFRQV-PDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTE 142 (834)
Q Consensus 64 iw~~~~-~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~ 142 (834)
|||.-. +.+..|+.+.+.++.....+|.|+.||||||++ ++.++|++++. +..+..+.|+++|||||++.+ +
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~-~~~~~~l~l~~dGNLvl~d~~-----~ 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTA-GATGCRAVLQSDGLLVILTAQ-----N 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCC-SCSCCBCCBCSSSCBCCBCTT-----T
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccC-CCCceEEEEeccCCEEEEccC-----C
Confidence 566543 557779999999998878899999999999988 57899999985 455788999999999999874 3
Q ss_pred ccccccccCCchhhccCCccccccccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEeeCC
Q 003280 143 SYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQ 214 (834)
Q Consensus 143 ~~~WqSFd~PtDtlLpg~kl~~~~~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~sg~ 214 (834)
.+||||+. +.++|.|.+.|+++|... ++ +.++|.+|.
T Consensus 76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlv--lY--~~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVT--IY--GPGLWDSGT 112 (115)
T ss_dssp CCSCCCCC-------------------------------CCCSSCCEEEECSSSCEE--EE--CSEEEECSC
T ss_pred CEEEEcCC-------------------------------CCCCCCEEEEECCCCcEE--Ee--CCCeecCCC
Confidence 78999852 346899999999999864 44 347898774
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.38 E-value=1.1e-13 Score=121.91 Aligned_cols=97 Identities=24% Similarity=0.342 Sum_probs=78.1
Q ss_pred cccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEecCCCceEEEe
Q 003280 32 SFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWST 111 (834)
Q Consensus 32 ~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~ 111 (834)
|.|.+|+.| .+|.|.|.|..+|+ |.|+. ..++||.+|...+ ..+.+.|+.||||||.|.++.+||++
T Consensus 15 ~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 15 QTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp SCCCTTCEE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred ceecCCCcE--EcCCEEEEECCCCe-----EEEEc---CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEEEEc
Confidence 555555566 35789999999887 66754 4578999997542 36789999999999999999999999
Q ss_pred ecccccCcceEEEccCCCeEEecCCCCCCccccccccc
Q 003280 112 NVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSF 149 (834)
Q Consensus 112 ~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSF 149 (834)
++....+..+++|+++|||||++. .+|+|-
T Consensus 82 ~t~~~~g~y~l~Lq~DGNlvlY~~--------~~Wssg 111 (115)
T d1dlpa1 82 GTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSG 111 (115)
T ss_dssp CCCCCSSCCEEEECSSSCEEEECS--------EEEECS
T ss_pred CCCCCCCCEEEEECCCCcEEEeCC--------CeecCC
Confidence 987666667899999999999963 489984
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.14 E-value=5.9e-11 Score=105.20 Aligned_cols=97 Identities=20% Similarity=0.316 Sum_probs=72.7
Q ss_pred cccCCCCeeeeCCCeeEEEEEcCCCCCceEEEEEEecCCCceEEEecCCCCCCCCCceEEEeecCceEEecCCCceEEEe
Q 003280 32 SFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWST 111 (834)
Q Consensus 32 ~~l~~~~~l~s~~~~f~~gf~~~~~~~~~yl~iw~~~~~~~~vw~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~ 111 (834)
+.|.+++.|. .|.|.|.|...|+ |.|+. ...+||.+|.. ..+..+.+.|+.+|||||.|.++.++|++
T Consensus 24 ~~l~~~q~l~--~g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~--~~~~~~~~~l~~~GnLvl~d~~~~~lW~S 91 (120)
T d1dlpa2 24 QTLHATQSLQ--LSPYRLSMETDCN-----LVLFD---RDDRVWSTNTA--GKGTGCRAVLQPNGRMDVLTNQNIAVWTS 91 (120)
T ss_dssp CEECSSCCCB--CSSCEEEEETTTE-----EEEEB---TTBCCSCCCCC--SSCSSCEEEEETTTEEEEEETTTEEEEEC
T ss_pred cEEcCCCeeE--cCCEEEEEcCCCc-----EEEec---CCcEEEEEccc--cCCCcEEEEEeCCeeEEEEcCCCCEEEEe
Confidence 4444444442 3667888877765 55542 34678998853 33456889999999999999999999999
Q ss_pred ecccccCcceEEEccCCCeEEecCCCCCCcccccccc
Q 003280 112 NVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQS 148 (834)
Q Consensus 112 ~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqS 148 (834)
++.......+++|+++|||||++. .+|.|
T Consensus 92 ~t~~~~~~~~l~Lq~DGnlvlY~~--------~~W~t 120 (120)
T d1dlpa2 92 GNSRSAGRYVFVLQPDRNLAIYGG--------ALWTT 120 (120)
T ss_dssp CCCCSSSCCEEEECSSSCEEEECC--------CCCBC
T ss_pred CCCCCCCcEEEEECCCCcEEEeCC--------CcccC
Confidence 986666667899999999999953 38976
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.88 E-value=2.8e-09 Score=93.88 Aligned_cols=85 Identities=25% Similarity=0.313 Sum_probs=65.8
Q ss_pred eEEEeecCceEEecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCCcccccccc
Q 003280 89 VLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKN 168 (834)
Q Consensus 89 ~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~~t 168 (834)
.|.|+.||||||.++ +.++|++++.+...+..+.|.++|||||++.+ +.++|+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~-----g~~vWsS~------------------- 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSP------------------- 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECS-------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCC-----CcEEEECC-------------------
Confidence 588999999999875 67899999876556688999999999999874 36789852
Q ss_pred ccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEeeCC
Q 003280 169 RLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQ 214 (834)
Q Consensus 169 ~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~sg~ 214 (834)
+.-+.|.|.+.|+.+|...+ + ..+.|.|+.
T Consensus 88 ------------t~~~~~~~~l~Lq~DGNlvl--Y--g~~~W~S~T 117 (119)
T d1b2pa_ 88 ------------VAGKAGHYVLVLQPDRNVVI--Y--GDALWATQT 117 (119)
T ss_dssp ------------CCCCSSCEEEEECTTSCEEE--E--ESEEEECCC
T ss_pred ------------CcCCCCceEEEEcCCCCEEE--E--CCCEeccCC
Confidence 11245778999999998664 3 246787764
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.72 E-value=1.5e-08 Score=87.76 Aligned_cols=86 Identities=23% Similarity=0.388 Sum_probs=64.8
Q ss_pred CceEEEeecCceEEecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCCcccccc
Q 003280 87 NAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDL 166 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~ 166 (834)
.-+|.|+.||||||++ .+.+||++++.+......++|.++|||||++.+ +.++|+|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~-----g~~vWsS------------------ 75 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS-----NKPIWAS------------------ 75 (108)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEEC------------------
T ss_pred CEEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCC-----ccceEEc------------------
Confidence 3468899999999987 468999999865555678999999999999874 3788986
Q ss_pred ccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEeeC
Q 003280 167 KNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSG 213 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~sg 213 (834)
.+..+.+.|.+.|+.+|...++ . .+.|.|+
T Consensus 76 -------------~t~~~~~~~~l~L~ddGNlVly--~--~~~W~S~ 105 (108)
T d1jpca_ 76 -------------NTGGQNGNYVCILQKDRNVVIY--G--TDRWATG 105 (108)
T ss_dssp -------------CCCCSCSCEEEEECTTSCEEEE--E--CCCCCCC
T ss_pred -------------cccCCCCcEEEEEcCCCCEEEe--C--CCcccCC
Confidence 1222456788899999886543 2 3466554
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.66 E-value=4.4e-08 Score=84.78 Aligned_cols=88 Identities=23% Similarity=0.367 Sum_probs=65.0
Q ss_pred CceEEEeecCceEEecCCCceEEEeeccc-ccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCCccccc
Q 003280 87 NAVLTISNKGNLVLLNQTNGTIWSTNVFS-EVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWD 165 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~-~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~ 165 (834)
.-.|.|+.||||||.+ .+.+||++++.. ...+..+.|.++|||||++.+ +.++|+|
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~s----------------- 76 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE-----GRSLWAS----------------- 76 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS-----SCEEEEC-----------------
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC-----CcEEEEE-----------------
Confidence 4568899999999986 568999999853 233567899999999999874 4788986
Q ss_pred cccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcCCeeeEeeCCC
Q 003280 166 LKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQW 215 (834)
Q Consensus 166 ~~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~~~~~~~sg~w 215 (834)
.+..+.|.|.+.|+.+|...+ ++ .+.|.|+.+
T Consensus 77 --------------~t~~~~~~~~l~L~ddGNlvl--y~--~~~W~S~t~ 108 (109)
T d1kj1a_ 77 --------------HSVRGNGNYVLVLQEDGNVVI--YG--SDIWSTGTY 108 (109)
T ss_dssp --------------CCCCCSSCCEEEECTTSCEEE--EC--CEEEECCCC
T ss_pred --------------eeECCCCCEEEEEeCCCcEEE--EC--CCEecCCCc
Confidence 112235678899999998654 43 357876643
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.50 E-value=2.5e-07 Score=80.58 Aligned_cols=88 Identities=23% Similarity=0.422 Sum_probs=65.3
Q ss_pred CceEEEeecCceEEecCCCceEEEeecccccCcceEEEccCCCeEEecCCCCCCccccccccccCCchhhccCCcccccc
Q 003280 87 NAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDL 166 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~ 166 (834)
.-.|.|+.||||||++ .+.+||++++.....+..++|..+|||||++.. +.+|.|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~------~~~w~s------------------ 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGS------RAIWAS------------------ 74 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEETT------EEEEEC------------------
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEecC------CeEEEE------------------
Confidence 4579999999999986 578999999865556678999999999999853 345543
Q ss_pred ccccceEEEEecCCCCCCCCceEEeeeecCCceEEEEcC-CeeeEeeCC
Q 003280 167 KNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNG-SVKFACSGQ 214 (834)
Q Consensus 167 ~t~~~~~l~Sw~s~~dps~G~f~~~l~~~~~~~~~~~~~-~~~~~~sg~ 214 (834)
.+.-..|.|.+.|+.+|...+ ++. ..+.|.|+.
T Consensus 75 -------------~t~~~~~~~~l~L~ddGNlvl--y~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -------------NTNRQNGNYYLILQRDRNVVI--YDNSNNAIWATHT 108 (112)
T ss_dssp -------------CCCCSCCCCEEEECTTSCEEE--ECTTSCEEEECCC
T ss_pred -------------eeccCCCceEEEEcCCCCEEE--ECCCCcEEecCCC
Confidence 222245678899999998653 443 356787764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.39 E-value=5.7e-07 Score=90.96 Aligned_cols=148 Identities=18% Similarity=0.112 Sum_probs=102.4
Q ss_pred HHHHhcCccccceeeeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhc-CCCcceEEeEEEecCeEEE
Q 003280 508 VAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKIL 586 (834)
Q Consensus 508 ~~~~~~~f~~~~~LG~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 586 (834)
+...-+.|++.+..+-++...||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+++..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 344446777766554455578998864 56778899887665555566788999888874 4446677888888889999
Q ss_pred EEeecCCCCccccccCCCCCCcCCHHHHHHHHHHHHHHHHHhhhc-----------------------------------
Q 003280 587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY----------------------------------- 631 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------- 631 (834)
||+++++.++....... .....++.++++.++.||+.
T Consensus 88 v~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999998875443211 11223444555555555531
Q ss_pred ---------------------CCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 632 ---------------------SRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 632 ---------------------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
....++|+|+.|.||++++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 112379999999999999876677999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.69 E-value=8.5e-05 Score=73.94 Aligned_cols=131 Identities=18% Similarity=0.163 Sum_probs=87.0
Q ss_pred eeeeecc-eeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcC--CCcceEEeEEEecCeEEEEEeecCCCCc
Q 003280 520 KLGEGGF-GPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH--RNLVKLLGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 520 ~LG~G~~-G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
.+..|.. +.||+.....+..+++|....... ..+..|...++.+.. -.+.+++.+..+.+..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4445543 678999887788899998765432 346778888887753 3356678888888889999999998776
Q ss_pred cccccCCCCCCcCCHHHHHHHHHHHHHHHHHhh-----------------------------------------------
Q 003280 597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH----------------------------------------------- 629 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH----------------------------------------------- 629 (834)
..... .. ...+.++.+.|+-||
T Consensus 94 ~~~~~--------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSHL--------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSCC--------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccccc--------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 44210 00 111122223333333
Q ss_pred ----hc----CCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 630 ----QY----SRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 630 ----~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
.. ....++|+|+.|.||+++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 11 122379999999999999876678999998854
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.36 E-value=0.00025 Score=75.57 Aligned_cols=75 Identities=9% Similarity=0.152 Sum_probs=49.1
Q ss_pred ceeeeecceeEEEEEECC-CcEEEEEEccCc-------ccccHHHHHHHHHHHHhhc-C-C-CcceEEeEEEecCeEEEE
Q 003280 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ-------SGQGLEEFKNEMMLIAKLQ-H-R-NLVKLLGCCVEQGEKILI 587 (834)
Q Consensus 519 ~~LG~G~~G~Vy~~~~~~-g~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~-H-p-nIv~l~~~~~~~~~~~lV 587 (834)
+.||.|....||+....+ ++.++||.-... .+...++...|.+.|..+. + | .+.+++. .+....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 578999999999998754 678999964321 1223455667888887763 3 2 3444544 355667899
Q ss_pred EeecCCCC
Q 003280 588 LEYMPNKS 595 (834)
Q Consensus 588 ~Ey~~~gs 595 (834)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.83 E-value=0.0019 Score=66.55 Aligned_cols=136 Identities=13% Similarity=0.108 Sum_probs=81.2
Q ss_pred ceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCc--ceEE-----eEEEecCeEEEEEeecCCCCccc
Q 003280 526 FGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL--VKLL-----GCCVEQGEKILILEYMPNKSLDV 598 (834)
Q Consensus 526 ~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI--v~l~-----~~~~~~~~~~lV~Ey~~~gsL~~ 598 (834)
--.||++..++|+.+++|+.+.. ....+++..|...+..|....+ +..+ ..+......+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35799999989999999998754 2345778889999888853322 1111 22345667889999998765432
Q ss_pred cc--------------c------CCCCCCcCCH-------------------HHHHHHHHHHHHHHHHhhh----cCCCc
Q 003280 599 FL--------------F------DPTKKRLLGW-------------------QARVTIIEGIAQGLLYLHQ----YSRFR 635 (834)
Q Consensus 599 ~l--------------~------~~~~~~~l~~-------------------~~~~~i~~~ia~~L~yLH~----~~~~~ 635 (834)
.- | ........+. .....+...+.+.++.+.. ..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 10 0 0001111111 1111222222333333332 22345
Q ss_pred eEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 636 IIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 636 ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.31 E-value=0.0085 Score=63.20 Aligned_cols=77 Identities=19% Similarity=0.302 Sum_probs=51.8
Q ss_pred CccccceeeeecceeEEEEEECC--------CcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCc-ceEEeEEEecCeE
Q 003280 514 NFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL-VKLLGCCVEQGEK 584 (834)
Q Consensus 514 ~f~~~~~LG~G~~G~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~ 584 (834)
.+++ +.|+.|---.+|+....+ .+.|++++... .. ......+|..+++.+.-.++ .++++++.+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 3444 578888889999998754 34577777653 22 23455689999998853344 466766642
Q ss_pred EEEEeecCCCCcc
Q 003280 585 ILILEYMPNKSLD 597 (834)
Q Consensus 585 ~lV~Ey~~~gsL~ 597 (834)
.+|+||+++..+.
T Consensus 117 g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 GRLEEYIPSRPLS 129 (395)
T ss_dssp EEEECCCCEEECC
T ss_pred ceEEEEeccccCC
Confidence 6899999886553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.90 E-value=0.029 Score=56.81 Aligned_cols=159 Identities=13% Similarity=0.015 Sum_probs=84.5
Q ss_pred ccHHHHHHHhcCcccccee-----eeecceeEEEEEECCCcEEEEEEccCcccccHHHHHHHHHHHHhhcCCCcc--eEE
Q 003280 503 FSLASVAAATENFSMQCKL-----GEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV--KLL 575 (834)
Q Consensus 503 ~~~~~~~~~~~~f~~~~~L-----G~G~~G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv--~l~ 575 (834)
.+.+++.....+|.+.+.. ..|---+.|+.+..+| .+++|+..... ..+++..|+.++..+.+.++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 3445666666778765443 4565678899887655 58999986532 224555677777777533221 111
Q ss_pred ------eEEEecCeEEEEEeecCCCCcccccc--------------------CCCCCCc------------------CCH
Q 003280 576 ------GCCVEQGEKILILEYMPNKSLDVFLF--------------------DPTKKRL------------------LGW 611 (834)
Q Consensus 576 ------~~~~~~~~~~lV~Ey~~~gsL~~~l~--------------------~~~~~~~------------------l~~ 611 (834)
.+.........++.+..+........ ....... ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 11223445667777776654422110 0000000 000
Q ss_pred HHHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCcEEEcCCCCceeeeecceee
Q 003280 612 QARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664 (834)
Q Consensus 612 ~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 664 (834)
......+..+...+...+.. -+..+||+|+.++||+++.+...-|+||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 11112222222223322221 234599999999999999887778999999864
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.71 E-value=0.09 Score=32.99 Aligned_cols=32 Identities=31% Similarity=0.609 Sum_probs=25.7
Q ss_pred CcCCCCCCCCCCcccCCC-CCCccccccCcccCC
Q 003280 286 EYCGKYGYCGANTICSPD-QKPICECLEGFKLKS 318 (834)
Q Consensus 286 ~~C~~~g~CG~~giC~~~-~~~~C~C~~Gf~~~~ 318 (834)
|.|.+-..|| +|.|++- ..-.|.|-.||+|..
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 6799999998 6889754 334699999999875
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.47 E-value=0.22 Score=33.37 Aligned_cols=32 Identities=22% Similarity=0.521 Sum_probs=24.7
Q ss_pred CcCCC-CCCCCCCcccCCC-CCCccccccCcccC
Q 003280 286 EYCGK-YGYCGANTICSPD-QKPICECLEGFKLK 317 (834)
Q Consensus 286 ~~C~~-~g~CG~~giC~~~-~~~~C~C~~Gf~~~ 317 (834)
+.|.. ...|..+|.|... ..-.|.|++||+-.
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYTGP 37 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEEST
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCcCC
Confidence 56775 5789999999854 34579999999743
|